When	O
CSF	O
[	O
HCO3	O
-]	O
is	O
shown	O
as	O
a	O
function	O
of	O
CSF	O
PCO2	O
the	O
data	O
of	O
K	O
-	O
depleted	O
rats	O
are	O
no	O
longer	O
displaced	O
when	O
compared	O
to	O
controls	O
but	O
still	O
have	O
a	O
significantly	O
greater	O
slope	O
(	O
1	O
.	O
21	O
+/-	O
0	O
.	O
23	O
vs	O
.	O

Beta	O
blocking	O
agents	O
.	O

When	O
extracorporeal	O
CO2	O
removal	O
approximated	O
CO2	O
production	O
(	O
VCO2	O
),	O
alveolar	O
ventilation	O
almost	O
ceased	O
.	O

When	O
the	O
CO2	O
content	O
reached	O
9	O
Vol	O
%	O
the	O
animals	O
became	O
apathic	O
and	O
lost	O
body	O
weight	O
.	O

With	O
the	O
exception	O
of	O
virus	O
assay	O
and	O
quantitation	O
,	O
these	O
methods	O
are	O
simple	O
and	O
inexpensive	O
enough	O
to	O
be	O
done	O
in	O
typical	O
shellfish	O
microbiology	O
laboratories	O
.	O

Takayasu	O
'	O
s	O
disease	O
:	O
association	O
with	O
HLA	B
-	I
B5	I
.	O

SGPT	B
,	O
SGOT	B
,	O
and	O
alkaline	B
phosphatase	I
concentrations	O
were	O
essentially	O
normal	O
in	O
all	O
subjects	O
.	O

Of	O
600	O
mediastinoscopies	O
carried	O
out	O
from	O
1966	O
to	O
1973	O
,	O
479	O
were	O
performed	O
to	O
assess	O
the	O
operability	O
of	O
a	O
pulmonary	O
carcinoma	O
.	O

A	O
mixture	O
of	O
human	B
albumin	I
5	O
%	O
and	O
hydroxy	O
-	O
ethyl	O
-	O
starch	O
was	O
used	O
as	O
a	O
solution	O
for	O
dilution	O
.	O

False	O
positive	O
amniotic	B
fluid	I
alpha	I
fetoprotein	I
levels	O
resulting	O
from	O
contamination	O
with	O
fetal	O
blood	O
:	O
results	O
of	O
an	O
experiment	O
.	O

Thirty	O
-	O
five	O
strains	O
of	O
Legionnaires	O
'	O
disease	O
bacteria	O
were	O
shown	O
to	O
belong	O
in	O
four	O
distinct	O
serologic	O
groups	O
on	O
the	O
basis	O
of	O
findings	O
obtained	O
with	O
direct	O
fluorescent	O
antibody	O
testing	O
.	O

On	O
the	O
other	O
hand	O
factor	B
IX	I
activity	O
is	O
decreased	O
in	O
coumarin	O
treatment	O
with	O
factor	B
IX	I
antigen	O
remaining	O
normal	O
.	O

T4	O
and	O
FT4I	O
followed	O
parallel	O
courses	O
in	O
both	O
groups	O
;	O
during	O
the	O
first	O
45	O
days	O
,	O
however	O
,	O
the	O
values	O
were	O
significantly	O
lower	O
in	O
premature	O
infants	O
under	O
34	O
weeks	O
'	O
EGA	O
than	O
in	O
term	O
infants	O
(	O
P	O
less	O
than	O
0	O
.	O
001	O
).	O

These	O
results	O
indicate	O
that	O
cynomolgus	O
monkeys	O
are	O
either	O
less	O
sensitive	O
or	O
respond	O
differently	O
than	O
rhesus	O
monkeys	O
to	O
some	O
of	O
the	O
pharmacological	O
effects	O
of	O
norcocaine	O
.	O

The	O
present	O
research	O
evaluated	O
the	O
possibility	O
that	O
polyethylene	O
glycol	O
400	O
(	O
PEG	O
400	O
)	O
might	O
be	O
efficacious	O
,	O
toxic	O
,	O
or	O
both	O
.	O

In	O
this	O
animal	O
,	O
infected	O
with	O
what	O
was	O
judged	O
previously	O
to	O
be	O
the	O
less	O
virulent	O
of	O
the	O
two	O
T	O
.	O
cruzi	O
stocks	O
used	O
('	O
strain	O
7	O
'),	O
there	O
was	O
severe	O
myocarditis	O
,	O
with	O
myofibre	O
degeneration	O
,	O
and	O
lesions	O
of	O
the	O
oesophagus	O
.	O

The	O
majority	O
of	O
tumors	O
occurred	O
in	O
the	O
nasal	O
cavities	O
,	O
although	O
significant	O
incidences	O
were	O
also	O
found	O
in	O
the	O
larynx	O
,	O
trachea	O
and	O
stem	O
bronchi	O
.	O

The	O
carcass	O
of	O
a	O
great	O
horned	O
owl	O
(	O
Bubo	O
virginianus	O
),	O
which	O
had	O
been	O
found	O
moribund	O
in	O
southern	O
Ontario	O
,	O
was	O
presented	O
for	O
necropsy	O
.	O

EEG	O
theta	O
waves	O
and	O
psychological	O
phenomena	O
:	O
a	O
review	O
and	O
analysis	O
.	O

Innervation	O
of	O
the	O
ventral	O
diaphragm	O
of	O
the	O
locust	O
(	O
Locusta	O
migratoria	O
).	O

Efforts	O
were	O
made	O
to	O
determine	O
the	O
amount	O
of	O
time	O
required	O
for	O
kidney	O
lesions	O
to	O
develop	O
and	O
,	O
if	O
possible	O
,	O
to	O
delineate	O
the	O
potential	O
site	O
of	O
action	O
of	O
PBB	O
.	O

In	O
both	O
these	O
respects	O
,	O
however	O
,	O
the	O
DBP	B
mRNA	I
resembles	O
the	O
late	O
messengers	O
of	O
SV40	O
and	O
polyoma	O
viruses	O
.	O

Anatomy	O
of	O
the	O
RNA	O
and	O
gene	O
products	O
of	O
MC29	O
and	O
MH2	O
,	O
two	O
defective	O
avian	O
tumor	O
viruses	O
causing	O
acute	O
leukemia	O
and	O
carcinoma	O
:	O
evidence	O
for	O
a	O
new	O
class	O
of	O
transforming	O
genes	O
.	O

Bertioga	O
(	O
Guama	O
group	O
)	O
and	O
Anhembi	O
(	O
Bunyamwera	O
group	O
),	O
two	O
new	O
arboviruses	O
isolated	O
in	O
Sao	O
Paulo	O
,	O
Brazil	O
.	O

Dopamine	B
receptor	I
blockade	O
and	O
the	O
neuroleptics	O
,	O
a	O
crystallographic	O
study	O
.	O

The	O
'	O
field	O
of	O
stress	O
'	O
of	O
the	O
supervisory	O
nurse	O

Here	O
the	O
conventional	O
tests	O
clearly	O
pointed	O
to	O
the	O
presence	O
of	O
retrocochlear	O
disease	O
.	O

The	O
uterine	O
response	O
to	O
prostaglandin	O
E2	O
(	O
PGE2	O
)	O
and	O
prostaglandin	O
F2alpha	O
(	O
administered	O
by	O
intravenous	O
and	O
intrauterine	O
routes	O
)	O
was	O
evaluated	O
during	O
different	O
phases	O
of	O
the	O
menstrual	O
cycle	O
in	O
five	O
functionally	O
infertile	O
women	O
.	O

The	O
response	O
of	O
serum	B
GH	I
to	O
arginine	O
infusion	O
was	O
normal	O
,	O
while	O
that	O
to	O
insulin	B
-	O
induced	O
hypoglycemia	O
was	O
poor	O
.	O

Williams	O
,	O
2	O
August	O
1977	O
.	O

Disrupted	O
vaccines	O
and	O
whole	O
-	O
virus	O
vaccines	O
containing	O
type	B
B	I
antigen	I
only	O
did	O
not	O
cause	O
significant	O
reactivity	O
.	O

255	O
-	O
61	O
.	O

Adriamycin	O
:	O
comparison	O
of	O
a	O
5	O
-	O
week	O
schedule	O
with	O
a	O
3	O
-	O
week	O
schedule	O
in	O
the	O
treatment	O
of	O
breast	O
cancer	O
.	O

Renin	B
studies	O
performed	O
in	O
34	O
hypertensive	O
patients	O
and	O
in	O
a	O
control	O
group	O
of	O
11	O
recipients	O
showed	O
that	O
elevation	O
of	O
plasma	B
renin	I
activity	O
and	O
of	O
plasma	O
aldosterone	O
level	O
is	O
frequent	O
but	O
difficult	O
to	O
interpret	O
,	O
particularly	O
when	O
a	O
renal	O
artery	O
stenosis	O
is	O
observed	O
.	O

In	O
this	O
article	O
,	O
the	O
clinical	O
actions	O
of	O
the	O
principal	O
dopamine	B
receptor	I
stimulating	O
agents	O
(	O
apomorphine	O
and	O
its	O
derivatives	O
;	O
piribedil	O
,	O
rye	O
-	O
ergot	O
derivatives	O
)	O
are	O
discussed	O
on	O
the	O
basis	O
of	O
their	O
biochemical	O
and	O
pharmacological	O
properties	O
.	O

Seventy	O
-	O
one	O
percent	O
of	O
patients	O
treated	O
with	O
ticarcillin	O
alone	O
responded	O
favorably	O
.	O

Neomycin	O
is	O
fairly	O
effective	O
against	O
staphylococci	O
,	O
less	O
effective	O
against	O
streptococci	O
,	O
and	O
fairly	O
effective	O
against	O
gram	O
-	O
negative	O
intestinal	O
organisms	O
.	O

Changes	O
in	O
tissue	O
PCO2	O
were	O
less	O
dramatic	O
and	O
did	O
not	O
vary	O
significantly	O
from	O
those	O
recorded	O
in	O
venous	O
blood	O
.	O

As	O
authorized	O
by	O
the	O
World	O
Health	O
Organization	O
29th	O
Expert	O
Committee	O
on	O
Biological	O
Standardization	O
,	O
the	O
preparation	O
of	O
human	B
prolactin	I
in	O
ampoules	O
coded	O
75	O
/	O
504	O
has	O
been	O
established	O
as	O
the	O
International	O
Reference	O
Preparation	O
(	O
IRP	O
)	O
of	O
human	B
prolactin	I
for	O
immunoassay	O
.	O

i	O
.	O

Plasma	O
ion	O
changes	O
in	O
venous	O
blood	O
incubated	O
with	O
beta	B
receptor	I
blockers	O
and	O
subjected	O
to	O
tonometry	O
in	O
vitro	O
.	O

The	O
systolic	O
pressure	O
gradient	O
(	O
SPG	O
)	O
between	O
the	O
left	O
ventricle	O
(	O
LV	O
)	O
and	O
left	O
atrium	O
(	O
LA	O
)	O
was	O
obtained	O
from	O
high	O
-	O
fidelity	O
pressure	O
transducers	O
.	O

On	O
the	O
basis	O
of	O
a	O
patient	O
'	O
s	O
report	O
of	O
one	O
inaccurate	O
Clinitemp	O
,	O
we	O
undertook	O
to	O
investigate	O
the	O
accuracy	O
of	O
this	O
thermometer	O
.	O

Ultimate	O
strengthes	O
seem	O
to	O
be	O
reached	O
for	O
cast	O
cobalt	O
alloys	O
,	O
whereas	O
titanium	O
alloys	O
,	O
such	O
as	O
Ta	O
6	O
V	O
,	O
present	O
very	O
high	O
fatigue	O
limit	O
under	O
corrosion	O
.	O

A	O
rise	O
of	O
hemoglobin	B
concentration	O
accompanied	O
by	O
an	O
increase	O
of	O
the	O
total	O
iron	O
in	O
the	O
blood	O
serum	O
of	O
white	O
mice	O
was	O
found	O
under	O
oxygen	O
pressure	O
of	O
4	O
atm	O
for	O
an	O
hour	O
(	O
preconvulsive	O
state	O
)	O
and	O
6	O
atm	O
(	O
convulsive	O
state	O
).	O

Efficacy	O
of	O
a	O
three	O
-	O
versus	O
a	O
five	O
-	O
week	O
alcohol	O
treatment	O
program	O
.	O

In	O
case	O
of	O
a	O
pathologically	O
convoluted	O
internal	O
carotid	O
the	O
common	O
carotid	O
artery	O
was	O
resected	O
with	O
an	O
end	O
-	O
to	O
-	O
end	O
anastomosis	O
.	O

Their	O
conduction	O
velocity	O
ranged	O
from	O
0	O
.	O
23	O
to	O
0	O
.	O
98	O
m	O
/	O
sec	O
(	O
group	O
C	O
).	O

It	O
has	O
come	O
out	O
that	O
CAEC	O
is	O
between	O
CC	O
and	O
CIEC	O
and	O
that	O
attacks	O
of	O
biliary	O
fever	O
and	O
high	O
levels	O
of	O
alkaline	B
phosphatase	I
and	O
transaminases	O
in	O
the	O
serum	O
are	O
the	O
helpful	O
findings	O
for	O
preoperative	O
diagnosis	O
.	O

The	O
sub	O
-	O
acute	O
inhalation	O
toxicity	O
of	O
furfural	O
was	O
studied	O
in	O
Syrian	O
golden	O
hamsters	O
.	O

The	O
present	O
study	O
examined	O
the	O
dependence	O
of	O
difference	O
tone	O
level	O
[	O
L	O
(	O
f2	O
-	O
f1	O
)]	O
on	O
the	O
following	O
parameters	O
of	O
the	O
two	O
-	O
tone	O
input	O
:	O
f1	O
,	O
f2	O
/	O
f1	O
(	O
f2	O
greater	O
than	O
f1	O
),	O
L1	O
,	O
L2	O
,	O
and	O
L1	O
=	O
L2	O
.	O

All	O
13	O
patients	O
showed	O
endoscopic	O
evidence	O
of	O
oesophagitis	O
,	O
moderate	O
in	O
4	O
and	O
severe	O
in	O
9	O
.	O

On	O
the	O
role	O
of	O
transferrin	B
in	O
the	O
uptake	O
of	O
gallium	O
by	O
tumor	O
cells	O
.	O

Changes	O
in	O
ionic	O
content	O
of	O
the	O
mucous	O
suggest	O
that	O
cholinergic	O
mechanisms	O
affect	O
pressure	O
in	O
the	O
excretory	O
duct	O
of	O
the	O
gland	O
.	O

Guinea	O
pigs	O
weighing	O
300	O
approximately	O
350	O
g	O
were	O
used	O
.	O

Under	O
halothane	O
anesthesia	O
,	O
the	O
flow	O
pneumocardiogram	O
(	O
PnCG	O
)	O
and	O
its	O
time	O
derivative	O
(	O
acceleration	O
pneumocardiogram	O
or	O
dPn	O
/	O
dt	O
)	O
were	O
transduced	O
during	O
apnea	O
by	O
a	O
small	O
high	O
-	O
gain	O
pneumotachograph	O
.	O

A	O
highly	O
significant	O
correlation	O
was	O
found	O
between	O
the	O
presence	O
of	O
fibrinolytic	O
degradation	O
products	O
(	O
FDP	O
)	O
and	O
the	O
incidence	O
of	O
nephropathy	O
and	O
renal	O
insufficiency	O
,	O
as	O
well	O
as	O
between	O
the	O
presence	O
of	O
fibrin	B
monomers	I
(	O
Godal	O
'	O
s	O
ethanol	O
-	O
gelification	O
test	O
)	O
and	O
the	O
evolutive	O
signs	O
of	O
the	O
primary	O
disease	O
(	O
fever	O
,	O
accelerated	O
ESR	O
).	O

Serum	O
levels	O
of	O
IgG	B
and	O
IgM	B
were	O
also	O
raised	O
,	O
but	O
contrary	O
to	O
the	O
findings	O
of	O
other	O
observers	O
IgA	B
levels	O
were	O
normal	O
.	O

To	O
study	O
the	O
sensitivity	O
of	O
some	O
central	O
brain	O
structures	O
to	O
the	O
action	O
of	O
an	O
electromagnetic	O
field	O
of	O
decimeter	O
waves	O
(	O
EMF	O
of	O
DW	O
)	O
a	O
dynamic	O
investigation	O
of	O
single	O
unit	O
activity	O
was	O
undertaken	O
.	O

1	O
The	O
effects	O
in	O
normal	O
subjects	O
of	O
a	O
single	O
oral	O
dose	O
of	O
Motival	O
(	O
one	O
tablet	O
,	O
containing	O
fluphenazine	O
0	O
.	O
5	O
mg	O
and	O
nortriptyline	O
10	O
mg	O
)	O
on	O
the	O
contingent	O
negative	O
variation	O
(	O
CNV	O
),	O
reaction	O
time	O
,	O
heart	O
rate	O
,	O
blood	O
pressure	O
and	O
self	O
-	O
rating	O
scales	O
for	O
alertness	O
,	O
anxiety	O
,	O
tension	O
,	O
detachment	O
and	O
depression	O
were	O
compared	O
with	O
those	O
of	O
diazepam	O
(	O
5	O
mg	O
and	O
7	O
.	O
5	O
mg	O
)	O
and	O
placebo	O
or	O
propranolol	O
(	O
60	O
mg	O
).	O

Smoking	O
was	O
regarded	O
as	O
the	O
major	O
contribution	O
to	O
pulmonary	O
dysfunction	O
.	O

Evaluation	O
of	O
the	O
Du	O
Pont	O
aca	O
ammonia	O
procedure	O
.	O

The	O
multiple	O
factors	O
affecting	O
plasma	O
renin	B
activity	O
in	O
essential	O
hypertension	O
.	O

Cortisone	O
induced	O
bone	O
changes	O
and	O
its	O
response	O
to	O
lipid	O
clearing	O
agents	O
.	O

Prevention	O
of	O
acute	O
paraquat	O
toxicity	O
in	O
rats	O
by	O
superoxide	B
dismutase	I
.	O

Increased	O
urinary	O
riboflavin	O
excretion	O
resulting	O
from	O
boric	O
acid	O
ingestion	O
.	O

During	O
the	O
following	O
9	O
1	O
/	O
2	O
years	O
three	O
sequential	O
liver	O
biopsies	O
were	O
performed	O
.	O

Incidental	O
findings	O
in	O
the	O
epidermis	O
and	O
in	O
the	O
intraepidermal	O
eccrine	O
sweat	O
duct	O
units	O
.	O

The	O
effect	O
of	O
pure	O
natural	O
porcine	B
secretin	I
on	O
endocrine	O
and	O
exocrine	O
pancreatic	O
secretion	O
was	O
studied	O
in	O
the	O
totally	O
isolated	O
perfused	O
porcine	O
pancreas	O
.	O

99mTc	O
phytate	O
,	O
198Au	O
colloid	O
,	O
and	O
99mTc	O
antimony	O
sulfide	O
have	O
been	O
used	O
;	O
the	O
last	O
appears	O
to	O
have	O
been	O
the	O
most	O
satisfactory	O
.	O

The	O
mass	O
of	O
UO2	O
in	O
the	O
extrapulmonary	O
bronchi	O
and	O
first	O
bifurcation	O
decreased	O
more	O
slowly	O
over	O
0	O
--	O
8	O
d	O
after	O
inhalation	O
than	O
the	O
corresponding	O
mass	O
on	O
the	O
trachea	O
.	O

It	O
was	O
postulated	O
that	O
persistent	O
challenge	O
by	O
M	O
.	O
leprae	O
or	O
its	O
antigens	O
to	O
the	O
IgA	B
immunocytes	O
of	O
the	O
intestinal	O
epithelium	O
might	O
have	O
induced	O
tolerance	O
leading	O
to	O
IgA	B
deficiency	O
and	O
subsequent	O
subtotal	O
atrophy	O
of	O
the	O
intestinal	O
villi	O
in	O
the	O
patients	O
with	O
lepromatous	O
leprosy	O
.	O

Thyroid	O
disease	O
and	O
pregnancy	O
.	O

Pathogens	O
(	O
Staphylococcus	O
aureus	O
or	O
Gram	O
-	O
negative	O
bacilli	O
)	O
were	O
isolated	O
from	O
only	O
one	O
member	O
of	O
staff	O
in	O
small	O
numbers	O
and	O
irregularly	O
and	O
rarely	O
in	O
large	O
numbers	O
from	O
patients	O
.	O

The	O
results	O
of	O
a	O
quantitative	O
study	O
of	O
vasculosyncytial	O
membranes	O
in	O
123	O
placentas	O
are	O
presented	O
.	O

Platelet	O
serotonin	O
(	O
5	O
-	O
HT	O
)	O
and	O
5	B
-	I
HT	I
releasing	I
factor	I
in	O
plasma	O
of	O
migrainous	O
patients	O
.	O

Biological	O
properties	O
of	O
sumithion	O
.	O

Carcinoembryonic	B
antigen	I
(	O
CEA	B
)	O
procedures	O
and	O
clinical	O
evaluation	O
.	O

On	O
the	O
basis	O
of	O
a	O
global	O
assessment	O
patients	O
showed	O
a	O
highly	O
significant	O
preference	O
for	O
imipramine	O
compared	O
with	O
placebo	O
as	O
adjunctive	O
therapy	O
.	O

Dialyzable	O
transfer	B
factor	I
.	O

Up	O
to	O
now	O
the	O
number	O
of	O
patients	O
examined	O
is	O
about	O
300	O
,	O
additionally	O
6	O
persons	O
who	O
underwent	O
binephrectomy	O
.	O

A	O
new	O
instrument	O
has	O
been	O
designed	O
for	O
freeze	O
-	O
fracturing	O
of	O
biological	O
material	O
in	O
ultra	O
high	O
vacuum	O
.	O

Deaths	O
stopped	O
11	O
hours	O
after	O
copper	O
concentrations	O
decreased	O
below	O
0	O
.	O
2	O
ppm	O
and	O
signs	O
of	O
distress	O
stopped	O
in	O
surviving	O
pinfish	O
by	O
approximately	O
6	O
hours	O
after	O
the	O
last	O
death	O
.	O

Adaptation	O
of	O
taurocholate	O
transport	O
maximum	O
to	O
increased	O
secretory	O
load	O
in	O
the	O
rat	O
.	O

Amikacin	O
was	O
used	O
in	O
the	O
treatment	O
of	O
56	O
serious	O
gram	O
-	O
negative	O
infections	O
in	O
54	O
patients	O
of	O
whom	O
47	O
survived	O
.	O

The	O
data	O
normally	O
available	O
are	O
insufficient	O
and	O
take	O
no	O
account	O
of	O
the	O
direction	O
of	O
recirculation	O
,	O
which	O
may	O
be	O
a	O
determining	O
factor	O
.	O

Estimation	O
of	O
L	O
-	O
alanine	O
in	O
serum	O
or	O
plasma	O
using	O
the	O
LKB	O
reaction	O
rate	O
analyser	O
.	O

Evaluation	O
of	O
the	O
new	O
Gravigard	O
IUCD	O
inserter	O
.	O

The	O
morphological	O
effects	O
of	O
two	O
snake	O
venoms	O
,	O
N	O
.	O
naja	O
and	O
A	O
.	O
piscivorus	O
,	O
and	O
of	O
the	O
Direct	B
Lytic	I
Factor	I
and	O
Phospholipase	B
-	I
A	I
,	O
compounds	O
purified	O
from	O
N	O
.	O
naja	O
crude	O
venom	O
,	O
were	O
investigated	O
on	O
lung	O
and	O
cremaster	O
vessels	O
of	O
rats	O
.	O

Wherever	O
the	O
site	O
of	O
the	O
conditioning	O
stimulation	O
,	O
these	O
modifications	O
disappeared	O
after	O
ischaemia	O
of	O
the	O
leg	O
.	O

The	O
mechanism	O
by	O
which	O
large	O
molecules	O
,	O
such	O
as	O
the	O
diphosphonate	O
99mTc	O
-	O
labeled	O
EHDP	O
or	O
99mTc	O
-	O
labeled	O
pyrophosphate	O
,	O
pass	O
through	O
capillaries	O
in	O
bone	O
is	O
by	O
passive	O
diffusion	O
.	O

Twenty	O
-	O
nine	O
days	O
after	O
injection	O
of	O
5	O
.	O
8	O
mCi	O
of	O
Tc	O
-	O
99m	O
,	O
which	O
gives	O
28	O
rads	O
to	O
the	O
testis	O
,	O
the	O
number	O
of	O
sperm	O
hads	O
decreased	O
to	O
70	O
%	O
of	O
control	O
.	O

The	O
prevalence	O
of	O
hepatitis	B
B	I
surface	I
antigen	I
(	O
HBsAg	B
)	O
and	O
anti	B
-	I
HBs	I
was	O
determined	O
by	O
a	O
sensitive	O
double	O
-	O
antibody	O
radio	O
-	O
immunoassay	O
technique	O
in	O
a	O
series	O
of	O
patients	O
with	O
chronic	O
liver	O
diseases	O
.	O

Biological	O
evaluation	O
of	O
mibolerone	O
in	O
the	O
female	O
Beagle	O
.	O

Levels	O
of	O
both	O
PGF	O
and	O
PGFM	O
were	O
significantly	O
higher	O
during	O
early	O
spontaneous	O
labour	O
,	O
at	O
a	O
cervical	O
dilatation	O
of	O
less	O
than	O
4	O
cm	O
,	O
than	O
before	O
the	O
onset	O
of	O
labour	O
.	O

Propranolol	O
(	O
Inderal	O
)	O
administered	O
in	O
a	O
dose	O
which	O
blocks	O
the	O
beta	O
-	O
adrenergic	O
apparatus	O
of	O
the	O
heart	O
prevents	O
the	O
development	O
of	O
the	O
positive	O
inotropic	O
effect	O
of	O
therapeutic	O
doses	O
of	O
strophanthin	O
K	O
on	O
a	O
hypodynamic	O
left	O
ventricular	O
myocardium	O
.	O

Recent	O
studies	O
have	O
shown	O
the	O
rat	O
larynx	O
to	O
be	O
an	O
important	O
organ	O
in	O
the	O
evaluation	O
of	O
irritancy	O
of	O
inhaled	O
materials	O
.	O

The	O
performance	O
of	O
three	O
commonly	O
used	O
chemical	O
cartridge	O
respirators	O
for	O
SO2	O
was	O
measured	O
under	O
working	O
conditions	O
in	O
a	O
copper	O
smelter	O
.	O

Stimulation	O
of	O
macrophage	O
function	O
by	O
killed	O
Bordetella	O
pertussis	O
cells	O
did	O
not	O
show	O
any	O
beneficial	O
effect	O
as	O
an	O
increased	O
susceptibility	O
became	O
apparent	O
.	O

Primary	O
amenorrhoea	O
in	O
a	O
phenotypically	O
female	O
individual	O
with	O
a	O
karyotype	O
46	O
,	O
xy	O
and	O
bilateral	O
gonadoblastoma	O

Toward	O
absolute	O
methods	O
in	O
clinical	O
chemistry	O
:	O
application	O
of	O
mass	O
fragmentography	O
to	O
high	O
-	O
accuracy	O
analyses	O
.	O

Application	O
of	O
the	O
2	O
-	O
deoxy	O
-	O
D	O
-	O
glucose	O
method	O
to	O
the	O
coupling	O
of	O
cerebral	O
metabolism	O
and	O
blood	O
flow	O
.	O

Serum	O
gastrin	B
levels	O
did	O
not	O
change	O
in	O
either	O
group	O
;	O
however	O
,	O
background	O
serum	O
gastrin	B
concentrations	O
were	O
significantly	O
greater	O
for	O
V	O
&	O
P	O
patients	O
than	O
V	O
&	O
A	O
patients	O
throughout	O
the	O
study	O
.	O

Efferent	O
projections	O
of	O
the	O
ventral	O
portion	O
of	O
the	O
putamen	O
to	O
the	O
frontal	O
,	O
parietal	O
and	O
temporal	O
regions	O
of	O
the	O
cat	O
cerebral	O
cortex	O

State	O
of	O
the	O
body	O
in	O
disorders	O
of	O
diurnal	O
physiological	O
rhythms	O
and	O
long	O
-	O
term	O
hypokinesia	O

Effect	O
of	O
trauma	O
on	O
plasma	B
glucagon	I
and	O
insulin	B
concentrations	O
in	O
sheep	O
.	O

Effect	O
of	O
indomethacin	O
on	O
coronary	O
circulation	O
:	O
effect	O
on	O
ECG	O
tracing	O

The	O
color	O
-	O
word	O
interference	O
effect	O
previously	O
reported	O
with	O
normal	O
populations	O
when	O
given	O
the	O
Stroop	O
test	O
was	O
demonstrated	O
for	O
this	O
retarded	O
sample	O
using	O
a	O
special	O
format	O
.	O

No	O
difference	O
in	O
the	O
clinical	O
acceptability	O
could	O
be	O
ascertained	O
between	O
the	O
two	O
groups	O
.	O

Plethysmographic	O
technique	O
and	O
indirect	O
blood	O
pressure	O
recordings	O
were	O
used	O
.	O

Lymphocyte	O
subpopulations	O
,	O
serum	B
IgE	I
and	O
total	O
eosinophil	O
counts	O
in	O
patients	O
with	O
bronchial	O
asthma	O
.	O

A	O
comparison	O
of	O
physical	O
and	O
cytogenetic	O
estimates	O
of	O
radiation	O
dose	O
in	O
patients	O
treated	O
with	O
iodine	O
-	O
131	O
for	O
thyroid	O
carcinoma	O
.	O

Assessment	O
of	O
the	O
carcinogenicity	O
of	O
non	O
-	O
nutritive	O
sweetners	O
II	O
:	O
Cyclamates	O
and	O
cyclohexylamine	O
.	O

The	O
discordant	O
behaviour	O
in	O
weakly	O
infected	O
mice	O
was	O
due	O
to	O
the	O
occurrence	O
in	O
some	O
animals	O
of	O
a	O
second	O
phase	O
of	O
more	O
rapid	O
increase	O
of	O
the	O
parasitemia	O
.	O

Following	O
intravenous	O
administration	O
,	O
the	O
myocardial	O
concentration	O
of	O
tracer	O
thallium	O
-	O
201	O
,	O
potassium	O
-	O
43	O
,	O
and	O
rubidium	O
-	O
81	O
were	O
determined	O
in	O
mice	O
;	O
thallium	O
was	O
present	O
in	O
the	O
greatest	O
concentration	O
in	O
the	O
myocardium	O
(	O
2	O
.	O
08	O
%	O
compared	O
1	O
.	O
25	O
%	O
for	O
potassium	O
and	O
1	O
.	O
15	O
%	O
for	O
rubidium	O
at	O
10	O
minutes	O
).	O

The	O
authors	O
describe	O
the	O
technique	O
of	O
transverse	O
axial	O
tomography	O
of	O
the	O
spine	O
and	O
give	O
a	O
detailed	O
description	O
of	O
the	O
axial	O
anatomy	O
of	O
the	O
normal	O
lumbar	O
spine	O
from	O
L	O
-	O
4	O
to	O
the	O
sacrum	O
.	O

Risk	O
of	O
infection	O
in	O
the	O
treatment	O
of	O
fractures	O

The	O
American	O
Burkitt	O
Lymphoma	O
Registry	O
:	O
a	O
progress	O
report	O
.	O

The	O
mean	O
plasma	O
sodium	O
concentration	O
which	O
was	O
135	O
.	O
95	O
(+/-	O
SD	O
4	O
.	O
14	O
)	O
mEq	O
/	O
kg	O
before	O
diuretic	O
treatment	O
was	O
significantly	O
decreased	O
during	O
treatment	O
to	O
129	O
.	O
19	O
(+/-	O
SD	O
2	O
.	O
77	O
)	O
mEq	O
/	O
kg	O
,	O
P	O
less	O
than	O
0	O
.	O
001	O
.	O

The	O
eluting	O
solvent	O
was	O
methanol	O
-	O
chloroform	O
(	O
10	O
+	O
90	O
)	O
at	O
a	O
flow	O
rate	O
of	O
2	O
.	O
0	O
ml	O
/	O
min	O
.	O

The	O
attainment	O
of	O
sexual	O
maturity	O
in	O
terms	O
of	O
secondary	O
sexual	O
characteristics	O
,	O
the	O
production	O
of	O
spermatozoa	O
in	O
the	O
male	O
,	O
and	O
the	O
cyclical	O
female	O
pattern	O
with	O
release	O
of	O
ova	O
are	O
end	O
-	O
points	O
of	O
the	O
developmental	O
process	O
.	O

This	O
reveals	O
a	O
new	O
test	O
for	O
short	O
saphenous	O
incompetence	O
and	O
shows	O
that	O
14	O
per	O
cent	O
of	O
varices	O
stem	O
from	O
a	O
saphenopopliteal	O
reflux	O
.	O

Air	O
ion	O
action	O
on	O
bacteria	O
.	O

No	O
evidence	O
of	O
either	O
positive	O
or	O
negative	O
chemography	O
was	O
found	O
.	O

Study	O
of	O
the	O
physico	O
-	O
chemical	O
state	O
of	O
plutonium	O
-	O
239	O
in	O
a	O
citrate	O
solution	O
-	O
blood	O
system	O

2	O
-	O
Chemical	O
occlusion	O
of	O
vas	O
is	O
quite	O
effective	O
in	O
producing	O
a	O
block	O
in	O
the	O
vas	O
deferens	O
of	O
dogs	O
.	O

Experimental	O
cardiotoxicity	O
of	O
adriamycin	O

(	O
5	O
)	O
An	O
increase	O
in	O
leukocyte	O
-	O
counts	O
occurred	O
on	O
the	O
administration	O
of	O
serum	O
obtained	O
from	O
rabbit	O
during	O
phase	O
-	O
2	O
.	O

The	O
results	O
obtained	O
tend	O
to	O
prove	O
that	O
the	O
reticuloendothelial	O
system	O
mainly	O
participated	O
in	O
beryllium	O
retention	O
.	O

In	O
both	O
cases	O
,	O
at	O
the	O
end	O
of	O
exposure	O
the	O
same	O
level	O
of	O
blood	B
carboxyhemoglobin	I
(	O
COHb	B
)	O
(	O
about	O
50	O
%)	O
was	O
reached	O
.	O

Her	O
serum	O
FT3	O
concentration	O
was	O
,	O
however	O
,	O
much	O
higher	O
than	O
the	O
ranges	O
in	O
normal	O
pregnancy	O
or	O
in	O
GTD	O
patients	O
without	O
clinical	O
hyperthyroidism	O
.	O

The	O
cochlear	O
compromise	O
.	O

The	O
study	O
of	O
calcium	O
metabolism	O
in	O
ten	O
thalassaemic	O
children	O
comperatively	O
with	O
controls	O
after	O
oral	O
administration	O
of	O
47Ca	O
has	O
shown	O
diminished	O
intestinal	O
absorption	O
.	O

The	O
authors	O
report	O
the	O
results	O
of	O
a	O
series	O
of	O
toxicological	O
tests	O
conducted	O
on	O
plastic	O
materials	O
(	O
polyethylene	O
)	O
activated	O
with	O
tetraphenylbutadiene	O
(	O
TPB	O
)	O
an	O
additive	O
recently	O
proposed	O
as	O
a	O
sensitizer	O
capable	O
of	O
photodegrading	O
plastic	O
materials	O
.	O

One	O
site	O
,	O
PAL	B
,	O
occurs	O
within	O
the	O
10	O
bp	O
sequence	O
GGGGAGGAGG	O
.	O

Treatment	O
and	O
staining	O
of	O
smears	O
and	O
sections	O
for	O
detection	O
of	O
microorganisms	O

Gene	O
constructs	O
consisting	O
of	O
human	B
growth	I
hormone	I
(	O
hGH	B
)	O
gene	O
driven	O
by	O
promoter	O
/	O
regulatory	O
sequence	O
of	O
mouse	B
metallothionein	I
(	O
mMT	B
),	O
viral	B
thymidine	I
kinase	I
(	O
vTK	B
),	O
rat	B
cholecystokinin	I
(	O
rCCK	B
),	O
or	O
chicken	B
beta	I
-	I
actin	I
(	O
cBA	B
)	O
gene	O
were	O
injected	O
into	O
the	O
cytoplasm	O
of	O
fertilized	O
medaka	O
eggs	O
via	O
the	O
micropyle	O
.	O

The	O
target	O
contained	O
between	O
positions	O
-	O
403	O
and	O
-	O
125	O
acts	O
independently	O
of	O
orientation	O
,	O
in	O
different	O
cell	O
types	O
and	O
species	O
,	O
and	O
in	O
the	O
context	O
of	O
a	O
heterologous	O
promoter	O
.	O

The	O
UCR	O
core	O
sequence	O
,	O
CGCCATTTT	O
,	O
binds	O
a	O
ubiquitous	O
nuclear	O
factor	O
and	O
mediates	O
negative	O
regulation	O
of	O
MuLV	O
promoter	O
activity	O
.	O

Possibly	O
,	O
the	O
scr1	B
-	I
1	I
mutation	I
does	O
not	O
affect	O
signal	O
recognition	O
or	O
translational	O
arrest	O
but	O
instead	O
results	O
in	O
maintenance	O
of	O
translational	O
arrest	O
of	O
AEP	B
synthesis	O
.	O

Both	O
Rep78	B
and	O
Rep68	B
cut	O
the	O
terminal	O
AAV	O
sequence	O
at	O
the	O
same	O
site	O
(	O
nucleotide	O
124	O
).	O

Analysis	O
of	O
the	O
entire	O
16	O
.	O
7	O
-	O
kb	O
mt	O
genome	O
determined	O
that	O
a	O
MDP1	B
mediates	O
cleavage	O
of	O
chick	O
mtDNA	O
in	O
vitro	O
at	O
three	O
H	O
-	O
and	O
two	O
L	O
-	O
strand	O
sequence	O
-	O
specific	O
target	O
sites	O
located	O
within	O
a	O
90	O
-	O
bp	O
A	O
+	O
T	O
-	O
rich	O
genomic	O
tract	O
,	O
theoretically	O
capable	O
of	O
forming	O
stable	O
secondary	O
structures	O
,	O
approximately	O
200	O
bases	O
upstream	O
from	O
the	O
H	O
-	O
strand	O
origin	O
(	O
OH	O
)	O
of	O
replication	O
.	O

The	O
goal	O
of	O
the	O
present	O
study	O
was	O
to	O
determine	O
the	O
feasibility	O
of	O
retrovirus	O
mediated	O
expression	O
of	O
rp47phox	B
in	O
the	O
HL60	O
and	O
U937	O
human	O
hematopoietic	O
cell	O
lines	O
,	O
and	O
in	O
an	O
Epstein	O
-	O
Barr	O
virus	O
transformed	O
B	O
-	O
lymphocyte	O
cell	O
line	O
(	O
EBV	O
-	O
BCL	O
)	O
derived	O
from	O
a	O
p47phox	B
-	O
deficient	O
CGD	O
patient	O
.	O

Analysis	O
of	O
nucleotide	O
sequence	O
of	O
the	O
rightmost	O
43	O
kbp	O
of	O
herpesvirus	O
saimiri	O
(	O
HVS	O
)	O
L	O
-	O
DNA	O
:	O
general	O
conservation	O
of	O
genetic	O
organization	O
between	O
HVS	O
and	O
Epstein	O
-	O
Barr	O
virus	O
.	O

Myogenic	O
differentiation	O
can	O
be	O
inhibited	O
by	O
the	O
adenovirus	O
E1a	B
protein	I
in	O
the	O
rat	O
L6	O
muscle	O
cell	O
line	O
.	O

The	O
DNA	O
sequence	O
of	O
the	O
sulfate	B
activation	I
locus	I
from	O
Escherichia	O
coli	O
K	O
-	O
12	O
has	O
been	O
determined	O
.	O

ROS	B
x	O
SRC	B
(	O
R	B
)	O
contains	O
a	O
16	O
-	O
amino	O
-	O
acid	O
deletion	O
that	O
includes	O
the	O
3	O
'	O
half	O
of	O
the	O
transmembrane	O
domain	O
of	O
ros	B
.	O

The	O
hit1	B
-	I
1	I
mutation	O
caused	O
a	O
defect	O
in	O
synthesis	O
of	O
a	O
74	B
-	I
kD	I
heat	I
shock	I
protein	I
.	O

Intermediate	O
levels	O
of	O
gene	O
activity	O
were	O
observed	O
for	O
TnI	B
enhancers	I
containing	O
E	O
-	O
boxes	O
derived	O
from	O
the	O
MCK	B
left	I
E	I
-	I
box	I
site	I
or	O
from	O
the	O
Ig	B
kappa	I
E2	I
E	I
-	I
box	I
.	O

Lastly	O
,	O
there	O
are	O
multiple	O
instances	O
in	O
which	O
short	O
oligonucleotide	O
direct	O
repeats	O
flank	O
a	O
region	O
absent	O
from	O
either	O
variola	O
or	O
vaccinia	O
virus	O
.	O

Mapping	O
the	O
cAMP	B
receptor	I
protein	I
contact	I
site	I
on	O
the	O
alpha	O
subunit	O
of	O
Escherichia	B
coli	I
RNA	I
polymerase	I
.	O

A	O
major	O
mechanism	O
whereby	O
steroid	B
hydroxylase	I
gene	I
transcription	O
is	O
regulated	O
in	O
the	O
adrenal	O
cortex	O
requires	O
the	O
pituitary	O
peptide	O
hormone	O
,	O
ACTH	B
,	O
which	O
acts	O
via	O
cAMP	O
.	O

A	O
combination	O
of	O
comparative	O
sequence	O
analysis	O
and	O
thermodynamic	O
methods	O
reveals	O
the	O
conservation	O
of	O
tertiary	O
structure	O
elements	O
in	O
the	O
5	O
'	O
untranslated	O
region	O
(	O
UTR	O
)	O
of	O
human	O
enteroviruses	O
and	O
rhinoviruses	O
.	O

Comparison	O
of	O
data	O
obtained	O
with	O
the	O
results	O
of	O
chronic	O
treatment	O
with	O
the	O
opioid	O
antagonist	O
permits	O
to	O
conclude	O
that	O
the	O
chronic	O
blockade	O
increases	O
the	O
fatiguability	O
to	O
a	O
great	O
extent	O
than	O
chronic	O
activation	O
of	O
opioid	O
system	O
.	O

Some	O
research	O
studies	O
have	O
related	O
this	O
kind	O
of	O
tumors	O
with	O
prolonged	O
ingestion	O
of	O
H2	O
inhibitors	O
and	O
others	O
antacid	O
.	O

Mapping	O
of	O
the	O
mouse	B
ornithine	I
decarboxylase	I
-	I
related	I
sequence	I
family	I
.	O

This	O
mutation	O
also	O
results	O
in	O
markedly	O
decreased	O
levels	O
of	O
CAD	B
mRNA	I
and	O
protein	O
in	O
the	O
mutant	O
.	O

In	O
a	O
retrospective	O
analysis	O
of	O
data	O
from	O
35	O
cases	O
with	O
malignant	O
lymphoma	O
from	O
a	O
cohort	O
of	O
2017	O
HIV	O
-	O
infected	O
patients	O
,	O
the	O
stage	O
of	O
HIV	O
-	O
disease	O
,	O
the	O
CD4	B
counts	O
at	O
the	O
time	O
of	O
diagnosis	O
,	O
and	O
the	O
use	O
of	O
antineoplastic	O
agents	O
or	O
radiotherapy	O
were	O
correlated	O
with	O
outcome	O
.	O

The	O
single	O
site	O
of	O
glycosylation	O
is	O
located	O
near	O
the	O
C	O
-	O
terminus	O
in	O
the	O
N	O
-	O
glycosylation	O
sequon	O
-	O
Asn	O
-	O
Cys	O
-	O
Ser	O
-	O
in	O
which	O
Cys	O
forms	O
part	O
of	O
a	O
disulphide	O
bridge	O
.	O

The	O
pulmonary	O
toxic	O
events	O
induced	O
by	O
acute	O
nitrogen	O
dioxide	O
(	O
NO	O
)	O
2	O
exposure	O
were	O
studied	O
in	O
the	O
rat	O
to	O
develop	O
an	O
inhalation	O
model	O
to	O
investigate	O
therapeutic	O
measures	O
.	O

The	O
subunit	O
protein	O
of	O
curli	B
was	O
highly	O
homologous	O
at	O
its	O
amino	O
terminus	O
to	O
SEF	B
-	I
17	I
,	O
the	O
subunit	O
protein	O
of	O
thin	O
,	O
aggregative	O
fimbriae	O
of	O
Salmonella	O
enteritidis	O
27655	O
strain	O
3b	O
,	O
suggesting	O
that	O
these	O
fibres	O
form	O
a	O
novel	O
class	O
of	O
surface	O
organelles	O
on	O
enterobacteria	O
.	O

This	O
computation	O
is	O
performed	O
by	O
a	O
parallel	O
network	O
of	O
locally	O
connected	O
neuron	O
-	O
like	O
elements	O
.	O

Visual	O
acuity	O
may	O
be	O
decreased	O
by	O
transient	O
changes	O
in	O
refractive	O
error	O
caused	O
by	O
sulfonamides	O
,	O
the	O
antifungal	O
agent	O
metronidazole	O
,	O
thiazide	O
diuretics	O
,	O
and	O
carbonic	B
anhydrase	I
inhibitors	O
.	O

In	O
addition	O
,	O
a	O
21	O
-	O
mer	O
subrepeat	O
structure	O
is	O
also	O
present	O
in	O
each	O
unit	O
.	O

In	O
addition	O
,	O
the	O
hGCSFR	B
gene	I
was	O
chromosomally	O
localized	O
by	O
Southern	O
blot	O
analysis	O
of	O
its	O
segregation	O
pattern	O
in	O
a	O
panel	O
of	O
rodent	O
-	O
human	O
hybrid	O
DNAs	O
using	O
the	O
radiolabeled	O
cDNA	O
probe	O
.	O

In	O
summary	O
,	O
the	O
segments	O
of	O
C3	B
represented	O
by	O
amino	O
acid	O
residues	O
1082	O
-	O
1118	O
,	O
1117	O
-	O
1155	O
,	O
1234	O
-	O
1294	O
and	O
1312	O
-	O
1404	O
accommodate	O
C3	B
(	I
D	I
)	I
epitopes	I
that	O
are	O
expressed	O
by	O
erythrocyte	O
-	O
bound	O
C3	B
fragments	I
,	O
but	O
not	O
by	O
the	O
corresponding	O
fluid	O
-	O
phase	O
fragment	O
,	O
whereas	O
the	O
segments	O
spanning	O
residues	O
973	O
-	O
1026	O
and	O
1477	O
-	O
1510	O
contain	O
C3	B
(	I
D	I
)	I
epitopes	I
that	O
are	O
exposed	O
exclusively	O
in	O
denatured	O
C3	B
and	O
therefore	O
hidden	O
in	O
physiological	O
fragments	O
of	O
the	O
protein	O
.	O

These	O
exons	O
,	O
further	O
identified	O
as	O
exons	O
9	O
,	O
10	O
,	O
and	O
11	O
,	O
together	O
encode	O
the	O
37	O
amino	O
acid	O
residues	O
present	O
in	O
alpha	B
s1	I
-	I
casein	I
variant	I
A	I
but	O
missing	O
in	O
variant	O
F	O
.	O

Neither	O
gene	O
possesses	O
a	O
distinct	O
transcriptional	O
start	O
site	O
as	O
shown	O
by	O
nuclease	B
S1	I
analysis	O
.	O

The	O
initial	O
translation	O
protein	O
encoded	O
by	O
the	O
cDNA	O
is	O
53	O
,	O
932	O
kDa	O
and	O
possesses	O
a	O
hydrophilic	O
amino	O
acid	O
composition	O
with	O
glutamic	O
acid	O
comprising	O
22	O
%	O
of	O
the	O
total	O
amino	O
acid	O
residues	O
.	O

Genetic	O
and	O
biochemical	O
evidence	O
suggests	O
that	O
v	B
-	I
Crk	I
can	O
induce	O
transformation	O
of	O
chicken	O
embryo	O
fibroblasts	O
by	O
influencing	O
the	O
activity	O
of	O
cellular	O
proteins	O
involved	O
in	O
growth	O
regulation	O
.	O

Between	O
acoR	B
and	O
acoXABC	B
,	O
two	O
different	O
types	O
of	O
sequences	O
with	O
dual	O
rotational	O
symmetry	O
[	O
CAC	O
-(	O
N11	O
to	O
N18	O
)-	O
GTG	O
and	O
TGT	O
-(	O
N10	O
to	O
N14	O
)-	O
ACA	O
]	O
were	O
found	O
;	O
these	O
sequences	O
are	O
similar	O
to	O
NtrC	B
and	O
NifA	B
upstream	I
activator	I
sequences	I
,	O
respectively	O
.	O

Furthermore	O
it	O
was	O
suggested	O
that	O
FK506	O
plasma	O
levels	O
were	O
concerned	O
with	O
the	O
appearance	O
of	O
side	O
effect	O
.	O

The	O
method	O
requires	O
a	O
reversed	O
-	O
phase	O
column	O
and	O
a	O
paired	O
-	O
ion	O
technique	O
to	O
separate	O
docusate	O
sodium	O
from	O
other	O
components	O
.	O

Comments	O
are	O
given	O
on	O
the	O
present	O
status	O
of	O
regulations	O
concerning	O
water	O
in	O
swimming	O
pools	O
and	O
baths	O
--	O
1991	O
--(	O
in	O
connection	O
with	O
the	O
KOK	O
regulations	O
--	O
1972	O
--	O
and	O
the	O
Federal	O
German	O
standard	O
[	O
DIN	O
]	O
No	O
.	O

The	O
treatment	O
group	O
also	O
showed	O
in	O
vivo	O
T	O
-	O
cell	O
activation	O
with	O
an	O
initial	O
lymphopenia	O
followed	O
by	O
a	O
rebound	O
lymphocytosis	O
and	O
upregulation	O
of	O
the	O
subset	O
markers	O
CD25	B
(	O
interleukin	B
2	I
receptor	I
)	O
and	O
CD45RO	B
(	O
T	O
-	O
memory	O
cells	O
).	O

Our	O
experiments	O
suggest	O
that	O
the	O
SCL	B
gene	I
can	O
be	O
a	O
target	O
for	O
the	O
erythroid	B
transcription	I
factor	I
GATA	I
-	I
1	I
and	O
that	O
the	O
SCL	B
gene	I
product	I
serves	O
as	O
a	O
positive	O
regulator	O
of	O
erythroid	O
differentiation	O
.	O

The	O
RNase	B
MRP	I
RNA	I
gene	I
was	O
deleted	O
by	O
insertional	O
replacement	O
and	O
found	O
to	O
be	O
essential	O
for	O
cellular	O
viability	O
,	O
indicating	O
a	O
critical	O
nuclear	O
role	O
for	O
RNase	B
MRP	I
.	O

Surprisingly	O
,	O
the	O
Xenopus	B
U7	I
gene	I
contains	O
two	O
adjacent	O
octamer	O
-	O
binding	O
motifs	O
located	O
only	O
12	O
and	O
24	O
bp	O
upstream	O
from	O
the	O
PSE	B
,	O
instead	O
of	O
the	O
usual	O
location	O
around	O
150	O
-	O
200	O
bp	O
upstream	O
.	O

These	O
results	O
demonstrate	O
that	O
endogenous	O
N	O
-	O
methylation	O
of	O
salsolinol	O
into	O
N	O
-	O
methylsalsolinol	O
occurs	O
in	O
the	O
brain	O
in	O
vivo	O
.	O

DR1	B
molecules	I
purified	O
from	O
human	O
lymphoblastoid	O
cell	O
lines	O
could	O
specifically	O
bind	O
to	O
these	O
peptide	O
sequences	O
expressed	O
on	O
the	O
phage	O
surface	O
.	O

Chronic	O
hepatitis	O
B	O
in	O
adopted	O
Romanian	O
children	O
.	O

Behind	O
the	O
ATPase	B
cluster	I
,	O
two	O
open	O
reading	O
frames	O
were	O
detected	O
that	O
are	O
not	O
homologous	O
to	O
any	O
known	O
chloroplast	O
gene	O
.	O

However	O
,	O
a	O
cosmid	O
clone	O
containing	O
the	O
entire	O
mouse	B
alpha	I
1	I
(	I
I	I
)	I
gene	I
,	O
including	O
3	O
.	O
7	O
kb	O
of	O
5	O
'-	O
and	O
4	O
kb	O
of	O
3	O
'-	O
flanking	O
DNA	O
,	O
was	O
expressed	O
at	O
reduced	O
levels	O
in	O
fibroblasts	O
overexpressing	O
oncogenic	B
ras	I
.	O

Sequencing	O
analysis	O
has	O
shown	O
that	O
each	O
rap1t	B
allele	I
contains	O
a	O
nonsense	O
mutation	O
within	O
a	O
discrete	O
region	O
between	O
amino	O
acids	O
663	O
and	O
684	O
.	O

By	O
screening	O
a	O
Y1	O
cell	O
cDNA	O
library	O
with	O
the	O
DNA	O
-	O
binding	O
region	O
of	O
the	O
H	B
-	I
2RIIBP	I
nuclear	I
hormone	I
receptor	I
cDNA	I
,	O
we	O
isolated	O
a	O
cDNA	O
that	O
is	O
selectively	O
expressed	O
in	O
steroidogenic	O
cells	O
.	O

Autopsy	O
demonstrated	O
good	O
survival	O
of	O
the	O
transplanted	O
cells	O
with	O
good	O
integration	O
with	O
the	O
brain	O
of	O
the	O
recipient	O
and	O
traces	O
of	O
positive	O
immunocytochemical	O
reaction	O
for	O
tyrosine	B
hydroxylase	I
.	O

We	O
found	O
that	O
both	O
the	O
E26	O
virus	O
-	O
encoded	O
v	B
-	I
ets	I
and	O
the	O
myeloid	B
/	I
B	I
-	I
cell	I
-	I
specific	I
factor	I
PU	I
.	I
1	I
bind	O
efficiently	O
to	O
this	O
site	O
in	O
vitro	O
.	O

In	O
8	O
healthy	O
volunteers	O
there	O
were	O
no	O
significant	O
differences	O
in	O
AUC	O
,	O
peak	O
plasma	O
concentrations	O
or	O
time	O
to	O
peak	O
concentration	O
when	O
OXC	O
was	O
administered	O
either	O
with	O
or	O
without	O
ERY	O
.	O

Thus	O
,	O
chronic	O
hematocrit	O
decrease	O
induced	O
by	O
H	O
or	O
P	O
resulted	O
in	O
a	O
significant	O
fall	O
in	O
blood	O
pressure	O
compared	O
to	O
control	O
(	O
201	O
+/-	O
3	O
v	O
175	O
+/-	O
4	O
,	O
167	O
+/-	O
4	O
mm	O
Hg	O
,	O
respectively	O
;	O
P	O
<	O
.	O
05	O
).	O

A	O
controlled	O
trial	O
of	O
recombinant	B
human	I
granulocyte	I
-	I
macrophage	I
colony	I
-	I
stimulating	I
factor	I
after	O
total	O
body	O
irradiation	O
,	O
high	O
-	O
dose	O
chemotherapy	O
,	O
and	O
autologous	O
bone	O
marrow	O
transplantation	O
for	O
acute	O
lymphoblastic	O
leukemia	O
or	O
malignant	O
lymphoma	O
.	O

These	O
data	O
demonstrate	O
that	O
DMVA	O
does	O
not	O
cause	O
more	O
myocardial	O
trauma	O
than	O
CPB	O
when	O
used	O
to	O
provide	O
resuscitative	O
circulatory	O
support	O
.	O

Examination	O
of	O
ANCA	B
is	O
not	O
only	O
a	O
significant	O
contribution	O
towards	O
a	O
more	O
accurate	O
diagnosis	O
of	O
renal	O
vasculitis	O
,	O
but	O
also	O
an	O
indicator	O
of	O
the	O
activity	O
of	O
the	O
disease	O
and	O
thus	O
of	O
the	O
effectiveness	O
of	O
immunosuppressive	O
treatment	O
.	O

Cicatricial	O
pemphigoid	O
is	O
an	O
autoimmune	O
systemic	O
disease	O
characterized	O
by	O
chronic	O
conjunctival	O
cicatrization	O
.	O

The	O
distinguishing	O
features	O
involved	O
eight	O
amino	O
acid	O
changes	O
,	O
including	O
a	O
single	O
lysine	O
deletion	O
relative	O
to	O
a	O
primate	O
consensus	O
sequence	O
in	O
the	O
first	O
complementary	O
-	O
determing	O
region	O
of	O
V1J1	B
.	O

The	O
highest	O
prevalence	O
of	O
reported	O
pet	O
allergy	O
,	O
chronic	O
cough	O
,	O
wheeze	O
,	O
attacks	O
of	O
shortness	O
of	O
breath	O
with	O
wheezing	O
,	O
and	O
doctor	O
-	O
diagnosed	O
asthma	O
was	O
found	O
in	O
children	O
who	O
had	O
pets	O
in	O
the	O
past	O
but	O
not	O
anymore	O
.	O

It	O
corresponds	O
to	O
the	O
complete	O
mitochondrial	O
presequence	O
and	O
the	O
lipoyl	O
-	O
bearing	O
domain	O
that	O
are	O
encoded	O
by	O
exons	O
I	O
through	O
IV	O
of	O
the	O
functional	O
E2	B
gene	I
.	O

The	O
second	O
method	O
,	O
the	O
"	O
macro	O
"	O
assay	O
,	O
has	O
a	O
sensitivity	O
range	O
of	O
0	O
.	O
03	O
-	O
5	O
.	O
0	O
micrograms	O
phosphorus	O
with	O
100	O
-	O
500	O
microliters	O
HClO4	O
.	O

Nucleotide	O
sequence	O
and	O
transcriptional	O
analysis	O
of	O
the	O
polyhedrin	B
gene	I
of	O
Spodoptera	O
exigua	O
nuclear	O
polyhedrosis	O
virus	O
.	O

As	O
a	O
consequence	O
of	O
dark	O
rearing	O
,	O
the	O
numerical	O
density	O
of	O
cortical	O
neurons	O
in	O
area	O
17	O
amounted	O
to	O
about	O
double	O
of	O
the	O
value	O
observed	O
in	O
normally	O
reared	O
kittens	O
and	O
was	O
also	O
significantly	O
higher	O
in	O
area	O
18	O
.	O

These	O
data	O
indicate	O
that	O
RNK	B
-	I
Met	I
-	I
1	I
is	O
a	O
serine	B
protease	I
with	O
unique	O
activity	O
that	O
is	O
expressed	O
in	O
the	O
granules	O
of	O
large	O
granular	O
lymphocytes	O
.	O

Administration	O
of	O
growth	B
hormone	I
leads	O
to	O
faster	O
growth	O
,	O
but	O
also	O
faster	O
bone	O
maturation	O
.	O

Laboratory	O
studies	O
showed	O
that	O
the	O
direct	O
fluorescent	O
-	O
antibody	O
kits	O
were	O
the	O
least	O
sensitive	O
in	O
this	O
case	O
and	O
did	O
not	O
detect	O
fewer	O
than	O
10	O
(	O
4	O
)	O
elementary	O
bodies	O
per	O
ml	O
,	O
while	O
most	O
ELISA	O
kits	O
detected	O
between	O
130	O
and	O
600	O
elementary	O
bodies	O
per	O
ml	O
.	O

Interestingly	O
,	O
a	O
portion	O
of	O
the	O
tail	O
domain	O
(	O
aa	O
,	O
1	O
,	O
094	O
-	O
1	O
,	O
830	O
)	O
shares	O
58	O
%	O
amino	O
acid	O
sequence	O
identity	O
with	O
a	O
723	O
-	O
aa	O
protein	O
from	O
mouse	O
brain	O
reported	O
to	O
be	O
a	O
glutamic	B
acid	I
decarboxylase	I
.	O

Distribution	O
and	O
changing	O
morphological	O
course	O

The	O
major	O
pathological	O
findings	O
of	O
the	O
placenta	O
were	O
prematuration	O
and	O
hypoplasia	O
.	O

The	O
5	O
'-	O
flanking	O
region	O
of	O
the	O
human	B
lactoferrin	I
gene	I
was	O
isolated	O
from	O
a	O
human	O
placental	O
genomic	O
library	O
.	O

We	O
found	O
that	O
the	O
gene	O
segment	O
containing	O
the	O
mu	O
m	O
poly	O
(	O
A	O
)	O
signals	O
,	O
along	O
with	O
536	O
bp	O
of	O
downstream	O
flanking	O
sequence	O
,	O
acted	O
as	O
a	O
transcription	O
terminator	O
in	O
both	O
myeloma	O
cells	O
and	O
L	O
cell	O
fibroblasts	O
.	O

Dopamine	O
neurons	O
in	O
subjects	O
that	O
received	O
6	O
-	O
OHDA	O
were	O
protected	O
by	O
pre	O
-	O
treatment	O
with	O
GBR	O
-	O
12909	O
.	O

The	O
mean	O
blood	O
flow	O
in	O
the	O
penile	O
foreskin	O
was	O
estimated	O
to	O
be	O
15	O
ml	O
/	O
min	O
/	O
100	O
g	O
and	O
it	O
increased	O
to	O
150	O
-	O
200	O
%	O
after	O
the	O
induction	O
of	O
anesthesia	O
,	O
and	O
then	O
decreased	O
to	O
72	O
%	O
at	O
the	O
tip	O
of	O
the	O
created	O
parameatal	O
foreskin	O
flap	O
.	O

Replacing	O
the	O
aspartic	O
acid	O
with	O
a	O
lysine	O
but	O
not	O
with	O
an	O
alanine	O
or	O
valine	O
residue	O
allowed	O
formation	O
of	O
disulfide	O
-	O
linked	O
dimers	O
.	O

During	O
V	O
-	O
A	O
bypass	O
,	O
hemodynamics	O
were	O
stable	O
.	O

Model	O
predictions	O
were	O
in	O
accord	O
with	O
the	O
nine	O
-	O
year	O
survival	O
experience	O
of	O
women	O
in	O
the	O
HIP	O
trial	O
,	O
and	O
,	O
with	O
the	O
exception	O
of	O
women	O
40	O
-	O
44	O
years	O
old	O
,	O
with	O
HIP	O
data	O
on	O
18	O
-	O
year	O
survival	O
.	O

Previously	O
,	O
we	O
showed	O
that	O
SNF2	B
,	O
SNF5	B
,	O
and	O
SNF6	B
function	O
interdependently	O
in	O
transcriptional	O
activation	O
,	O
possibly	O
forming	O
a	O
heteromeric	O
complex	O
.	O

George	O
T	O
.	O

Selected	O
topics	O
in	O
pediatric	O
ultrasonography	O
--	O
1992	O
.	O

Factors	O
associated	O
with	O
afterdrop	O
included	O
age	O
,	O
end	O
-	O
of	O
-	O
surgery	O
temperature	O
(	O
both	O
positively	O
)	O
and	O
body	O
mass	O
(	O
negatively	O
).	O

Thus	O
,	O
this	O
study	O
provides	O
evidence	O
that	O
a	O
novel	O
,	O
ubiquitous	O
factor	O
(	O
HF	B
-	I
1a	I
)	O
and	O
a	O
muscle	O
factor	O
(	O
HF	B
-	I
1b	I
/	O
MEF	B
-	I
2	I
)	O
can	O
form	O
a	O
novel	O
,	O
E	O
-	O
box	O
-	O
independent	O
pathway	O
for	O
muscle	O
-	O
specific	O
expression	O
in	O
ventricular	O
cardiac	O
muscle	O
cells	O
.	O

Estrogen	O
replacement	O
therapy	O
and	O
risk	O
of	O
breast	O
cancer	O
:	O
results	O
of	O
two	O
meta	O
-	O
analyses	O
.	O

Mature	B
tobacco	I
L12	I
protein	I
has	O
44	O
%	O
amino	O
acid	O
identity	O
with	O
ribosomal	O
protein	O
L7	B
/	O
L12	B
of	O
Escherichia	O
coli	O
.	O

Because	O
single	O
-	O
chamber	O
rate	O
-	O
adaptive	O
atrial	O
pacing	O
leaves	O
the	O
patient	O
exposed	O
to	O
the	O
risk	O
of	O
future	O
development	O
of	O
AV	O
block	O
and	O
DDD	O
pacing	O
does	O
not	O
provide	O
chronotropic	O
support	O
,	O
it	O
is	O
likely	O
that	O
the	O
new	O
rate	O
-	O
adaptive	O
dual	O
-	O
chamber	O
(	O
DDDR	O
)	O
devices	O
will	O
be	O
used	O
in	O
a	O
significant	O
number	O
of	O
these	O
patients	O
.(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

The	O
p130	B
and	O
p62	B
tyrosine	O
-	O
phosphorylated	O
proteins	O
that	O
complexed	O
v	B
-	I
Src	I
SH2	I
in	O
vitro	O
also	O
associated	O
with	O
v	B
-	I
Src	I
in	O
v	B
-	I
src	I
-	O
transformed	O
Rat	O
-	O
2	O
cells	O
;	O
this	O
in	O
vivo	O
binding	O
was	O
dependent	O
on	O
the	O
v	B
-	I
Src	I
SH2	I
domain	O
.	O

These	O
data	O
support	O
a	O
possible	O
biological	O
significance	O
of	O
the	O
frameshift	O
to	O
occur	O
at	O
this	O
position	O
of	O
the	O
large	O
overlap	O
by	O
including	O
the	O
putative	O
RNA	O
template	O
-	O
binding	O
site	O
of	O
the	O
PLRV	B
replicase	I
in	O
the	O
ORF2a	B
/	I
ORF2b	I
transframe	I
protein	I
.	O

Proprotein	O
processing	O
occurs	O
intracellularly	O
.	O

The	O
Caenorhabditis	B
elegans	I
vitellogenin	I
genes	I
are	O
subject	O
to	O
sex	O
-,	O
stage	O
-,	O
and	O
tissue	O
-	O
specific	O
regulation	O
:	O
they	O
are	O
expressed	O
solely	O
in	O
the	O
adult	O
hermaphrodite	O
intestine	O
.	O

This	O
DNA	O
motif	O
represents	O
a	O
novel	O
protein	O
-	O
binding	O
sequence	O
.	O

Preceptorship	O
of	O
CNS	O
students	O
:	O
an	O
exploratory	O
study	O
.	O

The	O
1	O
.	O
7	O
kb	O
cloned	O
fragment	O
was	O
sequenced	O
and	O
shown	O
to	O
contain	O
the	O
entire	O
fliA	B
gene	I
.	O

Lac	B
operators	O
were	O
introduced	O
into	O
several	O
positions	O
within	O
the	O
CAB	B
promoter	I
and	O
operator	O
-	O
free	O
plasmid	O
was	O
used	O
as	O
control	O
.	O

Various	O
companies	O
produce	O
this	O
type	O
of	O
lens	O
.	O

Domain	O
II	O
is	O
highly	O
homologous	O
to	O
the	O
LDL	B
receptor	I
and	O
contains	O
four	O
repeats	O
with	O
perfect	O
conservation	O
of	O
all	O
6	O
consecutive	O
cysteines	O
.	O

Two	O
variant	O
PRP	B
-	I
precursor	I
alleles	I
occur	O
which	O
slightly	O
differ	O
in	O
the	O
number	O
of	O
repeats	O
in	O
domain	O
C	O
.	O

At	O
the	O
C	O
-	O
terminus	O
of	O
the	O
protein	O
is	O
a	O
domain	O
that	O
contains	O
sequences	O
very	O
similar	O
to	O
those	O
found	O
in	O
the	O
breakpoint	O
cluster	O
region	O
gene	O
product	O
,	O
n	B
-	I
chimerin	I
,	O
and	O
rho	B
GAP	I
,	O
all	O
of	O
which	O
have	O
been	O
shown	O
to	O
possess	O
intrinsic	O
GAP	B
activity	O
on	O
small	B
GTPases	I
.	O

Site	O
-	O
directed	O
mutagenesis	O
revealed	O
that	O
two	O
clusters	O
of	O
basic	O
amino	O
acids	O
within	O
a	O
conserved	O
basic	O
region	O
and	O
two	O
amphipathic	O
helices	O
within	O
the	O
adjacent	O
HLH	O
domain	O
are	O
essential	O
for	O
sequence	O
-	O
specific	O
DNA	O
binding	O
and	O
hetero	O
-	O
oligomerization	O
,	O
respectively	O
.	O

SEA	O
was	O
recorded	O
with	O
bidirectional	O
filters	O
at	O
25	O
-	O
250	O
HZ	O
and	O
40	O
-	O
250	O
Hz	O
using	O
Simson	O
method	O
.	O

An	O
experiment	O
examined	O
the	O
effects	O
of	O
treatment	O
with	O
gonadotrophin	B
releasing	I
hormone	I
(	O
100	O
micrograms	O
GnRH	B
injected	O
24	O
h	O
after	O
progestagen	O
sponge	O
removal	O
),	O
season	O
of	O
treatment	O
(	O
autumn	O
v	O
.	O
spring	O
),	O
the	O
effect	O
of	O
supplementary	O
feeding	O
with	O
lupin	O
grain	O
(	O
in	O
autumn	O
only	O
,	O
from	O
12	O
days	O
before	O
until	O
8	O
days	O
after	O
sponge	O
removal	O
)	O
on	O
the	O
time	O
of	O
ovulation	O
in	O
182	O
mature	O
Merino	O
ewes	O
superovulated	O
with	O
a	O
combination	O
of	O
400	O
I	O
.	O
U	O
.	O
pregnant	B
mare	I
serum	I
gonadotrophin	I
(	O
PMSG	B
)	O
and	O
12	O
mg	O
follicle	B
stimulating	I
hormone	I
(	O
FSH	B
-	I
P	I
).	O

Total	O
body	O
irradiation	O
was	O
delivered	O
according	O
to	O
a	O
hyperfractionated	O
scheme	O
of	O
12	O
fractions	O
given	O
three	O
per	O
day	O
5	O
hr	O
apart	O
for	O
4	O
days	O
.	O

The	O
60A	B
transcripts	I
and	O
protein	O
are	O
first	O
detected	O
at	O
the	O
onset	O
of	O
gastrulation	O
,	O
primarily	O
in	O
the	O
mesoderm	O
of	O
the	O
extending	O
germ	O
band	O
.	O

These	O
results	O
support	O
the	O
diagnostic	O
validity	O
of	O
NFPD	O
in	O
CP	O
/	O
NCA	O
patients	O
,	O
because	O
such	O
patients	O
had	O
a	O
family	O
history	O
of	O
panic	O
disorder	O
similar	O
to	O
patients	O
with	O
a	O
more	O
classical	O
panic	O
disorder	O
presentation	O
.	O

Furthermore	O
,	O
no	O
transcripts	O
of	O
the	O
same	O
size	O
and	O
having	O
the	O
same	O
developmental	O
profile	O
as	O
those	O
generated	O
by	O
the	O
wild	B
-	I
type	I
E10	I
fragment	I
were	O
identified	O
by	O
probes	O
covering	O
the	O
remainder	O
of	O
the	O
cloned	O
region	O
.	O

These	O
mutant	O
proteins	O
retained	O
the	O
ability	O
to	O
competitively	O
inhibit	O
kappa	B
B	I
-	O
mediated	O
transcriptional	O
activation	O
of	O
the	O
human	B
immunodeficiency	I
virus	I
long	I
terminal	I
repeat	I
but	O
failed	O
to	O
efficiently	O
transform	O
chicken	O
lymphoid	O
cells	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

The	O
homologies	O
between	O
RAD16	B
,	O
RAD54	B
and	O
SNF2	B
are	O
also	O
shared	O
by	O
several	O
additional	O
,	O
recently	O
isolated	O
yeast	O
and	O
Drosophila	O
genes	O
.	O

In	O
the	O
Rett	O
syndrome	O
we	O
,	O
therefore	O
,	O
suspect	O
there	O
are	O
disturbances	O
in	O
the	O
brain	O
stem	O
functions	O
especially	O
in	O
the	O
ascending	O
reticular	O
activating	O
system	O
which	O
is	O
related	O
to	O
elevation	O
of	O
the	O
conscious	O
level	O
.	O

Two	O
cDNAs	O
encoding	O
casein	B
kinase	I
-	I
1	I
have	O
been	O
isolated	O
from	O
a	O
yeast	O
cDNA	O
library	O
and	O
termed	O
CKI1	B
and	O
CKI2	B
.	O

Incidence	O
rate	O
ranging	O
between	O
122	O
/	O
100	O
,	O
000	O
/	O
year	O
and	O
190	O
/	O
100	O
,	O
000	O
/	O
year	O
were	O
found	O
(	O
minimum	O
,	O
estimated	O
and	O
raw	O
datasets	O
).	O

The	O
final	O
screening	O
yielded	O
a	O
clone	O
containing	O
a	O
2	O
kilobase	O
(	O
kb	O
)	O
insert	O
.	O

Cardiovascular	O
risk	O
factors	O
were	O
measured	O
by	O
standardized	O
techniques	O
.	O

Lewis	O
,	O
N	O
.	O

This	O
open	O
reading	O
frame	O
was	O
confirmed	O
the	O
correct	O
one	O
by	O
direct	O
amino	O
-	O
terminal	O
sequence	O
analysis	O
of	O
the	O
overproduced	O
msgB	B
gene	I
product	I
.	O

The	O
virus	O
encodes	O
a	O
40	O
-	O
kDa	O
protein	O
,	O
tax	B
,	O
that	O
is	O
important	O
for	O
the	O
immortalization	O
of	O
T	O
cells	O
.	O

An	O
examination	O
of	O
the	O
role	O
of	O
the	O
carboxyl	O
terminus	O
in	O
regulating	O
NGFI	B
-	I
B	I
transcriptional	O
activity	O
revealed	O
that	O
,	O
in	O
accordance	O
with	O
other	O
nuclear	O
receptors	O
,	O
mutants	O
lacking	O
portions	O
of	O
the	O
carboxyl	O
terminus	O
had	O
greatly	O
decreased	O
activity	O
.	O

Recently	O
,	O
the	O
3	B
.	I
6	I
-	I
kb	I
full	I
-	I
length	I
alpha	I
-	I
GalNAc	I
cDNA	I
sequence	I
was	O
isolated	O
and	O
found	O
to	O
have	O
remarkable	O
nucleotide	O
and	O
predicted	O
amino	O
acid	O
homology	O
(	O
55	O
.	O
8	O
and	O
46	O
.	O
9	O
%,	O
respectively	O
)	O
with	O
the	O
human	B
alpha	I
-	I
galactosidase	I
A	I
(	O
alpha	B
-	I
Gal	I
A	I
)	O
cDNA	O
.	O

In	O
patients	O
with	O
limited	O
disease	O
,	O
the	O
survival	O
in	O
the	O
alternating	O
arm	O
was	O
significantly	O
superior	O
to	O
the	O
survival	O
in	O
the	O
CAV	O
arm	O
(	O
P	O
=	O
.	O
014	O
)	O
or	O
the	O
survival	O
in	O
the	O
PE	O
arm	O
(	O
P	O
=	O
.	O
023	O
).	O

These	O
experiments	O
delineate	O
a	O
186	O
-	O
bp	O
,	O
EBNA	B
-	I
2	I
-	O
responsive	O
cell	O
DNA	O
fragment	O
and	O
provide	O
firm	O
evidence	O
that	O
EBNA	B
-	I
2	I
transactivates	O
transcription	O
of	O
cell	O
genes	O
.	O

Plasma	O
vitamin	O
E	O
,	O
total	O
lipids	O
and	O
myeloperoxidase	B
levels	O
during	O
spinal	O
surgery	O
.	O

In	O
similar	O
transient	O
transfection	O
experiments	O
in	O
HeLa	O
cells	O
,	O
overexpression	O
of	O
the	O
wt	B
human	I
retinoblastoma	I
susceptibility	I
gene	I
product	I
,	O
RB	B
,	O
was	O
found	O
to	O
repress	O
the	O
serum	O
-	O
induced	O
IL	B
-	I
6	I
(-	O
225	O
to	O
+	O
13	O
),	O
c	B
-	I
fos	I
(-	O
711	O
to	O
+	O
42	O
),	O
and	O
beta	B
-	I
actin	I
(-	O
3400	O
to	O
+	O
912	O
)	O
promoters	O
but	O
not	O
the	O
PRV	O
-	O
induced	O
IL	B
-	I
6	I
(-	O
110	O
to	O
+	O
13	O
)	O
or	O
the	O
serum	O
-	O
induced	O
MHC	B
(-	O
528	O
to	O
-	O
38	O
)	O
promoters	O
.	O

At	O
1	O
,	O
5	O
,	O
and	O
9	O
months	O
after	O
initial	O
isolation	O
of	O
C	O
.	O
kutscheri	O
from	O
the	O
oral	O
cavity	O
,	O
hamsters	O
were	O
euthanatized	O
,	O
and	O
attempts	O
were	O
made	O
to	O
culture	O
C	O
.	O
kutscheri	O
from	O
13	O
additional	O
sites	O
.	O

The	O
two	O
genes	O
code	O
for	O
polypeptides	B
of	I
420	I
amino	I
acids	I
(	I
M	I
.	I
HgiCI	I
)	I
and	O
345	O
amino	O
acids	O
(	O
R	O
.	O
HgiCI	O
).	O

We	O
report	O
the	O
isolation	O
of	O
genomic	O
and	O
cDNA	O
clones	O
of	O
the	O
light	O
-	O
independent	O
Sn	B
:	I
bol3	I
allele	I
.	O

The	O
localization	O
of	O
this	O
proteoglycan	O
locus	O
in	O
the	O
human	O
genome	O
and	O
the	O
availability	O
of	O
new	O
RFLPs	O
provide	O
the	O
tools	O
for	O
future	O
studies	O
of	O
human	O
diseases	O
where	O
the	O
HSPG2	B
proteoglycan	I
gene	I
is	O
suspected	O
to	O
be	O
involved	O
.	O

During	O
coronary	O
stenosis	O
,	O
on	O
the	O
contrary	O
,	O
intracoronary	O
procaterol	O
at	O
the	O
same	O
dose	O
significantly	O
deteriorated	O
regional	O
myocardial	O
dysfunction	O
without	O
changing	O
LCX	O
flow	O
,	O
global	O
hemodynamics	O
and	O
cardiac	O
lactate	O
metabolism	O
.	O

Here	O
we	O
present	O
evidence	O
that	O
major	B
IE	I
proteins	I
IE86	I
,	O
IE72	B
,	O
and	O
IE55	B
are	O
capable	O
of	O
trans	O
-	O
activating	O
the	O
HIV	B
LTR	I
in	O
a	O
T	O
-	O
cell	O
line	O
,	O
HUT	O
-	O
78	O
.	O

The	O
cis	O
-	O
acting	O
element	O
mediating	O
glucocorticoid	O
inducibility	O
of	O
the	O
chicken	B
glutamine	I
synthetase	I
gene	I
has	O
been	O
identified	O
.	O

Treatment	O
of	O
human	O
myeloid	O
cell	O
lines	O
HL	O
-	O
60	O
and	O
U937	O
with	O
phorbol	O
12	O
-	O
myristate	O
13	O
-	O
acetate	O
(	O
PMA	O
)	O
increased	O
within	O
2	O
h	O
cellular	O
levels	O
of	O
the	O
RNA	O
hybridizable	O
to	O
LD78	B
cDNA	I
.	O

We	O
speculate	O
that	O
these	O
tumors	O
may	O
represent	O
congenital	O
hamartomatous	O
growths	O
.	O

Surprisingly	O
,	O
there	O
is	O
no	O
sequence	O
homology	O
between	O
this	O
region	O
of	O
Ly	B
-	I
6E	I
and	O
the	O
established	O
consensus	O
for	O
the	O
interferon	B
-	I
stimulated	I
response	I
element	I
,	O
which	O
has	O
been	O
shown	O
functionally	O
important	O
to	O
all	O
previously	O
characterized	O
alpha	B
/	I
beta	I
interferon	I
-	O
inducible	O
promoters	O
.	O

Relatively	O
large	O
DNA	O
rearrangements	O
spanning	O
the	O
region	O
with	O
tandem	O
direct	O
repeats	O
encoding	O
the	O
carboxy	O
-	O
terminal	O
histone	B
H1	I
-	I
like	I
structure	O
of	O
AlgP	B
were	O
detected	O
in	O
several	O
strains	O
upon	O
conversion	O
from	O
the	O
mucoid	O
to	O
the	O
nonmucoid	O
phenotype	O
.	O

Co	O
-	O
existence	O
of	O
these	O
regulatory	O
elements	O
with	O
other	O
elements	O
,	O
such	O
as	O
the	O
AP	B
-	I
2	I
element	I
or	O
CCAAT	O
box	O
,	O
was	O
also	O
found	O
.	O

Northern	O
blotting	O
analysis	O
indicates	O
that	O
expression	O
of	O
the	O
genes	O
corresponding	O
to	O
these	O
clones	O
is	O
confined	O
to	O
pollen	O
tissue	O
.	O

The	O
C5	B
alpha	I
-	I
chain	I
was	O
encoded	O
by	O
49	O
kilobases	O
containing	O
26	O
exons	O
;	O
the	O
beta	O
-	O
chain	O
was	O
encoded	O
by	O
29	O
kilobases	O
containing	O
16	O
exons	O
.	O

Regulation	O
of	O
the	O
alpha	B
inhibin	I
gene	I
by	O
cyclic	O
adenosine	O
3	O
',	O
5	O
'-	O
monophosphate	O
after	O
transfection	O
into	O
rat	O
granulosa	O
cells	O
.	O

Comparison	O
of	O
the	O
nucleotide	O
sequences	O
between	O
the	O
human	O
and	O
bovine	O
DNA	O
showed	O
that	O
the	O
sequence	O
similarity	O
extended	O
2400	O
bp	O
downstream	O
from	O
the	O
coding	O
region	O
.	O

Cloning	O
of	O
a	O
human	O
cDNA	O
encoding	O
a	O
CDC2	B
-	I
related	I
kinase	I
by	O
complementation	O
of	O
a	O
budding	B
yeast	I
cdc28	I
mutation	O
.	O

The	O
above	O
results	O
mean	O
that	O
the	O
increase	O
in	O
alpha	B
-	I
adrenergic	I
receptors	I
makes	O
the	O
prostate	O
,	O
which	O
has	O
been	O
already	O
hypertrophied	O
,	O
less	O
elastic	O
,	O
inhibiting	O
external	O
urinary	O
sphincter	O
function	O
.	O

Analysis	O
of	O
the	O
deduced	O
amino	O
acid	O
sequence	O
suggests	O
that	O
CHIP28	B
protein	I
contains	O
six	O
bilayer	O
-	O
spanning	O
domains	O
,	O
two	O
exofacial	O
potential	O
N	O
-	O
glycosylation	O
sites	O
,	O
and	O
intracellular	O
N	O
and	O
C	O
termini	O
.	O

The	O
qualitative	O
concentrations	O
of	O
HCG	B
had	O
a	O
sensitivity	O
of	O
37	O
.	O
5	O
%	O
and	O
a	O
specificity	O
of	O
100	O
%.	O

Epidemiology	O
and	O
prevention	O
of	O
hospital	O
infections	O
in	O
the	O
Local	O
Health	O
Unit	O
of	O
Sassari	O
:	O
profile	O
of	O
bacterial	O
resistance	O
and	O
antimicrobial	O
agents	O
of	O
large	O
usage	O
.	O

Max	B
:	O
functional	O
domains	O
and	O
interaction	O
with	O
c	B
-	I
Myc	I
.	O

Zn	O
(	O
II	O
)	O
coordination	O
domain	O
mutants	O
of	O
T4	O
gene	B
32	I
protein	O
.	O

We	O
have	O
partially	O
sequenced	O
the	O
RAP74	B
protein	I
from	O
purified	O
HeLa	O
cells	O
,	O
cloned	O
its	O
complementary	O
DNA	O
and	O
shown	O
that	O
its	O
translation	O
product	O
can	O
interact	O
with	O
RAP30	B
in	O
vitro	O
as	O
well	O
as	O
in	O
vivo	O
.	O

W	O
.	O
G	O
.	O

This	O
study	O
confirms	O
,	O
although	O
individual	O
reaction	O
is	O
remarkably	O
different	O
,	O
transportation	O
as	O
a	O
potent	O
stressor	O
for	O
Beagle	O
dogs	O
.	O

RESULTS	O
:	O
Plasma	B
AVP	I
responses	O
to	O
osmotic	O
stimulation	O
,	O
and	O
non	O
-	O
osmotic	O
inhibition	O
by	O
drinking	O
,	O
were	O
normal	O
in	O
patients	O
with	O
compulsive	O
water	O
drinking	O
.	O

Thrombolytic	O
therapy	O
in	O
spontaneous	O
coronary	O
artery	O
dissection	O
.	O

When	O
both	O
lesions	O
were	O
complete	O
lateral	O
hemisections	O
in	O
weanling	O
operates	O
,	O
little	O
behavioral	O
recovery	O
was	O
observed	O
,	O
similar	O
to	O
complete	O
spinal	O
cord	O
transection	O
(	O
N	O
=	O
3	O
).	O

We	O
have	O
isolated	O
cDNAs	O
for	O
a	O
gene	O
coding	O
for	O
a	O
G	B
protein	I
alpha	I
subunit	I
from	I
tomato	I
(	O
Lycopersicon	O
esculentum	O
,	O
cv	O
.	O

Transcriptional	O
activation	O
by	O
the	O
HIV	B
-	I
1	I
Tat	I
protein	I
requires	O
specific	O
residues	O
in	O
the	O
hexanucleotide	O
loop	O
and	O
trinucleotide	O
bulge	O
of	O
the	O
TAR	B
RNA	O
stem	O
-	O
loop	O
structure	O
found	O
in	O
the	O
5	O
'-	O
untranslated	O
leader	O
of	O
all	O
viral	O
transcripts	O
.	O

These	O
results	O
strongly	O
suggest	O
that	O
locally	O
-	O
applied	O
TTC	O
in	O
combination	O
with	O
FDBA	O
enhances	O
new	O
bone	O
formation	O
in	O
experimental	O
alveolar	O
bone	O
defects	O
.	O

As	O
an	O
initial	O
step	O
towards	O
the	O
characterization	O
of	O
replicative	O
DNA	B
polymerases	I
of	I
trypanosomes	I
,	O
we	O
have	O
cloned	O
,	O
sequenced	O
and	O
examined	O
the	O
expression	O
of	O
the	O
Trypanosoma	O
(	O
Trypanozoon	O
)	O
brucei	O
brucei	O
gene	O
that	O
encodes	O
the	O
DNA	B
polymerase	I
alpha	I
catalytic	I
core	I
(	O
pol	B
alpha	I
).	O

CONCLUSION	O
:	O
Monitoring	O
SpO2	O
at	O
the	O
nasal	O
septum	O
site	O
is	O
more	O
reliable	O
than	O
monitoring	O
it	O
at	O
the	O
finger	O
site	O
in	O
hypothermic	O
patients	O
.	O

Diltiazem	O
decreased	O
the	O
total	O
body	O
clearance	O
from	O
34	O
.	O
0	O
+/-	O
8	O
.	O
0	O
to	O
28	O
.	O
6	O
+/-	O
6	O
.	O
1	O
mL	O
/	O
min	O
(	O
P	O
less	O
than	O
.	O
01	O
),	O
and	O
prolonged	O
the	O
elimination	O
half	O
-	O
life	O
from	O
12	O
.	O
6	O
+/-	O
3	O
.	O
0	O
to	O
14	O
.	O
3	O
+/-	O
2	O
.	O
5	O
hours	O
(	O
P	O
less	O
than	O
.	O
01	O
)	O
of	O
antipyrine	O
without	O
any	O
changes	O
in	O
volume	O
of	O
distribution	O
.	O

Antibodies	O
specific	O
to	O
rE12	B
and	O
rNFIL	B
-	I
6	I
disrupt	O
nucleoprotein	O
complexes	O
with	O
these	O
DNA	O
-	O
binding	O
sites	O
,	O
confirming	O
the	O
interaction	O
of	O
native	O
in	O
vivo	O
factors	O
.	O

A	O
method	O
is	O
described	O
for	O
detecting	O
targeted	O
events	O
at	O
the	O
mu	B
heavy	I
chain	I
gene	I
which	O
relies	O
on	O
co	O
-	O
conversion	O
(	O
or	O
co	O
-	O
exchange	O
)	O
of	O
a	O
point	O
mutation	O
with	O
a	O
selectable	O
marker	O
contained	O
on	O
a	O
replacement	O
vector	O
.	O

Marked	O
thrombocytopenia	O
,	O
depletion	O
of	O
serum	B
fibrinogen	I
and	O
prolonged	O
prothrombin	B
and	O
activated	O
partial	O
thromboplastin	B
time	O
,	O
were	O
recorded	O
at	O
5	O
to	O
10	O
and	O
30	O
to	O
40	O
minutes	O
after	O
intravenous	O
envenomation	O
.	O

The	O
alcoholic	O
patient	O
,	O
his	O
work	O
and	O
the	O
subjectivity	O
of	O
the	O
period	O

If	O
delay	O
has	O
occurred	O
between	O
centrifugation	O
and	O
the	O
measurement	O
,	O
causing	O
substantial	O
loss	O
of	O
CO2	O
,	O
equilibration	O
of	O
the	O
sample	O
with	O
a	O
gas	O
mixture	O
corresponding	O
to	O
PCO2	O
=	O
5	O
.	O
3	O
kPa	O
prior	O
to	O
the	O
measurement	O
is	O
recommended	O
.	O

We	O
examined	O
behavioral	O
alterations	O
in	O
the	O
brown	O
cockroach	O
,	O
Periplaneta	O
brunnea	O
,	O
infected	O
with	O
the	O
acanthocephalan	O
,	O
Moniliformis	O
moniliformis	O
.	O

Ten	O
out	O
of	O
10	O
patients	O
with	O
progressive	O
disease	O
had	O
mast	O
cells	O
greater	O
than	O
or	O
equal	O
to	O
0	O
.	O
5	O
%,	O
hyaluronan	O
greater	O
than	O
or	O
equal	O
to	O
50	O
micrograms	O
.	O
l	O
-	O
1	O
and	O
fibronectin	B
greater	O
than	O
or	O
equal	O
to	O
350	O
micrograms	O
.	O
l	O
-	O
1	O
compared	O
to	O
eight	O
out	O
of	O
41	O
patients	O
with	O
stable	O
or	O
regressive	O
disease	O
.(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

Arsenic	O
contents	O
in	O
native	O
copper	O

Among	O
blood	O
donors	O
in	O
the	O
Republic	O
of	O
Serbia	O
,	O
regardless	O
the	O
number	O
of	O
blood	O
donations	O
,	O
the	O
percentage	O
of	O
female	O
donors	O
is	O
significantly	O
lower	O
compared	O
to	O
the	O
percentage	O
of	O
male	O
blood	O
donors	O
.	O

RU486	O
and	O
ONO	O
802	O
in	O
combination	O
have	O
been	O
shown	O
to	O
be	O
effective	O
in	O
early	O
termination	O
of	O
pregnancy	O
.	O

The	O
12S	B
E1A	I
product	I
does	O
not	O
activate	O
a	O
TRE	O
sequence	O
,	O
but	O
cotransfection	O
with	O
c	B
-	I
jun	I
circumvents	O
this	O
lack	O
of	O
stimulation	O
.	O

The	O
minus	O
-	O
end	O
-	O
directed	O
microtubule	O
motors	O
,	O
the	O
dyneins	B
,	O
may	O
also	O
constitute	O
a	O
superfamily	O
of	O
force	O
-	O
generating	O
proteins	O
with	O
distinct	O
attachment	O
domains	O
.	O

The	O
incompatibility	O
group	O
W	O
plasmid	O
pSa	O
suppresses	O
Agrobacterium	O
tumefaciens	O
oncogenicity	O
(	O
J	O
.	O

The	O
murine	B
Mov	I
-	I
34	I
gene	I
:	O
full	O
-	O
length	O
cDNA	O
and	O
genomic	O
organization	O
.	O

When	O
transfected	O
into	O
Drosophila	O
SL	O
-	O
2	O
cells	O
,	O
pCAT	O
plasmid	O
containing	O
2	O
,	O
090	O
bp	O
of	O
5	O
'-	O
flanking	O
region	O
shows	O
a	O
3	O
.	O
0	O
-	O
to	O
3	O
.	O
5	O
-	O
fold	O
increase	O
in	O
chloramphenicol	B
acetyltransferase	I
activity	O
after	O
induction	O
with	O
retinoic	O
acid	O
and	O
/	O
or	O
8	O
-	O
bromo	O
-	O
cAMP	O
.	O

The	O
RNA	O
genome	O
of	O
rabbit	O
hemorrhagic	O
disease	O
virus	O
(	O
RHDV	O
)	O
was	O
molecularly	O
cloned	O
.	O

Chagas	O
'	O
disease	O
,	O
visceral	O
leishmaniasis	O
,	O
anti	B
-	I
nuclear	I
factor	I
,	O
schistosomiasis	O
,	O
rheumatoid	B
factor	I
and	O
normal	O
controls	O
.	O

The	O
rad9	B
.	I
192	I
DNA	I
repair	I
mutant	I
from	I
the	I
fission	I
yeast	I
,	I
Schizosaccharomyces	I
pombe	I
,	O
is	O
sensitive	O
to	O
both	O
UV	O
and	O
ionising	O
radiation	O
.	O

These	O
features	O
were	O
considered	O
consistent	O
with	O
a	O
diagnosis	O
of	O
Rothmund	O
-	O
Thomson	O
syndrome	O
.	O

Human	B
immunodeficiency	I
virus	I
type	I
1	I
(	I
HIV	I
-	I
1	I
)	I
IN	I
,	O
expressed	O
in	O
Escherichia	O
coli	O
,	O
was	O
purified	O
to	O
near	O
homogeneity	O
.	O

Analysis	O
of	O
viral	O
mutants	O
in	O
vivo	O
demonstrated	O
that	O
the	O
NFIII	B
/	O
OCT	B
-	I
1	I
binding	O
site	O
and	O
a	O
conserved	O
ATF	B
motif	I
were	O
important	O
for	O
efficient	O
viral	O
growth	O
.	O

In	O
the	O
ileum	O
,	O
enterotoxin	O
increased	O
the	O
luminal	O
disappearance	O
(	O
P	O
less	O
than	O
0	O
.	O
05	O
)	O
and	O
peripheral	O
blood	O
appearance	O
(	O
P	O
less	O
than	O
0	O
.	O
001	O
)	O
of	O
chloroquine	O
.	O

All	O
members	O
are	O
also	O
capable	O
of	O
activating	O
in	O
vivo	O
transcription	O
from	O
promoters	O
that	O
contain	O
a	O
C	B
/	I
EBP	I
-	I
binding	I
site	I
.	O

The	O
domains	O
involved	O
in	O
superactivation	O
appear	O
to	O
be	O
a	O
subset	O
of	O
those	O
necessary	O
to	O
achieve	O
synergistic	O
activation	O
.	O

Chlamydia	O
trachomatis	O
and	O
Chlamydia	O
psittaci	O
were	O
not	O
affected	O
by	O
methanol	O
fixation	O
.	O

A	O
deletion	O
series	O
of	O
the	O
5	O
'	O
flanking	O
region	O
was	O
created	O
from	O
position	O
-	O
1329	O
to	O
-	O
74	O
relative	O
to	O
the	O
transcriptional	O
initiation	O
site	O
and	O
similarly	O
examined	O
in	O
transgenic	O
tobacco	O
.	O

Toxicity	O
was	O
very	O
mild	O
with	O
both	O
regimens	O
,	O
although	O
sedation	O
was	O
significantly	O
higher	O
in	O
arm	O
B	O
(	O
p	O
less	O
than	O
0	O
.	O
001	O
).	O

Ivermectin	O
uptake	O
and	O
distribution	O
in	O
the	O
plasma	O
and	O
tissue	O
of	O
Sudanese	O
and	O
Mexican	O
patients	O
infected	O
with	O
Onchocerca	O
volvulus	O
.	O

The	O
currently	O
proposed	O
extended	O
arch	O
repair	O
should	O
be	O
reserved	O
for	O
the	O
small	O
group	O
of	O
infants	O
with	O
transverse	O
aortic	O
arch	O
to	O
ascending	O
aorta	O
diameter	O
ratios	O
(	O
arch	O
indices	O
)	O
of	O
less	O
than	O
0	O
.	O
25	O
.	O

We	O
report	O
two	O
patients	O
receiving	O
maintenance	O
valproate	O
,	O
one	O
with	O
resolving	O
acute	O
hepatitis	O
C	O
and	O
the	O
other	O
with	O
chronic	O
persistent	O
hepatitis	O
C	O
,	O
with	O
incidental	O
microvesicular	O
steatosis	O
demonstrated	O
on	O
oil	O
-	O
red	O
O	O
stains	O
.	O

3	O
cases	O

One	O
of	O
its	O
lysine	O
residues	O
is	O
modified	O
by	O
spermidine	O
to	O
form	O
hypusine	O
,	O
a	O
posttranslational	O
modification	O
unique	O
to	O
eIF	B
-	I
5A	I
.	O

Transcription	O
of	O
the	O
metH	B
gene	I
in	I
Salmonella	I
typhimurium	I
and	I
Escherichia	I
coli	I
is	O
positively	O
regulated	O
by	O
the	O
metR	B
gene	I
product	I
,	O
a	O
DNA	O
binding	O
protein	O
.	O

INTERVENTIONS	O
:	O
Patients	O
received	O
rt	B
-	I
PA	I
,	O
heparin	O
,	O
and	O
aspirin	O
.	O

Consistent	O
with	O
the	O
in	O
vivo	O
result	O
,	O
the	O
pseudorevertant	O
endonucleases	O
in	O
the	O
crude	O
cell	O
extract	O
display	O
site	O
-	O
specific	O
partial	O
DNA	O
cleavage	O
activity	O
.	O

Anti	B
-	I
HBc	I
production	O
of	O
PBMC	O
was	O
enhanced	O
remarkably	O
in	O
this	O
case	O
.	O

Sequence	O
analysis	O
of	O
the	O
sMtCK	B
genomic	I
upstream	I
sequences	I
reveals	O
a	O
typical	O
TATAA	O
box	O
within	O
the	O
80	O
base	O
pairs	O
(	O
bp	O
)	O
that	O
,	O
by	O
transfection	O
experiments	O
,	O
are	O
sufficient	O
to	O
promote	O
expression	O
of	O
chimeric	O
plasmids	O
with	O
the	O
chloramphenicol	B
acetyltransferase	I
reporter	I
.	O

An	O
ASSEMBLER	O
routine	O
for	O
on	O
-	O
line	O
graphic	O
display	O
and	O
averaging	O
of	O
data	O
acquired	O
on	O
a	O
personal	O
microcomputer	O
.	O

Previous	O
investigators	O
have	O
suggested	O
that	O
subretinal	O
blood	O
damages	O
the	O
retina	O
in	O
part	O
because	O
of	O
its	O
solid	O
fibrin	B
meshwork	O
.	O

Neuro	O
-	O
otological	O
examinations	O
revealed	O
spontaneous	O
downbeat	O
nystagmus	O
,	O
bilateral	O
gaze	O
nystagmus	O
and	O
rebound	O
nystagmus	O
.	O

Insulin	B
-	I
like	I
growth	I
factor	I
1	I
(	O
IGF	B
-	I
1	I
)	O
in	O
burn	O
patients	O
.	O

Recombinant	B
human	I
TFIID	I
supported	O
weak	O
basal	O
transcription	O
in	O
heat	O
-	O
treated	O
nuclear	O
extracts	O
whereas	O
a	O
partially	O
purified	O
TFIID	B
fraction	O
from	O
HeLa	O
cells	O
reconstituted	O
a	O
maximal	O
level	O
of	O
transcription	O
.	O

The	O
effect	O
of	O
diffusion	O
limitation	O
was	O
quantified	O
in	O
terms	O
of	O
the	O
ratio	O
O2	O
uptake	O
/	O
O2	O
requirement	O
(=	O
fraction	O
of	O
cross	O
-	O
sectional	O
area	O
supplied	O
with	O
O2	O
),	O
assuming	O
local	O
O2	O
requirement	O
per	O
unit	O
volume	O
to	O
be	O
constant	O
and	O
independent	O
of	O
PO2	O
at	O
PO2	O
greater	O
than	O
0	O
.	O

At	O
the	O
time	O
of	O
the	O
seizure	O
,	O
the	O
patient	O
was	O
asked	O
to	O
read	O
a	O
test	O
phrase	O
aloud	O
until	O
it	O
was	O
read	O
correctly	O
and	O
clearly	O
.	O

Toluene	O
is	O
the	O
chemical	O
most	O
frequently	O
present	O
in	O
cases	O
involving	O
volatile	O
solvents	O
.	O

A	O
herpesvirus	O
proteinase	O
activity	O
has	O
been	O
identified	O
and	O
partially	O
characterized	O
by	O
using	O
the	O
cloned	O
enzyme	O
and	O
substrate	O
genes	O
in	O
transient	O
transfection	O
assays	O
.	O

Adult	O
H	O
,	O
but	O
not	O
R	O
,	O
manifested	O
the	O
burrowing	O
preference	O
whenever	O
offered	O
the	O
opportunity	O
.	O

Urine	O
specimens	O
containing	O
either	O
phencyclidine	O
(	O
PCP	O
)	O
or	O
11	O
-	O
nor	O
-	O
delta	O
9	O
-	O
tetrahydrocannabinol	O
-	O
9	O
-	O
carboxylic	O
acid	O
(	O
9	O
-	O
THC	O
-	O
COOH	O
)	O
were	O
adulterated	O
with	O
sodium	O
chloride	O
,	O
bleach	O
,	O
vinegar	O
,	O
potassium	O
hydroxide	O
,	O
liquid	O
soap	O
,	O
2	O
-	O
propanol	O
,	O
and	O
ammonia	O
.	O

We	O
conclude	O
that	O
the	O
beta	O
-	O
adrenergic	O
agonist	O
,	O
isoproterenol	O
,	O
has	O
little	O
influence	O
on	O
vascular	O
capacitance	O
or	O
liver	O
volume	O
of	O
dogs	O
,	O
unless	O
the	O
hepatic	O
outflow	O
resistance	O
is	O
elevated	O
by	O
agents	O
such	O
as	O
histamine	O
.	O

After	O
base	O
-	O
line	O
CBF	O
was	O
established	O
,	O
hexamethonium	O
bromide	O
(	O
2	O
mg	O
/	O
kg	O
iv	O
),	O
ipratropium	O
bromide	O
(	O
0	O
.	O
5	O
microgram	O
/	O
kg	O
iv	O
),	O
indomethacin	O
(	O
2	O
mg	O
/	O
kg	O
iv	O
),	O
or	O
intravenous	O
0	O
.	O
9	O
%	O
saline	O
was	O
administered	O
.	O

This	O
study	O
suggests	O
that	O
BSPMs	O
are	O
useful	O
in	O
the	O
assessment	O
of	O
AMI	O
in	O
terms	O
of	O
diagnosis	O
,	O
location	O
and	O
extent	O
of	O
myocardial	O
infarct	O
.	O

The	O
application	O
of	O
these	O
instruments	O
allows	O
occlusion	O
of	O
the	O
ascending	O
aorta	O
traversed	O
by	O
the	O
perfusion	O
cannula	O
inserted	O
directly	O
or	O
through	O
the	O
apex	O
of	O
the	O
heart	O
as	O
well	O
as	O
simultaneous	O
left	O
ventricular	O
venting	O
.	O

Adenylosuccinate	B
synthetase	I
(	O
IMP	O
:	O
L	B
-	I
aspartate	I
ligase	I
(	O
GDP	O
),	O
EC	B
6	I
.	I
3	I
.	I
4	I
.	I
4	I
)	O
plays	O
an	O
important	O
role	O
in	O
purine	O
biosynthesis	O
catalyzing	O
the	O
GTP	O
-	O
dependent	O
conversion	O
of	O
IMP	O
to	O
AMP	O
.	O

We	O
reviewed	O
the	O
records	O
of	O
151	O
patients	O
with	O
optic	O
neuritis	O
examined	O
over	O
an	O
eight	O
-	O
year	O
period	O
.	O

The	O
first	O
follow	O
-	O
up	O
was	O
at	O
a	O
nearly	O
constant	O
interval	O
of	O
5	O
.	O
1	O
years	O
in	O
Caerphilly	O
and	O
3	O
.	O
2	O
years	O
in	O
Speedwell	O
;	O
251	O
major	O
IHD	O
events	O
had	O
occurred	O
.	O

We	O
report	O
here	O
the	O
isolation	O
of	O
a	O
full	O
-	O
length	O
cDNA	O
clone	O
coding	O
for	O
a	O
hitherto	O
undiscovered	O
isoform	O
of	O
the	O
bovine	B
C	I
-	I
subunit	I
.	O

No	O
positive	O
family	O
history	O
was	O
obtained	O
.	O

Occupational	O
asthma	O
and	O
rhinoconjunctivitis	O
from	O
inhalation	O
of	O
crystalline	O
bovine	B
serum	I
albumin	I
powder	O
.	O

Amino	O
acid	O
sequence	O
comparisons	O
of	O
the	O
E74A	B
protein	I
reveal	O
a	O
highly	O
conserved	O
C	O
-	O
terminal	O
region	O
that	O
is	O
rich	O
in	O
basic	O
amino	O
acid	O
residues	O
and	O
which	O
has	O
been	O
proposed	O
to	O
possess	O
sequence	O
-	O
specific	O
DNA	O
binding	O
activity	O
.	O

We	O
found	O
that	O
the	O
relative	O
strengths	O
of	O
the	O
promoters	O
were	O
similar	O
in	O
different	O
contexts	O
.	O

After	O
6	O
months	O
,	O
definite	O
improvement	O
in	O
strength	O
occurred	O
in	O
4	O
of	O
7	O
carnitine	O
-	O
treated	O
patients	O
and	O
in	O
none	O
of	O
7	O
controls	O
.	O

Once	O
the	O
proliferation	O
of	O
fibroblasts	O
and	O
collagen	B
synthesis	O
had	O
led	O
to	O
an	O
increase	O
of	O
mechanical	O
strength	O
,	O
no	O
negative	O
effect	O
on	O
wound	O
healing	O
could	O
be	O
detected	O
applying	O
the	O
same	O
chemotherapeutic	O
agents	O
.	O

Using	O
an	O
ELISA	O
,	O
we	O
found	O
that	O
surfactant	B
protein	I
A	I
(	O
SP	B
-	I
A	I
)	O
was	O
markedly	O
elevated	O
in	O
the	O
pneumonia	O
patients	O
.	O

Two	O
patients	O
had	O
immediate	O
adverse	O
effects	O
from	O
NMF	O
;	O
one	O
had	O
a	O
grand	O
mal	O
seizure	O
and	O
the	O
other	O
developed	O
severe	O
abdominal	O
pain	O
.	O

The	O
muscles	O
from	O
the	O
ischemic	O
group	O
had	O
significantly	O
lower	O
(	O
P	O
less	O
than	O
.	O
05	O
)	O
values	O
for	O
capillary	O
density	O
and	O
capillary	O
to	O
fiber	O
ratio	O
and	O
significantly	O
higher	O
intercapillary	O
distance	O
than	O
those	O
from	O
the	O
normal	O
group	O
.	O

Polymerase	O
chain	O
reaction	O
analysis	O
of	O
ETS1	B
cDNA	I
identified	O
several	O
amplified	O
products	O
,	O
indicating	O
alternative	O
splicing	O
.	O

Most	O
of	O
the	O
expressed	O
human	B
E3	I
polypeptides	I
(	O
five	O
bands	O
)	O
were	O
found	O
in	O
the	O
insoluble	O
pellet	O
while	O
primarily	O
full	B
-	I
length	I
mature	I
E3	I
was	O
found	O
in	O
the	O
soluble	O
fraction	O
.	O

Eight	O
patients	O
with	O
ARC	O
and	O
renal	O
failure	O
were	O
recently	O
evaluated	O
.	O

Using	O
the	O
polymerase	O
chain	O
reaction	O
,	O
we	O
analyzed	O
the	O
U6	B
RNA	I
genes	I
of	O
52	O
organisms	O
.	O

To	O
facilitate	O
the	O
availability	O
of	O
important	O
new	O
therapeutic	O
agents	O
,	O
the	O
Food	O
and	O
Drug	O
Administration	O
(	O
FDA	O
)	O
in	O
the	O
mid	O
-	O
1970s	O
began	O
assigning	O
therapeutic	O
ratings	O
to	O
investigational	O
new	O
drugs	O
and	O
holding	O
end	O
-	O
of	O
-	O
phase	O
II	O
conferences	O
with	O
drug	O
sponsors	O
.	O

Furthermore	O
,	O
the	O
DNA	B
polymerase	I
II	I
complex	I
was	O
difficult	O
to	O
obtain	O
from	O
dpb2	B
-	I
1	I
mutant	O
cells	O
,	O
suggesting	O
that	O
a	O
stable	O
DNA	B
polymerase	I
II	I
complex	I
requires	O
DPB2	B
and	O
is	O
essential	O
for	O
chromosomal	O
replication	O
.	O

No	O
evidence	O
for	O
the	O
presence	O
of	O
introns	O
within	O
the	O
acvA	B
gene	I
has	O
been	O
found	O
.	O

Pargyline	O
,	O
a	O
monoamine	B
oxidase	I
inhibitor	O
,	O
reduces	O
peak	O
3	O
transiently	O
(	O
max	O
.	O

We	O
also	O
present	O
evidence	O
for	O
a	O
negative	O
regulatory	O
element	O
in	O
the	O
5	O
'	O
flanking	O
region	O
of	O
the	O
Mlu	B
I	I
upstream	I
activation	I
sequence	I
.	O

A	O
method	O
for	O
establishing	O
stimulus	O
control	O
of	O
ethanol	O
responding	O
was	O
developed	O
.	O

Menetrier	O
disease	O
in	O
a	O
child	O
.	O

The	O
TCF	B
-	I
1	I
alpha	I
binding	I
site	I
was	O
also	O
required	O
for	O
TCR	B
alpha	I
enhancer	I
activity	O
in	O
transcriptionally	O
active	O
extracts	O
from	O
Jurkat	O
but	O
not	O
HeLa	O
cells	O
,	O
confirming	O
that	O
TCF	B
-	I
1	I
alpha	I
is	O
a	O
T	B
-	I
cell	I
-	I
specific	I
transcription	I
factor	I
.	O

A	O
new	O
semi	O
-	O
automatic	O
method	O
for	O
quantifying	O
regional	O
cerebral	O
uptake	O
of	O
99m	O
technetium	O
-	O
hexamethylpropylene	O
amine	O
oxime	O
(	O
99mTc	O
-	O
HMPAO	O
)	O
was	O
used	O
to	O
assess	O
single	O
photon	O
emission	O
tomograms	O
from	O
5	O
normal	O
subjects	O
,	O
14	O
patients	O
with	O
Alzheimer	O
'	O
s	O
disease	O
,	O
14	O
patients	O
with	O
dementia	O
of	O
frontal	O
lobe	O
type	O
and	O
4	O
patients	O
with	O
dementia	O
with	O
motor	O
neurone	O
disease	O
.	O

ARPIA	O
has	O
been	O
implemented	O
by	O
using	O
a	O
relational	O
DBMS	O
,	O
very	O
cheap	O
and	O
highly	O
diffused	O
on	O
personal	O
computers	O
.	O

Immuno	O
-	O
cytochemistry	O
,	O
using	O
antisera	O
against	O
Campylobacter	O
jejuni	O
,	O
showed	O
that	O
the	O
positive	O
staining	O
in	O
altered	O
epithelial	O
cells	O
were	O
restricted	O
to	O
intracellular	O
organisms	O
having	O
a	O
structure	O
resembling	O
Campylobacter	O
spp	O
.	O

All	O
8	O
(	O
100	O
%)	O
patients	O
with	O
fulminant	O
hepatic	O
failure	O
who	O
received	O
grafts	O
survived	O
,	O
including	O
3	O
who	O
received	O
ABO	O
-	O
incompatible	O
grafts	O
,	O
though	O
2	O
of	O
these	O
subsequently	O
required	O
retransplantation	O
.	O

An	O
evolutionary	O
comparison	O
of	O
amino	O
acid	O
sequences	O
of	O
34	O
HSP70	B
proteins	I
from	O
17	O
species	O
suggests	O
that	O
BiP	B
genes	I
share	O
a	O
common	O
ancestor	O
,	O
which	O
diverged	O
from	O
other	O
HSP70	B
genes	I
near	O
the	O
time	O
when	O
eukaryotes	O
first	O
appeared	O
.	O

However	O
,	O
overexpression	O
of	O
both	O
the	O
STE4	B
and	O
STE18	B
proteins	I
did	O
not	O
generate	O
a	O
stronger	O
pheromone	O
response	O
than	O
overexpression	O
of	O
STE4	B
in	O
the	O
presence	O
of	O
wild	O
-	O
type	O
levels	O
of	O
STE18	B
.	O

To	O
evaluate	O
the	O
cost	O
and	O
benefits	O
of	O
screening	O
tests	O
for	O
Chlamydia	O
trachomatis	O
in	O
adolescent	O
males	O
,	O
we	O
developed	O
a	O
decision	O
analysis	O
model	O
and	O
compared	O
the	O
leukocyte	B
esterase	I
urine	O
dipstick	O
test	O
with	O
culture	O
,	O
with	O
direct	O
-	O
smear	O
fluorescent	O
antibody	O
(	O
DFA	O
),	O
and	O
with	O
the	O
option	O
of	O
no	O
screening	O
(	O
no	O
treatment	O
).	O

Sequencing	O
the	O
gene	O
for	O
an	O
imipenem	O
-	O
cefoxitin	O
-	O
hydrolyzing	O
enzyme	O
(	O
CfiA	B
)	O
from	O
Bacteroides	O
fragilis	O
TAL2480	O
reveals	O
strong	O
similarity	O
between	O
CfiA	B
and	O
Bacillus	B
cereus	I
beta	I
-	I
lactamase	I
II	I
.	O

Inspired	O
CO2	O
causing	O
changes	O
from	O
hypo	O
-	O
to	O
normocapnia	O
has	O
previously	O
been	O
shown	O
to	O
improve	O
arterial	O
O2	O
tension	O
(	O
PaO2	O
)	O
and	O
to	O
reduce	O
alveolar	O
-	O
arterial	O
O2	O
difference	O
.	O

Expression	O
,	O
nucleotide	O
sequence	O
and	O
mutational	O
analysis	O
of	O
two	O
open	O
reading	O
frames	O
in	O
the	O
nif	B
gene	I
region	I
of	I
Anabaena	I
sp	I
.	I
strain	I
PCC7120	I
.	O

Our	O
results	O
suggest	O
that	O
a	O
sequence	O
match	O
between	O
enhancers	O
and	O
certain	O
promoter	O
elements	O
is	O
critical	O
.	O

In	O
this	O
paper	O
,	O
we	O
have	O
analyzed	O
the	O
structure	O
of	O
human	O
gene	O
for	O
Gx	B
alpha	I
,	O
which	O
spans	O
more	O
than	O
60	O
kilobases	O
.	O

Uses	O
of	O
orthoclone	O
OKT3	B
for	O
prophylaxis	O
of	O
rejection	O
and	O
induction	O
in	O
initial	O
nonfunction	O
in	O
kidney	O
transplantation	O
.	O

Influence	O
of	O
metoprolol	O
treatment	O
on	O
sympatho	O
-	O
adrenal	O
activation	O
of	O
fibrinolysis	O
.	O

In	O
Denmark	O
only	O
1	O
-	O
3	O
cases	O
of	O
transfusion	O
-	O
associated	O
hepatitis	O
NANB	O
(	O
TAH	O
-	O
NANB	O
)	O
are	O
registered	O
annually	O
or	O
about	O
1	O
case	O
per	O
100	O
,	O
000	O
units	O
transfused	O
.	O

A	O
second	O
isotype	O
of	O
Raja	B
immunoglobulin	I
heavy	I
chain	I
genes	I
has	O
been	O
detected	O
by	O
screening	O
a	O
spleen	O
cDNA	O
library	O
with	O
homologous	O
Raja	B
VH	I
-	O
and	O
CH1	B
-	O
specific	O
probes	O
complementing	O
the	O
respective	O
regions	O
of	O
the	O
mu	B
-	I
like	I
isotype	I
.	O

Human	O
recombinant	O
DNA	O
-	O
derived	O
antihemophilic	B
factor	I
(	O
factor	B
VIII	I
)	O
in	O
the	O
treatment	O
of	O
hemophilia	O
A	O
.	O
recombinant	O
Factor	B
VIII	I
Study	O
Group	O
.	O

Like	O
other	O
members	O
of	O
this	O
family	O
,	O
the	O
AP	B
-	I
4	I
HLH	O
motif	O
and	O
the	O
adjacent	O
basic	O
domain	O
are	O
necessary	O
and	O
sufficient	O
to	O
confer	O
site	O
-	O
specific	O
DNA	O
binding	O
.	O

Effects	O
of	O
a	O
selective	O
monoamine	B
oxidase	I
(	I
MAO	I
)--	I
A	I
inhibitor	O
,	O
clorgyline	O
,	O
a	O
selective	O
MAO	B
-	I
B	I
inhibitor	O
,	O
deprenyl	O
,	O
and	O
a	O
non	O
-	O
selective	O
MAO	B
inhibitor	O
,	O
nialamide	O
,	O
were	O
investigated	O
on	O
footshock	O
-	O
induced	O
aggression	O
(	O
FIA	O
)	O
in	O
paired	O
rats	O
.	O

Of	O
848	O
patients	O
,	O
819	O
cases	O
with	O
complete	O
description	O
of	O
patient	O
'	O
s	O
background	O
were	O
evaluable	O
:	O
Group	O
A	O
(	O
surgery	O
+	O
MMC	O
+	O
5	O
-	O
FU	O
:	O
chemotherapy	O
)	O
253	O
cases	O
,	O
group	O
B	O
(	O
surgery	O
+	O
MMC	O
+	O
5	O
-	O
FU	O
+	O
OK	O
-	O
432	O
or	O
PSK	O
:	O
immunochemotherapy	O
)	O
282	O
and	O
group	O
C	O
(	O
surgery	O
alone	O
)	O
284	O
.	O

The	O
nuclear	O
proteins	O
encoded	O
by	O
the	O
c	B
-	I
fos	I
and	O
c	B
-	I
jun	I
protooncogenes	I
are	O
expressed	O
during	O
the	O
proliferation	O
period	O
of	O
osteoblast	O
phenotype	O
development	O
.	O

The	O
experimental	O
group	O
consisted	O
of	O
61	O
examinees	O
class	O
II	O
/	O
2	O
orthodontic	O
anomalies	O
.	O

Subjects	O
were	O
16	O
male	O
chronic	O
schizophrenics	O
consisting	O
of	O
8	O
DST	O
suppressors	O
and	O
8	O
nonsuppressors	O
.	O

From	O
S3	O
(	O
CBF	O
:	O
79	O
-	O
60	O
%)	O
to	O
S5	O
(	O
CBF	O
:	O
39	O
-	O
0	O
%),	O
%	O
WTh	O
,	O
1	O
/	O
TPC	O
and	O
1	O
/	O
T	O
were	O
significantly	O
decreased	O
from	O
those	O
of	O
the	O
control	O
levels	O
(	O
all	O
p	O
less	O
than	O
0	O
.	O
01	O
).	O

9	O
,	O
1498	O
-	O
1506	O
).	O

In	O
a	O
highly	O
select	O
group	O
of	O
stable	O
hypertensive	O
patients	O
,	O
we	O
have	O
assessed	O
the	O
strength	O
of	O
association	O
between	O
various	O
blood	O
pressure	O
measurements	O
(	O
24	O
h	O
average	O
automated	O
ambulatory	O
blood	O
pressure	O
,	O
4	O
h	O
automated	O
ambulatory	O
morning	O
average	O
blood	O
pressure	O
,	O
multiple	O
office	O
visit	O
average	O
blood	O
pressure	O
,	O
and	O
a	O
single	O
office	O
visit	O
average	O
blood	O
pressure	O
)	O
and	O
various	O
echocardiographic	O
indices	O
of	O
hypertensive	O
cardiac	O
target	O
organ	O
damage	O
(	O
left	O
atrial	O
diameter	O
,	O
left	O
ventricular	O
end	O
diastolic	O
diameter	O
,	O
posterior	O
wall	O
thickness	O
,	O
combined	O
wall	O
thickness	O
,	O
relative	O
wall	O
thickness	O
,	O
left	O
ventricular	O
mass	O
and	O
mass	O
index	O
,	O
and	O
combined	O
wall	O
thickness	O
/	O
left	O
ventricular	O
diastolic	O
diameter	O
ratio	O
).	O

We	O
have	O
previously	O
identified	O
,	O
by	O
screening	O
a	O
lambda	O
gt11	O
expression	O
library	O
,	O
murine	B
protein	I
mXBP	I
,	O
which	O
binds	O
to	O
a	O
sequence	O
which	O
overlaps	O
the	O
3	O
'	O
end	O
of	O
the	O
murine	B
class	I
II	I
major	I
histocompatibility	I
complex	I
A	I
alpha	I
gene	I
X	I
box	I
,	O
a	O
conserved	O
transcription	O
element	O
found	O
upstream	O
of	O
all	O
class	O
II	O
genes	O
.	O

The	O
major	O
promoter	O
responds	O
strongly	O
to	O
virus	O
-	O
encoded	O
trans	O
activators	O
EIA	B
and	O
EIV	B
and	O
contains	O
four	O
elements	O
:	O
a	O
TAGA	O
motif	O
analogous	O
to	O
the	O
TATA	O
box	O
,	O
two	O
EIIF	B
sites	I
present	O
in	O
an	O
inverted	O
orientation	O
,	O
and	O
an	O
ATF	B
/	O
CREB	B
site	O
.	O

Impaction	O
of	O
gastrostomy	O
tube	O
in	O
the	O
abdominal	O
wall	O
.	O

Both	O
antidepressants	O
elevated	O
the	O
pain	O
threshold	O
acutely	O
,	O
while	O
pretreatment	O
with	O
pCPA	O
largely	O
blocked	O
the	O
analgesia	O
.	O

TCR	B
alpha	I
and	I
beta	I
gene	I
expression	O
may	O
be	O
regulated	O
by	O
a	O
common	O
set	O
of	O
T	B
-	I
cell	I
nuclear	I
proteins	I
in	O
that	O
the	O
T	B
beta	I
2	I
element	I
binding	O
a	O
set	O
of	O
cyclic	B
AMP	I
response	I
element	I
-	I
binding	I
proteins	I
that	O
are	O
also	O
bound	O
by	O
the	O
T	B
alpha	I
1	I
element	I
of	O
the	O
human	O
TCR	B
alpha	I
enhancer	O
and	O
the	O
decamer	O
element	O
present	O
in	O
a	O
large	O
number	O
of	O
human	O
and	O
murine	O
TCR	B
beta	I
promoters	O
.	O

The	O
3	O
'	O
stem	O
-	O
loop	O
is	O
highly	O
divergent	O
in	O
structure	O
among	O
species	O
and	O
lies	O
immediately	O
upstream	O
of	O
the	O
binding	O
site	O
for	O
Sm	B
proteins	I
.	O

A	O
4	O
.	O
8	O
-	O
kilobase	O
BamHI	B
-	O
HindIII	B
fragment	O
encoding	O
the	O
entire	B
Neurospora	I
crassa	I
CuZn	I
superoxide	I
dismutase	I
gene	I
(	O
herein	O
designated	O
sod	B
-	I
1	I
)	O
was	O
isolated	O
from	O
a	O
genomic	O
library	O
using	O
two	O
60	O
-	O
base	O
deoxyoligonucleotide	O
probes	O
corresponding	O
to	O
the	O
published	O
N	O
.	O
crassa	O
amino	O
acid	O
sequence	O
.	O

In	O
contrast	O
,	O
the	O
CRE	O
of	O
the	O
human	B
c	I
-	I
fos	I
promoter	I
located	O
at	O
-	O
60	O
was	O
weakly	O
induced	O
by	O
cAMP	O
and	O
E1a	B
in	O
both	O
HeLa	O
and	O
PC12	O
cells	O
.	O

We	O
have	O
isolated	O
and	O
sequenced	O
the	O
gene	O
encoding	O
the	O
human	B
U1	I
-	I
70K	I
snRNP	I
protein	I
.	O

The	O
nmr	B
gene	I
is	O
the	O
major	O
negative	O
regulatory	O
gene	O
in	O
the	O
nitrogen	O
control	O
circuit	O
of	O
Neurospora	O
crassa	O
,	O
which	O
,	O
together	O
with	O
positive	O
regulatory	O
genes	O
,	O
governs	O
the	O
expression	O
of	O
multiple	O
unlinked	O
structural	O
genes	O
of	O
the	O
circuit	O
.	O

The	O
PC2	B
protein	I
also	O
shows	O
great	O
similarity	O
to	O
the	O
incomplete	O
NH2	O
-	O
terminal	O
sequence	O
of	O
the	O
human	B
furin	I
gene	I
product	I
,	O
a	O
putative	O
membrane	O
-	O
inserted	O
receptor	O
-	O
like	O
molecule	O
.	O

The	O
possible	O
benefits	O
of	O
LMW	O
heparin	O
(	O
reduced	O
frequency	O
of	O
bleeding	O
,	O
alleviation	O
of	O
hypertriglyceridemia	O
)	O
were	O
not	O
,	O
however	O
,	O
apparent	O
,	O
possibly	O
because	O
of	O
the	O
short	O
observation	O
period	O
and	O
the	O
low	O
incidence	O
of	O
hemorrhagic	O
complications	O
in	O
routine	O
dialyses	O
.	O

The	O
deduced	O
amino	O
acid	O
sequence	O
of	O
destrin	B
is	O
165	O
residues	O
long	O
and	O
is	O
very	O
similar	O
(	O
71	O
%	O
identical	O
)	O
to	O
that	O
of	O
cofilin	B
,	O
a	O
widely	O
distributed	O
,	O
pH	O
-	O
sensitive	O
actin	B
-	O
modulating	O
protein	O
.	O

This	O
points	O
to	O
a	O
specific	O
interference	O
with	O
HSV	O
-	O
induced	O
DNA	O
amplification	O
.	O

The	O
antinociceptive	O
properties	O
,	O
as	O
measured	O
by	O
the	O
tail	O
-	O
flick	O
and	O
hot	O
-	O
plate	O
tests	O
,	O
and	O
the	O
motor	O
effects	O
of	O
an	O
intrathecally	O
-	O
administered	O
benzodiazepine	O
agonist	O
midazolam	O
,	O
alone	O
,	O
and	O
in	O
combination	O
with	O
morphine	O
,	O
was	O
examined	O
in	O
rats	O
.	O

Constructs	O
were	O
made	O
in	O
which	O
an	O
AATAAA	O
and	O
the	O
GT	O
-	O
rich	O
region	O
were	O
separated	O
by	O
various	O
distances	O
ranging	O
from	O
7	O
to	O
43	O
bp	O
.	O

We	O
show	O
that	O
cytR	B
expression	O
is	O
negatively	O
controlled	O
by	O
the	O
CytR	B
protein	I
and	O
positively	O
affected	O
by	O
the	O
cAMP	B
/	I
CAP	I
complex	I
.	O

Our	O
studies	O
extend	O
these	O
findings	O
and	O
show	O
that	O
the	O
E2	B
transactivation	I
gene	I
is	O
expressed	O
from	O
multiple	O
promoters	O
.	O

A	O
portion	O
of	O
Region	O
II	O
also	O
resembles	O
part	O
of	O
the	O
human	O
c	B
-	I
jun	I
oncoprotein	O
'	O
s	O
leucine	O
zipper	O
,	O
which	O
in	O
turn	O
,	O
has	O
been	O
demonstrated	O
to	O
be	O
the	O
heterodimerization	O
site	O
between	O
the	O
jun	B
and	O
fos	B
oncoproteins	I
.	O

Five	O
healthy	O
male	O
subjects	O
inspired	O
air	O
for	O
20	O
min	O
and	O
then	O
5	O
%	O
CO2	O
/	O
95	O
%	O
O2	O
for	O
30	O
min	O
,	O
of	O
which	O
the	O
first	O
10	O
min	O
was	O
used	O
to	O
achieve	O
a	O
steady	O
-	O
state	O
end	O
-	O
tidal	O
CO2	O
measurement	O
.	O

Some	O
of	O
the	O
mutations	O
obtained	O
do	O
not	O
contain	O
a	O
copy	O
of	O
the	O
Ulysses	B
element	I
at	O
the	O
mutant	O
locus	O
,	O
suggesting	O
that	O
a	O
different	O
transposable	O
element	O
may	O
be	O
responsible	O
for	O
the	O
mutation	O
.	O

Moreover	O
,	O
radiolabeled	O
EFI	B
,	O
NF	B
-	I
Y	I
,	O
or	O
CBF	B
DNAs	I
give	O
rise	O
to	O
identical	O
gel	O
retardation	O
patterns	O
in	O
extracts	O
from	O
a	O
variety	O
of	O
different	O
cell	O
types	O
.	O

The	O
characterized	O
Y	B
'	I
repeated	I
sequence	I
families	I
provide	O
an	O
experimental	O
system	O
in	O
which	O
repeated	O
sequence	O
interactions	O
and	O
subsequent	O
evolution	O
can	O
be	O
studied	O
.	O

Kinetic	O
experiments	O
revealed	O
that	O
within	O
10	O
min	O
this	O
radiolabeled	O
precursor	O
protein	O
was	O
converted	O
in	O
HL	O
-	O
60	O
cells	O
into	O
an	O
Mr	O
approximately	O
150	O
,	O
000	O
chondroitin	O
sulfate	O
proteoglycan	O
intermediate	O
.	O

Three	O
of	O
the	O
short	O
ORFs	O
in	O
the	O
central	O
region	O
of	O
BIV	O
have	O
been	O
identified	O
by	O
location	O
and	O
structural	O
similarity	O
to	O
the	O
nonstructural	O
/	O
regulatory	O
genes	O
(	O
vif	B
,	O
tat	B
,	O
and	O
rev	B
)	O
of	O
other	O
lentiviruses	O
;	O
we	O
also	O
discovered	O
two	O
unique	O
ORFs	O
,	O
termed	O
W	O
and	O
Y	O
,	O
which	O
may	O
serve	O
as	O
exons	O
for	O
novel	O
genes	O
.	O

The	O
Saccharomyces	B
cerevisiae	I
14DM	I
gene	I
,	O
encoding	O
cytochrome	B
P450	I
lanosterol	I
14	I
alpha	I
-	I
demethylase	I
(	O
14DM	B
),	O
was	O
overexpressed	O
in	O
various	O
S	O
.	O
cerevisiae	O
strains	O
under	O
the	O
control	O
of	O
three	O
strong	O
heterologous	O
yeast	O
transcription	O
promoters	O
(	O
pADC1	B
,	O
pGPD	B
,	O
pPHO5	B
)	O
and	O
under	O
the	O
control	O
of	O
its	O
own	O
promoter	O
.	O

Pulmonary	O
vascular	O
resistance	O
was	O
not	O
altered	O
,	O
ejection	O
fraction	O
remained	O
unchanged	O
and	O
isovolumic	O
relaxation	O
period	O
was	O
lengthened	O
(	O
119	O
+/-	O
20	O
.	O
1	O
to	O
147	O
.	O
39	O
+/-	O
21	O
.	O
15	O
,	O
P	O
less	O
than	O
0	O
.	O
05	O
).	O

No	O
therapy	O
exists	O
for	O
halting	O
the	O
progression	O
of	O
the	O
disease	O
with	O
the	O
possible	O
exception	O
of	O
laser	O
photocoagulation	O
treatment	O
used	O
to	O
ablate	O
subretinal	O
neovascular	O
membranes	O
in	O
an	O
attempt	O
to	O
avoid	O
complications	O
of	O
subretinal	O
hemorrhages	O
.	O

Therapeutic	O
effects	O
of	O
cefpirome	O
(	O
HR	O
810	O
)	O
on	O
experimental	O
mixed	O
infections	O
with	O
Enterococcus	O
faecalis	O
and	O
Escherichia	O
coli	O
in	O
mice	O
.	O

Homozygous	O
individuals	O
usually	O
develop	O
purpura	O
fulminans	O
as	O
newborns	O
;	O
heterozygous	O
protein	B
C	I
-	O
deficient	O
individuals	O
are	O
at	O
increased	O
risk	O
for	O
venous	O
thrombosis	O
and	O
pulmonary	O
embolism	O
.	O

These	O
results	O
suggest	O
that	O
5	O
KE	O
X	O
3	O
/	O
W	O
may	O
be	O
the	O
optimal	O
regimen	O
to	O
augment	O
the	O
antitumor	O
immunity	O
of	O
RNL	O
.	O

Yeast	B
Gal11	I
protein	I
mediates	O
the	O
transcriptional	O
activation	O
signal	O
of	O
two	O
different	O
transacting	O
factors	O
,	O
Gal4	B
and	O
general	B
regulatory	I
factor	I
I	I
/	O
repressor	B
/	I
activator	I
site	I
binding	I
protein	I
1	I
/	I
translation	I
upstream	I
factor	I
.	O

The	O
computer	O
-	O
programmed	O
cytocentrifuge	O
is	O
currently	O
most	O
popular	O
.	O

The	O
efficacy	O
and	O
safety	O
of	O
a	O
novel	O
percutaneous	O
anaesthetic	O
preparation	O
based	O
on	O
amethocaine	O
has	O
been	O
investigated	O
in	O
the	O
paediatric	O
clinical	O
environment	O
.	O

The	O
grandfather	O
and	O
the	O
granddaughter	O
both	O
had	O
microtia	O
and	O
meatal	O
atresia	O
,	O
whereas	O
the	O
daughter	O
had	O
a	O
normal	O
outer	O
ear	O
except	O
for	O
a	O
narrow	O
meatus	O
and	O
auricular	O
appendages	O
.	O

Abnormal	O
intrapulmonary	O
shunting	O
(	O
IPS	O
),	O
which	O
was	O
proved	O
in	O
4	O
cases	O
by	O
whole	O
-	O
body	O
radionuclide	O
scanning	O
with	O
99mTc	O
-	O
MAA	O
,	O
is	O
suggested	O
as	O
the	O
major	O
cause	O
of	O
cyanosis	O
in	O
liver	O
cirrhosis	O
.	O

More	O
generally	O
,	O
Ets1	B
and	O
Ets2	B
could	O
regulate	O
transcription	O
of	O
cellular	O
genes	O
.	O

Standardized	O
gastric	O
wall	O
specimens	O
from	O
the	O
area	O
of	O
grossly	O
healed	O
ulcers	O
were	O
obtained	O
,	O
processed	O
,	O
and	O
evaluated	O
by	O
light	O
microscopy	O
and	O
by	O
transmission	O
electron	O
microscopy	O
.	O

The	O
effects	O
of	O
coenzyme	O
Q10	O
(	O
CoQ	O
)	O
and	O
captopril	O
on	O
functional	O
capacity	O
,	O
hemodynamics	O
and	O
survival	O
were	O
studied	O
in	O
154	O
rats	O
that	O
recovered	O
after	O
experimental	O
myocardial	O
infarction	O
.	O

The	O
interrelation	O
of	O
the	O
levels	O
of	O
glucocorticoids	O
and	O
insulin	B
in	O
the	O
blood	O
of	O
irradiated	O
animals	O

Gene	O
constructs	O
possessing	O
the	O
complete	B
tat	I
,	O
rev	B
(	O
tat	B
+	I
rev	O
+)	O
and	O
env	B
genes	I
were	O
transiently	O
expressed	O
in	O
COS	O
-	O
1	O
cells	O
as	O
precursor	B
SU	I
-	I
TM	I
(	O
gp160	B
),	O
SU	B
.	I
TM	I
(	O
gp120	B
x	I
41	I
),	O
and	O
nucleolar	B
rev	I
protein	I
.	O

Patients	O
with	O
detectable	O
serum	O
TNF	B
levels	O
had	O
significantly	O
lower	O
serum	O
T3	O
concentrations	O
compared	O
to	O
those	O
with	O
undetectable	O
levels	O
[	O
1	O
.	O
072	O
+/-	O
0	O
.	O
588	O
vs	O
.	O

Further	O
studies	O
of	O
mandibular	O
movement	O
at	O
initial	O
tooth	O
contact	O
.	O

Droperidol	O
-	O
induced	O
extrapyramidal	O
symptoms	O
in	O
an	O
adolescent	O
following	O
strabismus	O
surgery	O
.	O

These	O
results	O
indicate	O
that	O
the	O
cis	O
-	O
regulatory	O
elements	O
required	O
for	O
developmental	O
control	O
of	O
the	O
HaG3	B
-	I
A	I
helianthinin	I
gene	I
are	O
located	O
in	O
a	O
2	O
.	O
4	O
kb	O
upstream	O
region	O
of	O
this	O
gene	O
.	O

The	O
induction	O
by	O
pseudorabies	O
virus	O
of	O
an	O
IL	B
-	I
6	I
construct	I
containing	O
the	O
IL	B
-	I
6	I
TATA	I
box	I
and	O
the	O
RNA	O
start	O
site	O
("	O
initiator	O
"	O
or	O
Inr	O
element	O
)	O
but	O
not	O
the	O
MRE	O
region	O
was	O
also	O
repressed	O
by	O
Dex	O
in	O
the	O
presence	O
of	O
wild	B
-	I
type	I
GR	I
.	O

The	O
glial	O
cyst	O
wall	O
was	O
lined	O
in	O
part	O
by	O
flattened	O
or	O
cuboidal	O
epithelium	O
.	O

We	O
conclude	O
that	O
class	O
I	O
cytologic	O
smears	O
with	O
moderate	O
to	O
severe	O
inflammation	O
may	O
be	O
associated	O
with	O
findings	O
of	O
condylomata	O
and	O
cervical	O
dysplasia	O
.	O

The	O
Ets	B
-	I
1	I
binding	I
site	I
was	O
localized	O
to	O
a	O
17	O
-	O
base	O
pair	O
(	O
bp	O
)	O
region	O
from	O
the	O
3	O
'	O
end	O
of	O
T	B
alpha	I
2	I
.	O

Cerebral	O
flow	O
and	O
resistance	O
showed	O
minor	O
reductions	O
with	O
HD	O
.	O

We	O
have	O
now	O
identified	O
,	O
after	O
21	O
serial	O
undiluted	O
passages	O
of	O
MHV	O
,	O
a	O
small	B
DI	I
RNA	I
,	O
DIssF	B
,	O
which	O
is	O
efficiently	O
packaged	O
into	O
virions	O
.	O

The	O
result	O
suggests	O
that	O
this	O
non	O
-	O
invasive	O
TTD	O
method	O
is	O
easily	O
available	O
and	O
useful	O
in	O
monitoring	O
the	O
intraoperative	O
cardiac	O
output	O
.	O

The	O
Mauriceville	O
and	O
Varkud	O
mitochondrial	O
plasmids	O
are	O
closely	O
related	O
,	O
closed	O
-	O
circular	O
DNAs	O
(	O
3	O
.	O
6	O
and	O
3	O
.	O
7	O
kb	O
,	O
respectively	O
)	O
that	O
have	O
characteristics	O
of	O
mtDNA	O
introns	O
and	O
retroid	O
elements	O
.	O

Finally	O
,	O
a	O
complementary	O
footprinting	O
analysis	O
of	O
the	O
upstream	O
region	O
of	O
the	O
constitutively	O
expressed	O
HSC82	B
gene	I
reveals	O
the	O
presence	O
of	O
three	O
discrete	O
protein	O
complexes	O
.	O

Unfortunately	O
,	O
these	O
preservatives	O
may	O
also	O
interfere	O
with	O
microbiological	O
assays	O
used	O
to	O
determine	O
product	O
sterility	O
or	O
bioburden	O
levels	O
.	O

In	O
both	O
groups	O
there	O
were	O
5	O
management	O
failure	O
of	O
therapy	O
,	O
so	O
that	O
alternative	O
medication	O
or	O
a	O
cesarean	O
section	O
lead	O
to	O
delivery	O
.	O

The	O
corn	O
and	O
mineral	O
oil	O
emulsions	O
were	O
almost	O
as	O
effective	O
as	O
milk	O
but	O
less	O
effective	O
than	O
sucrose	O
(	O
0	O
.	O
3M	O
)	O
in	O
stimulating	O
ingestion	O
.	O

Using	O
an	O
audiotape	O
cassette	O
and	O
headphones	O
the	O
duration	O
of	O
the	O
hallucinations	O
decreased	O
significantly	O
.	O

Interlimb	O
coordination	O
during	O
fictive	O
locomotion	O
in	O
the	O
thalamic	O
cat	O
.	O

No	O
causal	O
relations	O
may	O
be	O
inferred	O
from	O
the	O
correlation	O
between	O
the	O
level	O
of	O
trapezius	O
activity	O
and	O
complaints	O
,	O
though	O
it	O
indicates	O
that	O
individual	O
,	O
inexpedient	O
muscle	O
activity	O
patterns	O
may	O
constitute	O
an	O
important	O
risk	O
factor	O
for	O
development	O
of	O
musculo	O
-	O
skeletal	O
complaints	O
.	O

To	O
determine	O
the	O
effects	O
on	O
the	O
pulmonary	O
barrier	O
of	O
several	O
surface	O
active	O
agents	O
,	O
a	O
series	O
of	O
metered	O
dose	O
inhalers	O
(	O
MDIs	O
)	O
was	O
prepared	O
and	O
used	O
to	O
dose	O
aerosolized	O
surfactant	O
to	O
the	O
airways	O
of	O
isolated	O
perfused	O
rat	O
lungs	O
.	O

The	O
beta	O
chain	O
contains	O
five	O
potential	O
N	O
-	O
linked	O
glycosylation	O
sites	O
,	O
and	O
endoglycosidase	B
digestion	O
suggested	O
that	O
the	O
beta	O
chain	O
contained	O
multiple	O
complex	O
carbohydrate	O
side	O
chains	O
.	O

The	O
therapeutic	O
protocole	O
used	O
at	O
the	O
Gustave	O
Roussy	O
Institute	O
for	O
invasive	O
epithelioma	O
of	O
the	O
uterine	O
cervix	O
rests	O
,	O
for	O
limited	O
forms	O
(	O
T1B	O
-	O
T2	O
proximal	O
),	O
on	O
combined	O
radiology	O
and	O
surgery	O
.	O

After	O
an	O
initial	O
titration	O
period	O
and	O
adjustment	O
of	O
the	O
therapeutic	O
dose	O
,	O
the	O
individual	O
doses	O
were	O
from	O
21	O
to	O
500	O
micrograms	O
/	O
24	O
hrs	O
(	O
mean	O
160	O
micrograms	O
/	O
24	O
hrs	O
).	O

In	O
the	O
first	O
series	O
of	O
experiments	O
,	O
Sprague	O
-	O
Dawley	O
male	O
rats	O
were	O
implanted	O
unilaterally	O
with	O
guide	O
cannulas	O
aimed	O
at	O
the	O
lateral	O
ventricle	O
.	O

In	O
18	O
%	O
lymphography	O
was	O
clearly	O
positive	O
and	O
CT	O
negative	O
.	O

The	O
present	O
study	O
examined	O
the	O
effect	O
of	O
intensity	O
,	O
rate	O
,	O
and	O
polarity	O
on	O
the	O
spectral	O
content	O
of	O
ABRs	O
of	O
15	O
normal	O
-	O
hearing	O
subjects	O
.	O

Similar	O
memory	O
impairments	O
found	O
in	O
medial	O
septal	O
-	O
vertical	O
diagonal	O
band	O
of	O
Broca	O
and	O
nucleus	O
basalis	O
lesioned	O
rats	O
:	O
are	O
memory	O
defects	O
induced	O
by	O
nucleus	O
basalis	O
lesions	O
related	O
to	O
the	O
degree	O
of	O
non	O
-	O
specific	O
subcortical	O
cell	O
loss	O
?	O
The	O
function	O
of	O
nucleus	O
basalis	O
(	O
NB	O
)	O
and	O
medial	O
septal	O
-	O
vertical	O
diagonal	O
band	O
of	O
Broca	O
(	O
MS	O
-	O
VDBB	O
)	O
in	O
a	O
place	O
navigation	O
task	O
requiring	O
reference	O
memory	O
was	O
investigated	O
.	O

Patients	O
with	O
acute	O
myocardial	O
infarction	O
had	O
higher	O
plasma	O
concentrations	O
of	O
neutrophil	B
elastase	I
and	O
the	O
non	O
-	O
peroxide	O
diene	O
conjugated	O
isomer	O
of	O
linoleic	O
acid	O
than	O
normal	O
volunteers	O
or	O
patients	O
with	O
stable	O
ischaemic	O
heart	O
disease	O
.	O

The	O
clinical	O
relevance	O
of	O
these	O
findings	O
is	O
strengthened	O
by	O
the	O
observation	O
that	O
similar	O
results	O
were	O
obtained	O
when	O
P	O
.	O
HCl	O
was	O
given	O
by	O
the	O
intravenous	O
route	O
.	O

Intron	O
1	O
is	O
6	O
.	O
5	O
kb	O
long	O
,	O
and	O
the	O
minimal	O
sizes	O
of	O
introns	O
2	O
and	O
3	O
are	O
estimated	O
to	O
be	O
32	O
kb	O
each	O
.	O

Methods	O
used	O
include	O
Cobb	O
angle	O
and	O
a	O
segmental	O
evaluation	O
(	O
T7	O
-	O
T12	O
)	O
of	O
each	O
of	O
convex	O
and	O
concave	O
rib	O
-	O
vertebra	O
angles	O
(	O
RVAs	O
),	O
rib	O
-	O
vertebra	O
angle	O
differences	O
(	O
RVADs	O
),	O
vertebral	O
rotation	O
,	O
tilt	O
and	O
displacement	O
.	O

The	O
effects	O
of	O
mean	O
luminance	O
were	O
also	O
measured	O
and	O
a	O
general	O
expression	O
that	O
would	O
take	O
them	O
into	O
account	O
was	O
derived	O
.	O

Mean	O
(+/-	O
SE	O
)	O
measurements	O
of	O
clearance	O
(	O
24	O
.	O
5	O
+/-	O
2	O
.	O
06	O
v	O
26	O
.	O
5	O
+/-	O
2	O
.	O
05	O
mL	O
/	O
min	O
/	O
m2	O
),	O
half	O
-	O
life	O
(	O
5	O
.	O
7	O
+/-	O
0	O
.	O
5	O
v	O
6	O
.	O
4	O
+/-	O
0	O
.	O
5	O
hours	O
),	O
and	O
volume	O
of	O
distribution	O
(	O
12	O
.	O
4	O
+/-	O
1	O
.	O
1	O
v	O
13	O
.	O
7	O
+/-	O
1	O
.	O
6	O
L	O
/	O
m2	O
)	O
were	O
not	O
significantly	O
different	O
in	O
patients	O
with	O
jaundice	O
when	O
compared	O
with	O
controls	O
.	O

The	O
patient	O
was	O
treated	O
with	O
benzathine	O
penicillin	O
,	O
2	O
,	O
400	O
,	O
000	O
U	O
weekly	O
for	O
three	O
weeks	O
.	O

This	O
proposed	O
method	O
is	O
similar	O
in	O
principle	O
to	O
the	O
sets	O
technique	O
but	O
is	O
shown	O
to	O
have	O
much	O
better	O
expected	O
time	O
to	O
alarm	O
properties	O
.	O

100	O
of	O
the	O
patients	O
who	O
would	O
have	O
died	O
survive	O
.	O

Co	O
-	O
administration	O
of	O
5FU	O
,	O
angiotensin	B
II	I
and	O
microspheres	O
via	O
the	O
hepatic	O
artery	O
may	O
reduce	O
drug	O
exposure	O
in	O
the	O
systemic	O
compartment	O
and	O
therefore	O
may	O
increase	O
the	O
therapeutic	O
ratio	O
of	O
5FU	O
administration	O
via	O
the	O
hepatic	O
artery	O
.	O

Transient	O
expression	O
of	O
human	B
and	I
chicken	I
progesterone	I
receptors	I
does	O
not	O
support	O
alternative	O
translational	O
initiation	O
from	O
a	O
single	O
mRNA	O
as	O
the	O
mechanism	O
generating	O
two	O
receptor	O
isoforms	O
.	O

The	O
eluent	O
from	O
the	O
column	O
was	O
mixed	O
with	O
the	O
chemiluminescent	O
solution	O
containing	O
lucigenin	B
and	O
Triton	O
X	O
-	O
100	O
and	O
a	O
0	O
.	O
28	O
M	O
KOH	O
solution	O
by	O
pumps	O
and	O
monitored	O
by	O
a	O
chemiluminescence	O
detector	O
.	O

The	O
pattern	O
for	O
catalytic	O
zinc	O
sites	O
included	O
two	O
ligands	O
close	O
in	O
sequence	O
,	O
a	O
sequence	O
-	O
distant	O
ligand	O
,	O
and	O
a	O
main	O
-	O
chain	O
hydrogen	O
bond	O
joining	O
two	O
ligands	O
.	O

Results	O
of	O
the	O
long	O
-	O
term	O
observation	O
and	O
treatment	O
of	O
patients	O
with	O
arterial	O
hypertension	O

The	O
trk	B
-	I
2h	I
oncogene	I
,	O
isolated	O
from	O
the	O
human	O
breast	O
carcinoma	O
cell	O
line	O
MDA	O
-	O
MB	O
231	O
by	O
genomic	O
DNA	O
-	O
transfection	O
into	O
NIH3T3	O
cells	O
,	O
consists	O
of	O
the	O
trk	B
proto	I
-	I
oncogene	I
receptor	I
kinase	I
domain	I
fused	O
to	O
a	O
N	O
-	O
terminal	O
41	O
amino	O
acid	O
activating	O
sequence	O
(	O
Kozma	O
,	O
S	O
.	O
C	O
.,	O
Redmond	O
,	O
S	O
.	O
M	O
.	O
S	O
.,	O
Xiao	O
-	O
Chang	O
,	O
F	O
.,	O
Saurer	O
,	O
S	O
.	O
M	O
.,	O
Groner	O
,	O
B	O
.	O
and	O
Hynes	O
,	O
N	O
.	O
E	O
.	O

These	O
characteristics	O
of	O
N22	O
/	O
P22	O
indicate	O
that	O
it	O
is	O
a	O
localized	O
synaptically	O
dependent	O
event	O
conforming	O
to	O
a	O
transverse	O
dipole	O
with	O
dorsal	O
negativity	O
and	O
a	O
simultaneous	O
anterior	O
positivity	O
.	O

Role	O
of	O
superoxide	B
dismutase	I
in	O
cellular	O
oxidative	O
processes	O
and	O
method	O
of	O
its	O
determination	O
in	O
biological	O
materials	O

The	O
levels	O
of	O
both	O
MAP1	B
-	I
specific	I
and	I
MAP2	I
-	I
specific	I
mRNAs	I
decline	O
in	O
the	O
postnatal	O
developing	O
brain	O
;	O
the	O
level	O
of	O
MAP1	B
-	I
specific	I
mRNA	I
also	O
increases	O
slightly	O
in	O
rat	O
PC12	O
cells	O
upon	O
exposure	O
to	O
nerve	B
growth	I
factor	I
.	O

Furthermore	O
,	O
beta	B
2	I
-	I
adrenoceptor	I
sensitivity	O
appears	O
to	O
be	O
unaltered	O
in	O
BHT	O
.	O

Comparison	O
of	O
elastase	B
-	I
1	I
with	O
amylase	B
,	O
lipase	B
,	O
and	O
trypsin	B
-	O
like	O
immunoreactivity	O
in	O
the	O
diagnosis	O
of	O
acute	O
pancreatitis	O
.	O

A	O
probe	O
evoked	O
potentials	O
procedure	O
was	O
used	O
to	O
assess	O
the	O
relative	O
engagement	O
of	O
both	O
cerebral	O
hemispheres	O
during	O
a	O
language	O
task	O
in	O
the	O
following	O
four	O
groups	O
of	O
dextral	O
adults	O
:	O
left	O
hemisphere	O
(	O
LH	O
)-	O
damaged	O
aphasics	O
recovering	O
from	O
stroke	O
,	O
dysarthrics	O
,	O
right	O
hemisphere	O
(	O
RH	O
)-	O
damaged	O
nonaphasic	O
patients	O
,	O
and	O
normal	O
control	O
subjects	O
.	O

ASL	O
-	O
8123	O
demonstrated	O
weak	O
competitive	O
beta	B
-	I
adrenoreceptor	I
blocking	O
activity	O
in	O
isolated	O
guinea	O
pig	O
right	O
atria	O
with	O
a	O
pA2	O
of	O
3	O
.	O
73	O
+/-	O
0	O
.	O
07	O
;	O
no	O
agonist	O
-	O
like	O
activity	O
was	O
observed	O
in	O
this	O
tissue	O
at	O
concentrations	O
of	O
ASL	O
-	O
8123	O
from	O
3	O
X	O
10	O
(-	O
5	O
)	O
to	O
1	O
X	O
10	O
(-	O
2	O
)	O
M	O
.	O

The	O
small	B
IGF	I
-	I
binding	I
protein	I
is	O
abundant	O
in	O
human	O
amniotic	O
fluid	O
.	O

This	O
approach	O
was	O
examined	O
utilizing	O
the	O
fetal	O
protein	O
,	O
HGB	B
F	I
.	O

Endocrine	O
cells	O
were	O
studied	O
by	O
means	O
of	O
Grimelius	O
'	O
silver	O
staining	O
and	O
immunostaining	O
for	O
chromogranin	B
,	O
a	O
general	O
marker	O
of	O
endocrine	O
cells	O
.	O

The	O
ratio	O
of	O
radioactivity	O
in	O
tumour	O
compared	O
with	O
normal	O
tissue	O
(	O
T	O
:	O
N	O
ratio	O
)	O
was	O
determined	O
after	O
simultaneously	O
injecting	O
microspheres	O
into	O
the	O
portal	O
and	O
arterial	O
circulation	O
of	O
each	O
animal	O
.	O

Tissue	O
necrosis	O
was	O
evaluated	O
using	O
triphenyltetrazolium	O
staining	O
and	O
was	O
related	O
to	O
two	O
major	O
baseline	O
predictors	O
of	O
infarct	O
size	O
:	O
anatomic	O
risk	O
zone	O
size	O
and	O
coronary	O
collateral	O
flow	O
.	O

Sequence	O
analysis	O
of	O
the	O
5	O
'	O
flanking	O
region	O
revealed	O
several	O
GC	O
boxes	O
but	O
no	O
identifiable	O
TATA	O
box	O
.	O

Similarly	O
,	O
a	O
human	O
but	O
not	O
a	O
bovine	B
alpha	I
transgene	I
was	O
expressed	O
in	O
placenta	O
in	O
transgenic	O
mice	O
.	O

Thus	O
,	O
phosphodiesterase	O
inhibitors	O
that	O
produce	O
an	O
opiate	O
quasi	O
-	O
withdrawal	O
syndrome	O
potentiate	O
interoceptive	O
stimuli	O
and	O
weight	O
loss	O
associated	O
with	O
the	O
withdrawal	O
syndrome	O
precipitated	O
by	O
naltrexone	O
in	O
morphine	O
-	O
dependent	O
rats	O
.	O

The	O
diagnostic	O
value	O
of	O
blood	O
serum	O
and	O
urinary	B
amylase	I
,	O
lipase	B
,	O
and	O
trypsin	B
in	O
exacerbations	O
of	O
chronic	O
relapsing	O
pancreatitis	O
is	O
discussed	O
.	O

When	O
considered	O
with	O
the	O
known	O
neurotoxic	O
effects	O
on	O
children	O
of	O
"	O
low	O
levels	O
"	O
of	O
exposure	O
to	O
lead	O
,	O
these	O
results	O
also	O
suggest	O
that	O
either	O
an	O
excessively	O
narrow	O
margin	O
of	O
safety	O
or	O
insufficient	O
safety	O
is	O
provided	O
by	O
present	O
U	O
.	O
S	O
.	O
guidelines	O
,	O
which	O
classify	O
an	O
elevated	O
blood	O
lead	O
concentration	O
as	O
25	O
micrograms	O
/	O
dl	O
or	O
greater	O
.	O

In	O
resting	O
3T3	O
cells	O
,	O
jun	B
-	I
D	I
is	O
expressed	O
at	O
a	O
higher	O
level	O
compared	O
to	O
c	B
-	I
jun	I
and	O
jun	B
-	I
B	I
,	O
and	O
its	O
transcription	O
is	O
stimulated	O
only	O
slightly	O
by	O
serum	O
growth	O
factors	O
.	O

The	O
thrombolytic	O
effects	O
of	O
native	O
tissue	B
-	I
type	I
plasminogen	I
activator	I
(	O
AK	B
-	I
124	I
)	O
on	O
experimental	O
canine	O
coronary	O
thrombosis	O
.	O

In	O
transformed	O
E	O
.	O
coli	O
,	O
constitutive	B
CAT	I
expression	O
is	O
maintained	O
when	O
as	O
little	O
as	O
0	O
.	O
3	O
kilobase	O
of	O
DNA	O
from	O
the	O
3	O
'	O
end	O
of	O
the	O
1	O
.	O
6	O
-	O
kilobase	O
segment	O
is	O
inserted	O
in	O
the	O
correct	O
orientation	O
in	O
front	O
of	O
the	O
CAT	B
gene	I
.	O

Lowering	O
of	O
the	O
renal	O
blood	O
flow	O
alters	O
the	O
glomerular	O
and	O
tubular	O
excretion	O
processes	O
.	O

Isolation	O
of	O
Weeksella	O
virosa	O
(	O
formerly	O
CDC	O
group	O
IIf	O
)	O
from	O
a	O
vaginal	O
sample	O
.	O

The	O
ORF1	O
product	O
was	O
required	O
for	O
competence	O
,	O
while	O
ORF2	O
,	O
which	O
was	O
cotranscribed	O
with	O
ORF1	O
and	O
encoded	O
a	O
predicted	O
protein	O
of	O
126	O
amino	O
acids	O
,	O
was	O
not	O
.	O

In	O
all	O
sessions	O
under	O
IFN	B
,	O
the	O
latency	O
of	O
the	O
P100	O
component	O
of	O
the	O
VEP	O
was	O
shortened	O
as	O
compared	O
to	O
baseline	O
conditions	O
.	O

Gastric	O
CO2	O
/	O
HCO3	O
was	O
determined	O
in	O
absence	O
of	O
simultaneous	O
inhibition	O
of	O
acid	O
secretion	O
by	O
intra	O
-	O
and	O
extragastric	O
pCO2	O
/	O
pH	O
measurements	O
in	O
23	O
persons	O
and	O
calculated	O
using	O
the	O
equation	O
of	O
Henderson	O
-	O
Hasselbalch	O
.	O
pCO2	O
was	O
measured	O
with	O
use	O
of	O
a	O
new	O
electrode	O
.	O

Neonatal	O
Chagas	O
disease	O
:	O
laboratory	O
diagnosis	O
during	O
the	O
first	O
year	O
of	O
life	O

S1	B
nuclease	I
analysis	O
of	O
RNA	O
from	O
chemically	O
induced	O
B95	O
-	O
8	O
cells	O
and	O
from	O
Vero	O
cells	O
cotransfected	O
with	O
NotI	B
repeat	I
promoter	I
-	O
CAT	B
and	O
Z	B
showed	O
that	O
Z	B
transactivation	O
increased	O
the	O
level	O
of	O
correctly	O
initiated	O
,	O
stable	O
RNA	O
transcripts	O
.	O

The	O
negative	O
calcium	O
balance	O
with	O
hyperparathyroidemia	O
occurred	O
after	O
continuous	O
oral	O
administration	O
of	O
Cd	O
and	O
developed	O
via	O
increased	O
urinary	O
excretion	O
of	O
calcium	O
.	O

The	O
unique	O
nature	O
and	O
arrangement	O
of	O
the	O
ANT1	B
transcriptional	I
control	I
elements	I
may	O
account	O
for	O
this	O
differential	O
expression	O
.	O

The	O
Bacillus	B
subtilis	I
phage	I
phi	I
105	I
repressor	I
,	O
a	O
lambda	B
repressor	I
-	O
like	O
transcriptional	O
regulatory	O
protein	O
,	O
was	O
overproduced	O
in	O
Escherichia	O
coli	O
and	O
purified	O
to	O
near	O
homogeneity	O
in	O
order	O
to	O
examine	O
its	O
in	O
vitro	O
DNA	O
-	O
binding	O
properties	O
.	O

In	O
contrast	O
,	O
a	O
similar	O
fragment	O
lacking	O
the	O
38	O
-	O
base	O
-	O
pair	O
region	O
had	O
no	O
such	O
stabilizing	O
effect	O
.	O

Somatostatin	B
gene	I
expression	O
in	O
pancreatic	O
islet	O
cells	O
is	O
directed	O
by	O
cell	O
-	O
specific	O
DNA	O
control	O
elements	O
and	O
DNA	O
-	O
binding	O
proteins	O
.	O

After	O
termination	O
of	O
medication	O
the	O
animals	O
were	O
kindled	O
electrically	O
in	O
the	O
nucleus	O
amygdala	O
.	O

Tumour	B
necrosis	I
factor	I
and	O
adult	O
respiratory	O
distress	O
syndrome	O
.	O

We	O
have	O
therefore	O
evaluated	O
the	O
efficacy	O
and	O
safety	O
of	O
doxazosin	O
,	O
a	O
new	O
orally	O
active	O
selective	O
alpha	B
1	I
blocker	O
,	O
in	O
patients	O
with	O
systemic	O
hypertension	O
with	O
concomitant	O
airflow	O
limitation	O
.	O

Analysis	O
of	O
the	O
inferred	O
1	B
,	I
859	I
-	I
residue	I
ama	I
-	I
1	I
product	I
showed	O
considerable	O
identity	O
with	O
the	O
largest	O
subunit	O
of	O
RNAP	B
II	I
from	O
other	O
organisms	O
,	O
including	O
the	O
presence	O
of	O
a	O
zinc	O
finger	O
motif	O
near	O
the	O
amino	O
terminus	O
,	O
and	O
a	O
carboxyl	O
-	O
terminal	O
domain	O
of	O
42	O
tandemly	O
reiterated	O
heptamers	O
with	O
the	O
consensus	O
Tyr	O
Ser	O
Pro	O
Thr	O
Ser	O
Pro	O
Ser	O
.	O

5	O
.	O

We	O
conclude	O
that	O
at	O
steady	O
state	O
the	O
timing	O
of	O
a	O
light	O
meal	O
is	O
unlikely	O
to	O
alter	O
in	O
any	O
clinically	O
important	O
manner	O
the	O
pharmacokinetics	O
of	O
nifedipine	O
released	O
from	O
'	O
biphasic	O
'	O
tablets	O
.	O

The	O
GALT	O
-	O
primed	O
calves	O
had	O
increased	O
serum	O
IgG	B
,	O
lavage	O
IgG	B
and	O
IgA	B
and	O
increased	O
LNA	B
titers	O
in	O
both	O
lavage	O
fluids	O
and	O
serum	O
following	O
the	O
SC	O
dose	O
of	O
killed	O
bacteria	O
.	O

The	O
lowest	O
detectable	O
concentration	O
was	O
1	O
.	O
0	O
ng	O
/	O
ml	O
in	O
the	O
serum	O
.	O

Significance	O
of	O
delta	O
-	O
aminolevulinic	O
acid	O
analysis	O
in	O
clinical	O
tests	O

The	O
maximum	O
stress	O
due	O
to	O
the	O
hygroscopic	O
examination	O
of	O
the	O
composite	O
was	O
0	O
.	O
74	O
kg	O
/	O
mm2	O
at	O
equilibrium	O
of	O
the	O
water	O
absorbed	O
of	O
the	O
composite	O
.	O

Potential	O
consensus	O
sequences	O
for	O
early	O
and	O
late	O
regulatory	O
elements	O
were	O
identified	O
.	O

In	O
Rat	O
-	O
1a	O
cells	O
the	O
expression	O
of	O
human	B
c	I
-	I
jun	I
mRNA	I
was	O
associated	O
with	O
the	O
ability	O
to	O
clone	O
in	O
soft	O
agarose	O
and	O
form	O
tumors	O
in	O
nude	O
mice	O
.	O

Postcoital	O
contraception	O
:	O
a	O
family	O
planning	O
study	O
.	O

Many	O
studies	O
have	O
pointed	O
out	O
the	O
possibility	O
of	O
"	O
masked	O
"	O
organic	O
factors	O
in	O
erectile	O
impotence	O
,	O
detectable	O
only	O
by	O
means	O
of	O
laboratory	O
investigations	O
:	O
mild	O
hypogonadism	O
,	O
hyperprolactinemia	O
,	O
occlusions	O
selectively	O
located	O
at	O
the	O
site	O
of	O
the	O
sexual	O
arteries	O
,	O
venous	O
incompetence	O
,	O
subclinical	O
neuropathies	O
.	O

There	O
were	O
3	O
/	O
32	O
(	O
9	O
.	O
4	O
per	O
cent	O
)	O
adverse	O
reactions	O
(	O
ADRs	O
),	O
and	O
one	O
case	O
each	O
of	O
nausea	O
,	O
dizziness	O
and	O
increased	O
menstrual	O
flow	O
.	O

The	O
p34	B
.	I
8	I
gene	I
has	O
a	O
strong	O
codon	O
usage	O
bias	O
which	O
is	O
strikingly	O
different	O
from	O
that	O
of	O
the	O
polyhedrin	B
gene	I
.	O

Of	O
the	O
single	O
-	O
stranded	O
DNA	O
transformants	O
,	O
65	O
%	O
resulted	O
from	O
replacement	O
of	O
the	O
resident	O
met2	B
mutation	I
by	O
the	O
exogenous	O
wild	O
-	O
type	O
allele	O
.	O

62	O
:	O
2491	O
-	O
2499	O
,	O
1987	O
).	O

Survival	O
rates	O
for	O
the	O
original	O
treatment	O
group	O
were	O
84	O
.	O
5	O
%	O
and	O
57	O
.	O
6	O
%	O
at	O
12	O
and	O
21	O
months	O
,	O
respectively	O
;	O
for	O
the	O
delayed	O
treatment	O
group	O
,	O
78	O
.	O
8	O
%	O
and	O
64	O
.	O
6	O
%	O
at	O
12	O
and	O
21	O
months	O
,	O
respectively	O
,	O
and	O
78	O
.	O
8	O
%	O
and	O
47	O
.	O
5	O
%	O
at	O
12	O
and	O
21	O
months	O
,	O
respectively	O
,	O
for	O
77	O
subjects	O
with	O
AIDS	O
and	O
93	O
.	O
0	O
%	O
and	O
71	O
.	O
8	O
%,	O
respectively	O
,	O
for	O
50	O
subjects	O
with	O
AIDS	O
-	O
related	O
complex	O
in	O
the	O
original	O
treatment	O
group	O
.	O

The	O
products	O
of	O
genes	O
ura10	B
and	O
ura3	B
are	O
proposed	O
to	O
participate	O
in	O
the	O
channeling	O
of	O
orotidine	O
monophosphate	O
.	O

In	O
order	O
to	O
study	O
the	O
structural	O
and	O
functional	O
organization	O
of	O
the	O
eukaryotic	O
nucleolus	O
,	O
we	O
have	O
started	O
to	O
isolate	O
and	O
characterize	O
nucleolar	O
components	O
of	O
the	O
yeast	O
Saccharomyces	O
cerevisiae	O
.	O

A	O
transcription	O
factor	O
exclusion	O
assay	O
was	O
used	O
to	O
show	O
that	O
the	O
PCF1	B
mutation	I
affects	O
two	O
distinct	O
stages	O
in	O
transcription	O
:	O
one	O
prior	O
to	O
and	O
one	O
after	O
stable	O
complex	O
formation	O
;	O
and	O
that	O
these	O
effects	O
are	O
mediated	O
by	O
a	O
component	O
of	O
the	O
stable	O
complex	O
.	O

The	O
encoded	O
protein	O
has	O
a	O
leader	O
sequence	O
of	O
27	O
amino	O
acids	O
.	O

Thus	O
RV	O
O2	O
demand	O
fell	O
when	O
RC	O
O2	O
supply	O
was	O
reduced	O
,	O
although	O
a	O
flow	O
reserve	O
was	O
available	O
.	O

Liquid	O
chromatography	O
with	O
amperometric	O
detection	O
(	O
LC	O
/	O
AD	O
)	O
is	O
used	O
to	O
determine	O
fluazifop	O
acid	O
produced	O
from	O
the	O
metabolism	O
or	O
base	O
hydrolysis	O
of	O
fluazifop	O
-	O
butyl	O
in	O
soybeans	O
and	O
soybean	O
oil	O
.	O

Validation	O
of	O
the	O
survey	O
of	O
work	O
styles	O
:	O
a	O
profile	O
measure	O
of	O
the	O
type	O
A	O
behaviour	O
pattern	O
.	O

Normocapnic	O
(	O
PACO2	O
=	O
40	O
mm	O
Hg	O
)	O
ventilatory	O
drive	O
increased	O
significantly	O
(	O
p	O
less	O
than	O
0	O
.	O
05	O
)	O
in	O
six	O
subjects	O
(	O
Type	O
1	O
response	O
)	O
and	O
decreased	O
substantially	O
in	O
the	O
others	O
(	O
Type	O
2	O
response	O
);	O
with	O
hypercapnia	O
,	O
the	O
changes	O
in	O
drive	O
were	O
attenuated	O
in	O
both	O
groups	O
.	O

Fundus	O
changes	O
in	O
(	O
type	O
II	O
)	O
mesangiocapillary	O
glomerulonephritis	O
simulating	O
drusen	O
:	O
a	O
histopathological	O
report	O
.	O

Handgrip	O
dynamometry	O
was	O
also	O
carried	O
out	O
in	O
249	O
of	O
the	O
patients	O
.	O

The	O
relative	O
toxicity	O
of	O
nickel	O
oxide	O
(	O
NiO	O
),	O
nickel	O
sulfate	O
hexahydrate	O
(	O
NiSO4	O
.	O
6H2O	O
),	O
and	O
nickel	O
subsulfide	O
(	O
Ni3S2	O
)	O
was	O
studied	O
in	O
F344	O
/	O
N	O
rats	O
and	O
B6C3F1	O
mice	O
after	O
inhalation	O
exposure	O
for	O
6	O
hr	O
/	O
day	O
,	O
5	O
days	O
/	O
week	O
,	O
for	O
13	O
weeks	O
.	O

COUP	B
transcription	I
factor	I
is	O
a	O
member	O
of	O
the	O
steroid	B
receptor	I
superfamily	I
.	O

The	O
present	O
study	O
investigates	O
whether	O
prostaglandins	O
"	O
cytoprotect	O
"	O
the	O
gastric	O
mucosa	O
against	O
hemorrhage	O
-	O
induced	O
stress	O
ulceration	O
by	O
assessing	O
the	O
influence	O
of	O
16	O
,	O
16	O
-	O
dimethyl	O
prostaglandin	O
E2	O
(	O
16	O
,	O
16	O
-	O
dm	O
PGE2	O
)	O
on	O
gross	O
and	O
microscopic	O
lesion	O
formation	O
,	O
intramucosal	O
tissue	O
pH	O
,	O
H	O
+	O
back	O
-	O
diffusion	O
,	O
and	O
mucosal	O
blood	O
flow	O
in	O
rat	O
gastric	O
mucosa	O
exposed	O
to	O
luminal	O
acid	O
(	O
100	O
mM	O
HCl	O
)	O
during	O
hemorrhagic	O
shock	O
(	O
13	O
ml	O
/	O
kg	O
for	O
20	O
min	O
).	O

The	O
mobility	O
of	O
the	O
upper	O
and	O
lower	O
premolars	O
under	O
load	O
was	O
investigated	O
in	O
relation	O
to	O
the	O
interproximal	O
contact	O
and	O
occlusal	O
facets	O
.	O

Isolated	O
proteinuria	O
(	O
i	O
.	O
e	O
.	O
without	O
hematuria	O
and	O
/	O
or	O
pyuria	O
)	O
is	O
a	O
frequent	O
finding	O
.	O

Lithium	O
delays	O
the	O
circadian	O
rhythm	O
of	O
wheel	O
-	O
running	O
in	O
Syrian	O
hamsters	O
at	O
plasma	O
concentrations	O
(	O
0	O
.	O
59	O
-	O
0	O
.	O
74	O
mM	O
)	O
that	O
also	O
cause	O
toxic	O
weight	O
loss	O
.	O

Brain	B
cholinesterase	I
activity	O
of	O
nestling	O
great	O
egrets	O
,	O
snowy	O
egrets	O
and	O
black	O
-	O
crowned	O
night	O
-	O
herons	O
.	O
inhibition	O
of	O
brain	B
cholinesterase	I
(	O
ChE	B
)	O
activity	O
in	O
birds	O
is	O
often	O
used	O
to	O
diagnose	O
exposure	O
or	O
death	O
from	O
organophosphorus	O
or	O
carbamate	O
pesticides	O
.	O

Heating	O
cells	O
to	O
43	O
degrees	O
C	O
decreased	O
the	O
amount	O
of	O
newly	O
synthesized	O
rRNA	O
to	O
less	O
than	O
5	O
%	O
of	O
the	O
control	O
level	O
and	O
led	O
to	O
greater	O
than	O
95	O
%	O
inhibition	O
of	O
transcription	O
termination	O
at	O
a	O
region	O
355	O
to	O
362	O
nucleotides	O
downstream	O
of	O
the	O
3	O
'	O
end	O
of	O
28S	B
rRNA	I
,	O
with	O
readthrough	O
continuing	O
into	O
the	O
next	O
transcription	O
unit	O
.	O

The	O
author	O
gives	O
an	O
account	O
of	O
antipsychotic	O
,	O
analgetic	O
,	O
myorelaxing	O
and	O
vasodilatating	O
effects	O
of	O
some	O
calcium	O
antagonists	O
,	O
and	O
their	O
clinical	O
application	O
is	O
discussed	O
.	O

A	O
hospital	O
-	O
based	O
study	O
of	O
the	O
relationship	O
between	O
retained	O
placenta	O
and	O
mastitis	O
in	O
dairy	O
cows	O
.	O

This	O
indicates	O
that	O
lipid	O
peroxidation	O
may	O
be	O
involved	O
in	O
the	O
development	O
of	O
senile	O
cataract	O
and	O
,	O
as	O
a	O
direct	O
consequence	O
of	O
retinal	O
damage	O
,	O
also	O
in	O
the	O
pathogenesis	O
of	O
cataract	O
in	O
diabetes	O
and	O
in	O
severe	O
myopia	O
.	O

The	O
clinical	O
tolerance	O
and	O
pharmacokinetics	O
of	O
FCE	O
22101	O
(	O
sodium	O
(	O
5R	O
,	O
6S	O
)-	O
6	O
-[(	O
1R	O
)-	O
hydroxyethyl	O
]-	O
2	O
-	O
carbamoyloxymethyl	O
-	O
2	O
-	O
penem	O
-	O
3	O
-	O
carboxylate	O
),	O
a	O
new	O
penem	O
antibiotic	O
,	O
have	O
been	O
studied	O
after	O
giving	O
a	O
single	O
i	O
.	O
v	O
.	O
dose	O
of	O
4	O
mg	O
.	O
kg	O
-	O
1	O
to	O
ten	O
healthy	O
male	O
volunteers	O
.	O

DNA	O
blot	O
hybridization	O
suggests	O
that	O
the	O
rat	O
genome	O
may	O
contain	O
more	O
than	O
one	O
gene	O
encoding	O
PtdIns	B
transfer	I
protein	I
.	O

1	O
-(	O
1	O
-	O
Naphthyl	O
)	O
piperazine	O
(	O
1	O
-	O
NP	O
)	O
has	O
been	O
reported	O
to	O
have	O
serotonin	O
antagonist	O
properties	O
at	O
the	O
5	B
-	I
HT2	I
subtype	I
of	O
receptor	O
,	O
and	O
it	O
has	O
been	O
suggested	O
that	O
it	O
may	O
have	O
agonist	O
actions	O
at	O
the	O
5	B
-	I
HT1	I
site	I
.	O

1	O
-(	O
m	O
-	O
Chlorophenyl	O
)	O
piperazine	O
(	O
mCPP	O
,	O
0	O
.	O
1	O
-	O
3	O
.	O
0	O
mg	O
/	O
kg	O
)	O
and	O
1	O
-(	O
m	O
-	O
trifluoromethylphenyl	O
)	O
piperazine	O
(	O
TFMPP	O
,	O
0	O
.	O
1	O
-	O
3	O
.	O
0	O
mg	O
/	O
kg	O
),	O
both	O
thought	O
to	O
act	O
primarily	O
at	O
5	B
-	I
HT1	I
sites	I
,	O
also	O
decreased	O
responding	O
and	O
this	O
effect	O
was	O
blocked	O
by	O
methysergide	O
and	O
by	O
1	O
-	O
NP	O
,	O
but	O
not	O
by	O
ketanserin	O
.	O

Histiocytic	O
panniculitis	O
was	O
observed	O
in	O
biopsy	O
specimens	O
with	O
cytophagocytosis	O
.	O

We	O
have	O
utilized	O
the	O
human	B
4F2	I
heavy	I
chain	I
(	O
4F2HC	B
)	O
gene	O
as	O
a	O
model	O
system	O
in	O
studies	O
designed	O
to	O
elucidate	O
the	O
molecular	O
events	O
involved	O
in	O
regulating	O
inducible	O
gene	O
expression	O
during	O
normal	O
human	O
T	O
-	O
cell	O
activation	O
.	O

The	O
two	O
IL6	B
mRNA	I
species	O
are	O
generated	O
by	O
alternative	O
polyadenylation	O
at	O
sites	O
separated	O
by	O
a	O
distance	O
of	O
1	O
.	O
2	O
kilobases	O
.	O

Within	O
each	O
lobe	O
,	O
the	O
PA	O
dispersion	O
was	O
up	O
to	O
10	O
cmH2O	O
at	O
CFV	O
of	O
90	O
l	O
/	O
min	O
;	O
when	O
flow	O
decreased	O
,	O
PA	O
at	O
all	O
sites	O
decreased	O
,	O
as	O
did	O
the	O
intralobar	O
dispersion	O
.	O

Since	O
1948	O
,	O
the	O
use	O
of	O
saline	O
-	O
washed	O
red	O
cells	O
(	O
WRBCs	O
)	O
has	O
been	O
advocated	O
to	O
minimize	O
hemolysis	O
after	O
transfusion	O
to	O
patients	O
with	O
PNH	O
.	O

The	O
use	O
of	O
an	O
appropriate	O
solution	O
of	O
methylene	O
blue	O
(	O
0	O
.	O
2	O
%	O
in	O
0	O
.	O
9	O
M	O
NaCl	O
for	O
15	O
min	O
)	O
permits	O
the	O
staining	O
of	O
premalignant	O
areas	O
and	O
CIS	O
,	O
and	O
their	O
early	O
diagnosis	O
.	O

Lower	O
limits	O
(	O
to	O
10	O
micrograms	O
/	O
kg	O
)	O
were	O
detectable	O
,	O
but	O
with	O
lower	O
reliability	O
(	O
60	O
%).	O

The	O
congenital	O
forms	O
(	O
7	O
cases	O
)	O
all	O
occurred	O
in	O
female	O
infants	O
and	O
involved	O
the	O
mucosa	O
overlying	O
either	O
the	O
anterior	O
ridge	O
of	O
the	O
maxilla	O
or	O
the	O
mandible	O
.	O

Pacing	O
the	O
Roux	O
limb	O
abolished	O
the	O
ectopic	O
pacemakers	O
,	O
restored	O
the	O
slow	O
emptying	O
of	O
liquids	O
to	O
the	O
more	O
rapid	O
rate	O
found	O
in	O
the	O
Billroth	O
dogs	O
(	O
t1	O
/	O
2	O
:	O
paced	O
Roux	O
,	O
72	O
+/-	O
15	O
minutes	O
;	O
Billroth	O
,	O
43	O
+/-	O
9	O
minutes	O
;	O
p	O
greater	O
than	O
0	O
.	O
05	O
)	O
and	O
did	O
not	O
change	O
emptying	O
of	O
solids	O
.	O

In	O
terms	O
of	O
sequence	O
repetitions	O
,	O
seven	O
tandemly	O
repeated	O
copies	O
of	O
the	O
hexanucleotide	O
ATTGTT	O
and	O
three	O
flanking	O
regions	O
of	O
dyad	O
symmetry	O
were	O
detected	O
,	O
all	O
in	O
ORF	O
T3C	O
.	O

Anoxia	O
was	O
introduced	O
by	O
perfusing	O
the	O
gill	O
with	O
water	O
deprived	O
of	O
oxygen	O
or	O
by	O
halting	O
the	O
water	O
flow	O
to	O
the	O
gill	O
.	O

RPA190	B
encodes	O
a	O
polypeptide	O
chain	O
of	O
186	O
,	O
270	O
daltons	O
in	O
a	O
large	O
uninterrupted	O
reading	O
frame	O
.	O

We	O
detected	O
mos	B
transcripts	I
by	O
Northern	O
(	O
RNA	O
)	O
analyses	O
in	O
RNA	O
prepared	O
from	O
chicken	O
and	O
quail	O
ovaries	O
and	O
testes	O
.	O

The	O
results	O
suggest	O
that	O
the	O
organization	O
of	O
functional	O
units	O
of	O
the	O
72	O
-	O
bp	O
repeat	O
required	O
for	O
transcriptional	O
enhancement	O
of	O
the	O
early	O
promoter	O
is	O
different	O
from	O
that	O
required	O
for	O
late	O
promoter	O
function	O
.	O

Amino	O
acid	O
sequence	O
of	O
one	O
human	O
liver	O
clone	O
(	O
HL	O
-	O
14	O
)	O
was	O
identical	O
to	O
the	O
rabbit	B
skeletal	I
muscle	I
phosphatase	I
2A	I
cDNA	I
(	O
with	O
97	O
%	O
nucleotide	O
identity	O
).	O

(	O
anti	B
-	I
IIa	I
)	O
and	O
Holmer	O
et	O
al	O
.	O

Substitution	O
of	O
a	O
threonine	O
residue	O
by	O
an	O
alanine	O
residue	O
at	O
position	O
-	O
2	O
(	O
P2	O
)	O
of	O
this	O
cleavage	O
site	O
abolished	O
cleavage	O
,	O
whereas	O
substitution	O
of	O
a	O
tyrosine	O
residue	O
by	O
a	O
phenylalanine	O
residue	O
at	O
amino	O
acid	O
position	O
-	O
1	O
(	O
P1	O
)	O
of	O
the	O
cleavage	O
site	O
did	O
not	O
influence	O
processing	O
.	O

The	O
SV40	B
enhancer	I
augmented	O
replication	O
1	O
.	O
5	O
-	O
10	O
fold	O
.	O

Use	O
of	O
serum	O
thyroglobulin	B
determination	O
in	O
the	O
follow	O
-	O
up	O
of	O
differentiated	O
carcinomas	O
of	O
the	O
thyroid	O

Double	O
-	O
blind	O
randomised	O
trial	O
of	O
intravenous	O
tissue	B
-	I
type	I
plasminogen	I
activator	I
versus	O
placebo	O
in	O
acute	O
myocardial	O
infarction	O
.	O

Fentanyl	O
,	O
a	O
prototypic	O
mu	B
-	I
opiate	I
receptor	I
agonist	O
,	O
has	O
been	O
previously	O
shown	O
to	O
produce	O
a	O
syndrome	O
characterized	O
by	O
marked	O
analgesia	O
and	O
locomotor	O
stimulation	O
as	O
well	O
as	O
tachycardia	O
,	O
tachypnoea	O
and	O
behavioural	O
arousal	O
.	O

The	O
sensitivity	O
of	O
the	O
vas	O
deferens	O
to	O
adrenaline	O
was	O
also	O
reduced	O
in	O
scorbutic	O
guinea	O
pigs	O
,	O
thus	O
decreasing	O
their	O
fertility	O
rate	O
.	O

Testing	O
blood	O
donors	O
for	O
non	O
-	O
A	O
,	O
non	O
-	O
B	O
hepatitis	O
:	O
irrational	O
,	O
perhaps	O
,	O
but	O
inescapable	O
.	O

In	O
a	O
randomised	O
double	O
-	O
blind	O
study	O
,	O
46	O
first	O
episode	O
schizophrenics	O
were	O
given	O
pimozide	O
or	O
flupenthixol	O
for	O
up	O
to	O
5	O
weeks	O
;	O
the	O
mean	O
daily	O
dose	O
at	O
the	O
end	O
was	O
18	O
.	O
8	O
mg	O
pimozide	O
and	O
20	O
mg	O
flupenthixol	O
.	O

Direct	O
and	O
inverted	O
repeat	O
elements	O
of	O
10	O
,	O
11	O
,	O
16	O
,	O
19	O
,	O
and	O
22	O
nucleotides	O
(	O
nt	O
)	O
flank	O
the	O
promoter	O
site	O
.	O

Oestrogen	O
implant	O
overdose	O
.	O

The	O
subunit	B
-	I
a	I
gene	I
is	O
preceded	O
by	O
a	O
gene	O
coding	O
for	O
a	O
small	O
hydrophobic	O
protein	O
,	O
as	O
has	O
been	O
observed	O
previously	O
in	O
the	O
atp	B
operons	I
in	O
E	O
.	O
coli	O
,	O
bacterium	O
PS3	O
and	O
cyanobacteria	O
.	O

In	O
the	O
first	O
group	O
,	O
0	O
.	O
02	O
%	O
Prazosin	O
(	O
0	O
.	O
5	O
mg	O
/	O
kg	O
)	O
was	O
administered	O
intravenously	O
for	O
1	O
.	O
5	O
hours	O
before	O
the	O
application	O
of	O
Oxy	O
-	O
Hb	O
or	O
PGF2	O
alpha	O
.	O

Recently	O
,	O
an	O
electrical	O
-	O
mechanical	O
analog	O
model	O
of	O
heat	O
flow	O
within	O
the	O
brain	O
has	O
been	O
developed	O
from	O
which	O
an	O
expression	O
for	O
CBF	O
has	O
been	O
derived	O
:	O
CBF	O
=	O
Cb	O
/(	O
tau	O
rho	O
c	O
)	O
where	O
tau	O
is	O
the	O
thermal	O
decay	O
constant	O
,	O
rho	O
is	O
the	O
density	O
of	O
blood	O
,	O
and	O
c	O
is	O
its	O
specific	O
heat	O
.	O

All	O
of	O
the	O
newly	O
acquired	O
proviruses	O
identified	O
in	O
mosaic	O
founder	O
SWR	O
/	O
J	O
-	O
RF	O
/	O
J	O
mice	O
that	O
could	O
be	O
transmitted	O
through	O
the	O
germ	O
line	O
were	O
also	O
present	O
in	O
somatic	O
tissues	O
,	O
demonstrating	O
that	O
viral	O
integration	O
occurred	O
before	O
the	O
germ	O
line	O
was	O
set	O
aside	O
from	O
the	O
somatic	O
lineages	O
.	O

By	O
adapting	O
a	O
method	O
for	O
DNA	O
-	O
footprinting	O
using	O
impure	O
extracts	O
of	O
ner	B
overproducing	O
cells	O
,	O
we	O
were	O
able	O
to	O
determine	O
that	O
the	O
ner	B
-	I
binding	I
sites	I
are	O
located	O
between	O
nucleotides	O
1026	O
and	O
1058	O
from	O
the	O
Mu	O
left	O
end	O
.	O

Group	O
A	O
was	O
treated	O
with	O
three	O
or	O
four	O
doses	O
of	O
hepatitis	B
B	I
immune	I
globulin	I
(	O
HBIG	B
)	O
in	O
one	O
of	O
three	O
different	O
schedules	O
.	O

Thus	O
,	O
quantitative	O
analysis	O
of	O
thallium	O
-	O
201	O
uptake	O
and	O
washout	O
provided	O
objective	O
evidence	O
for	O
improved	O
myocardial	O
perfusion	O
after	O
coronary	O
angioplasty	O
.	O

This	O
study	O
reports	O
the	O
effects	O
of	O
a	O
preparation	O
with	O
50	O
micrograms	O
ethinyl	O
estradiol	O
and	O
2	O
mg	O
cyproterone	O
acetate	O
on	O
gonadotropins	B
,	O
prolactin	B
,	O
testosterone	O
,	O
sex	B
hormone	I
binding	I
globulin	I
(	O
SHBG	B
),	O
androstenedione	O
,	O
and	O
calculated	O
free	O
testosterone	O
index	O
before	O
and	O
after	O
six	O
months	O
of	O
treatment	O
.	O

The	O
clinical	O
picture	O
and	O
laboratory	O
parameters	O
were	O
consistent	O
with	O
a	O
serum	O
sickness	O
reaction	O
.	O

Ig	B
D	I
-	O
JH	B
recombinations	O
may	O
precede	O
TcR	B
gene	I
recombination	O
in	O
these	O
early	O
T	O
cell	O
lines	O
,	O
and	O
some	O
but	O
not	O
all	O
express	O
sterile	O
Cmu	B
transcripts	I
.	O

Plots	O
of	O
RV	O
,	O
LV	O
+	O
S	O
and	O
2A	O
weight	O
vs	O
real	O
hematocrit	O
showed	O
sharp	O
upward	O
inflections	O
at	O
real	O
hematocrit	O
65	O
%,	O
suggesting	O
a	O
possible	O
role	O
of	O
increased	O
viscosity	O
in	O
CO	O
cardiomegaly	O
at	O
the	O
higher	O
hematocrit	O
.	O

After	O
one	O
accommodation	O
night	O
,	O
sleep	O
EEG	O
recordings	O
were	O
performed	O
during	O
three	O
consecutive	O
nights	O
in	O
ten	O
drug	O
-	O
free	O
inpatients	O
presenting	O
generalized	O
anxiety	O
disorder	O
(	O
GAD	O
)	O
with	O
significant	O
depression	O
,	O
compared	O
with	O
a	O
age	O
-	O
and	O
sex	O
-	O
matched	O
group	O
of	O
patients	O
with	O
GAD	O
and	O
a	O
group	O
of	O
primary	O
major	O
depressive	O
disorder	O
(	O
MDD	O
)	O
patients	O
.	O

An	O
unusual	O
feature	O
of	O
these	O
replicative	O
genes	O
is	O
that	O
the	O
smaller	O
mRNA	O
begins	O
within	O
a	O
long	O
open	O
reading	O
frame	O
of	O
the	O
larger	O
mRNA	O
.	O

In	O
the	O
absence	O
of	O
enhancer	O
sequences	O
,	O
the	O
adenovirus	B
E1A	I
gene	I
can	O
not	O
stimulate	O
CATase	B
synthesis	O
.	O

FK	O
33	O
-	O
824	O
,	O
a	O
methionine	O
-	O
enkephalin	B
analogue	O
,	O
suppressed	O
plasma	O
ACTH	B
to	O
85	O
%	O
of	O
basal	O
level	O
,	O
while	O
bromocriptine	O
(	O
CB	O
-	O
154	O
)	O
caused	O
no	O
significant	O
change	O
.	O

Six	O
(	O
four	O
FAP	O
;	O
two	O
primary	O
amyloidosis	O
)	O
also	O
had	O
diffusely	O
positive	O
myocardial	O
uptakes	O
,	O
but	O
the	O
intensity	O
was	O
less	O
than	O
that	O
of	O
the	O
sternum	O
.	O

The	O
intensity	O
of	O
myocardial	O
uptake	O
of	O
Tc	O
-	O
99m	O
-	O
PYP	O
in	O
patients	O
with	O
echocardiographic	O
left	O
ventricular	O
hypertrophy	O
and	O
/	O
or	O
highly	O
refractile	O
myocardial	O
echoes	O
,	O
so	O
-	O
called	O
granular	O
sparkling	O
appearance	O
(	O
GS	O
)	O
was	O
slightly	O
greater	O
than	O
that	O
in	O
patients	O
with	O
neither	O
myocardial	O
hypertrophy	O
nor	O
GS	O
.	O

When	O
phosphorylation	O
of	O
exogenous	O
peptide	O
substrates	O
was	O
measured	O
as	O
a	O
function	O
of	O
receptor	O
self	O
-	O
phosphorylation	O
,	O
tyrosine	B
kinase	I
activity	O
was	O
found	O
to	O
be	O
enhanced	O
two	O
to	O
threefold	O
at	O
1	O
-	O
2	O
mol	O
of	O
phosphate	O
per	O
mol	O
of	O
receptor	O
.	O

Comparison	O
with	O
a	O
recently	O
described	O
c	B
-	I
sis	I
cDNA	I
clone	I
(	O
Collins	O
et	O
al	O
.,	O
Nature	O
316	O
,	O
748	O
-	O
750	O
(	O
1985	O
))	O
revealed	O
that	O
the	O
1	O
.	O
9	O
kbp	O
DNA	O
region	O
contained	O
a	O
large	O
5	B
'	I
c	I
-	I
sis	I
exon	I
of	O
at	O
least	O
1050	O
bp	O
.	O

Unlike	O
P135gag	B
-	O
myb	B
-	O
ets	B
and	O
the	O
Mr	O
75	O
,	O
000	O
translation	O
product	O
of	O
c	B
-	I
myb	I
(	O
P75c	B
-	I
myb	I
),	O
which	O
are	O
nuclear	O
proteins	O
,	O
P54c	B
-	I
ets	I
was	O
found	O
to	O
be	O
predominantly	O
cytoplasmic	O
.	O

Thirty	O
of	O
the	O
clones	O
contained	O
a	O
complete	O
340	O
base	O
-	O
pair	O
dimer	O
unit	O
of	O
the	O
repeat	O
.	O

In	O
order	O
to	O
study	O
the	O
influence	O
of	O
iron	O
overload	O
on	O
the	O
polymorphonuclear	O
leucocyte	O
(	O
PMN	O
)	O
metabolism	O
of	O
patients	O
on	O
chronic	O
hemodialysis	O
,	O
generation	O
of	O
superoxide	O
anion	O
(	O
O2	O
-)	O
by	O
PMN	O
in	O
whole	O
blood	O
was	O
compared	O
in	O
two	O
groups	O
of	O
hemodialyzed	O
patients	O
:	O
group	O
A	O
consisted	O
of	O
twenty	O
-	O
one	O
individuals	O
with	O
serum	O
ferritin	B
levels	O
above	O
1000	O
ng	O
/	O
ml	O
and	O
group	O
B	O
of	O
nineteen	O
individuals	O
with	O
serum	O
ferritin	B
levels	O
below	O
1000	O
ng	O
/	O
ml	O
.	O

Cattaneo	O
,	O
and	O
J	O
.	O

Human	B
alpha	I
-	I
galactosidase	I
A	I
:	O
nucleotide	O
sequence	O
of	O
a	O
cDNA	O
clone	O
encoding	O
the	O
mature	O
enzyme	O
.	O

Diazepam	O
(	O
3	O
mg	O
/	O
kg	O
)	O
generalized	O
to	O
Ro	O
11	O
-	O
6896	O
whereas	O
the	O
structurally	O
related	O
Ro	O
5	O
-	O
4864	O
(	O
3	O
mg	O
/	O
kg	O
and	O
30	O
mg	O
/	O
kg	O
)	O
did	O
not	O
.	O

Analysis	O
of	O
glucocorticoid	O
unresponsive	O
cell	O
variants	O
using	O
a	O
mouse	B
glucocorticoid	I
receptor	I
complementary	O
DNA	O
clone	O
.	O

Next	O
,	O
with	O
carcinoma	O
presenting	O
a	O
leather	O
bottle	O
(	O
linitis	O
plastica	O
type	O
)	O
of	O
the	O
stomach	O
itself	O
,	O
the	O
II	O
c	O
portion	O
of	O
the	O
stomach	O
consisted	O
of	O
fundic	O
glands	O
(	O
undifferentiated	O
carcinoma	O
)	O
shall	O
become	O
the	O
primary	O
focus	O
supporting	O
Nakamura	O
'	O
s	O
theory	O
.	O

Five	O
patients	O
developed	O
metastatic	O
spread	O
,	O
and	O
all	O
of	O
them	O
died	O
of	O
tumor	O
.	O

The	O
52	O
-	O
protein	O
subunit	O
of	O
T4	B
DNA	I
topoisomerase	I
is	O
homologous	O
to	O
the	O
gyrA	B
-	I
protein	I
of	O
gyrase	B
.	O

Insertion	O
of	O
4	O
bp	O
reduced	O
SV40	B
early	I
promoter	I
-	O
dependent	O
chloramphenicol	B
acetyltransferase	I
(	O
CAT	B
)	O
expression	O
by	O
six	O
-	O
to	O
eightfold	O
.	O

The	O
96	O
-	O
bp	O
insert	O
contained	O
a	O
termination	O
signal	O
which	O
caused	O
the	O
premature	O
termination	O
of	O
the	O
protein	O
,	O
leading	O
to	O
the	O
generation	O
of	O
a	O
p53	B
product	I
9	O
amino	O
acids	O
shorter	O
than	O
usual	O
.	O

Two	O
mutants	O
,	O
each	O
representative	O
of	O
a	O
separate	O
pet	B
complementation	O
group	O
,	O
have	O
been	O
analyzed	O
.	O

The	O
second	O
group	O
of	O
homologous	O
elements	O
is	O
present	O
in	O
the	O
upstream	O
region	O
of	O
both	O
genes	O
.	O

Constitutive	O
function	O
of	O
a	O
positively	O
regulated	O
promoter	O
reveals	O
new	O
sequences	O
essential	O
for	O
activity	O
.	O

Active	O
lambda	B
and	I
kappa	I
antibody	I
gene	I
rearrangement	O
in	O
Abelson	O
murine	O
leukemia	O
virus	O
-	O
transformed	O
pre	O
-	O
B	O
cell	O
lines	O
.	O

Northern	O
analyses	O
of	O
RNAs	O
from	O
mouse	O
tissues	O
and	O
cell	O
lines	O
indicated	O
that	O
p11	B
mRNA	I
levels	O
vary	O
widely	O
.	O

One	O
group	O
of	O
six	O
cDNA	O
clones	O
was	O
derived	O
from	O
a	O
2	O
.	O
9	O
-	O
kilobase	O
early	O
transcript	O
encoded	O
by	O
the	O
IR2	O
repeat	O
element	O
and	O
showed	O
restriction	O
site	O
polymorphism	O
for	O
the	O
enzyme	B
SmaI	I
.	O

The	O
gene	O
is	O
essential	O
for	O
yeast	O
vegetative	O
growth	O
.	O

4	O
.	O

The	O
relationship	O
between	O
primary	O
malignant	O
lymphoma	O
of	O
the	O
thyroid	O
and	O
chronic	O
thyroiditis	O
is	O
discussed	O
.	O

The	O
in	O
vitro	O
activity	O
of	O
mecillinam	O
and	O
amoxicillin	O
/	O
clavulanic	O
acid	O
against	O
Escherichia	O
coli	O
strains	O
producing	O
beta	B
-	I
lactamases	I
of	O
the	O
TEM	B
-	I
1	I
,	O
Oxa	B
-	I
1	I
and	O
chromosomal	O
type	O
were	O
studied	O
using	O
the	O
broth	O
and	O
agar	O
dilution	O
technique	O
.	O

The	O
efficacy	O
of	O
these	O
immunosuppressive	O
drugs	O
is	O
clinical	O
proven	O
.	O

Amounts	O
of	O
glucose	O
infused	O
during	O
the	O
last	O
20	O
min	O
of	O
each	O
2	O
hour	O
insulin	B
infusion	O
were	O
(	O
at	O
1	O
and	O
10	O
m	O
/	O
kg	O
/	O
min	O
respectively	O
):	O
before	O
treatment	O
(	O
K	O
+	O
=	O
2	O
.	O
7	O
mmol	O
/	O
l	O
):	O
2	O
.	O
4	O
and	O
8	O
.	O
4	O
mg	O
/	O
kg	O
/	O
min	O
;	O
after	O
spironolactone	O
(	O
K	O
+	O
=	O
3	O
.	O
9	O
mmol	O
/	O
l	O
):	O
3	O
.	O
3	O
and	O
15	O
.	O
4	O
mg	O
/	O
kg	O
/	O
min	O
;	O
after	O
indomethacine	O
(	O
K	O
+	O
=	O
3	O
.	O
7	O
mmol	O
/	O
l	O
):	O
5	O
and	O
19	O
mg	O
/	O
kg	O
/	O
min	O
after	O
stopping	O
drugs	O
(	O
K	O
+	O
=	O
2	O
.	O
9	O
mmol	O
/	O
l	O
):	O
2	O
.	O
5	O
and	O
5	O
.	O
3	O
mg	O
/	O
kg	O
/	O
min	O
.	O

Modifications	O
of	O
the	O
involuntary	O
postcontraction	O
in	O
diseased	O
people	O
.	O

The	O
effects	O
of	O
glutaraldehyde	O
on	O
dimensions	O
and	O
ultrastructure	O
of	O
microvascular	O
beds	O
in	O
rat	O
mesentery	O
were	O
studied	O
in	O
two	O
kinds	O
of	O
experiment	O
,	O
administering	O
the	O
fixative	O
by	O
intra	O
-	O
arterial	O
perfusion	O
at	O
a	O
pressure	O
of	O
80	O
mm	O
Hg	O
and	O
by	O
superfusion	O
of	O
the	O
exteriorized	O
mesenteric	O
membrane	O
.	O

Ritanserin	O
is	O
a	O
new	O
substance	O
with	O
highly	O
selective	O
blocking	O
activity	O
on	O
S2	B
receptors	I
for	O
5	O
-	O
HT	O
in	O
the	O
central	O
nervous	O
system	O
.	O

During	O
BH	O
the	O
ventilator	O
was	O
disconnected	O
and	O
a	O
bias	O
flow	O
of	O
50	O
%	O
O2	O
at	O
4	O
-	O
5	O
l	O
/	O
min	O
was	O
delivered	O
through	O
the	O
side	O
ports	O
of	O
a	O
small	O
catheter	O
whose	O
tip	O
was	O
positioned	O
1	O
cm	O
cephalad	O
of	O
the	O
carina	O
.	O

In	O
addition	O
,	O
a	O
wild	O
-	O
type	O
strain	O
containing	O
a	O
temperature	B
-	I
sensitive	I
threonyl	I
-	I
tRNA	I
synthetase	I
mutation	I
showed	O
increased	O
thr	B
operon	I
expression	O
at	O
the	O
non	O
-	O
permissive	O
temperature	O
,	O
whereas	O
none	O
of	O
the	O
mutants	O
showed	O
any	O
change	O
.	O

Clinical	O
and	O
biological	O
correlates	O
of	O
panic	O
states	O
.	O

Of	O
7	O
patients	O
treated	O
with	O
cyclophosphamide	O
,	O
hexamethylmelamine	O
,	O
adriamycin	O
and	O
cisplatin	O
(	O
CHAP	O
-	O
5	O
),	O
6	O
had	O
measurable	O
disease	O
,	O
of	O
whom	O
5	O
yielded	O
a	O
response	O
(	O
2	O
complete	O
responses	O
for	O
19	O
+	O
and	O
40	O
months	O
and	O
3	O
partial	O
responses	O
for	O
4	O
,	O
7	O
and	O
8	O
months	O
).	O

In	O
64	O
%	O
a	O
small	O
cardiac	O
vein	O
does	O
not	O
exist	O
,	O
but	O
its	O
origin	O
,	O
the	O
right	O
marginal	O
vein	O
,	O
joins	O
the	O
system	O
of	O
anterior	O
cardiac	O
veins	O
.	O

The	O
Euglena	B
ribosomal	I
protein	I
gene	I
cluster	I
resembles	O
the	O
S	B
-	I
10	I
ribosomal	I
protein	I
operon	I
of	I
Escherichia	I
coli	I
in	O
gene	O
organization	O
and	O
follows	O
the	O
exact	O
linear	O
order	O
of	O
the	O
analogous	O
genes	O
in	O
the	O
tobacco	O
and	O
liverwort	O
chloroplast	O
genomes	O
.	O

The	O
nucleotide	O
sequence	O
of	O
the	O
region	O
upstream	O
from	O
M	B
.	I
voltae	I
ORFtrpA	I
was	O
determined	O
and	O
revealed	O
the	O
presence	O
of	O
an	O
ORF	O
of	O
1227	O
nucleotides	O
(	O
ORFtrpB	B
)	O
encoding	O
a	O
409	O
amino	O
acid	O
polypeptide	O
of	O
mol	O
.	O
wt	O
.	O

Of	O
49	O
receptors	O
which	O
fired	O
in	O
phase	O
with	O
ventilation	O
,	O
13	O
behaved	O
like	O
mammalian	O
rapidly	O
adapting	O
pulmonary	O
stretch	O
receptors	O
,	O
19	O
like	O
mammalian	O
slowly	O
adapting	O
pulmonary	O
stretch	O
receptors	O
(	O
PSR	O
),	O
and	O
17	O
like	O
avian	O
intrapulmonary	O
CO2	O
-	O
sensitive	O
chemoreceptors	O
(	O
IPC	O
).	O

Symptomatic	O
hyperventilators	O
had	O
a	O
larger	O
number	O
of	O
sighs	O
and	O
abnormally	O
wide	O
fluctuations	O
in	O
baseline	O
for	O
inspiratory	O
time	O
,	O
expiratory	O
time	O
,	O
and	O
PETCO2	O
.	O

In	O
the	O
IA	O
task	O
,	O
post	O
-	O
training	O
intraperitoneal	O
injections	O
of	O
picrotoxin	O
and	O
bicuculline	O
induced	O
a	O
dose	O
-	O
dependent	O
enhancement	O
of	O
retention	O
measured	O
24	O
h	O
after	O
the	O
training	O
,	O
while	O
retention	O
was	O
not	O
affected	O
by	O
bicuculline	O
methiodide	O
(	O
a	O
GABA	B
receptor	I
antagonist	O
that	O
does	O
not	O
readily	O
cross	O
the	O
blood	O
-	O
brain	O
barrier	O
).	O

The	O
5	O
'	O
end	O
of	O
the	O
coding	O
region	O
was	O
located	O
precisely	O
by	O
comparing	O
the	O
deduced	O
amino	O
acid	O
sequence	O
to	O
the	O
actual	O
N	O
-	O
terminal	O
amino	O
acid	O
sequence	O
of	O
IHF	B
.	O

The	O
CHARGE	O
association	O
is	O
a	O
collection	O
of	O
multisystem	O
congenital	O
anomalies	O
including	O
choanal	O
atresia	O
.	O

Esophageal	O
brush	O
cytological	O
screening	O
was	O
undertaken	O
and	O
blood	O
concentrations	O
of	O
micronutrients	O
(	O
vitamin	O
A	O
,	O
E	O
,	O
B12	O
,	O
folic	O
acid	O
and	O
methionine	O
)	O
determined	O
from	O
adults	O
at	O
risk	O
for	O
esophageal	O
carcinoma	O
(	O
EC	O
)	O
in	O
Transkei	O
and	O
Ciskei	O
,	O
Southern	O
Africa	O
.	O

Comparison	O
was	O
made	O
with	O
other	O
neuroradiological	O
imaging	O
modalities	O
including	O
CT	O
,	O
myelography	O
,	O
CT	O
ventriculography	O
,	O
and	O
CT	O
myelocisternography	O
.	O

In	O
a	O
112	O
-	O
d	O
feedlot	O
trial	O
,	O
105	O
heifers	O
were	O
assigned	O
to	O
light	O
,	O
medium	O
and	O
heavy	O
weight	O
blocks	O
on	O
five	O
treatments	O
:	O
dietary	O
MGA	O
(.	O
5	O
mg	O
.	O
hd	O
-	O
1	O
.	O
d	O
-	O
1	O
),	O
control	O
(	O
no	O
MGA	O
)	O
or	O
DEPO	O
-	O
MGA	O
on	O
d	O
1	O
at	O
.	O
5	O
,	O
1	O
.	O
0	O
or	O
1	O
.	O
5	O
ml	O
/	O
hd	O
(	O
30	O
,	O
60	O
or	O
90	O
mg	O
MGA	O
/	O
hd	O
,	O
respectively	O
).	O

The	O
partial	O
sequence	O
of	O
the	O
62	B
-	I
kDa	I
nuclear	I
pore	I
glycoprotein	I
shows	O
little	O
similarity	O
to	O
other	O
characterized	O
proteins	O
and	O
elucidates	O
structural	O
features	O
of	O
a	O
member	O
of	O
the	O
family	O
of	O
nuclear	B
pore	I
glycoproteins	I
.	O

Of	O
the	O
43	O
infants	O
with	O
a	O
(	O
probable	O
)	O
loss	O
18	O
were	O
examined	O
again	O
at	O
3	O
months	O
corrected	O
age	O
.	O

Not	O
even	O
extensive	O
pancreatic	O
resection	O
could	O
prevent	O
pancreatic	O
remnant	O
infection	O
.	O

Effect	O
of	O
the	O
methods	O
of	O
cutaneous	O
administration	O
of	O
methyl	O
isobutyl	O
ketone	O
on	O
its	O
toxicity	O

Increasing	O
the	O
phosphorus	O
content	O
of	O
the	O
diet	O
improved	O
the	O
reabsorption	O
of	O
calcium	O
and	O
magnesium	O
.	O

The	O
purposes	O
of	O
this	O
study	O
were	O
1	O
)	O
to	O
examine	O
the	O
effect	O
of	O
high	O
intensity	O
,	O
low	O
frequency	O
transcutaneous	O
electrical	O
nerve	O
stimulation	O
at	O
auricular	O
acupuncture	O
points	O
on	O
experimental	O
pain	O
threshold	O
measured	O
at	O
the	O
wrist	O
and	O
2	O
)	O
to	O
determine	O
the	O
changes	O
in	O
effect	O
over	O
time	O
.	O

Records	O
of	O
31	O
children	O
with	O
AIDS	O
or	O
AIDS	O
-	O
related	O
complex	O
admitted	O
to	O
the	O
pediatric	O
intensive	O
care	O
unit	O
for	O
acute	O
respiratory	O
failure	O
throughout	O
a	O
46	O
-	O
month	O
period	O
were	O
reviewed	O
.	O

SPECT	O
is	O
an	O
important	O
aid	O
in	O
the	O
diagnosis	O
of	O
AIDS	O
dementia	O
complex	O
and	O
contributes	O
to	O
the	O
understanding	O
of	O
the	O
pathophysiological	O
mechanisms	O
of	O
this	O
disorder	O
.	O

We	O
concluded	O
that	O
Ga	O
-	O
fbg	O
scintigraphy	O
is	O
a	O
very	O
simple	O
method	O
and	O
sufficiently	O
useful	O
for	O
detecting	O
active	O
left	O
ventricular	O
thrombi	O
and	O
for	O
monitoring	O
the	O
effect	O
of	O
anticoagulant	O
therapy	O
.	O

We	O
report	O
the	O
use	O
of	O
a	O
new	O
technetium	O
-	O
99m	O
-	O
albumin	B
colloid	O
white	O
blood	O
cell	O
(	O
TAC	O
-	O
WBC	O
)	O
scan	O
in	O
the	O
evaluation	O
of	O
appendicitis	O
.	O

Finally	O
,	O
over	O
a	O
similar	O
range	O
of	O
QO2	O
,	O
oxygen	O
extraction	O
was	O
greater	O
in	O
patients	O
with	O
ARDS	O
compared	O
to	O
patients	O
with	O
non	O
-	O
ARDS	O
respiratory	O
failure	O
(	O
r	O
=	O
-	O
0	O
.	O
67	O
and	O
slope	O
=	O
-	O
0	O
.	O
62	O
vs	O
r	O
=	O
-	O
0	O
.	O
45	O
and	O
slope	O
=	O
-	O
0	O
.	O
35	O
;	O
p	O
less	O
than	O
0	O
.	O
05	O
).	O

Minor	O
differences	O
were	O
noted	O
with	O
latamoxef	O
producing	O
mild	O
persistant	O
elevation	O
of	O
prothrombin	B
time	O
(	O
0	O
.	O
7	O
second	O
)	O
associated	O
with	O
depression	O
of	O
factor	B
II	I
and	O
factor	B
VII	I
.	O

Contrary	O
to	O
the	O
observation	O
made	O
with	O
other	O
S	O
.	O
pombe	O
genes	O
transcribed	O
in	O
the	O
budding	O
yeast	O
,	O
the	O
heterologous	O
actin	B
gene	I
transcript	I
is	O
initiated	O
39	O
nucleotides	O
upstream	O
of	O
the	O
initiation	O
start	O
site	O
used	O
in	O
the	O
homologous	O
yeast	O
.	O

A	O
multicentre	O
study	O
involving	O
9	O
Italian	O
institutions	O
was	O
carried	O
out	O
to	O
compare	O
the	O
efficacy	O
and	O
safety	O
of	O
ranitidine	O
150	O
mg	O
b	O
.	O
i	O
.	O
d	O
.	O
and	O
ranitidine	O
300	O
mg	O
nocte	O
in	O
the	O
treatment	O
of	O
reflux	O
oesophagitis	O
.	O

The	O
N3	O
wave	O
of	O
the	O
SSEP	O
'	O
s	O
,	O
which	O
has	O
been	O
found	O
to	O
correlate	O
best	O
with	O
neurological	O
recovery	O
,	O
returned	O
to	O
65	O
%	O
+/-	O
48	O
%	O
of	O
the	O
preischemia	O
amplitude	O
in	O
the	O
insulin	B
-	O
treated	O
animals	O
,	O
compared	O
to	O
40	O
%	O
+/-	O
34	O
%	O
in	O
the	O
fasted	O
group	O
and	O
26	O
%	O
+/-	O
24	O
%	O
in	O
the	O
control	O
animals	O
.	O

In	O
contrast	O
to	O
this	O
mRNA	O
,	O
90	O
%	O
of	O
alpha	B
and	I
beta	I
actin	I
mRNAs	I
were	O
translated	O
in	O
both	O
myoblasts	O
and	O
myotubes	O
.	O

Cephradine	O
250	O
mg	O
at	O
night	O
for	O
12	O
months	O
was	O
given	O
as	O
a	O
prophylactic	O
measure	O
to	O
33	O
female	O
patients	O
of	O
mean	O
age	O
41	O
.	O
6	O
years	O
,	O
who	O
had	O
a	O
history	O
in	O
the	O
preceding	O
12	O
months	O
of	O
between	O
three	O
and	O
24	O
(	O
median	O
=	O
7	O
)	O
episodes	O
of	O
frequency	O
and	O
/	O
or	O
dysuria	O
.	O

Hand	O
-	O
held	O
,	O
continuous	O
-	O
wave	O
Doppler	O
probes	O
,	O
coupled	O
with	O
sound	O
spectral	O
analysis	O
,	O
can	O
successfully	O
predict	O
carotid	O
artery	O
stenosis	O
.	O

High	O
concentrations	O
of	O
tumor	O
-	O
associated	O
trypsin	B
inhibitor	O
in	O
hemodialyzed	O
patients	O
.	O

With	O
histology	O
and	O
Evans	O
blue	O
injections	O
,	O
blood	O
-	O
brain	O
barrier	O
alterations	O
were	O
seen	O
as	O
early	O
as	O
4	O
days	O
after	O
a	O
dose	O
of	O
50	O
Gy	O
.	O

The	O
correlation	O
between	O
PaCO2	O
and	O
PtcO2	O
in	O
RDS	O
was	O
insufficient	O
to	O
make	O
clinical	O
judgement	O
.	O

The	O
epidermal	B
growth	I
factor	I
(	I
EGF	I
)	I
receptor	I
,	O
which	O
exhibits	O
intrinsic	O
protein	B
tyrosine	I
kinase	I
activity	O
,	O
undergoes	O
a	O
rapid	O
,	O
intramolecular	O
self	O
-	O
phosphorylation	O
reaction	O
following	O
EGF	B
activation	O
.	O

There	O
are	O
regions	O
with	O
long	O
runs	O
of	O
up	O
to	O
45	O
%	O
C	O
or	O
35	O
%	O
G	O
residues	O
.	O

Vocal	O
cord	O
abduction	O
rehabilitation	O
by	O
nervous	O
selective	O
anastomosis	O
.	O

After	O
the	O
meal	O
containing	O
potato	O
,	O
plasma	O
glucose	O
levels	O
rose	O
sharply	O
,	O
peaked	O
at	O
30	O
-	O
45	O
min	O
and	O
fell	O
below	O
initial	O
levels	O
2	O
to	O
3	O
h	O
later	O
.	O

Such	O
a	O
change	O
may	O
involve	O
increased	O
mammary	O
utilization	O
of	O
pre	O
-	O
formed	O
long	O
-	O
chain	O
fatty	O
acid	O
and	O
increased	O
metabolism	O
of	O
glucose	O
via	O
glycolysis	O
.	O

Because	O
of	O
its	O
great	O
reliability	O
,	O
conventional	O
arteriography	O
occupies	O
a	O
place	O
of	O
choice	O
among	O
the	O
medical	O
imaging	O
techniques	O
.	O

The	O
former	O
group	O
did	O
excrete	O
less	O
dry	O
fecal	O
material	O
compared	O
to	O
both	O
other	O
groups	O
.	O

Electronic	O
data	O
processing	O
(	O
EDP	O
)	O
latex	O
immunoassay	O
using	O
anti	B
-	I
human	I
seminal	I
acid	I
phosphatase	I
(	O
anti	B
-	I
HSAP	I
)	O
immune	O
serum	O
was	O
applied	O
for	O
the	O
species	O
and	O
organ	O
identification	O
of	O
human	O
seminal	O
stains	O
.	O

The	O
spermicide	O
nonoxynol	O
-	O
9	O
is	O
a	O
member	O
of	O
a	O
homologous	O
series	O
of	O
alkylphenol	O
-	O
ethoxylates	O
(	O
polyethoxyethanols	O
)	O
of	O
general	O
formula	O
C9H19	O
-	O
C6H6	O
-	O
O	O
-(	O
CH2CH2O	O
)	O
n	O
-	O
1	O
CH2CH2OH	O
.	O

Depending	O
on	O
the	O
location	O
and	O
size	O
of	O
the	O
mass	O
,	O
a	O
wide	O
range	O
of	O
clinical	O
presentations	O
is	O
associated	O
with	O
the	O
lesion	O
.	O

The	O
development	O
and	O
distribution	O
of	O
Trypanosoma	O
congolense	O
,	O
T	O
vivax	O
and	O
T	O
brucei	O
in	O
the	O
skin	O
of	O
goats	O
was	O
examined	O
after	O
the	O
animals	O
were	O
bitten	O
by	O
infected	O
Glossina	O
morsitans	O
centralis	O
.	O

Electroglottography	O
is	O
a	O
useful	O
,	O
non	O
-	O
invasive	O
technique	O
that	O
can	O
assist	O
in	O
the	O
assessment	O
of	O
vocal	O
fold	O
dysfunction	O
.	O

Statistical	O
analysis	O
of	O
the	O
degrees	O
of	O
secondary	O
spinal	O
cord	O
compression	O
was	O
performed	O
in	O
group	O
-	O
1	O
dogs	O
by	O
measuring	O
and	O
comparing	O
ratios	O
of	O
the	O
vertical	O
to	O
the	O
horizontal	O
diameters	O
of	O
the	O
transverse	O
spinal	O
cord	O
sections	O
from	O
locations	O
within	O
(	O
T12	O
to	O
L1	O
)	O
and	O
out	O
of	O
(	O
T11	O
,	O
T11	O
-	O
12	O
,	O
L1	O
-	O
2	O
,	O
and	O
L2	O
)	O
the	O
region	O
of	O
surgical	O
intervention	O
.	O

Thyroid	O
function	O
tests	O
were	O
performed	O
on	O
300	O
admissions	O
,	O
leaving	O
707	O
untested	O
.	O

Pregnant	O
rats	O
were	O
exposed	O
to	O
one	O
of	O
the	O
following	O
:	O
(	O
1	O
)	O
10	O
%	O
O2	O
in	O
N2	O
or	O
100	O
%	O
O2	O
for	O
2	O
days	O
beginning	O
at	O
day	O
7	O
,	O
11	O
,	O
14	O
,	O
or	O
18	O
of	O
pregnancy	O
;	O
(	O
2	O
)	O
10	O
%	O
O2	O
in	O
N2	O
or	O
100	O
%	O
O2	O
for	O
10	O
h	O
/	O
day	O
beginning	O
at	O
day	O
7	O
;	O
or	O
(	O
3	O
)	O
14	O
-	O
11	O
%	O
O2	O
in	O
N2	O
continuously	O
beginning	O
at	O
day	O
14	O
till	O
day	O
21	O
when	O
they	O
were	O
sacrificed	O
.	O

A	O
Golgi	O
study	O
of	O
the	O
sixth	O
layer	O
of	O
the	O
cerebral	O
cortex	O
.	O

Ultrastructural	O
study	O
of	O
polyarteritis	O

X2	O
test	O
,	O
with	O
Yates	O
correction	O
if	O
need	O
,	O
was	O
used	O
as	O
statistical	O
.	O
method	O
.	O

Clinical	O
method	O
for	O
the	O
treatment	O
of	O
Class	O
II	O
occlusal	O
anomalies	O
with	O
open	O
bite	O

Autonomic	O
dysfunctions	O
were	O
restricted	O
to	O
tonic	O
pupils	O
.	O

In	O
a	O
previous	O
interim	O
report	O
we	O
noted	O
more	O
prompt	O
resolution	O
of	O
dermatomal	O
signs	O
and	O
symptoms	O
with	O
acyclovir	O
treatment	O
.	O

Pharmacologic	O
properties	O
of	O
serotonergic	O
agents	O
and	O
antidepressant	O
drugs	O
.	O

Hexsyn	O
is	O
the	O
Goodyear	O
Tire	O
and	O
Rubber	O
Company	O
tradename	O
for	O
a	O
polyolefin	O
rubber	O
synthesized	O
from	O
1	O
-	O
hexene	O
with	O
3	O
-	O
5	O
%	O
methylhexadiene	O
as	O
the	O
source	O
of	O
residual	O
double	O
bonds	O
for	O
vulcanization	O
.	O

Neither	O
ethanol	O
nor	O
estrogen	O
has	O
been	O
shown	O
to	O
cause	O
UROD	B
-	O
deficiency	O
in	O
animals	O
.	O

All	O
patients	O
then	O
received	O
suxamethonium	O
1	O
.	O
5	O
mg	O
kg	O
-	O
1	O
i	O
.	O
v	O
.	O

State	O
-	O
approved	O
schools	O
of	O
nursing	O
R	O
.	O
N	O
.	O

The	O
small	O
size	O
and	O
placement	O
of	O
the	O
mutagenesis	O
marker	O
(	O
the	O
supF	B
suppressor	I
tRNA	I
gene	I
from	I
Escherichia	I
coli	I
)	O
within	O
the	O
vector	O
substantially	O
reduced	O
the	O
frequency	O
of	O
spontaneous	O
mutations	O
normally	O
observed	O
after	O
transfection	O
of	O
mammalian	O
cells	O
with	O
plasmid	O
DNA	O
;	O
hence	O
,	O
UV	O
-	O
induced	O
mutations	O
were	O
easily	O
identified	O
above	O
the	O
spontaneous	O
background	O
.	O

Tetrad	O
analysis	O
and	O
mitotic	O
recombination	O
experiments	O
localized	O
the	O
PEP4	B
gene	I
proximal	O
to	O
GAL4	B
on	O
chromosome	O
XVI	O
.	O

Based	O
on	O
our	O
observations	O
,	O
we	O
propose	O
a	O
model	O
whereby	O
inactive	O
precursor	O
molecules	O
produced	O
from	O
the	O
PEP4	B
gene	I
self	O
-	O
activate	O
within	O
the	O
yeast	O
vacuole	O
and	O
subsequently	O
activate	O
other	O
vacuolar	B
hydrolases	I
.	O

The	O
poly	O
(	O
A	O
)	O
segment	O
of	O
the	O
RNA	O
was	O
selectively	O
cross	O
-	O
linked	O
to	O
the	O
72	O
,	O
000	O
-	O
molecular	O
-	O
weight	O
protein	O
(	O
72K	O
protein	O
).	O

SCL	O
prolonged	O
promptly	O
after	O
verapamil	O
,	O
and	O
sinus	O
arrest	O
developed	O
in	O
two	O
of	O
10	O
group	O
2	O
and	O
two	O
of	O
five	O
group	O
3	O
animals	O
.	O

Development	O
of	O
a	O
yeast	O
system	O
to	O
assay	O
mutational	O
specificity	O
.	O

The	O
latter	O
was	O
determined	O
as	O
follows	O
:	O
Type	O
I	O
-	O
solid	O
tumor	O
tissue	O
without	O
significant	O
peripheral	O
isolated	O
tumor	O
cells	O
;	O
Type	O
II	O
-	O
solid	O
tumor	O
tissue	O
associated	O
with	O
peripheral	O
isolated	O
tumor	O
cells	O
;	O
Type	O
III	O
-	O
isolated	O
tumor	O
cells	O
only	O
.	O

For	O
signal	O
durations	O
less	O
than	O
10	O
ms	O
,	O
however	O
,	O
the	O
SoNo	O
and	O
S	O
pi	O
No	O
threshold	O
functions	O
converged	O
and	O
the	O
masking	O
-	O
level	O
difference	O
decreased	O
.	O

Reward	O
value	O
of	O
prosodic	O
features	O
of	O
language	O
for	O
autistic	O
,	O
mentally	O
retarded	O
,	O
and	O
normal	O
children	O
.	O

Significantly	O
lower	O
heart	O
rate	O
reactivity	O
and	O
significantly	O
less	O
pronounced	O
left	O
temporal	O
artery	O
pulse	O
amplitude	O
responses	O
were	O
found	O
in	O
non	O
-	O
medicated	O
TH	O
subjects	O
than	O
in	O
controls	O
.	O

Drugs	O
that	O
are	O
transformed	O
via	O
phase	O
II	O
reactions	O
usually	O
do	O
not	O
require	O
dosage	O
adjustment	O
.	O

Heat	O
-	O
labile	O
-	O
like	O
enterotoxin	O
(	O
LT	B
)	O
was	O
produced	O
by	O
26	O
of	O
42	O
stool	O
isolates	O
(	O
62	O
%),	O
while	O
only	O
1	O
of	O
the	O
42	O
isolates	O
(	O
2	O
%)	O
produced	O
enterotoxinlike	O
activity	O
in	O
suckling	O
mice	O
;	O
65	O
%	O
of	O
the	O
cytotoxin	O
-	O
producing	O
strains	O
also	O
produced	O
an	O
LT	B
-	I
like	I
material	O
.	O

The	O
other	O
model	O
was	O
a	O
continuous	O
exponential	O
plus	O
constant	O
of	O
the	O
form	O
La	O
-	O
=	O
a	O
+	O
b	O
[	O
exp	O
(	O
cVO2	O
)].	O

The	O
effect	O
of	O
dietary	O
zinc	O
deficiency	O
on	O
the	O
mossy	O
fiber	O
zinc	O
content	O
of	O
the	O
rat	O
hippocampus	O
.	O

Weaned	O
rats	O
were	O
fed	O
a	O
normal	O
diet	O
or	O
a	O
low	O
-	O
protein	O
,	O
low	O
-	O
energy	O
diet	O
,	O
and	O
injected	O
with	O
saline	O
or	O
thyroxine	O
(	O
5	O
micrograms	O
/	O
100	O
g	O
BW	O
)	O
for	O
22	O
days	O
.	O

Data	O
from	O
119	O
men	O
and	O
40	O
women	O
undergoing	O
coronary	O
angiography	O
provide	O
an	O
opportunity	O
to	O
compare	O
these	O
associations	O
in	O
relation	O
to	O
a	O
direct	O
and	O
continuous	O
measure	O
of	O
atherosclerosis	O
while	O
controlling	O
for	O
age	O
,	O
sex	O
,	O
income	O
,	O
hypertension	O
,	O
serum	O
cholesterol	O
,	O
smoking	O
,	O
angina	O
,	O
diabetes	O
,	O
family	O
history	O
of	O
heart	O
disease	O
,	O
Type	O
A	O
behavior	O
pattern	O
,	O
and	O
hostility	O
.	O

An	O
intralobar	O
change	O
in	O
temperature	O
above	O
or	O
below	O
36	O
degrees	O
C	O
decreases	O
only	O
the	O
lobar	O
bronchial	O
blood	O
flow	O
and	O
does	O
not	O
influence	O
blood	O
flow	O
to	O
other	O
nearby	O
tissues	O
including	O
those	O
vascularized	O
by	O
the	O
bronchial	O
circulation	O
.	O

In	O
addition	O
,	O
on	O
the	O
Cohler	O
'	O
s	O
maternal	O
scale	O
,	O
Korean	O
mothers	O
were	O
found	O
to	O
view	O
their	O
infants	O
as	O
more	O
passive	O
and	O
dependent	O
than	O
American	O
mothers	O
did	O
(	O
P	O
less	O
than	O
0	O
.	O
00	O
).	O

Hyperthyroidism	O

UVA	O
-	O
induced	O
melanocytic	O
lesions	O
.	O

Ex	O
vivo	O
MAO	B
inhibition	O
data	O
indicated	O
DPGPEA	O
to	O
be	O
an	O
inhibitor	O
of	O
MAO	B
-	I
B	I
,	O
although	O
the	O
effect	O
was	O
much	O
weaker	O
than	O
seen	O
with	O
tranylcypromine	O
or	O
pargyline	O
.	O

The	O
average	O
deviations	O
in	O
the	O
X	O
-	O
ray	O
counts	O
of	O
the	O
constant	O
elements	O
from	O
the	O
series	O
means	O
were	O
used	O
to	O
correct	O
the	O
recorded	O
count	O
of	O
the	O
variable	O
element	O
in	O
each	O
block	O
.	O

Today	O
there	O
is	O
no	O
doubt	O
that	O
elevated	O
plasma	O
cholesterol	O
levels	O
should	O
be	O
lowered	O
first	O
by	O
dietary	O
modification	O
even	O
in	O
early	O
childhood	O
,	O
beginning	O
at	O
the	O
age	O
of	O
two	O
years	O
.	O

Endurance	O
training	O
resulted	O
in	O
an	O
increase	O
of	O
stiffness	O
associated	O
with	O
a	O
decrease	O
of	O
type	O
II	O
fibers	O
.	O

A	O
rate	O
-	O
decreasing	O
dose	O
of	O
physostigmine	O
,	O
an	O
acetylcholinesterase	B
inhibitor	O
,	O
was	O
studied	O
in	O
combination	O
with	O
the	O
range	O
of	O
atropine	O
doses	O
.	O

Salzburg	O
,	O
9	O
-	O
12	O
September	O
1987	O
.	O

Two	O
of	O
these	O
six	O
cases	O
showed	O
mucosal	O
spread	O
without	O
stromal	O
invasion	O
(	O
type	O
A	O
);	O
the	O
remaining	O
four	O
cases	O
presented	O
a	O
direct	O
extension	O
(	O
type	O
B	O
)	O
from	O
muscle	O
-	O
invasive	O
carcinomas	O
of	O
the	O
bladder	O
.	O

Contraction	O
of	O
the	O
tracheal	O
muscle	O
and	O
the	O
activity	O
of	O
stretch	O
receptors	O
in	O
the	O
trachea	O

The	O
selenium	O
level	O
and	O
glutathione	B
peroxidase	I
activity	O
in	O
the	O
blood	O
,	O
liver	O
,	O
and	O
stomach	O
mucosa	O
were	O
significantly	O
higher	O
in	O
the	O
high	O
-	O
selenium	O
diet	O
group	O
than	O
in	O
the	O
low	O
-	O
selenium	O
diet	O
group	O
.	O

Oxygen	O
delivery	O
and	O
consumption	O
and	O
P50	O
in	O
patients	O
with	O
acute	O
myocardial	O
infarction	O
.	O

Amikacin	O
was	O
the	O
most	O
stable	O
and	O
tobramycin	O
was	O
the	O
least	O
stable	O
aminoglycoside	O
under	O
the	O
conditions	O
tested	O
.	O

A	O
significant	O
herd	O
X	O
period	O
interaction	O
existed	O
for	O
liver	O
TG	O
and	O
serum	O
dextran	O
precipitable	O
cholesterol	O
concentrations	O
.	O

Pharmacological	O
action	O
of	O
eptazocine	O
(	O
l	O
-	O
1	O
,	O
4	O
-	O
dimethyl	O
-	O
10	O
-	O
hydroxy	O
-	O
2	O
,	O
3	O
,	O
4	O
,	O
5	O
,	O
6	O
,	O
7	O
-	O
hexahydro	O
-	O
1	O
,	O
6	O
-	O
methano	O
-	O
1H	O
-	O
4	O
-	O
benz	O
azonine	O
).	O

On	O
transition	O
from	O
high	O
to	O
low	O
voltage	O
there	O
was	O
a	O
significant	O
fall	O
in	O
arterial	O
pressure	O
(	O
7	O
%)	O
and	O
an	O
increase	O
in	O
flow	O
(	O
19	O
-	O
38	O
%)	O
to	O
areas	O
of	O
the	O
brain	O
corresponding	O
to	O
the	O
arborization	O
of	O
the	O
reticular	O
formation	O
,	O
i	O
.	O
e	O
.	O
excluding	O
the	O
cerebrum	O
and	O
cerebellum	O
.	O

There	O
have	O
been	O
five	O
problems	O
(	O
extravasation	O
2	O
,	O
suspected	O
sepsis	O
1	O
,	O
and	O
hematoma	O
2	O
)	O
during	O
a	O
total	O
of	O
2	O
,	O
927	O
days	O
of	O
exposure	O
.	O

Malignant	O
lymphoma	O
is	O
very	O
heterogeneous	O
in	O
terms	O
of	O
its	O
biological	O
behavior	O
.	O

Of	O
the	O
cases	O
with	O
PLD	O
,	O
50	O
%	O
had	O
associated	O
renal	O
cysts	O
and	O
10	O
%	O
of	O
the	O
cases	O
with	O
APCD	O
had	O
associated	O
liver	O
cysts	O
.	O

The	O
relations	O
between	O
type	O
A	O
behavior	O
,	O
clinically	O
relevant	O
behavior	O
,	O
academic	O
achievement	O
,	O
and	O
IQ	O
in	O
children	O
.	O

Incidences	O
of	O
nonfatal	O
stroke	O
,	O
myocardial	O
infarction	O
,	O
angina	O
pectoris	O
und	O
left	O
ventricular	O
hypertrophy	O
could	O
also	O
be	O
lowered	O
.	O

We	O
analyzed	O
data	O
from	O
56	O
patients	O
with	O
Systemic	O
Lupus	O
Erythematosus	O
(	O
SLE	O
)	O
in	O
whom	O
renal	O
biopsies	O
were	O
done	O
systematically	O
.	O

The	O
possibility	O
of	O
a	O
hereditary	O
disorder	O
leading	O
to	O
a	O
minor	O
defect	O
in	O
elastic	O
fibre	O
structure	O
which	O
could	O
be	O
responsible	O
for	O
the	O
spontaneous	O
lesions	O
is	O
discussed	O
.	O

Only	O
seven	O
patients	O
,	O
five	O
of	O
whom	O
have	O
metastatic	O
disease	O
,	O
survive	O
more	O
than	O
10	O
years	O
after	O
first	O
presentation	O
;	O
nine	O
patients	O
,	O
one	O
of	O
whom	O
has	O
secondaries	O
,	O
survive	O
for	O
5	O
years	O
or	O
less	O
.	O

Although	O
differences	O
were	O
not	O
significant	O
,	O
infants	O
in	O
the	O
experimental	O
group	O
had	O
more	O
changes	O
in	O
the	O
intermittent	O
mandatory	O
ventilation	O
(	O
IMV	O
)	O
settings	O
during	O
transport	O
,	O
and	O
more	O
such	O
infants	O
arrived	O
at	O
the	O
receiving	O
hospital	O
with	O
acceptable	O
pH	O
and	O
PCO2	O
values	O
.	O

An	O
exaggerated	O
tissue	O
response	O
adjacent	O
to	O
the	O
cyanoacrylate	O
site	O
suggested	O
a	O
potential	O
toxic	O
chemical	O
or	O
thermal	O
reaction	O
,	O
or	O
both	O
,	O
to	O
the	O
tissue	O
adhesive	O
,	O
but	O
there	O
was	O
no	O
evidence	O
of	O
any	O
distant	O
ocular	O
effects	O
.	O

While	O
the	O
examiner	O
observed	O
the	O
interior	O
of	O
the	O
eye	O
with	O
indirect	O
ophthalmoscopy	O
,	O
the	O
point	O
source	O
of	O
light	O
from	O
the	O
fiberoptic	O
light	O
pipe	O
was	O
moved	O
along	O
the	O
margins	O
of	O
the	O
episcleral	O
plaque	O
.	O

These	O
fusion	O
proteins	O
also	O
allowed	O
the	O
localization	O
of	O
the	O
transcriptional	O
activation	O
and	O
DNA	O
binding	O
domains	O
of	O
the	O
ToxR	B
protein	I
to	O
its	O
cytoplasmically	O
located	O
N	O
-	O
terminal	O
portion	O
.	O

The	O
lethal	O
toxicity	O
of	O
inorganic	O
(	O
HgCl2	O
)	O
and	O
organic	O
(	O
CH3HgCl	O
)	O
mercury	O
chloride	O
was	O
compared	O
for	O
Coturnix	O
(	O
Japanese	O
quail	O
,	O
Coturnix	O
japonica	O
)	O
of	O
different	O
ages	O
from	O
hatch	O
through	O
adulthood	O
by	O
single	O
-	O
dose	O
acute	O
oral	O
and	O
intramuscular	O
injections	O
and	O
by	O
a	O
5	O
-	O
d	O
dietary	O
trial	O
.	O

Since	O
the	O
integrated	O
13h00	O
-	O
16h00	O
plasma	O
cortisol	O
estimation	O
is	O
cheaper	O
and	O
simpler	O
than	O
the	O
mean	O
13h00	O
-	O
16h00	O
plasma	O
cortisol	O
estimation	O
,	O
we	O
recommend	O
it	O
as	O
an	O
adjunct	O
in	O
the	O
diagnosis	O
of	O
Cushing	O
'	O
s	O
syndrome	O
.	O

Chlorambucil	O
and	O
interferon	B
for	O
low	O
grade	O
non	O
-	O
Hodgkin	O
'	O
s	O
lymphoma	O
.	O

Framingham	O
Type	O
A	O
behavior	O
was	O
positively	O
associated	O
with	O
diastolic	O
blood	O
pressure	O
(	O
r	O
=	O
0	O
.	O
17	O
,	O
p	O
less	O
than	O
0	O
.	O
05	O
)	O
among	O
the	O
women	O
.	O

The	O
in	O
vitro	O
antibacterial	O
potency	O
is	O
greatest	O
when	O
the	O
1	O
-	O
substituent	O
is	O
2	O
,	O
4	O
-	O
difluorophenyl	O
and	O
the	O
7	O
-	O
substituent	O
is	O
a	O
3	O
-	O
amino	O
-	O
1	O
-	O
pyrrolidinyl	O
group	O
.	O

An	O
ion	O
chromatographic	O
method	O
was	O
used	O
to	O
determine	O
Br	O
ion	O
in	O
the	O
urine	O
of	O
Greyhounds	O
.	O

Laryngographic	O
changes	O
following	O
endotracheal	O
intubation	O
in	O
adults	O
.	O

Autotransplantation	O
of	O
a	O
vein	O
segment	O
with	O
valve	O
in	O
the	O
treatment	O
of	O
deep	O
vein	O
valvular	O
insufficiency	O
of	O
the	O
lower	O
extremity	O

The	O
observation	O
of	O
late	O
effects	O
after	O
irradiations	O
or	O
after	O
space	O
flights	O
show	O
the	O
difficulties	O
encountered	O
in	O
assessing	O
radiative	O
risks	O
during	O
long	O
duration	O
space	O
flights	O
.	O

The	O
M	O
-	O
3	O
subtype	O
was	O
an	O
adverse	O
prognostic	O
factor	O
.	O

In	O
memory	O
of	O
Magdelaine	O
Comtesse	O

The	O
Mean	O
was	O
74	O
,	O
3	O
+/-	O
53	O
,	O
6	O
micrograms	O
J	O
/	O
g	O
Cr	O
,	O
the	O
Median	O
61	O
micrograms	O
J	O
/	O
g	O
Cr	O
.	O

Such	O
a	O
concept	O
is	O
crucial	O
to	O
our	O
understanding	O
of	O
the	O
pathology	O
of	O
ageing	O
in	O
general	O
.	O

We	O
have	O
earlier	O
evolved	O
an	O
experimental	O
model	O
by	O
means	O
of	O
which	O
changes	O
identical	O
to	O
the	O
microembolism	O
syndrome	O
can	O
be	O
induced	O
from	O
a	O
reproducible	O
musculo	O
-	O
skeletal	O
trauma	O
in	O
pigs	O
observed	O
under	O
long	O
-	O
term	O
anesthesia	O
under	O
standardized	O
conditions	O
.	O

Mild	O
orbital	O
discomfort	O
occurred	O
in	O
some	O
patients	O
.	O

This	O
article	O
will	O
briefly	O
review	O
the	O
published	O
data	O
on	O
the	O
morphology	O
,	O
function	O
,	O
and	O
biochemistry	O
of	O
the	O
normal	O
renal	O
medulla	O
and	O
the	O
pathology	O
associated	O
with	O
RPN	O
,	O
together	O
with	O
the	O
secondary	O
changes	O
which	O
give	O
rise	O
to	O
cortical	O
degeneration	O
or	O
epithelial	O
carcinoma	O
.	O

Tissue	O
pressure	O
,	O
rCBF	O
,	O
and	O
water	O
content	O
were	O
measured	O
from	O
gray	O
matter	O
in	O
the	O
central	O
core	O
and	O
the	O
peripheral	O
margin	O
of	O
the	O
MCA	O
territory	O
over	O
6	O
h	O
after	O
MCAO	O
.	O

During	O
this	O
time	O
,	O
the	O
patients	O
all	O
had	O
the	O
characteristic	O
plasma	O
thyroid	O
hormone	O
changes	O
associated	O
with	O
amiodarone	O
therapy	O
,	O
i	O
.	O
e	O
.	O
increased	O
T4	O
,	O
free	O
T4	O
,	O
and	O
rT3	O
and	O
decreased	O
T3	O
,	O
while	O
remaining	O
clinically	O
euthyroid	O
.	O

In	O
each	O
compartment	O
O2	O
is	O
removed	O
by	O
the	O
tissues	O
as	O
a	O
chemical	O
reaction	O
takes	O
place	O
between	O
O2	O
and	O
oxyhemoglobin	B
(	O
HbO2	B
).	O

The	O
results	O
from	O
the	O
first	O
five	O
years	O
of	O
follow	O
up	O
in	O
1972	O
showed	O
a	O
4	O
.	O
7	O
-	O
fold	O
excess	O
mortality	O
for	O
ischaemic	O
and	O
other	O
heart	O
diseases	O
(	O
ICD	O
A83	O
-	O
A84	O
)	O
compared	O
with	O
a	O
comparable	O
reference	O
cohort	O
of	O
paper	O
mill	O
workers	O
.	O

Shoulder	O
forearm	O
support	O
for	O
the	O
subluxed	O
shoulder	O
.	O

The	O
frequency	O
of	O
lactase	B
phenotypes	I
in	O
Aymara	O
children	O
.	O

Electrochemical	O
detection	O
of	O
depressed	O
circulating	O
levels	O
of	O
vitamin	O
K1	O
in	O
osteoporosis	O
.	O

The	O
POEMS	O
syndrome	O
(	O
Polyneuropathy	O
,	O
Organomegaly	O
,	O
Endocrinopathy	O
,	O
Monoclonal	O
component	O
,	O
Skin	O
).	O

Two	O
siblings	O
with	O
hemolytic	O
anemia	O
caused	O
by	O
triosephosphate	B
isomerase	I
deficiency	O
developed	O
a	O
progressive	O
neurological	O
syndrome	O
featuring	O
dystonic	O
movements	O
,	O
tremor	O
,	O
pyramidal	O
tract	O
signs	O
,	O
and	O
evidence	O
of	O
spinal	O
motor	O
neuron	O
involvement	O
.	O

In	O
the	O
10	O
patients	O
with	O
a	O
more	O
severe	O
degree	O
of	O
steatorrhea	O
the	O
decrease	O
in	O
fat	O
loss	O
approached	O
20	O
%	O
and	O
a	O
close	O
relationship	O
was	O
found	O
(	O
r	O
=	O
0	O
.	O
84	O
,	O
p	O
less	O
than	O
0	O
.	O
01	O
)	O
between	O
the	O
extent	O
of	O
the	O
fatty	O
acid	O
loss	O
on	O
placebo	O
and	O
the	O
decrease	O
of	O
this	O
loss	O
on	O
taurine	O
.	O

Aortic	O
diameters	O
in	O
infants	O
and	O
young	O
children	O
:	O
normative	O
angiographic	O
data	O
.	O

Since	O
1970	O
the	O
frequency	O
of	O
potassium	O
-	O
induced	O
ulceration	O
has	O
been	O
low	O
--	O
3	O
cases	O
per	O
100	O
000	O
patient	O
-	O
years	O
of	O
slow	O
-	O
release	O
tablet	O
use	O
.	O

For	O
comparison	O
conventional	O
heparin	O
was	O
used	O
during	O
18	O
dialyses	O
in	O
the	O
same	O
patients	O
.	O

Chenodeoxycholic	O
acid	O
(	O
cheno	O
)	O
and	O
ursodeoxycholic	O
acid	O
(	O
urso	O
)	O
dissolve	O
cholesterol	O
gallstones	O
in	O
man	O
.	O

Ultrastructure	O
of	O
the	O
heart	O
muscle	O
in	O
experimental	O
myocardial	O
infarct	O
following	O
physical	O
training	O

Vitiligo	O
in	O
diabetes	O
mellitus	O
.	O

Rabbit	O
eyes	O
were	O
removed	O
and	O
held	O
in	O
temperature	O
-	O
regulated	O
chambers	O
and	O
irrigated	O
with	O
saline	O
.	O

Before	O
birth	O
,	O
there	O
were	O
a	O
few	O
perivascular	O
adrenergic	O
nerves	O
and	O
correspondingly	O
low	O
ovarian	O
NE	O
levels	O
.	O

Treatment	O
with	O
oxyphenylbutazone	O
and	O
hydrocortisone	O
failed	O
to	O
inhibit	O
the	O
raised	O
serum	B
CPN	I
levels	O
.	O

The	O
Cox	O
proportional	O
hazards	O
model	O
was	O
applied	O
to	O
the	O
data	O
in	O
order	O
to	O
determine	O
the	O
prognostic	O
factors	O
for	O
long	O
-	O
term	O
survival	O
.	O

Pharmacologic	O
doses	O
of	O
vitamin	O
B6	O
administered	O
to	O
lactating	O
women	O
have	O
been	O
reported	O
to	O
suppress	O
plasma	B
prolactin	I
.	O

Greater	O
attenuation	O
of	O
the	O
N1	O
-	O
P2	O
and	O
baseline	O
-	O
P2	O
amplitude	O
of	O
the	O
probe	O
EPs	O
was	O
observed	O
when	O
the	O
probe	O
stimulus	O
was	O
presented	O
to	O
the	O
right	O
ear	O
and	O
the	O
verbal	O
material	O
presented	O
to	O
the	O
left	O
ear	O
than	O
when	O
the	O
opposite	O
stimulation	O
arrangement	O
was	O
used	O
.	O

Twenty	O
-	O
five	O
patients	O
(	O
80	O
,	O
6	O
%)	O
with	O
mixed	O
neoplasms	O
were	O
operated	O
on	O
by	O
total	O
conservative	O
parotidectomy	O
(	O
T	O
.	O
C	O
.	O
P	O
.),	O
3	O
(	O
9	O
,	O
7	O
%)	O
by	O
S	O
.	O
P	O
.	O
and	O
3	O
(	O
9	O
,	O
7	O
%)	O
by	O
En	O
.	O

[	O
14C	O
]-	O
beta	O
-	O
phenethylamine	O
,	O
its	O
distribution	O
after	O
administration	O
by	O
various	O
routes	O
to	O
cats	O
,	O
and	O
the	O
effects	O
of	O
monoamine	B
oxidase	I
inhibitors	O
.	O

Daily	O
and	O
seasonal	O
rhythmicity	O
in	O
the	O
methylation	O
of	O
pineal	O
indolic	O
compounds	O
in	O
adult	O
male	O
golden	O
hamsters	O
,	O
kept	O
under	O
natural	O
conditions	O
.	O

The	O
transit	O
time	O
was	O
significantly	O
shortened	O
.	O

Activity	O
of	O
acid	B
hydrolases	I
of	O
peripheral	O
blood	O
leukocytes	O
in	O
focal	O
and	O
segmental	O
pneumonia	O
in	O
children	O

Treatment	O
of	O
Paget	O
'	O
s	O
disease	O
.	O

The	O
effect	O
of	O
a	O
tissue	O
emulsion	O
,	O
vitamin	O
A	O
and	O
nonspecific	O
gamma	B
-	I
globulin	I
on	O
the	O
blood	O
clearance	O
in	O
rabbits	O

They	O
also	O
discuss	O
the	O
existing	O
nomenclature	O
.	O

Relaxation	O
of	O
catch	O
in	O
a	O
molluscan	O
smooth	O
muscle	O
.	O

Hypothalamic	O
control	O
of	O
coronary	O
circulation	O
in	O
the	O
dog	O
.	O

Evidence	O
for	O
two	O
distinctive	O
clinical	O
,	O
epidemiological	O
,	O
and	O
immunological	O
types	O
of	O
infection	O
.	O

To	O
the	O
problem	O
of	O
the	O
stimulation	O
of	O
the	O
growth	O
of	O
transplantable	O
tumors	O
of	O
animals	O
previously	O
treated	O
with	O
antineoplastic	O
antibiotics	O

Disorders	O
of	O
platelet	O
function	O
in	O
chronic	O
myeloid	O
leukemias	O

Effect	O
of	O
immune	O
lymphocytes	O
and	O
of	O
rabbit	B
-	I
anti	I
-	I
lymphocyte	I
globulin	I
(	O
RAMLG	B
)	O
on	O
infected	O
macrophages	O
exposed	O
to	O
increased	O
incubation	O
temperature	O
in	O
vitro	O
.	O

Age	O
and	O
sex	O
structure	O
of	O
the	O
natural	O
population	O
of	O
Ornithodoros	O
tatarovski	O
Ol	O
.	O

The	O
incidence	O
of	O
tumours	O
in	O
young	O
chickens	O
.	O

Familial	O
glutathione	B
reductase	I
deficiency	O
and	O
disorder	O
of	O
glutathione	O
synthesis	O
in	O
the	O
erythrocyte	O

Studies	O
on	O
swine	O
enteroviruses	O
.	O

Conditions	O
influencing	O
inhibitors	O
of	O
the	O
colony	B
-	I
stimulating	I
factor	I
(	O
CSF	B
).	O

Absence	O
of	O
action	O
potentials	O
in	O
frog	O
slow	O
muscle	O
fibres	O
paralysed	O
by	O
botulinum	B
toxin	I
.	O

Disulfiram	O
and	O
the	O
drug	O
-	O
induced	O
effects	O
on	O
motility	O
.	O

Pathology	O
of	O
neuritis	O
caudae	O
equinae	O
in	O
the	O
horse	O

Electrocardiograms	O
of	O
the	O
month	O
.	O

Composites	O
as	O
restoration	O
materials	O

Value	O
of	O
Normotest	O
and	O
antithrombin	B
3	I
in	O
the	O
assessment	O
of	O
liver	O
function	O
.	O

Measurement	O
of	O
open	O
-	O
loop	O
responses	O
to	O
electrical	O
stimulation	O
in	O
olfactory	O
bulb	O
of	O
cat	O
.	O

The	O
relationship	O
of	O
human	O
umbilical	O
arterial	O
and	O
venous	O
plasma	O
levels	O
of	O
corticosteroids	O
to	O
gestational	O
age	O
.	O

Sulfuric	O
acid	O
concentration	O
in	O
the	O
catalyzed	O
breathalyzer	O
ampules	O
.	O

Range	O
behavior	O
of	O
Hereford	O
,	O
Hereford	O
x	O
Holstein	O
and	O
Holstein	O
non	O
-	O
lactating	O
heifers	O
.	O

Compensative	O
justice	O
and	O
moral	O
investment	O
among	O
Japanese	O
,	O
Chinese	O
,	O
and	O
Koreans	O
.	O

Effects	O
of	O
cortisone	O
,	O
starvation	O
,	O
and	O
rickets	O
on	O
oxidative	O
enzyme	O
activities	O
of	O
epiphyseal	O
cartilage	O
from	O
rats	O
.	O

Choice	O
of	O
vessel	O
.	O

Suppression	O
of	O
food	O
intake	O
in	O
the	O
rat	O
by	O
tung	O
oil	O
.	O

Polycythemia	O
-	O
1973	O
.	O

Possibilities	O
of	O
needleless	O
administration	O
of	O
various	O
substances	O
to	O
animals	O

Evaluation	O
of	O
1	O
,	O
10	O
-	O
phenanthroline	O
as	O
a	O
reagent	O
for	O
sialic	O
acid	O
determinations	O
.	O

Nonteratogenicity	O
in	O
rats	O
of	O
blighted	O
potatoes	O
and	O
compounds	O
contained	O
in	O
them	O
.	O

VII	O
.	O

Electrocardiographic	O
QRS	O
complexes	O
and	O
vectorcardiographic	O
QRS	O
loop	O

The	O
metabolism	O
and	O
pharmacology	O
of	O
5	O
-	O
fluorouracil	O
.	O

LA	O
-	O
3848	O
-	O
MS	O
.	O

Angiography	O
of	O
aneurysmal	O
bone	O
cyst	O
.	O

Serum	O
lipid	O
changes	O
during	O
pregnancy	O
due	O
to	O
oral	O
calcium	O
administration	O

Periodic	O
breathing	O
and	O
apnea	O
in	O
preterm	O
infants	O
.	O

Clinicopathologic	O
studies	O
in	O
feminizing	O
tumors	O
of	O
the	O
ovary	O
.	O

On	O
the	O
constituents	O
of	O
Dryopteris	O
polylepis	O

Antiviral	O
agents	O
.	O

6	O
.	O

1st	O
data	O
on	O
the	O
immunosuppressive	O
therapy	O
of	O
scleroderma	O

1	O
.	O

Results	O
of	O
the	O
official	O
inspection	O
of	O
the	O
commercial	O
anti	O
-	O
inflammatory	O
enzyme	O
preparations	O
containing	O
chymotrypsin	B
and	O
trypsin	B
by	O
means	O
of	O
modified	O
NF	O
13	O
methods	O

Studies	O
on	O
the	O
hereditary	O
nature	O
of	O
sole	O
prints	O
--	O
with	O
special	O
reference	O
to	O
interdigital	O
and	O
triradii	O

Successive	O
abdominal	O
scintillation	O
with	O
131	O
-	O
I	O
-	O
tagged	O
BSP	O
--	O
description	O
of	O
the	O
thyroid	O
gland	O
,	O
kidney	O
and	O
spleen	O
(	O
comparison	O
with	O
131	O
-	O
I	O
-	O
RB	O
)	O

Osteosarcoma	O
caused	O
by	O
3	O
,	O
4	O
-	O
benzopyrene	O

The	O
non	O
-	O
role	O
of	O
fluoride	O
in	O
the	O
control	O
of	O
plasma	O
calcium	O
in	O
the	O
parathyroidectomized	O
rat	O
.	O

SAM	O
-	O
TR	O
-	O
68	O
-	O
54	O
.	O

Auto	O
-	O
and	O
isotopy	O
of	O
the	O
conjunctiva	O

Histopathology	O
and	O
pathogenesis	O
of	O
exanthematous	O
viroses	O

Diethylene	O
benzene	O

Antidromic	O
invasion	O
of	O
impulses	O
and	O
recurrent	O
collateral	O
inhibition	O
in	O
pyramidal	O
tract	O
neurones	O
.	O

The	O
distribution	O
of	O
body	O
fluids	O
following	O
hemorrhage	O
and	O
resuscitation	O
in	O
combat	O
casualties	O
.	O

Mae	O
West	O
and	O
the	O
doctor	O
shortage	O
.	O

Bimodal	O
cochlear	O
response	O
curves	O
in	O
rodents	O
.	O

Foreign	O
profiles	O
in	O
air	O
pollution	O
control	O
activities	O
.	O

Quantitation	O
of	O
exocrine	B
IgA	I
in	O
human	O
serum	O
in	O
health	O
and	O
disease	O
.	O

V	O
.	O

Behavioral	O
and	O
electrographic	O
expression	O
of	O
natural	O
sleep	O
and	O
wakefulness	O
in	O
reptiles	O

Changing	O
and	O
predicting	O
doses	O
of	O
Cs137	O
irradiation	O

Dermoid	O
cyst	O
in	O
a	O
free	O
skin	O
flap	O
as	O
the	O
complication	O
after	O
treatment	O
of	O
recurring	O
hernia	O

Children	O
with	O
defective	O
vision	O

Relations	O
between	O
adrenergic	O
mechanisms	O
and	O
analgesic	O
effects	O

Estrus	O
and	O
copulative	O
abilities	O
of	O
androgen	O
-	O
sterilized	O
rats	O

Hemodynamics	O
changes	O
in	O
man	O
during	O
flight	O

Clinical	O
applications	O
of	O
inhibition	O
of	O
beta	B
-	I
adrenergic	I
receptors	I
with	O
propranolol	O
.	O

Measurement	O
of	O
gastric	O
acid	O
secretion	O
by	O
conductivity	O
.	O

Evidence	O
forthe	O
electroosmosis	O
theory	O
of	O
transport	O
in	O
the	O
phloem	O
.	O

Effect	O
of	O
heparin	O
on	O
the	O
inactivation	O
of	O
serum	B
lipoprotein	I
lipase	I
by	O
the	O
liver	O
in	O
unanesthetized	O
dogs	O
.	O

I	O
.	O

Statistics	O
of	O
the	O
past	O
5	O
years	O

Naphthalene	O
and	O
paradichlorobenzene	O
in	O
clinical	O
toxicology	O

Studies	O
on	O
powdered	O
preparations	O
.	O

Further	O
studies	O
on	O
a	O
"	O
new	O
"	O
human	O
isoprecipitin	B
system	O
(	O
Australia	O
antigen	O
).	O

Story	O
of	O
a	O
hospital	O
that	O
filmed	O
its	O
employee	O
orientation	O
program	O
.	O

I	O
.	O

Value	O
of	O
the	O
method	O
of	O
passive	O
hemagglutination	O
with	O
polysaccharide	O
C	O
in	O
detecting	O
C	B
-	I
reactive	I
protein	I
as	O
compared	O
to	O
precipitation	O
in	O
capillaries	O
and	O
slide	O
latex	O
test	O
with	O
anti	B
-	I
CRP	I
serum	O

On	O
the	O
amount	O
and	O
significance	O
of	O
the	O
effective	O
glucose	O
level	O
in	O
tumors	O
.	O

Pharmacodynamic	O
studies	O
on	O
the	O
cardiovascular	O
system	O
of	O
spontaneously	O
hypertensive	O
rats	O
.	O

XXI	O
.	O

Electrophoretic	O
characteriaztion	O
of	O
virus	O
-	O
induced	O
interferon	B
of	O
the	O
blood	O
and	O
urine	O
in	O
rabbits	O

Symposium	O
on	O
presenile	O
spongy	O
encephalopathies	O
.	O

Courses	O
were	O
repeated	O
monthly	O
upon	O
recovery	O
of	O
myelosuppression	O
.	O

The	O
PEPCK	B
promoter	O
fragment	O
was	O
introduced	O
either	O
in	O
the	O
proper	O
orientation	O
for	O
transcription	O
of	O
the	O
TK	B
gene	I
or	O
in	O
the	O
opposite	O
orientation	O
.	O

Neither	O
side	O
effect	O
nor	O
abnormal	O
laboratory	O
findings	O
due	O
to	O
this	O
drug	O
were	O
observed	O
.	O

Diagnosis	O
and	O
treatment	O
of	O
insulin	B
-	O
secreting	O
tumours	O
.	O

Theories	O
proffered	O
to	O
account	O
for	O
the	O
modality	O
shift	O
effect	O
are	O
critically	O
evaluated	O
.	O

Endorphins	B
at	O
the	O
approach	O
of	O
death	O
.	O

Trial	O
treatment	O
of	O
schizophrenia	O
with	O
des	B
-	I
Tyr	I
-	I
gamma	I
-	I
endorphin	I

Two	O
patients	O
withdrew	O
from	O
therapy	O
,	O
one	O
for	O
personal	O
reasons	O
and	O
one	O
because	O
a	O
paraspinal	O
mass	O
developed	O
.	O

We	O
have	O
followed	O
37	O
phenytoin	O
-	O
treated	O
patients	O
with	O
reduced	O
serum	B
IgA	I
concentrations	O
for	O
2	O
-	O
7	O
years	O
.	O

In	O
the	O
latter	O
category	O
particular	O
emphasis	O
is	O
being	O
placed	O
on	O
new	O
anthracycline	O
analogues	O
of	O
doxorubicin	O
and	O
analogues	O
of	O
cisplatinum	O
diammine	O
dichloride	O
.	O

Unusual	O
course	O
of	O
plasmocytosis	O
.	O

The	O
construction	O
of	O
a	O
small	O
library	O
of	O
mouse	O
repetitive	O
DNA	O
has	O
been	O
previously	O
reported	O
(	O
Pietras	O
et	O
al	O
.,	O
Nucleic	O
Acids	O
Res	O
.	O

At	O
Cabras	O
(	O
Oristano	O
),	O
a	O
town	O
characterized	O
by	O
a	O
high	O
incidence	O
of	O
thalassaemia	O
and	O
G6PD	B
deficiency	O
less	O
than	O
half	O
the	O
people	O
between	O
18	O
and	O
35	O
have	O
a	O
fair	O
knowledge	O
of	O
genetic	O
diseases	O
and	O
of	O
their	O
prevention	O
.	O

Experience	O
with	O
the	O
tensor	O
fasciae	O
latae	O
free	O
flap	O
.	O

Hepatitis	O
-	O
B	O
vaccination	O
in	O
the	O
elderly	O
.	O

Ventricular	O
volume	O
stiffness	O
vs	O
.	O
the	O
mean	O
wall	O
stress	O
relationship	O
of	O
LVH	O
shifted	O
upward	O
,	O
whereas	O
the	O
normalized	O
wall	O
muscle	O
stiffness	O
vs	O
.	O
the	O
mean	O
wall	O
stress	O
relationship	O
of	O
LVH	O
showed	O
a	O
smaller	O
slope	O
.	O

Synthesis	O
of	O
(+)-	O
lysergic	O
acid	O
diethylamide	O
tartrate	O

The	O
effect	O
of	O
treatment	O
may	O
thus	O
be	O
divided	O
into	O
two	O
main	O
phases	O
--	O
an	O
initial	O
phase	O
with	O
a	O
reduction	O
in	O
LV	O
mass	O
and	O
a	O
reduction	O
in	O
cardiac	O
output	O
and	O
no	O
change	O
in	O
total	O
peripheral	O
resistance	O
--	O
and	O
a	O
second	O
phase	O
with	O
a	O
constant	O
LV	O
mass	O
but	O
an	O
increase	O
in	O
cardiac	O
output	O
to	O
the	O
pretreatment	O
level	O
again	O
and	O
a	O
concomitant	O
decrease	O
in	O
total	O
peripheral	O
resistance	O
.	O

Restriction	O
enzyme	O
and	O
heteroduplex	O
analyses	O
confirmed	O
that	O
sequences	O
unique	O
to	O
FeSV	O
(	O
src	B
sequences	I
)	O
are	O
located	O
at	O
the	O
center	O
of	O
the	O
FeSV	O
genome	O
and	O
are	O
approximately	O
1	O
.	O
5	O
kilobase	O
pairs	O
in	O
length	O
.	O

Poly	O
(	O
dT	O
)	O
and	O
denatured	O
calf	O
thymus	O
DNA	O
were	O
more	O
effective	O
than	O
were	O
other	O
polynucleotides	O
tested	O
in	O
promoting	O
accumulation	O
of	O
19	O
HDP	O
*;	O
(	O
dT	O
)	O
8	O
was	O
as	O
effective	O
as	O
were	O
longer	O
molecules	O
of	O
(	O
dT	O
)	O
n	O
,	O
but	O
(	O
dT	O
)	O
4	O
and	O
(	O
dT	O
)	O
6	O
were	O
much	O
less	O
effective	O
,	O
indicating	O
that	O
the	O
binding	O
site	O
involved	O
in	O
19	O
HDP	B
*	I
accumulation	O
covered	O
between	O
6	O
and	O
8	O
residues	O
of	O
(	O
dT	O
)	O
n	O
.	O

Thus	O
it	O
appears	O
that	O
insertion	O
of	O
a	O
transposable	O
element	O
near	O
the	O
5	O
'	O
terminus	O
of	O
the	O
structural	O
gene	O
can	O
produce	O
constitutive	O
expression	O
of	O
a	O
normally	O
glucose	O
-	O
repressed	O
enzyme	O
.	O

Five	O
experiments	O
examined	O
the	O
influence	O
of	O
opiate	O
antagonists	O
on	O
both	O
the	O
short	O
-	O
term	O
analgesic	O
reaction	O
resulting	O
30	O
min	O
after	O
exposure	O
to	O
inescapable	O
shock	O
and	O
the	O
long	O
-	O
term	O
analgesic	O
reaction	O
resulting	O
after	O
reexposure	O
to	O
shock	O
24	O
hr	O
after	O
inescapable	O
shock	O
exposure	O
.	O

Replicating	O
simian	O
virus	O
40	O
(	O
SV40	O
)	O
chromosomes	O
were	O
found	O
to	O
be	O
similar	O
to	O
other	O
eukaryotic	O
chromosomes	O
in	O
that	O
the	O
rate	O
and	O
extent	O
of	O
micrococcal	B
nuclease	I
(	O
MNase	B
)	O
digestion	O
were	O
greater	O
with	O
replicating	O
than	O
with	O
nonreplicating	O
mature	O
SV40	O
chromatin	O
.	O

WR	O
-	O
2721	O
(	O
S	O
-	O
2	O
-(	O
3	O
aminopropylamino	O
)	O
ethylphosphorothioic	O
acid	O
)	O
has	O
been	O
investigated	O
for	O
its	O
ability	O
to	O
protect	O
gut	O
,	O
lung	O
,	O
and	O
testis	O
,	O
as	O
well	O
as	O
fibrosarcoma	O
(	O
FSa	O
)	O
tumor	O
nodules	O
,	O
in	O
the	O
lungs	O
of	O
mice	O
from	O
gamma	O
-	O
radiation	O
injury	O
.	O

Of	O
115	O
hepatitis	O
B	O
patients	O
seen	O
at	O
12	O
months	O
,	O
6	O
%	O
had	O
chronic	O
hepatitis	O
Bs	O
antigenaemia	O
,	O
60	O
%	O
had	O
developed	O
anti	B
-	I
HBs	I
antibodies	I
,	O
and	O
7	O
.	O
3	O
%	O
still	O
had	O
abnormal	O
liver	O
function	O
.	O

A	O
cDNA	O
cloning	O
vector	O
that	O
permits	O
expression	O
of	O
cDNA	O
inserts	O
in	O
mammalian	O
cells	O
.	O

Naloxone	O
(	O
2	O
mg	O
/	O
kg	O
bolus	O
+	O
2	O
mg	O
X	O
kg	O
-	O
1	O
X	O
h	O
-	O
1	O
)	O
was	O
given	O
with	O
one	O
of	O
the	O
two	O
doses	O
of	O
the	O
lipopolysaccharide	O
.	O

Gel	O
route	O
preparation	O
of	O
low	O
fusing	O
dental	O
porcelain	O
frit	O
.	O

I	O
.	O

Molecular	O
structure	O
and	O
evolutionary	O
origin	O
of	O
human	B
cardiac	I
muscle	I
actin	I
gene	I
.	O

Plasmids	O
for	O
the	O
cloning	O
and	O
expression	O
of	O
full	O
-	O
length	O
double	O
-	O
stranded	O
cDNAs	O
under	O
control	O
of	O
the	O
SV40	B
early	I
or	O
late	B
gene	I
promoter	O
.	O

Overall	O
prevalences	O
of	O
antibody	O
were	O
70	O
per	O
cent	O
in	O
cattle	O
,	O
67	O
per	O
cent	O
in	O
sheep	O
and	O
76	O
per	O
cent	O
in	O
goats	O
as	O
assessed	O
by	O
an	O
immunodiffusion	O
test	O
.	O

NPT	B
II	I
synthesis	O
,	O
measured	O
by	O
agar	O
plate	O
assays	O
of	O
kanamycin	O
resistance	O
and	O
by	O
immunoprecipitation	O
of	O
the	O
NPT	B
II	I
protein	I
,	O
was	O
repressed	O
in	O
the	O
presence	O
of	O
cysteine	O
and	O
derepressed	O
in	O
its	O
absence	O
.	O

Furthermore	O
,	O
no	O
Shine	O
-	O
Dalgarno	O
sequences	O
are	O
present	O
upstream	O
of	O
the	O
presumed	O
translational	O
start	O
codons	O
.	O

The	O
same	O
-	O
sized	O
EBNA	B
protein	I
(	I
approximately	I
78	I
,	I
000	I
)	I
was	O
made	O
after	O
transfection	O
with	O
BamHI	B
-	I
K	I
(	I
5	I
.	I
2	I
kilobase	I
pairs	I
[	I
kbp	I
])	I
or	O
the	O
I1f	O
subfragment	O
(	O
2	O
.	O
9	O
kbp	O
).	O

They	O
generated	O
ca	O
.	O

Here	O
we	O
have	O
determined	O
the	O
nucleotide	O
sequence	O
of	O
3	O
.	O
5	O
kb	O
from	O
the	O
3	O
'	O
end	O
of	O
delta	B
gag	I
to	O
the	O
3	O
'	O
end	O
of	O
molecularly	O
cloned	O
proviral	O
MH2	O
DNA	O
,	O
in	O
order	O
to	O
elucidate	O
the	O
genetic	O
structure	O
of	O
the	O
virus	O
and	O
to	O
compare	O
it	O
with	O
other	O
mht	B
-	O
and	O
myc	B
-	O
containing	O
oncogenic	O
viruses	O
as	O
well	O
as	O
with	O
the	O
chicken	B
proto	I
-	I
myc	I
gene	I
.	O

USA	O
80	O
,	O
802	O
-	O
806	O
]	O
was	O
used	O
to	O
isolate	O
a	O
genomic	O
clone	O
lambda	O
PGK	B
-	I
1	I
containing	O
a	O
portion	O
of	O
an	O
autosomal	O
locus	O
for	O
phosphoglycerate	B
kinase	I
(	O
PGK	B
).	O

An	O
immunologic	O
test	O
using	O
stomach	O
and	O
tumor	O
antigens	O
for	O
screening	O
of	O
those	O
at	O
high	O
risk	O
for	O
stomach	O
cancer	O
is	O
suggested	O
.	O

Blood	O
glucose	O
and	O
plasma	O
insulin	B
were	O
measured	O
at	O
zero	O
time	O
and	O
then	O
at	O
15	O
,	O
30	O
,	O
60	O
,	O
90	O
and	O
120	O
min	O
after	O
ingestion	O
of	O
25	O
g	O
glucose	O
,	O
fructose	O
or	O
lactose	O
,	O
or	O
30	O
g	O
honey	O
,	O
50	O
g	O
white	O
bread	O
,	O
125	O
g	O
white	O
rice	O
or	O
potatoes	O
,	O
150	O
g	O
apples	O
or	O
260	O
g	O
carrots	O
.	O

These	O
results	O
indicate	O
that	O
both	O
naturally	O
acquired	O
and	O
passive	O
(	O
modified	O
immune	B
serum	I
globulin	I
)	O
antibodies	O
to	O
type	B
III	I
group	I
B	I
Streptococcus	I
antigen	I
are	O
partially	O
protective	O
against	O
intra	O
-	O
amniotic	O
infection	O
.	O

The	O
enzymic	O
hydrolysis	O
of	O
urea	O
produces	O
ammonia	O
which	O
causes	O
a	O
vivid	O
yellow	O
to	O
purple	O
colour	O
change	O
in	O
the	O
pH	O
indicator	O
.	O

Side	O
effect	O
including	O
subjective	O
and	O
objective	O
symptoms	O
were	O
strictly	O
evaluated	O
in	O
163	O
cases	O
(	O
KS	O
-	O
R1	O
group	O
in	O
83	O
cases	O
,	O
oral	O
group	O
in	O
80	O
cases	O
),	O
but	O
the	O
incidence	O
rate	O
which	O
was	O
22	O
.	O
9	O
%	O
for	O
the	O
KS	O
-	O
R1	O
group	O
and	O
23	O
.	O
8	O
%	O
for	O
the	O
oral	O
group	O
showed	O
no	O
significant	O
difference	O
.	O

Martin	O
Luther	O
and	O
his	O
physicians	O
.	O

These	O
data	O
suggest	O
that	O
a	O
major	O
part	O
of	O
the	O
reduction	O
in	O
food	O
intake	O
in	O
hyperphagic	O
rats	O
eating	O
a	O
quinine	O
-	O
adulterated	O
diet	O
is	O
due	O
to	O
postingestional	O
events	O
.	O

EGV	O
had	O
no	O
detectable	O
effect	O
on	O
PP	B
secretion	O
under	O
basal	O
or	O
stimulated	O
conditions	O
.	O

Management	O
of	O
hypertension	O
in	O
the	O
elderly	O
.	O

Ten	O
patients	O
with	O
advanced	O
,	O
diffuse	O
Hodgkin	O
'	O
s	O
and	O
non	O
-	O
Hodgkin	O
'	O
s	O
lymphomas	O
responding	O
poorly	O
to	O
the	O
most	O
widely	O
employed	O
primary	O
chemotherapy	O
regimens	O
were	O
treated	O
with	O
a	O
high	O
-	O
dose	O
chemotherapy	O
(	O
HDC	O
)	O
followed	O
by	O
rescue	O
with	O
non	O
-	O
frozen	O
autologous	O
bone	O
marrow	O
infusion	O
(	O
ABMT	O
).	O

Eighteen	O
patients	O
were	O
untreated	O
,	O
and	O
8	O
had	O
been	O
given	O
previous	O
treatment	O
with	O
depot	O
testosterone	O
100	O
mg	O
intramuscularly	O
every	O
2	O
-	O
3	O
weeks	O
for	O
an	O
average	O
duration	O
of	O
4	O
.	O
7	O
years	O
.	O

If	O
facilities	O
for	O
measurements	O
of	O
O2	O
consumption	O
and	O
hence	O
metabolic	O
rate	O
are	O
available	O
,	O
these	O
should	O
be	O
utilized	O
.	O

Total	O
cumulative	O
doses	O
of	O
doxorubicin	O
ranged	O
from	O
145	O
to	O
625	O
mg	O
./	O
m	O
.	O
2	O
.	O

Cimetidine	O
800	O
mg	O
given	O
at	O
night	O
is	O
as	O
effective	O
as	O
400	O
mg	O
twice	O
daily	O
;	O
the	O
single	O
dose	O
regimen	O
may	O
improve	O
patient	O
compliance	O
,	O
thus	O
facilitating	O
treatment	O
.	O

Ceftazidime	O
shows	O
promise	O
as	O
single	O
-	O
agent	O
therapy	O
for	O
serious	O
gram	O
-	O
negative	O
bacillary	O
infections	O
.	O

Regional	O
CBF	O
was	O
determined	O
by	O
clearance	O
of	O
xenon	O
133	O
in	O
67	O
patients	O
undergoing	O
coronary	O
bypass	O
grafting	O
procedures	O
.	O

Each	O
causative	O
organism	O
has	O
a	O
species	O
-	O
specific	O
preference	O
and	O
requirement	O
for	O
temperature	O
,	O
salinity	O
,	O
pH	O
,	O
the	O
basic	O
nutrients	O
,	O
and	O
growth	O
factors	O
,	O
and	O
the	O
toxin	O
formation	O
is	O
affected	O
by	O
these	O
environmental	O
factors	O
.	O

Deformities	O
of	O
the	O
tip	O
of	O
the	O
olecranon	O
and	O
of	O
the	O
coronoid	O
process	O
are	O
also	O
described	O
(	O
De	O
Palma	O
1956	O
,	O
Jordan	O
1958	O
,	O
Ahlberg	O
1965	O
,	O
Weseloh	O
1973	O
).	O

The	O
development	O
and	O
histostructural	O
organization	O
of	O
intrahepatic	O
biliary	O
ducts	O
were	O
studied	O
on	O
a	O
human	O
embryofetal	O
material	O
6	O
to	O
32	O
weeks	O
old	O
.	O

Cardiovascular	O
and	O
adrenal	O
medullo	O
-	O
sympathetic	O
reactions	O
to	O
acute	O
tobacco	O
poisoning	O

Endothelium	O
of	O
the	O
central	O
ear	O
artery	O
of	O
an	O
anesthetized	O
rabbit	O
is	O
damaged	O
by	O
placing	O
artery	O
forceps	O
on	O
the	O
ear	O
directly	O
over	O
the	O
vessel	O
.	O

Catch	O
-	O
up	O
growth	O
was	O
observed	O
only	O
for	O
a	O
12	O
-	O
month	O
period	O
in	O
4	O
children	O
with	O
a	O
bone	O
age	O
of	O
7	O
to	O
8	O
years	O
.	O

In	O
two	O
experiments	O
,	O
neonatal	O
female	O
BALB	O
/	O
cCrgl	O
or	O
BALB	O
/	O
cfC3HCrgl	O
mice	O
were	O
given	O
subcutaneous	O
injections	O
of	O
5	O
micrograms	O
17	O
beta	O
-	O
estradiol	O
or	O
sesame	O
oil	O
for	O
the	O
first	O
3	O
days	O
of	O
life	O
and	O
were	O
ovariectomized	O
at	O
60	O
days	O
of	O
age	O
,	O
at	O
which	O
time	O
vaginal	O
concretions	O
(	O
Experiments	O
I	O
and	O
II	O
)	O
or	O
silica	O
(	O
Experiment	O
II	O
)	O
were	O
implanted	O
intravaginally	O
.	O

For	O
228	O
of	O
425	O
deaths	O
(	O
54	O
%)	O
occurring	O
among	O
26	O
100	O
people	O
of	O
known	O
age	O
in	O
the	O
Malumfashi	O
area	O
of	O
northern	O
Nigeria	O
,	O
data	O
were	O
collected	O
on	O
symptoms	O
present	O
prior	O
to	O
death	O
.	O

Salivary	O
estradiol	O
17	O
beta	O
(	O
E2	O
-	O
17	O
beta	O
)	O
and	O
progesterone	O
(	O
P	O
)	O
were	O
determined	O
by	O
using	O
radioimmunoassay	O
techniques	O
in	O
30	O
pregnant	O
females	O
in	O
the	O
first	O
,	O
second	O
and	O
third	O
trimesters	O
as	O
well	O
as	O
in	O
10	O
non	O
-	O
pregnant	O
controls	O
during	O
the	O
luteal	O
phase	O
of	O
the	O
menstrual	O
cycle	O
.	O

The	O
results	O
imply	O
that	O
kindling	O
does	O
not	O
produce	O
its	O
facilitating	O
effect	O
on	O
acquisition	O
of	O
HPC	O
SS	O
by	O
removing	O
a	O
disruptive	O
effect	O
of	O
the	O
stimulation	O
.	O

SFP	O
was	O
significantly	O
elevated	O
in	O
Hn	O
(	O
s	O
).	O

The	O
average	O
birth	O
mass	O
of	O
these	O
newborns	O
was	O
3491	O
.	O
9	O
+/-	O
2	O
SD	O
780	O
.	O
5	O
g	O
and	O
that	O
in	O
the	O
control	O
group	O
3	O
,	O
767	O
.	O
5	O
+/-	O
2	O
SD	O
824	O
.	O
2	O
g	O
(	O
P	O
less	O
than	O
0	O
.	O
05	O
).	O

This	O
machine	O
drift	O
,	O
which	O
was	O
not	O
associated	O
with	O
a	O
rise	O
in	O
water	O
phantom	O
temperature	O
and	O
did	O
not	O
consistently	O
correlate	O
with	O
estimated	O
x	O
-	O
ray	O
tube	O
heat	O
,	O
could	O
result	O
in	O
a	O
significant	O
overestimation	O
of	O
regional	O
cerebral	O
blood	O
flow	O
(	O
rCBF	O
)	O
for	O
a	O
xenon	O
/	O
CT	O
rCBF	O
protocol	O
involving	O
5	O
-	O
7	O
sequential	O
scans	O
obtained	O
at	O
1	O
-	O
min	O
interscan	O
intervals	O
.	O

Other	O
uncertainties	O
in	O
the	O
dosimetry	O
at	O
Y	O
-	O
12	O
and	O
Vinca	O
are	O
unaltered	O
.	O

Reaction	O
of	O
human	O
organism	O
to	O
exercise	O
.	O

HA	O
resulted	O
in	O
decreased	O
(	O
p	O
less	O
than	O
0	O
.	O
05	O
)	O
Tre	O
(	O
0	O
.	O
4	O
degrees	O
C	O
)	O
and	O
HR	O
(	O
17	O
b	O
X	O
min	O
-	O
1	O
),	O
and	O
increased	O
(	O
p	O
less	O
than	O
0	O
.	O
05	O
)	O
Msw	O
(	O
16	O
g	O
X	O
m	O
-	O
2	O
X	O
h	O
-	O
1	O
)	O
during	O
the	O
saline	O
experiments	O
.	O

The	O
results	O
obtained	O
were	O
as	O
follows	O
:	O
The	O
mitral	O
valve	O
orifice	O
area	O
(	O
MVA	O
)	O
was	O
significantly	O
smaller	O
in	O
patients	O
with	O
type	O
III	O
of	O
the	O
LVIT	O
flow	O
velocity	O
pattern	O
than	O
in	O
patients	O
with	O
type	O
I	O
(	O
p	O
less	O
than	O
0	O
.	O
001	O
).	O

Azygos	O
vein	O
abutting	O
the	O
posterior	O
wall	O
of	O
the	O
right	O
main	O
and	O
upper	O
lobe	O
bronchi	O
:	O
a	O
normal	O
CT	O
variant	O
.	O

All	O
other	O
changes	O
at	O
the	O
3	O
-,	O
5	O
-,	O
and	O
6	O
-	O
positions	O
,	O
as	O
well	O
as	O
the	O
replacement	O
of	O
the	O
phenyl	O
group	O
at	O
position	O
2	O
,	O
caused	O
a	O
marked	O
decrease	O
of	O
activity	O
.	O

Limb	O
allografts	O
in	O
rats	O
immunosuppressed	O
with	O
cyclosporin	O
A	O
.	O

Sixteen	O
patients	O
were	O
studied	O
within	O
24	O
hours	O
of	O
resuscitation	O
and	O
all	O
showed	O
depressed	O
right	O
ventricular	O
ejection	O
(	O
RVEF	O
)	O
and	O
/	O
or	O
an	O
increased	O
end	O
-	O
diastolic	O
volume	O
(	O
RVEDVI	O
).	O

The	O
population	O
of	O
between	O
75	O
,	O
000	O
and	O
100	O
,	O
000	O
was	O
largely	O
unstable	O
,	O
and	O
cost	O
per	O
capita	O
was	O
$	O
0	O
.	O
95	O
to	O
$	O
1	O
.	O
21	O
.	O

HL	O
02	O
type	O
oculomotor	O
stimulator	O
.	O

Four	O
patients	O
(	O
group	O
1	O
)	O
had	O
type	O
I	O
basement	O
membrane	O
nephropathy	O
,	O
characterized	O
by	O
marked	O
thickening	O
and	O
lamellation	O
of	O
the	O
basement	O
membrane	O
in	O
a	O
pattern	O
resembling	O
that	O
of	O
Alport	O
'	O
s	O
syndrome	O
.	O

Angionephroscintigraphy	O
in	O
the	O
diagnosis	O
of	O
diseases	O
of	O
the	O
kidney	O

An	O
intravenous	O
drip	O
infusion	O
of	O
AMK	O
in	O
adequate	O
dosage	O
would	O
be	O
beneficial	O
to	O
use	O
against	O
some	O
infectious	O
diseases	O
of	O
otorhinolaryngologic	O
field	O
.	O

The	O
concentrations	O
of	O
C4	B
and	O
C1	B
-	I
INH	I
increased	O
with	O
advancing	O
stage	O
of	O
disease	O
and	O
were	O
above	O
normal	O
mean	O
values	O
in	O
all	O
stages	O
.	O

Less	O
antibacterial	O
activity	O
was	O
shown	O
toward	O
the	O
Gram	O
-	O
negative	O
bacilli	O
,	O
i	O
.	O
e	O
.,	O
Pseudomonas	O
,	O
Klebsiella	O
-	O
Enterobacter	O
,	O
Shigella	O
,	O
Escherichia	O
coli	O
,	O
Serratia	O
marcescens	O
and	O
Proteus	O
.	O

The	O
Prolactin	B
levels	O
were	O
within	O
the	O
physiological	O
norms	O
;	O
the	O
responses	O
to	O
TRH	B
were	O
normal	O
,	O
and	O
elevated	O
only	O
in	O
a	O
few	O
cases	O
.	O

Antithrombin	B
III	I
in	O
hip	O
surgery	O

The	O
pyramidal	O
tract	O
and	O
Mesencephalic	O
Reticular	O
Formation	O
(	O
MRF	O
)	O
were	O
stimulated	O
before	O
and	O
after	O
the	O
transection	O
.	O

Further	O
,	O
the	O
reduction	O
in	O
5	O
-	O
hydroxytryptophan	O
(	O
5	O
-	O
HTP	O
)	O
accumulation	O
by	O
LSD	O
showed	O
regional	O
differences	O
in	O
inhibition	O
by	O
methiothepin	O
(	O
hypothalamus	O
greater	O
than	O
cortex	O
greater	O
than	O
striatum	O
)	O
which	O
paralleled	O
the	O
autoreceptor	O
antagonist	O
activity	O
of	O
methiothepin	O
in	O
vitro	O
.(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

Blood	O
pressure	O
in	O
children	O
.	O

The	O
maps	O
of	O
Case	O
2	O
showed	O
that	O
a	O
maximum	O
first	O
appeared	O
on	O
the	O
upper	O
right	O
back	O
and	O
then	O
moved	O
down	O
the	O
right	O
side	O
of	O
the	O
posterior	O
thorax	O
.	O

Urinary	O
urate	O
excretion	O
,	O
urate	O
clearance	O
,	O
and	O
fractional	O
excretion	O
of	O
urate	O
all	O
increased	O
significantly	O
during	O
water	O
immersion	O
,	O
and	O
decreased	O
in	O
the	O
hour	O
following	O
water	O
immersion	O
.	O

Mutations	O
in	O
seven	O
other	O
lts	B
genes	I
do	O
not	O
result	O
in	O
the	O
mak	B
-	I
phenotype	I
.	O

4	O
Five	O
patients	O
died	O
within	O
one	O
month	O
of	O
captopril	O
and	O
five	O
between	O
four	O
and	O
seven	O
months	O
,	O
three	O
of	O
whom	O
had	O
improved	O
to	O
class	O
IIM	O
and	O
one	O
to	O
IIS	O
before	O
death	O
.	O

Multiresistant	O
strains	O
isolated	O
from	O
humans	O
in	O
enteral	O
toxico	O
-	O
infections	O
kill	O
orally	O
infected	O
mice	O
more	O
frequently	O
than	O
strains	O
isolated	O
in	O
hospital	O
infections	O
.	O

Single	O
tooth	O
replacement	O
with	O
the	O
aid	O
of	O
the	O
ITI	O
(	O
International	O
Team	O
fur	O
Implantologie	O
)	O
type	O
F	O
hollow	O
-	O
cylinder	O
implant	O

Measurements	O
of	O
perfusion	O
also	O
showed	O
significantly	O
higher	O
values	O
under	O
active	O
therapy	O
.	O

1	O
.	O

A	O
convenient	O
measure	O
of	O
this	O
impairment	O
may	O
be	O
obtained	O
using	O
the	O
ratio	O
of	O
urine	O
volume	O
(	O
V	O
)	O
divided	O
by	O
lithium	O
clearance	O
(	O
CLi	O
).	O

Production	O
of	O
C	B
mu	I
RNAs	I
,	O
unlike	O
mu	B
mRNAs	I
,	O
does	O
not	O
require	O
recombination	O
with	O
the	O
joining	B
region	I
(	O
JH	B
)	O
locus	O
.	O

The	O
1	O
.	O
9	O
-	O
kb	O
C	B
mu	I
RNA	O
contains	O
the	O
3	O
'	O
sequence	O
characteristic	O
of	O
secreted	O
mu	B
chain	I
,	O
whereas	O
the	O
longer	O
species	O
bear	O
that	O
of	O
membrane	O
-	O
bound	O
mu	B
chin	O
.	O

Transcripts	O
of	O
the	O
immunoglobulin	B
C	I
mu	I
gene	I
vary	O
in	O
structure	O
and	O
splicing	O
during	O
lymphoid	O
development	O
.	O

Lens	B
aldose	I
reductase	I
in	O
diabetic	O
and	O
galactosemic	O
cataracts	O
.	O

Fenfluramine	O
(	O
in	O
doses	O
ranging	O
from	O
0	O
.	O
0625	O
-	O
4	O
.	O
0	O
mg	O
/	O
kg	O
/	O
infusion	O
)	O
did	O
not	O
maintain	O
self	O
-	O
administration	O
behavior	O
at	O
or	O
above	O
the	O
minimum	O
requirement	O
(	O
FR	O
30	O
).	O

In	O
the	O
course	O
of	O
Hepatitis	B
A	I
HBs	I
-	I
and	I
HBe	I
-	I
antigen	I
as	O
well	O
as	O
HBc	B
(	I
IgM	I
and	I
IgG	I
)-,	I
HBs	I
-	I
and	I
HBe	I
-	I
antibodies	I
can	O
be	O
detected	O
.	O

Factor	B
VIII	I
procoagulant	O
activity	O
,	O
antigen	O
concentration	O
and	O
von	B
Willebrand	I
activity	O
as	O
ristocetin	B
cofactor	I
were	O
determined	O
several	O
times	O
in	O
10	O
patients	O
with	O
DIC	O
.	O

For	O
steers	O
the	O
urinary	O
N	O
values	O
were	O
403	O
and	O
295	O
mg	O
/	O
kg	O
W0	O
.	O
75	O
at	O
200	O
and	O
350	O
kg	O
live	O
weight	O
respectively	O
and	O
total	O
N	O
excretion	O
including	O
faecal	O
N	O
was	O
408	O
and	O
320	O
mg	O
/	O
kg	O
W0	O
.	O
75	O
.	O

Comparison	O
of	O
three	O
different	O
preparations	O
of	O
disodium	O
cromoglycate	O
in	O
the	O
prevention	O
of	O
exercise	O
-	O
induced	O
bronchospasm	O
:	O
a	O
double	O
-	O
blind	O
study	O
.	O

Apo	B
A	I
-	I
I	I
level	O
was	O
unrelated	O
to	O
age	O
,	O
but	O
increased	O
with	O
ethanol	O
consumption	O
and	O
decreased	O
with	O
adiposity	O
.	O

Of	O
270	O
patients	O
with	O
well	O
-	O
defined	O
drug	O
reactions	O
,	O
190	O
(	O
70	O
per	O
cent	O
)	O
gave	O
a	O
positive	O
response	O
to	O
the	O
mast	O
cell	O
test	O
.	O

This	O
study	O
was	O
undertaken	O
to	O
define	O
the	O
mechanism	O
for	O
the	O
respiratory	O
inhibition	O
observed	O
during	O
high	O
-	O
frequency	O
oscillatory	O
ventilation	O
(	O
HFOV	O
).	O

Of	O
254	O
children	O
with	O
neuroblastoma	O
treated	O
at	O
St	O
.	O

Distal	O
tubular	O
acidification	O
and	O
the	O
threshold	O
for	O
proximal	O
tubular	O
bicarbonate	O
reabsorption	O
were	O
normal	O
,	O
as	O
was	O
urine	O
concentrating	O
capacity	O
.	O

Disturbances	O
of	O
placental	O
maturation	O
,	O
2	O
.	O

Leads	O
from	O
the	O
MMWR	O
.	O

The	O
results	O
confirm	O
and	O
extend	O
previous	O
work	O
by	O
other	O
researchers	O
.	O

Total	O
PGE	O
levels	O
in	O
synovial	O
fluid	O
remained	O
significantly	O
depressed	O
in	O
the	O
patient	O
group	O
for	O
24	O
hours	O
after	O
the	O
400	O
-	O
mg	O
test	O
dose	O
of	O
tolmetin	O
on	O
day	O
8	O
.	O

Use	O
of	O
prostaglandin	O
F2	O
alpha	O
(	O
PGF2	O
alpha	O
)	O
in	O
cattle	O
breeding	O
.	O

Thus	O
it	O
appears	O
that	O
the	O
management	O
of	O
blood	O
,	O
including	O
washing	O
is	O
of	O
great	O
importance	O
.	O

The	O
scores	O
are	O
dependent	O
in	O
part	O
on	O
the	O
reliability	O
of	O
faculty	O
evaluations	O
.	O

Utero	O
-	O
placental	O
blood	O
flow	O
and	O
the	O
effect	O
of	O
beta	B
2	I
-	I
adrenoceptor	I
stimulating	O
drugs	O
.	O

The	O
monoexponential	O
rate	O
of	O
clearance	O
of	O
tracer	O
--	O
obtained	O
from	O
the	O
portion	O
of	O
the	O
residue	O
-	O
detection	O
curve	O
reflecting	O
metabolism	O
of	O
fatty	O
acid	O
incorporated	O
into	O
neutral	O
lipids	O
--	O
correlated	O
directly	O
with	O
induced	O
changes	O
in	O
tension	O
-	O
time	O
index	O
after	O
injections	O
into	O
the	O
left	O
atrium	O
(	O
r	O
=	O
0	O
.	O
96	O
,	O
n	O
=	O
12	O
),	O
right	O
atrium	O
(	O
r	O
=	O
0	O
.	O
86	O
,	O
n	O
=	O
14	O
),	O
and	O
ear	O
vein	O
(	O
r	O
=	O
0	O
.	O
93	O
,	O
n	O
=	O
14	O
).	O

Similar	O
clinical	O
evaluation	O
of	O
an	O
obligate	O
carrier	O
revealed	O
no	O
ocular	O
abnormalities	O
.	O

The	O
extraction	O
measurements	O
were	O
used	O
to	O
test	O
for	O
extracerebral	O
contamination	O
of	O
venous	O
outflow	O
.	O

In	O
rubella	O
patients	O
with	O
serologic	O
confirmation	O
by	O
HI	O
,	O
the	O
IF	O
test	O
detected	O
significant	O
rises	O
in	O
219	O
(	O
99	O
.	O
1	O
%)	O
of	O
221	O
patients	O
and	O
the	O
PHA	B
test	O
detected	O
antibody	O
conversion	O
in	O
68	O
(	O
93	O
%)	O
of	O
73	O
patients	O
.	O

Ten	O
days	O
of	O
cefadroxil	O
therapy	O
was	O
used	O
to	O
treat	O
44	O
children	O
with	O
urinary	O
tract	O
infection	O
and	O
CRP	B
values	O
greater	O
than	O
or	O
equal	O
to	O
28	O
microgram	O
/	O
ml	O
(	O
CRP	B
-	O
positive	O
group	O
).	O

After	O
acclimation	O
,	O
resting	O
supine	O
and	O
sitting	O
DPB	O
decreased	O
(	O
P	O
less	O
than	O
0	O
.	O
05	O
)	O
by	O
6	O
and	O
9	O
mmHg	O
,	O
respectively	O
.	O

The	O
"	O
cracked	O
-	O
tooth	O
"	O
syndrome	O
.	O

The	O
foregoing	O
results	O
show	O
that	O
CXD	O
has	O
high	O
efficacy	O
and	O
safety	O
and	O
it	O
can	O
be	O
said	O
that	O
it	O
is	O
a	O
drug	O
required	O
in	O
the	O
pediatric	O
field	O
.	O

Facts	O
on	O
the	O
Economic	O
Recovery	O
Tax	O
Act	O
of	O
1981	O
for	O
speech	O
-	O
language	O
pathologists	O
and	O
audiologists	O
.	O

We	O
compared	O
the	O
volume	O
of	O
the	O
pulmonary	O
extravascular	O
,	O
extracellular	O
water	O
space	O
using	O
sodium	O
and	O
sucrose	O
indicators	O
in	O
8	O
normal	O
and	O
11	O
edematous	O
rabbit	O
lungs	O
by	O
steady	O
-	O
state	O
techniques	O
.	O

The	O
differential	O
investigation	O
of	O
lipoproteins	O
,	O
however	O
,	O
showed	O
that	O
the	O
high	B
-	I
density	I
lipoprotein	I
(	O
HDL	B
)	O
fractions	O
are	O
absolutely	O
or	O
relatively	O
decreased	O
with	O
respect	O
to	O
low	B
-	I
density	I
lipoproteins	I
(	O
LDL	B
)	O
in	O
cerebral	O
infarcts	O
and	O
in	O
transient	O
ischaemic	O
attacks	O
.	O

Before	O
turnout	O
,	O
a	O
morantel	O
sustained	O
release	O
bolus	O
(	O
MSRB	O
)	O
was	O
administered	O
to	O
each	O
animal	O
in	O
the	O
"	O
treated	O
"	O
category	O
.	O

Conjugated	O
and	O
unconjugated	O
phenylacetic	O
acid	O
and	O
m	O
-	O
and	O
p	O
-	O
hydroxyphenylacetic	O
acid	O
have	O
been	O
determined	O
in	O
the	O
plasma	O
of	O
normal	O
,	O
healthy	O
subjects	O
after	O
fasting	O
,	O
consumption	O
of	O
a	O
meal	O
and	O
ingestion	O
of	O
deuterium	O
labelled	O
amine	O
precursors	O
,	O
by	O
high	O
-	O
resolution	O
gas	O
chromatography	O
--	O
high	O
resolution	O
mass	O
spectrometry	O
with	O
selected	O
ion	O
monitoring	O
of	O
their	O
trifluoroethyl	O
-	O
pentafluoropropionyl	O
derivatives	O
.	O

There	O
were	O
no	O
significant	O
differences	O
in	O
EF	O
between	O
the	O
two	O
studies	O
,	O
both	O
at	O
rest	O
(	O
56	O
.	O
0	O
+/-	O
13	O
.	O
8	O
%	O
vs	O
58	O
.	O
2	O
+/-	O
11	O
.	O
7	O
%,	O
p	O
=	O
NS	O
)	O
and	O
with	O
exercise	O
(	O
51	O
.	O
1	O
+/-	O
17	O
.	O
6	O
%	O
vs	O
54	O
.	O
3	O
+/-	O
17	O
.	O
6	O
%,	O
p	O
=	O
NS	O
)	O
and	O
a	O
highly	O
significant	O
correlation	O
was	O
shown	O
between	O
the	O
two	O
groups	O
of	O
values	O
(	O
rest	O
r	O
=	O
0	O
.	O
90	O
,	O
exercise	O
r	O
=	O
0	O
.	O
93	O
,	O
p	O
less	O
than	O
0	O
.	O
001	O
).	O

Specifically	O
,	O
by	O
the	O
type	O
of	O
adjuvant	O
therapy	O
,	O
the	O
median	O
disease	O
-	O
free	O
interval	O
and	O
survival	O
from	O
stage	O
IVA	O
for	O
23	O
patients	O
receiving	O
Corynebacterium	O
parvum	O
were	O
6	O
.	O
9	O
and	O
19	O
months	O
;	O
for	O
39	O
patients	O
receiving	O
BCG	O
,	O
eight	O
months	O
and	O
26	O
months	O
;	O
for	O
24	O
patients	O
receiving	O
BCG	O
+	O
DTIC	O
,	O
eight	O
and	O
17	O
.	O
4	O
months	O
;	O
and	O
for	O
all	O
51	O
DTIC	O
treated	O
patients	O
6	O
.	O
3	O
and	O
17	O
.	O
8	O
months	O
,	O
respectively	O
.	O

Parasitological	O
and	O
pathological	O
findings	O
in	O
capuchin	O
monkeys	O
infected	O
with	O
Schistosoma	O
japonicum	O
or	O
Schistosoma	O
mansoni	O
.	O

Modification	O
of	O
enteral	O
resorption	O
by	O
cytostatic	O
therapy	O

A	O
limiting	O
factor	O
were	O
disturbances	O
in	O
the	O
system	O
of	O
energy	O
transport	O
(	O
creatine	O
phosphate	O
,	O
creatine	B
phosphokinase	I
)	O
and	O
of	O
the	O
calcium	O
pump	O
(	O
Ca	B
++-	I
ATPase	I
of	O
the	O
sarcoplasmic	O
reticulum	O
,	O
SPR	O
),	O
which	O
evidently	O
led	O
to	O
a	O
decrease	O
of	O
the	O
inotropic	O
properties	O
of	O
the	O
myocardium	O
at	O
70	O
%	O
restriction	O
of	O
coronary	O
blood	O
flow	O
.	O

The	O
cause	O
of	O
death	O
is	O
often	O
quite	O
apparent	O
from	O
the	O
pathological	O
and	O
toxicological	O
findings	O
;	O
however	O
,	O
the	O
manner	O
of	O
death	O
often	O
gives	O
the	O
examining	O
official	O
some	O
difficulty	O
.	O

A	O
further	O
study	O
on	O
plasminogen	B
activator	I
release	O
by	O
vasoactive	O
agents	O
in	O
the	O
isolated	O
perfused	O
dog	O
leg	O
.	O

Treatment	O
of	O
meat	O
muscle	O
800	O
V	O
for	O
45	O
s	O
reduced	O
weeping	O
but	O
increased	O
slightly	O
the	O
rate	O
of	O
autoxidation	O
of	O
lipids	O
.	O

A	O
method	O
for	O
determining	O
cumulative	O
behavioral	O
toxicity	O
after	O
chronic	O
oral	O
administration	O
of	O
l	O
-	O
alpha	O
-	O
acetylmethadol	O
to	O
female	O
rats	O
.	O

Adverse	O
reaction	O
of	O
the	O
apparently	O
healthy	O
partner	O
in	O
response	O
to	O
improvement	O
in	O
the	O
overtly	O
dysfunctional	O
partner	O
.	O

A	O
unified	O
approach	O
to	O
the	O
standardization	O
of	O
allergens	O
.	O

Several	O
authors	O
have	O
recently	O
reported	O
interference	O
in	O
theophylline	O
analysis	O
by	O
paraxanthine	O
(	O
1	O
,	O
7	O
-	O
dimethylxanthine	O
),	O
an	O
important	O
metabolite	O
of	O
caffeine	O
.	O

Following	O
extended	O
recovery	O
hippocampal	O
EEG	O
was	O
normal	O
despite	O
extensive	O
cellular	O
loss	O
in	O
areas	O
CA3	O
and	O
CA4	O
.	O

While	O
all	O
deletions	O
within	O
the	O
sequence	O
coding	O
for	O
the	O
mature	O
tRNA	O
led	O
to	O
inactivity	O
of	O
the	O
mutated	O
genes	O
,	O
substitution	O
of	O
the	O
central	O
portion	O
by	O
concatenated	B
Hind	I
III	I
linkers	I
produced	O
gene	O
units	O
active	O
in	O
transcription	O
.	O

Recording	O
of	O
the	O
digital	O
sphygmic	O
activity	O
in	O
the	O
lower	O
extremities	O
with	O
the	O
photoplethysmographic	O
and	O
strain	O
-	O
gauge	O
methods	O
.	O

These	O
women	O
should	O
not	O
be	O
given	O
the	O
current	O
estrogen	O
PPI	O
,	O
which	O
was	O
designed	O
to	O
warn	O
women	O
of	O
the	O
risks	O
of	O
long	O
-	O
term	O
estrogen	O
use	O
;	O
a	O
PPI	O
should	O
be	O
written	O
specifically	O
for	O
patients	O
receiving	O
short	O
courses	O
.	O

Corticosteroid	O
therapy	O
is	O
known	O
to	O
be	O
hazardous	O
in	O
patients	O
with	O
occult	O
infection	O
but	O
the	O
mechanism	O
by	O
which	O
the	O
host	O
parasite	O
relationship	O
is	O
altered	O
by	O
steroids	O
is	O
not	O
known	O
.	O
We	O
have	O
used	O
an	O
intestinal	O
protozoal	O
parasite	O
,	O
Giardia	O
muris	O
,	O
to	O
examine	O
the	O
effects	O
of	O
corticosteroids	O
on	O
the	O
number	O
of	O
parasites	O
in	O
the	O
intestine	O
in	O
the	O
course	O
of	O
a	O
primary	O
infection	O
.	O

Of	O
the	O
117	O
patients	O
(	O
out	O
of	O
the	O
136	O
)	O
with	O
serologic	O
evidence	O
of	O
chronic	O
thyroiditis	O
who	O
could	O
be	O
studied	O
,	O
eight	O
(	O
7	O
%)	O
had	O
hyperthyroidism	O
and	O
45	O
(	O
38	O
%)	O
were	O
hypothyroid	O
.	O

The	O
relationship	O
between	O
estrogenic	O
properties	O
of	O
Tamoxifen	O
and	O
breast	O
cancer	O
management	O
is	O
discussed	O
.	O

The	O
new	O
semi	O
-	O
synthetic	O
oral	O
cephalosporin	O
,	O
CGP	O
9	O
,	O
000	O
,	O
has	O
been	O
evaluated	O
in	O
a	O
large	O
number	O
of	O
hospitalized	O
patients	O
with	O
urinary	O
infections	O
.	O

A	O
fluoroimmunoassay	O
for	O
the	O
determination	O
of	O
serum	O
of	O
plasma	O
levels	O
of	O
propranolol	O
was	O
developed	O
using	O
antibodies	O
to	O
propranolol	O
coupled	O
to	O
magnetizable	O
solid	O
-	O
phase	O
particles	O
and	O
fluorescein	O
-	O
labeled	O
propranolol	O
as	O
tracer	O
.	O

When	O
pollen	O
allergen	O
from	O
three	O
grass	O
species	O
were	O
used	O
,	O
The	O
RAST	O
-	O
test	O
results	O
did	O
not	O
differ	O
from	O
duplicate	O
values	O
either	O
.	O

DMI	O
and	O
2	O
-	O
OH	O
-	O
DMI	O
concentrations	O
were	O
determined	O
in	O
a	O
similar	O
group	O
of	O
61	O
DMI	O
-	O
treated	O
patients	O
.	O

It	O
has	O
been	O
shown	O
in	O
experiments	O
in	O
vitro	O
that	O
the	O
hepatotrophic	O
organic	O
anions	O
,	O
the	O
radiographic	O
contrast	O
agent	O
(	O
RCA	O
)	O
bilignost	O
used	O
in	O
cholecystography	O
and	O
Bengal	O
pink	O
,	O
have	O
an	O
affinity	O
,	O
unlike	O
the	O
urographic	O
RCA	O
triombrin	O
and	O
renotrophic	O
dye	O
indigo	O
-	O
carmine	O
,	O
for	O
the	O
plasmatic	O
membranes	O
(	O
PM	O
)	O
of	O
liver	O
cells	O
.	O

Leukocyte	O
enzyme	O
activity	O
and	O
blood	O
lymphocyte	O
blast	O
transformation	O
in	O
chronic	O
bronchitis	O

In	O
literature	O
,	O
the	O
HBE	O
has	O
been	O
displayed	O
by	O
application	O
of	O
the	O
averaging	O
method	O
.	O

Delayed	O
or	O
paradoxically	O
emptying	O
regions	O
of	O
the	O
left	O
ventricle	O
were	O
detected	O
by	O
a	O
relatively	O
new	O
nuclear	O
technique	O
--	O
phase	O
imaging	O
.	O

Responses	O
to	O
brainstem	O
of	O
nuclei	O
medialis	O
dorsalis	O
,	O
lateralis	O
posterior	O
were	O
of	O
considerably	O
longer	O
latency	O
.	O

Nineteen	O
patients	O
with	O
non	O
-	O
visualized	O
gallbladder	O
with	O
OCG	O
subsequently	O
had	O
Tc	O
-	O
99m	O
-	O
PyG	O
cholescintigraphy	O
performed	O
.	O

The	O
determination	O
of	O
physical	O
performance	O
capacity	O
was	O
based	O
on	O
W170	O
,	O
W85	O
%	O
and	O
on	O
predicted	O
VO2	O
max	O
measured	O
with	O
continuously	O
increasing	O
work	O
load	O
on	O
a	O
bicycle	O
ergometer	O
.	O

Nutritional	O
cataracts	O
in	O
timber	O
wolves	O
.	O

Prevention	O
of	O
transfusion	O
reactions	O
by	O
the	O
use	O
of	O
saline	O
washed	O
red	O
blood	O
cells	O
.	O

Twenty	O
patients	O
aged	O
45	O
or	O
older	O
with	O
the	O
diagnosis	O
of	O
endogenous	O
depression	O
were	O
evaluated	O
in	O
terms	O
of	O
safety	O
and	O
efficacy	O
in	O
their	O
response	O
to	O
multiple	O
monitored	O
electroconvulsive	O
therapy	O
(	O
MMECT	O
)	O
versus	O
single	O
electroconvulsive	O
therapy	O
(	O
SECT	O
).	O

The	O
following	O
aspects	O
were	O
assessed	O
:	O
(	O
1	O
)	O
The	O
effect	O
on	O
the	O
cardiovascular	O
system	O
in	O
terms	O
of	O
brachial	O
arterial	O
pressure	O
,	O
pulse	O
rate	O
,	O
and	O
oxygen	O
consumption	O
(	O
VO2	O
)	O
during	O
exercise	O
in	O
5	O
health	O
volunteers	O
;	O
(	O
2	O
)	O
emg	O
activity	O
of	O
the	O
tibialis	O
anterior	O
and	O
gastrocnemius	O
muscles	O
during	O
exercise	O
in	O
the	O
same	O
5	O
volunteers	O
;	O
and	O
(	O
3	O
)	O
postexercise	O
ankle	O
pressure	O
changes	O
in	O
10	O
subjects	O
with	O
angiographically	O
proven	O
occlusive	O
arterial	O
diseases	O
of	O
the	O
lower	O
extremities	O
.	O

Specific	O
clotting	O
factor	O
assays	O
showed	O
an	O
isolated	O
deficiency	O
of	O
factor	B
X	I
ranging	O
from	O
7	O
to	O
12	O
per	O
cent	O
on	O
three	O
determinations	O
.	O

The	O
ability	O
of	O
sodium	O
phenobarbital	O
(	O
60	O
mg	O
/	O
kg	O
)	O
and	O
sodium	O
barbital	O
(	O
80	O
mg	O
/	O
kg	O
)	O
to	O
produce	O
a	O
taste	O
aversion	O
in	O
23	O
hr	O
fluid	O
deprived	O
rats	O
was	O
examined	O
using	O
a	O
discrimination	O
or	O
two	O
bottle	O
taste	O
aversion	O
task	O
(	O
0	O
.	O
125	O
%	O
sodium	O
saccharin	O
solution	O
or	O
water	O
).	O

Underestimations	O
by	O
as	O
much	O
as	O
35	O
%	O
may	O
occur	O
due	O
to	O
the	O
problems	O
in	O
the	O
existing	O
methodologies	O
.	O

Although	O
stone	O
-	O
formers	O
were	O
not	O
found	O
to	O
display	O
any	O
features	O
of	O
magnesium	O
metabolism	O
that	O
were	O
different	O
from	O
those	O
in	O
the	O
control	O
group	O
,	O
their	O
lower	O
urinary	O
excretion	O
of	O
magnesium	O
in	O
relation	O
to	O
calcium	O
may	O
be	O
a	O
factor	O
in	O
their	O
increased	O
stone	O
-	O
forming	O
propensity	O
.	O

Fasting	O
plasma	O
and	O
lipoprotein	O
lipid	O
concentrations	O
,	O
adipose	B
tissue	I
lipoprotein	I
lipase	I
activity	O
,	O
anthropometric	O
data	O
,	O
alcohol	O
consumption	O
,	O
smoking	O
habits	O
,	O
weekly	O
mileage	O
run	O
and	O
performance	O
on	O
a	O
bicycle	O
ergometer	O
were	O
recorded	O
before	O
and	O
after	O
the	O
training	O
period	O
.	O

We	O
propose	O
that	O
refeeding	O
may	O
be	O
an	O
important	O
mechanism	O
for	O
activation	O
of	O
certain	O
viral	O
infections	O
previously	O
suppressed	O
by	O
famine	O
.	O

The	O
symptoms	O
and	O
objective	O
findings	O
were	O
caused	O
by	O
a	O
malignant	O
lymphoma	O
,	O
and	O
the	O
diagnosis	O
was	O
established	O
from	O
a	O
drill	O
biopsy	O
.	O

At	O
pH	O
6	O
.	O
9	O
,	O
the	O
same	O
lidocaine	O
concentrations	O
significantly	O
reduced	O
resting	O
potential	O
(	O
3	O
-	O
10	O
%),	O
action	O
potential	O
amplitude	O
(	O
3	O
-	O
8	O
%)	O
and	O
Vmax	O
(	O
14	O
-	O
22	O
%).	O

In	O
patients	O
,	O
the	O
effect	O
of	O
CCK	B
-	O
PZ	B
on	O
the	O
movement	O
of	O
the	O
terminal	O
part	O
of	O
the	O
bile	O
duct	O
was	O
measured	O
with	O
a	O
pressure	O
sensor	O
using	O
a	O
duodenofiberscope	O
.	O

The	O
ESEG	O
'	O
s	O
are	O
a	O
direct	O
result	O
of	O
the	O
NEXT	O
study	O
.	O

The	O
mean	O
values	O
of	O
the	O
concentrations	O
of	O
the	O
components	O
due	O
to	O
tobacco	O
smoke	O
are	O
:	O
CO	O
=	O
1	O
.	O
1	O
ppm	O
,	O
NO	O
=	O
32	O
ppb	O
,	O
NO2	O
=	O
24	O
ppb	O
,	O
nicotine	O
=	O
0	O
.	O
9	O
micrograms	O
/	O
m3	O
,	O
particulate	O
matter	O
=	O
133	O
micrograms	O
/	O
m3	O
.	O

At	O
4	O
wk	O
however	O
,	O
tumor	O
relapse	O
was	O
noted	O
in	O
6	O
of	O
7	O
group	O
4	O
responders	O
,	O
10	O
of	O
12	O
in	O
group	O
5	O
,	O
13	O
of	O
16	O
in	O
group	O
7	O
,	O
but	O
only	O
4	O
of	O
19	O
group	O
8	O
responders	O
(	O
p	O
less	O
than	O
.	O
001	O
group	O
8	O
versus	O
4	O
,	O
5	O
,	O
7	O
).	O

Patients	O
with	O
psychotropic	O
drugs	O
showed	O
significantly	O
higher	O
PRL	B
levels	O
.	O

Considerably	O
high	O
levels	O
of	O
IgE	B
antibodies	I
was	O
also	O
established	O
while	O
other	O
pollens	O
did	O
not	O
show	O
such	O
correspondence	O
.	O

Functional	O
analysis	O
of	O
aryl	B
hydrocarbon	I
receptor	I
nuclear	I
translocator	I
interactions	O
with	O
aryl	B
hydrocarbon	I
receptor	I
in	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
.	O

These	O
are	O
two	O
regions	O
of	O
known	O
conserved	O
synteny	O
,	O
providing	O
further	O
evidence	O
that	O
the	O
human	B
STEP	I
is	O
a	O
true	O
homolog	O
of	O
the	O
murine	B
STEP	I
gene	I
.	O

The	O
latter	O
domain	O
appears	O
to	O
be	O
involved	O
in	O
targeting	O
Num1p	B
to	O
the	O
mother	O
cell	O
cortex	O
.	O

Results	O
of	O
the	O
ECAT	O
Angina	O
Pectoris	O
Study	O
Group	O
.	O

Common	O
history	O
and	O
prospects	O
in	O
surgical	O
gynecology	O
of	O
the	O
Charite	O
and	O
the	O
Vienna	O
University	O
Clinic	O

The	O
effects	O
of	O
a	O
1	O
-	O
or	O
24	O
-	O
hour	O
pretreatment	O
regimen	O
with	O
monophosphoryl	O
lipid	O
A	O
(	O
MLA	O
,	O
35	O
micrograms	O
/	O
kg	O
i	O
.	O
v	O
.)	O
on	O
myocardial	O
stunning	O
produced	O
by	O
repetitive	O
coronary	O
occlusions	O
were	O
studied	O
in	O
barbital	O
-	O
anesthetized	O
dogs	O
.	O

The	O
avidin	B
-	I
biotin	I
complex	I
peroxidase	I
(	O
ABC	B
-	I
P	I
)	O
method	O
was	O
used	O
to	O
detect	O
Mycobacterium	O
bovis	O
,	O
and	O
the	O
results	O
were	O
compared	O
with	O
those	O
obtained	O
by	O
the	O
Ziehl	O
-	O
Neelsen	O
(	O
ZN	O
)	O
technique	O
.	O

Tyrosine	O
phosphorylation	O
of	O
cellular	O
proteins	O
is	O
the	O
earliest	O
identifiable	O
event	O
following	O
T	B
-	I
cell	I
antigen	I
receptor	I
(	O
TCR	B
)	O
stimulation	O
and	O
is	O
essential	O
for	O
activating	O
downstream	O
signaling	O
machinery	O
.	O

Moreover	O
,	O
Lck	B
was	O
reversibly	O
co	O
-	O
immunoprecipitated	O
with	O
p95Vav	B
,	O
and	O
the	O
stoichiometry	O
of	O
binding	O
increased	O
in	O
anti	B
-	I
CD3	I
-	O
treated	O
Jurkat	O
cells	O
.	O

On	O
the	O
other	O
hand	O
,	O
cells	O
containing	O
a	O
PTP1C	B
in	O
which	O
the	O
catalytic	O
site	O
had	O
been	O
inactivated	O
through	O
mutagenesis	O
,	O
stably	O
phosphorylated	O
the	O
phosphatase	O
.	O

A	O
particularly	O
striking	O
HpaII	B
tiny	O
fragment	O
island	O
,	O
extending	O
over	O
nearly	O
2	O
,	O
000	O
base	O
pairs	O
,	O
surrounds	O
the	O
USF2	B
translation	I
initiation	I
site	I
.	O

Diagnosis	O
of	O
prostatic	O
carcinoma	O
:	O
the	O
yield	O
of	O
serum	B
prostate	I
specific	I
antigen	I
,	O
digital	O
rectal	O
examination	O
and	O
transrectal	O
ultrasonography	O
.	O

However	O
,	O
expression	O
of	O
sigma	B
3	I
from	O
S4	B
(	O
3	B
'	I
UTR	I
/	I
S1	I
),	O
which	O
included	O
the	O
PKR	B
activator	I
sequence	I
from	O
S1	B
within	O
the	O
3	B
'-	I
UTR	I
of	I
S4	I
,	O
was	O
comparable	O
to	O
that	O
from	O
wild	B
-	I
type	I
S4	I
.	O

Although	O
both	O
transfected	O
cell	O
lines	O
contain	O
FGF	B
-	I
1	I
cell	I
surface	I
receptors	I
as	O
judged	O
by	O
crosslinking	O
studies	O
,	O
the	O
wild	O
-	O
type	O
transfectants	O
are	O
refractory	O
to	O
exogenous	O
FGF	B
-	I
1	I
,	O
whereas	O
the	O
mutant	O
transfectants	O
respond	O
normally	O
.(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

All	O
subsequent	O
patients	O
were	O
treated	O
at	O
the	O
maximal	O
tolerated	O
dose	O
of	O
EDXR	O
(	O
35	O
mg	O
/	O
m2	O
/	O
day	O
).	O

Horvath	O
,	O
I	O
.	O

Cell	O
lines	O
derived	O
from	O
the	O
tumors	O
were	O
examined	O
by	O
fluorescent	O
in	O
situ	O
hybridization	O
for	O
the	O
status	O
of	O
the	O
transferred	O
human	O
chromosome	O
and	O
by	O
PCR	O
for	O
marker	O
loss	O
.	O

The	O
FinO	B
protein	I
of	O
IncF	O
plasmids	O
binds	O
FinP	B
antisense	I
RNA	I
and	O
its	O
target	O
,	O
traJ	B
mRNA	I
,	O
and	O
promotes	O
duplex	O
formation	O
.	O

These	O
data	O
suggest	O
that	O
these	O
sequences	O
located	O
immediately	O
3	O
'	O
to	O
the	O
breakpoint	O
of	O
the	O
HPFH	B
-	I
3	I
deletion	I
,	O
exhibit	O
both	O
the	O
structure	O
and	O
the	O
function	O
of	O
an	O
enhancer	O
,	O
and	O
can	O
modify	O
the	O
developmental	O
specificity	O
of	O
the	O
fetal	B
gamma	I
-	I
globin	I
genes	I
,	O
resulting	O
in	O
their	O
continued	O
expression	O
during	O
adult	O
life	O
.	O

As	O
expected	O
,	O
the	O
insulin	B
effect	O
to	O
increase	O
ras	B
GTP	I
formation	O
and	O
MAP	B
kinase	I
activity	O
was	O
negligible	O
in	O
A	O
/	O
K1018	O
cells	O
but	O
normal	O
,	O
or	O
supernormal	O
,	O
in	O
Y	O
/	O
F2	O
cells	O
.	O

Morphologic	O
variables	O
included	O
cancer	O
volume	O
,	O
histologic	O
grade	O
,	O
capsular	O
penetration	O
,	O
seminal	O
vesicle	O
invasion	O
,	O
and	O
lymph	O
node	O
metastasis	O
.	O

Sources	O
of	O
noise	O
in	O
these	O
signals	O
were	O
evaluated	O
in	O
preparations	O
stained	O
with	O
the	O
potentiometric	O
probe	O
RH	O
-	O
414	O
.	O

The	O
gene	O
product	O
of	O
cotS	B
was	O
confirmed	O
to	O
be	O
identical	O
to	O
Cot40	B
-	I
2	I
by	O
SDS	O
-	O
PAGE	O
and	O
immunoblotting	O
from	O
Escherichia	O
coli	O
transformed	O
with	O
a	O
plasmid	O
containing	O
the	O
cotS	B
region	I
.	O

We	O
showed	O
previously	O
that	O
a	O
fusion	O
protein	O
(	O
GAL4	B
-	O
p40	B
)	O
containing	O
the	O
DNA	O
-	O
binding	O
domain	O
of	O
GAL4	B
and	O
sequences	O
of	O
chicken	B
l	I
kappa	I
B	I
-	I
alpha	I
(	O
p40	B
)	O
inhibits	O
growth	O
in	O
the	O
yeast	O
Saccharomyces	O
cerevisiae	O
.	O

15	O
,	O
2500	O
-	O
2508	O
;	O
O	O
'	O
Neill	O
,	O
T	O
.	O

Several	O
different	O
oncogenes	O
and	O
growth	O
factors	O
promote	O
G1	O
phase	O
progression	O
.	O

Comparisons	O
of	O
rrnB	B
P1	I
-	O
lacZ	B
expression	O
at	O
different	O
ppGpp	O
levels	O
is	O
interpreted	O
for	O
the	O
rpoD	B
(	I
P504L	I
)	I
mutant	I
as	O
resulting	O
from	O
a	O
hypersensitivity	O
to	O
ppGpp	O
.	O

Here	O
we	O
demonstrate	O
genetically	O
that	O
plus	O
-	O
strand	O
DNA	O
synthesis	O
of	O
the	O
yeast	B
Ty1	I
element	I
is	O
initiated	O
at	O
two	O
sites	O
located	O
at	O
the	O
5	O
'	O
boundary	O
of	O
the	O
3	O
'	O
long	O
terminal	O
repeat	O
(	O
PPT1	B
)	O
and	O
near	O
the	O
middle	O
of	O
the	O
pol	B
gene	I
in	O
the	O
integrase	B
coding	I
sequence	I
(	O
PPT2	B
).	O

The	O
expression	O
of	O
the	O
pilin	B
gene	I
,	O
tcpA	B
,	O
is	O
dependent	O
upon	O
ToxR	B
and	O
upon	O
ToxT	B
.	O

The	O
chloramphenicol	B
-	I
resistance	I
transposon	I
Tn4451	I
undergoes	O
precise	O
conjugative	O
deletion	O
from	O
its	O
parent	O
plasmid	O
plP401	O
in	O
Clostridium	O
perfringens	O
and	O
precise	O
spontaneous	O
excision	O
from	O
multicopy	O
plasmids	O
in	O
Escherichia	O
coli	O
.	O

In	O
cells	O
limited	O
for	O
His	O
,	O
increased	O
expression	O
of	O
arg	B
-	I
2	I
and	O
cpc	B
-	I
1	I
,	O
and	O
decreased	O
expression	O
of	O
cox	B
-	I
5	I
,	O
also	O
had	O
translational	O
and	O
transcriptional	O
components	O
.	O

Expression	O
and	O
regulation	O
by	O
interferon	B
of	O
a	O
double	B
-	I
stranded	I
-	I
RNA	I
-	I
specific	I
adenosine	I
deaminase	I
from	O
human	O
cells	O
:	O
evidence	O
for	O
two	O
forms	O
of	O
the	O
deaminase	O
.	O

Deletions	O
were	O
examined	O
in	O
the	O
LYS2	B
gene	I
,	O
using	O
a	O
set	O
of	O
31	O
-	O
to	O
156	O
-	O
bp	O
inserts	O
that	O
included	O
inserts	O
with	O
no	O
apparent	O
potential	O
for	O
secondary	O
structure	O
as	O
well	O
as	O
two	O
quasipalindromes	O
.	O

The	O
kinase	O
is	O
essential	O
in	O
vivo	O
for	O
normal	O
phosphorylation	O
of	O
the	O
CTD	O
and	O
for	O
normal	O
growth	O
and	O
differentiation	O
.	O

Individual	O
mutations	O
in	O
motifs	O
III	O
,	O
IV	O
,	O
and	O
V	O
had	O
distinctive	O
effects	O
on	O
the	O
affinity	O
of	O
enzyme	O
for	O
GTP	O
,	O
the	O
rate	O
of	O
covalent	O
catalysis	O
(	O
EpG	O
formation	O
),	O
or	O
the	O
transfer	O
of	O
GMP	O
from	O
enzyme	O
to	O
RNA	O
.	O

Deletion	O
or	O
inactivation	O
of	O
CRY1	B
leads	O
to	O
5	O
-	O
to	O
10	O
-	O
fold	O
-	O
increased	O
levels	O
of	O
CRY2	B
mRNA	I
.	O

(	O
1986	O
)	O
method	O
of	O
separation	O
of	O
Cryptosporidium	O
spp	O
.	O
oocysts	O
from	O
feces	O
by	O
using	O
a	O
percoll	O
discontinuous	O
density	O
gradient	O
appeared	O
a	O
method	O
of	O
choice	O
for	O
obtaining	O
large	O
numbers	O
of	O
oocysts	O
of	O
C	O
.	O
parvum	O
free	O
of	O
fecal	O
contamination	O
.	O

Our	O
findings	O
also	O
provide	O
the	O
basis	O
for	O
the	O
development	O
of	O
assays	O
to	O
screen	O
for	O
the	O
ligands	O
to	O
testis	B
receptor	I
2	I
and	O
hERR1	B
.	O

All	O
carcasses	O
resulted	O
in	O
contamination	O
with	O
aerobic	O
mesophilic	O
bacteria	O
in	O
the	O
range	O
from	O
6	O
x	O
10	O
(	O
3	O
)	O
to	O
1	O
.	O
2	O
x	O
10	O
(	O
6	O
)	O
CFU	O
/	O
ml	O
liquid	O
washed	O
,	O
and	O
94	O
%	O
them	O
with	O
sporulate	O
bacteria	O
,	O
the	O
threshold	O
being	O
under	O
100	O
CFU	O
/	O
ml	O
(	O
Figure	O
1	O
).	O

As	O
for	O
31	O
stage	O
I	O
-	O
II	O
lung	O
cancer	O
patients	O
,	O
CR	O
has	O
been	O
observed	O
in	O
82	O
.	O
8	O
%	O
of	O
them	O
and	O
PR	O
in	O
13	O
.	O
8	O
%;	O
the	O
response	O
was	O
always	O
assessed	O
with	O
chest	O
radiography	O
,	O
CT	O
,	O
FBS	O
,	O
cytology	O
and	O
/	O
or	O
histology	O
.	O

An	O
abnormally	O
high	O
percentage	O
of	O
hypertensive	O
patients	O
(	O
approximately	O
30	O
%)	O
undergoing	O
cardiac	O
catheterization	O
because	O
of	O
anginal	O
pain	O
and	O
/	O
or	O
exercise	O
-	O
induced	O
ST	O
-	O
segment	O
depressions	O
has	O
angiographically	O
normal	O
coronary	O
arteries	O
.	O

cDNA	O
encoding	O
a	O
functional	O
feline	B
liver	I
/	I
bone	I
/	I
kidney	I
-	I
type	I
alkaline	I
phosphatase	I
.	O

Taken	O
together	O
,	O
these	O
data	O
suggest	O
that	O
the	O
Mif2	B
protein	I
interacts	O
with	O
Cep1p	B
at	O
the	O
centromere	O
and	O
that	O
the	O
yeast	O
centromere	O
indeed	O
exists	O
as	O
a	O
higher	O
order	O
protein	O
-	O
DNA	O
complex	O
.	O

In	O
men	O
with	O
BMI	O
<	O
30	O
,	O
the	O
OR	O
was	O
1	O
.	O
83	O
for	O
postprandial	O
TG	O
(	O
P	O
=	O
.	O
041	O
)	O
and	O
2	O
.	O
77	O
for	O
postprandial	O
RP	O
(	O
P	O
=	O
.	O
032	O
)	O
in	O
models	O
that	O
included	O
fasting	O
TG	O
,	O
LDL	B
-	I
C	I
,	O
and	O
hypertension	O
.	O

Overexpression	O
of	O
wild	B
-	I
type	I
p53	I
also	O
induces	O
apoptosis	O
in	O
an	O
LCL	O
.	O

In	O
Trial	O
1	O
,	O
eight	O
sows	O
were	O
allowed	O
to	O
farrow	O
naturally	O
(	O
d	O
114	O
,	O
NF	O
sows	O
)	O
and	O
eight	O
sows	O
were	O
induced	O
to	O
farrow	O
(	O
IF	O
sows	O
)	O
prematurely	O
by	O
injection	O
of	O
prostaglandin	O
F2	O
alpha	O
on	O
d	O
112	O
of	O
gestation	O
.	O

However	O
,	O
the	O
few	O
studies	O
that	O
address	O
antimicrobial	O
prophylaxis	O
in	O
bone	O
marrow	O
transplantation	O
have	O
not	O
always	O
shown	O
a	O
survival	O
benefit	O
.	O

The	O
fracture	O
groups	O
were	O
significantly	O
older	O
and	O
had	O
more	O
years	O
since	O
menopause	O
than	O
the	O
control	O
groups	O
.	O

Analysis	O
of	O
this	O
sequence	O
combined	O
with	O
that	O
previously	O
reported	O
for	O
the	O
5	O
'-	O
flanking	O
region	O
directly	O
proximal	O
to	O
the	O
start	O
of	O
transcription	O
revealed	O
several	O
putative	O
regulatory	O
sequences	O
.	O

Total	O
cholesterol	O
was	O
also	O
reduced	O
at	O
week	O
12	O
by	O
17	O
.	O
0	O
%	O
(	O
20	O
mg	O
/	O
day	O
)	O
and	O
15	O
.	O
7	O
%	O
(	O
20	O
-	O
30	O
mg	O
/	O
day	O
),	O
and	O
at	O
week	O
52	O
by	O
20	O
.	O
4	O
%	O
(<	O
or	O
=	O
20	O
mg	O
/	O
day	O
)	O
and	O
19	O
.	O
2	O
%	O
(>	O
or	O
=	O
30	O
mg	O
/	O
day	O
).	O

The	O
structural	O
gene	O
encoding	O
the	O
novel	O
lantibiotic	O
epilancin	B
K7	I
from	O
Staphylococcus	O
epidermidis	O
K7	O
was	O
cloned	O
and	O
its	O
nucleotide	O
sequence	O
was	O
determined	O
.	O

The	O
spectrum	O
of	O
phenotypes	O
caused	O
by	O
these	O
mutations	O
was	O
strikingly	O
different	O
than	O
mutations	O
in	O
the	O
adaptor	O
for	O
the	O
VP16	B
activation	I
domain	I
.	O

In	O
addition	O
,	O
depletion	O
of	O
Oct	B
-	I
1	I
from	O
the	O
nuclear	O
extract	O
by	O
using	O
Oct	B
-	I
1	I
-	O
specific	O
antiserum	O
or	O
a	O
sequence	O
-	O
specific	O
DNA	O
affinity	O
resin	O
decreased	O
in	O
vitro	O
transcription	O
from	O
the	O
wild	O
-	O
type	O
MMTV	O
promoter	O
to	O
a	O
level	O
identical	O
to	O
that	O
obtained	O
from	O
a	O
promoter	O
in	O
which	O
all	O
three	O
octamer	O
-	O
related	O
sequences	O
were	O
mutated	O
.	O

Oncological	O
,	O
clinical	O
and	O
psychological	O
aspects	O
are	O
evaluated	O
according	O
to	O
experience	O
accumulated	O
in	O
recent	O
years	O
,	O
with	O
immediate	O
and	O
delayed	O
reconstruction	O
,	O
carried	O
out	O
in	O
the	O
most	O
diverse	O
specialized	O
centers	O
.	O

The	O
cryptococcal	B
antigen	I
test	O
was	O
positive	O
at	O
1	O
:	O
125	O
by	O
latex	O
agglutination	O
.	O

Functional	O
analysis	O
of	O
DNase	B
-	I
I	I
hypersensitive	O
sites	O
at	O
the	O
mouse	B
porphobilinogen	I
deaminase	I
gene	I
locus	I
.	O

Purified	O
CarP	B
binds	O
in	O
vitro	O
to	O
the	O
carAB	B
control	I
region	I
and	O
protects	O
against	O
DNase	B
I	I
two	O
approximately	O
25	O
bp	O
long	O
stretches	O
,	O
one	O
of	O
which	O
is	O
located	O
just	O
downstream	O
of	O
the	O
GATC	O
sequence	O
.	O

D	O
.	O

Acute	O
decrease	O
in	O
body	O
temperature	O
(	O
TB	O
)	O
lowered	O
PaCO2	O
(	O
32	O
.	O
5	O
to	O
14	O
.	O
5	O
mmHg	O
)	O
and	O
[	O
HCO3	O
-]	O
a	O
(	O
24	O
.	O
20	O
mEq	O
/	O
L	O
to	O
17	O
.	O
56	O
mEq	O
/	O
L	O
),	O
increased	O
pHa	O
(	O
7	O
.	O
481	O
to	O
7	O
.	O
608	O
)	O
and	O
diminished	O
the	O
[	O
OH	O
-]/[	O
H	O
+]	O
ratio	O
,	O
but	O
had	O
no	O
significant	O
effect	O
on	O
[	O
SID	O
]	O
or	O
[	O
Atot	O
],	O
although	O
both	O
total	O
phosphorus	O
[	O
PT	O
]	O
and	O
inorganic	O
phosphate	O
[	O
Pi	O
]	O
increased	O
.	O

Hepatitis	O
B	O
vaccine	O
:	O
still	O
has	O
its	O
problems	O
.	O

Basal	O
promoter	O
activity	O
is	O
enhanced	O
by	O
a	O
functional	O
M1	O
domain	O
in	O
LHR	B
-	O
expressing	O
mouse	O
Leydig	O
tumor	O
cells	O
(	O
MLTC	O
)	O
but	O
not	O
in	O
non	O
-	O
expressing	O
CHO	O
cells	O
.	O

For	O
Al	O
,	O
the	O
exposure	O
to	O
1	O
.	O
36	O
mg	O
/	O
m3	O
during	O
the	O
shift	O
corresponded	O
to	O
a	O
urinary	O
concentration	O
at	O
the	O
end	O
of	O
the	O
shift	O
of	O
200	O
microgram	O
/	O
g	O
creatinine	O
.	O

The	O
Drosophila	B
insulin	I
receptor	I
homolog	I
:	O
a	O
gene	O
essential	O
for	O
embryonic	O
development	O
encodes	O
two	O
receptor	O
isoforms	O
with	O
different	O
signaling	O
potential	O
.	O

SCA	B
was	O
resistant	O
to	O
inhibitors	O
of	O
serine	O
,	O
aspartyl	O
,	O
and	O
metalloproteases	B
,	O
but	O
it	O
was	O
sensitive	O
to	O
N	O
-	O
ethylmaleimide	O
.	O

However	O
,	O
a	O
similar	O
mutation	O
of	O
a	O
leucine	O
residue	O
to	O
arginine	O
at	O
position	O
422	O
showed	O
no	O
alteration	O
of	O
heterodimerization	O
,	O
DNA	O
binding	O
,	O
or	O
transcriptional	O
activation	O
.	O

We	O
have	O
found	O
that	O
the	O
expression	O
of	O
GTPase	B
-	O
deficient	O
mutants	O
of	O
alpha	B
12	I
(	O
alpha	B
12Q229L	I
)	O
or	O
alpha	B
13	I
(	O
alpha	B
13Q226L	I
)	O
leads	O
to	O
robust	O
activation	O
of	O
the	O
Jun	B
kinase	I
/	O
stress	B
-	I
activated	I
protein	I
kinase	I
(	O
JNK	B
/	O
SAPK	B
)	O
pathway	O
.	O

Structural	O
organization	O
and	O
developmental	O
expression	O
pattern	O
of	O
the	O
mouse	B
WD	I
-	I
repeat	I
gene	I
DMR	I
-	I
N9	I
immediately	O
upstream	O
of	O
the	O
myotonic	B
dystrophy	I
locus	I
.	O

One	O
month	O
after	O
the	O
DTaP	O
booster	O
vaccination	O
,	O
both	O
groups	O
had	O
6	O
-	O
to	O
40	O
-	O
fold	O
increases	O
in	O
serum	O
antibody	O
concentrations	O
to	O
all	O
antigens	O
tested	O
;	O
the	O
concentrations	O
against	O
the	O
three	O
pertussis	B
antigens	I
were	O
higher	O
in	O
the	O
DTaP	O
-	O
primed	O
children	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

To	O
investigate	O
the	O
potential	O
role	O
of	O
SP1	B
,	O
we	O
examined	O
nuclear	O
extracts	O
from	O
HCMV	O
-	O
infected	O
cells	O
.	O

Here	O
we	O
show	O
that	O
messenger	O
RNAs	O
encoding	O
trans	O
-	O
sialidases	O
containing	O
the	O
repeats	O
are	O
not	O
present	O
in	O
epimastigotes	O
but	O
are	O
abundant	O
in	O
trypomastigotes	O
.	O

The	O
C	O
-	O
terminal	O
peptide	O
sequences	O
of	O
the	O
human	B
lymphocyte	I
-	I
specific	I
high	I
mobility	I
group	I
(	I
HMG	I
)-	I
box	I
transcription	I
factor	I
TCF	I
-	I
1	I
are	O
determined	O
by	O
alternative	O
splice	O
mechanisms	O
affecting	O
the	O
exons	O
VIII	O
to	O
X	O
.	O

Thromboxane	O
B2	O
increased	O
(	O
97	O
+/-	O
105	O
versus	O
40	O
+/-	O
26	O
pg	O
/	O
ml	O
)	O
and	O
was	O
significantly	O
higher	O
during	O
heparin	O
free	O
hemodialysis	O
than	O
during	O
hemodialysis	O
with	O
heparin	O
(	O
p	O
=	O
0	O
.	O
01	O
,	O
Wilcoxon	O
matched	O
pairs	O
signed	O
rank	O
test	O
).	O

A	O
new	O
vector	O
,	O
pHBK280	O
,	O
was	O
designed	O
to	O
facilitate	O
this	O
analysis	O
.	O

Furthermore	O
,	O
microinjection	O
of	O
dominant	O
negative	O
forms	O
of	O
Rac	B
and	O
Cdc42	B
or	O
of	O
the	O
Rho	B
inhibitor	O
C3	B
transferase	I
blocked	O
serum	O
-	O
induced	O
DNA	O
synthesis	O
.	O

INF	B
-	I
alpha	I
therapy	O
has	O
been	O
a	O
major	O
development	O
in	O
the	O
treatment	O
of	O
CML	O
.	O

These	O
results	O
indicate	O
that	O
K	B
-	I
glypican	I
is	O
a	O
novel	O
GPI	B
-	I
anchored	I
HSPG	I
involved	O
in	O
embryonic	O
development	O
.	O

Protein	B
S	I
levels	O
were	O
virtually	O
undetectable	O
at	O
the	O
time	O
of	O
admission	O
and	O
failed	O
to	O
respond	O
to	O
infusions	O
of	O
fresh	O
frozen	O
plasma	O
,	O
despite	O
correction	O
of	O
other	O
procoagulant	O
and	O
anticoagulant	O
factors	O
.	O

Incubation	O
of	O
the	O
purified	O
fusion	O
proteins	O
with	O
[	O
gamma	O
-	O
32P	O
]	O
ATP	O
in	O
an	O
in	O
vitro	O
assay	O
showed	O
that	O
both	O
proteins	O
were	O
capable	O
of	O
autophosphorylation	O
.	O

The	O
synthetic	O
DNA	O
sequence	O
was	O
constructed	O
to	O
achieve	O
efficient	O
base	O
pairing	O
with	O
Escherichia	B
coli	I
16S	I
ribosomal	I
RNA	I
,	O
avoidance	O
of	O
internal	O
secondary	O
structure	O
,	O
and	O
optimal	O
codon	O
usage	O
for	O
high	O
-	O
level	O
protein	O
expression	O
in	O
accord	O
with	O
the	O
known	O
preferences	O
in	O
E	O
.	O
coli	O
.	O

A	O
.	O

Primer	O
extension	O
and	O
S1	B
nuclease	I
mapping	O
experiments	O
were	O
used	O
to	O
locate	O
the	O
transcription	O
initiation	O
site	O
of	O
Nramp1	B
and	O
revealed	O
the	O
presence	O
of	O
one	O
major	O
and	O
several	O
minor	O
initiation	O
sites	O
.	O

EsaR	B
can	O
repress	O
its	O
own	O
expression	O
but	O
seems	O
not	O
to	O
regulate	O
the	O
expression	O
of	O
esaI	B
.	O

All	O
clinical	O
isolates	O
were	O
concomitantly	O
tested	O
by	O
disk	O
diffusion	O
and	O
agar	O
dilution	O
procedures	O
as	O
outlined	O
by	O
the	O
National	O
Committee	O
for	O
Clinical	O
Laboratory	O
Standards	O
.	O

The	O
nucleotide	O
sequence	O
of	O
the	O
chloroplast	O
(	O
cp	O
)	O
DNA	O
from	O
maize	O
(	O
Zea	O
mays	O
)	O
has	O
been	O
completed	O
.	O

Initiation	O
of	O
translation	O
of	O
the	O
human	O
hepatitis	O
C	O
virus	O
(	O
HCV	O
)	O
RNA	O
genome	O
occurs	O
by	O
internal	O
ribosome	O
entry	O
into	O
the	O
5	O
'	O
noncoding	O
region	O
(	O
5	O
'	O
NCR	O
)	O
in	O
a	O
cap	O
-	O
independent	O
manner	O
.	O

The	O
association	O
of	O
p255	B
with	O
splicing	O
complexes	O
is	O
suggested	O
by	O
the	O
finding	O
that	O
mAb	B
CC3	I
can	O
inhibit	O
in	O
vitro	O
splicing	O
and	O
immunoprecipitate	O
pre	O
-	O
messenger	O
RNA	O
and	O
splicing	O
products	O
.	O

(	O
1991	O
).	O

The	O
tyrosine	O
-	O
phosphorylated	O
state	O
of	O
CAK	B
beta	I
was	O
not	O
reduced	O
on	O
trypsinization	O
,	O
nor	O
enhanced	O
in	O
response	O
to	O
plating	O
3Y1	O
cells	O
onto	O
fibronectin	B
.	O

A	O
single	O
-	O
case	O
experimental	O
ABAB	O
multiple	O
baseline	O
design	O
was	O
employed	O
to	O
test	O
for	O
treatment	O
effectiveness	O
.	O

The	O
serum	O
concentration	O
of	O
iP	O
before	O
dialysis	O
(	O
HD	O
)	O
was	O
on	O
average	O
3	O
.	O
06	O
(+/-	O
0	O
.	O
81	O
)	O
mmol	O
/	O
l	O
and	O
D	O
was	O
on	O
average	O
55	O
.	O
6	O
(+/-	O
10	O
.	O
0	O
)	O
mmol	O
.	O

A	O
significant	O
correlation	O
between	O
a	O
number	O
of	O
functional	O
parameters	O
of	O
gastric	O
secretion	O
,	O
incretion	O
and	O
histological	O
changes	O
of	O
gastric	O
mucosa	O
was	O
found	O
in	O
patients	O
with	O
chronic	O
gastritis	O
.	O

The	O
TAF	O
factor	O
appears	O
to	O
be	O
particularly	O
significant	O
in	O
OCD	O
.	O

RNase	B
protection	O
analyses	O
indicate	O
that	O
either	O
61	B
-	I
kDa	I
CaM	I
PDE	I
mRNA	I
or	O
structurally	O
related	O
transcripts	O
encoding	O
different	O
CaM	B
PDE	I
isoforms	I
are	O
expressed	O
in	O
a	O
tissue	O
-	O
specific	O
manner	O
.	O

The	O
roles	O
of	O
phorbol	O
esters	O
and	O
cyclic	O
AMP	O
in	O
mediating	O
the	O
GnRH	B
response	O
were	O
also	O
investigated	O
.	O

The	O
genomic	O
structure	O
of	O
four	O
members	O
of	O
the	O
SRC	B
-	I
family	I
revealed	O
nearly	O
identical	O
exon	O
/	O
intron	O
boundaries	O
within	O
the	O
catalytic	O
domain	O
of	O
this	O
family	O
.	O

Since	O
we	O
have	O
observed	O
effects	O
of	O
growth	O
factors	O
and	O
cAMP	O
as	O
well	O
as	O
estradiol	O
(	O
E2	O
)	O
on	O
regulation	O
of	O
expression	O
of	O
some	O
genes	O
stimulated	O
by	O
the	O
estrogen	B
receptor	I
(	O
ER	B
),	O
we	O
have	O
undertaken	O
studies	O
to	O
examine	O
directly	O
whether	O
activators	O
of	O
protein	O
kinases	O
can	O
modulate	O
transcriptional	O
activity	O
of	O
the	O
ER	B
.	O

Since	O
RCC1p	B
acts	O
as	O
GNRP	B
for	O
Ran	B
,	O
a	O
small	B
nuclear	I
GTPase	I
of	O
the	O
ras	B
superfamily	I
,	O
we	O
have	O
identified	O
two	O
homologs	O
of	O
Ran	B
in	O
S	O
.	O
cerevisiae	O
(	O
CNR1	B
and	O
CNR2	B
).	O

Of	O
these	O
carriers	O
149	O
were	O
diagnosed	O
to	O
be	O
asymptomatic	O
clinically	O
,	O
biochemically	O
and	O
echographically	O
.	O

This	O
agent	O
,	O
isolated	O
from	O
the	O
fungus	O
Streptomyces	O
tsukubaensis	O
,	O
has	O
a	O
mechanism	O
of	O
action	O
similar	O
to	O
that	O
of	O
cyclosporine	O
.	O

Insulin	B
-	I
like	I
growth	I
factor	I
-	I
binding	I
protein	I
-	I
2	I
(	O
IGF	B
-	I
BP	I
-	I
2	I
)	O
transcription	O
in	O
rat	O
liver	O
varies	O
with	O
developmental	O
age	O
and	O
fasting	O
.	O

The	O
presence	O
of	O
the	O
RV	O
5	O
'(+)	O
SL	O
sequence	O
had	O
the	O
primary	O
enhancing	O
effect	O
on	O
translation	O
.	O

PATIENTS	O
AND	O
METHODS	O
:	O
We	O
report	O
our	O
experience	O
with	O
seven	O
children	O
with	O
active	O
small	O
bowel	O
Crohn	O
'	O
s	O
disease	O
given	O
a	O
casein	B
-	O
based	O
,	O
polymeric	O
feed	O
rich	O
in	O
TGF	B
-	I
beta	I
2	I
(	O
Specific	O
Polymeric	O
Diet	O
;	O
Nestle	O
-	O
Clintec	O
;	O
Vevey	O
,	O
Switzerland	O
)	O
as	O
complete	O
nutrition	O
for	O
8	O
weeks	O
.	O

RESULTS	O
:	O
Closure	O
time	O
of	O
fistulas	O
in	O
patients	O
receiving	O
TPN	O
+	O
somatostatin	B
was	O
significantly	O
shorter	O
(	O
13	O
.	O
86	O
+/-	O
1	O
.	O
84	O
versus	O
20	O
.	O
4	O
+/-	O
2	O
.	O
89	O
days	O
)	O
than	O
in	O
those	O
receiving	O
TPN	O
alone	O
.	O

To	O
determine	O
which	O
sequences	O
in	O
the	O
rat	B
P450c17	I
promoter	I
may	O
be	O
responsible	O
for	O
basal	O
and	O
cAMP	O
-	O
stimulated	O
gene	O
transcription	O
,	O
deletion	O
constructs	O
containing	O
between	O
-	O
1	O
,	O
560	O
and	O
-	O
53	O
base	O
pairs	O
of	O
5	O
'-	O
flanking	O
DNA	O
from	O
the	O
rat	B
P450c17	I
gene	I
were	O
ligated	O
to	O
plasmids	O
expressing	O
the	O
reporter	O
gene	O
luciferase	B
and	O
transfected	O
into	O
two	O
mouse	O
cell	O
lines	O
,	O
adrenal	O
Y	O
-	O
1	O
cells	O
,	O
and	O
testicular	O
Leydig	O
MA	O
-	O
10	O
cells	O
.	O

While	O
daily	O
food	O
intake	O
was	O
almost	O
constant	O
regardless	O
of	O
the	O
dietary	O
protein	O
level	O
,	O
water	O
intake	O
and	O
urine	O
volume	O
increased	O
with	O
increasing	O
the	O
dietary	O
protein	O
.	O

Transcriptional	O
regulation	O
of	O
the	O
vacuolar	B
H	I
(+)-	I
ATPase	I
B2	I
subunit	I
gene	I
in	O
differentiating	O
THP	O
-	O
1	O
cells	O
.	O

Inhibition	O
assays	O
performed	O
with	O
over	O
30	O
different	O
natural	O
and	O
synthetic	O
sialylated	O
and	O
/	O
or	O
sulfated	O
compounds	O
are	O
utilized	O
to	O
define	O
in	O
greater	O
detail	O
specific	O
structural	O
features	O
involved	O
in	O
oligosaccharide	O
-	O
protein	O
binding	O
.	O

In	O
293	O
cells	O
,	O
expression	O
of	O
the	O
NF	B
-	I
kappa	I
B	I
inhibitor	O
,	O
I	B
kappa	I
B	I
-	I
alpha	I
,	O
reduced	O
the	O
stimulatory	O
activity	O
of	O
LMP	B
.	O

This	O
experimental	O
design	O
was	O
used	O
to	O
determine	O
the	O
effect	O
of	O
displacement	O
of	O
the	O
alpha	B
4	I
-	I
2	I
binding	I
site	I
on	O
the	O
repression	O
of	O
alpha	B
4	I
gene	I
transcription	O
by	O
ICP4	B
.	O

Weak	O
allergenicity	O
of	O
recombinant	B
hirudin	I
CGP	I
39393	I
(	O
REVASC	O
)	O
in	O
immunocompetent	O
volunteers	O
.	O

The	O
Ng	B
/	I
RC3	I
and	O
PKC	B
-	I
gamma	I
genes	I
have	O
a	O
similar	O
expression	O
pattern	O
in	O
the	O
brain	O
during	O
development	O
.	O

Short	O
therapy	O
with	O
omeprazole	O
20	O
mg	O
/	O
b	O
.	O
i	O
.	O
d	O
.,	O
clarithromycin	O
500	O
mg	O
/	O
b	O
.	O
i	O
.	O
d	O
.,	O
and	O
CBS	O
120	O
mg	O
/	O
q	O
.	O
i	O
.	O
d	O
.	O
is	O
a	O
safe	O
,	O
well	O
tolerated	O
combination	O
that	O
achieves	O
a	O
80	O
.	O
6	O
%	O
eradication	O
rate	O
of	O
H	O
.	O
pylori	O
and	O
duodenal	O
ulcer	O
healing	O
rates	O
as	O
good	O
as	O
those	O
achieved	O
by	O
omeprazole	O
20	O
mg	O
/	O
d	O
when	O
given	O
for	O
4	O
wk	O
.	O

Whole	O
bowel	O
irrigation	O
is	O
a	O
recently	O
described	O
technique	O
to	O
enhance	O
the	O
passage	O
of	O
drugs	O
already	O
beyond	O
the	O
pylorus	O
.	O

However	O
,	O
the	O
mouse	O
has	O
previously	O
been	O
shown	O
to	O
possess	O
only	O
three	O
forms	O
of	O
ADH	B
.	O

To	O
establish	O
a	O
possible	O
association	O
between	O
familial	O
dysfibrinogenemia	O
and	O
thrombophilia	O
,	O
data	O
on	O
cases	O
with	O
both	O
affections	O
were	O
collected	O
in	O
a	O
study	O
within	O
the	O
framework	O
of	O
the	O
SSC	O
Subcommittee	O
on	O
Fibrinogen	B
of	O
the	O
International	O
Society	O
on	O
Thrombosis	O
and	O
Haemostasis	O
.	O

These	O
six	O
districts	O
have	O
an	O
area	O
of	O
34	O
,	O
000	O
km2	O
and	O
hold	O
a	O
population	O
of	O
30	O
million	O
.	O

Binding	O
activity	O
in	O
rat	O
liver	O
nuclear	O
extracts	O
includes	O
these	O
orphan	O
receptors	O
as	O
judged	O
from	O
electromobility	O
supershift	O
experiments	O
and	O
from	O
results	O
obtained	O
with	O
expressed	O
receptors	O
,	O
although	O
the	O
element	O
in	O
CYP2C11	B
did	O
not	O
bind	O
HNF	B
-	I
4	I
.	O

Radioligand	O
binding	O
was	O
indistinguishable	O
for	O
both	O
transiently	O
expressed	O
constructs	O
.	O

Diagnosis	O
of	O
FHCS	O
has	O
been	O
weighed	O
upon	O
laparoscopic	O
findings	O
.	O

Lung	O
function	O
tests	O
(	O
EFR	O
)	O
were	O
performed	O
on	O
these	O
patients	O
for	O
a	O
period	O
of	O
19	O
.	O
2	O
+/-	O
3	O
.	O
4	O
months	O
.	O

In	O
addition	O
,	O
two	O
internal	O
promoters	O
,	O
PmiaA	B
and	O
P1hfq	B
were	O
identified	O
and	O
mapped	O
to	O
201	O
and	O
837	O
nucleotides	O
upstream	O
from	O
the	O
respective	O
translation	O
start	O
sites	O
.	O

The	O
2	O
kb	O
of	O
5	O
'-	O
flanking	O
region	O
and	O
the	O
1	O
.	O
1	O
kb	O
of	O
the	O
entire	O
sGTH	B
alpha	I
subunit	I
coding	O
region	O
were	O
sequenced	O
from	O
the	O
genomic	O
clone	O
,	O
sGTH	B
alpha	I
-	I
G1	I
.	O

Functional	O
analysis	O
of	O
the	O
sGTH	B
alpha	I
subunit	I
promoter	I
by	O
the	O
transient	O
transfection	O
of	O
several	O
sGTH	B
alpha	I
/	O
CAT	B
chimeric	O
plasmids	O
into	O
rainbow	O
trout	O
pituitary	O
cells	O
suggests	O
that	O
its	O
pituitary	O
-	O
specific	O
expression	O
is	O
GSE	B
-	O
dependent	O
.	O

Indium	O
-	O
111	O
OncoScint	O
CR	O
/	O
OV	O
and	O
F	O
-	O
18	O
FDG	O
in	O
colorectal	O
and	O
ovarian	O
carcinoma	O
recurrences	O
.	O

His	O
carnitine	B
palmitoyltransferase	I
(	I
CPT	I
)	I
I	I
and	I
II	I
activities	O
were	O
0	O
.	O
06	O
and	O
0	O
.	O
12	O
nmol	O
/	O
min	O
/	O
mg	O
protein	O
,	O
as	O
compared	O
with	O
a	O
mean	O
value	O
of	O
0	O
.	O
22	O
+/-	O
0	O
.	O
14	O
and	O
0	O
.	O
27	O
+/-	O
0	O
.	O
07	O
nmol	O
/	O
min	O
/	O
mg	O
protein	O
,	O
respectively	O
,	O
in	O
control	O
subjects	O
.	O

Thus	O
,	O
VF	O
resistant	O
to	O
defibrillation	O
is	O
not	O
necessarily	O
associated	O
with	O
both	O
toxic	O
plasma	O
drug	O
level	O
and	O
remarkably	O
decreased	O
conduction	O
.	O

A	O
polymorphic	O
dinucleotide	O
(	O
GT	O
/	O
CA	O
)	O
n	O
repeat	O
contained	O
in	O
the	O
NHE5	O
cosmid	O
was	O
identified	O
and	O
developed	O
into	O
a	O
microsatellite	O
PCR	O
marker	O
.	O

The	O
proteins	O
are	O
more	O
than	O
90	O
%	O
identical	O
to	O
each	O
other	O
within	O
the	O
protein	O
kinase	O
domain	O
but	O
only	O
51	O
-	O
59	O
%	O
identical	O
to	O
other	O
casein	B
kinase	I
I	I
isoforms	I
within	O
this	O
region	O
.	O

Despite	O
the	O
activation	O
of	O
these	O
intracellular	O
signaling	O
molecules	O
,	O
PDGF	B
beta	I
receptor	I
activation	O
elicited	O
no	O
detectable	O
effect	O
on	O
cell	O
proliferation	O
or	O
differentiation	O
.	O

Short	O
-	O
course	O
amphotericin	O
B	O
therapy	O
for	O
candidemia	O
in	O
pediatric	O
patients	O
.	O

Polypeptides	O
of	O
the	O
same	O
apparent	O
sizes	O
are	O
detected	O
in	O
spores	O
of	O
a	O
cotE	B
null	O
mutant	O
,	O
on	O
which	O
basis	O
we	O
infer	O
that	O
the	O
products	O
of	O
the	O
cotJ	B
operon	I
are	O
required	O
for	O
the	O
normal	O
formation	O
of	O
the	O
inner	O
layers	O
of	O
the	O
coat	O
or	O
are	O
themselves	O
structural	O
components	O
of	O
the	O
coat	O
.	O

EEA1	B
is	O
a	O
conserved	O
alpha	O
-	O
helical	O
peripheral	O
membrane	O
protein	O
flanked	O
by	O
cysteine	O
"	O
fingers	O
"	O
and	O
contains	O
a	O
calmodulin	B
-	I
binding	I
IQ	I
motif	I
.	O

Elevation	O
of	O
the	O
tissues	O
of	O
the	O
face	O
is	O
essentially	O
vertical	O
and	O
acts	O
on	O
the	O
forehead	O
,	O
temporal	O
region	O
,	O
gaze	O
and	O
cheekbones	O
.	O

This	O
region	O
binds	O
two	O
ubiquitous	O
nuclear	O
factors	O
,	O
USF	B
/	O
MLTF	B
and	O
the	O
CAAT	B
-	I
binding	I
transcription	I
factor	I
/	O
nuclear	B
factor	I
1	I
(	O
CTF	B
/	O
NF1	B
).	O

The	O
c	B
-	I
myc	I
gene	I
is	O
overexpressed	O
in	O
a	O
variety	O
of	O
tumor	O
types	O
and	O
appears	O
to	O
play	O
an	O
important	O
role	O
in	O
the	O
abnormal	O
growth	O
of	O
a	O
number	O
of	O
cell	O
types	O
.	O

Two	O
major	O
and	O
one	O
minor	O
transcription	O
initiation	O
sites	O
were	O
assigned	O
to	O
positions	O
+	O
1	O
and	O
+	O
24	O
and	O
position	O
+	O
14	O
,	O
respectively	O
,	O
by	O
a	O
combination	O
of	O
ribonuclease	O
protection	O
,	O
primer	O
extension	O
,	O
and	O
5	O
'	O
RACE	O
analyses	O
.	O

We	O
demonstrate	O
here	O
that	O
the	O
-	O
DEDDDL	O
sequence	O
stabilizes	O
GDP	O
binding	O
to	O
Ran	B
,	O
and	O
that	O
the	O
domain	O
is	O
required	O
for	O
high	O
affinity	O
interaction	O
with	O
a	O
Ran	B
-	I
binding	I
protein	I
,	O
HTF9A	B
/	O
RanBP1	B
.	O

Serial	O
followup	O
strength	O
data	O
for	O
2	O
patients	O
were	O
compared	O
to	O
change	O
in	O
creatinine	B
kinase	I
(	O
CK	B
)	O
levels	O
.	O

Unlike	O
most	O
other	O
small	B
G	I
proteins	I
which	O
are	O
expressed	O
ubiquitously	O
,	O
TTF	B
was	O
transcribed	O
only	O
in	O
hemopoietic	O
cells	O
as	O
a	O
2	O
.	O
2	O
kb	O
transcript	O
.	O

The	O
provisional	O
reports	O
are	O
based	O
mainly	O
upon	O
macroscopic	O
findings	O
,	O
whereas	O
the	O
final	O
reports	O
include	O
the	O
information	O
provided	O
by	O
supplementary	O
investigations	O
such	O
as	O
microscopy	O
,	O
histochemistry	O
,	O
more	O
rarely	O
electron	O
microscopy	O
,	O
immunohistochemistry	O
and	O
/	O
or	O
microbiology	O
.	O

Otte	O
,	O
Mol	O
.	O

Examination	O
of	O
neurohumoral	O
factors	O
revealed	O
a	O
hyperactive	O
sympathetic	O
nervous	O
system	O
and	O
an	O
increase	O
in	O
plasma	O
renin	B
activity	O
.	O

The	O
deduced	O
amino	O
acid	O
sequences	O
of	O
each	O
of	O
the	O
W3A1	B
ETF	I
subunits	I
exhibit	O
only	O
approximately	O
30	O
%	O
identity	O
with	O
the	O
corresponding	O
subunits	O
of	O
the	O
ETF	B
from	O
human	O
,	O
rat	O
,	O
and	O
Paracoccus	O
denitrificans	O
,	O
which	O
as	O
a	O
group	O
are	O
greater	O
than	O
50	O
%	O
identical	O
.	O

By	O
contrast	O
,	O
deletion	O
of	O
this	O
Ras	B
-	I
binding	I
site	I
did	O
not	O
diminish	O
activation	O
of	O
Raf	B
-	I
1	I
kinase	I
by	O
Src	B
,	O
implying	O
that	O
Src	B
and	O
Ras	B
can	O
activate	O
Raf	B
-	I
1	I
through	O
independent	O
mechanisms	O
.	O

The	O
first	O
gene	O
,	O
NSR1	B
,	O
a	O
previously	O
identified	O
gene	O
,	O
encodes	O
a	O
protein	O
involved	O
in	O
ribosomal	O
RNA	O
maturation	O
and	O
possibly	O
in	O
transport	O
of	O
proteins	O
into	O
the	O
nucleus	O
.	O

Characterization	O
of	O
the	O
promoter	O
for	O
the	O
human	B
85	I
kDa	I
cytosolic	I
phospholipase	I
A2	I
gene	I
.	O

Comparative	O
study	O
of	O
the	O
differential	O
white	O
blood	O
cell	O
count	O
using	O
three	O
automated	O
analyzers	O
:	O
Coulter	O
STKS	O
,	O
Sysmex	O
NE	O
8000	O
and	O
Technicon	O
H	O
-	O
1	O
.	O

Characterization	O
of	O
FIII	B
/	O
YY1	B
,	O
a	O
Xenopus	B
laevis	I
conserved	I
zinc	I
-	I
finger	I
protein	I
binding	O
to	O
the	O
first	O
exon	O
of	O
L1	B
and	O
L14	B
ribosomal	I
protein	I
genes	I
.	O

Both	O
can	O
be	O
elevated	O
on	O
a	O
single	O
vascular	O
pedicle	O
based	O
on	O
the	O
superficial	O
temporal	O
artery	O
,	O
the	O
double	O
-	O
layered	O
temporal	O
fascia	O
flap	O
.	O

Endo16	B
transcripts	I
are	O
confined	O
to	O
the	O
definitive	O
vegetal	O
plate	O
in	O
blastula	O
stage	O
embryos	O
;	O
at	O
gastrula	O
stage	O
this	O
gene	O
is	O
expressed	O
throughout	O
the	O
archenteron	O
,	O
but	O
later	O
only	O
in	O
the	O
midgut	O
.	O

Increase	O
in	O
blood	O
NEFA	O
was	O
further	O
augmented	O
by	O
fat	O
plus	O
AA	O
supplementation	O
,	O
but	O
no	O
changes	O
in	O
concentrations	O
of	O
Lys	O
or	O
Met	O
in	O
blood	O
were	O
found	O
.	O

Furthermore	O
,	O
the	O
identification	O
of	O
a	O
Dr1	B
-	I
like	I
protein	I
in	O
A	O
.	O
thaliana	O
strongly	O
argues	O
for	O
the	O
ubiquity	O
of	O
this	O
protein	O
among	O
eukaryotic	O
genera	O
and	O
for	O
a	O
conserved	O
mechanism	O
to	O
regulate	O
transcription	O
initiation	O
that	O
involves	O
Dr1	B
.	O

Similarly	O
approximately	O
300	O
bp	O
of	O
sequence	O
downstream	O
of	O
the	O
translation	O
terminator	O
TGA	O
of	O
the	O
beta	B
-	I
tubulin	I
2	I
(	O
BTU2	B
)	O
gene	O
could	O
substitute	O
for	O
the	O
3	O
'	O
region	O
of	O
the	O
H4	B
-	I
I	I
gene	I
.	O

Tumor	B
necrosis	I
factor	I
alpha	I
,	O
the	O
cytokine	O
that	O
participates	O
in	O
the	O
autocrine	O
growth	O
control	O
of	O
hairy	O
cell	O
leukemia	O
has	O
strong	O
bone	O
resorptive	O
properties	O
.	O

The	O
negative	O
regulatory	O
activity	O
of	O
the	O
N	O
-	O
terminal	O
domain	O
was	O
antagonized	O
by	O
a	O
C	O
-	O
terminal	O
segment	O
of	O
Pho81p	B
supplied	O
in	O
trans	O
.	O

The	O
marker	O
orders	O
from	O
the	O
genetic	O
and	O
RH	O
maps	O
were	O
consistent	O
.	O

Integrated	O
mapping	O
analysis	O
of	O
the	O
Werner	O
syndrome	O
region	O
of	O
chromosome	O
8	O
.	O

To	O
further	O
our	O
knowledge	O
about	O
the	O
systemic	O
humoral	O
immune	O
system	O
response	O
to	O
weak	O
hapten	O
-	O
syngeneic	O
or	O
allogeneic	O
protein	O
conjugates	O
(	O
corrosion	O
and	O
wear	O
products	O
of	O
metallic	O
orthopedic	O
devices	O
),	O
a	O
sensitive	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
method	O
for	O
testing	O
for	O
antibody	O
(	O
humoral	O
immunity	O
)	O
to	O
metals	O
was	O
developed	O
.	O

In	O
contrast	O
,	O
peak	O
filling	O
rate	O
(	O
PFR	O
),	O
normalized	O
to	O
end	O
diastolic	O
volume	O
(	O
EDV	O
),	O
or	O
stroke	O
volume	O
(	O
SV	O
),	O
or	O
expressed	O
as	O
the	O
ratio	O
of	O
PFR	O
-	O
to	O
-	O
PER	O
was	O
reduced	O
(	O
p	O
<	O
0	O
.	O
01	O
),	O
time	O
to	O
PFR	O
(	O
TPFR	O
)	O
was	O
prolonged	O
(	O
p	O
<	O
0	O
.	O
01	O
),	O
and	O
echocardiographic	O
left	O
ventricular	O
mass	O
index	O
was	O
higher	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
in	O
patients	O
with	O
acromegaly	O
compared	O
to	O
normals	O
.	O

Nucleotide	O
sequence	O
and	O
transcriptional	O
analysis	O
of	O
the	O
DNA	B
polymerase	I
gene	I
of	I
Bombyx	I
mori	I
nuclear	I
polyhedrosis	I
virus	I
.	O

The	O
drug	O
sensitivity	O
was	O
100	O
%	O
for	O
vancomycin	O
(	O
VCM	O
),	O
30	O
%	O
for	O
imipenam	O
(	O
IMP	O
),	O
31	O
%	O
for	O
minomycin	O
(	O
MINO	O
),	O
31	O
%	O
for	O
amikacin	O
(	O
AMK	O
),	O
and	O
7	O
%	O
for	O
fosfomycin	O
(	O
FOM	O
).	O

However	O
,	O
cotransfection	O
studies	O
indicate	O
that	O
RVR	B
does	O
not	O
activate	O
transcription	O
when	O
this	O
hormone	O
response	O
element	O
is	O
linked	O
to	O
a	O
reporter	O
gene	O
but	O
rather	O
acts	O
as	O
a	O
potent	O
competitive	O
repressor	O
of	O
ROR	B
alpha	I
function	O
.	O

A	O
comparison	O
of	O
the	O
Flavobacterium	O
glycosylasparaginase	B
with	O
a	O
mammalian	O
glycosylasparaginase	B
revealed	O
30	O
%	O
structural	O
identity	O
and	O
60	O
%	O
overall	O
similarity	O
between	O
the	O
prokaryotic	O
and	O
eukaryotic	O
forms	O
of	O
the	O
enzyme	O
.	O

Molecular	O
cloning	O
and	O
sequencing	O
of	O
a	O
cDNA	O
encoding	O
SR	B
beta	I
revealed	O
that	O
SR	B
beta	I
is	O
a	O
transmembrane	O
protein	O
and	O
,	O
like	O
SR	B
alpha	I
and	O
SRP54	B
,	O
is	O
a	O
member	O
of	O
the	O
GTPase	B
superfamily	I
.	O

The	O
mRNAs	O
of	O
the	O
GRF	B
genes	I
are	O
encoded	O
by	O
six	O
exons	O
interrupted	O
by	O
five	O
introns	O
.	O

Physical	O
analysis	O
maps	O
SAL6	B
to	O
chromosome	O
XVI	O
between	O
TPK2	B
and	O
spt14	B
.	O

The	O
newly	O
devised	O
DCT	O
method	O
yields	O
reliable	O
data	O
in	O
measuring	O
TBF	O
.	O

Removal	O
of	O
PDMP	O
from	O
the	O
cell	O
medium	O
resulted	O
in	O
reversal	O
of	O
the	O
cell	O
cycle	O
changes	O
,	O
with	O
cells	O
re	O
-	O
entering	O
the	O
S	O
phase	O
.	O

The	O
requirement	O
of	O
PilE	B
in	O
pilus	O
biogenesis	O
was	O
confirmed	O
by	O
demonstrating	O
that	O
chromosomal	B
pilE	I
insertion	I
mutants	I
were	O
pilus	O
-	O
and	O
twitching	O
-	O
motility	O
deficient	O
.	O

The	O
pilE	B
gene	I
product	I
of	I
Pseudomonas	I
aeruginosa	I
,	O
required	O
for	O
pilus	O
biogenesis	O
,	O
shares	O
amino	O
acid	O
sequence	O
identity	O
with	O
the	O
N	O
-	O
termini	O
of	O
type	B
4	I
prepilin	I
proteins	I
.	O

The	O
expression	O
of	O
this	O
clone	O
in	O
a	O
wee1	B
/	O
mik1	B
-	O
deficient	O
mutant	O
causes	O
an	O
elongated	O
cell	O
phenotype	O
under	O
non	O
-	O
permissive	O
growth	O
conditions	O
.	O

This	O
region	O
constitutes	O
the	O
DNA	O
-	O
binding	O
domain	O
with	O
basic	O
-	O
helix	O
-	O
loop	O
-	O
helix	O
and	O
leucine	O
-	O
zipper	O
motifs	O
,	O
features	O
common	O
to	O
the	O
myc	B
-	I
related	I
transcription	I
factor	I
family	I
.	O

Such	O
an	O
intervention	O
may	O
be	O
of	O
considerable	O
use	O
for	O
the	O
treatment	O
of	O
angiogenesis	O
-	O
dependent	O
diseases	O
involving	O
FGF	B
-	I
2	I
.	O

This	O
mutant	O
was	O
identified	O
by	O
screening	O
with	O
a	O
TGF	B
-	I
beta	I
-	O
inducible	O
vector	O
a	O
series	O
of	O
mink	O
lung	O
epithelial	O
cell	O
clones	O
that	O
have	O
normal	O
TGF	B
-	I
beta	I
binding	O
activity	O
but	O
have	O
lost	O
antiproliferative	O
and	O
transcriptional	O
responses	O
to	O
TGF	B
-	I
beta	I
.	O

METHODS	O
:	O
Ten	O
influenza	O
A	O
(	O
H3N2	O
)	O
viruses	O
isolated	O
during	O
the	O
outbreaks	O
were	O
examined	O
for	O
resistance	O
to	O
amantadine	O
and	O
rimantadine	O
by	O
means	O
of	O
an	O
enzyme	O
immunoassay	O
and	O
by	O
sequencing	O
of	O
the	O
viral	O
nucleic	O
acid	O
that	O
encodes	O
the	O
transmembrane	O
domain	O
of	O
the	O
M2	B
protein	I
.	O

Gene	O
expression	O
occurs	O
in	O
a	O
circadian	O
rhythm	O
and	O
induced	O
by	O
light	O
in	O
leaves	O
of	O
dark	O
-	O
adapted	O
plants	O
.	O

In	O
a	O
second	O
experiment	O
involving	O
an	O
18	O
-	O
h	O
lung	O
clearance	O
assay	O
,	O
we	O
used	O
the	O
mAb	B
3	I
.	I
2	I
.	I
3	I
to	O
deplete	O
rats	O
of	O
LGL	O
/	O
NK	O
cells	O
with	O
the	O
following	O
rationale	O
:	O
if	O
LGL	O
/	O
NK	O
cells	O
are	O
necessary	O
to	O
mediate	O
an	O
event	O
,	O
then	O
in	O
their	O
absence	O
,	O
that	O
event	O
should	O
not	O
occur	O
.	O

In	O
nucleus	O
ventralis	O
anterior	O
thalami	O
-	O
nucleus	O
ventralis	O
lateralis	O
thalami	O
neurons	O
with	O
an	O
inhibitory	O
input	O
from	O
nucleus	O
entopeduncularis	O
,	O
a	O
shortening	O
of	O
inhibition	O
from	O
17	O
.	O
5	O
+/-	O
3	O
.	O
6	O
to	O
9	O
.	O
1	O
+/-	O
1	O
.	O
8	O
ms	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
under	O
the	O
haloperidol	O
influence	O
was	O
evident	O
.	O

Analysis	O
of	O
the	O
sequence	O
upstream	O
of	O
this	O
initiation	O
codon	O
reveals	O
the	O
presence	O
of	O
a	O
promotor	O
sequence	O
.	O

The	O
NR2	O
hybrid	O
is	O
a	O
powerful	O
tool	O
for	O
the	O
mapping	O
of	O
new	O
probes	O
of	O
this	O
region	O
,	O
as	O
well	O
as	O
for	O
obtaining	O
new	O
informative	O
probes	O
specific	O
for	O
the	O
deletion	O
by	O
subtractive	O
cloning	O
of	O
the	O
region	O
.	O

TDEYA	O
at	O
doses	O
of	O
200	O
to	O
500	O
mg	O
/	O
kg	O
significantly	O
suppressed	O
xanthine	B
oxidase	I
(	O
XO	B
)	O
activity	O
in	O
the	O
stomach	O
tissue	O
following	O
its	O
oral	O
administration	O
.	O

Expression	O
of	O
class	B
IV	I
ADH	I
mRNA	I
was	O
detected	O
in	O
human	O
stomach	O
but	O
not	O
liver	O
.	O

Mutation	O
of	O
the	O
P450BM	B
-	I
3	I
Barbie	I
box	I
significantly	O
increased	O
the	O
expression	O
of	O
both	O
P450BM	B
-	I
3	I
and	O
Bm3P1	B
(	O
another	O
small	O
gene	O
located	O
upstream	O
of	O
the	O
P450BM	B
-	I
3	I
gene	I
that	O
encodes	O
a	O
second	O
putative	O
regulatory	O
protein	O
)	O
in	O
response	O
to	O
pentobarbital	O
induction	O
but	O
left	O
the	O
basal	O
levels	O
unaffected	O
.	O

In	O
the	O
course	O
of	O
a	O
study	O
of	O
low	O
dose	O
X	O
-	O
rays	O
effects	O
,	O
we	O
found	O
that	O
male	O
ICR	O
white	O
Swiss	O
mice	O
showed	O
remarkable	O
suppression	O
of	O
mounting	O
behavior	O
after	O
whole	O
body	O
irradiation	O
by	O
5	O
to	O
15	O
cGy	O
X	O
-	O
rays	O
.	O

A	O
quantitative	O
analysis	O
of	O
the	O
diffraction	O
intensity	O
as	O
function	O
of	O
the	O
accumulated	O
electron	O
dose	O
suggests	O
the	O
possibility	O
of	O
recording	O
up	O
to	O
250	O
diffraction	O
patterns	O
with	O
3	O
.	O
5	O
A	O
resolution	O
from	O
a	O
single	O
crotoxin	O
complex	O
crystal	O
128	O
A	O
thick	O
.	O

A	O
DNA	O
fragment	O
encoding	O
the	O
DNA	O
-	O
binding	O
domain	O
(	O
amino	O
acids	O
1	O
-	O
60	O
)	O
of	O
the	O
Escherichia	B
coli	I
fru	I
transcriptional	I
regulator	I
was	O
cloned	O
into	O
the	O
pGEX	O
-	O
KT	O
vector	O
and	O
expressed	O
in	O
frame	O
with	O
the	O
fused	O
gene	O
encoding	O
glutathione	B
S	I
-	I
transferase	I
.	O

With	O
a	O
population	O
of	O
853	O
million	O
there	O
should	O
be	O
51	O
,	O
204	O
patients	O
with	O
hemophilia	O
A	O
in	O
India	O
assuming	O
a	O
prevalence	O
of	O
6	O
/	O
100	O
,	O
000	O
population	O
.	O

When	O
combined	O
with	O
serum	O
ferritin	B
and	O
hemoglobin	B
determinations	O
,	O
the	O
serum	O
transferrin	B
receptor	I
assay	O
is	O
a	O
valuable	O
addition	O
in	O
epidemiologic	O
surveys	O
because	O
it	O
provides	O
a	O
quantitative	O
measure	O
of	O
functional	O
iron	O
deficiency	O
and	O
it	O
distinguishes	O
true	O
IDA	O
from	O
the	O
anemia	O
of	O
chronic	O
disease	O
.	O

Current	O
status	O
of	O
telepathology	O
.	O

The	O
PSD2	B
gene	I
was	O
heterologously	O
expressed	O
by	O
infection	O
of	O
Sf	O
-	O
9	O
insect	O
cells	O
with	O
recombinant	O
baculovirus	O
,	O
resulting	O
in	O
a	O
10	O
-	O
fold	O
increase	O
in	O
PSD	B
activity	O
.	O

Computerized	O
detection	O
of	O
abnormal	O
asymmetry	O
in	O
digital	O
chest	O
radiographs	O
.	O

Moreover	O
,	O
the	O
hypoxia	O
-	O
induced	O
expression	O
of	O
the	O
endogenous	O
Epo	B
gene	I
was	O
significantly	O
inhibited	O
in	O
Hep3B	O
cells	O
stably	O
transfected	O
with	O
HNF	B
-	I
4	I
delta	I
C	I
.	O

Both	O
factors	O
demonstrated	O
significant	O
correlations	O
with	O
rCBF	O
in	O
the	O
medial	O
prefrontal	O
cortex	O
and	O
frontal	O
polar	O
cortex	O
while	O
for	O
each	O
factor	O
there	O
were	O
also	O
unique	O
patterns	O
of	O
correlations	O
with	O
posterior	O
brain	O
regions	O
.	O

Glomerular	O
hemodynamics	O
during	O
abortion	O
induced	O
by	O
RU	O
486	O
and	O
sepsis	O
in	O
rats	O
.	O

The	O
contribution	O
of	O
skin	O
flow	O
to	O
the	O
changes	O
in	O
760	O
-	O
800	O
nm	O
absorption	O
was	O
investigated	O
by	O
simultaneous	O
measurement	O
of	O
skin	O
flow	O
by	O
laser	O
flow	O
Doppler	O
and	O
NIR	O
recordings	O
during	O
hot	O
water	O
immersion	O
.	O

The	O
relative	O
risk	O
of	O
graft	O
loss	O
after	O
conversion	O
to	O
azathioprine	O
compared	O
with	O
graft	O
loss	O
after	O
conversion	O
to	O
azathioprine	O
compared	O
with	O
cyclosporin	O
maintenance	O
was	O
0	O
.	O
71	O
(	O
0	O
.	O
37	O
-	O
1	O
.	O
38	O
)	O
and	O
the	O
relative	O
risk	O
of	O
patient	O
death	O
was	O
0	O
.	O
57	O
(	O
0	O
.	O
23	O
-	O
1	O
.	O
41	O
).	O

Three	O
classes	O
of	O
test	O
objects	O
were	O
considered	O
:	O
(	O
1	O
)	O
a	O
multicompartment	O
test	O
object	O
for	O
31P	O
MRS	O
measurements	O
performed	O
with	O
slice	O
-	O
selective	O
sequences	O
;	O
(	O
2	O
)	O
a	O
two	O
-	O
compartment	O
test	O
object	O
for	O
volume	O
-	O
selection	O
1H	O
MRS	O
;	O
and	O
(	O
3	O
)	O
two	O
-	O
compartment	O
test	O
objects	O
for	O
assessing	O
the	O
performance	O
of	O
experimental	O
systems	O
using	O
ISIS	O
as	O
volume	O
localization	O
sequence	O
in	O
31P	O
MRS	O
.	O

Pregnancy	O
screening	O
by	O
uterine	O
artery	O
Doppler	O
velocimetry	O
--	O
which	O
criterion	O
performs	O
best	O
?	O
OBJECTIVE	O
:	O
To	O
test	O
whether	O
repeating	O
Doppler	O
studies	O
of	O
the	O
uteroplacental	O
circulation	O
late	O
in	O
gestation	O
will	O
improve	O
the	O
test	O
'	O
s	O
power	O
for	O
predicting	O
pregnancy	O
-	O
induced	O
hypertension	O
and	O
fetal	O
growth	O
restriction	O
(	O
FGR	O
),	O
and	O
whether	O
analysis	O
based	O
on	O
a	O
combination	O
of	O
quantitative	O
and	O
qualitative	O
assessments	O
of	O
the	O
uterine	O
arterial	O
waveforms	O
will	O
yield	O
better	O
results	O
than	O
analysis	O
based	O
on	O
either	O
alone	O
.	O

To	O
determine	O
whether	O
food	O
and	O
/	O
or	O
water	O
in	O
the	O
gastrointestinal	O
tract	O
affects	O
restitution	O
of	O
blood	O
volume	O
and	O
plasma	O
protein	O
after	O
hemorrhage	O
,	O
fed	O
and	O
24	O
-	O
h	O
-	O
fasted	O
awake	O
rats	O
received	O
a	O
20	O
ml	O
.	O
kg	O
-	O
1	O
x	O
3	O
min	O
-	O
1	O
hemorrhage	O
,	O
and	O
restitution	O
of	O
blood	O
volume	O
was	O
measured	O
by	O
Evans	O
blue	O
dye	O
and	O
dilution	O
of	O
hematocrit	O
.	O

In	O
this	O
study	O
,	O
we	O
demonstrate	O
that	O
BOX	O
DNA	O
enhances	O
transcription	O
from	O
the	O
thymidine	B
kinase	I
(	O
TK	B
)	O
promoter	O
in	O
various	O
EC	O
cells	O
.	O

313	O
,	O
98	O
-	O
102	O
).	O

To	O
examine	O
the	O
possibility	O
that	O
LNNB	O
performance	O
of	O
the	O
schizophrenic	O
groups	O
may	O
have	O
been	O
related	O
to	O
neuroleptic	O
medication	O
,	O
analyses	O
were	O
completed	O
on	O
the	O
relationship	O
between	O
medication	O
levels	O
and	O
LNNB	O
scores	O
.	O

The	O
use	O
of	O
specific	O
antibodies	O
allowed	O
the	O
identification	O
of	O
at	O
least	O
RAR	B
beta	I
in	O
some	O
of	O
the	O
DNA	O
-	O
protein	O
complexes	O
,	O
although	O
the	O
four	O
sequences	O
bind	O
single	O
RARs	B
transfected	O
in	O
COS	O
cells	O
much	O
less	O
efficiently	O
,	O
or	O
not	O
at	O
all	O
,	O
when	O
compared	O
to	O
a	O
canonical	O
RAR	B
responsive	I
element	I
.	O

A	O
decanucleotide	O
promoter	O
sequence	O
homologous	O
to	O
those	O
found	O
in	O
humans	O
and	O
mice	O
was	O
located	O
in	O
the	O
5	O
'	O
untranslated	O
region	O
of	O
one	O
horse	O
gene	O
.	O

The	O
gene	O
for	O
the	O
RNA	B
-	I
dependent	I
eIF	I
-	I
2	I
alpha	I
protein	I
kinase	I
(	O
PKR	B
)	O
was	O
isolated	O
from	O
mouse	O
genomic	O
DNA	O
and	O
characterized	O
.	O

Detailed	O
molecular	O
organization	O
of	O
the	O
coding	O
and	O
upstream	O
regulatory	O
regions	O
of	O
the	O
murine	O
homeodomain	B
-	I
containing	I
gene	I
,	O
Msx	B
-	I
1	I
,	O
is	O
reported	O
.	O

This	O
virus	O
is	O
not	O
merely	O
a	O
South	O
African	O
strain	O
of	O
passion	O
fruit	O
woodiness	O
virus	O
(	O
PWV	O
):	O
the	O
deduced	O
CP	B
sequence	I
is	O
only	O
distantly	O
related	O
to	O
CPs	B
of	O
other	O
sequenced	O
strains	O
of	O
PWV	O
,	O
although	O
it	O
is	O
part	O
of	O
a	O
distinct	O
subgroup	O
of	O
potyviruses	O
related	O
to	O
PWV	O
.	O

In	O
addition	O
,	O
both	O
the	O
exon	O
1	O
-	O
and	O
exon	O
2	O
-	O
initiated	O
forms	O
of	O
the	O
c	B
-	I
Myc	I
protein	I
stimulated	O
transcription	O
of	O
a	O
Myc	B
/	O
Max	B
-	O
responsive	O
reporter	O
construct	O
to	O
a	O
similar	O
level	O
.	O

Immunoreactive	O
AR	B
content	O
in	O
transfected	O
COS	O
-	O
1	O
cells	O
was	O
not	O
influenced	O
by	O
exposure	O
to	O
8	O
-	O
Br	O
-	O
cAMP	O
.	O

Genetic	O
alterations	O
in	O
elements	O
of	O
normal	O
signal	O
transduction	O
mechanisms	O
are	O
known	O
to	O
be	O
oncogenic	O
events	O
often	O
resulting	O
in	O
aberrant	O
activation	O
of	O
programs	O
of	O
gene	O
transcription	O
.	O

NOT4	B
interacts	O
with	O
NOT1	B
and	O
NOT3	B
in	O
the	O
two	O
-	O
hybrid	O
assay	O
,	O
and	O
overexpression	O
of	O
NOT3	B
or	O
NOT4	B
suppresses	O
not1	B
and	O
not2	B
mutations	O
.	O

We	O
show	O
that	O
the	O
en	B
stripes	O
expand	O
anteriorly	O
in	O
slp	B
mutant	O
embryos	O
and	O
that	O
slp	B
activity	O
is	O
an	O
absolute	O
requirement	O
for	O
maintenance	O
of	O
wg	B
expression	O
at	O
the	O
same	O
time	O
that	O
wg	B
transcription	O
is	O
dependent	O
on	O
hh	B
.	O

The	O
DNA	O
sequence	O
adjacent	O
to	O
the	O
lacZ	B
gene	I
has	O
been	O
determined	O
for	O
91	O
vegetative	O
fusion	O
genes	O
whose	O
products	O
have	O
been	O
localized	O
and	O
for	O
43	O
meiotically	O
induced	O
fusions	O
.	O

ORF	O
2	O
potentially	O
encoded	O
a	O
hydrophobic	O
protein	O
of	O
29	O
,	O
705	O
Da	O
with	O
six	O
potential	O
membrane	O
-	O
spanning	O
regions	O
.	O

Plasmids	O
were	O
constructed	O
with	O
the	O
mouse	O
promoter	O
region	O
linked	O
to	O
the	O
reporter	B
gene	I
chloramphenicol	I
acetyltransferase	I
(	O
CAT	B
),	O
and	O
transiently	O
and	O
stably	O
transfected	O
in	O
the	O
INS	O
-	O
1	O
cells	O
.	O

Specifically	O
,	O
this	O
study	O
determined	O
the	O
influence	O
of	O
:	O
(	O
1	O
)	O
an	O
awareness	O
strategy	O
,	O
(	O
2	O
)	O
a	O
non	O
-	O
awareness	O
strategy	O
,	O
(	O
3	O
)	O
a	O
Five	O
-	O
Step	O
Approach	O
strategy	O
and	O
(	O
4	O
)	O
a	O
control	O
condition	O
.	O

The	O
protein	O
encoded	O
is	O
114	O
kDa	O
and	O
contains	O
eight	O
zinc	O
finger	O
motifs	O
,	O
seven	O
of	O
which	O
are	O
present	O
in	O
two	O
clusters	O
at	O
opposite	O
ends	O
of	O
the	O
molecule	O
.	O

Tissue	O
-	O
specific	O
expression	O
of	O
the	O
diazepam	B
-	I
binding	I
inhibitor	I
in	O
Drosophila	O
melanogaster	O
:	O
cloning	O
,	O
structure	O
,	O
and	O
localization	O
of	O
the	O
gene	O
.	O

Because	O
endogenous	O
HSF	B
DNA	O
-	O
binding	O
activity	O
is	O
low	O
and	O
anti	B
-	I
hHSF1	I
antibody	I
does	O
not	O
recognize	O
Xenopus	B
HSF	I
,	O
we	O
employed	O
this	O
system	O
for	O
mapping	O
regions	O
in	O
hHSF1	B
that	O
are	O
required	O
for	O
the	O
maintenance	O
of	O
the	O
monomeric	O
state	O
.	O

Interestingly	O
,	O
these	O
response	O
elements	O
display	O
dramatically	O
reduced	O
affinity	O
for	O
retinoic	B
acid	I
receptor	I
-	O
retinoid	B
-	I
X	I
receptor	I
heterodimers	O
.	O

Mutation	O
of	O
KRKR	O
to	O
NGER	O
retains	O
MO15	B
in	O
the	O
cytoplasmic	O
compartment	O
,	O
whilst	O
the	O
wild	O
-	O
type	O
protein	O
is	O
detected	O
exclusively	O
in	O
the	O
nucleus	O
.	O

This	O
work	O
unravels	O
a	O
new	O
model	O
for	O
the	O
ets	B
-	I
1	I
/	O
ets	B
-	I
2	I
gene	I
'	O
s	O
evolution	O
,	O
based	O
for	O
the	O
first	O
time	O
on	O
both	O
structural	O
and	O
functional	O
evidences	O
.	O

Laser	O
therapy	O
of	O
penile	O
carcinoma	O

The	O
site	O
-	O
directed	O
mutation	O
of	O
the	O
kappa	B
B	I
motif	I
in	O
IL	B
-	I
6	I
/	O
CAT	B
plasmid	O
resulted	O
in	O
the	O
complete	O
abrogation	O
of	O
IL	B
-	I
6	I
promoter	I
activity	O
in	O
these	O
cells	O
.	O

Curiously	O
,	O
testololactone	O
was	O
earlier	O
and	O
more	O
widely	O
used	O
than	O
aminoglutethimide	O
in	O
treating	O
advanced	O
breast	O
carcinoma	O
.	O

Intraventricular	O
injection	O
of	O
(	O
2S	O
,	O
1	O
'	O
R	O
,	O
2	O
'	O
R	O
,	O
3	O
'	O
R	O
)-	O
2	O
-(	O
2	O
,	O
3	O
-	O
dicarboxycyclopropyl	O
)	O
glycine	O
(	O
DCG	O
-	O
IV	O
),	O
a	O
potent	O
agonist	O
for	O
metabotropic	O
glutamate	B
receptors	I
,	O
to	O
rats	O
retarded	O
dose	O
-	O
dependently	O
the	O
recovery	O
from	O
halothane	O
anesthesia	O
at	O
a	O
dose	O
range	O
from	O
30	O
to	O
300	O
pmol	O
/	O
rat	O
.	O

A	O
strong	O
trithorax	B
binding	I
site	I
was	O
found	O
at	O
the	O
cytological	O
location	O
of	O
the	O
fork	B
head	I
gene	I
,	O
a	O
region	O
-	O
specific	O
homeotic	B
gene	I
not	O
located	O
within	O
a	O
homeotic	B
complex	I
.	O

Peter	O
Elfer	O
explores	O
the	O
implications	O
of	O
the	O
ruling	O
.	O

The	O
physical	O
and	O
chemical	O
stability	O
of	O
a	O
combination	O
of	O
drugs	O
commonly	O
administered	O
into	O
the	O
epidural	O
or	O
intrathecal	O
space	O
for	O
the	O
treatment	O
of	O
chronic	O
pain	O
was	O
investigated	O
.	O

Regulators	O
responsible	O
for	O
the	O
pervasive	O
,	O
nonsex	O
-	O
specific	O
alternative	O
pre	O
-	O
mRNA	O
splicing	O
characteristic	O
of	O
metazoans	O
are	O
almost	O
entirely	O
unknown	O
or	O
uncertain	O
.	O

Determination	O
of	O
potassium	O
iodide	O
in	O
Polish	O
edible	O
salt	O

Sequencing	O
of	O
the	O
TP53	B
transcripts	I
from	O
exons	O
2	O
to	O
10	O
,	O
however	O
,	O
did	O
not	O
reveal	O
mutations	O
of	O
the	O
remaining	O
allele	O
in	O
any	O
of	O
these	O
tumors	O
.	O

All	O
other	O
ejaculate	O
parameters	O
(	O
density	O
,	O
motility	O
,	O
swelling	O
test	O
,	O
penetration	O
test	O
)	O
remained	O
unchanged	O
,	O
and	O
there	O
was	O
only	O
one	O
post	O
-	O
therapeutic	O
pregnancy	O
.	O

KRN2391	O
and	O
cromakalim	O
produced	O
a	O
dose	O
-	O
dependent	O
increase	O
in	O
aortic	O
and	O
coronary	O
blood	O
flow	O
.	O

Type	O
2	O
genomes	O
containing	O
this	O
sequence	O
presumably	O
more	O
closely	O
reflect	O
the	O
structure	O
of	O
the	O
infectious	O
,	O
replication	O
-	O
competent	O
retrovirus	O
ancestors	O
of	O
the	O
HERV	O
-	O
K	O
family	O
than	O
do	O
type	O
1	O
genomes	O
that	O
lack	O
the	O
sequence	O
.	O

Moreover	O
,	O
by	O
complementation	O
of	O
the	O
WA	B
fyuA	I
mutant	I
by	O
the	O
cloned	O
fyuA	B
gene	I
,	O
yersiniabactin	O
uptake	O
and	O
mouse	O
virulence	O
were	O
restored	O
.	O

The	O
ICBF	O
in	O
the	O
ischaemic	O
cortex	O
revealed	O
a	O
graded	O
reduction	O
from	O
the	O
ischaemic	O
centre	O
to	O
the	O
surrounding	O
tissues	O
.	O

Moreover	O
,	O
the	O
ability	O
to	O
selectivity	O
arrest	O
elongation	O
by	O
polIII	B
at	O
defined	O
positions	O
within	O
the	O
tRNA	O
gene	O
transcription	O
unit	O
has	O
permitted	O
the	O
identification	O
of	O
discrete	O
functional	O
properties	O
of	O
paused	O
mammalian	B
polIII	I
ternary	I
complexes	I
.	O

Propafenone	O
is	O
well	O
tolerated	O
in	O
the	O
majority	O
of	O
young	O
patients	O
.	O

Mutational	O
analysis	O
of	O
yeast	B
CEG1	I
demonstrated	O
that	O
four	O
of	O
the	O
five	O
conserved	O
motifs	O
are	O
essential	O
for	O
capping	B
enzyme	I
function	O
in	O
vivo	O
.	O

The	O
data	O
show	O
conclusively	O
that	O
phosphorylation	O
of	O
His	O
-	O
304	O
is	O
not	O
essential	O
for	O
any	O
of	O
the	O
known	O
functions	O
of	O
A	B
.	I
vinelandii	I
NifL	I
.	O

Splice	O
variations	O
in	O
genes	O
coding	O
for	O
the	O
transmembrane	B
FGF	I
receptor	I
(	O
FGFR	B
)	O
result	O
in	O
isoforms	O
that	O
vary	O
in	O
the	O
ectodomain	O
,	O
intracellular	O
juxtamembrane	O
domain	O
,	O
and	O
the	O
intracellular	O
kinase	O
domain	O
.	O

These	O
same	O
regions	O
showed	O
remarkable	O
homology	O
to	O
two	O
invertebrate	O
proteins	O
,	O
CNC	B
and	O
skin	B
-	I
1	I
,	O
postulated	O
to	O
regulate	O
embryonic	O
development	O
in	O
Drosophila	O
melanogaster	O
and	O
Caenorhabditis	O
elegans	O
,	O
respectively	O
.	O

DNA	O
sequence	O
analysis	O
has	O
confirmed	O
that	O
this	O
mutation	O
affects	O
the	O
C	O
-	O
terminal	O
region	O
of	O
the	O
alpha	O
subunit	O
,	O
changing	O
a	O
leucine	O
residue	O
at	O
position	O
290	O
to	O
a	O
histidine	O
(	O
rpoAL290H	B
).	O

The	O
IPL1	B
gene	I
is	O
required	O
for	O
high	O
-	O
fidelity	O
chromosome	O
segregation	O
in	O
the	O
budding	O
yeast	O
Saccharomyces	O
cerevisiae	O
.	O

The	O
presence	O
of	O
regulatory	O
sequences	O
for	O
the	O
binding	O
of	O
transcription	O
factors	O
such	O
as	O
NF	B
-	I
kappa	I
B	I
and	O
AP	B
-	I
2	I
,	O
whose	O
activation	O
is	O
associated	O
with	O
the	O
immediate	O
response	O
of	O
the	O
cell	O
to	O
an	O
injury	O
,	O
may	O
be	O
an	O
indication	O
of	O
the	O
important	O
role	O
which	O
HO	B
-	I
1	I
may	O
play	O
in	O
defense	O
mechanisms	O
against	O
tissue	O
injury	O
.	O

A	O
randomised	O
,	O
controlled	O
trial	O
was	O
undertaken	O
in	O
40	O
patients	O
with	O
active	O
Crohn	O
'	O
s	O
disease	O
to	O
evaluate	O
clinical	O
and	O
nutritional	O
outcomes	O
after	O
an	O
amino	O
acid	O
based	O
diet	O
containing	O
3	O
%	O
fat	O
was	O
given	O
by	O
a	O
feeding	O
tube	O
compared	O
with	O
a	O
peptide	O
based	O
diet	O
containing	O
33	O
%	O
fat	O
.	O

These	O
results	O
demonstrate	O
that	O
a	O
class	O
of	O
proline	O
-	O
rich	O
activator	O
proteins	O
and	O
RNA	B
polymerase	I
II	I
possess	O
a	O
common	O
structural	O
and	O
functional	O
component	O
which	O
can	O
interact	O
with	O
the	O
same	O
target	O
in	O
the	O
general	O
transcription	O
machinery	O
.	O

Cloning	O
of	O
higher	B
plant	I
omega	I
-	I
3	I
fatty	I
acid	I
desaturases	I
.	O

The	O
availability	O
of	O
sequence	O
from	O
multiple	O
species	O
has	O
permitted	O
us	O
to	O
determine	O
that	O
the	O
UBE	O
site	O
has	O
close	O
similarity	O
to	O
motifs	O
that	O
bind	O
members	O
of	O
the	O
NF	B
-	I
1	I
family	I
of	I
transcription	I
factors	I
.	O

Stable	O
expression	O
of	O
truncated	B
inositol	I
1	I
,	I
4	I
,	I
5	I
-	I
trisphosphate	I
receptor	I
subunits	I
in	O
3T3	O
fibroblasts	O
.	O

In	O
addition	O
,	O
computer	O
analysis	O
suggests	O
that	O
sequences	O
similar	O
to	O
the	O
A	O
stem	O
element	O
are	O
present	O
within	O
the	O
three	O
AAV	B
promoter	I
regions	O
.	O

At	O
least	O
some	O
of	O
the	O
difference	O
in	O
stability	O
of	O
the	O
two	O
kinds	O
of	O
complexes	O
was	O
due	O
to	O
the	O
fact	O
that	O
the	O
dissociation	O
rate	O
of	O
the	O
A	O
stem	O
substrate	O
from	O
the	O
protein	O
-	O
DNA	O
complexes	O
was	O
approximately	O
fourfold	O
faster	O
than	O
that	O
of	O
the	O
complete	O
TR	B
.	O

We	O
speculate	O
that	O
mast	O
cell	O
degranulation	O
may	O
be	O
involved	O
in	O
the	O
pathogenesis	O
of	O
necrobiosis	O
by	O
altering	O
fibroblast	O
enzyme	O
activity	O
and	O
/	O
or	O
producing	O
prolonged	O
inflammatory	O
reactions	O
.	O

In	O
earlier	O
studies	O
we	O
identified	O
several	O
regulatory	O
elements	O
that	O
control	O
transcriptional	O
activation	O
and	O
aerobic	O
repression	O
of	O
one	O
of	O
these	O
genes	O
,	O
COX5b	B
.	O

This	O
DNA	O
containing	O
promoter	O
activity	O
has	O
been	O
sequenced	O
in	O
its	O
entirety	O
and	O
found	O
to	O
contain	O
multiple	O
putative	O
regulatory	O
sites	O
.	O

However	O
,	O
Southern	O
blot	O
and	O
karyotype	O
analyses	O
did	O
not	O
reveal	O
any	O
significant	O
changes	O
in	O
copy	O
number	O
or	O
gross	O
rearrangements	O
of	O
the	O
p53	B
gene	I
in	O
any	O
of	O
the	O
p53	B
-	I
cell	O
lines	O
.	O

HupI	B
showed	O
strong	O
identity	O
to	O
rubredoxin	B
and	O
rubredoxin	B
-	I
like	I
proteins	I
from	O
many	O
other	O
bacteria	O
.	O

The	O
PCr	O
resynthesis	O
rate	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
and	O
the	O
effective	O
maximal	O
rate	O
of	O
mitochondrial	O
ATP	O
synthesis	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
also	O
improved	O
.	O

We	O
have	O
examined	O
by	O
in	O
vitro	O
footprinting	O
a	O
region	O
located	O
downstream	O
of	O
the	O
human	O
immunodeficiency	O
virus	O
,	O
type	O
1	O
(	O
HIV	O
-	O
1	O
)	O
promoter	O
found	O
to	O
be	O
hypersensitive	O
to	O
DNase	B
I	I
digestion	O
in	O
vivo	O
.	O

A	O
constitutive	O
mutant	O
form	O
with	O
a	O
single	O
substitution	O
(	O
V88A	O
)	O
in	O
the	O
amino	O
-	O
terminal	O
(	O
response	O
regulator	O
)	O
region	O
was	O
used	O
.	O

We	O
have	O
found	O
a	O
satisfactory	O
reproducibility	O
in	O
vitro	O
(	O
T1	O
:	O
1	O
.	O
9	O
%;	O
T2	O
:	O
6	O
.	O
2	O
%),	O
while	O
the	O
reproducibility	O
was	O
less	O
satisfactory	O
in	O
vivo	O
(	O
T1	O
:	O
16	O
.	O
4	O
%;	O
T2	O
:	O
13	O
.	O
4	O
%).	O

We	O
find	O
that	O
beta	B
II	I
PKC	I
phosphorylates	O
nuclear	B
envelope	I
lamin	I
B	I
at	O
10	O
-	O
20	O
times	O
the	O
rate	O
of	O
alpha	B
PKC	I
,	O
whereas	O
both	O
kinases	O
phosphorylate	O
soluble	B
lamin	I
B	I
at	O
similar	O
rates	O
.	O

We	O
conclude	O
that	O
c	B
-	I
Abl	I
activates	O
c	B
-	I
myc	I
transcription	O
indirectly	O
with	O
no	O
requirement	O
for	O
DNA	O
binding	O
by	O
c	B
-	I
Abl	I
.	O

The	O
Oct	B
-	I
2	I
glutamine	O
-	O
rich	O
and	O
proline	O
-	O
rich	O
activation	O
domains	O
can	O
synergize	O
with	O
each	O
other	O
or	O
duplicates	O
of	O
themselves	O
to	O
activate	O
transcription	O
.	O

Binding	O
of	O
U2	B
small	I
nuclear	I
ribonucleoprotein	I
(	O
snRNP	O
)	O
to	O
the	O
pre	O
-	O
mRNA	O
is	O
an	O
early	O
and	O
important	O
step	O
in	O
spliceosome	O
assembly	O
.	O

Taken	O
together	O
,	O
our	O
data	O
suggest	O
that	O
Dbf8p	B
plays	O
an	O
essential	O
role	O
in	O
chromosome	O
segregation	O
.	O

Ariga	O
,	O
Biochem	O
.	O

Marine	O
oils	O
and	O
cardiovascular	O
reactivity	O
.	O

Roux	O
-	O
en	O
-	O
Y	O
gastroenterostomy	O
severely	O
disturbs	O
emptying	O
of	O
the	O
gallbladder	O
.	O

Surface	O
-	O
coil	O
experiments	O
on	O
phantoms	O
and	O
on	O
human	O
calf	O
muscles	O
in	O
vivo	O
are	O
presented	O
.	O

The	O
partial	O
ORF	O
was	O
found	O
to	O
be	O
identical	O
to	O
the	O
C	O
terminus	O
of	O
HrpJ2	B
.	O

The	O
partial	O
ORF	O
was	O
found	O
to	O
be	O
identical	O
to	O
the	O
C	O
terminus	O
of	O
HrpJ2	B
.	O

Rapid	O
detection	O
of	O
this	O
mutation	O
is	O
achieved	O
by	O
restriction	O
digestion	O
of	O
PCR	O
-	O
amplified	O
genomic	O
DNA	O
;	O
a	O
mismatch	O
primer	O
combined	O
with	O
the	O
point	O
mutation	O
creates	O
a	O
Tru9I	B
restriction	I
site	I
.	O

Use	O
of	O
Medi	O
-	O
Jector	O
EZ	O
dermojet	O
for	O
anesthesia	O
in	O
minor	O
surgery	O

2	O
.	O

Reduced	O
NK	O
activity	O
correlates	O
with	O
active	O
disease	O
in	O
HIV	O
-	O
patients	O
with	O
multidrug	O
-	O
resistant	O
pulmonary	O
tuberculosis	O
.	O

(	O
LH	B
P	O
<	O
0	O
.	O
05	O
,	O
LH	B
/	O
FSH	B
P	O
<	O
0	O
.	O
01	O
).	O

The	O
relative	O
R	O
-	O
and	O
L	O
-	O
brain	O
weights	O
were	O
found	O
to	O
be	O
inversely	O
related	O
to	O
the	O
relative	O
R	O
-	O
L	O
brain	O
weight	O
only	O
in	O
the	O
RH	O
female	O
cats	O
with	O
R	O
-	O
L	O
brain	O
weight	O
smaller	O
than	O
zero	O
(	O
testosterone	O
in	O
males	O
,	O
estrogen	O
in	O
females	O
).	O

This	O
mode	O
of	O
ternary	O
complex	O
formation	O
is	O
in	O
contrast	O
to	O
the	O
one	O
seen	O
in	O
the	O
promoter	O
of	O
the	O
c	B
-	I
fos	I
protooncogene	I
,	O
where	O
formation	O
of	O
the	O
ternary	O
complex	O
is	O
dependent	O
on	O
the	O
prior	O
assembly	O
of	O
the	O
serum	B
response	I
factor	I
-	I
DNA	I
binary	I
complex	I
.	O

Vaccinia	O
virus	O
-	O
expressed	O
,	O
purified	O
full	B
-	I
length	I
HPV	I
-	I
16	I
and	I
BPV	I
-	I
1	I
E2	I
proteins	I
bound	O
a	O
consensus	O
E2	B
site	I
with	O
high	O
specific	O
affinities	O
(	O
Kd	O
=	O
approximately	O
10	O
(-	O
9	O
)	O
M	O
)	O
and	O
stimulated	O
in	O
vitro	O
transcription	O
up	O
to	O
six	O
-	O
to	O
eightfold	O
.	O

This	O
alternatively	O
spliced	O
transcript	O
contained	O
an	O
open	O
reading	O
frame	O
extending	O
from	O
the	O
upstream	O
J	O
alpha	O
11	O
-	O
2	O
region	O
to	O
82	O
nucleotides	O
downstream	O
of	O
the	O
beginning	O
of	O
the	O
TCR	B
C	I
alpha	I
region	I
,	O
and	O
potentially	O
encoded	O
a	O
36	O
amino	O
acid	O
polypeptide	O
.	O

We	O
describe	O
49	O
cases	O
with	O
papillary	O
tumor	O
<	O
1	O
cm	O
.	O

Comparison	O
with	O
the	O
bovine	O
gene	O
showed	O
that	O
the	O
5	O
'-	O
flanking	O
region	O
of	O
the	O
hATP1	B
gene	I
has	O
an	O
unconserved	O
guanine	O
-	O
cytosine	O
(	O
GC	O
)	O
rich	O
region	O
,	O
including	O
several	O
binding	O
motifs	O
of	O
transcriptional	O
factors	O
,	O
such	O
as	O
Sp1	B
,	O
AP	B
-	I
2	I
,	O
and	O
GCF	B
.	O

Structure	O
,	O
promoter	O
analysis	O
and	O
chromosomal	O
assignment	O
of	O
the	O
human	B
APEX	I
gene	I
.	O

Thus	O
,	O
in	O
stress	O
-	O
induced	O
arrhythmic	O
disease	O
as	O
well	O
as	O
in	O
ischemic	O
heart	O
disease	O
,	O
the	O
main	O
pathogenetic	O
links	O
are	O
outside	O
the	O
heart	O
,	O
but	O
they	O
differ	O
from	O
those	O
observed	O
in	O
ischemia	O
.	O

Here	O
,	O
we	O
present	O
genetic	O
evidence	O
in	O
Saccharomyces	O
cerevisiae	O
for	O
a	O
functional	O
interaction	O
between	O
the	O
DEAH	B
protein	I
Prp16	I
,	O
and	O
the	O
U6	B
and	O
U2	B
spliceosomal	I
snRNAs	I
.	O

The	O
high	O
level	O
of	O
transformation	O
-	O
associated	O
deletions	O
in	O
the	O
human	O
YACs	O
was	O
reduced	O
over	O
10	O
-	O
fold	O
when	O
the	O
host	O
was	O
a	O
recombination	O
-	O
deficient	O
strain	O
deleted	O
for	O
the	O
RAD52	B
gene	I
.	O

In	O
addition	O
,	O
the	O
megabase	O
region	O
surrounding	O
the	O
dagA	B
locus	I
was	O
mapped	O
.	O

We	O
present	O
evidence	O
that	O
DNA	B
polymerase	I
delta	I
of	I
Saccharomyces	I
cerevisiae	I
,	O
an	O
enzyme	O
that	O
is	O
essential	O
for	O
viability	O
and	O
chromosomal	O
replication	O
,	O
is	O
also	O
required	O
for	O
base	O
excision	O
repair	O
of	O
exogenous	O
DNA	O
methylation	O
damage	O
.	O

We	O
have	O
identified	O
two	O
Marek	O
'	O
s	O
Disease	O
Virus	O
(	O
MDV	O
)	O
genes	O
within	O
the	O
EcoRI	B
-	I
B	I
fragment	I
of	O
MDV	O
-	O
GA	O
genomic	O
DNA	O
.	O

Novel	O
8	O
-	O
base	O
pair	O
sequence	O
(	O
Drosophila	O
DNA	O
replication	O
-	O
related	O
element	O
)	O
and	O
specific	O
binding	O
factor	O
involved	O
in	O
the	O
expression	O
of	O
Drosophila	O
genes	O
for	O
DNA	B
polymerase	I
alpha	I
and	O
proliferating	B
cell	I
nuclear	I
antigen	I
.	O

Previous	O
studies	O
showed	O
that	O
mutations	O
in	O
the	O
6K	O
protein	O
led	O
to	O
the	O
slow	O
release	O
of	O
aberrant	O
,	O
multi	O
-	O
cored	O
infectious	O
virions	O
.	O

Isolation	O
and	O
characterization	O
of	O
SRF	B
accessory	I
proteins	I
.	O

The	O
indoor	O
radon	O
concentration	O
in	O
the	O
summer	O
(	O
1990	O
)	O
period	O
ranged	O
between	O
8	O
and	O
81	O
Bq	O
m	O
-	O
3	O
,	O
while	O
in	O
the	O
winter	O
(	O
1989	O
-	O
1990	O
)	O
it	O
ranged	O
between	O
20	O
and	O
143	O
Bq	O
m	O
-	O
3	O
for	O
the	O
first	O
year	O
of	O
measurements	O
or	O
between	O
8	O
and	O
92	O
Bq	O
m	O
-	O
3	O
in	O
the	O
summer	O
(	O
1991	O
)	O
period	O
and	O
between	O
12	O
and	O
119	O
Bq	O
m	O
-	O
3	O
in	O
the	O
winter	O
(	O
1990	O
-	O
1991	O
)	O
for	O
the	O
second	O
year	O
of	O
measurements	O
.	O

The	O
results	O
indicate	O
that	O
hrpRS	B
and	O
hrpL	B
are	O
part	O
of	O
a	O
regulatory	O
cascade	O
in	O
which	O
HrpR	B
and	O
HrpS	B
activate	O
expression	O
of	O
hrpL	B
and	O
HrpL	B
,	O
a	O
putative	O
sigma	B
factor	I
,	O
induces	O
expression	O
of	O
HrpL	B
-	I
responsive	I
genes	I
.	O

When	O
the	O
promoter	O
region	O
was	O
linked	O
with	O
a	O
heterologous	O
reporter	O
gene	O
,	O
we	O
found	O
that	O
the	O
promoter	O
region	O
is	O
inducible	O
by	O
both	O
interferons	B
(	O
interferon	B
-	I
alpha	I
and	I
-	I
gamma	I
)	O
and	O
interferon	B
regulatory	I
factor	I
1	I
.	O

All	O
other	O
normal	O
and	O
transformed	O
lymphoid	O
and	O
nonlymphoid	O
cell	O
lines	O
and	O
normal	O
tissues	O
were	O
negative	O
for	O
PANG	B
expression	O
except	O
for	O
the	O
brain	O
,	O
wherein	O
unique	O
4	O
.	O
0	O
-	O
and	O
6	O
.	O
1	O
-	O
kb	O
transcripts	O
were	O
detected	O
.	O

The	O
cis	O
-	O
acting	O
regulatory	O
properties	O
of	O
an	O
872	O
bp	O
promoter	O
fragment	O
of	O
a	O
B	O
.	O
napus	O
oleosin	B
gene	I
were	O
examined	O
by	O
analysis	O
of	O
beta	B
-	I
glucuronidase	I
(	O
GUS	B
)	O
expression	O
in	O
transgenic	O
tobacco	O
plants	O
containing	O
an	O
oleosin	B
promoter	I
-	O
GUS	B
transcriptional	O
fusion	O
.	O

Increasing	O
the	O
extracellular	O
calcium	O
concentration	O
enhanced	O
detrusor	O
contractility	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
in	O
both	O
control	O
and	O
obstructed	O
bladders	O
.	O

Western	O
blotting	O
(	O
immunoblotting	O
)	O
with	O
an	O
antiserum	O
to	O
a	O
partial	O
SOD	B
expressed	O
in	O
Escherichia	O
coli	O
revealed	O
two	O
proteins	O
with	O
estimated	O
molecular	O
masses	O
of	O
19	O
and	O
29	O
kDa	O
.	O

The	O
gene	O
organization	O
of	O
CRSV	B
RNA	I
-	I
1	I
is	O
similar	O
to	O
those	O
of	O
red	O
clover	O
necrotic	O
mosaic	O
(	O
RCNMV	O
)	O
and	O
sweet	O
clover	O
necrotic	O
mosaic	O
(	O
SCNMV	O
)	O
dianthoviruses	O
with	O
the	O
exception	O
that	O
CRSV	B
RNA	I
-	I
1	I
contains	O
the	O
additional	O
3	O
'-	O
terminal	O
ORF	O
.	O

Members	O
of	O
the	O
myocyte	B
-	I
specific	I
enhancer	I
-	I
binding	I
factor	I
2	I
(	O
MEF2	B
)	O
family	O
of	O
transcription	O
factors	O
bind	O
a	O
conserved	O
A	O
/	O
T	O
-	O
rich	O
sequence	O
in	O
the	O
control	O
regions	O
of	O
numerous	O
muscle	O
-	O
specific	O
genes	O
.	O

We	O
have	O
investigated	O
the	O
role	O
of	O
cellular	B
p21ras	I
protein	I
in	O
insulin	B
and	O
insulin	B
-	I
like	I
growth	I
factor	I
-	I
I	I
(	O
IGF	B
-	I
I	I
)	O
signaling	O
pathways	O
.	O

However	O
,	O
a	O
correlation	O
was	O
observed	O
between	O
SF	O
levels	O
of	O
IL	B
-	I
8	I
with	O
those	O
of	O
lactate	O
,	O
LDH	B
,	O
beta	B
2	I
-	I
microglobulin	I
and	O
glucose	O
.	O

The	O
previously	O
described	O
enhanced	O
translation	O
of	O
spinach	O
L12	B
mRNA	I
from	O
its	O
two	O
tandem	O
AUG	O
codons	O
and	O
the	O
two	O
functional	O
rpl12	B
genes	I
in	O
Arabidopsis	O
probably	O
provide	O
two	O
mechanisms	O
for	O
generating	O
the	O
four	O
copies	O
of	O
L12	B
/	I
chloroplast	I
ribosome	I
,	O
qualitatively	O
different	O
from	O
those	O
attempted	O
in	O
eubacteria	O
.	O

In	O
these	O
experiments	O
we	O
begin	O
to	O
study	O
the	O
potential	O
functions	O
of	O
the	O
alpha	B
7	I
cytoplasmic	I
domain	I
by	O
analyzing	O
homologies	O
between	O
the	O
rat	O
and	O
human	O
sequences	O
,	O
by	O
immunologic	O
studies	O
using	O
an	O
anti	O
-	O
cytoplasmic	O
domain	O
antiserum	O
,	O
and	O
by	O
identifying	O
two	O
alternate	O
forms	O
.	O

The	O
alpha	O
7A	O
form	O
RNA	O
contains	O
an	O
additional	O
113	O
nucleotides	O
compared	O
to	O
the	O
B	O
form	O
,	O
and	O
a	O
common	O
coding	O
region	O
in	O
the	O
A	O
and	O
B	O
form	O
RNAs	O
is	O
used	O
in	O
alternate	O
reading	O
frames	O
.	O

The	O
c	B
-	I
myc	I
and	O
skeletal	B
alpha	I
-	I
actin	I
gene	I
promoters	I
contain	O
YY1	B
binding	I
sites	I
thought	O
to	O
act	O
either	O
as	O
positive	O
or	O
negative	O
cis	O
-	O
acting	O
elements	O
.	O

Moreover	O
,	O
the	O
major	O
site	O
of	O
transcriptional	O
initiation	O
,	O
which	O
was	O
localized	O
by	O
primer	O
extension	O
250	O
bp	O
upstream	O
of	O
the	O
5	O
'	O
end	O
of	O
the	O
Ets	B
-	I
1	I
cDNA	I
clone	I
,	O
was	O
shown	O
to	O
be	O
identical	O
in	O
normal	O
cells	O
and	O
tumors	O
carrying	O
a	O
provirus	O
in	O
the	O
Tpl	B
-	I
1	I
locus	I
.	O

Specifically	O
,	O
by	O
oligonucleotide	O
-	O
directed	O
site	O
-	O
specific	O
mutagenesis	O
,	O
we	O
demonstrate	O
that	O
of	O
10	O
cysteine	O
residues	O
in	O
the	O
ORF4	O
polypeptide	O
,	O
only	O
C	O
-	O
421	O
and	O
C	O
-	O
426	O
are	O
essential	O
for	O
transactivator	O
function	O
and	O
suggest	O
that	O
these	O
cysteine	O
residues	O
may	O
participate	O
in	O
critical	O
protein	O
-	O
protein	O
interactions	O
rather	O
than	O
protein	O
-	O
nucleic	O
acid	O
interactions	O
to	O
mediate	O
ORF4	O
inducibility	O
.	O

In	O
Rat	O
1a	O
cells	O
,	O
m1R	B
stimulation	O
of	O
phospholipase	B
C	I
beta	I
and	O
the	O
marked	O
rise	O
in	O
intracellular	O
calcium	O
stimulated	O
cyclic	O
AMP	O
(	O
cAMP	O
)	O
synthesis	O
,	O
resulting	O
in	O
the	O
activation	O
of	O
protein	B
kinase	I
A	I
.	O

A	O
segment	O
of	O
mRNA	O
encoding	O
the	O
leader	O
peptide	O
of	O
the	O
CPA1	B
gene	I
confers	O
repression	O
by	O
arginine	O
on	O
a	O
heterologous	O
yeast	O
gene	O
transcript	O
.	O

To	O
search	O
for	O
genes	O
that	O
interact	O
with	O
the	O
SLK1	B
-	O
SLT2	B
pathway	O
,	O
a	O
synthetic	O
lethal	O
suppression	O
screen	O
was	O
carried	O
out	O
.	O

Identical	O
components	O
of	O
yeast	O
transcription	B
factor	I
IIIB	I
are	O
required	O
and	O
sufficient	O
for	O
transcription	O
of	O
TATA	O
box	O
-	O
containing	O
and	O
TATA	O
-	O
less	O
genes	O
.	O

Restoration	O
of	O
opponens	O
function	O
with	O
transplantation	O
of	O
free	O
composites	O
dorsal	O
pedal	O
skin	O
flap	O
containing	O
m	O
.	O
extensor	O
hallucis	O
brevis	O

Neither	O
ethanol	O
regimen	O
impaired	O
spontaneous	O
alternation	O
,	O
but	O
the	O
4	O
g	O
ethanol	O
.	O
kg	O
-	O
1	O
x	O
day	O
-	O
1	O
regimen	O
increased	O
the	O
percent	O
completed	O
trials	O
.	O

ATP	O
by	O
itself	O
also	O
reduced	O
polypeptide	O
binding	O
to	O
Ssb1	B
/	I
2p	I
to	O
a	O
level	O
that	O
was	O
intermediate	O
between	O
that	O
observed	O
for	O
the	O
Ssa	B
Hsp70	I
proteins	I
tested	O
and	O
BiP	B
and	O
DnaK	B
.	O

Signaling	O
by	O
tyrosine	B
kinases	I
involves	O
direct	O
associations	O
between	O
proteins	O
with	O
Src	B
homology	I
2	I
(	O
SH2	B
)	O
domains	O
and	O
sites	O
of	O
tyrosine	O
phosphorylation	O
.	O

Structure	O
and	O
expression	O
of	O
the	O
alternative	O
sigma	B
factor	I
,	O
RpoN	B
,	O
in	O
Rhodobacter	O
capsulatus	O
;	O
physiological	O
relevance	O
of	O
an	O
autoactivated	O
nifU2	B
-	O
rpoN	B
superoperon	O
.	O

The	O
degree	O
of	O
lung	O
destruction	O
,	O
reflected	O
by	O
interstitial	O
hemorrhage	O
was	O
assessed	O
by	O
measuring	O
hemoglobin	B
content	O
in	O
the	O
fluid	O
of	O
the	O
lavaged	O
lungs	O
.	O

The	O
revertant	O
TATA	O
boxes	O
accelerated	O
the	O
kinetics	O
of	O
HIV	O
replication	O
when	O
present	O
in	O
the	O
context	O
of	O
an	O
LTR	O
containing	O
a	O
Sp1	B
mutation	O
(	O
deletion	O
or	O
site	O
specific	O
);	O
no	O
effect	O
was	O
observed	O
on	O
the	O
infectivity	O
of	O
wild	O
-	O
type	O
HIV	O
.	O

Panlobular	O
emphysema	O

Gel	O
shift	O
analysis	O
indicates	O
that	O
the	O
full	B
-	I
length	I
ERM	I
protein	I
is	O
able	O
to	O
bind	O
specifically	O
to	O
an	O
oligonucleotide	O
containing	O
the	O
consensus	O
nucleotide	O
core	O
sequence	O
GGAA	O
recognized	O
by	O
the	O
Ets	B
proteins	O
.	O

These	O
issues	O
include	O
the	O
use	O
of	O
LMWHs	O
in	O
patients	O
with	O
arterial	O
thrombosis	O
or	O
myocardial	O
infarction	O
(	O
e	O
.	O
g	O
.	O
in	O
conjunction	O
with	O
thrombolytic	O
treatment	O
),	O
and	O
in	O
patients	O
with	O
pulmonary	O
embolism	O
.	O

The	O
Saccharomyces	B
cerevisiae	I
APS1	I
gene	I
encodes	O
a	O
homolog	O
of	O
the	O
small	O
subunit	O
of	O
the	O
mammalian	B
clathrin	I
AP	I
-	I
1	I
complex	I
:	O
evidence	O
for	O
functional	O
interaction	O
with	O
clathrin	B
at	O
the	O
Golgi	O
complex	O
.	O

These	O
results	O
are	O
the	O
first	O
to	O
demonstrate	O
the	O
structural	O
organization	O
of	O
a	O
vertebrate	O
gene	O
encoding	O
an	O
integral	O
membrane	O
protein	O
of	O
the	O
nuclear	O
envelope	O
that	O
may	O
be	O
a	O
member	O
of	O
a	O
family	O
of	O
polypeptides	O
conserved	O
in	O
evolution	O
.	O

All	O
patients	O
with	O
deterioriation	O
in	O
mental	O
status	O
showed	O
a	O
marked	O
increase	O
in	O
liver	O
enzymes	O
(	O
aspartate	B
and	I
alanine	I
aminotransaminases	I
)	O
and	O
severe	O
coagulopathy	O
.	O

All	O
of	O
the	O
basal	O
TPN	O
solutions	O
were	O
isonitrogenous	O
and	O
identical	O
in	O
nutrient	O
composition	O
,	O
except	O
for	O
the	O
difference	O
in	O
energy	O
level	O
,	O
which	O
was	O
adjusted	O
with	O
glucose	O
.	O

The	O
ligand	O
for	O
RXR	B
,	O
9	O
-	O
cis	O
retinoic	O
acid	O
,	O
has	O
the	O
opposite	O
effect	O
of	O
destabilizing	O
the	O
heterodimeric	O
-	O
DNA	O
complex	O
.	O

Location	O
and	O
orientation	O
of	O
an	O
activating	O
region	O
in	O
the	O
Escherichia	O
coli	O
transcription	O
factor	O
,	O
FNR	B
.	O

Moxidectin	O
(	O
at	O
3	O
times	O
the	O
therapeutic	O
dose	O
)	O
did	O
not	O
have	O
deleterious	O
effects	O
on	O
cow	O
reproductive	O
performance	O
as	O
examined	O
(	O
eg	O
,	O
at	O
folliculogenesis	O
,	O
ovulation	O
,	O
and	O
the	O
early	O
embryonic	O
phase	O
of	O
development	O
).	O

Simple	O
reaction	O
time	O
(	O
RT	O
)	O
to	O
a	O
peripheral	O
visual	O
target	O
(	O
S2	O
)	O
is	O
shortened	O
when	O
a	O
non	O
-	O
informative	O
cue	O
(	O
S1	O
)	O
is	O
flashed	O
at	O
the	O
S2	O
location	O
100	O
-	O
150	O
ms	O
before	O
target	O
onset	O
(	O
early	O
facilitation	O
).	O

Five	O
concensus	O
poly	O
A	O
addition	O
sites	O
are	O
located	O
in	O
the	O
350	O
base	O
pairs	O
immediately	O
following	O
the	O
protein	B
IX	I
coding	O
region	O
.	O

Frequent	O
loss	O
of	O
heterozygosity	O
(	O
LOH	O
)	O
of	O
>	O
30	O
%	O
of	O
the	O
informative	O
cases	O
was	O
observed	O
on	O
chromosomes	O
3p	O
(	O
41	O
.	O
1	O
%),	O
5q	O
(	O
52	O
.	O
6	O
%),	O
6p	O
(	O
30	O
.	O
4	O
%),	O
8p	O
(	O
33	O
.	O
3	O
%),	O
9p	O
(	O
35	O
.	O
7	O
%),	O
9q	O
(	O
30	O
.	O
8	O
%),	O
11p	O
(	O
32	O
.	O
4	O
%),	O
13q	O
(	O
52	O
.	O
7	O
%),	O
17p	O
(	O
55	O
.	O
2	O
%),	O
17q	O
(	O
33	O
.	O
3	O
%),	O
18q	O
(	O
45	O
.	O
7	O
%),	O
and	O
19q	O
(	O
30	O
.	O
4	O
%).	O

Glutamyl	B
-	I
tRNA	I
synthetase	I
and	O
prolyl	B
-	I
tRNA	I
synthetase	I
belong	O
to	O
different	O
classes	O
of	O
aminoacyl	B
-	I
tRNA	I
synthetases	I
that	O
are	O
thought	O
to	O
have	O
evolved	O
along	O
independent	O
evolutionary	O
pathways	O
.	O

The	O
transcription	B
factor	I
AP	I
-	I
2	I
is	O
encoded	O
by	O
a	O
gene	O
located	O
on	O
chromosome	O
6	O
near	O
the	O
HLA	B
locus	I
.	O

San	O
Martin	O
'	O
s	O
psychological	O
traits	O
coupled	O
to	O
his	O
work	O
with	O
masonic	O
lodges	O
that	O
allowed	O
him	O
to	O
display	O
his	O
abilities	O
as	O
strategist	O
and	O
political	O
ruler	O
.	O

This	O
strategy	O
was	O
used	O
to	O
place	O
both	O
the	O
Tn903	B
neo	I
gene	I
and	O
the	O
Rhodosporidium	B
toruloides	I
phenylalanine	I
ammonia	I
lyase	I
(	O
PAL	B
)-	O
encoding	O
gene	O
under	O
the	O
transcriptional	O
control	O
of	O
pPGK	B
::	O
REP2	B
.	O

A	O
genomic	O
clone	O
for	O
the	O
cyc07	B
gene	I
,	O
which	O
is	O
expressed	O
specifically	O
at	O
the	O
S	O
phase	O
during	O
the	O
cell	O
cycle	O
in	O
synchronous	O
cultures	O
of	O
periwinkle	O
(	O
Catharanthus	O
roseus	O
)	O
cells	O
,	O
was	O
isolated	O
.	O

The	O
p53	B
tumor	I
suppressor	I
gene	I
product	I
,	O
a	O
sequence	O
-	O
specific	O
DNA	O
-	O
binding	O
protein	O
,	O
has	O
been	O
shown	O
to	O
act	O
as	O
a	O
transcriptional	O
activator	O
and	O
repressor	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

Cloning	O
and	O
sequencing	O
of	O
the	O
corresponding	O
cDNAs	O
indicates	O
that	O
,	O
via	O
alternative	O
splicing	O
,	O
the	O
rearranged	O
gene	O
codes	O
for	O
two	O
proteins	O
of	O
84	O
and	O
85	O
kD	O
(	O
p84	B
/	I
85	I
)	O
which	O
retain	O
the	O
DNA	O
-	O
binding	O
rel	B
domain	I
and	O
the	O
first	O
five	O
ankyrin	B
repeats	O
,	O
but	O
have	O
lost	O
their	O
carboxy	O
-	O
terminus	O
including	O
the	O
seventh	O
ankyrin	B
repeat	O
.	O

The	O
ns2	B
gene	I
comprises	O
an	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
encoding	O
a	O
putative	O
nonstructural	O
(	O
ns	O
)	O
protein	O
of	O
279	O
amino	O
acids	O
with	O
a	O
predicted	O
molecular	O
mass	O
of	O
32	O
-	O
kDa	O
.	O

Co	O
-	O
transfection	O
of	O
a	O
tat	B
expressing	O
plasmid	O
with	O
these	O
viruses	O
containing	O
the	O
tat	B
ORF	I
mutations	O
resulted	O
in	O
higher	O
levels	O
of	O
virus	O
production	O
demonstrating	O
that	O
the	O
effects	O
of	O
both	O
mutants	O
are	O
tat	B
specific	O
.	O

Thus	O
,	O
we	O
have	O
identified	O
a	O
GRE	O
sufficient	O
to	O
account	O
for	O
full	O
glucocorticoid	O
inducibility	O
and	O
an	O
HNF	B
-	I
1	I
site	I
close	O
to	O
the	O
promoter	O
that	O
are	O
major	O
determinants	O
of	O
transcriptional	O
control	O
of	O
the	O
Xenopus	B
fibrinogen	I
B	I
beta	I
subunit	I
gene	I
in	O
cells	O
from	O
normal	O
liver	O
tissue	O
.	O

GGS1	B
is	O
the	O
same	O
gene	O
as	O
TPS1	B
which	O
was	O
identified	O
as	O
encoding	O
a	O
subunit	O
of	O
the	O
trehalose	B
-	I
6	I
-	I
phosphate	I
synthase	I
/	I
phosphatase	I
complex	I
and	O
it	O
is	O
allelic	O
to	O
the	O
fdp1	B
,	O
byp1	B
,	O
glc6	B
and	O
cif1	O
mutations	O
.	O

There	O
was	O
no	O
apparent	O
effect	O
of	O
growth	O
temperature	O
on	O
the	O
steady	O
-	O
state	O
levels	O
of	O
fad7	B
mRNA	I
in	O
wild	O
type	O
plants	O
.	O

A	O
second	O
important	O
molecule	O
in	O
TCR	B
signal	O
transduction	O
is	O
the	O
guanine	B
nucleotide	I
binding	I
protein	I
,	O
p21ras	B
,	O
which	O
is	O
coupled	O
to	O
the	O
TCR	B
by	O
a	O
protein	B
tyrosine	I
kinase	I
dependent	O
mechanism	O
.	O

Most	O
smokers	O
would	O
prefer	O
to	O
quit	O
smoking	O
on	O
their	O
own	O
.	O

The	O
product	O
of	O
the	O
vpr	B
open	I
reading	I
frame	I
of	I
human	I
immunodeficiency	I
virus	I
type	I
1	I
(	I
HIV	I
-	I
1	I
)	I
is	O
a	O
15	O
-	O
kDa	O
,	O
arginine	O
-	O
rich	O
protein	O
that	O
is	O
present	O
in	O
virions	O
in	O
molar	O
quantities	O
equivalent	O
to	O
that	O
of	O
Gag	B
.	O

The	O
bioavailability	O
of	O
etodolac	O
from	O
capsules	O
exposed	O
to	O
stressed	O
conditions	O
was	O
compared	O
in	O
both	O
dogs	O
and	O
humans	O
to	O
capsules	O
stored	O
at	O
RT	O
conditions	O
.	O

Effects	O
of	O
diltiazem	O
on	O
netilmicin	O
-	O
induced	O
nephrotoxicity	O
in	O
rabbits	O
.	O

Three	O
cysteine	O
and	O
four	O
tryptophan	O
residues	O
,	O
previously	O
identified	O
as	O
conserved	O
amongst	O
nitrous	B
-	I
oxide	I
reductases	I
,	O
are	O
found	O
in	O
the	O
Paracoccus	O
enzyme	O
.	O

These	O
results	O
demonstrate	O
the	O
existence	O
of	O
different	O
PI	B
3	I
-	I
kinase	I
isoforms	I
and	O
define	O
a	O
family	O
of	O
genes	O
encoding	O
distinct	O
PI	B
3	I
-	I
kinase	I
catalytic	I
subunits	I
that	O
can	O
associate	O
with	O
p85	B
.	O

The	O
rate	O
of	O
enzymic	O
stimulation	O
induced	O
by	O
a	O
given	O
nitrate	O
correlates	O
closely	O
with	O
the	O
rate	O
of	O
measured	O
NO	O
production	O
from	O
the	O
nitrate	O
molecule	O
.	O

Using	O
a	O
series	O
of	O
mutant	B
T	I
antigens	I
expressed	O
by	O
recombinant	O
baculoviruses	O
in	O
Sf9	O
cells	O
,	O
we	O
find	O
that	O
the	O
origin	O
unwinding	O
activities	O
of	O
both	O
TS677	O
-->	O
A	O
and	O
TS677	O
,	O
679	O
-->	O
A	O
are	O
inhibited	O
by	O
the	O
T	B
-	I
antigen	I
kinase	I
,	O
as	O
is	O
wild	B
-	I
type	I
T	I
antigen	I
.	O

In	O
the	O
present	O
study	O
,	O
lesions	O
of	O
the	O
OPT	O
complex	O
(	O
the	O
thalamic	O
source	O
of	O
afferents	O
to	O
IHA	O
and	O
HD	O
)	O
were	O
found	O
to	O
have	O
no	O
effect	O
on	O
color	O
-	O
reversal	O
learning	O
performance	O
.	O

CONCLUSIONS	O
:	O
In	O
our	O
patients	O
and	O
within	O
the	O
range	O
of	O
treatment	O
variables	O
studied	O
,	O
age	O
,	O
Karnofsky	O
index	O
,	O
and	O
graft	O
-	O
versus	O
-	O
host	O
disease	O
are	O
the	O
most	O
important	O
factors	O
related	O
with	O
early	O
mortality	O
.	O

This	O
intron	O
occupies	O
a	O
conserved	O
position	O
corresponding	O
to	O
that	O
of	O
intron	O
1	O
in	O
the	O
transit	O
peptide	O
region	O
of	O
chloroplast	B
GAPDH	I
genes	I
(	O
GapA	B
and	O
GapB	B
)	O
of	O
higher	O
plants	O
.	O

TGF	B
beta	I
1	I
expression	O
is	O
largely	O
governed	O
by	O
three	O
AP	B
-	I
1	I
binding	I
sites	I
located	O
in	O
two	O
different	O
promoters	O
of	O
this	O
gene	O
.	O

The	O
therapeutic	O
action	O
of	O
cyclosporin	O
A	O
(	O
Sandimmun	O
):	O
its	O
application	O
in	O
rheumatoid	O
arthritis	O
.	O

Drug	O
effect	O
,	O
measured	O
as	O
postural	O
sway	O
,	O
was	O
also	O
similar	O
in	O
the	O
patients	O
with	O
cirrhosis	O
and	O
control	O
subjects	O
;	O
therefore	O
the	O
ratio	O
of	O
effect	O
area	O
under	O
the	O
curve	O
to	O
concentration	O
area	O
under	O
the	O
curve	O
,	O
a	O
measure	O
of	O
sensitivity	O
,	O
did	O
not	O
differ	O
significantly	O
between	O
the	O
patients	O
with	O
cirrhosis	O
and	O
the	O
control	O
subjects	O
.	O

We	O
present	O
evidence	O
that	O
YY1	B
,	O
a	O
ubiquitously	O
expressed	O
DNA	O
-	O
binding	O
protein	O
,	O
regulates	O
the	O
activity	O
of	O
the	O
c	B
-	I
fos	I
promoter	I
primarily	O
through	O
an	O
effect	O
on	O
DNA	O
structure	O
.	O

The	O
kinase	O
inhibitor	O
staurosporine	O
(	O
1	O
microM	O
)	O
blocks	O
LPA	O
-	O
induced	O
,	O
but	O
not	O
epidermal	O
growth	O
factor	O
-	O
induced	O
,	O
activation	O
of	O
p21ras	B
and	O
MAP	B
kinase	I
,	O
consistent	O
with	O
an	O
intermediate	O
protein	O
kinase	O
linking	O
the	O
LPA	B
receptor	I
to	O
p21ras	B
activation	O
.	O

The	O
survival	O
rate	O
at	O
forty	O
months	O
in	O
15	O
patients	O
with	O
N2	O
disease	O
who	O
underwent	O
R2b	O
operation	O
was	O
51	O
%.	O

G	O
.	O

When	O
Hy	O
-	O
Vac	O
SPF	O
type	O
V	O
embryos	O
were	O
exposed	O
to	O
either	O
0	O
.	O
20	O
ml	O
50	O
%	O
ethanol	O
in	O
CRS	O
or	O
to	O
0	O
.	O
20	O
ml	O
CRS	O
(	O
controls	O
),	O
ethanol	O
-	O
treated	O
embryos	O
showed	O
a	O
VSD	O
incidence	O
of	O
34	O
.	O
1	O
%	O
compared	O
with	O
a	O
3	O
.	O
6	O
%	O
incidence	O
in	O
the	O
controls	O
(	O
P	O
=	O
0	O
.	O
0017	O
).	O

Peripheral	O
vitreochorioretinal	O
dystrophies	O
in	O
myopia	O
patients	O

In	O
our	O
studies	O
,	O
we	O
utilized	O
HIV	O
-	O
1	O
HXB2	B
and	O
HIV	O
-	O
1	O
Z2Z6	B
core	I
enhancers	I
because	O
the	O
Z2Z6	B
strain	O
has	O
a	O
single	O
point	O
mutation	O
flanking	O
the	O
right	O
ETS	B
-	I
binding	I
site	I
.	O

The	O
secondary	O
,	O
but	O
not	O
the	O
primary	O
,	O
antibody	O
responses	O
of	O
male	O
C57Bl	O
/	O
6	O
mice	O
were	O
higher	O
among	O
mice	O
housed	O
alone	O
compared	O
to	O
mice	O
housed	O
in	O
groups	O
;	O
differences	O
were	O
observed	O
for	O
both	O
IgM	B
and	O
IgG	B
anti	I
-	I
KLH	I
antibodies	I
.	O

Other	O
parameters	O
of	O
iron	O
metabolism	O
,	O
including	O
ferritin	B
,	O
were	O
not	O
found	O
to	O
contribute	O
to	O
the	O
risk	O
.	O

Responses	O
to	O
the	O
Plowright	O
Rinderpest	O
vaccine	O
by	O
43	O
calves	O
and	O
70	O
adult	O
cattle	O
in	O
Uganda	O
in	O
1990	O
,	O
through	O
the	O
production	O
of	O
IgG	B
antibodies	I
,	O
were	O
monitored	O
for	O
4	O
weeks	O
using	O
the	O
ELISA	O
assay	O
.	O

Repression	O
is	O
alleviated	O
when	O
the	O
two	O
(	O
for	O
E2	B
)	O
or	O
three	O
(	O
for	O
E2	B
-	I
C	I
)	O
promoter	O
-	O
proximal	O
copies	O
of	O
E2	B
-	O
RS	O
are	O
mutated	O
.	O

Therefore	O
,	O
Mxi1	B
and	O
Mad	B
might	O
antagonize	O
Myc	B
function	O
and	O
are	O
candidate	O
tumor	O
suppressor	O
genes	O
.	O

Animal	O
age	O
and	O
sex	O
had	O
no	O
significant	O
effects	O
on	O
CSF	O
composition	O
,	O
but	O
serum	O
IgG	B
concentration	O
increased	O
with	O
age	O
.	O

Analysis	O
of	O
the	O
intact	O
hGH	B
gene	I
or	O
hGH	B
5	I
'-	I
flanking	I
DNA	I
(	I
5	I
'-	I
FR	I
)	I
coupled	O
to	O
the	O
hGh	B
cDNA	I
or	O
chloramphenicol	B
acetyltransferase	I
or	O
luciferase	B
genes	I
,	O
indicated	O
that	O
cAMP	O
primarily	O
stimulated	O
hGH	B
promoter	I
activity	O
.	O

This	O
distribution	O
parallels	O
that	O
of	O
the	O
neurotransmitters	O
glutamate	O
and	O
aspartate	O
;	O
however	O
,	O
neither	O
of	O
these	O
excitatory	O
amino	O
acids	O
is	O
a	O
substrate	O
for	O
transport	O
.	O

Praziquantel	O
and	O
Albendazole	O
were	O
found	O
effective	O
in	O
the	O
treatment	O
of	O
neurocysticercosis	O
,	O
but	O
because	O
of	O
serious	O
side	O
effects	O
encountered	O
in	O
some	O
cases	O
,	O
the	O
drugs	O
should	O
be	O
used	O
cautiously	O
in	O
selected	O
cases	O
only	O
.	O

Inhibition	O
of	O
erythromycin	O
synthesis	O
by	O
disruption	O
of	O
malonyl	B
-	I
coenzyme	I
A	I
decarboxylase	I
gene	I
eryM	I
in	O
Saccharopolyspora	O
erythraea	O
.	O

This	O
region	O
is	O
required	O
for	O
activation	O
of	O
DNA	O
binding	O
of	O
MyoD	B
and	O
E12	B
homodimers	I
and	O
E12	B
/	O
MyoD	B
heterodimers	O
.	O

Monospecific	O
antibodies	O
raised	O
against	O
rat	B
cytochrome	I
P	I
-	I
450	I
1A1	I
recognized	O
a	O
protein	O
in	O
the	O
hepatic	O
microsomes	O
of	O
the	O
double	O
-	O
crested	O
cormorant	O
,	O
and	O
also	O
in	O
those	O
of	O
the	O
great	O
blue	O
heron	O
(	O
Ardea	O
herodias	O
),	O
using	O
immunoblotting	O
.	O

In	O
the	O
present	O
report	O
,	O
66	O
hemochromatosis	O
families	O
yielding	O
151	O
hemochromatosis	O
chromosomes	O
and	O
182	O
normal	O
chromosomes	O
were	O
RFLP	O
-	O
typed	O
with	O
a	O
battery	O
of	O
probes	O
,	O
including	O
two	O
newly	O
derived	O
polymorphic	O
markers	O
from	O
the	O
6	O
.	O
7	O
and	O
HLA	B
-	I
F	I
loci	I
located	O
150	O
and	O
250	O
kb	O
telomeric	O
to	O
HLA	B
-	I
A	I
,	O
respectively	O
.	O

Pronounced	O
microangiopathy	O
characterized	O
by	O
avascular	O
fields	O
,	O
enlarged	O
and	O
tortuous	O
capillaries	O
and	O
increased	O
transcapillary	O
diffusion	O
of	O
sodium	O
fluorescein	O
,	O
was	O
clearly	O
demonstrable	O
in	O
the	O
area	O
of	O
the	O
nodules	O
.	O

Epigenetic	O
switching	O
of	O
transcriptional	O
states	O
:	O
cis	O
-	O
and	O
trans	O
-	O
acting	O
factors	O
affecting	O
establishment	O
of	O
silencing	O
at	O
the	O
HMR	B
locus	I
in	O
Saccharomyces	O
cerevisiae	O
.	O

The	O
two	O
methods	O
identify	O
the	O
same	O
patients	O
only	O
if	O
micturitional	O
pressures	O
are	O
normal	O
(	O
40	O
to	O
60	O
cmH2O	O
)	O
to	O
high	O
(	O
over	O
60	O
cmH2O	O
)	O
and	O
the	O
Sussett	O
formula	O
is	O
used	O
with	O
a	O
higher	O
(	O
95th	O
centile	O
)	O
cutoff	O
.	O

There	O
was	O
no	O
clear	O
correlation	O
between	O
the	O
MFA	O
and	O
the	O
severity	O
of	O
the	O
UTS	O
phenotype	O
.	O

Chicken	O
sterol	B
carrier	I
protein	I
2	I
/	O
sterol	B
carrier	I
protein	I
x	I
:	O
cDNA	O
cloning	O
reveals	O
evolutionary	O
conservation	O
of	O
structure	O
and	O
regulated	O
expression	O
.	O

These	O
lesions	O
were	O
asymptomatic	O
,	O
but	O
both	O
were	O
characterized	O
clinically	O
by	O
central	O
ulceration	O
.	O

Previous	O
studies	O
indicated	O
that	O
the	O
20S	B
proteasome	I
is	O
a	O
catalytic	O
core	O
of	O
the	O
26S	B
proteolytic	I
complex	I
that	O
possesses	O
a	O
latent	O
multicatalytic	O
proteinase	O
activity	O
and	O
catalyzes	O
an	O
ATP	O
-	O
dependent	O
,	O
selective	O
breakdown	O
of	O
proteins	O
ligated	O
to	O
ubiquitin	B
.	O

The	O
influence	O
of	O
a	O
high	O
ionic	O
strength	O
on	O
the	O
resolution	O
was	O
clearly	O
shown	O
.	O

The	O
number	O
of	O
bacteria	O
in	O
the	O
lung	O
,	O
peripheral	O
white	O
blood	O
cell	O
and	O
BAL	O
fluid	O
cell	O
also	O
decreased	O
by	O
the	O
administration	O
of	O
FN	B
.	O

GAP	B
-	I
N	I
bound	O
constitutively	O
to	O
p190	B
in	O
both	O
serum	O
-	O
deprived	O
and	O
growth	O
factor	O
-	O
stimulated	O
cells	O
.	O

Sequence	O
comparison	O
indicates	O
that	O
exons	O
5	O
'/	O
L	O
and	O
L	O
/	O
N	O
in	O
PSG12	B
and	O
PSG12	B
psi	I
are	O
99	O
%	O
identical	O
,	O
except	O
that	O
the	O
L	O
/	O
N	O
exon	O
in	O
the	O
PSG12	B
psi	I
gene	I
contains	O
a	O
stop	O
codon	O
.	O

We	O
recently	O
found	O
that	O
17	O
beta	O
-	O
estradiol	O
(	O
E2	O
)	O
not	O
only	O
suppresses	O
bone	O
resorption	O
but	O
also	O
stimulates	O
bone	O
formation	O
in	O
the	O
cancellous	O
bone	O
of	O
female	O
rats	O
.	O

Single	O
-	O
photon	O
emission	O
computed	O
tomography	O
(	O
SPECT	O
)	O
with	O
99mTc	O
-	O
hexamethylpropyleneamine	O
oxime	O
(	O
HMPAO	O
)	O
was	O
used	O
to	O
investigate	O
changes	O
in	O
cerebral	O
blood	O
flow	O
in	O
seven	O
patients	O
with	O
cortical	O
visual	O
impairment	O
.	O

2	O
-	O
AP	O
induced	O
marked	O
,	O
steady	O
rises	O
in	O
mRNA	O
accumulation	O
from	O
both	O
transfected	O
and	O
chromosomally	O
integrated	O
HIV	O
-	O
1	O
constructs	O
but	O
no	O
increases	O
from	O
an	O
endogenous	O
gene	O
encoding	O
gamma	B
-	I
actin	I
or	O
glucose	B
6	I
-	I
phosphate	I
dehydrogenase	I
.	O

The	O
UV	O
induction	O
of	O
c	B
-	I
jun	I
is	O
mediated	O
by	O
two	O
UV	O
response	O
elements	O
consisting	O
of	O
AP	B
-	I
1	I
-	I
like	I
sequences	I
within	O
its	O
5	O
'	O
control	O
region	O
.	O

ST	O
elevation	O
occurs	O
in	O
5	O
patients	O
(	O
55	O
.	O
5	O
%)	O
of	O
subgroup	O
A	O
and	O
in	O
no	O
patient	O
of	O
the	O
subgroup	O
B	O
.	O

HTLV	O
-	O
1	O
gene	O
expression	O
by	O
defective	O
proviruses	O
in	O
an	O
infected	O
T	O
-	O
cell	O
line	O
.	O

Most	O
importantly	O
,	O
the	O
addition	O
of	O
purified	O
17S	B
U2	I
snRNPs	I
,	O
but	O
not	O
of	O
12S	B
U2	I
snRNPs	I
,	O
to	O
HeLa	O
splicing	O
extracts	O
in	O
which	O
the	O
endogeneous	B
U2	I
snRNPs	I
have	O
been	O
functionally	O
neutralized	O
with	O
anti	B
-	I
PRP9	I
antibodies	I
fully	O
restores	O
the	O
mRNA	O
-	O
splicing	O
activity	O
of	O
the	O
extracts	O
.	O

Differences	O
in	O
profiles	O
of	O
viscosity	O
variables	O
between	O
subgroups	O
of	O
EAD	O
in	O
RA	O
patients	O
were	O
observed	O
.	O

Dissipation	O
of	O
claudication	O
pain	O
after	O
walking	O
:	O
implications	O
for	O
endurance	O
training	O
.	O

To	O
analyze	O
the	O
VH	O
regions	O
of	O
polyreactive	O
antibodies	O
,	O
with	O
particular	O
attention	O
at	O
their	O
somatically	O
mutated	O
status	O
,	O
we	O
generated	O
five	O
IgG	B
(	O
three	O
IgG1	B
and	O
two	O
IgG3	B
)	O
mAb	O
(	O
using	O
B	O
cells	O
from	O
a	O
healthy	O
subject	O
,	O
a	O
patient	O
with	O
insulin	B
-	O
dependent	O
diabetes	O
mellitus	O
and	O
a	O
patient	O
with	O
SLE	O
),	O
which	O
bound	O
with	O
various	O
efficiencies	O
a	O
number	O
of	O
different	O
self	O
and	O
foreign	O
Ag	O
.	O

The	O
7	O
-	O
kb	O
mRNA	O
differs	O
by	O
alternative	O
splicing	O
such	O
that	O
it	O
encodes	O
a	O
protein	O
with	O
a	O
distinct	O
amino	O
terminus	O
.	O

McCann	O
III	O
,	O
F	O
.	O

The	O
low	O
molecular	O
mass	O
polypeptide	O
complex	O
is	O
assumed	O
to	O
be	O
involved	O
in	O
antigen	O
presentation	O
,	O
generating	O
peptides	O
from	O
cytosolic	O
protein	O
antigens	O
,	O
which	O
are	O
subsequently	O
presented	O
to	O
cytotoxic	O
T	O
-	O
lymphocytes	O
on	O
the	O
cell	O
surface	O
.	O

Since	O
the	O
-	O
172	O
/-	O
148	O
element	O
also	O
conferred	O
estrogen	O
and	O
thyroid	O
hormone	O
responsiveness	O
,	O
it	O
can	O
be	O
considered	O
a	O
composite	O
hormone	O
response	O
element	O
.	O

All	O
four	O
of	O
the	O
genes	O
have	O
a	O
similar	O
structure	O
,	O
with	O
the	O
receptor	O
protein	O
encoded	O
in	O
a	O
single	O
exon	O
.	O

Identity	O
of	O
GABP	B
with	O
NRF	B
-	I
2	I
,	O
a	O
multisubunit	O
activator	O
of	O
cytochrome	B
oxidase	I
expression	O
,	O
reveals	O
a	O
cellular	O
role	O
for	O
an	O
ETS	B
domain	I
activator	O
of	O
viral	O
promoters	O
.	O

Nuclear	B
protein	I
phosphatase	I
2A	I
dephosphorylates	O
protein	B
kinase	I
A	I
-	O
phosphorylated	O
CREB	B
and	O
regulates	O
CREB	B
transcriptional	O
stimulation	O
.	O

In	O
contrast	O
to	O
the	O
situation	O
in	O
mammalian	O
cells	O
,	O
prolonged	O
exposure	O
of	O
the	O
agonist	O
(	O
24	O
h	O
)	O
does	O
not	O
result	O
in	O
down	O
regulation	O
of	O
the	O
remaining	O
70	O
%	O
of	O
the	O
receptors	O
.	O

Expression	O
in	O
established	O
LCLs	O
,	O
occurring	O
irrespective	O
of	O
virus	O
producer	O
status	O
,	O
was	O
not	O
a	O
consequence	O
of	O
continued	O
in	O
vitro	O
passage	O
;	O
thus	O
,	O
appropriately	O
spliced	O
BamHI	B
-	I
A	I
transcripts	I
could	O
be	O
amplified	O
from	O
normal	O
B	O
cells	O
within	O
1	O
day	O
of	O
their	O
experimental	O
infection	O
in	O
vitro	O
,	O
along	O
with	O
BamHI	B
-	I
C	I
/	I
W	I
promoter	O
-	O
initiated	O
but	O
not	O
BamHI	B
-	I
F	I
promoter	I
-	I
initiated	I
mRNAs	I
.	O

Losses	O
during	O
the	O
complete	O
procedure	O
are	O
corrected	O
for	O
using	O
radioactive	O
estrogen	O
conjugates	O
during	O
the	O
first	O
steps	O
and	O
later	O
by	O
adding	O
deuterated	O
internal	O
standards	O
of	O
all	O
compounds	O
measured	O
(	O
matairesinol	O
,	O
enterodiol	O
,	O
enterolactone	O
,	O
daidzein	O
,	O
O	O
-	O
desmethylangolensin	O
,	O
equol	O
,	O
and	O
genistein	O
).	O

Nuclear	O
localization	O
and	O
protein	O
sequence	O
similarities	O
suggested	O
that	O
the	O
SPT2	B
/	O
SIN1	B
protein	O
may	O
be	O
related	O
to	O
the	O
nonhistone	B
chromosomal	I
protein	I
HMG1	I
.	O

Liu	O
,	O
B	O
.	O

It	O
contains	O
three	O
putative	O
binding	O
sites	O
for	O
transcription	B
factor	I
Sp1	I
as	O
well	O
as	O
several	O
short	O
sequences	O
that	O
are	O
similar	O
to	O
known	O
cis	O
-	O
acting	O
enhancers	O
or	O
binding	O
sites	O
for	O
transcription	O
factors	O
.	O

When	O
introduced	O
into	O
recJ	B
+	I
strains	O
,	O
srjA	B
mutations	O
conferred	O
hyperrecombinational	O
and	O
hyper	B
-	I
UVr	I
phenotypes	O
.	O

Hops	O
,	O
and	O
L	O
.	O

Creutzfeldt	O
-	O
Jakob	O
disease	O
and	O
lyophilised	O
dura	O
mater	O
grafts	O
:	O
report	O
of	O
two	O
cases	O
.	O

These	O
results	O
indicate	O
that	O
Rb	B
protein	I
is	O
interacting	O
with	O
some	O
component	O
(	O
s	O
)	O
of	O
the	O
cell	O
cycle	O
-	O
regulatory	O
machinery	O
during	O
G2	O
phase	O
.	O

MDBP	B
from	O
HeLa	O
and	O
Raji	O
cells	O
formed	O
DNA	O
-	O
protein	O
complexes	O
with	O
X	O
-	O
box	O
oligonucleotides	O
that	O
coelectrophoresed	O
with	O
those	O
containing	O
standard	O
MDBP	B
sites	I
.	O

METHODS	O
:	O
Fifty	O
-	O
one	O
healthy	O
eyes	O
,	O
169	O
ocular	O
hypertensive	O
eyes	O
with	O
normal	O
visual	O
fields	O
,	O
and	O
132	O
glaucomatous	O
eyes	O
with	O
early	O
visual	O
field	O
defects	O
were	O
evaluated	O
with	O
qualitative	O
and	O
quantitative	O
measures	O
of	O
structural	O
damage	O
to	O
the	O
optic	O
nerve	O
and	O
nerve	O
fiber	O
layer	O
.	O

The	O
ADP	B
-	I
ribosylation	I
factor	I
(	O
ARF	B
)	O
family	O
is	O
one	O
of	O
four	O
subfamilies	O
of	O
the	O
RAS	B
superfamily	I
of	O
low	B
molecular	I
weight	I
GTP	I
-	I
binding	I
proteins	I
(	O
G	B
proteins	I
).	O

Instead	O
,	O
mRNA	O
of	O
2	O
.	O
0	O
and	O
2	O
.	O
8	O
kb	O
are	O
detected	O
in	O
varying	O
abundance	O
.	O

Mutations	O
truncating	O
as	O
many	O
as	O
143	O
C	O
-	O
terminal	O
residues	O
from	O
the	O
transcriptional	O
activator	O
encoded	O
by	O
the	O
areA	B
gene	I
,	O
mediating	O
nitrogen	O
metabolite	O
repression	O
in	O
Aspergillus	O
nidulans	O
,	O
do	O
not	O
significantly	O
reduce	O
the	O
ability	O
of	O
the	O
areA	B
product	I
to	O
activate	O
expression	O
of	O
most	O
genes	O
under	O
areA	B
control	O
.	O

The	O
amino	O
acid	O
sequence	O
alignment	O
of	O
TC	B
II	I
with	O
that	O
of	O
other	O
Cbl	B
binding	I
proteins	I
(	O
rat	B
intrinsic	I
factor	I
,	O
human	B
transcobalamin	I
I	I
and	O
porcine	B
haptocorrin	I
)	O
revealed	O
only	O
33	O
%	O
overall	O
homology	O
.	O

The	O
evaluation	O
was	O
performed	O
using	O
a	O
retrospective	O
study	O
design	O
with	O
newborn	O
blood	O
samples	O
from	O
three	O
screening	O
centres	O
.	O

These	O
studies	O
demonstrate	O
that	O
both	O
G	B
alpha	I
i	I
genes	I
are	O
dynamically	O
regulated	O
in	O
LLC	O
-	O
PK1	O
cells	O
by	O
both	O
growth	O
,	O
differentiation	O
,	O
and	O
hormone	O
signals	O
.	O

Constructs	O
containing	O
the	O
full	B
-	I
length	I
PfCPK	I
cDNA	I
have	O
been	O
expressed	O
in	O
Escherichia	O
coli	O
at	O
a	O
high	O
level	O
to	O
generate	O
a	O
60	O
-	O
kDa	O
recombinant	O
protein	O
.	O

When	O
ligated	O
to	O
the	O
proIL	B
-	I
1	I
beta	I
cap	I
site	I
-	I
proximal	I
region	I
(	O
located	O
between	O
-	O
131	O
to	O
+	O
12	O
),	O
both	O
the	O
proIL	B
-	I
1	I
beta	I
and	O
the	O
simian	B
virus	I
40	I
enhancer	I
elements	I
functioned	O
more	O
efficiently	O
in	O
monocytes	O
than	O
in	O
HeLa	O
cells	O
,	O
which	O
are	O
not	O
normally	O
competent	O
for	O
IL	B
-	I
1	I
beta	I
expression	O
.	O

We	O
have	O
isolated	O
and	O
characterized	O
the	O
GCD6	B
and	O
GCD7	B
genes	I
and	O
shown	O
that	O
their	O
products	O
are	O
required	O
to	O
repress	O
GCN4	B
translation	O
under	O
nonstarvation	O
conditions	O
.	O

The	O
SCH9	B
protein	I
kinase	I
mRNA	I
contains	O
a	O
long	O
5	O
'	O
leader	O
with	O
a	O
small	O
open	O
reading	O
frame	O
.	O

Zinc	O
fingers	O
(	O
Zf	O
)	O
are	O
a	O
common	O
structural	O
motif	O
found	O
in	O
many	O
nucleic	O
acid	O
-	O
binding	O
proteins	O
.	O

Type	O
II	O
could	O
be	O
divided	O
further	O
into	O
two	O
forms	O
(	O
IIA	O
and	O
IIB	O
)	O
that	O
may	O
represent	O
two	O
underscribed	O
species	O
or	O
developmental	O
stages	O
of	O
the	O
same	O
species	O
.	O

Endosonography	O
accurately	O
assessed	O
tumor	O
extension	O
in	O
two	O
T2	O
tumors	O
,	O
14	O
T3	O
tumors	O
,	O
and	O
seven	O
T4	O
tumors	O
.	O

The	O
method	O
involves	O
preliminary	O
isolation	O
of	O
oxiracetam	O
and	O
internal	O
standard	O
from	O
plasma	O
by	O
solid	O
-	O
phase	O
extraction	O
prior	O
to	O
the	O
formation	O
of	O
their	O
n	O
-	O
propyl	O
carbamate	O
derivatives	O
.	O

Initial	O
results	O
indicate	O
that	O
this	O
23S	B
pre	I
-	I
rRNA	I
is	O
the	O
same	O
as	O
the	O
species	O
detected	O
on	O
depletion	O
of	O
the	O
small	B
nucleolar	I
RNA	I
-	I
associated	I
proteins	I
NOP1	I
and	O
GAR1	B
and	O
in	O
an	O
snr10	B
mutant	I
strain	O
.	O

Estradiol	O
is	O
known	O
to	O
induce	O
expression	O
of	O
certain	O
proto	O
-	O
oncogenes	O
,	O
and	O
this	O
led	O
us	O
to	O
examine	O
potential	O
regulatory	O
regions	O
of	O
the	O
cellular	B
c	I
-	I
fos	I
oncogene	I
.	O

5	O
micrograms	O
/	O
l	O
was	O
detected	O
in	O
urine	O
from	O
some	O
non	O
-	O
occupationally	O
exposed	O
persons	O
.	O

This	O
was	O
performed	O
in	O
a	O
double	O
blinded	O
,	O
randomized	O
,	O
placebo	O
-	O
controlled	O
study	O
.	O

Effects	O
of	O
intramammary	O
endotoxin	O
infusion	O
on	O
milking	O
-	O
induced	O
oxytocin	B
release	O
.	O

Further	O
evidence	O
for	O
a	O
clustered	O
organization	O
of	O
FAX	B
-	O
ZFP	B
transcription	O
units	O
is	O
provided	O
by	O
Southern	O
blot	O
analysis	O
of	O
large	O
genomic	O
restriction	O
fragments	O
separated	O
by	O
transverse	O
field	O
gel	O
electrophoresis	O
,	O
and	O
by	O
in	O
situ	O
hybridization	O
on	O
intact	O
chromosomes	O
.	O

We	O
obtained	O
the	O
prevalence	O
of	O
IgG	B
antibodies	I
against	O
Trypanosoma	O
cruzi	O
among	O
1076	O
blood	O
donors	O
at	O
the	O
Instituto	O
Nacional	O
de	O
Cardiologia	O
"	O
Ignacio	O
Chavez	O
"	O
in	O
Mexico	O
City	O
.	O

Examination	O
of	O
the	O
immediate	O
sequence	O
5	O
'	O
to	O
the	O
mRNA	O
start	O
site	O
reveals	O
no	O
TATA	O
box	O
and	O
multiple	O
known	O
enhancer	O
sequences	O
.	O

The	O
short	O
-	O
term	O
synthesis	O
and	O
infant	O
-	O
regulated	O
removal	O
of	O
milk	O
in	O
lactating	O
women	O
.	O

Bipolarity	O
in	O
Jungian	O
type	O
theory	O
and	O
the	O
Myers	O
-	O
Briggs	O
Type	O
Indicator	O
.	O

This	O
may	O
account	O
,	O
at	O
least	O
in	O
part	O
,	O
for	O
the	O
ability	O
of	O
excess	O
wt	B
p53	I
to	O
inhibit	O
cell	O
proliferation	O
and	O
to	O
interfere	O
with	O
neoplastic	O
processes	O
.	O

Neither	O
clone	O
encoded	O
the	O
cognate	O
endonuclease	O
.	O

Northern	O
blot	O
analysis	O
of	O
total	O
cellular	O
RNA	O
indicated	O
that	O
xylP	B
encodes	O
a	O
1	O
.	O
3	O
-	O
kb	O
transcript	O
which	O
is	O
induced	O
by	O
xylan	O
.	O

These	O
data	O
show	O
that	O
PTH	B
and	O
cAMP	O
can	O
repress	O
collagen	B
promoter	I
activity	O
in	O
calvariae	O
from	O
transgenic	O
mice	O
,	O
suggesting	O
that	O
the	O
alpha	B
1	I
(	I
I	I
)	I
collagen	I
promoter	I
may	O
contain	O
cis	O
elements	O
down	O
-	O
stream	O
of	O
-	O
2	O
.	O
3	O
kilobases	O
that	O
mediate	O
PTH	B
and	O
cAMP	O
repression	O
of	O
collagen	B
gene	I
expression	O
in	O
bone	O
.	O

The	O
alpha	O
-	O
subunit	O
by	O
itself	O
binds	O
to	O
telomeric	O
DNA	O
.	O

We	O
conclude	O
that	O
the	O
alpha	O
-	O
subunit	O
of	O
the	O
telomere	B
-	I
binding	I
protein	I
,	O
like	O
many	O
transcription	O
factors	O
,	O
has	O
separable	O
DNA	O
-	O
binding	O
and	O
protein	O
-	O
protein	O
interaction	O
domains	O
.	O

The	O
active	O
open	O
reading	O
frame	O
in	O
the	O
clone	O
maps	O
at	O
27	O
min	O
on	O
the	O
E	O
.	O
coli	O
chromosome	O
and	O
is	O
identical	O
in	O
sequence	O
to	O
a	O
wild	O
type	O
counterpart	O
.	O

Subsequent	O
cloning	O
and	O
nucleotide	O
sequence	O
analysis	O
of	O
the	O
S	B
.	I
pombe	I
adenylate	I
kinase	I
gene	I
,	O
adk1	B
,	O
revealed	O
a	O
coding	O
region	O
of	O
660	O
nucleotides	O
.	O

However	O
,	O
essential	O
contrast	O
differences	O
existing	O
between	O
the	O
FSE	O
sequences	O
and	O
their	O
routine	O
asymmetric	O
dual	O
SE	O
counterpart	O
can	O
be	O
identified	O
.	O

The	O
gene	O
encoding	O
the	O
receptor	O
for	O
macrophage	B
colony	I
-	I
stimulating	I
factor	I
1	I
(	O
CSF	B
-	I
1	I
),	O
the	O
c	B
-	I
fms	I
protooncogene	I
,	O
is	O
selectively	O
expressed	O
in	O
immature	O
and	O
mature	O
mononuclear	O
phagocytes	O
and	O
trophoblasts	O
.	O

Maximum	O
number	O
of	O
strains	O
(	O
39	O
.	O
1	O
%)	O
were	O
resistant	O
in	O
S	O
.	O
bareilly	O
serotype	O
,	O
followed	O
by	O
S	O
.	O
typhimurium	O
(	O
21	O
.	O
7	O
%)	O
and	O
least	O
in	O
S	O
.	O
typhi	O
(	O
17	O
.	O
4	O
%).	O

In	O
mammalian	O
cells	O
,	O
phosphorylation	O
of	O
eIF	B
-	I
2	I
alpha	I
inhibits	O
the	O
activity	O
of	O
eIF	B
-	I
2B	I
,	O
the	O
GDP	B
-	I
GTP	I
exchange	I
factor	I
for	O
eIF	B
-	I
2	I
.	O

Analysis	O
of	O
the	O
binding	O
of	O
Lrp	B
to	O
a	O
set	O
of	O
circularly	O
permuted	O
DNA	O
fragments	O
from	O
this	O
region	O
indicates	O
that	O
Lrp	B
induces	O
DNA	O
bending	O
.	O

The	O
patients	O
were	O
divided	O
into	O
ischaemia	O
and	O
non	O
-	O
ischaemia	O
groups	O
on	O
the	O
basis	O
of	O
the	O
change	O
in	O
lactate	O
extraction	O
ratio	O
during	O
balloon	O
inflation	O
.	O

The	O
first	O
involved	O
complementation	O
of	O
a	O
nonphotosynthetic	O
mutant	O
of	O
Chlamydomonas	O
,	O
CC	O
-	O
2341	O
(	O
ac	O
-	O
u	O
-	O
g	O
-	O
2	O
.	O
3	O
),	O
which	O
has	O
a	O
frameshift	O
mutation	O
in	O
the	O
psaB	B
gene	I
,	O
and	O
selection	O
of	O
photosynthetic	O
transformants	O
on	O
minimal	O
medium	O
.	O

Here	O
,	O
we	O
have	O
more	O
closely	O
investigated	O
transactivation	O
of	O
the	O
human	B
HSP70	I
promoter	I
by	O
Myb	B
proteins	I
.	O

We	O
have	O
found	O
out	O
that	O
one	O
-	O
year	O
-	O
old	O
carps	O
are	O
extremely	O
sensitive	O
to	O
ichthiomycin	O
in	O
concentrations	O
between	O
25	O
-	O
125	O
micrograms	O
/	O
dm3	O
.	O

The	O
GTPase	B
activity	O
of	O
CDC42Ce	B
is	O
moderately	O
stimulated	O
by	O
human	B
n	I
-	I
chimaerin	I
,	O
a	O
GTPase	B
-	I
activating	I
protein	I
for	O
the	O
related	O
p21	B
rac1	I
.	O

Tl	O
-	O
201	O
uptake	O
ratio	O
of	O
the	O
right	O
ventricle	O
,	O
which	O
represents	O
the	O
ratio	O
of	O
total	O
counts	O
of	O
the	O
right	O
ventricle	O
to	O
counts	O
of	O
the	O
administered	O
dose	O
of	O
Tl	O
-	O
201	O
,	O
was	O
higher	O
in	O
COPD	O
,	O
especially	O
in	O
pulmonary	O
emphysema	O
and	O
B	O
type	O
COPD	O
by	O
Burrows	O
classification	O
than	O
in	O
controls	O
.	O

A	O
second	O
hydrophobic	O
domain	O
,	O
bordered	O
by	O
two	O
hydrophilic	O
regions	O
strongly	O
suggests	O
a	O
transmembrane	O
region	O
.	O

This	O
gene	O
spans	O
23	O
kb	O
and	O
is	O
composed	O
of	O
five	O
exons	O
and	O
four	O
introns	O
.	O

The	O
5	O
'	O
flanking	O
regions	O
of	O
both	O
pelA	B
and	O
pelB	B
were	O
translationally	O
fused	O
to	O
the	O
beta	B
-	I
glucuronidase	I
gene	I
and	O
introduced	O
into	O
F	O
.	O
solani	O
f	O
.	O
sp	O
.	O
pisi	O
,	O
and	O
beta	B
-	I
glucuronidase	I
activities	O
of	O
the	O
transformants	O
were	O
measured	O
.	O

The	O
human	B
papillomavirus	I
type	I
16	I
E7	I
protein	I
complements	O
adenovirus	B
type	I
5	I
E1A	I
amino	O
-	O
terminus	O
-	O
dependent	O
transactivation	O
of	O
adenovirus	B
type	I
5	I
early	I
genes	I
and	O
increases	O
ATF	B
and	O
Oct	B
-	I
1	I
DNA	O
binding	O
activity	O
.	O

A	O
chaotropic	O
detergent	O
,	O
0	O
.	O
1	O
%	O
Nonidet	O
P	O
-	O
40	O
,	O
also	O
abolished	O
the	O
interaction	O
,	O
further	O
supporting	O
the	O
hydrophobic	O
nature	O
of	O
the	O
interaction	O
.	O

Degradation	O
of	O
the	O
soybean	B
ribulose	I
-	I
1	I
,	I
5	I
-	I
bisphosphate	I
carboxylase	I
small	I
-	I
subunit	I
mRNA	I
,	O
SRS4	B
,	O
initiates	O
with	O
endonucleolytic	O
cleavage	O
.	O

Similarly	O
,	O
expression	O
of	O
a	O
transiently	O
transfected	O
wild	B
-	I
type	I
prothymosin	I
alpha	I
gene	I
as	O
the	O
reporter	O
was	O
not	O
affected	O
by	O
a	O
repertoire	O
of	O
myc	B
-	I
derived	I
genes	I
,	O
including	O
myc	B
itself	O
and	O
dominant	O
or	O
recessive	O
negative	O
myc	B
mutants	I
.	O

The	O
skp1	B
+	I
gene	I
is	O
not	O
essential	O
.	O

The	O
TEA1	B
(	O
Ty	B
enhancer	I
activator	I
)	O
gene	O
sequence	O
predicts	O
a	O
protein	O
of	O
86	O
.	O
9	O
kDa	O
whose	O
N	O
terminus	O
contains	O
a	O
zinc	O
cluster	O
and	O
dimerization	O
motif	O
typical	O
of	O
the	O
Gal4	B
-	I
type	I
family	I
of	O
DNA	O
-	O
binding	O
proteins	O
.	O

Comparison	O
of	O
promoters	O
repressed	O
by	O
c	B
-	I
myc	I
reveals	O
a	O
weak	O
consensus	O
sequence	O
of	O
the	O
initiator	O
(	O
Inr	O
)	O
element	O
:	O
TCA	O
(+	O
1	O
)	O
YYYNY	O
.	O

Transfection	O
analyses	O
indicate	O
that	O
mutation	O
of	O
any	O
one	O
of	O
these	O
TGACCT	O
motifs	O
or	O
truncation	O
of	O
the	O
entire	O
HD	B
PPRE	O
into	O
a	O
separate	O
DR1	O
and	O
DR2	O
element	O
significantly	O
reduced	O
the	O
transcriptional	O
response	O
of	O
HD	B
PPRE	O
to	O
peroxisome	O
proliferators	O
.	O

Unlike	O
ARF	B
,	O
the	O
ARP	B
immunoreactivity	O
was	O
detected	O
in	O
plasma	O
membranes	O
but	O
not	O
in	O
cytosol	O
of	O
fractionated	O
3T3	O
-	O
L1	O
cells	O
.	O

In	O
particular	O
,	O
the	O
highly	O
expressed	O
ADH1	B
gene	I
is	O
represented	O
in	O
this	O
database	O
by	O
no	O
less	O
than	O
20	O
EST	O
sequences	O
.	O

The	O
subjects	O
from	O
the	O
two	O
regions	O
with	O
a	O
higher	O
pollution	O
level	O
had	O
lower	O
FVC	O
and	O
FEV1	O
values	O
than	O
those	O
from	O
the	O
Viskovo	O
region	O
.	O

All	O
three	O
NR	B
isoforms	O
are	O
expressed	O
in	O
cv	O
.	O

The	O
Arabidopsis	B
FAD7	I
gene	I
encodes	O
a	O
chloroplast	B
omega	I
-	I
3	I
fatty	I
acid	I
desaturase	I
that	O
catalyzes	O
the	O
desaturation	O
of	O
lipid	O
-	O
linked	O
dienoic	O
fatty	O
acids	O
(	O
18	O
:	O
2	O
and	O
16	O
:	O
2	O
).	O

A	O
human	O
recombinant	O
cDNA	O
clone	O
that	O
encoded	O
253	O
amino	O
acids	O
residues	O
of	O
a	O
zinc	B
-	I
finger	I
protein	I
(	O
THZif	B
-	I
1	I
)	O
was	O
cloned	O
by	O
screening	O
a	O
cDNA	O
library	O
prepared	O
from	O
human	O
promyelocytic	O
leukemia	O
HL60	O
cells	O
with	O
synthetic	O
oligodeoxynucleotide	O
probes	O
that	O
corresponded	O
to	O
the	O
amino	O
acid	O
sequences	O
of	O
tryptic	O
peptides	O
derived	O
from	O
the	O
DNA	O
-	O
binding	O
protein	O
specific	O
for	O
the	O
nuclease	B
-	I
hypersensitive	I
element	I
(	O
NHE	B
)	O
of	O
the	O
human	B
c	I
-	I
myc	I
gene	I
.	O

There	O
is	O
no	O
TATA	O
box	O
around	O
the	O
transcriptional	O
start	O
points	O
(	O
tsp	O
),	O
as	O
determined	O
by	O
primer	O
extension	O
analysis	O
.	O

According	O
to	O
the	O
investigation	O
,	O
the	O
recent	O
burst	O
of	O
pseudoterranovosis	O
in	O
this	O
area	O
can	O
be	O
attributed	O
to	O
the	O
increased	O
presence	O
of	O
sea	O
lions	O
,	O
which	O
proliferate	O
in	O
the	O
Arctic	O
region	O
,	O
then	O
migrate	O
to	O
the	O
northern	O
Japan	O
Sea	O
and	O
eat	O
the	O
intermediate	O
host	O
fish	O
.	O

Characterization	O
of	O
an	O
EcR	B
/	O
USP	B
heterodimer	O
target	O
site	O
that	O
mediates	O
ecdysone	O
responsiveness	O
of	O
the	O
Drosophila	B
Lsp	I
-	I
2	I
gene	I
.	O

Thus	O
,	O
SPECT	O
was	O
not	O
as	O
sensitive	O
as	O
PET	O
in	O
this	O
activation	O
task	O
.	O

By	O
comparing	O
the	O
abundances	O
of	O
many	O
yeast	O
transcripts	O
in	O
isogenic	O
wild	O
-	O
type	O
and	O
paf1	B
mutant	I
strains	O
,	O
we	O
have	O
identified	O
genes	O
whose	O
expression	O
is	O
affected	O
by	O
PAF1	B
.	O

Molecular	O
characterization	O
of	O
malignant	O
melanoma	O
of	O
soft	O
parts	O
or	O
soft	O
tissue	O
clear	O
cell	O
sarcoma	O
which	O
shares	O
t	O
(	O
12	O
;	O
22	O
)	O
chromosome	O
translocation	O
revealed	O
fusion	O
of	O
EWS	B
with	O
a	O
transcriptional	O
factor	O
gene	B
ATF	I
-	I
1	I
.	O

A	O
short	O
open	O
reading	O
frame	O
(	O
ORF2	O
),	O
of	O
unknown	O
function	O
,	O
is	O
present	O
in	O
all	O
FIV	O
isolates	O
.	O

Human	B
LAF	I
-	I
4	I
readily	O
hybridized	O
with	O
genes	O
in	O
mouse	O
and	O
chicken	O
,	O
thus	O
showing	O
that	O
this	O
gene	O
family	O
has	O
been	O
highly	O
conserved	O
during	O
vertebrate	O
evolution	O
.	O

Although	O
a	O
great	O
deal	O
is	O
understood	O
about	O
how	O
bHLH	B
factors	I
activate	O
gene	O
transcription	O
via	O
E	O
-	O
box	O
DNA	O
consensus	O
sequences	O
,	O
studies	O
of	O
bHLH	B
factor	I
function	O
in	O
higher	O
eukaryotes	O
often	O
have	O
been	O
hindered	O
by	O
the	O
presence	O
of	O
multiple	O
family	O
members	O
.	O

Mobility	O
and	O
supershift	O
assays	O
demonstrated	O
that	O
upstream	B
stimulatory	I
factor	I
(	O
USF	B
)	O
and	O
Sp1	B
bind	O
to	O
the	O
former	O
elements	O
and	O
competition	O
experiments	O
confirmed	O
that	O
CREB	B
/	O
ATF	B
and	O
AP	B
-	I
1	I
bind	O
to	O
the	O
CRE	O
/	O
TRE	O
element	O
.	O

Strontium	O
chloride	O
Sr	O
89	O
is	O
costly	O
,	O
but	O
preliminary	O
analysis	O
indicates	O
that	O
it	O
may	O
reduce	O
management	O
expenditures	O
overall	O
.(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

We	O
propose	O
that	O
epigenetic	O
features	O
of	O
tissue	O
-	O
specific	O
control	O
and	O
of	O
the	O
control	O
of	O
allelic	O
expression	O
are	O
intricately	O
linked	O
.	O

We	O
propose	O
that	O
CTS1	B
and	I
CTS2	I
of	I
Ci	I
are	O
members	O
of	O
two	O
distinct	O
classes	O
of	O
fungal	B
chitinases	I
,	O
an	O
observation	O
not	O
previously	O
reported	O
for	O
a	O
single	O
fungus	O
.	O

A	O
mutant	B
areA	I
product	I
truncated	O
immediately	O
after	O
the	O
last	O
residue	O
of	O
the	O
highly	O
conserved	O
GATA	B
(	I
DNA	I
-	I
binding	I
)	I
domain	I
retains	O
partial	O
function	O
.	O

Oligonucleotides	O
,	O
designed	O
on	O
the	O
basis	O
of	O
conserved	O
flanking	O
amino	O
acid	O
sequence	O
segments	O
within	O
the	O
catalytic	O
domain	O
of	O
eukaryotic	B
protein	I
kinase	I
C	I
(	O
PKC	B
)	O
proteins	O
,	O
were	O
used	O
as	O
primers	O
for	O
polymerase	O
chain	O
reactions	O
to	O
amplify	O
a	O
427	O
-	O
bp	O
chromosomal	O
DNA	O
fragment	O
from	O
the	O
filamentous	O
fungus	O
Trichoderma	O
reesei	O
.	O

These	O
primers	O
yielded	O
a	O
PCR	O
product	O
of	O
a	O
characteristic	O
length	O
within	O
most	O
Xanthomonas	O
species	O
and	O
pathovars	O
tested	O
.	O

RNase	B
protection	O
assays	O
revealed	O
a	O
correlation	O
between	O
the	O
levels	O
of	O
dorsal	O
and	O
ventral	O
skin	O
expression	O
with	O
pigmentation	O
/	O
phaeomelanin	O
phenotypes	O
.	O

To	O
elucidate	O
the	O
functional	O
significance	O
of	O
Fyn	B
in	O
the	O
expression	O
of	O
viral	O
promoters	O
,	O
we	O
transfected	O
a	O
Fyn	B
-	O
expression	O
vector	O
together	O
with	O
a	O
reporter	O
plasmid	O
containing	O
the	O
chloramphenicol	B
acetyltransferase	I
gene	I
driven	O
by	O
HIV	B
LTR	I
into	O
a	O
human	O
T	O
cell	O
line	O
,	O
Jurkat	O
.	O

These	O
studies	O
indicate	O
that	O
the	O
acidimetric	O
test	O
was	O
less	O
sensitive	O
than	O
the	O
chromogenic	O
cephalosporin	O
substrates	O
and	O
that	O
nitrocefin	O
and	O
S1	O
could	O
be	O
used	O
to	O
screen	O
for	O
beta	B
-	I
lactamase	I
production	O
in	O
these	O
tested	O
species	O
.	O

Sixty	O
-	O
five	O
patients	O
(	O
aged	O
between	O
3	O
years	O
5	O
months	O
and	O
60	O
years	O
)	O
suffering	O
from	O
medically	O
resistant	O
temporal	O
lobe	O
epilepsy	O
(	O
TLE	O
)	O
were	O
operated	O
on	O
over	O
a	O
period	O
of	O
33	O
months	O
in	O
Bethel	O
Epilepsy	O
Center	O
.	O

Significant	O
correlations	O
existed	O
between	O
FEV1	O
and	O
the	O
corresponding	O
values	O
of	O
Raw	O
,	O
MEF50	O
and	O
MEF25	O
,	O
although	O
there	O
were	O
considerable	O
individual	O
differences	O
between	O
test	O
results	O
.	O

Occupational	O
exposure	O
to	O
hepatitis	O
B	O
virus	O
and	O
human	O
immunodeficiency	O
virus	O
:	O
a	O
comparative	O
risk	O
analysis	O
.	O

Hybrid	O
female	O
mice	O
(	O
C57BL	O
x	O
CBA	O
)	O
were	O
paired	O
with	O
breeder	O
males	O
(	O
CD	O
-	O
1	O
)	O
and	O
LNG	O
pellets	O
were	O
implanted	O
on	O
day	O
0	O
,	O
the	O
day	O
on	O
which	O
copulation	O
plugs	O
were	O
found	O
,	O
or	O
on	O
day	O
2	O
or	O
day	O
3	O
in	O
the	O
postcoital	O
period	O
.	O

This	O
gene	O
encodes	O
a	O
putative	O
transcription	O
factor	O
with	O
regions	O
of	O
homology	O
to	O
several	O
other	O
proteins	O
including	O
the	O
zinc	O
fingers	O
and	O
other	O
domains	O
of	O
the	O
Drosophila	B
trithorax	I
gene	I
product	I
,	O
and	O
the	O
"	O
AT	O
-	O
hook	O
"	O
DNA	O
-	O
binding	O
motif	O
of	O
high	B
mobility	I
group	I
proteins	I
.	O

The	O
purified	O
recombinant	O
enzyme	O
catalyzed	O
specific	O
phosphoryl	O
transfer	O
from	O
ATP	O
to	O
UMP	O
and	O
CMP	O
.	O

In	O
nondiabetics	O
the	O
response	O
of	O
tcPO2	O
but	O
not	O
of	O
LDF	O
was	O
influenced	O
by	O
the	O
values	O
at	O
rest	O
.	O

This	O
study	O
proposes	O
an	O
estimator	O
for	O
such	O
global	O
synchronizing	O
effects	O
upon	O
unit	O
-	O
pair	O
correlations	O
based	O
on	O
local	O
field	O
potentials	O
(	O
LFPs	O
).	O

The	O
DNA	O
sequences	O
upstream	O
of	O
these	O
termini	O
exhibit	O
homology	O
to	O
plant	O
mitochondrial	O
-	O
processing	O
sites	O
,	O
therefore	O
the	O
proximal	O
5	O
'	O
ends	O
are	O
most	O
probably	O
generated	O
by	O
RNA	O
processing	O
.	O

Curing	O
shrinkage	O
and	O
volumetric	O
changes	O
of	O
resin	O
-	O
modified	O
glass	O
ionomer	O
restorative	O
materials	O
.	O

Our	O
data	O
suggest	O
that	O
trans	O
-	O
activation	O
from	O
the	O
prothymosin	B
intron	I
enhancer	I
is	O
a	O
faithful	O
reflection	O
of	O
the	O
transforming	O
properties	O
of	O
the	O
Myc	B
protein	I
.	O

Carboxy	O
-	O
terminal	O
Spc110p	B
truncations	O
lacking	O
the	O
calmodulin	B
binding	O
site	O
can	O
support	O
growth	O
and	O
are	O
also	O
phosphorylated	O
in	O
a	O
cell	O
cycle	O
-	O
specific	O
manner	O
.	O

Both	O
EWS	B
-	O
FLI	B
-	I
1	I
and	O
FLI	B
-	I
1	I
proteins	I
function	O
as	O
transcription	O
factors	O
that	O
bind	O
specifically	O
to	O
ets	B
sequences	O
(	O
the	O
ets	B
boxes	O
)	O
present	O
in	O
promoter	O
elements	O
.	O

In	O
electromobility	O
shift	O
assays	O
,	O
EWS	B
-	O
FLI	B
-	I
1	I
binding	O
to	O
the	O
SRE	O
is	O
detectable	O
in	O
the	O
absence	O
of	O
SRF	B
whereas	O
the	O
binding	O
of	O
FLI	B
-	I
1	I
is	O
not	O
,	O
suggesting	O
that	O
the	O
interaction	O
with	O
DNA	O
is	O
the	O
step	O
which	O
limits	O
ternary	O
complex	O
formation	O
by	O
FLI	B
-	I
1	I
.	O

Additional	O
studies	O
with	O
new	O
and	O
reprocessed	O
regenerated	O
cellulose	O
dialyzers	O
comparing	O
450	O
and	O
220	O
mL	O
/	O
min	O
blood	O
flow	O
rates	O
at	O
10	O
minutes	O
showed	O
no	O
change	O
in	O
BTG	O
.	O

The	O
viral	B
LTR	I
was	O
used	O
as	O
the	O
promoter	O
.	O

Although	O
some	O
residues	O
are	O
found	O
reactive	O
toward	O
dimethylsulphate	O
and	O
kethoxal	O
in	O
regions	O
predicted	O
to	O
be	O
unpaired	O
by	O
the	O
phylogenetic	O
secondary	O
structure	O
model	O
of	O
4	B
.	I
5S	I
RNA	I
,	O
generally	O
the	O
reactivity	O
is	O
low	O
,	O
and	O
some	O
residues	O
in	O
internal	O
loops	O
are	O
not	O
reactive	O
at	O
all	O
.	O

Ongoing	O
and	O
future	O
investigations	O
may	O
better	O
define	O
the	O
optimal	O
approach	O
for	O
local	O
control	O
,	O
the	O
optimal	O
duration	O
of	O
maintenance	O
chemotherapy	O
,	O
and	O
the	O
possible	O
role	O
of	O
biologic	O
response	O
modifiers	O
and	O
growth	O
factors	O
in	O
further	O
improving	O
the	O
outcome	O
for	O
patients	O
with	O
this	O
disease	O
.	O

The	O
two	O
different	O
phosphoforms	O
of	O
STAT5	B
have	O
identical	O
in	O
vitro	O
DNA	O
binding	O
specificity	O
and	O
reactivity	O
with	O
tyrosine	O
phosphopeptides	O
,	O
but	O
differ	O
in	O
their	O
cellular	O
localization	O
.	O

TNF	B
Treatment	O
of	O
cell	O
activated	O
the	O
p38	B
MAP	I
kinase	I
pathway	O
,	O
as	O
revealed	O
by	O
increased	O
phosphorylation	O
of	O
p38	B
MAP	I
kinase	I
itself	O
,	O
activation	O
of	O
the	O
substrate	O
protein	O
MAPKAP	B
kinase	I
-	I
2	I
,	O
and	O
culminating	O
in	O
the	O
phosphorylation	O
of	O
the	O
heat	B
shock	I
protein	I
27	I
(	O
hsp27	B
).	O

In	O
contrast	O
to	O
the	O
selective	O
expression	O
of	O
the	O
receptor	O
,	O
FL	B
expression	O
was	O
detected	O
in	O
90	O
-	O
100	O
%	O
of	O
the	O
various	O
cell	O
types	O
of	O
leukemia	O
cell	O
lines	O
from	O
all	O
hematopoietic	O
cell	O
lineages	O
.	O

We	O
measured	O
serum	B
hepatocyte	I
growth	I
factor	I
(	O
HGF	B
)	O
in	O
patients	O
with	O
acute	O
myocardial	O
infarction	O
,	O
angina	O
pectoris	O
,	O
and	O
other	O
heart	O
diseases	O
.	O

In	O
addition	O
,	O
anti	B
-	I
phosphotyrosine	I
antibodies	I
immunoprecipitated	O
80K	B
-	I
H	I
from	O
cell	O
lysates	O
of	O
FGF	B
-	O
stimulated	O
but	O
not	O
from	O
control	O
fibroblasts	O
.	O

Thus	O
,	O
hGRbeta	B
potentially	O
functions	O
as	O
a	O
dominant	O
negative	O
inhibitor	O
of	O
hGRalpha	B
activity	O
.	O

Gas6	B
contains	O
an	O
NH2	O
-	O
terminal	O
Gla	O
domain	O
followed	O
by	O
four	O
epidermal	B
growth	I
factor	I
-	I
like	I
repeats	I
and	O
tandem	O
globular	O
(	O
G	O
)	O
domains	O
.	O

Polymerization	O
of	O
neurofilament	B
L	I
protein	I
in	O
vitro	O
was	O
inhibited	O
by	O
phosphorylation	O
of	O
neurofilament	B
L	I
protein	I
by	O
PKN	B
.	O

We	O
and	O
others	O
have	O
demonstrated	O
that	O
the	O
c	B
-	I
cbl	I
proto	I
-	I
oncogene	I
product	I
is	O
one	O
of	O
the	O
earliest	O
targets	O
of	O
tyrosine	O
phosphorylation	O
upon	O
T	B
cell	I
receptor	I
stimulation	O
.	O

An	O
AP	B
-	I
1	I
binding	I
sequence	I
is	O
essential	O
for	O
regulation	O
of	O
the	O
human	B
alpha2	I
(	I
I	I
)	I
collagen	I
(	O
COL1A2	B
)	O
promoter	O
activity	O
by	O
transforming	B
growth	I
factor	I
-	I
beta	I
.	O

Conversely	O
,	O
when	O
VDR	B
is	O
overexpressed	O
,	O
vitamin	O
D3	O
attenuates	O
9	O
-	O
cis	O
RA	O
induction	O
from	O
an	O
RXR	B
-	O
responsive	O
element	O
.	O

Electrophoretic	O
mobility	O
shift	O
assays	O
(	O
EMSAs	O
)	O
using	O
purified	O
glucocorticoid	B
receptor	I
DNA	I
binding	I
domain	I
(	O
DBD	O
)	O
demonstrated	O
that	O
both	O
GRE	B
-	I
2	I
and	I
-	I
3	I
motifs	I
interact	O
with	O
DBD	O
and	O
oligonucleotide	O
competition	O
experiments	O
established	O
that	O
these	O
have	O
different	O
affinities	O
for	O
DBD	O
.	O

Lyn	B
kinase	I
immunoprecipitated	O
from	O
lysates	O
of	O
irradiated	O
BCP	O
as	O
well	O
as	O
a	O
full	O
-	O
length	O
glutathione	B
S	I
-	I
transferase	I
(	O
GST	B
)-	O
Lyn	B
fusion	O
protein	O
-	O
phosphorylated	O
recombinant	B
human	I
p34cdc2	I
on	O
tyrosine	O
15	O
.	O

Am	O
.	O

EMSA	O
competition	O
experiments	O
showed	O
that	O
mutations	O
within	O
the	O
direct	O
repeats	O
failed	O
to	O
compete	O
for	O
binding	O
of	O
the	O
nuclear	O
proteins	O
to	O
labeled	O
wild	O
type	O
oligonucleotide	O
.	O

Retinoid	O
-	O
dependent	O
activation	O
of	O
the	O
tissue	B
transglutaminase	I
promoter	I
depends	O
on	O
both	O
a	O
proximal	O
regulatory	O
region	O
containing	O
sequences	O
highly	O
conserved	O
between	O
the	O
human	O
and	O
the	O
mouse	B
tissue	I
transglutaminase	I
promoters	I
and	O
a	O
distal	O
region	O
that	O
includes	O
a	O
30	O
-	O
base	O
pair	O
retinoid	O
response	O
element	O
(	O
mTGRRE1	O
).	O
mTGRRE1	O
contains	O
three	O
hexanucleotide	O
half	O
-	O
sites	O
(	O
two	O
canonical	O
and	O
one	O
non	O
-	O
canonical	O
)	O
in	O
a	O
DR7	B
/	O
DR5	B
motif	O
that	O
bind	O
both	O
RAR	B
*	O
RXR	B
heterodimers	O
and	O
RXR	B
homodimers	I
.	O

Vertebrate	B
synapsins	I
constitute	O
a	O
family	O
of	O
synaptic	O
proteins	O
that	O
participate	O
in	O
the	O
regulation	O
of	O
neurotransmitter	O
release	O
.	O

CM	B
-	I
ACO3	I
is	O
expressed	O
in	O
flowers	O
and	O
is	O
not	O
induced	O
by	O
any	O
of	O
the	O
stimuli	O
tested	O
.	O

Several	O
cytokines	O
exhibit	O
a	O
high	O
degree	O
of	O
temporal	O
regulation	O
as	O
well	O
as	O
somnogenic	O
potency	O
(	O
e	O
.	O
g	O
.,	O
interleukin	B
-	I
1	I
[	O
IL	B
-	I
1	I
],	O
tumor	B
necrosis	I
factor	I
-	I
alpha	I
[	O
TNF	B
-	I
alpha	I
]).	O

Consistent	O
with	O
ErbB	B
-	I
2	I
being	O
a	O
shared	O
receptor	O
subunit	O
,	O
its	O
tyrosine	O
phosphorylation	O
was	O
increased	O
by	O
both	O
heterologous	O
ligands	O
and	O
it	O
mediated	O
a	O
trans	O
-	O
inhibitory	O
effect	O
of	O
NDF	B
on	O
EGF	B
binding	O
.	O

The	O
members	O
of	O
the	O
Myb	B
family	I
of	I
transcription	I
factors	I
are	O
defined	O
by	O
homology	O
in	O
the	O
DNA	O
-	O
binding	O
domain	O
;	O
all	O
bind	O
the	O
Myb	B
-	I
binding	I
site	I
(	O
MBS	B
)	O
sequence	O
(	O
YG	O
(	O
A	O
/	O
G	O
)	O
C	O
(	O
A	O
/	O
C	O
/	O
G	O
)	O
GTT	O
(	O
G	O
/	O
A	O
)).	O

In	O
contrast	O
,	O
when	O
the	O
isoform	O
containing	O
the	O
C	O
epsilon4	O
domain	O
joined	O
directly	O
to	O
the	O
M2	O
exon	O
(	O
IgE	B
grande	I
)	O
is	O
expressed	O
in	O
the	O
J558L	O
cell	O
line	O
,	O
it	O
is	O
degraded	O
intracellularly	O
,	O
suggesting	O
a	O
cell	O
line	O
-	O
dependent	O
regulation	O
of	O
secretion	O
.	O

The	O
antibodies	O
inhibited	O
specifically	O
the	O
transcription	O
of	O
DNA	B
polymerase	I
alpha	I
promoter	O
in	O
vitro	O
.	O

The	O
genome	O
of	O
all	O
retroviruses	O
consists	O
of	O
two	O
identical	O
RNAs	O
noncovalently	O
linked	O
near	O
their	O
5	O
'	O
end	O
.	O

A	O
study	O
was	O
performed	O
to	O
compare	O
the	O
ONLINE	O
and	O
EMIT	O
II	O
immunoassays	O
with	O
gas	O
chromatographic	O
/	O
mass	O
spectrometric	O
(	O
GC	O
/	O
MS	O
)	O
analysis	O
of	O
methaqualone	O
metabolites	O
on	O
urine	O
using	O
samples	O
obtained	O
from	O
a	O
clinical	O
study	O
.	O

Results	O
were	O
supported	O
by	O
the	O
agar	O
diffusion	O
method	O
for	O
Y	O
.	O
enterocolitica	O
,	O
whereas	O
inhibition	O
activity	O
was	O
not	O
found	O
for	O
A	O
.	O
hydrophila	O
.	O

T	O
cell	O
leukemia	O
-	O
associated	O
human	O
Notch	B
/	O
translocation	O
-	O
associated	O
Notch	B
homologue	O
has	O
I	B
kappa	I
B	I
-	O
like	O
activity	O
and	O
physically	O
interacts	O
with	O
nuclear	B
factor	I
-	I
kappa	I
B	I
proteins	O
in	O
T	O
cells	O
.	O

Each	O
immunoprecipitate	O
contained	O
a	O
complex	O
of	O
N1	B
(	I
deltaEC	I
)	I
and	O
CBF1	B
.	O

Subcellular	O
localizations	O
of	O
the	O
wild	B
-	I
type	I
CBFbeta	I
and	O
the	O
CBFbeta	B
-	O
SMMHC	B
fusion	O
protein	O
were	O
determined	O
by	O
immunofluorescence	O
of	O
NIH	O
3T3	O
cells	O
that	O
overexpress	O
wild	O
-	O
type	O
or	O
fusion	O
protein	O
.	O

We	O
report	O
the	O
isolation	O
of	O
human	O
cDNAs	O
homologous	O
to	O
the	O
Drosophila	B
dishevelled	I
(	O
dsh	B
)	O
segment	O
-	O
polarity	O
gene	O
.	O

Escherichia	O
coli	O
BL21	O
(	O
DE3	O
)	O
plysS	O
,	O
harbouring	O
a	O
recombinant	O
plasmid	O
containing	O
the	O
catalase	B
-	O
peroxidase	B
gene	O
,	O
produced	O
a	O
large	O
amount	O
of	O
proteins	O
that	O
co	O
-	O
migrated	O
on	O
SDS	O
/	O
PAGE	O
with	O
the	O
native	O
enzyme	O
.	O

Ligation	O
of	O
CD40	B
rescues	O
Ramos	O
-	O
Burkitt	O
lymphoma	O
B	O
cells	O
from	O
calcium	O
ionophore	O
-	O
and	O
antigen	O
receptor	O
-	O
triggered	O
apoptosis	O
by	O
inhibiting	O
activation	O
of	O
the	O
cysteine	B
protease	I
CPP32	I
/	O
Yama	B
and	O
cleavage	O
of	O
its	O
substrate	O
PARP	B
.	O

Northern	O
blot	O
hybridization	O
demonstrated	O
that	O
HEP	B
-	O
COP	B
was	O
expressed	O
in	O
a	O
wide	O
range	O
of	O
human	O
adult	O
and	O
fetal	O
tissues	O
.	O

A	O
human	O
cytoplasmic	O
signaling	O
protein	O
has	O
been	O
cloned	O
that	O
possesses	O
the	O
same	O
structural	O
arrangement	O
of	O
SH3	B
-	O
SH2	B
-	O
SH3	B
domains	O
as	O
Grb2	B
.	O

E3	B
/	I
19K	I
resides	O
in	O
the	O
endoplasmic	O
reticulum	O
where	O
it	O
binds	O
to	O
MHC	B
class	I
I	I
molecules	I
,	O
thereby	O
preventing	O
their	O
transport	O
to	O
the	O
cell	O
surface	O
.	O

ORF	B
E8	I
colinear	O
with	O
ORF	B
E6	I
,	O
which	O
could	O
generate	O
a	O
50	O
-	O
amino	O
-	O
acid	O
protein	O
with	O
a	O
hydrophobic	O
segment	O
,	O
did	O
not	O
transform	O
cells	O
when	O
cloned	O
into	O
the	O
pZipNeo	O
vector	O
.	O

The	O
carboxy	O
terminus	O
of	O
Mbp1	B
is	O
sufficient	O
for	O
interaction	O
with	O
Swi6	B
,	O
and	O
the	O
carboxy	O
terminus	O
of	O
Swi6	B
is	O
required	O
for	O
interaction	O
with	O
Mbp1	B
.	O

A	O
new	O
UASH	O
consensus	O
sequence	O
derived	O
from	O
this	O
mutational	O
analysis	O
closely	O
matches	O
a	O
consensus	O
Abf1	B
binding	I
site	I
.	O

The	O
growth	O
defect	O
of	O
a	O
reg1	B
reg2	I
double	I
mutant	I
is	O
alleviated	O
by	O
a	O
loss	O
-	O
of	O
-	O
function	O
mutation	O
in	O
the	O
SNF1	B
-	I
encoded	I
protein	I
kinase	I
.	O

We	O
found	O
that	O
120	O
bp	O
of	O
the	O
enhancer	O
'	O
s	O
transcriptional	O
core	O
becomes	O
DNase	B
I	I
hypersensitive	O
early	O
in	O
B	O
-	O
cell	O
development	O
.	O

The	O
heterogeneity	O
of	O
bovine	B
IgG2	I
--	I
VIII	I
.	O

The	O
DNA	O
sequence	O
immediately	O
upstream	O
from	O
the	O
-	O
10	O
hexamer	O
contained	O
the	O
TGn	O
motif	O
described	O
as	O
an	O
extended	O
-	O
10	O
region	O
in	O
prokaryotic	O
promoters	O
.	O

We	O
found	O
strand	O
selective	O
repair	O
in	O
DNA	O
fragments	O
within	O
two	O
active	O
genes	O
,	O
DHFR	B
and	O
an	O
unknown	O
gene	O
adjacent	O
to	O
DHFR	B
.	O

In	O
an	O
effort	O
to	O
contribute	O
to	O
the	O
transcript	O
map	O
of	O
human	O
chromosome	O
21	O
and	O
the	O
understanding	O
of	O
the	O
pathophysiology	O
of	O
trisomy	O
21	O
,	O
we	O
have	O
used	O
exon	O
trapping	O
to	O
identify	O
fragments	O
of	O
chromosome	O
21	O
genes	O
.	O

Transcriptional	O
blockade	O
was	O
reversed	O
by	O
co	O
-	O
transfections	O
of	O
a	O
wild	B
-	I
type	I
SRF	I
expression	O
vector	O
,	O
but	O
was	O
not	O
rescued	O
by	O
the	O
expression	O
of	O
other	O
myogenic	O
factors	O
,	O
such	O
as	O
MyoD	B
and	O
Mef	B
-	I
2C	I
.	O

Human	B
MN	I
/	I
CA9	I
gene	I
,	O
a	O
novel	O
member	O
of	O
the	O
carbonic	B
anhydrase	I
family	I
:	O
structure	O
and	O
exon	O
to	O
protein	O
domain	O
relationships	O
.	O

The	O
exon	O
-	O
intron	O
distribution	O
of	O
Cdebp	B
appears	O
strikingly	O
similar	O
to	O
that	O
of	O
the	O
App	B
gene	I
in	O
the	O
regions	O
encoding	O
the	O
conserved	O
domains	O
,	O
with	O
a	O
divergent	O
structure	O
in	O
the	O
other	O
parts	O
.	O

Three	O
separate	O
activation	O
subdomains	O
,	O
and	O
one	O
negative	O
-	O
acting	O
region	O
,	O
which	O
function	O
in	O
yeast	O
were	O
located	O
in	O
the	O
carboxyl	O
-	O
terminal	O
region	O
of	O
NIT4	B
.	O

The	O
corresponding	O
gene	O
was	O
identified	O
in	O
the	O
GenBankTM	O
data	O
base	O
by	O
sequence	O
alignment	O
and	O
termed	O
RPS30A	B
.	O

The	O
location	O
of	O
multiple	O
GRK2	B
and	O
GRK5	B
phosphoacceptor	I
sites	I
at	O
the	O
extreme	O
carboxyl	O
terminus	O
of	O
the	O
beta2AR	B
is	O
highly	O
reminiscent	O
of	O
GRK1	B
-	O
mediated	O
phosphorylation	O
of	O
rhodopsin	B
.	O

The	O
receptor	B
for	I
hyaluronan	I
mediated	I
motility	I
(	I
RHAMM	I
)	I
gene	I
expression	O
is	O
markedly	O
elevated	O
in	O
fibrosarcomas	O
exposed	O
to	O
transforming	B
growth	I
factor	I
-	I
beta1	I
(	O
TGF	B
-	I
beta1	I
).	O

The	O
promoter	O
of	O
the	O
rat	B
PGS	I
-	I
2	I
gene	I
contains	O
a	O
CAAT	B
enhancer	I
-	I
binding	I
protein	I
consensus	I
site	I
(	I
CAAT	I
box	I
)	I
which	O
can	O
confer	O
hormone	O
inducibility	O
to	O
a	O
PGS	B
-	I
2	I
.	O
CAT	B
reporter	O
gene	O
,	O
as	O
well	O
as	O
a	O
putative	O
E	O
-	O
box	O
region	O
.	O

Clinical	O
evaluation	O
of	O
the	O
Allergan	O
Humphrey	O
500	O
autorefractor	O
and	O
the	O
Nidek	O
AR	O
-	O
1000	O
autorefractor	O
.	O

These	O
changes	O
may	O
be	O
the	O
result	O
of	O
,	O
on	O
the	O
one	O
hand	O
,	O
an	O
increased	O
sensitivity	O
of	O
the	O
neuromuscular	O
transmission	O
and	O
/	O
or	O
decreased	O
muscle	O
contractility	O
and	O
,	O
on	O
the	O
other	O
hand	O
,	O
the	O
result	O
of	O
a	O
reduced	O
plasma	O
clearance	O
during	O
hypothermia	O
.	O

Furthermore	O
,	O
we	O
have	O
identified	O
a	O
43	O
-	O
bp	O
region	O
of	O
the	O
24p3	B
promoter	I
required	O
for	O
the	O
Dex	O
responsiveness	O
.	O

Our	O
data	O
demonstrate	O
directly	O
that	O
Rpm1r	B
is	O
transcribed	O
with	O
its	O
substrates	O
,	O
tRNA	B
met	I
f	I
and	O
tRNAPro	B
,	O
from	O
a	O
promoter	O
located	O
upstream	O
of	O
the	O
tRNA	B
met	I
f	I
gene	I
and	O
suggest	O
that	O
a	O
portion	O
also	O
originates	O
from	O
a	O
second	O
promoter	O
,	O
located	O
between	O
the	O
tRNA	B
met	I
f	I
gene	I
and	O
RPM1	B
.	O

FTF	B
is	O
also	O
abundantly	O
expressed	O
in	O
the	O
pancreas	O
and	O
may	O
exert	O
differentiation	O
functions	O
in	O
endodermal	O
sublineages	O
,	O
similar	O
to	O
SF	B
-	I
1	I
in	O
steroidogenic	O
tissues	O
.	O

Mean	O
increase	O
of	O
milk	O
protein	O
yield	O
was	O
46	O
g	O
/	O
d	O
with	O
Met	O
plus	O
Lys	O
,	O
and	O
mean	O
increase	O
of	O
true	O
protein	O
content	O
was	O
1	O
.	O
1	O
g	O
/	O
kg	O
of	O
milk	O
.	O

A	O
phylogenetic	O
tree	O
of	O
members	O
of	O
the	O
T2	B
/	I
S	I
-	I
RNase	I
superfamily	I
in	O
plants	O
was	O
obtained	O
.	O

In	O
a	O
Hoosier	O
Oncology	O
Group	O
randomized	O
study	O
involving	O
extensive	O
-	O
disease	O
SCLC	O
patients	O
,	O
VIP	O
was	O
superior	O
to	O
etoposide	O
/	O
cisplatin	O
with	O
regard	O
to	O
median	O
time	O
to	O
progression	O
(	O
6	O
.	O
6	O
v	O
5	O
.	O
8	O
months	O
),	O
median	O
survival	O
times	O
(	O
9	O
.	O
1	O
v	O
7	O
.	O
3	O
months	O
),	O
and	O
2	O
-	O
and	O
3	O
-	O
year	O
survival	O
rates	O
(	O
13	O
%	O
v	O
5	O
%	O
and	O
5	O
%	O
v	O
0	O
%,	O
respectively	O
).	O

Atopic	O
allergy	O
and	O
other	O
hypersensitivities	O
.	O

After	O
6	O
h	O
of	O
reperfusion	O
,	O
PO2	O
/	O
FlO2	O
ratio	O
was	O
significantly	O
better	O
after	O
Combined	O
Therapy	O
(	O
372	O
+/-	O
52	O
mm	O
Hg	O
)	O
than	O
in	O
the	O
Recipient	O
Instilled	O
(	O
117	O
+/-	O
47	O
mm	O
Hg	O
)	O
and	O
Control	O
groups	O
(	O
87	O
+/-	O
26	O
mm	O
Hg	O
),	O
with	O
intermediate	O
values	O
in	O
Donor	O
Aerosol	O
dogs	O
(	O
232	O
+/-	O
64	O
mm	O
Hg	O
).	O

One	O
complex	O
containing	O
a	O
70	O
D	O
protein	O
was	O
found	O
to	O
be	O
associated	O
specifically	O
with	O
transcriptionally	O
active	O
leukemia	O
cells	O
.	O

Recently	O
,	O
our	O
laboratory	O
developed	O
a	O
screen	O
that	O
identified	O
five	O
multicopy	O
suppressors	O
that	O
can	O
rescue	O
lethal	O
strains	O
of	O
clathrin	B
heavy	O
chain	O
-	O
deficient	O
yeast	O
(	O
Chc	B
-	O
scd1	B
-	I
i	I
)	O
to	O
viability	O
.	O

Reproductive	O
period	O
affects	O
water	O
intake	O
in	O
heat	O
-	O
stressed	O
dehydrated	O
goats	O
.	O

The	O
logistic	O
regression	O
analysis	O
of	O
the	O
manual	O
method	O
(	O
percentage	O
normal	O
morphology	O
)	O
and	O
IVOS	O
indicated	O
that	O
both	O
were	O
predictors	O
of	O
fertilization	O
.	O

The	O
Pro	O
-	O
258	O
-->	O
Leu	O
(	O
P258L	O
)	O
mutation	O
caused	O
constitutive	O
receptor	O
signaling	O
that	O
was	O
equivalent	O
to	O
about	O
45	O
%	O
of	O
the	O
maximum	O
level	O
observed	O
in	O
wild	O
-	O
type	O
cells	O
stimulated	O
with	O
alpha	B
-	I
factor	I
.	O

By	O
using	O
a	O
DNA	O
sequence	O
selected	O
for	O
its	O
ability	O
to	O
bind	O
recombinant	B
BCL	I
-	I
6	I
in	O
vitro	O
,	O
we	O
show	O
here	O
that	O
BCL	B
-	I
6	I
is	O
present	O
in	O
DNA	O
-	O
binding	O
complexes	O
in	O
nuclear	O
extracts	O
from	O
various	O
B	O
-	O
cell	O
lines	O
.	O

CONCLUSIONS	O
:	O
Our	O
findings	O
suggest	O
that	O
pre	O
-	O
treatment	O
with	O
coenzyme	O
Q10	O
may	O
play	O
a	O
protective	O
role	O
during	O
routine	O
vascular	O
procedures	O
requiring	O
abdominal	O
aortic	O
cross	O
clamping	O
by	O
attenuating	O
the	O
degree	O
of	O
peroxidative	O
damage	O
.	O

Because	O
chromosome	O
X	O
is	O
frequently	O
involved	O
in	O
structural	O
alterations	O
in	O
neoplastic	O
Syrian	O
hamster	O
cells	O
transformed	O
by	O
chemical	O
carcinogens	O
and	O
oncogenic	O
viruses	O
,	O
the	O
localization	O
of	O
the	O
cph	B
locus	I
on	O
this	O
chromosome	O
supports	O
the	O
notion	O
that	O
the	O
cph	B
oncogene	I
plays	O
a	O
role	O
in	O
the	O
malignant	O
conversion	O
of	O
chemically	O
transformed	O
hamster	O
fibroblasts	O
.	O

The	O
mechanism	O
involves	O
Gbetagamma	B
subunit	O
-	O
mediated	O
increases	O
in	O
tyrosine	O
phosphorylation	O
of	O
the	O
Shc	B
adapter	I
protein	I
,	O
Shc	B
*	O
Grb2	B
complex	O
formation	O
,	O
and	O
recruitment	O
of	O
Ras	B
guanine	I
nucleotide	I
exchange	I
factor	I
activity	O
.	O

The	O
cis	O
-	O
acting	O
elements	O
that	O
control	O
promoter	O
activity	O
include	O
binding	O
sites	O
for	O
transcription	O
factors	O
Sp1	B
and	O
alphaCbf	B
,	O
a	O
60	B
-	I
kDa	I
CCAAT	I
box	I
-	I
binding	I
protein	I
.	O

Therefore	O
,	O
we	O
have	O
identified	O
a	O
cis	O
-	O
acting	O
element	O
,	O
the	O
E1	O
E	O
-	O
box	O
,	O
located	O
in	O
the	O
GAP	B
-	I
43	I
promoter	O
region	O
that	O
modulates	O
either	O
positively	O
or	O
negatively	O
the	O
expression	O
of	O
the	O
GAP	B
-	I
43	I
gene	I
depending	O
on	O
which	O
E	B
-	I
box	I
-	I
binding	I
proteins	I
occupy	O
this	O
site	O
.	O

It	O
is	O
exclusively	O
observed	O
in	O
smooth	O
muscle	O
cells	O
by	O
Northern	O
blotting	O
and	O
immunohistochemical	O
analysis	O
and	O
therefore	O
designated	O
"	B
smoothelin	I
."	I
A	O
human	O
smooth	O
muscle	O
cDNA	O
library	O
was	O
screened	O
with	O
the	O
monoclonal	B
antibody	I
R4A	I
,	O
and	O
a	O
full	O
-	O
size	O
cDNA	O
of	O
the	O
protein	O
was	O
selected	O
.	O

The	O
data	O
further	O
indicate	O
that	O
the	O
IL	B
-	I
7R	I
alpha	I
chains	I
are	O
directly	O
involved	O
in	O
the	O
activation	O
of	O
JAKs	B
and	O
STATs	B
and	O
have	O
a	O
major	O
role	O
in	O
proliferative	O
signaling	O
in	O
precursor	O
B	O
cells	O
.	O

While	O
fusion	O
to	O
the	O
N	O
-	O
terminus	O
required	O
a	O
linker	O
to	O
become	O
surface	O
accessible	O
,	O
both	O
fusion	O
to	O
the	O
N	O
-	O
terminus	O
and	O
to	O
the	O
C	O
-	O
terminus	O
was	O
compatible	O
with	O
particle	O
assembly	O
and	O
preserved	O
the	O
native	O
antigenicity	O
and	O
immunogenicity	O
of	O
HBcAg	B
.	O

The	O
standard	O
dosage	O
of	O
anti	B
-	I
D	I
currently	O
given	O
at	O
all	O
gestational	O
ages	O
is	O
1	O
ampoule	O
containing	O
125	O
micrograms	O
of	O
anti	B
-	I
D	I
.	O

U24	B
has	O
two	O
separate	O
12	O
nt	O
long	O
complementarities	O
to	O
a	O
highly	O
conserved	O
tract	O
of	O
28S	B
rRNA	I
.	O

This	O
complex	O
interacts	O
at	O
the	O
GTPase	B
domain	I
in	O
the	O
large	O
subunit	O
rRNA	O
,	O
overlapping	O
the	O
binding	O
site	O
of	O
the	O
protein	B
L11	I
-	I
like	I
eukaryotic	I
counterpart	I
(	O
Saccharomyces	B
cerevisiae	I
protein	I
L15	I
and	O
mammalian	B
protein	I
L12	I
).	O

Chromatin	O
repression	O
of	O
these	O
replacement	O
genes	O
would	O
be	O
avoided	O
,	O
consistent	O
with	O
the	O
high	O
,	O
constitutive	O
expression	O
of	O
replacement	O
H3	B
histone	I
genes	I
in	O
plants	O
.	O

Ten	O
weeks	O
after	O
reconstruction	O
,	O
the	O
regenerating	O
nerves	O
already	O
resembled	O
normal	O
nerves	O
.	O

The	O
SEB1	B
homologue	O
thus	O
isolated	O
,	O
SEB2	B
,	O
encodes	O
a	O
protein	O
53	O
%	O
identical	O
to	O
Seb1p	B
.	O

Large	O
ones	O
were	O
similar	O
in	O
size	O
to	O
the	O
main	O
lobe	O
and	O
small	O
ones	O
were	O
approximately	O
1	O
/	O
4	O
of	O
the	O
length	O
of	O
the	O
main	O
lobe	O
.	O

Fifty	O
-	O
one	O
patients	O
with	O
primary	O
refractory	O
or	O
relapsed	O
malignant	O
lymphoma	O
(	O
47	O
non	O
-	O
Hodgkin	O
'	O
s	O
lymphoma	O
and	O
four	O
Hodgkin	O
'	O
s	O
disease	O
)	O
were	O
treated	O
with	O
a	O
new	O
chemotherapeutic	O
regimen	O
(	O
cisplatinum	O
,	O
methyl	O
GAG	O
,	O
bleomocyin	O
,	O
methyl	O
prednisolon	O
).	O

AIMS	O
/	O
METHODS	O
:	O
Reticuloendothelial	O
system	O
function	O
,	O
as	O
assessed	O
by	O
clearance	O
of	O
radiolabelled	O
bacteria	O
,	O
was	O
evaluated	O
in	O
acute	O
liver	O
injury	O
induced	O
by	O
D	O
-	O
galactosamine	O
in	O
rats	O
,	O
and	O
compared	O
with	O
that	O
after	O
70	O
%	O
liver	O
resection	O
model	O
.	O

Study	O
groups	O
were	O
control	O
,	O
and	O
those	O
treated	O
with	O
the	O
alpha1	B
-	I
adrenoceptor	I
-	I
subtype	I
blockers	O
WB4101	O
(	O
0	O
.	O
5	O
mg	O
/	O
kg	O
i	O
.	O
v	O
.)	O
or	O
chloroethylclonidine	O
(	O
1	O
.	O
9	O
mg	O
/	O
kg	O
i	O
.	O
v	O
.).	O

This	O
caused	O
severe	O
cortical	O
damage	O
and	O
neuronal	O
loss	O
in	O
hippocampus	O
subfields	O
CA1	O
,	O
CA3	O
,	O
and	O
hilus	O
.	O

The	O
upTRE	O
binds	O
more	O
T3R	B
homodimers	I
and	O
less	O
T3R	B
-	O
RXR	B
heterodimers	O
than	O
the	O
dnTRE	O
,	O
and	O
T3	O
more	O
readily	O
facilitates	O
heterodimer	O
binding	O
to	O
the	O
dn	O
-	O
than	O
to	O
the	O
upTRE	O
.	O

Previous	O
studies	O
have	O
suggested	O
that	O
the	O
616	O
amino	O
acid	O
,	O
70	B
-	I
kDa	I
subunit	I
of	I
RPA	I
(	O
RPA	B
70	I
)	O
is	O
composed	O
of	O
multiple	O
structural	O
/	O
functional	O
domains	O
.	O

The	O
cDNA	O
clone	O
was	O
used	O
as	O
a	O
homologous	O
probe	O
to	O
isolate	O
a	O
truncated	O
genomic	O
clone	O
encoding	O
H2A1	B
.	O

The	O
effect	O
of	O
ligustrazine	O
hydrochloride	O
(	O
LTH	O
)	O
on	O
depressing	O
pulmonary	O
artery	O
hypertension	O
has	O
been	O
proved	O
in	O
recent	O
studies	O
.	O

It	O
is	O
the	O
oxidation	O
peak	O
of	O
this	O
product	O
,	O
arising	O
in	O
acidic	O
media	O
at	O
0	O
.	O
42	O
V	O
,	O
which	O
was	O
analysed	O
using	O
DPV	O
,	O
again	O
following	O
the	O
accumulation	O
of	O
clenbuterol	O
at	O
the	O
Nafion	O
-	O
modified	O
CPE	O
.	O

A	O
.	O

Because	O
the	O
hcf109	B
locus	I
was	O
mapped	O
at	O
a	O
distance	O
<	O
0	O
.	O
1	O
centimorgans	O
from	O
the	O
phytochrome	B
C	I
gene	I
,	O
its	O
molecular	O
characterization	O
by	O
positional	O
cloning	O
is	O
possible	O
.	O

We	O
have	O
recently	O
shown	O
that	O
the	O
tissue	O
-	O
specific	O
expression	O
of	O
the	O
RAR	B
beta	I
2	I
gene	I
in	I
mouse	I
embryos	I
is	O
regulated	O
at	O
the	O
translational	O
level	O
by	O
short	O
upstream	O
open	O
reading	O
frames	O
(	O
uORFs	O
)	O
In	O
the	O
5	O
'-	O
untranslated	O
region	O
(	O
Zimmer	O
,	O
A	O
.,	O
A	O
.	O
M	O
.	O

Increased	O
PTHRP	B
production	O
by	O
a	O
tyrosine	B
kinase	I
oncogene	I
,	O
Tpr	B
-	I
Met	I
:	O
role	O
of	O
the	O
Ras	B
signaling	O
pathway	O
.	O

To	O
test	O
whether	O
Sp1	B
and	O
zif268	B
/	O
egr	B
-	I
1	I
interact	O
with	O
this	O
motif	O
,	O
gel	O
retardation	O
assays	O
were	O
performed	O
.	O

Stably	O
transfected	O
human	O
kidney	O
293	O
cells	O
expressing	O
the	O
wild	B
type	I
rat	I
LH	I
/	I
CG	I
receptor	I
(	O
rLHR	B
)	O
or	O
receptors	O
with	O
C	O
-	O
terminal	O
tails	O
truncated	O
at	O
residues	O
653	O
,	O
631	O
,	O
or	O
628	O
(	O
designated	O
rLHR	B
-	I
t653	I
,	O
rLHR	B
-	I
t631	I
,	O
and	O
rLHR	B
-	I
t628	I
)	O
were	O
used	O
to	O
probe	O
the	O
importance	O
of	O
this	O
region	O
on	O
the	O
regulation	O
of	O
hormonal	O
responsiveness	O
.	O

Improved	O
methods	O
have	O
been	O
developed	O
for	O
maintaining	O
and	O
breeding	O
the	O
neotropical	O
short	O
-	O
tailed	O
fruit	O
bat	O
,	O
Carollia	O
perspicillata	O
,	O
in	O
an	O
easily	O
-	O
reproduced	O
,	O
laboratory	O
setting	O
.	O

Also	O
like	O
the	O
thrombin	B
receptor	I
,	O
PAR2	B
can	O
be	O
activated	O
by	O
the	O
hexapeptide	O
corresponding	O
to	O
its	O
tethered	O
ligand	O
sequence	O
independent	O
of	O
receptor	O
cleavage	O
.	O

The	O
data	O
presented	O
in	O
this	O
work	O
indicate	O
that	O
thi1	B
may	O
also	O
be	O
involved	O
in	O
DNA	O
damage	O
tolerance	O
in	O
plant	O
cells	O
.	O

In	O
the	O
rat	B
rnu	I
allele	I
described	O
here	O
,	O
a	O
nonsense	O
mutation	O
in	O
exon	O
8	O
of	O
the	O
whn	B
gene	I
was	O
identified	O
.	O

Such	O
an	O
increase	O
in	O
the	O
steady	O
-	O
state	O
testicular	B
TIMP	I
-	I
2	I
mRNA	I
level	O
apparently	O
is	O
not	O
the	O
result	O
of	O
an	O
up	O
-	O
regulation	O
by	O
germ	O
cells	O
because	O
germ	O
cells	O
cocultured	O
with	O
Sertoli	O
cells	O
failed	O
to	O
elicit	O
an	O
increase	O
in	O
the	O
Sertoli	O
cell	O
steady	O
-	O
state	O
TIMP	B
-	I
2	I
mRNA	I
level	O
.	O

Control	O
intact	O
rats	O
were	O
age	O
-	O
matched	O
to	O
the	O
different	O
treated	O
groups	O
.	O

On	O
the	O
basis	O
of	O
its	O
bZIP	O
structural	O
homology	O
,	O
meq	B
is	O
perhaps	O
the	O
only	O
member	O
of	O
the	O
jun	B
-	O
fos	B
gene	O
family	O
completely	O
viral	O
in	O
origin	O
.	O

Although	O
basal	O
vessels	O
may	O
constrict	O
distal	O
parenchymal	O
vessels	O
tend	O
to	O
dilate	O
after	O
SAH	O
.	O

Several	O
lines	O
of	O
evidence	O
presented	O
here	O
suggest	O
that	O
PKC	B
-	I
zeta	I
plays	O
a	O
role	O
in	O
alpha	B
2	I
integrin	I
gene	I
expression	O
.	O

The	O
amount	O
of	O
these	O
factors	O
was	O
reduced	O
in	O
GEO	O
cells	O
in	O
which	O
the	O
u	B
-	I
PAR	I
gene	I
is	O
only	O
weakly	O
transcriptionally	O
activated	O
.	O

Myelomatous	O
pleural	O
effusion	O
as	O
presentation	O
form	O
of	O
multiple	O
myeloma	O

The	O
partial	O
categories	O
of	O
the	O
SIP	O
that	O
were	O
more	O
affected	O
were	O
work	O
,	O
recreation	O
and	O
pastimes	O
,	O
home	O
management	O
,	O
and	O
sleep	O
and	O
rest	O
.	O

Transcripts	O
for	O
both	O
ODV	B
-	I
E18	I
and	O
ODV	B
-	I
EC27	I
initiate	O
from	O
conserved	O
TAAG	O
motifs	O
,	O
and	O
transcripts	O
are	O
detected	O
from	O
16	O
through	O
72	O
hr	O
p	O
.	O
i	O
.	O

A	O
3	O
-	O
yr	O
retrospective	O
review	O
is	O
effective	O
and	O
detects	O
94	O
%	O
of	O
the	O
undercalls	O
.	O

Ha	B
-	I
RasV12	I
and	O
activated	O
proteins	O
in	O
both	O
the	O
extra	B
-	I
cellular	I
regulated	I
kinase	I
(	O
ERK	B
)	O
and	O
the	O
stress	B
-	I
activated	I
protein	I
kinase	I
(	O
SAPK	B
)	O
or	O
Jun	B
N	I
-	I
terminal	I
kinase	I
(	O
JNK	B
)	O
cascades	O
independently	O
stimulated	O
PEA3	B
-	O
mediated	O
gene	O
expression	O
.	O

Here	O
we	O
demonstrate	O
that	O
another	O
cellular	O
protein	O
linked	O
to	O
BCR	B
/	O
ABL	B
through	O
the	O
CRKL	B
-	O
SH2	B
domain	O
is	O
p130	B
(	O
CAS	B
).	O
p130	B
(	O
CAS	B
)	O
was	O
found	O
to	O
be	O
tyrosine	O
phosphorylated	O
and	O
associated	O
with	O
CRKL	B
in	O
BCR	B
/	O
ABL	B
expressing	O
cell	O
lines	O
and	O
in	O
samples	O
obtained	O
from	O
CML	O
and	O
ALL	O
patients	O
,	O
but	O
not	O
in	O
samples	O
from	O
controls	O
.	O

These	O
results	O
indicate	O
that	O
inhibition	O
of	O
Jun	B
kinase	I
activation	O
was	O
sufficient	O
to	O
inhibit	O
Ras	B
transformation	O
even	O
in	O
the	O
presence	O
of	O
activated	O
Erk	B
-	I
2	I
.	O

Identification	O
of	O
Ste4	B
as	O
a	O
potential	O
regulator	O
of	O
Byr2	B
in	O
the	O
sexual	O
response	O
pathway	O
of	O
Schizosaccharomyces	O
pombe	O
.	O

The	O
retinoid	B
Z	I
receptor	I
beta	I
(	O
RZR	B
beta	I
),	O
an	O
orphan	O
receptor	O
,	O
is	O
a	O
member	O
of	O
the	O
retinoic	B
acid	I
receptor	I
(	O
RAR	B
)/	O
thyroid	B
hormone	I
receptor	I
(	O
TR	B
)	O
subfamily	O
of	O
nuclear	O
receptors	O
.	O

Moreover	O
,	O
following	O
a	O
single	O
intravenous	O
injection	O
of	O
the	O
bicistronic	O
vector	O
complexed	O
to	O
cationic	O
liposomes	O
into	O
recipient	O
mice	O
,	O
delivery	O
of	O
MDR1	B
and	O
GC	B
cDNAs	I
was	O
achieved	O
in	O
all	O
the	O
organs	O
we	O
tested	O
.	O

Despite	O
the	O
presence	O
of	O
one	O
additional	O
ribonucleotide	B
reductase	I
,	O
the	O
nrdAB	B
-	I
encoded	I
enzyme	I
is	O
essential	O
to	O
the	O
aerobic	O
growth	O
of	O
the	O
cell	O
because	O
nrdAB	B
-	I
defective	I
mutants	I
of	O
both	O
species	O
are	O
not	O
viable	O
in	O
the	O
presence	O
of	O
oxygen	O
.	O

Altogether	O
,	O
the	O
results	O
demonstrate	O
that	O
the	O
two	O
isoforms	O
elicit	O
similar	O
responses	O
in	O
vivo	O
despite	O
differences	O
in	O
their	O
regulation	O
.	O

Motivational	O
factors	O
focusing	O
on	O
attitudes	O
,	O
perceived	O
susceptibility	O
to	O
pregnancy	O
,	O
and	O
normative	O
factors	O
were	O
also	O
relevant	O
.	O

High	O
-	O
resolution	O
structure	O
of	O
the	O
diphtheria	B
toxin	I
repressor	I
complexed	O
with	O
cobalt	O
and	O
manganese	O
reveals	O
an	O
SH3	B
-	I
like	I
third	O
domain	O
and	O
suggests	O
a	O
possible	O
role	O
of	O
phosphate	O
as	O
co	O
-	O
corepressor	O
.	O

Chernoff	O
,	O
submitted	O
for	O
publication	O
).	O

Human	O
ESP1	B
/	O
CRP2	B
protein	O
has	O
two	O
LIM	B
domains	O
,	O
and	O
each	O
shares	O
35	O
.	O
1	O
%	O
and	O
77	O
or	O
79	O
%	O
identical	O
residues	O
with	O
human	B
cysteine	I
-	I
rich	I
protein	I
(	O
CRP	B
)	O
and	O
rat	B
CRIP	I
,	O
respectively	O
.	O

DNA	O
sequence	O
analysis	O
of	O
a	O
3213	O
bp	O
BamHI	B
-	O
ClaI	B
fragment	O
revealed	O
that	O
three	O
open	O
reading	O
frames	O
(	O
ORFs	O
)	O
were	O
encoded	O
in	O
the	O
same	O
orientation	O
.	O

This	O
element	O
,	O
termed	O
CREsp	O
-	O
a	O
(	O
TGACCTCA	O
),	O
differs	O
by	O
one	O
nucleotide	O
from	O
a	O
palindromic	O
CRE	O
(	O
CREpal	O
,	O
TGACGTCA	O
),	O
which	O
is	O
known	O
to	O
bind	O
CREB	B
as	O
a	O
homodimer	O
.	O

Analysis	O
of	O
human	O
genomic	O
DNA	O
reveals	O
an	O
intronless	O
sequence	O
with	O
strong	O
homology	O
to	O
human	B
G	I
alpha	I
q	I
cDNA	I
.	O

An	O
inverted	O
Alu	B
repeat	O
element	O
,	O
flanked	O
by	O
nonamer	O
direct	O
repeats	O
,	O
was	O
identified	O
within	O
the	O
region	O
-	O
913	O
/-	O
620	O
,	O
relative	O
to	O
the	O
cap	O
site	O
.	O

The	O
CD4	B
count	O
at	O
which	O
remission	O
occurs	O
may	O
reflect	O
severe	O
immunodeficiency	O
such	O
that	O
risk	O
for	O
AIDS	O
-	O
related	O
infection	O
is	O
high	O
.	O

Neither	O
CES1	B
nor	O
CES4	B
is	O
essential	O
for	O
cell	O
growth	O
,	O
and	O
a	O
double	O
deletion	O
mutant	O
is	O
viable	O
.	O

Their	O
use	O
established	O
that	O
the	O
BrAAP	O
activity	O
catalyzed	O
both	O
a	O
postproline	O
and	O
a	O
postglutamate	O
cleavage	O
and	O
therefore	O
has	O
a	O
broader	O
specificity	O
than	O
previously	O
recognized	O
.	O

To	O
understand	O
further	O
the	O
expression	O
and	O
regulation	O
of	O
the	O
V1aR	B
,	O
we	O
now	O
describe	O
the	O
genomic	O
characteristics	O
,	O
tissue	O
expression	O
,	O
chromosomal	O
localization	O
,	O
and	O
regional	O
mapping	O
of	O
the	O
human	B
V1aR	I
gene	I
,	O
AVPR1A	B
.	O

Two	O
of	O
the	O
ORFs	O
are	O
completely	O
internal	O
to	O
longer	O
ones	O
and	O
a	O
third	O
is	O
partially	O
embedded	O
in	O
G2850	B
.	O

Two	O
classes	O
of	O
inactive	O
receptors	O
were	O
identified	O
:	O
one	O
in	O
which	O
both	O
transcriptional	O
activation	O
and	O
dimerization	O
were	O
compromised	O
and	O
a	O
second	O
in	O
which	O
only	O
transcriptional	O
activation	O
was	O
abolished	O
.	O

Two	O
techniques	O
based	O
on	O
assay	O
coefficients	O
of	O
variation	O
were	O
employed	O
to	O
characterize	O
a	O
normal	O
circadian	O
pattern	O
of	O
cortisol	O
.	O

We	O
have	O
performed	O
toeprinting	O
analyses	O
on	O
repA	B
mRNA	I
of	O
plasmid	O
R1	O
,	O
both	O
free	O
and	O
in	O
duplex	O
with	O
the	O
antisense	O
RNA	O
,	O
CopA	B
.	O

A	O
system	O
is	O
described	O
in	O
which	O
the	O
volume	O
flow	O
rate	O
of	O
blood	O
in	O
a	O
vessel	O
is	O
determined	O
using	O
transverse	O
colour	O
Doppler	O
ultrasound	O
imaging	O
.	O

CONCLUSION	O
:	O
During	O
chronic	O
treatment	O
,	O
the	O
haemodynamic	O
response	O
to	O
oral	O
cilazapril	O
was	O
attenuated	O
,	O
indicating	O
that	O
continued	O
clinical	O
improvement	O
in	O
patients	O
with	O
CHF	O
on	O
CLZ	O
is	O
independent	O
of	O
to	O
its	O
acute	O
haemodynamic	O
effects	O
.	O

Transcription	O
factor	O
recognition	O
surface	O
on	O
the	O
RNA	B
polymerase	I
alpha	I
subunit	I
is	O
involved	O
in	O
contact	O
with	O
the	O
DNA	O
enhancer	O
element	O
.	O

The	O
elevations	O
achieved	O
by	O
LDEE	O
given	O
s	O
.	O
c	O
.	O
were	O
higher	O
than	O
those	O
achieved	O
after	O
i	O
.	O
p	O
.	O
administration	O
and	O
lasted	O
for	O
longer	O
periods	O
.	O

Thus	O
,	O
although	O
p28	B
may	O
play	O
only	O
a	O
limited	O
role	O
during	O
the	O
early	O
embryonic	O
cleavages	O
,	O
it	O
may	O
function	O
later	O
in	O
development	O
to	O
establish	O
a	O
somatic	O
type	O
of	O
cell	O
cycle	O
.	O

Previous	O
studies	O
demonstrated	O
that	O
the	O
flavin	B
-	I
containing	I
monooxygenases	I
(	O
FMO	B
)	O
are	O
expressed	O
in	O
a	O
tissue	O
-	O
specific	O
manner	O
.	O

MSSP	B
proteins	I
have	O
been	O
identified	O
by	O
their	O
binding	O
to	O
an	O
upstream	O
element	O
of	O
c	B
-	I
myc	I
.	O

Discrimination	O
between	O
HIV	O
-	O
1	O
and	O
HIV	O
-	O
2	O
showed	O
evidence	O
for	O
the	O
presence	O
of	O
HIV	O
-	O
1	O
only	O
.	O

However	O
,	O
an	O
intrinsic	O
DNA	O
-	O
binding	O
subunit	O
for	O
HiNF	B
-	I
D	I
was	O
not	O
identified	O
.	O

Recently	O
,	O
a	O
distantly	O
related	O
UmuC	B
-	I
homolog	I
,	O
DinB	B
,	O
has	O
also	O
been	O
identified	O
in	O
E	O
.	O
coli	O
.	O

The	O
intranodal	O
mesothelial	O
cells	O
occupied	O
the	O
sinusoids	O
of	O
the	O
lymph	O
nodes	O
and	O
were	O
initially	O
suspected	O
of	O
being	O
metastatic	O
from	O
the	O
ovarian	O
tumor	O
in	O
each	O
case	O
.	O

Thus	O
,	O
the	O
N	B
-	O
Nus	B
complex	O
may	O
be	O
affected	O
through	O
contacts	O
with	O
the	O
CTD	O
of	O
the	O
alpha	O
subunit	O
of	O
RNA	B
polymerase	I
,	O
as	O
is	O
a	O
group	O
of	O
regulatory	O
proteins	O
that	O
influences	O
initiation	O
of	O
transcription	O
.	O

Administration	O
of	O
RIFA	O
at	O
200	O
mg	O
/	O
kg	O
/	O
day	O
in	O
combination	O
with	O
ATO	O
at	O
100	O
mg	O
/	O
kg	O
/	O
day	O
resulted	O
in	O
a	O
marked	O
prolongation	O
of	O
survival	O
compared	O
with	O
that	O
for	O
mice	O
that	O
received	O
ATO	O
or	O
RIFA	O
alone	O
.	O

Eight	O
-	O
four	O
ACOAs	O
were	O
tested	O
in	O
order	O
to	O
examine	O
the	O
fit	O
of	O
the	O
model	O
to	O
the	O
data	O
by	O
path	O
analysis	O
with	O
LISREL	O
VII	O
.	O

Interferon	B
stimulated	I
gene	I
factor	I
3	I
(	O
ISGF3	B
)	O
is	O
a	O
trimeric	O
transcription	O
factor	O
activated	O
on	O
treatment	O
of	O
cells	O
with	O
interferon	B
-	I
alpha	I
and	I
beta	I
(	O
type	B
I	I
IFNs	I
).	O

Three	O
mutants	O
were	O
isolated	O
from	O
the	O
widely	O
used	O
strain	O
,	O
PAO1	O
.	O

Selection	O
was	O
based	O
on	O
expression	O
of	O
an	O
integrated	O
DNA	O
fragment	O
containing	O
the	O
con	B
-	I
10	I
promoter	I
-	I
regulatory	I
region	I
followed	O
by	O
the	O
initial	O
segment	O
of	O
the	O
con	B
-	I
10	I
open	I
reading	I
frame	I
fused	O
in	O
frame	O
with	O
the	O
bacterial	B
hygromycin	I
B	I
phosphotransferase	I
structural	I
gene	I
(	O
con10	B
'-'	I
hph	I
).	O

In	O
contrast	O
,	O
cotransfection	O
of	O
TFIIB	B
and	O
IRF	B
-	I
1	I
into	O
NIH	O
3T3	O
cells	O
resulted	O
in	O
a	O
dose	O
-	O
dependent	O
repression	O
of	O
promoter	O
activation	O
which	O
occurred	O
in	O
a	O
TATA	O
-	O
dependent	O
manner	O
.	O

Expression	O
of	O
the	O
proapoptotic	B
protein	I
Bax	I
under	O
the	O
control	O
of	O
a	O
GAL10	B
promoter	I
in	O
Saccharomyces	O
cerevisiae	O
resulted	O
in	O
galactose	O
-	O
inducible	O
cell	O
death	O
.	O

We	O
show	O
that	O
the	O
5	O
'	O
UTR	O
characteristic	O
of	O
testis	B
-	I
specific	I
c	I
-	I
mos	I
mRNA	I
strongly	O
represses	O
translation	O
relative	O
to	O
the	O
translation	O
of	O
transcripts	O
that	O
contain	O
a	O
5	O
'	O
UTR	O
derived	O
from	O
beta	B
-	I
globin	I
mRNA	I
,	O
and	O
this	O
is	O
mainly	O
due	O
to	O
the	O
four	O
uORFs	O
.	O

To	O
address	O
the	O
biological	O
effect	O
of	O
specific	O
isoform	O
expression	O
,	O
NIH3T3	O
cells	O
were	O
transfected	O
with	O
a	O
eukaryotic	O
expression	O
vector	O
containing	O
cDNA	O
for	O
FGF8a	B
,	O
FGF8b	B
,	O
or	O
FGF8e	B
.	O

When	O
this	O
DNA	O
fragment	O
was	O
placed	O
upstream	O
of	O
the	O
chloramphenicol	B
acetyltransferase	I
(	O
CAT	B
)	O
reporter	O
gene	O
and	O
transfected	O
into	O
a	O
carp	O
CF	O
cell	O
line	O
,	O
it	O
could	O
drive	O
the	O
synthesis	O
of	O
CAT	B
enzyme	I
16	O
times	O
more	O
efficiently	O
than	O
the	O
promoterless	O
pCAT	B
-	I
Basic	I
.	O

Oncogenic	O
activation	O
of	O
the	O
tyrosine	B
kinase	I
domain	I
of	O
the	O
human	B
trk	I
proto	I
-	I
oncogene	I
by	O
fusion	O
to	O
a	O
cell	O
adhesion	O
molecule	O
.	O

Natural	O
FL	B
protein	I
has	O
been	O
purified	O
from	O
a	O
stromal	O
cell	O
line	O
and	O
shown	O
to	O
be	O
a	O
65	O
kD	O
nondisulfide	O
-	O
linked	O
homodimeric	O
glycoprotein	O
comprised	O
of	O
30	O
kD	O
subunits	O
,	O
each	O
containing	O
12	O
kD	O
of	O
N	O
-	O
and	O
O	O
-	O
linked	O
sugars	O
.	O

Spliced	O
exons	O
of	O
adenovirus	O
late	O
RNAs	O
colocalize	O
with	O
snRNP	O
in	O
a	O
specific	O
nuclear	O
domain	O
.	O

Infection	O
with	O
Neisseria	O
meningitidis	O
group	O
B	O
has	O
been	O
difficult	O
to	O
detect	O
,	O
partly	O
because	O
this	O
bacterial	O
group	O
'	O
s	O
polysaccharide	O
is	O
a	O
weak	O
immunogen	O
.	O

220	O
,	O
263	O
-	O
273	O
).	O

These	O
two	O
contigs	O
contain	O
a	O
total	O
of	O
163	O
open	O
reading	O
frames	O
(	O
ORFs	O
)	O
in	O
26	O
-	O
29	O
putative	O
operons	O
;	O
56	O
ORFs	O
could	O
be	O
identified	O
with	O
reasonable	O
certainty	O
.	O

The	O
evidence	O
in	O
support	O
of	O
this	O
was	O
derived	O
from	O
the	O
fact	O
that	O
the	O
affinity	O
or	O
interaction	O
between	O
the	O
two	O
subunits	O
was	O
impaired	O
as	O
indicated	O
by	O
the	O
first	O
order	O
rate	O
constant	O
of	O
hCG	B
alpha	I
1	I
beta	I
(	O
km	O
=	O
4	O
.	O
1	O
x	O
10	O
(-	O
2	O
)	O
min	O
-	O
1	O
)	O
at	O
pH	O
3	O
.	O
0	O
at	O
23	O
degrees	O
C	O
which	O
is	O
one	O
order	O
of	O
magnitude	O
greater	O
relative	O
to	O
rehCG	B
(	O
kw	O
=	O
4	O
.	O
6	O
x	O
10	O
(-	O
3	O
)	O
min	O
-	O
1	O
).	O

The	O
majority	O
of	O
the	O
cases	O
with	O
0	O
-	O
I	O
or	O
0	O
-	O
III	O
components	O
were	O
sm	O
.	O
cancer	O
.	O

This	O
observation	O
calls	O
for	O
careful	O
monitoring	O
of	O
calcium	O
and	O
alkaline	B
phosphatase	I
values	O
and	O
possible	O
adjustments	O
of	O
vitamin	O
D	O
intake	O
when	O
fortifiers	O
are	O
used	O
for	O
extended	O
periods	O
.	O

Signaling	O
from	O
the	O
small	B
GTP	I
-	I
binding	I
proteins	I
Rac1	I
and	O
Cdc42	B
to	O
the	O
c	B
-	I
Jun	I
N	I
-	I
terminal	I
kinase	I
/	O
stress	B
-	I
activated	I
protein	I
kinase	I
pathway	O
.	O

Percent	O
identities	O
of	O
the	O
mouse	B
PP2	I
to	O
mouse	B
Y1	I
,	O
mouse	O
Y4	B
/	O
PP1	B
and	O
human	B
Y2	I
receptors	I
are	O
53	O
,	O
42	O
,	O
and	O
31	O
,	O
respectively	O
.	O

Rifabutin	O
has	O
substantial	O
efficacy	O
when	O
combined	O
with	O
other	O
agents	O
.	O

Ninety	O
-	O
four	O
percent	O
of	O
the	O
EPs	O
were	O
tubal	O
,	O
and	O
90	O
%	O
of	O
the	O
tubes	O
exhibited	O
some	O
pathologic	O
changes	O
,	O
including	O
chronic	O
salpingitis	O
(	O
49	O
.	O
5	O
%)	O
and	O
follicular	O
salpingitis	O
(	O
10	O
%),	O
among	O
others	O
.	O

Magnetic	O
resonance	O
imaging	O
in	O
coccidioidal	O
arthritis	O
.	O

Moloney	O
murine	O
leukemia	O
virus	O
(	O
MMLV	O
)-	O
derived	O
pUCMoTiN	O
-	O
based	O
retroviral	O
vectors	O
were	O
engineered	O
to	O
allow	O
constitutive	O
and	O
Tat	B
(	O
trans	B
-	I
activator	I
of	I
transcription	I
)-	O
inducible	O
expression	O
of	O
five	O
hammerhead	O
ribozymes	O
targeted	O
against	O
highly	O
conserved	O
sequences	O
within	O
the	O
group	B
antigen	I
(	O
Gag	B
),	O
protease	B
(	O
Pro	B
),	O
reverse	B
transcriptase	I
(	O
RT	B
),	O
tat	B
,	O
and	O
envelope	B
(	O
Env	B
)	O
coding	O
regions	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
-	O
1	O
(	O
HIV	O
-	O
1	O
)	O
RNA	O
.	O

BACKGROUND	O
:	O
The	O
Bazett	O
-	O
corrected	O
QT	O
(	O
QTc	O
)	O
interval	O
during	O
exercise	O
has	O
been	O
used	O
as	O
a	O
marker	O
for	O
ischemic	O
disease	O
,	O
arrhythmogenic	O
substrate	O
and	O
the	O
long	O
QT	O
syndrome	O
.	O

In	O
vitro	O
DNase	B
I	I
footprinting	O
showed	O
that	O
OxyR	B
-	I
C199S	I
protected	O
Pmom	B
from	O
-	O
104	O
to	O
-	O
46	O
on	O
the	O
top	O
strand	O
and	O
produced	O
a	O
protection	O
pattern	O
characteristic	O
of	O
reduced	B
wild	I
-	I
type	I
OxyR	I
.	O

Analysis	O
of	O
one	O
cDNA	O
revealed	O
an	O
unusual	O
splicing	O
event	O
involving	O
EZH1	B
and	O
a	O
tandemly	O
linked	O
gene	O
GPR2	B
and	O
suggests	O
a	O
potential	O
mechanism	O
for	O
modifying	O
the	O
EZH1	B
protein	I
in	O
the	O
conserved	O
C	O
-	O
terminal	O
domain	O
.	O

They	O
lack	O
a	O
predicted	O
single	O
stranded	O
(	O
ss	O
)	O
DNA	O
binding	O
motif	O
that	O
is	O
unique	O
the	O
large	O
terminase	B
proteins	I
in	O
T4	B
gp17	I
,	O
and	O
that	O
has	O
been	O
implicated	O
in	O
recognizing	O
ssDNA	O
regions	O
in	O
replicating	O
and	O
recombining	O
T4DNA	O
destined	O
to	O
be	O
packaged	O
.	O

It	O
can	O
be	O
concluded	O
that	O
in	O
normotensive	O
subjects	O
,	O
uric	O
acid	O
and	O
xanthine	B
oxidase	I
have	O
significant	O
association	O
with	O
blood	O
pressure	O
and	O
thus	O
are	O
one	O
of	O
the	O
many	O
factors	O
which	O
are	O
involved	O
in	O
the	O
cause	O
or	O
effect	O
of	O
hypertension	O
.	O

The	O
current	O
study	O
defines	O
the	O
vinculin	B
-	O
and	O
FAK	B
-	I
interaction	I
domains	I
on	O
paxillin	B
and	O
identifies	O
the	O
principal	O
paxillin	B
focal	O
adhesion	O
targeting	O
motif	O
.	O

Jerseys	O
had	O
higher	O
hepatic	O
Cu	O
concentrations	O
than	O
did	O
Holsteins	O
on	O
d	O
60	O
(	O
346	O
vs	O
.	O

However	O
,	O
the	O
ratio	O
M	O
/	O
Pc	O
provides	O
a	O
useful	O
index	O
that	O
seems	O
to	O
be	O
independent	O
of	O
the	O
metabolic	O
demand	O
.	O

The	O
accumulation	O
of	O
both	O
LHA4	B
and	O
LHA2	B
mRNAs	I
is	O
induced	O
by	O
the	O
addition	O
of	O
exogenous	O
sugars	O
and	O
this	O
induction	O
appears	O
to	O
be	O
dependent	O
on	O
sugar	O
uptake	O
and	O
metabolism	O
,	O
because	O
mannitol	O
and	O
3	O
-	O
O	O
-	O
methylglucose	O
do	O
not	O
stimulate	O
mRNA	O
accumulation	O
.	O

Using	O
the	O
yeast	O
one	O
-	O
hybrid	O
screen	O
with	O
integrated	O
NRE	O
and	O
flanking	O
DNA	O
as	O
bait	O
,	O
the	O
predominant	O
clone	O
obtained	O
was	O
bovine	B
Nrl	I
.	O

These	O
findings	O
suggest	O
that	O
fodrin	B
proteolysis	O
in	O
vivo	O
may	O
reflect	O
the	O
activity	O
of	O
multiple	O
ICE	B
/	O
Ced	B
-	I
3	I
proteases	O
whose	O
partial	O
sensitivity	O
to	O
DEVD	O
-	O
CHO	O
reflects	O
a	O
limited	O
contribution	O
from	O
CPP32	B
,	O
or	O
an	O
ICE	B
/	O
Ced	B
-	I
3	I
protease	O
less	O
sensitive	O
than	O
CPP32	B
to	O
DEVD	O
-	O
CHO	O
inhibition	O
.	O

The	O
Escherichia	B
coli	I
tet	I
-	I
repressor	I
(	O
TetR	B
)	O
operator	O
system	O
was	O
used	O
to	O
develop	O
a	O
variation	O
of	O
the	O
yeast	O
two	O
-	O
hybrid	O
assay	O
in	O
which	O
disruptions	O
of	O
protein	O
-	O
protein	O
interactions	O
can	O
be	O
identified	O
by	O
a	O
positive	O
selection	O
.	O

Structural	O
basis	O
for	O
activation	O
of	O
human	B
lymphocyte	I
kinase	I
Lck	I
upon	O
tyrosine	O
phosphorylation	O
.	O

These	O
results	O
suggest	O
that	O
Rho1p	B
regulates	O
cytoskeletal	O
reorganization	O
at	O
least	O
through	O
Bni1p	B
and	O
Pkc1p	B
.	O

Several	O
particular	O
features	O
of	O
this	O
polypeptide	O
fragment	O
from	O
the	O
hamster	B
lysyl	I
-	I
tRNA	I
synthetase	I
suggest	O
that	O
it	O
is	O
implicated	O
in	O
the	O
assembly	O
of	O
that	O
enzyme	O
within	O
the	O
multisynthetase	O
complex	O
.	O

The	O
0	O
.	O
22	O
-	O
kb	O
NheI	B
/	O
BglII	B
promoter	O
exhibited	O
PMA	O
inducibility	O
in	O
myeloid	O
cells	O
and	O
contained	O
a	O
PMA	O
-	O
responsive	O
element	O
recognized	O
by	O
Sp1	B
and	O
EGR	B
-	I
1	I
transcription	I
factors	I
.	O

These	O
results	O
suggested	O
that	O
the	O
GG	O
motifs	O
contributed	O
to	O
the	O
cell	O
-	O
specific	O
transcription	O
of	O
the	O
human	B
insulin	I
gene	I
in	O
association	O
with	O
the	O
binding	O
of	O
the	O
sequence	O
-	O
specific	O
nuclear	O
factor	O
.	O

327	O
and	O
736	O
protocols	O
of	O
postmortem	O
examinations	O
from	O
Moscow	O
hospitals	O
N	O
31	O
and	O
57	O
,	O
respectively	O
,	O
were	O
evaluated	O
statistically	O
.	O

The	O
promoter	O
segment	O
was	O
inactive	O
when	O
introduced	O
into	O
the	O
rat	O
glioma	O
cell	O
line	O
C6B4	O
,	O
the	O
rat	O
submandibular	O
cell	O
line	O
RSMT	O
-	O
A5	O
,	O
and	O
the	O
rat	O
pancreatic	O
beta	O
cell	O
line	O
RIN	O
-	O
5AH	O
,	O
all	O
of	O
which	O
do	O
not	O
express	O
the	O
endogenous	O
alpha2c	B
-	I
AR	I
gene	I
.	O

The	O
sequencing	O
of	O
the	O
conditional	O
lethal	O
mutation	O
ts	O
-	O
A13	O
,	O
localized	O
in	O
the	O
nrdE	B
cistron	I
,	O
and	O
the	O
lethality	O
of	O
insertional	O
mutations	O
targeted	O
in	O
the	O
internal	O
region	O
of	O
nrdE	B
and	O
nrdF	B
,	O
demonstrated	O
the	O
essential	O
role	O
of	O
this	O
locus	O
.	O

On	O
the	O
basis	O
of	O
serological	O
studies	O
,	O
the	O
highly	O
conserved	O
A	O
domain	O
of	O
HspA	B
was	O
found	O
to	O
be	O
the	O
immunodominant	O
domain	O
.	O

Fas	B
has	O
been	O
shown	O
to	O
require	O
ICE	B
(	O
interleukin	B
-	I
1	I
beta	I
-	I
converting	I
enzyme	I
)	O
family	O
proteases	O
to	O
induce	O
apoptosis	O
from	O
studies	O
utilizing	O
the	O
cowpox	O
ICE	B
inhibitor	I
protein	I
CrmA	I
,	O
the	O
synthetic	O
tetrapeptide	O
ICE	B
inhibitor	O
YVAD	B
-	I
CMK	I
,	O
and	O
the	O
tripeptide	O
pan	O
-	O
ICE	B
inhibitor	O
Z	B
-	I
VAD	I
-	I
FMK	I
.	O

In	O
this	O
report	O
,	O
we	O
demonstrate	O
that	O
hGCN5	B
is	O
also	O
an	O
HAT	B
and	O
has	O
the	O
same	O
substrate	O
specificity	O
as	O
yGCN5	B
.	O

Several	O
cDNAs	O
corresponding	O
to	O
the	O
human	B
PWP2	I
gene	I
were	O
identified	O
and	O
partially	O
sequenced	O
.	O

To	O
examine	O
whether	O
thiamine	O
(	O
vitamin	O
B1	O
)	O
deficiency	O
is	O
associated	O
with	O
recurrent	O
aphthous	O
stomatitis	O
,	O
we	O
studied	O
vitamin	O
B1	O
levels	O
in	O
70	O
patients	O
with	O
recurrent	O
aphthous	O
stomatitis	O
and	O
in	O
50	O
members	O
of	O
a	O
control	O
group	O
.	O

Such	O
multisensory	O
interactions	O
can	O
be	O
significant	O
for	O
behavior	O
.	O

Mortality	O
on	O
the	O
last	O
ranch	O
was	O
particularly	O
severe	O
among	O
certain	O
segregated	O
groups	O
of	O
turkeys	O
that	O
included	O
toms	O
,	O
heavier	O
birds	O
,	O
and	O
birds	O
undergoing	O
a	O
stressful	O
event	O
such	O
as	O
artificial	O
insemination	O
.	O

Further	O
,	O
the	O
PIP2	O
content	O
of	O
the	O
85	O
-	O
90	O
kDa	O
protein	O
appeared	O
to	O
decrease	O
with	O
CSF	B
-	I
1	I
treatment	O
.	O

Further	O
,	O
the	O
PIP2	O
content	O
of	O
the	O
85	O
-	O
90	O
kDa	O
protein	O
appeared	O
to	O
decrease	O
with	O
CSF	B
-	I
1	I
treatment	O
.	O

Just	O
before	O
inserting	O
on	O
the	O
anterior	O
margin	O
and	O
apex	O
of	O
the	O
iliac	O
crest	O
it	O
widens	O
,	O
assuming	O
the	O
aspect	O
of	O
a	O
small	O
cone	O
.	O

INTERVENTION	O
(	O
S	O
):	O
Twenty	O
-	O
six	O
hemostasis	O
parameters	O
evaluated	O
repeatedly	O
in	O
patients	O
undergoing	O
IVF	O
-	O
ET	O
.	O

The	O
most	O
common	O
risk	O
factor	O
reported	O
for	O
both	O
recent	O
and	O
all	O
other	O
hepatitis	O
C	O
cases	O
was	O
a	O
history	O
of	O
injecting	O
drug	O
use	O
,	O
although	O
the	O
proportion	O
of	O
cases	O
with	O
that	O
history	O
was	O
different	O
in	O
NT	O
from	O
ACT	O
and	O
Queensland	O
.	O

Although	O
p48	B
gene	I
induction	O
is	O
dependent	O
on	O
STAT1	B
and	O
JAK1	B
,	O
activated	O
STAT1	B
does	O
not	O
bind	O
to	O
GATE	B
.	O

The	O
syndrome	O
of	O
resistance	O
to	O
thyroid	O
hormone	O
is	O
characterized	O
by	O
elevated	O
serum	O
free	O
thyroid	O
hormones	O
,	O
failure	O
to	O
suppress	O
pituitary	B
thyrotropin	I
secretion	O
,	O
and	O
variable	O
peripheral	O
refractoriness	O
to	O
hormone	O
action	O
.	O

SUMMARY	O
BACKGROUND	O
DATA	O
:	O
Melanoma	O
care	O
has	O
not	O
changed	O
significantly	O
in	O
the	O
last	O
20	O
years	O
,	O
and	O
the	O
controversy	O
of	O
elective	O
lymph	O
node	O
dissections	O
in	O
this	O
disease	O
continues	O
to	O
be	O
discussed	O
.	O

Its	O
transcription	O
product	O
,	O
a	O
1	O
.	O
3	O
kb	O
mRNA	O
,	O
is	O
polyadenylated	O
at	O
a	O
site	O
containing	O
consensus	O
eukaryotic	O
polyadenylation	O
signals	O
and	O
mapping	O
87	O
bp	O
downstream	O
of	O
the	O
translation	O
termination	O
codon	O
for	O
CG30	B
.	O

NUP145	B
was	O
previously	O
identified	O
by	O
using	O
a	O
genetic	O
synthetic	O
lethal	O
screen	O
(	O
E	O
.	O

A	O
total	O
of	O
1459	O
men	O
aged	O
48	O
to	O
84	O
years	O
,	O
who	O
were	O
diagnosed	O
for	O
the	O
first	O
time	O
by	O
physicians	O
as	O
having	O
BPH	O
in	O
1994	O
and	O
who	O
had	O
not	O
received	O
treatment	O
,	O
participated	O
in	O
the	O
study	O
.	O

Control	O
examination	O
was	O
performed	O
at	O
the	O
end	O
of	O
each	O
period	O
.	O

The	O
results	O
demonstrate	O
(	O
i	O
)	O
that	O
the	O
selenocysteine	O
-	O
specific	O
UGA	O
codon	O
is	O
readily	O
suppressed	O
under	O
conditions	O
where	O
the	O
homologous	B
SelB	I
protein	I
is	O
absent	O
and	O
(	O
ii	O
)	O
that	O
apart	O
from	O
the	O
specificity	O
of	O
the	O
SelB	B
-	I
mRNA	I
interaction	O
,	O
a	O
structural	O
compatibility	O
of	O
the	O
quaternary	O
complex	O
with	O
the	O
ribosome	O
is	O
required	O
.	O

One	O
linker	O
-	O
peptide	O
insertion	O
in	O
the	O
RsaA	B
C	I
terminus	I
(	I
amino	I
acid	I
784	I
)	I
had	O
no	O
effect	O
on	O
S	O
-	O
layer	O
biogenesis	O
,	O
while	O
another	O
(	O
amino	O
acid	O
907	O
)	O
disrupted	O
secretion	O
of	O
the	O
protein	O
,	O
suggesting	O
that	O
RsaA	B
possesses	O
a	O
secretion	O
signal	O
lying	O
C	O
terminal	O
to	O
amino	O
acid	O
784	O
,	O
near	O
or	O
including	O
amino	O
acid	O
907	O
.	O

PrpB	B
showed	O
homology	O
to	O
carboxyphosphonoenolpyruvate	B
phosphonomutase	I
of	I
Streptomyces	I
hygroscopicus	I
and	O
to	O
its	O
homolog	O
in	O
the	O
carnation	O
Dianthus	O
caryophyllus	O
;	O
PrpC	B
was	O
homologous	O
to	O
both	O
archaeal	B
and	I
bacterial	I
citrate	I
synthases	I
;	O
PrpD	B
showed	O
homology	O
to	O
yeast	O
and	O
Bacillus	O
subtilis	O
proteins	O
of	O
unknown	O
function	O
;	O
PrpE	B
showed	O
homology	O
to	O
acetyl	B
coenzyme	I
A	I
synthetases	I
.	O

Sp1	B
binds	O
the	O
CTC	O
repeat	O
with	O
an	O
affinity	O
,	O
KD	O
=	O
0	O
.	O
37	O
nM	O
,	O
at	O
least	O
as	O
high	O
as	O
the	O
consensus	O
GC	O
box	O
.	O

CDNA	O
cloning	O
of	O
chick	B
brain	I
alpha	I
-	I
amino	I
-	I
3	I
-	I
hydroxy	I
-	I
5	I
-	I
methyl	I
-	I
4	I
-	I
isoxazolepropionic	I
acid	I
receptors	I
reveals	O
conservation	O
of	O
structure	O
,	O
function	O
and	O
post	O
-	O
transcriptional	O
processes	O
with	O
mammalian	O
receptors	O
.	O

Serotonin	B
receptors	I
in	O
suicide	O
victims	O
with	O
major	O
depression	O
.	O

The	O
Y	O
-	O
type	O
structural	O
motif	O
is	O
also	O
conserved	O
among	O
a	O
number	O
of	O
divergent	O
BiP	B
mRNAs	I
.	O

A	O
false	O
positive	O
marker	O
screen	O
was	O
associated	O
with	O
the	O
occurrence	O
of	O
hand	O
-	O
foot	O
syndrome	O
even	O
when	O
the	O
effect	O
of	O
regimen	O
was	O
accounted	O
for	O
by	O
stratification	O
(	O
p	O
=	O
.	O
01	O
).	O

Complexes	O
of	O
qTBP42	B
with	O
each	O
complementary	O
strand	O
of	O
telomeric	O
DNA	O
and	O
with	O
quadruplex	O
forms	O
of	O
the	O
guanine	O
-	O
rich	O
strand	O
had	O
3	O
.	O
7	O
-	O
14	O
.	O
6	O
nM	O
dissociation	O
constants	O
,	O
Kd	O
,	O
whereas	O
complexes	O
with	O
double	O
-	O
stranded	O
telomeric	O
DNA	O
had	O
up	O
to	O
100	O
-	O
fold	O
higher	O
Kd	O
values	O
.	O

Moreover	O
,	O
the	O
effect	O
exerted	O
by	O
TIS1	B
appeared	O
to	O
be	O
selective	O
for	O
the	O
MCK	B
promoter	I
.	O

cDNA	O
cloning	O
,	O
expression	O
analysis	O
,	O
and	O
chromosomal	O
localization	O
of	O
a	O
gene	O
with	O
high	O
homology	O
to	O
wheat	B
eIF	I
-(	I
iso	I
)	I
4F	I
and	O
mammalian	B
eIF	I
-	I
4G	I
.	O

In	O
rlf2	B
mutants	I
,	O
telomeric	O
chromatin	O
is	O
perturbed	O
:	O
Telomeric	O
silencing	O
is	O
reduced	O
and	O
Rap1p	B
localization	O
is	O
altered	O
.	O

Most	O
kinases	O
are	O
not	O
significantly	O
inhibited	O
by	O
roscovitine	O
.	O
cdc2	B
/	O
cyclin	B
B	I
,	O
cdk2	B
/	O
cyclin	B
A	I
,	O
cdk2	B
/	O
cyclin	B
E	I
and	O
cdk5	B
/	O
p35	B
only	O
are	O
substantially	O
inhibited	O
(	O
IC50	O
values	O
of	O
0	O
.	O
65	O
,	O
0	O
.	O
7	O
,	O
0	O
.	O
7	O
and	O
0	O
.	O
2	O
microM	O
,	O
respectively	O
).	O
cdk4	B
/	O
cyclin	B
D1	I
and	O
cdk6	B
/	O
cyclin	B
D2	I
are	O
very	O
poorly	O
inhibited	O
by	O
roscovitine	O
(	O
IC50	O
>	O
100	O
microM	O
).	O

Interaction	O
of	O
Ets	B
-	I
1	I
and	O
the	O
POU	B
-	I
homeodomain	I
protein	I
GHF	I
-	I
1	I
/	O
Pit	B
-	I
1	I
reconstitutes	O
pituitary	O
-	O
specific	O
gene	O
expression	O
.	O

Using	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
to	O
screen	O
for	O
proteins	O
which	O
interact	O
with	O
Tax1	B
,	O
we	O
isolated	O
the	O
B	O
subunit	O
of	O
the	O
CCAAT	O
binding	O
protein	O
NF	B
-	I
Y	I
from	O
a	O
HeLa	O
cDNA	O
library	O
.	O

Enhancer	O
activity	O
requires	O
both	O
the	O
AP	B
-	I
1	I
site	I
and	O
these	O
adjacent	O
sequences	O
.	O

Furthermore	O
,	O
Rac1	B
activation	O
of	O
JNK	B
or	O
SRF	B
,	O
or	O
induction	O
of	O
lamellipodia	O
,	O
was	O
neither	O
necessary	O
nor	O
sufficient	O
for	O
Rac1	B
transforming	O
activity	O
.	O

Overexpression	O
of	O
the	O
bZip	O
interaction	O
domain	O
of	O
CBP	B
specifically	O
abolishes	O
the	O
positive	O
cross	O
talk	O
between	O
TR	B
and	O
p45	B
/	O
NF	B
-	I
E2	I
.	O

Identification	O
of	O
a	O
promoter	O
-	O
specific	O
transactivation	O
domain	O
in	O
the	O
herpes	B
simplex	I
virus	I
regulatory	I
protein	I
ICP4	I
.	O

In	O
summary	O
,	O
p56	B
(	O
lck	B
)	O
activity	O
stimulates	O
G1	O
/	O
S	O
transition	O
in	O
immature	O
thymoblasts	O
and	O
maintains	O
cell	O
viability	O
via	O
transduction	O
of	O
constitutive	O
activation	O
signals	O
downstream	O
to	O
components	O
of	O
the	O
Ras	B
/	O
Raf	B
/	O
MAPK	B
pathway	O
.	O

METHODS	O
:	O
Fifty	O
-	O
eight	O
patients	O
who	O
underwent	O
a	O
curative	O
hepatic	O
resection	O
for	O
HCC	O
and	O
whose	O
preoperative	O
AFP	B
levels	O
were	O
>	O
100	O
ng	O
/	O
ml	O
,	O
were	O
selected	O
for	O
this	O
study	O
.	O

Here	O
we	O
show	O
that	O
the	O
type	O
of	O
tyrosine	B
kinase	I
receptor	I
stimulated	O
also	O
participates	O
in	O
the	O
nature	O
of	O
the	O
cAMP	O
effect	O
.	O

The	O
best	O
endometrial	O
ablation	O
was	O
seen	O
when	O
SnET2	O
was	O
given	O
by	O
intrauterine	O
administration	O
with	O
light	O
treatment	O
at	O
150	O
J	O
/	O
cm	O
24	O
hours	O
later	O
.	O

Transient	O
cotransfection	O
of	O
tat	B
cDNA	I
in	O
sense	O
orientation	O
(	O
tat	B
/	I
S	I
),	O
together	O
with	O
a	O
plasmid	O
containing	O
the	O
c	B
-	I
fos	I
promoter	I
(	O
FC3	B
,	O
from	O
-	O
711	O
to	O
+	O
42	O
)	O
in	O
front	O
of	O
the	O
bacterial	B
chloramphenicol	I
acetyltransferase	I
(	O
CAT	B
)	O
gene	O
significantly	O
enhanced	O
CAT	B
activity	O
in	O
Jurkat	O
cells	O
activated	O
by	O
the	O
addition	O
of	O
15	O
%	O
fetal	O
calf	O
serum	O
(	O
FCS	O
)	O
or	O
5	O
micrograms	O
/	O
mL	O
phytohemagglutinin	B
plus	O
10	O
(-	O
7	O
)	O
mol	O
/	O
L	O
phorbol	O
myristate	O
acetate	O
(	O
PMA	O
)	O
and	O
U937	O
cells	O
activated	O
by	O
15	O
%	O
FCS	O
or	O
10	O
(-	O
7	O
)	O
mol	O
/	O
L	O
PMA	O
.	O

To	O
avoid	O
complications	O
,	O
accurate	O
quantitative	O
analysis	O
of	O
NO	O
and	O
NO2	O
is	O
necessary	O
during	O
this	O
therapy	O
.	O

Functional	O
tests	O
using	O
a	O
reporter	O
gene	O
,	O
containing	O
Stat5	B
-	I
binding	I
elements	I
,	O
confirmed	O
that	O
while	O
the	O
variant	O
form	O
was	O
inactive	O
by	O
itself	O
,	O
it	O
could	O
inhibit	O
the	O
function	O
of	O
the	O
full	O
-	O
length	O
receptor	O
.	O

Sixty	O
-	O
nine	O
(	O
44	O
%)	O
patients	O
were	O
administered	O
250	O
MBq	O
(	O
7	O
mCi	O
)	O
99Tcm	O
-	O
tetrofosmin	O
at	O
rest	O
followed	O
4	O
h	O
later	O
by	O
750	O
MBq	O
(	O
21	O
mCi	O
)	O
during	O
stress	O
(	O
the	O
1	O
day	O
protocol	O
),	O
whereas	O
88	O
(	O
56	O
%)	O
patients	O
had	O
rest	O
and	O
stress	O
imaging	O
studies	O
on	O
two	O
separate	O
days	O
,	O
receiving	O
a	O
500	O
MBq	O
(	O
14	O
mCi	O
)	O
dose	O
of	O
99Tcm	O
-	O
tetrofosmin	O
on	O
each	O
occasion	O
(	O
the	O
2	O
day	O
protocol	O
).	O

We	O
have	O
thus	O
identified	O
the	O
first	O
mammalian	B
homolog	I
of	I
yeast	I
UPF1	I
,	O
a	O
protein	O
that	O
regulates	O
levels	O
of	O
nonsense	O
mRNA	O
,	O
and	O
we	O
tentatively	O
name	O
this	O
protein	O
human	B
HUPF1	I
(	O
for	O
human	B
homolog	I
of	I
UPF1	I
).	O

DNA	O
strand	O
exchange	O
catalyzed	O
by	O
Rad51	B
protein	I
is	O
also	O
greatly	O
stimulated	O
by	O
RPA	B
.	O

In	O
cell	O
lines	O
transformed	O
by	O
BCR	B
/	O
ABL	B
,	O
CRKL	B
was	O
tyrosine	O
phosphorylated	O
,	O
while	O
CRK	B
was	O
not	O
.	O

Type	O
IV	O
splice	O
pattern	O
,	O
containing	O
exon	O
U3	O
and	O
S	O
was	O
found	O
both	O
in	O
kidney	O
and	O
ovary	O
.	O

During	O
the	O
febrile	O
period	O
,	O
pleocytosis	O
was	O
associated	O
with	O
high	O
levels	O
of	O
IgG	B
,	O
IL	B
-	I
6	I
,	O
TNF	B
-	I
alpha	I
,	O
and	O
PGE2	O
in	O
the	O
cerebrospinal	O
fluid	O
.	O

The	O
minimum	O
and	O
essential	O
subunits	O
for	O
RNA	O
synthesis	O
have	O
not	O
yet	O
been	O
identified	O
.	O

Members	O
of	O
the	O
MAPK	B
family	I
include	O
the	O
extracellular	B
response	I
kinases	I
(	O
ERKs	B
or	O
p42	B
/	I
44	I
(	O
MAPK	B
)),	O
the	O
c	B
-	I
Jun	I
amino	I
-	I
terminal	I
kinases	I
(	O
JNKs	B
),	O
and	O
the	O
p38	B
/	O
Hog	B
1	I
protein	O
kinases	O
.	O

Molecular	O
characterization	O
of	O
a	O
large	O
Borrelia	O
burgdorferi	O
motility	O
operon	O
which	O
is	O
initiated	O
by	O
a	O
consensus	O
sigma70	B
promoter	I
.	O

Therefore	O
more	O
active	O
and	O
tolerable	O
salvage	O
regimens	O
are	O
needed	O
.	O

While	O
TGF	B
-	I
beta1	I
does	O
not	O
alter	O
the	O
mitogen	O
-	O
induced	O
expression	O
and	O
abundance	O
of	O
G1	O
phase	O
cyclin	B
D1	I
and	O
cdks	B
4	I
and	I
2	I
in	O
MCs	O
,	O
it	O
inhibits	O
cyclin	B
E	I
-	O
cdk	B
2	I
activity	O
,	O
thus	O
preventing	O
mitogen	O
-	O
elicited	O
phosphorylation	O
and	O
inactivation	O
of	O
pRb	B
in	O
G1	O
phase	O
and	O
transition	O
to	O
S	O
phase	O
.	O

It	O
is	O
also	O
homologous	O
to	O
other	O
sugar	O
carriers	O
from	O
human	O
,	O
mouse	O
and	O
Escherichia	O
coli	O
.	O

Until	O
now	O
,	O
each	O
of	O
these	O
loci	O
was	O
considered	O
to	O
contain	O
three	O
genes	O
(	O
for	O
regulator	B
,	O
permease	B
and	O
alpha	B
-	I
glucosidase	I
),	O
but	O
a	O
fourth	O
gene	O
,	O
presumably	O
an	O
extra	O
alpha	B
-	I
glucosidase	I
gene	I
,	O
was	O
found	O
at	O
MAL1	B
adjacent	O
to	O
the	O
usual	O
cluster	O
of	O
three	O
genes	O
.	O

Diacylglycerol	B
kinase	I
(	O
DGK	B
)	O
attenuates	O
levels	O
of	O
second	O
messenger	O
diacylglycerol	O
in	O
cells	O
and	O
produces	O
another	O
(	O
putative	O
)	O
messenger	O
,	O
phosphatidic	O
acid	O
.	O

Thirty	O
Class	O
I	O
and	O
Class	O
II	O
recessions	O
in	O
30	O
patients	O
were	O
treated	O
with	O
a	O
modified	O
subepithelial	O
connective	O
tissue	O
graft	O
procedure	O
.	O

The	O
derivatives	O
of	O
the	O
latter	O
two	O
cell	O
lines	O
showed	O
increased	O
expression	O
of	O
the	O
p27Kip1	B
protein	I
and	O
inhibition	O
of	O
cell	O
growth	O
.	O

Chronic	O
renal	O
failure	O
patients	O
essentially	O
die	O
from	O
cardiovascular	O
causes	O
,	O
and	O
the	O
frequency	O
of	O
malignant	O
disease	O
responsible	O
for	O
death	O
is	O
estimated	O
to	O
be	O
10	O
%.	O

Similarly	O
,	O
the	O
DNA	O
-	O
binding	O
activity	O
of	O
activator	B
protein	I
1	I
(	O
AP	B
-	I
1	I
)	O
is	O
modified	O
by	O
a	O
DNA	B
repair	I
enzyme	I
,	O
redox	B
factor	I
1	I
(	O
Ref	B
-	I
1	I
),	O
which	O
is	O
identical	O
to	O
a	O
DNA	B
repair	I
enzyme	I
,	O
AP	B
endonuclease	I
.	O

Upon	O
induction	O
of	O
SOS	O
,	O
viability	O
increased	O
2	O
-	O
6	O
-	O
fold	O
.	O

Little	O
is	O
known	O
about	O
the	O
mechanism	O
,	O
but	O
the	O
availability	O
of	O
rapid	O
facile	O
assays	O
for	O
monitoring	O
immunoglobulin	B
hypermutation	O
would	O
greatly	O
aid	O
the	O
development	O
of	O
culture	O
systems	O
for	O
hypermutating	O
B	O
cells	O
as	O
well	O
as	O
the	O
screening	O
for	O
individuals	O
deficient	O
in	O
the	O
process	O
.	O

Of	O
these	O
proteins	O
,	O
five	O
have	O
previously	O
been	O
shown	O
to	O
be	O
phosphorylated	O
during	O
mitosis	O
(	O
epithelial	B
-	I
microtubule	I
associated	I
protein	I
-	I
115	I
,	O
Oct91	B
,	O
Elongation	B
factor	I
1gamma	I
,	O
BRG1	B
and	O
Ribosomal	B
protein	I
L18A	I
),	O
five	O
are	O
related	O
to	O
proteins	O
postulated	O
to	O
have	O
roles	O
in	O
mitosis	O
(	O
epithelial	B
-	I
microtubule	I
associated	I
protein	I
-	I
115	I
,	O
Schizosaccharomyces	B
pombe	I
Cdc5	I
,	O
innercentrosome	B
protein	I
,	O
BRG1	B
and	O
the	O
RNA	B
helicase	I
WM6	I
),	O
and	O
nine	O
are	O
related	O
to	O
transcription	O
factors	O
(	O
BRG1	B
,	O
negative	B
co	I
-	I
factor	I
2alpha	I
,	O
Oct91	B
,	O
S	O
.	O
pombe	O
Cdc5	B
,	O
HoxD1	B
,	O
Sox3	B
,	O
Vent2	B
,	O
and	O
two	O
isoforms	O
of	O
Xbr1b	B
).	O

RESULTS	O
:	O
Of	O
the	O
29	O
patients	O
who	O
received	O
concurrent	O
chemotherapy	O
and	O
G	B
-	I
CSF	I
,	O
ten	O
(	O
34	O
%;	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
],	O
17	O
.	O
9	O
to	O
54	O
.	O
3	O
%)	O
were	O
believed	O
to	O
have	O
clinically	O
significant	O
bleomycin	O
toxicity	O
.	O

Domains	O
I	O
and	O
II	O
of	O
B	B
"	I
are	O
buried	O
upon	O
assembly	O
of	O
the	O
TFIIIB	B
-	I
DNA	I
complex	I
,	O
as	O
determined	O
by	O
protein	O
footprinting	O
.	O

These	O
activities	O
are	O
all	O
required	O
for	O
stimulation	O
of	O
cell	O
growth	O
by	O
middle	B
-	I
T	I
and	O
activate	O
members	O
of	O
the	O
MAP	B
kinase	I
family	I
.	O

The	O
pigment	O
intensity	O
of	O
both	O
melanized	O
colonies	O
and	O
appressoria	O
of	O
CAL	O
transformants	O
was	O
weaker	O
than	O
that	O
of	O
the	O
wild	O
type	O
.	O

Comparison	O
of	O
the	O
p50	B
sequence	I
to	O
other	O
cloned	O
proteins	O
revealed	O
89	O
%	O
homology	O
with	O
a	O
glycosaminoglycan	O
-	O
binding	O
protein	O
and	O
54	O
%	O
homology	O
with	O
Drosophila	B
cell	I
cycle	I
control	I
protein	I
(	I
cdc	I
)	I
37	O
.	O

Additional	O
information	O
including	O
echocardiographic	O
sequences	O
,	O
perioperative	O
video	O
sequences	O
,	O
x	O
-	O
ray	O
analysis	O
,	O
angiograms	O
,	O
etc	O
.	O
is	O
represented	O
in	O
the	O
program	O
.	O

Thus	O
,	O
the	O
P	O
.	O
aeruginosa	O
orfX	O
and	O
vfr	B
promoters	I
are	O
arranged	O
in	O
a	O
back	O
-	O
to	O
-	O
back	O
orientation	O
rather	O
than	O
the	O
face	O
-	O
to	O
-	O
face	O
orientation	O
of	O
the	O
dorf	O
and	O
crp	B
promoters	I
.	O

In	O
contrast	O
,	O
the	O
Anabaena	O
strain	O
7120	O
leuA	B
gene	O
did	O
not	O
complement	O
the	O
nifV	B
mutation	I
of	O
R229I	O
efficiently	O
.	O

This	O
finding	O
is	O
the	O
first	O
example	O
of	O
utilization	O
of	O
noncomplementary	O
dinucleotide	O
primer	O
by	O
an	O
RNA	B
polymerase	I
.	O

This	O
conformer	O
features	O
a	O
Type	O
I	O
beta	O
-	O
turn	O
and	O
has	O
extensive	O
hydrophobic	O
contacts	O
with	O
the	O
FKBP12	B
binding	O
surface	O
.	O

Respiratory	O
chain	O
enzyme	O
activity	O
was	O
normal	O
.	O

A	O
promising	O
new	O
cement	O
,	O
4	O
-	O
META	O
/	O
MMA	O
-	O
TBB	O
opaque	O
resin	O
,	O
has	O
shown	O
remarkable	O
adhesive	O
properties	O
as	O
a	O
bone	O
cement	O
in	O
vivo	O
.	O

Each	O
sample	O
was	O
analysed	O
as	O
soon	O
as	O
possible	O
,	O
and	O
repeated	O
15	O
,	O
30	O
,	O
60	O
and	O
120	O
min	O
after	O
sampling	O
.	O

Molecular	O
characterization	O
and	O
expression	O
of	O
the	O
Erwinia	B
carotovora	I
hrpNEcc	I
gene	I
,	O
which	O
encodes	O
an	O
elicitor	O
of	O
the	O
hypersensitive	O
reaction	O
.	O

The	O
mRNA	O
from	O
this	O
gene	O
,	O
termed	O
HES1	B
,	O
is	O
ubiquitously	O
expressed	O
,	O
but	O
strongly	O
so	O
in	O
heart	O
and	O
skeletal	O
muscle	O
.	O

In	O
several	O
studies	O
the	O
RDFS	O
has	O
shown	O
evidence	O
of	O
reliability	O
and	O
validity	O
.	O

Latanoprost	O
produces	O
an	O
additional	O
reduction	O
of	O
intraocular	O
pressure	O
(	O
IOP	O
)	O
when	O
used	O
in	O
combination	O
with	O
timolol	O
,	O
pilocarpine	O
,	O
acetazolamide	O
and	O
dipivefrin	O
.	O

These	O
results	O
suggest	O
that	O
dietary	O
safflower	O
phospholipids	O
may	O
be	O
a	O
valuable	O
ingredient	O
to	O
layers	O
for	O
reducing	O
liver	O
triglycerides	O
and	O
serum	O
cholesterol	O
without	O
any	O
adverse	O
effects	O
.	O

Transient	O
overexpression	O
of	O
c	B
-	I
Jun	I
induced	O
tenascin	B
-	I
C	I
expression	O
in	O
primary	O
REF	O
and	O
in	O
FR3T3	O
,	O
an	O
established	O
fibroblast	O
cell	O
line	O
.	O

Previous	O
studies	O
have	O
indicated	O
that	O
a	O
hamster	O
cell	O
line	O
(	O
ts13	O
)	O
with	O
a	O
point	O
mutation	O
in	O
the	O
TAF	B
(	I
II	I
)	I
250	I
/	O
CCG1	B
(	O
TAF	B
(	I
II	I
)	I
250	I
)	O
gene	O
shows	O
temperature	O
-	O
sensitive	O
expression	O
of	O
a	O
subset	O
of	O
genes	O
and	O
arrests	O
in	O
late	O
G1	O
at	O
39	O
.	O
5	O
degrees	O
C	O
.	O

Both	O
quantitative	O
and	O
qualitative	O
analysis	O
of	O
individual	O
cytoarchitectonic	O
peculiarities	O
of	O
Meynart	O
'	O
s	O
nucleus	O
as	O
well	O
as	O
of	O
external	O
part	O
of	O
dorsomedial	O
nucleus	O
of	O
thalamus	O
was	O
performed	O
in	O
mentally	O
normal	O
individuals	O
.	O

As	O
opposed	O
to	O
in	O
vitro	O
co	O
-	O
precipitation	O
studies	O
,	O
the	O
yeast	O
two	O
-	O
hybrid	O
screen	O
reveals	O
in	O
vivo	O
protein	O
-	O
protein	O
interactions	O
.	O

An	O
alternatively	O
spliced	O
MAdCAM	B
-	I
1	I
variant	O
was	O
identified	O
that	O
lacks	O
exon	O
4	O
encoding	O
the	O
mucin	B
domain	O
,	O
and	O
may	O
mediate	O
leukocyte	O
adhesion	O
to	O
LPAM	B
-	I
1	I
without	O
adhesion	O
to	O
the	O
alternate	O
receptor	O
,	O
L	B
-	I
selectin	I
.	O

In	O
unc	B
-	I
4	I
mutants	I
,	O
VA	O
motor	O
neurons	O
assume	O
the	O
pattern	O
of	O
synaptic	O
input	O
normally	O
reserved	O
for	O
their	O
lineal	O
sister	O
cells	O
,	O
the	O
VB	O
motor	O
neurons	O
;	O
the	O
loss	O
of	O
normal	O
input	O
to	O
the	O
VAs	O
produces	O
a	O
distinctive	O
backward	O
movement	O
defect	O
.	O

Intracavitary	O
irradiation	O
was	O
carried	O
out	O
with	O
a	O
microSelectron	O
HDR	O
afterloading	O
device	O
and	O
usually	O
22	O
.	O
5	O
Gy	O
was	O
given	O
in	O
three	O
fractions	O
repeated	O
weekly	O
.	O

The	O
close	O
proximity	O
of	O
the	O
two	O
neuropeptide	B
Y	I
receptor	I
genes	I
suggests	O
that	O
they	O
have	O
evolved	O
from	O
a	O
gene	O
duplication	O
event	O
with	O
the	O
small	O
intron	O
interrupting	O
the	O
coding	O
sequence	O
of	O
the	O
y1	B
gene	I
being	O
converted	O
into	O
a	O
functional	O
sequence	O
within	O
the	O
y5	B
gene	I
,	O
while	O
the	O
reverse	O
complementary	O
sequence	O
was	O
utilized	O
as	O
an	O
alternatively	O
spliced	O
5	O
'	O
exon	O
for	O
the	O
y1	B
gene	I
.	O

In	O
the	O
studies	O
reported	O
here	O
,	O
the	O
5	O
'-	O
flanking	O
region	O
of	O
the	O
human	B
gp130	I
gene	I
was	O
isolated	O
and	O
the	O
transcription	O
initiation	O
sites	O
were	O
mapped	O
.	O

Localization	O
of	O
the	O
cytokine	O
response	O
element	O
by	O
5	O
'-	O
deletion	O
analysis	O
and	O
site	O
-	O
directed	O
mutagenesis	O
revealed	O
a	O
cis	O
-	O
acting	O
binding	O
site	O
for	O
activated	O
STAT	B
complexes	O
.	O

Pax	B
-	I
3	I
is	O
a	O
paired	B
-	I
type	I
homeobox	I
gene	I
that	O
is	O
specifically	O
expressed	O
in	O
the	O
dorsal	O
and	O
posterior	O
neural	O
tube	O
.	O

These	O
mutations	O
create	O
stop	O
codons	O
in	O
exon	O
7	O
and	O
8	O
,	O
respectively	O
,	O
and	O
probably	O
result	O
in	O
truncated	O
proteins	O
lacking	O
HLH	O
-	O
Zip	O
or	O
Zip	O
structure	O
.	O

Diver	O
respiratory	O
responses	O
to	O
a	O
tunable	O
closed	O
-	O
circuit	O
breathing	O
apparatus	O
.	O

It	O
is	O
concluded	O
that	O
fludarabine	O
is	O
a	O
highly	O
useful	O
agent	O
in	O
CLL	O
.	O

EGF	B
acts	O
primarily	O
by	O
means	O
of	O
transactivation	O
domain	O
AF	O
-	O
1	O
,	O
whereas	O
cAMP	O
acts	O
via	O
transactivation	O
domain	O
AF	O
-	O
2	O
of	O
the	O
ER	B
.	O

Recently	O
we	O
have	O
performed	O
a	O
detailed	O
analysis	O
of	O
specific	O
neuronal	O
populations	O
affected	O
by	O
the	O
mutation	O
which	O
shed	O
new	O
light	O
on	O
the	O
role	O
of	O
Krox	B
-	I
20	I
in	O
the	O
segmentation	O
and	O
on	O
the	O
physiological	O
consequences	O
of	O
its	O
inactivation	O
.	O

Using	O
a	O
conditional	O
-	O
lethal	O
mutant	O
allele	O
of	O
SUP45	B
(	O
sup45	B
-	I
2	I
)	O
and	O
a	O
combination	O
of	O
in	O
vivo	O
and	O
in	O
vitro	O
approaches	O
,	O
we	O
demonstrate	O
that	O
the	O
product	O
of	O
the	O
SUP45	B
gene	I
(	O
Sup45p	B
or	O
eRF1	B
)	O
is	O
a	O
factor	O
required	O
for	O
translation	O
termination	O
in	O
yeast	O
.	O

The	O
findings	O
suggest	O
that	O
ERP	O
effects	O
of	O
distinct	O
memory	O
processes	O
are	O
differentially	O
influenced	O
by	O
the	O
encoding	O
instructions	O
.	O

Furthermore	O
,	O
the	O
NH2	O
-	O
terminal	O
portion	O
of	O
the	O
homologue	O
was	O
not	O
translocated	O
into	O
the	O
outer	O
membrane	O
without	O
its	O
COOH	O
-	O
terminal	O
part	O
.	O

Organization	O
of	O
the	O
human	B
LU	I
gene	I
and	O
molecular	O
basis	O
of	O
the	O
Lu	O
(	O
a	O
)/	O
Lu	B
(	I
b	I
)	I
blood	O
group	O
polymorphism	O
.	O

Sequence	O
divergence	O
is	O
observed	O
in	O
untranslated	O
regions	O
which	O
allows	O
the	O
definition	O
of	O
gene	O
-	O
specific	O
probes	O
.	O

We	O
suggest	O
that	O
apart	O
from	O
the	O
World	O
Summit	O
for	O
Children	O
'	O
s	O
under	O
-	O
five	O
mortality	O
target	O
for	O
the	O
year	O
2000	O
,	O
intraregional	O
targets	O
to	O
reduce	O
geographical	O
inequalities	O
in	O
under	O
-	O
five	O
mortality	O
should	O
be	O
specified	O
.	O

In	O
adherent	O
macrophages	O
,	O
absence	O
of	O
CD45	B
led	O
to	O
the	O
hyperphosphorylation	O
and	O
hyperactivation	O
of	O
p56	B
/	I
59	I
(	O
hck	B
)	O
and	O
p53	B
/	I
56	I
(	O
lyn	B
),	O
but	O
not	O
of	O
p58	B
(	O
c	B
-	I
fgr	I
).	O

Strikingly	O
,	O
stoichiometric	O
association	O
of	O
p107	B
or	O
p130	B
with	O
either	O
cyclin	B
E	I
-	O
cdk2	B
or	O
cyclin	B
A	I
-	O
cdk2	B
negated	O
the	O
activities	O
of	O
these	O
kinases	O
.	O

With	O
a	O
view	O
to	O
identifying	O
other	O
important	O
U14	B
interactions	O
,	O
a	O
stem	O
-	O
loop	O
domain	O
required	O
for	O
activity	O
of	O
Saccharomyces	B
cerevisiae	I
U14	I
RNAs	I
(	O
the	O
Y	O
domain	O
)	O
was	O
first	O
subjected	O
to	O
detailed	O
mutational	O
analysis	O
.	O

Clinical	O
and	O
haematological	O
signs	O
are	O
not	O
specific	O
in	O
this	O
setting	O
,	O
and	O
the	O
diagnosis	O
relies	O
on	O
histological	O
features	O
,	O
mainly	O
bone	O
marrow	O
examination	O
.	O

The	O
C	O
-	O
terminal	O
mature	O
region	O
is	O
highly	O
conserved	O
in	O
other	O
serine	B
carboxypeptidases	I
.	O

Here	O
we	O
demonstrate	O
that	O
AML1a	B
,	O
which	O
solely	O
has	O
no	O
effects	O
as	O
a	O
transcriptional	O
regulator	O
,	O
dominantly	O
suppresses	O
transcriptional	O
activation	O
by	O
AML1b	B
,	O
and	O
that	O
AML1a	B
exhibits	O
the	O
higher	O
affinity	O
for	O
DNA	O
-	O
binding	O
than	O
AML1b	B
.	O

However	O
,	O
using	O
ATL	O
-	O
16T	O
nuclear	O
extract	O
,	O
we	O
demonstrated	O
that	O
GATA	B
-	I
4	I
is	O
the	O
only	O
GATA	B
-	I
binding	I
protein	I
that	O
forms	O
specific	O
DNA	O
-	O
protein	O
complex	O
with	O
the	O
-	O
70	O
GATA	O
site	O
.	O

Stromelysin	B
-	I
1	I
,	O
matrix	B
metalloproteinase	I
-	I
3	I
(	O
MMP	B
-	I
3	I
),	O
is	O
an	O
important	O
endopeptidase	O
selectively	O
expressed	O
by	O
somatic	O
cells	O
in	O
organ	O
tissues	O
.	O

Invited	O
editorial	O
on	O
"	O
Acute	O
and	O
chronic	O
effects	O
of	O
exercise	O
on	O
leptin	B
levels	O
in	O
humans	O
".	O

Both	O
promoters	O
lack	O
a	O
TATA	O
box	O
,	O
and	O
Pint	B
belongs	O
to	O
the	O
MED	B
-	I
1	I
class	O
of	O
promoters	O
,	O
which	O
initiate	O
transcription	O
at	O
multiple	O
sites	O
.	O

Serum	B
response	I
factor	I
(	O
SRF	B
),	O
a	O
member	O
of	O
an	O
ancient	O
family	O
of	O
DNA	O
-	O
binding	O
proteins	O
,	O
is	O
generally	O
assumed	O
to	O
be	O
a	O
ubiquitous	O
transcription	O
factor	O
involved	O
in	O
regulating	O
growth	O
factor	O
-	O
responsive	O
genes	O
.	O

A	O
soluble	O
62	O
-	O
kDa	O
protein	O
was	O
produced	O
without	O
the	O
proteolytic	O
processing	O
by	O
inserting	O
the	O
coding	O
sequence	O
of	O
amino	O
acids	O
112	O
to	O
660	O
of	O
ORF	O
-	O
2	O
in	O
a	O
baculovirus	O
expression	O
vector	O
and	O
using	O
the	O
corresponding	O
virus	O
to	O
infect	O
Sf9	O
cells	O
.	O

The	O
CPK	B
-	I
MB	I
isoenzyme	O
showed	O
no	O
percentage	O
increase	O
of	O
total	O
CPK	B
higher	O
than	O
5	O
%,	O
measured	O
at	O
6	O
,	O
12	O
,	O
and	O
24	O
h	O
after	O
the	O
shock	O
,	O
independent	O
of	O
the	O
number	O
of	O
attempts	O
of	O
cardioversion	O
.	O

Results	O
support	O
the	O
hypothesis	O
that	O
endogenous	B
corticotropin	I
-	I
releasing	I
factor	I
,	O
perhaps	O
acting	O
at	O
a	O
peripheral	O
binding	O
site	O
,	O
suppresses	O
the	O
active	O
behavioral	O
response	O
characteristic	O
of	O
pups	O
during	O
the	O
early	O
phase	O
of	O
isolation	O
in	O
novel	O
surroundings	O
.	O

The	O
current	O
study	O
demonstrates	O
that	O
T3	O
-	O
activated	O
transcription	O
of	O
the	O
NADPH	B
:	I
cytochrome	I
P450	I
oxidoreductase	I
(	O
P450R	B
)	O
gene	O
is	O
dependent	O
on	O
the	O
thyroid	O
hormonal	O
status	O
of	O
the	O
animal	O
,	O
with	O
both	O
transcriptional	O
and	O
post	O
-	O
transcriptional	O
pathways	O
being	O
important	O
in	O
regulating	O
the	O
cellular	O
P450R	B
mRNA	O
level	O
.	O

NF	B
-	I
kappa	I
B	I
/	O
Rel	B
transcription	O
factors	O
participate	O
in	O
the	O
activation	O
of	O
numerous	O
genes	O
involved	O
in	O
immune	O
regulation	O
/	O
inflammation	O
including	O
cytokines	O
,	O
cell	O
surface	O
receptors	O
,	O
adhesion	O
molecules	O
,	O
and	O
acute	O
phase	O
proteins	O
.	O

Though	O
the	O
BACTEC	O
9000	O
MB	O
system	O
is	O
recommended	O
for	O
respiratory	O
specimens	O
,	O
we	O
demonstrated	O
that	O
it	O
can	O
be	O
successfully	O
used	O
also	O
for	O
recovery	O
of	O
mycobacteria	O
from	O
clinical	O
specimens	O
from	O
various	O
extrapulmonary	O
sites	O
.	O

We	O
further	O
found	O
that	O
KmMig1p	B
is	O
fully	O
functional	O
when	O
expressed	O
in	O
S	O
.	O
cerevisiae	O
.	O

Future	O
analysis	O
of	O
long	O
-	O
term	O
outcome	O
measures	O
of	O
performance	O
with	O
the	O
implant	O
will	O
confirm	O
or	O
dispute	O
the	O
benefit	O
of	O
ear	O
selection	O
using	O
the	O
Prom	O
-	O
EABR	O
.	O

The	O
two	O
mouse	O
lines	O
carrying	O
the	O
unfragmented	O
Hnf3g	B
-	O
lacZ	B
YAC	O
showed	O
tissue	O
-	O
specific	O
,	O
copy	O
number	O
-	O
dependent	O
and	O
position	O
-	O
independent	O
expression	O
,	O
proving	O
that	O
170	O
kb	O
of	O
the	O
Hnf3g	B
locus	O
contain	O
all	O
elements	O
important	O
in	O
the	O
regulation	O
of	O
Hnf3g	B
.	O

Second	O
,	O
plasmid	O
-	O
derived	O
transgenes	O
and	O
gene	O
targeting	O
of	O
the	O
endogenous	B
Hnf3g	I
gene	I
locus	I
were	O
used	O
to	O
demonstrate	O
that	O
the	O
3	O
'-	O
flanking	O
region	O
of	O
the	O
gene	O
is	O
necessary	O
and	O
sufficient	O
to	O
direct	O
reporter	O
gene	O
expression	O
in	O
liver	O
,	O
pancreas	O
,	O
stomach	O
and	O
small	O
intestine	O
.	O

JNK	B
is	O
additionally	O
regulated	O
by	O
the	O
Ras	B
-	O
related	O
G	B
proteins	I
Rac	I
and	O
Cdc42	B
.	O

Confirming	O
measures	O
made	O
by	O
nurses	O
and	O
additionally	O
,	O
ABPM	O
for	O
women	O
,	O
seem	O
to	O
lessen	O
this	O
effect	O
.	O

In	O
a	O
series	O
of	O
patients	O
with	O
neuroinfection	O
,	O
Lyme	O
disease	O
,	O
Guillain	O
Barre	O
syndrome	O
,	O
demyelinization	O
,	O
partial	O
or	O
generalized	O
,	O
epilepsy	O
,	O
we	O
have	O
investigated	O
antiphospholipid	O
antibodies	O
of	O
IgG	B
and	O
IgM	B
subtypes	O
,	O
together	O
with	O
anticoagulant	O
factors	O
,	O
member	O
of	O
thrombocytes	O
,	O
sedimentation	O
rate	O
of	O
erythrocytes	O
.	O

(	O
1996a	O
)	O
Biochemistry	O
35	O
,	O
1589	O
-	O
1598	O
].	O

Second	O
,	O
the	O
membrane	O
expression	O
of	O
alpha	O
and	O
beta	O
subunits	O
was	O
mimicked	O
by	O
cholesterol	O
and	O
17	O
-	O
ketocholesterol	O
,	O
both	O
of	O
which	O
inhibit	O
HMG	B
-	I
CoA	I
reductase	I
.	O

The	O
remaining	O
80	O
patients	O
underwent	O
recordings	O
of	O
ECG	O
,	O
beat	O
-	O
to	O
-	O
beat	O
arterial	O
oxygen	O
saturation	O
(	O
SaO2	O
),	O
and	O
respiration	O
during	O
both	O
spontaneous	O
and	O
controlled	O
breathing	O
.	O

Volunteers	O
were	O
irradiated	O
on	O
their	O
backs	O
with	O
suberythemal	O
UV	O
daily	O
for	O
5	O
d	O
after	O
application	O
of	O
the	O
sunscreens	O
and	O
their	O
base	O
lotion	O
to	O
different	O
sites	O
.	O

METHODS	O
:	O
Four	O
hundred	O
fifty	O
patients	O
with	O
the	O
diagnosis	O
of	O
squamous	O
cell	O
carcinoma	O
of	O
the	O
oral	O
cavity	O
received	O
their	O
primary	O
treatment	O
at	O
Roswell	O
Park	O
Cancer	O
Center	O
(	O
RPCI	O
)	O
from	O
1971	O
to	O
1991	O
.	O

Thirty	O
-	O
two	O
rats	O
were	O
divided	O
into	O
four	O
groups	O
.	O

Reactive	O
lymphoid	O
hyperplasia	O
was	O
found	O
in	O
15	O
cases	O
,	O
2	O
cases	O
had	O
angiofollicular	O
lymphoid	O
hyperplasia	O
or	O
Castleman	O
'	O
s	O
disease	O
,	O
atypical	O
lymphoid	O
hyperplasia	O
suggestive	O
of	O
malignant	O
lymphoma	O
was	O
observed	O
in	O
3	O
cases	O
,	O
and	O
malignant	O
lymphoma	O
was	O
diagnosed	O
in	O
the	O
remaining	O
4	O
cases	O
.	O

Then	O
we	O
correlated	O
HRCT	O
findings	O
with	O
the	O
clinical	O
features	O
,	O
pulmonary	O
functions	O
and	O
methacholine	O
PC20	O
(	O
PC20M	O
)	O
and	O
studied	O
their	O
clinical	O
significance	O
.	O

Gtx	B
mRNA	I
accumulates	O
in	O
parallel	O
with	O
the	O
RNAs	O
encoding	O
the	O
major	O
structural	O
proteins	O
of	O
myelin	O
,	O
myelin	B
basic	I
protein	I
(	O
MBP	B
),	O
and	O
proteolipid	B
protein	I
(	O
PLP	B
)	O
during	O
postnatal	O
brain	O
development	O
;	O
Gtx	B
mRNA	I
decreases	O
in	O
parallel	O
with	O
MBP	B
and	O
PLP	B
mRNAs	I
in	O
the	O
brains	O
of	O
myelin	O
-	O
deficient	O
rats	O
,	O
which	O
have	O
a	O
point	O
mutation	O
in	O
the	O
PLP	B
gene	I
.	O

RESULTS	O
:	O
For	O
E1	O
,	O
itraconazole	O
plasma	O
drug	O
concentration	O
extrapolated	O
to	O
time	O
zero	O
(	O
IV	O
dose	O
)	O
was	O
5	O
.	O
2	O
+/-	O
1	O
.	O
4	O
micrograms	O
/	O
ml	O
,	O
and	O
mean	O
residence	O
time	O
(	O
MRT	O
)	O
was	O
37	O
+/-	O
16	O
hours	O
.	O

Supershift	O
assays	O
,	O
using	O
Jun	B
and	I
Fos	I
family	I
member	I
-	I
specific	I
antibodies	I
,	O
showed	O
that	O
protein	O
complexes	O
formed	O
by	O
AtT	O
-	O
20	O
cell	O
nuclear	O
extracts	O
bound	O
to	O
the	O
c	B
-	I
jun	I
AP	I
-	I
1	I
site	I
were	O
comprised	O
of	O
Jun	B
family	O
members	O
,	O
JunD	B
,	O
JunB	B
,	O
and	O
cJun	B
.	O

The	O
mouse	O
extracellular	B
signal	I
-	I
regulated	I
kinase	I
2	I
gene	I
.	O

MR	O
imaging	O
of	O
traumatic	O
head	O
injuries	O
using	O
FLAIR	O
technique	O

Genes	O
belonging	O
to	O
the	O
ras	B
superfamily	I
encode	O
low	B
-	I
molecular	I
-	I
weight	I
GTP	I
/	I
GDP	I
-	I
binding	I
proteins	I
that	O
are	O
highly	O
conserved	O
in	O
wide	O
variety	O
of	O
organisms	O
.	O

Heterogeneous	B
nuclear	I
ribonucleoprotein	I
A1	I
binds	O
to	O
the	O
transcription	O
-	O
regulatory	O
region	O
of	O
mouse	O
hepatitis	O
virus	O
RNA	O
.	O

Overexpression	O
of	O
CARP	B
in	O
cardiomyocytes	O
suppresses	O
cardiac	B
troponin	I
C	I
and	O
atrial	B
natriuretic	I
factor	I
transcription	O
.	O

CONCLUSION	O
:	O
Patients	O
wit	O
clinically	O
palpable	O
neck	O
disease	O
(	O
N1	O
-	O
3	O
),	O
histological	O
evidence	O
of	O
metastatic	O
nodal	O
disease	O
,	O
extracapsular	O
spread	O
,	O
and	O
three	O
or	O
more	O
positive	O
lymph	O
nodes	O
are	O
at	O
greater	O
risk	O
of	O
developing	O
failure	O
at	O
distant	O
sites	O
.	O

4	O
.	O

Human	B
Duo	I
contains	O
a	O
guanine	B
nucleotide	I
exchange	I
factor	I
(	O
GEF	B
)	O
domain	O
that	O
is	O
likely	O
to	O
be	O
rac1	B
-	O
specific	O
,	O
a	O
pleckstrin	B
homology	I
(	O
PH	B
)	O
domain	O
and	O
spectrin	B
-	I
like	I
repeat	I
units	I
.	O

Plasma	B
leptin	I
concentrations	O
were	O
higher	O
in	O
women	O
than	O
men	O
,	O
even	O
after	O
the	O
adjustment	O
for	O
differences	O
in	O
fat	O
mass	O
(	O
28	O
+/-	O
3	O
ng	O
/	O
ml	O
for	O
women	O
vs	O
.	O

A	O
specific	O
distal	O
promoter	O
controls	O
gamma	B
-	I
glutamyl	I
transpeptidase	I
gene	I
expression	O
in	O
undifferentiated	O
rat	O
transformed	O
liver	O
cells	O
.	O

These	O
repressor	O
sites	O
are	O
pyrimidine	O
rich	O
and	O
bind	O
avidly	O
to	O
the	O
polypyrimidine	B
tract	I
binding	I
protein	I
(	O
PTB	B
)	O
in	O
HeLa	O
nuclear	O
extracts	O
as	O
determined	O
by	O
UV	O
crosslinking	O
/	O
competition	O
assays	O
.	O

For	O
higher	O
expression	O
of	O
lipA	B
in	O
S	O
.	O
lividans	O
,	O
the	O
gene	O
was	O
cloned	O
next	O
to	O
the	O
strong	O
aphII	B
promoter	I
.	O

In	O
support	O
of	O
this	O
interpretation	O
we	O
demonstrate	O
that	O
MQ9b	B
binds	O
strongly	O
5	O
of	O
17	O
motif	O
-	O
positive	O
,	O
pathogen	O
-	O
derived	O
synthetic	O
peptides	O
.	O

For	O
sputum	B
interleukin	I
-	I
8	I
there	O
was	O
an	O
estimated	O
true	O
treatment	O
median	O
difference	O
of	O
142	O
pg	O
/	O
ml	O
(	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
8	O
to	O
2866	O
pg	O
/	O
ml	O
)	O
in	O
favour	O
of	O
placebo	O
;	O
while	O
for	O
maximal	O
expiratory	O
flow	O
at	O
25	O
%	O
(	O
MEF25	O
%)	O
remaining	O
forced	O
vital	O
capacity	O
predicted	O
for	O
sex	O
and	O
height	O
there	O
was	O
a	O
15	O
percentage	O
points	O
(	O
pp	O
)	O
(	O
95	O
%	O
CI	O
4	O
to	O
26	O
pp	O
)	O
mean	O
treatment	O
difference	O
in	O
favour	O
of	O
placebo	O
.	O

However	O
,	O
although	O
deletion	O
of	O
Fp1	B
in	O
the	O
hCRBP1	B
gene	I
yielded	O
increased	O
CAT	B
activity	O
,	O
pointing	O
toward	O
a	O
negative	O
regulatory	O
function	O
exerted	O
by	O
this	O
element	O
,	O
its	O
insertion	O
upstream	O
of	O
the	O
p12	B
basal	I
promoter	I
results	O
in	O
an	O
impressive	O
positive	O
stimulation	O
of	O
CAT	B
gene	I
expression	O
.	O

The	O
5	O
'	O
flanking	O
region	O
contains	O
potential	O
binding	O
sites	O
for	O
TATA	B
-	I
binding	I
protein	I
,	O
Sp1	B
,	O
nuclear	B
factor	I
1	I
(	O
NF1	B
),	O
CAAT	B
-	I
box	I
binding	I
protein	I
(	O
C	B
/	I
EBP	I
),	O
hepatocyte	B
nuclear	I
factors	I
1	I
and	I
5	I
(	O
HNF1	B
,	O
HNF5	B
)	O
and	O
activator	B
proteins	I
1	I
and	I
2	I
(	O
AP1	B
,	O
AP2	B
).	O

The	O
recognition	O
specificity	O
of	O
the	O
p55	B
PDZ	I
domain	I
appears	O
to	O
be	O
unique	O
,	O
since	O
the	O
three	O
PDZ	B
domains	I
of	O
hDlg	B
(	O
human	O
lymphocyte	O
homologue	O
of	O
the	O
Drosophila	B
discs	I
large	I
tumor	I
suppressor	I
)	O
do	O
not	O
bind	O
the	O
cytoplasmic	O
domain	O
of	O
glycophorin	B
C	I
.	O

Mnt	B
:	O
Max	B
complexes	O
also	O
efficiently	O
suppress	O
Myc	B
-	O
dependent	O
activation	O
from	O
the	O
same	O
promoter	O
.	O

The	O
distributed	O
current	O
density	O
J	O
is	O
calculated	O
within	O
the	O
volume	O
defined	O
by	O
the	O
motor	O
unit	O
.	O

In	O
our	O
previous	O
studies	O
,	O
transcriptional	O
activation	O
was	O
shown	O
to	O
correlate	O
with	O
IEP86	B
binding	O
to	O
both	O
the	O
TATA	B
-	I
box	I
binding	I
protein	I
(	O
TBP	B
)	O
and	O
the	O
transcription	O
factor	O
bound	O
upstream	O
.	O

However	O
,	O
we	O
were	O
unable	O
to	O
identify	O
a	O
p4	B
molecule	O
.	O

Protein	B
phosphatase	I
2A	I
is	O
a	O
critical	O
regulator	O
of	O
protein	B
kinase	I
C	I
zeta	I
signaling	O
targeted	O
by	O
SV40	B
small	I
t	I
to	O
promote	O
cell	O
growth	O
and	O
NF	B
-	I
kappaB	I
activation	O
.	O

Deletion	O
of	O
the	O
POR2	B
gene	I
alone	O
had	O
no	O
detectable	O
phenotype	O
,	O
while	O
yeasts	O
with	O
deletions	O
of	O
both	O
the	O
POR1	B
and	O
POR2	B
genes	I
were	O
viable	O
and	O
able	O
to	O
grow	O
on	O
glycerol	O
at	O
30	O
degrees	O
C	O
,	O
albeit	O
more	O
slowly	O
than	O
delta	B
por1	I
single	I
mutants	I
.	O

This	O
newly	O
described	O
organism	O
was	O
difficult	O
to	O
identify	O
due	O
to	O
discrepancies	O
between	O
the	O
Vitek	O
and	O
API	O
20E	O
identification	O
systems	O
.	O

Ig	B
heavy	I
chain	I
class	O
switching	O
is	O
directed	O
by	O
cytokines	O
inducing	O
transcription	O
from	O
unrearranged	O
CH	B
genes	I
.	O

These	O
results	O
suggest	O
that	O
UBP41	B
may	O
play	O
an	O
important	O
role	O
in	O
the	O
recycling	O
of	O
ubiquitin	B
by	O
hydrolysis	O
of	O
branched	B
poly	I
-	I
ubiquitin	I
chains	I
generated	O
by	O
the	O
action	O
of	O
26	B
S	I
proteasome	I
on	O
poly	O
-	O
ubiquitinated	O
protein	O
substrates	O
,	O
as	O
well	O
as	O
in	O
the	O
production	O
of	O
free	O
ubiquitin	B
from	O
linear	B
poly	I
-	I
ubiquitin	I
chains	I
and	O
of	O
certain	O
ribosomal	O
proteins	O
from	O
ubiquitin	B
fusion	I
proteins	I
.	O

The	O
sequenced	O
cDNA	O
predicts	O
a	O
704	O
-	O
amino	O
acid	O
protein	O
80	O
%	O
identical	O
to	O
human	B
progelatinase	I
B	I
.	O

RESULTS	O
:	O
The	O
standardised	O
mortality	O
ratio	O
(	O
SMR	O
)	O
for	O
all	O
malignant	O
neoplasms	O
was	O
94	O
(	O
95	O
%	O
CI	O
74	O
to	O
118	O
).	O

Using	O
5	O
'	O
RACE	O
and	O
reverse	O
transcription	O
-	O
PCR	O
(	O
RT	O
-	O
PCR	O
)	O
methodologies	O
,	O
we	O
cloned	O
these	O
sequences	O
from	O
brain	O
and	O
placenta	O
and	O
found	O
this	O
material	O
to	O
be	O
composed	O
of	O
alternatively	O
spliced	O
exons	O
using	O
a	O
previously	O
reported	O
noncoding	O
exon	O
(	O
1A	O
)	O
and	O
a	O
novel	O
97	O
-	O
bp	O
noncoding	O
exon	O
(	O
1B	O
).	O

Expression	O
from	O
this	O
element	O
is	O
regulated	O
by	O
a	O
heteromeric	O
protein	O
complex	O
containing	O
ubiquitous	O
(	O
i	O
.	O
e	O
.	O
the	O
E2A	B
-	O
and	O
HEB	B
-	I
encoded	I
proteins	I
)	O
and	O
islet	O
-	O
enriched	O
members	O
of	O
the	O
bHLH	B
family	I
.	O

The	O
most	O
common	O
grade	O
3	O
toxicity	O
was	O
neutropenia	O
,	O
thrombocytopenia	O
,	O
and	O
parasthesias	O
(	O
observed	O
in	O
<	O
10	O
%	O
of	O
cycles	O
).	O

The	O
genomic	O
structure	O
of	O
brk	B
consists	O
of	O
8	O
exons	O
,	O
whose	O
boundaries	O
are	O
distinct	O
from	O
other	O
non	O
-	O
receptor	O
PTK	B
family	I
members	O
,	O
again	O
indicating	O
a	O
structural	O
and	O
functional	O
divergence	O
.	O

Surprisingly	O
,	O
calf	B
thymus	I
CstF	I
contained	O
an	O
additional	O
,	O
novel	O
form	O
of	O
the	O
64	O
-	O
kDa	O
subunit	O
with	O
a	O
molecular	O
mass	O
of	O
70	O
kDa	O
.	O

Ea	O
value	O
was	O
calculated	O
as	O
the	O
ratio	O
of	O
the	O
steady	O
-	O
state	O
end	O
-	O
systolic	O
aortic	O
pressure	O
(	O
ESAP	O
)	O
to	O
stroke	O
volume	O
(	O
thermodilution	O
).	O

Likewise	O
,	O
rad6	B
-	I
delta	I
reduces	O
silencing	O
of	O
the	O
telomere	B
-	I
located	I
RNAP	I
II	I
-	I
transcribed	I
genes	I
URA3	I
and	O
ADE2	B
.	O

The	O
cellular	O
rate	O
of	O
anticoagulant	B
heparan	I
sulfate	I
proteoglycan	I
(	O
HSPGact	B
)	O
generation	O
is	O
determined	O
by	O
the	O
level	O
of	O
a	O
kinetically	O
limiting	O
microsomal	O
activity	O
,	O
HSact	O
conversion	O
activity	O
,	O
which	O
is	O
predominantly	O
composed	O
of	O
the	O
long	O
sought	O
heparan	B
sulfate	I
D	I
-	I
glucosaminyl	I
3	I
-	I
O	I
-	I
sulfotransferase	I
(	O
3	B
-	I
OST	I
)	O
(	O
Shworak	O
,	O
N	O
.	O

However	O
,	O
besides	O
the	O
kinase	O
catalytic	O
domain	O
and	O
double	O
leucine	O
/	O
isoleucine	O
zippers	O
,	O
there	O
was	O
no	O
significant	O
homology	O
with	O
known	O
proteins	O
.	O

Codon	O
optimization	O
for	O
high	O
-	O
level	O
expression	O
of	O
human	B
erythropoietin	I
(	O
EPO	B
)	O
in	O
mammalian	O
cells	O
.	O

20	O
%	O
of	O
total	O
HSL	B
transcripts	I
in	O
human	O
subcutaneous	O
adipocytes	O
.	O

An	O
unusual	O
cysteine	O
triplet	O
conserved	O
in	O
the	O
sequences	O
of	O
TB	B
domains	I
is	O
localized	O
to	O
the	O
hydrophobic	O
core	O
,	O
at	O
the	O
C	O
-	O
terminus	O
of	O
an	O
alpha	O
-	O
helix	O
.	O

Xenopus	B
Ran	I
-	I
binding	I
protein	I
1	I
:	O
molecular	O
interactions	O
and	O
effects	O
on	O
nuclear	O
assembly	O
in	O
Xenopus	O
egg	O
extracts	O
.	O

METHODS	O
:	O
Total	O
muscle	O
paralysis	O
was	O
induced	O
under	O
general	O
anesthesia	O
in	O
a	O
group	O
of	O
obese	O
persons	O
(	O
n	O
=	O
9	O
;	O
body	O
mass	O
index	O
,	O
32	O
+/-	O
3	O
kg	O
[-	O
2	O
])	O
and	O
in	O
a	O
group	O
of	O
nonobese	O
persons	O
(	O
n	O
=	O
9	O
;	O
body	O
mas	O
index	O
,	O
21	O
+/-	O
2	O
kg	O
[-	O
2	O
]).	O

We	O
argue	O
that	O
the	O
primary	O
role	O
of	O
hh	B
in	O
controlling	O
polarity	O
is	O
to	O
cause	O
anterior	O
compartment	O
cells	O
to	O
reverse	O
their	O
interpretation	O
of	O
an	O
underlying	O
symmetric	O
polarization	O
.	O

Transfection	O
analyses	O
indicated	O
that	O
the	O
expression	O
of	O
Tbxas1	B
is	O
controlled	O
by	O
a	O
short	O
(	O
70	O
-	O
bp	O
)	O
positive	O
regulatory	O
sequence	O
and	O
several	O
upstream	O
repressive	O
elements	O
.	O

In	O
this	O
study	O
,	O
we	O
examine	O
the	O
effects	O
of	O
Msx2	B
expression	O
on	O
OC	B
promoter	I
activation	O
(	O
luciferase	B
reporter	I
)	O
by	O
FGF2	B
/	O
FSK	B
and	O
calcitriol	O
in	O
MC3T3	O
-	O
E1	O
osteoblasts	O
.	O

In	O
Arabidopsis	O
,	O
the	O
induction	O
of	O
a	O
dehydration	O
-	O
responsive	O
gene	O
,	O
rd22	B
,	O
is	O
mediated	O
by	O
abscisic	O
acid	O
(	O
ABA	O
)	O
and	O
requires	O
protein	O
biosynthesis	O
for	O
ABA	O
-	O
dependent	O
gene	O
expression	O
.	O

An	O
open	O
reading	O
frame	O
of	O
2862	O
bp	O
encoding	O
a	O
954	O
amino	O
acid	O
protein	O
was	O
identified	O
.	O

Strain	O
CFN037	O
is	O
an	O
R	O
.	O
etli	O
mutant	O
induced	O
by	O
a	O
single	O
Tn5mob	B
insertion	O
in	O
the	O
promoter	O
region	O
of	O
the	O
thiCOGE	B
gene	I
cluster	I
.	O

Expression	O
of	O
thiamin	O
biosynthetic	O
genes	O
(	O
thiCOGE	B
)	O
and	O
production	O
of	O
symbiotic	B
terminal	I
oxidase	I
cbb3	I
in	O
Rhizobium	O
etli	O
.	O

The	O
yeast	O
silent	B
information	I
regulator	I
Sir4p	I
anchors	O
and	O
partitions	O
plasmids	O
.	O

We	O
found	O
14	O
protein	O
binding	O
sites	O
that	O
were	O
occupied	O
in	O
vivo	O
.	O

Radiation	O
decreased	O
the	O
levels	O
of	O
T4	O
and	O
T3	O
6	O
h	O
and	O
72	O
h	O
in	O
group	O
C	O
,	O
in	O
group	O
A	O
at	O
72	O
h	O
,	O
in	O
group	O
B	O
at	O
24	O
h	O
postexposure	O
.	O

We	O
have	O
reviewed	O
the	O
experience	O
of	O
a	O
major	O
MMT	O
general	O
practice	O
with	O
hepatitis	O
C	O
virus	O
(	O
HCV	O
)	O
infection	O
from	O
1991	O
to	O
1995	O
.	O

447	O
microns	O
for	O
A	O
.	O
microcephalum	O
and	O
350	O
microns	O
for	O
A	O
.	O
wedli	O
),	O
and	O
fewer	O
testes	O
per	O
proglottis	O
(	O
44	O
-	O
73	O
vs	O
.	O

The	O
ZnF20	B
cDNA	I
hybridized	O
to	O
multiple	O
transcripts	O
in	O
a	O
thyroid	O
cancer	O
cell	O
line	O
(	O
8	O
.	O
0	O
,	O
4	O
.	O
5	O
and	O
2	O
kb	O
)	O
that	O
increased	O
after	O
cycloheximide	O
treatment	O
and	O
decayed	O
<	O
2	O
h	O
after	O
addition	O
of	O
actinomycin	O
D	O
.	O

Furthermore	O
,	O
DNA	O
-	O
bound	O
LAZ3	B
/	O
BCL6	B
recruits	O
SMRT	B
in	O
vivo	O
,	O
and	O
both	O
overexpressed	O
proteins	O
completely	O
colocalize	O
in	O
nuclear	O
dots	O
.	O

First	O
,	O
two	O
MCTs	O
using	O
a	O
long	O
electrode	O
,	O
3	O
cm	O
in	O
size	O
,	O
were	O
performed	O
in	O
the	O
central	O
area	O
of	O
the	O
tumor	O
,	O
and	O
eight	O
MCTs	O
by	O
a	O
short	O
electrode	O
,	O
2	O
cm	O
in	O
size	O
,	O
were	O
done	O
in	O
the	O
peripheral	O
and	O
surrounding	O
area	O
of	O
the	O
tumor	O
.	O

BACKGROUND	O
:	O
Checkpoint	O
pathways	O
prevent	O
cell	O
-	O
cycle	O
progression	O
in	O
the	O
event	O
of	O
DNA	O
lesions	O
.	O

Direct	O
proof	O
that	O
the	O
heightened	O
renal	O
cellular	O
apoptosis	O
in	O
PKD	O
is	O
not	O
occurring	O
through	O
p53	B
was	O
obtained	O
by	O
successive	O
matings	O
between	O
SBM	O
and	O
p53	B
(-/-)	O
mice	O
.	O

We	O
also	O
show	O
by	O
immunogold	O
electron	O
microscopy	O
immunocytochemistry	O
that	O
amphiphysin	B
I	I
is	O
localized	O
in	O
the	O
nerve	O
terminal	O
cytomatrix	O
and	O
is	O
partially	O
associated	O
with	O
endocytic	O
intermediates	O
.	O

Thus	O
,	O
Hex	B
expression	O
marks	O
the	O
earliest	O
unequivocal	O
molecular	O
anteroposterior	O
asymmetry	O
in	O
the	O
mouse	O
embryo	O
and	O
indicates	O
that	O
the	O
anteroposterior	O
axis	O
of	O
the	O
embryo	O
develops	O
from	O
conversion	O
of	O
a	O
proximodistal	O
asymmetry	O
established	O
in	O
the	O
primitive	O
endoderm	O
lineage	O
.	O

Western	O
blot	O
analysis	O
of	O
various	O
bovine	O
tissues	O
with	O
human	O
NMT	B
peptide	I
antibody	I
indicated	O
a	O
common	O
prominent	O
immunoreactive	O
band	O
with	O
an	O
apparent	O
molecular	O
mass	O
of	O
48	O
.	O
5	O
-	O
50	O
kDa	O
in	O
all	O
tissues	O
.	O

We	O
speculate	O
that	O
the	O
human	O
papillomavirus	O
late	O
mRNAs	O
,	O
produced	O
from	O
several	O
hundred	O
copies	O
of	O
the	O
virus	O
genome	O
present	O
in	O
infected	O
cells	O
,	O
compete	O
with	O
the	O
c	B
-	I
fos	I
mRNAs	I
for	O
destabilizing	O
cellular	O
factors	O
and	O
that	O
this	O
may	O
lead	O
to	O
elevated	O
Fos	B
protein	I
levels	O
in	O
human	O
papillomavirus	O
infected	O
cells	O
.	O

CKbeta4GT	B
-	I
II	I
is	O
predicted	O
to	O
encode	O
a	O
type	B
II	I
transmembrane	I
glycoprotein	I
of	O
43	O
kDa	O
with	O
five	O
potential	O
N	O
-	O
linked	O
glycosylation	O
sites	O
.	O

We	O
now	O
demonstrate	O
that	O
CCAAT	B
/	I
enhancer	I
-	I
binding	I
protein	I
(	I
C	I
/	I
EBP	I
)	I
delta	I
is	O
a	O
major	O
component	O
of	O
a	O
PGE2	O
-	O
stimulated	O
DNA	O
-	O
protein	O
complex	O
involving	O
HS3D	B
and	O
find	O
that	O
C	B
/	I
EBPdelta	I
transactivates	O
IGF	B
-	I
I	I
promoter	I
1	I
through	O
this	O
site	O
.	O

Responsibility	O
matters	O
--	O
this	O
is	O
a	O
scientific	O
council	O

Here	O
,	O
we	O
report	O
that	O
a	O
transfected	O
Chinese	O
hamster	O
ovary	O
(	O
CHO	O
)	O
cell	O
line	O
expressing	O
a	O
murine	B
CD4	I
fragment	I
containing	O
the	O
first	O
two	O
N	O
-	O
terminal	O
domains	O
secretes	O
both	O
monomeric	O
molecules	O
and	O
disulfide	O
-	O
linked	O
multimers	O
.	O

SCID	O
V	B
(	O
D	B
)	O
J	B
recombination	O
can	O
be	O
partly	O
rescued	O
in	O
T	O
-	O
lymphocytes	O
by	O
either	O
DNA	O
-	O
damaging	O
agents	O
(	O
gamma	O
-	O
irradiation	O
and	O
bieomycin	O
)	O
or	O
a	O
null	O
mutation	O
of	O
the	O
p53	B
gene	I
,	O
possibly	O
because	O
of	O
transiently	O
elevated	O
DNA	O
repair	O
activity	O
in	O
response	O
to	O
DNA	O
damage	O
or	O
to	O
delayed	O
apoptosis	O
in	O
the	O
absence	O
of	O
p53	B
.	O

During	O
the	O
conditioning	O
procedure	O
,	O
the	O
C	O
-	O
fiber	O
reflex	O
was	O
facilitated	O
(	O
wind	O
-	O
up	O
)	O
in	O
a	O
stimulus	O
-	O
dependent	O
fashion	O
in	O
intact	O
,	O
anesthetized	O
animals	O
during	O
the	O
application	O
of	O
the	O
first	O
seven	O
conditioning	O
stimuli	O
;	O
thereafter	O
,	O
the	O
magnitude	O
of	O
the	O
responses	O
reached	O
a	O
plateau	O
and	O
then	O
decreased	O
.	O

Upon	O
UV	O
damage	O
,	O
Crb2	B
is	O
transiently	O
modified	O
,	O
probably	O
phosphorylated	O
,	O
with	O
a	O
similar	O
timing	O
of	O
phosphorylation	O
in	O
Chk1	B
kinase	I
,	O
which	O
is	O
reported	O
to	O
restrain	O
Cdc2	B
activation	O
.	O

Moreover	O
,	O
moderate	O
overexpression	O
of	O
Chk1	B
suppresses	O
the	O
phenotypes	O
of	O
cut5	B
and	O
crb2	B
mutants	I
.	O

Stability	O
of	O
pyrimethamine	O
in	O
a	O
liquid	O
dosage	O
formulation	O
stored	O
for	O
three	O
months	O
.	O

Diet	O
therapy	O
with	O
soy	O
proteins	O
for	O
chronic	O
stomach	O
ulcers	O

Gel	O
-	O
shift	O
assays	O
identified	O
two	O
Sp1	B
binding	I
sites	I
within	O
this	O
element	O
.	O

Gel	O
mobility	O
shift	O
and	O
super	O
-	O
shift	O
assays	O
using	O
liver	O
nuclear	O
extracts	O
from	O
either	O
rat	O
liver	O
or	O
DDT1MF	O
-	O
2	O
cells	O
demonstrated	O
that	O
the	O
CRE	O
in	O
the	O
alpha	B
1B	I
-	I
AR	I
gene	I
bound	O
CRE	B
binding	I
protein	I
.	O

These	O
results	O
indicate	O
that	O
in	O
addition	O
to	O
Grb2	B
-	O
mediated	O
activation	O
of	O
Ras	B
,	O
PLC	B
-	I
gamma1	I
-	O
mediated	O
DAG	O
production	O
is	O
required	O
for	O
EGF	B
-	O
and	O
PDGF	B
-	O
induced	O
S	O
-	O
phase	O
entry	O
and	O
gene	O
expression	O
,	O
possibly	O
through	O
activation	O
of	O
PKC	B
.	O

MpB	B
GroEL	I
has	O
extensive	O
sequence	O
similarity	O
(	O
92	O
%)	O
with	O
Escherichia	B
coli	I
GroEL	I
and	O
other	O
members	O
of	O
the	O
chaperonin	B
-	I
60	I
family	I
.	O

Deadenylation	O
and	O
decay	O
of	O
beta	B
-	I
globin	I
mRNA	I
in	O
K562	O
cells	O
is	O
extraordinarily	O
slow	O
compared	O
with	O
NIH	O
3T3	O
cells	O
,	O
suggesting	O
that	O
the	O
increased	O
stability	O
gained	O
by	O
beta	B
-	I
globin	I
mRNA	I
in	O
K562	O
cells	O
is	O
mainly	O
controlled	O
at	O
the	O
deadenylation	O
step	O
.	O

A	O
.,	O
Swift	O
,	O
A	O
.	O

Taken	O
together	O
,	O
our	O
data	O
suggest	O
that	O
the	O
antagonistic	O
effects	O
of	O
CRP	B
and	O
KdgR	B
on	O
the	O
expression	O
of	O
the	O
pectinolysis	B
genes	I
occur	O
by	O
different	O
mechanisms	O
,	O
including	O
direct	O
competition	O
between	O
the	O
two	O
regulators	O
or	O
between	O
the	O
repressor	O
and	O
RNA	B
polymerase	I
for	O
the	O
occupation	O
of	O
a	O
common	O
DNA	O
region	O
on	O
the	O
target	O
genes	O
.	O

The	O
purpose	O
of	O
this	O
investigation	O
was	O
to	O
describe	O
a	O
new	O
formulation	O
of	O
silver	O
sulfadiazine	O
in	O
a	O
water	O
soluble	O
gel	O
,	O
poloxamer	O
188	O
.	O

The	O
gene	O
contains	O
six	O
exons	O
separated	O
by	O
1	O
.	O
1	O
-	O
5	O
.	O
8	O
kb	O
introns	O
and	O
has	O
been	O
localized	O
to	O
the	O
murine	O
chromosome	O
2	O
by	O
linkage	O
analysis	O
.	O

A	O
genomic	O
clone	O
was	O
isolated	O
that	O
contained	O
12	O
.	O
5	O
kb	O
of	O
the	O
5	O
'-	O
flanking	O
region	O
and	O
the	O
first	O
exon	O
of	O
the	O
p69	B
/	I
71	I
2	I
-	I
5A	I
synthetase	I
gene	I
.	O

In	O
the	O
clinical	O
study	O
,	O
the	O
defect	O
size	O
shown	O
by	O
BMIPP	O
imaging	O
was	O
greater	O
in	O
anterior	O
than	O
in	O
inferior	O
infarcts	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
correlated	O
well	O
with	O
the	O
risk	O
area	O
revealed	O
by	O
contrast	O
ventriculography	O
(	O
r	O
=	O
0	O
.	O
80	O
,	O
p	O
<	O
0	O
.	O
0001	O
)	O
CONCLUSION	O
:	O
The	O
above	O
preliminary	O
data	O
,	O
admittedly	O
from	O
a	O
small	O
group	O
of	O
patients	O
,	O
suggest	O
that	O
tomographic	O
BMIPP	O
imaging	O
provides	O
an	O
accurate	O
quantification	O
of	O
defect	O
size	O
by	O
means	O
of	O
a	O
simple	O
threshold	O
technique	O
and	O
,	O
in	O
the	O
subacute	O
phase	O
,	O
permits	O
determination	O
of	O
the	O
amount	O
of	O
myocardium	O
at	O
risk	O
after	O
acute	O
myocardial	O
infarction	O
.	O

Transient	O
overexpression	O
of	O
mutant	B
EphB1	I
receptors	I
(	O
Y594F	O
)	O
blocked	O
Nck	B
recruitment	O
to	O
EphB1	B
,	O
attenuated	O
downstream	O
JNK	B
activation	O
,	O
and	O
blocked	O
cell	O
attachment	O
responses	O
.	O

The	O
promoter	O
for	O
HMG	B
-	I
CoA	I
synthase	I
contains	O
two	O
binding	O
sites	O
for	O
the	O
sterol	B
regulatory	I
element	I
-	I
binding	I
proteins	I
(	O
SREBPs	B
).	O

Here	O
we	O
demonstrate	O
that	O
Hh	B
and	O
Patched	B
(	O
Ptc	B
)	O
act	O
through	O
those	O
Ci	B
binding	O
sites	O
to	O
modulate	O
the	O
level	O
of	O
Ci	B
-	O
dependent	O
transcriptional	O
activation	O
in	O
S2	O
cells	O
.	O

Our	O
results	O
showed	O
that	O
compared	O
to	O
the	O
primary	O
photon	O
fluence	O
,	O
the	O
extra	O
-	O
focal	O
photon	O
fluence	O
from	O
the	O
primary	O
collimator	O
and	O
the	O
flattening	O
filter	O
was	O
11	O
%-	O
16	O
%	O
at	O
the	O
isocenter	O
,	O
among	O
which	O
70	O
%	O
was	O
contributed	O
by	O
the	O
flattening	O
filter	O
.	O

Isomers	O
were	O
differentiated	O
based	O
on	O
the	O
MS	O
-	O
MS	O
data	O
of	O
the	O
trofluoroacetyl	O
-	O
biphenylol	O
derivatives	O
.	O

To	O
examine	O
the	O
role	O
of	O
this	O
CE2	O
element	O
in	O
regulating	O
Hoxa1	B
expression	O
in	O
vivo	O
,	O
transgenic	O
mice	O
were	O
generated	O
which	O
express	O
a	O
Hoxa1	B
beta	I
-	I
galactosidase	I
reporter	O
gene	O
that	O
contains	O
a	O
mutation	O
in	O
the	O
CE2	O
element	O
.	O

RESULTS	O
:	O
The	O
bovine	O
cDNA	O
insert	O
sequence	O
was	O
273	O
nucleotides	O
in	O
length	O
for	O
the	O
entire	O
mRNA	O
coding	O
region	O
,	O
212	O
nucleotides	O
in	O
the	O
5	O
'	O
untranslated	O
region	O
,	O
83	O
nucleotides	O
in	O
the	O
3	O
'	O
untranslated	O
region	O
and	O
a	O
poly	O
(	O
A	O
)	O
tail	O
.	O

P	O
.,	O
Peyron	O
,	O
J	O
.	O

A	O
hybridoma	O
clone	O
(	O
7H1	O
)	O
resulting	O
from	O
the	O
fusion	O
between	O
CEMLAI	O
/	O
NP	O
and	O
human	O
embryonic	O
fibroblasts	O
MRC5	O
cells	O
produced	O
very	O
large	O
amounts	O
of	O
P47	B
that	O
was	O
purified	O
using	O
Jacalin	B
lectin	I
(	O
specific	O
for	O
O	O
-	O
glycans	O
)	O
and	O
microsequenced	O
.	O

A	O
fusion	O
protein	O
composed	O
of	O
beta	B
-	I
galactosidase	I
and	O
full	B
-	I
length	I
Ahr	I
translocates	O
from	O
the	O
cytoplasm	O
to	O
the	O
nucleus	O
in	O
a	O
ligand	O
-	O
dependent	O
manner	O
.	O

Consistent	O
with	O
this	O
interpretation	O
,	O
a	O
mutant	O
form	O
of	O
XRN1	B
,	O
which	O
encodes	O
a	O
5	O
'-	O
3	O
'	O
exonuclease	O
,	O
was	O
identified	O
as	O
an	O
extragenic	O
suppressor	O
that	O
increases	O
the	O
half	O
-	O
life	O
of	O
rhis4	B
mRNA	I
,	O
leading	O
to	O
a	O
10	O
-	O
fold	O
increase	O
in	O
steady	O
-	O
state	O
mRNA	O
levels	O
compared	O
to	O
the	O
wild	B
-	I
type	I
HIS4	I
mRNA	I
level	O
.	O

We	O
have	O
cloned	O
a	O
kinase	O
,	O
Nlk	B
,	O
that	O
is	O
a	O
murine	B
homolog	I
of	I
the	I
Drosophila	I
nemo	I
(	O
nmo	B
)	O
gene	O
.	O

Our	O
findings	O
suggest	O
that	O
striatal	O
FDG	O
and	O
particularly	O
RACLO	O
are	O
sensitive	O
and	O
effective	O
measures	O
of	O
striatal	O
function	O
and	O
may	O
help	O
characterizing	O
patients	O
with	O
multiple	O
system	O
atrophy	O
.	O

Childhood	O
misbehavior	O
and	O
the	O
risk	O
of	O
injecting	O
drug	O
use	O
.	O

Our	O
purpose	O
was	O
to	O
determine	O
if	O
intact	O
perianal	O
(	O
S4	O
-	O
5	O
)	O
pin	O
sensation	O
(	O
PPS	O
)	O
and	O
bulbocavernosus	O
(	O
S2	O
-	O
4	O
)	O
reflex	O
(	O
BCR	O
)	O
shortly	O
after	O
spinal	O
cord	O
injury	O
(	O
SCI	O
)	O
are	O
predictive	O
of	O
bladder	O
function	O
recovery	O
.	O

The	O
correct	O
termination	O
of	O
retroviral	O
transcripts	O
at	O
the	O
3	O
'	O
LTR	O
R	O
/	O
U5	O
junction	O
is	O
primarily	O
dependent	O
on	O
the	O
canonical	O
AAUAAA	O
polyadenylation	O
signal	O
,	O
so	O
we	O
have	O
analyzed	O
the	O
effect	O
of	O
mutating	O
the	O
polyadenylation	O
signal	O
sequences	O
on	O
the	O
properties	O
of	O
a	O
selectable	O
murine	O
retroviral	O
vector	O
.	O

51	O
.	O
9	O
%	O
(	O
P	O
=	O
0	O
.	O
0006	O
)	O
in	O
the	O
MMF	O
versus	O
the	O
AZA	O
groups	O
,	O
respectively	O
.	O

Our	O
study	O
was	O
designed	O
to	O
investigate	O
the	O
effect	O
of	O
MMF	O
on	O
in	O
vivo	O
bone	O
mineral	O
metabolism	O
.	O

Typical	O
configurations	O
of	O
psychosocial	O
stress	O
factors	O
of	O
psychiatrically	O
conspicuous	O
children	O
and	O
adolescents	O

Sibling	O
aggregation	O
of	O
low	B
-	I
and	I
high	I
-	I
density	I
lipoprotein	I
cholesterol	I
and	O
apolipoproteins	B
B	I
and	I
A	I
-	I
I	I
levels	O
in	O
black	O
and	O
white	O
children	O
:	O
the	O
Bogalusa	O
Heart	O
Study	O
.	O

The	O
CAPLC1	B
protein	I
also	O
exhibited	O
several	O
unique	O
features	O
,	O
including	O
a	O
novel	O
stretch	O
of	O
18	O
-	O
19	O
amino	O
acid	O
residues	O
within	O
the	O
X	O
domain	O
and	O
an	O
unusually	O
long	O
N	O
-	O
terminus	O
which	O
did	O
not	O
contain	O
a	O
recognizable	O
EF	O
-	O
hand	O
Ca	O
(	O
2	O
+)-	O
binding	O
domain	O
.	O

Pet	B
-	I
1	I
can	O
bind	O
specifically	O
to	O
a	O
PEA3	B
ETS	I
DNA	O
-	O
binding	O
motif	O
and	O
can	O
modulate	O
transcription	O
of	O
synthetic	O
promoter	O
constructs	O
in	O
a	O
sequence	O
-	O
specific	O
manner	O
.	O

The	O
cloned	O
alcR	B
gene	I
provided	O
in	O
trans	O
restored	O
these	O
siderophore	O
system	O
activities	O
to	O
the	O
mutants	O
.	O

Copyright	O
1998	O
Academic	O
Press	O
.	O

We	O
analyzed	O
the	O
P	O
-	O
SAECG	O
in	O
the	O
time	O
and	O
frequency	O
domain	O
in	O
23	O
patients	O
with	O
Paf	O
and	O
19	O
controls	O
.	O

Oncostatin	B
M	I
stimulates	O
c	B
-	I
Fos	I
to	O
bind	O
a	O
transcriptionally	O
responsive	O
AP	B
-	I
1	I
element	I
within	O
the	O
tissue	B
inhibitor	I
of	I
metalloproteinase	I
-	I
1	I
promoter	I
.	O

To	O
elucidate	O
the	O
regulatory	O
mechanism	O
of	O
human	B
AM	I
gene	I
expression	O
,	O
functional	O
elements	O
of	O
5	O
'-	O
flanking	O
region	O
of	O
AM	B
gene	I
were	O
studied	O
in	O
human	O
aortic	O
endothelial	O
cells	O
(	O
HAEC	O
).	O

The	O
inhibition	O
of	O
focus	O
formation	O
observed	O
in	O
the	O
presence	O
of	O
C3G	B
was	O
not	O
due	O
to	O
toxic	O
effects	O
on	O
cell	O
viability	O
,	O
since	O
transfected	O
C3G	B
cells	O
exhibited	O
the	O
same	O
survival	O
and	O
growth	O
rates	O
as	O
untransfected	O
NIH3T3	O
cells	O
or	O
cells	O
transfected	O
with	O
plasmid	O
vector	O
alone	O
.	O

C	O
.	O
D2	O
-	O
Chr	O
4	O
congenic	O
strains	O
harboring	O
DBA	O
/	O
2	O
alleles	O
associated	O
with	O
the	O
Pctr1	B
locus	I
contained	O
DBA	O
/	O
2	O
"	O
resistant	O
"	O
alleles	O
of	O
the	O
CDK4	B
/	O
CDK6	B
inhibitors	O
p16	B
and	O
p15	B
.	O

The	O
TATA	B
box	I
-	I
binding	I
protein	I
(	O
TBP	B
)	O
plays	O
an	O
essential	O
role	O
in	O
transcription	O
by	O
all	O
three	O
eukaryotic	O
nuclear	B
RNA	I
polymerases	I
,	O
polymerases	B
(	I
Pol	I
)	I
I	I
,	I
II	I
,	I
and	I
III	I
.	O

Localized	O
fluorescence	O
was	O
detectable	O
only	O
in	O
cells	O
containing	O
a	O
visible	O
midcell	O
constriction	O
,	O
suggesting	O
that	O
FtsK	B
targeting	O
normally	O
occurs	O
only	O
at	O
a	O
late	O
stage	O
of	O
septation	O
.	O

Structural	O
and	O
evolutionary	O
studies	O
on	O
sterol	B
14	I
-	I
demethylase	I
P450	I
(	O
CYP51	B
),	O
the	O
most	O
conserved	O
P450	B
monooxygenase	I
:	O
I	O
.	O

CONCLUSIONS	O
:	O
XCoe2	B
may	O
play	O
a	O
pivotal	O
role	O
in	O
the	O
transcriptional	O
cascade	O
that	O
specifies	O
primary	O
neurons	O
in	O
Xenopus	O
embryos	O
:	O
by	O
maintaining	O
Delta	B
-	O
Notch	B
signalling	O
,	O
XCoe2	B
stabilises	O
the	O
higher	O
neural	O
potential	O
of	O
selected	O
progenitor	O
cells	O
that	O
express	O
X	B
-	I
ngnr	I
-	I
1	I
,	O
ensuring	O
the	O
transition	O
between	O
neural	O
competence	O
and	O
irreversible	O
commitment	O
to	O
a	O
neural	O
fate	O
;	O
and	O
it	O
promotes	O
neuronal	O
differentiation	O
by	O
activating	O
XNeuroD	B
expression	O
,	O
directly	O
or	O
indirectly	O
.	O

Therapeutic	O
use	O
of	O
cannabis	O
.	O

Peripheral	O
visual	O
stimuli	O
and	O
monoaural	O
auditory	O
stimuli	O
were	O
used	O
as	O
targets	O
.	O

A	O
review	O
of	O
studies	O
published	O
between	O
1983	O
and	O
1995	O
shows	O
that	O
there	O
are	O
some	O
common	O
factors	O
as	O
regards	O
the	O
psychological	O
distress	O
and	O
social	O
and	O
functional	O
limitations	O
this	O
group	O
of	O
patients	O
has	O
to	O
deal	O
with	O
.	O

Identification	O
and	O
characterization	O
of	O
specific	O
DNA	O
-	O
binding	O
complexes	O
containing	O
members	O
of	O
the	O
Myc	B
/	O
Max	B
/	O
Mad	B
network	O
of	O
transcriptional	O
regulators	O
.	O

Human	O
ZFM1	B
protein	I
is	O
a	O
transcriptional	O
repressor	O
that	O
interacts	O
with	O
the	O
transcription	B
activation	I
domain	I
of	I
stage	I
-	I
specific	I
activator	I
protein	I
.	O

The	O
risk	O
factors	O
for	O
hematuria	O
in	O
patients	O
with	O
renal	O
hypouricemia	O
are	O
the	O
elevation	O
of	O
urinary	O
urate	O
concentration	O
and	O
the	O
subtypes	O
of	O
Post	O
and	O
Secretion	O
.	O

In	O
all	O
cells	O
,	O
the	O
accumulation	O
of	O
high	O
Dsg	B
protein	I
levels	O
required	O
calcium	O
and	O
was	O
not	O
observed	O
in	O
low	O
calcium	O
(	O
0	O
.	O
05	O
-	O
0	O
.	O
07	O
mM	O
)	O
media	O
.	O

Purification	O
of	O
MvaT	B
enriched	O
for	O
two	O
polypeptides	O
of	O
approximate	O
molecular	O
mass	O
15	O
kDa	O
and	O
16	O
kDa	O
,	O
designated	O
P15	B
and	O
P16	B
.	O

These	O
results	O
indicate	O
that	O
TGF	B
-	I
betaf	I
potentiates	O
the	O
c	B
-	I
fos	I
SRE	O
activated	O
by	O
PKC	B
through	O
the	O
SRF	B
binding	I
site	I
.	O

RT	O
-	O
PCR	O
indicated	O
that	O
p21	B
mRNA	I
was	O
induced	O
1	O
.	O
4	O
-,	O
2	O
.	O
0	O
-,	O
and	O
3	O
.	O
1	O
-	O
fold	O
in	O
the	O
2	O
-	O
day	O
neonatal	O
,	O
7	O
-	O
day	O
neonatal	O
,	O
and	O
adult	O
stages	O
,	O
respectively	O
,	O
compared	O
to	O
the	O
17	O
-	O
day	O
fetal	O
stage	O
.	O

National	O
certification	O
:	O
a	O
vital	O
component	O
of	O
quality	O
assurance	O
.	O

Chimaeric	O
VP16	B
-	O
E2	B
molecules	O
suggest	O
that	O
the	O
epithelial	O
specific	O
transcriptional	O
activation	O
of	O
the	O
BPV	B
-	I
4	I
LCR	I
promoter	I
is	O
mediated	O
by	O
the	O
E2	B
transactivation	I
domain	I
.	O

APETALA3	B
transcripts	I
are	O
first	O
detected	O
in	O
a	O
meristematic	O
region	O
that	O
will	O
give	O
rise	O
to	O
the	O
petal	O
and	O
stamen	O
primordia	O
,	O
and	O
expression	O
is	O
maintained	O
in	O
this	O
region	O
during	O
subsequent	O
development	O
of	O
these	O
organs	O
.	O

Rex	B
-	I
1	I
,	O
a	O
gene	O
encoding	O
a	O
transcription	O
factor	O
expressed	O
in	O
the	O
early	O
embryo	O
,	O
is	O
regulated	O
via	O
Oct	B
-	I
3	I
/	I
4	I
and	O
Oct	B
-	I
6	I
binding	O
to	O
an	O
octamer	O
site	O
and	O
a	O
novel	O
protein	O
,	O
Rox	B
-	I
1	I
,	O
binding	O
to	O
an	O
adjacent	O
site	O
.	O

The	O
RAS	B
-	O
cyclic	B
AMP	I
-	I
dependent	I
protein	I
kinase	I
cAPK	I
pathway	O
prevents	O
the	O
UAS	O
activity	O
of	O
IREu	B
in	O
the	O
presence	O
of	O
glucose	O
as	O
the	O
sole	O
carbon	O
source	O
,	O
while	O
the	O
transcriptional	O
activators	O
Msn2p	B
and	O
Msn4p	B
promote	O
the	O
UAS	O
activity	O
of	O
this	O
repeat	O
in	O
the	O
presence	O
of	O
acetate	O
.	O

In	O
some	O
cases	O
,	O
the	O
aberrant	O
methylation	O
of	O
CpGs	O
within	O
5	O
'	O
regulatory	O
regions	O
has	O
led	O
to	O
suppression	O
of	O
gene	O
activity	O
.	O

The	O
genomic	O
fragments	O
were	O
fused	O
upstream	O
of	O
the	O
luciferase	B
reporter	I
gene	I
.	O

SNAC	O
or	O
PBS	O
was	O
infused	O
for	O
6	O
.	O
5	O
h	O
,	O
beginning	O
30	O
min	O
before	O
ischemia	O
and	O
continuing	O
throughout	O
the	O
duration	O
of	O
reperfusion	O
.	O

Despite	O
its	O
requirement	O
for	O
enhancer	O
-	O
dependent	O
splicing	O
activity	O
in	O
vitro	O
,	O
the	O
dU2AF38	B
RS	I
domain	I
was	O
also	O
inessential	O
in	O
vivo	O
.	O

The	O
addition	O
of	O
a	O
Paf	B
-	O
containing	O
extract	O
does	O
not	O
lead	O
to	O
significant	O
protein	O
binding	O
to	O
these	O
two	O
hly	B
target	I
sequences	I
in	O
the	O
absence	O
of	O
PrfA	B
but	O
converts	O
the	O
complex	O
(	O
CIII	O
)	O
consisting	O
of	O
PrfA	B
and	O
the	O
109	B
bp	I
hly	I
DNA	I
fragment	I
to	O
a	O
slower	O
migrating	O
PrfA	B
-	O
Paf	B
-	O
DNA	O
complex	O
(	O
CI	O
).	O

Among	O
three	O
isoforms	O
,	O
the	O
beta	O
isoform	O
has	O
the	O
greatest	O
Vmax	O
value	O
for	O
the	O
PtdIns	B
(	I
4	I
)	I
P	I
kinase	I
activity	O
and	O
the	O
gamma	O
isoform	O
is	O
most	O
markedly	O
stimulated	O
by	O
phosphatidic	O
acid	O
.	O

In	O
a	O
gntR	B
deletion	I
mutant	I
,	O
the	O
expression	O
of	O
a	O
chromosomal	O
gntT	B
::	O
lacZ	B
fusion	O
is	O
both	O
high	O
and	O
constitutive	O
,	O
confirming	O
that	O
GntR	B
is	O
the	O
negative	O
regulator	O
of	O
gntT	B
.	O

Of	O
these	O
sites	O
,	O
PEA3	B
and	O
STAT	B
contributed	O
specifically	O
to	O
induction	O
by	O
v	B
-	I
src	I
,	O
whereas	O
the	O
remaining	O
elements	O
were	O
also	O
involved	O
in	O
induction	O
by	O
the	O
phorbol	O
ester	O
phorbol	O
myristate	O
acetate	O
(	O
PMA	O
).	O

In	O
this	O
report	O
,	O
we	O
investigate	O
the	O
mechanism	O
underlying	O
Ras	B
activation	O
upon	O
stimulation	O
of	O
these	O
two	O
types	O
of	O
receptors	O
in	O
hematopoietic	O
cells	O
.	O

Furthermore	O
,	O
in	O
the	O
ischemia	O
/	O
angiotension	B
II	I
-	O
induced	O
AHF	O
model	O
,	O
NIC	O
decreased	O
left	O
ventricular	O
end	O
-	O
diastolic	O
pressure	O
(	O
LVEDP	O
).	O

The	O
ether	O
phospholipid	O
1	O
-	O
O	O
-	O
octadecyl	O
-	O
2	O
-	O
O	O
-	O
methyl	O
-	O
rac	O
-	O
glycero	O
-	O
3	O
-	O
phosphocholine	O
(	O
ET	O
-	O
18	O
-	O
OCH3	O
;	O
edelfosine	O
)	O
is	O
a	O
potent	O
inducer	O
of	O
apoptosis	O
in	O
human	O
tumor	O
cells	O
.	O

RNAs	O
are	O
not	O
only	O
essential	O
components	O
of	O
both	O
ribosomal	O
subunits	O
but	O
also	O
transiently	O
interacting	O
factors	O
during	O
particle	O
formation	O
.	O

Fluorescence	O
in	O
situ	O
hybridization	O
of	O
metaphase	O
spreads	O
of	O
chromosome	O
8	O
,	O
containing	O
hybrid	O
cell	O
line	O
706	O
-	O
B6	O
clone	O
17	O
(	O
CL	O
-	O
17	O
)	O
with	O
cosmid	O
c101F1	O
,	O
placed	O
the	O
9804	B
gene	I
close	O
to	O
the	O
telomere	O
at	O
8q24	O
.	O
3	O
.	O

The	O
interaction	O
between	O
piroxicam	O
and	O
poloxamer	O
was	O
studied	O
by	O
x	O
-	O
ray	O
diffractometry	O
(	O
XRD	O
),	O
infrared	O
(	O
IR	O
)	O
spectroscopy	O
and	O
differential	O
thermal	O
analysis	O
(	O
DTA	O
)	O
with	O
a	O
solid	O
dispersion	O
,	O
coprecipitate	O
,	O
or	O
physical	O
mixture	O
.	O

An	O
in	O
vivo	O
ZAP	B
-	I
70	I
substrate	O
,	O
SLP	B
-	I
76	I
,	O
implicated	O
in	O
Erk	B
activation	O
,	O
also	O
became	O
rapidly	O
tyrosine	O
-	O
phosphorylated	O
in	O
Jurkat	O
cells	O
,	O
but	O
not	O
in	O
P116	O
cells	O
,	O
upon	O
treatment	O
with	O
H2O2	O
.	O

The	O
pharmacokinetic	O
patterns	O
of	O
estradiol	O
(	O
CAS	O
50	O
-	O
28	O
-	O
2	O
)	O
and	O
of	O
estrone	O
(	O
CAS	O
53	O
-	O
16	O
-	O
7	O
)	O
were	O
investigated	O
in	O
18	O
women	O
in	O
natural	O
or	O
surgical	O
menopause	O
during	O
the	O
application	O
of	O
a	O
new	O
estradiol	O
transdermal	O
patch	O
with	O
active	O
matrix	O
and	O
without	O
absorption	O
enhancers	O
designed	O
for	O
epicutaneous	O
applications	O
of	O
7	O
days	O
(	O
hereinafter	O
called	O
"	O
patch	O
7D	O
").	O

Further	O
studies	O
demonstrated	O
that	O
the	O
PPARalpha	B
ligand	O
8	O
(	O
S	O
)-	O
hydroxyeicosatetraenoic	O
acid	O
strongly	O
promotes	O
the	O
interaction	O
of	O
PPARalpha	B
with	O
the	O
co	O
-	O
activator	O
RIP	B
-	I
140	I
but	O
decreases	O
the	O
interaction	O
of	O
PPARalpha	B
with	O
the	O
co	O
-	O
repressor	O
SMRT	B
.	O

We	O
previously	O
demonstrated	O
that	O
acute	O
expression	O
of	O
the	O
bovine	O
papillomavirus	O
type	O
1	O
(	O
BPV1	O
)	O
E2	B
protein	I
in	O
HeLa	O
and	O
HT	O
-	O
3	O
cervical	O
carcinoma	O
cell	O
lines	O
greatly	O
reduced	O
cellular	O
proliferation	O
by	O
imposing	O
a	O
specific	O
G1	O
/	O
S	O
phase	O
growth	O
arrest	O
.	O

A	O
cDNA	O
,	O
cak1At	B
,	O
was	O
isolated	O
that	O
suppressed	O
the	O
CAK	B
mutation	I
in	O
budding	O
yeast	O
,	O
and	O
it	O
also	O
complemented	O
a	O
fission	B
yeast	I
CAK	I
mutant	I
.	O
cak1At	B
encodes	O
a	O
protein	O
related	O
to	O
animal	B
CAKs	I
.	O

In	O
addition	O
to	O
restoring	O
checkpoint	O
control	O
,	O
overexpression	O
of	O
sum1	B
+	I
inhibits	O
the	O
normal	O
cell	O
cycle	O
response	O
to	O
osmotic	O
stress	O
.	O

Rhesus	O
macaques	O
and	O
BALB	O
/	O
c	O
mice	O
inoculated	O
with	O
the	O
Mengo	O
virus	O
SIV	O
recombinants	O
failed	O
to	O
develop	O
CTL	O
responses	O
against	O
the	O
SIV	O
gene	O
products	O
,	O
while	O
one	O
of	O
the	O
HIV	B
-	I
Nef	I
recombinants	I
induced	O
a	O
weak	O
CTL	O
response	O
in	O
mice	O
directed	O
to	O
an	O
HIV1	B
Nef	I
peptide	I
spanning	O
positions	O
182	O
-	O
198	O
.	O

Posttranslational	O
regulation	O
of	O
Ty1	B
retrotransposition	O
by	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
Fus3	I
.	O

In	O
this	O
study	O
,	O
the	O
effect	O
of	O
acute	O
administration	O
of	O
various	O
doses	O
of	O
malathion	O
via	O
oral	O
and	O
dermal	O
routes	O
to	O
mice	O
and	O
rats	O
on	O
serum	O
levels	O
of	O
histamine	O
was	O
evaluated	O
.	O

PURPOSE	O
:	O
To	O
introduce	O
an	O
image	O
analysis	O
of	O
the	O
cornea	O
in	O
photorefractive	O
keratectomy	O
(	O
PRK	O
)	O
for	O
preoperative	O
and	O
early	O
postoperative	O
determination	O
of	O
changes	O
in	O
the	O
condition	O
of	O
the	O
cornea	O
.	O

The	O
new	O
algorithm	O
,	O
called	O
RBI	O
-	O
MAP	O
,	O
is	O
based	O
on	O
the	O
rescaled	O
block	O
iterative	O
EM	O
(	O
RBI	O
-	O
EM	O
)	O
algorithm	O
.	O

Transcriptional	O
repression	O
mediated	O
by	O
LysR	B
-	I
type	I
regulator	I
CatR	I
bound	O
at	O
multiple	O
binding	O
sites	O
.	O

A	O
site	O
-	O
directed	O
R618K	O
mutation	O
in	O
the	O
Stat5	B
SH2	I
domain	I
abolished	O
the	O
phosphorylation	O
by	O
Jak2	B
,	O
while	O
deletion	O
of	O
the	O
C	O
terminus	O
led	O
to	O
Stat5	B
hyperphosphorylation	O
.	O

The	O
present	O
results	O
demonstrate	O
that	O
rats	O
with	O
relatively	O
small	O
remnants	O
of	O
one	O
olfactory	O
bulb	O
can	O
perform	O
a	O
variety	O
of	O
odor	O
detection	O
and	O
discrimination	O
tasks	O
as	O
well	O
or	O
nearly	O
as	O
well	O
as	O
controls	O
.	O

The	O
predicted	O
amino	O
acid	O
sequence	O
is	O
78	O
.	O
0	O
%	O
identical	O
to	O
the	O
cytoplasmic	B
dynein	I
heavy	I
chain	I
of	I
Neurospora	I
crassa	I
,	O
70	O
.	O
2	O
%	O
identical	O
to	O
that	O
of	O
Aspergillus	O
nidulans	O
and	O
24	O
.	O
8	O
%	O
identical	O
to	O
that	O
of	O
Saccharomyces	O
cerevisiae	O
.	O

Molecular	O
modelling	O
suggested	O
that	O
the	O
tetramerization	O
domain	O
was	O
a	O
four	O
-	O
helix	O
bundle	O
,	O
stabilized	O
by	O
interactions	O
of	O
seven	O
conserved	O
aromatic	O
amino	O
acids	O
.	O

To	O
explore	O
the	O
function	O
of	O
human	O
SINA	B
-	I
homologous	I
(	I
Siah	I
)	I
proteins	I
,	O
expression	O
plasmids	O
encoding	O
Siah	B
-	I
1A	I
were	O
transiently	O
transfected	O
into	O
293	O
epithelial	O
cells	O
and	O
GM701	O
fibroblast	O
cells	O
,	O
resulting	O
in	O
growth	O
arrest	O
without	O
induction	O
of	O
apoptosis	O
.	O

We	O
have	O
shown	O
previously	O
that	O
GH3	O
cells	O
transfected	O
with	O
the	O
rat	B
GnRH	I
receptor	I
cDNA	I
(	O
GGH3	O
-	O
1	O
'	O
cells	O
)	O
support	O
the	O
expression	O
of	O
a	O
cotransfected	O
fusion	O
gene	O
composed	O
of	O
797	O
base	O
pairs	O
of	O
rat	B
LHbeta	I
gene	I
5	I
'-	I
flanking	I
sequence	I
and	O
the	O
first	O
5	O
base	O
pairs	O
of	O
the	O
5	O
'-	O
untranslated	O
region	O
fused	O
to	O
a	O
luciferase	B
reporter	I
(-	I
797	I
/+	I
5LHbetaLUC	I
)	I
and	O
respond	O
to	O
a	O
GnRH	B
agonist	O
with	O
a	O
10	O
-	O
fold	O
stimulation	O
of	O
activity	O
.	O

OBJECTIVES	O
:	O
To	O
measure	O
coagulation	B
factor	I
VIII	I
:	I
coagulant	I
(	O
F	B
.	I
VIII	I
:	I
C	I
)	O
and	O
C1	B
-	I
esterase	I
inhibitor	I
(	O
C1	B
-	I
INH	I
),	O
hemostasis	O
-	O
associated	O
acute	O
-	O
phase	O
reactant	O
proteins	O
and	O
coagulation	B
factors	I
VII	I
(	O
F	B
.	I
VII	I
),	O
IX	O
(	O
F	B
.	I
IX	I
),	O
and	O
X	O
(	O
F	B
.	I
X	I
),	O
hemostasis	O
proteins	O
not	O
associated	O
with	O
an	O
acute	O
-	O
phase	O
response	O
,	O
in	O
a	O
select	O
population	O
of	O
horses	O
with	O
colic	O
and	O
hemostasis	O
abnormalities	O
,	O
and	O
presumed	O
to	O
have	O
acute	O
-	O
phase	O
changes	O
.	O

The	O
data	O
suggest	O
that	O
plasminogen	B
,	O
alpha	B
2AP	I
,	O
and	O
C1	B
-	I
INH	I
,	O
should	O
be	O
considered	O
equine	O
acute	O
-	O
phase	O
proteins	O
.	O

None	O
of	O
the	O
patients	O
was	O
obese	O
.	O

The	O
same	O
IL	B
-	I
4	I
-	O
inducible	O
reporter	O
gene	O
is	O
also	O
synergistically	O
activated	O
by	O
the	O
endogenous	B
Stat6	I
and	O
NF	B
-	I
kappaB	I
proteins	I
in	O
IL	B
-	I
4	I
-	O
stimulated	O
I	O
.	O
29mu	O
B	O
lymphoma	O
cells	O
.	O

All	O
patients	O
diagnosed	O
of	O
H	O
.	O
influenza	O
type	O
b	O
meningitis	O
were	O
less	O
than	O
3	O
years	O
old	O
.	O

The	O
lines	O
also	O
differed	O
in	O
postsynaptic	O
,	O
but	O
not	O
presynaptic	O
,	O
5	B
-	I
HT1A	I
receptors	I
.	O

A	O
stratified	O
random	O
sample	O
of	O
20	O
active	O
employees	O
from	O
a	O
cohort	O
of	O
phenoxy	O
herbicide	O
workers	O
was	O
selected	O
in	O
1995	O
for	O
determining	O
PCDD	O
and	O
PCDF	O
congeners	O
in	O
blood	O
lipids	O
to	O
assess	O
the	O
extent	O
of	O
past	O
PCDD	O
and	O
PCDF	O
exposure	O
in	O
this	O
cohort	O
and	O
whether	O
that	O
exposure	O
might	O
explain	O
site	O
-	O
specific	O
cancer	O
findings	O
in	O
the	O
total	O
cohort	O
.	O

In	O
contrast	O
to	O
other	O
known	O
retroviruses	O
,	O
the	O
FV	B
pol	I
genes	I
are	O
expressed	O
via	O
spliced	O
transcripts	O
.	O

We	O
specially	O
devised	O
3	O
types	O
of	O
turbo	O
pumps	O
,	O
a	O
centrifugal	O
pump	O
(	O
CFP	O
),	O
a	O
mixed	O
flow	O
pump	O
(	O
MFP	O
),	O
and	O
an	O
axial	O
flow	O
pump	O
(	O
AFP	O
),	O
and	O
analyzed	O
their	O
in	O
vitro	O
performance	O
.	O

Examination	O
of	O
the	O
mitochondrial	B
bc1	I
complex	I
crystal	I
structure	I
[	O
Zhang	O
,	O
Z	O
.,	O
Huang	O
,	O
L	O
.,	O
Shulmeister	O
,	O
V	O
.	O

Two	O
protease	O
-	O
resistant	O
fragments	O
spanning	O
the	O
N	O
-	O
and	O
C	O
-	O
terminal	O
halves	O
of	O
the	O
nuclease	O
were	O
identified	O
using	O
different	O
proteases	O
which	O
cleave	O
the	O
protein	O
in	O
the	O
same	O
region	O
.	O

The	O
ability	O
to	O
maintain	O
expression	O
of	O
FAS1	B
in	O
nmt1	B
-	O
451Dino2	B
Delta	O
cells	O
suggests	O
the	O
existence	O
of	O
another	O
transcription	O
factor	O
,	O
or	O
factors	O
,	O
whose	O
expression	O
/	O
activity	O
is	O
inversely	O
related	O
to	O
overall	O
levels	O
of	O
cellular	O
protein	O
N	O
-	O
myristoy	O
-	O
lation	O
.	O

Elimination	O
of	O
the	O
inducible	O
response	O
requires	O
simultaneous	O
mutation	O
of	O
both	O
sequences	O
,	O
however	O
,	O
in	O
the	O
presence	O
of	O
an	O
intact	O
EpRE	O
the	O
upstream	O
AP	B
-	I
1	I
site	I
is	O
irrelevant	O
to	O
induction	O
.	O

Three	O
high	B
mobility	I
group	I
-	I
like	I
sequences	I
within	O
a	O
48	O
-	O
base	O
pair	O
enhancer	O
of	O
the	O
Col2a1	B
gene	I
are	O
required	O
for	O
cartilage	O
-	O
specific	O
expression	O
in	O
vivo	O
.	O

In	O
mammals	O
,	O
the	O
Rb	B
protein	I
interacts	O
specifically	O
with	O
D	B
-	I
type	I
cyclins	I
and	O
regulates	O
cell	O
proliferation	O
by	O
binding	O
and	O
inhibiting	O
E2F	B
transcription	I
factors	I
.	O

Moreover	O
,	O
the	O
observation	O
of	O
enhanced	O
luteal	B
HSP	I
-	I
27	I
phosphorylation	O
in	O
vivo	O
,	O
in	O
late	O
pregnancy	O
,	O
when	O
PKC	B
-	I
delta	I
is	O
abundant	O
and	O
active	O
,	O
suggests	O
that	O
select	O
PKC	B
family	I
members	I
contribute	O
to	O
sHSP	B
phosphorylation	O
events	O
in	O
vivo	O
.	O

Two	O
members	O
of	O
the	O
Cbl	B
family	I
have	O
since	O
been	O
defined	O
in	O
mammals	O
(	O
c	B
-	I
Cbl	I
and	O
Cbl	B
-	I
b	I
),	O
one	O
in	O
C	O
.	O
elegans	O
(	O
Sli	B
-	I
1	I
)	O
and	O
one	O
in	O
Drosophila	O
(	O
D	B
-	I
Cbl	I
).	O

The	O
therapeutic	O
use	O
of	O
botulinum	B
toxin	I
(	O
Botox	B
)	O
is	O
increasing	O
in	O
popularity	O
.	O

We	O
have	O
applied	O
the	O
mRNA	O
differential	O
display	O
method	O
to	O
compare	O
and	O
analyze	O
mRNAs	O
prepared	O
from	O
five	O
normal	O
nasopharyngeal	O
epithelial	O
cell	O
cultures	O
and	O
five	O
nasopharyngeal	O
carcinoma	O
cell	O
lines	O
.	O

RESULT	O
(	O
S	O
):	O
In	O
patients	O
with	O
elevated	O
FSH	B
levels	O
on	O
cycle	O
day	O
3	O
,	O
a	O
low	O
oocyte	O
yield	O
was	O
achieved	O
(	O
7	O
versus	O
11	O
)	O
and	O
a	O
high	O
number	O
of	O
ampules	O
of	O
hMG	B
was	O
necessary	O
(	O
56	O
versus	O
33	O
).	O

In	O
the	O
ePTFE	O
specimens	O
,	O
tissue	O
coverage	O
had	O
increased	O
.	O

Thus	O
,	O
included	O
in	O
the	O
KG1a	O
EST	O
dataset	O
are	O
candidates	O
for	O
new	O
human	O
genes	O
that	O
may	O
play	O
roles	O
in	O
hematopoietic	O
differentiative	O
progression	O
and	O
lineage	O
commitment	O
.	O

The	O
opioid	O
antagonist	O
naltrexone	O
(	O
0	O
.	O
01	O
-	O
1	O
.	O
0	O
mg	O
/	O
kg	O
)	O
antagonized	O
the	O
discriminative	O
stimulus	O
effects	O
of	O
heroin	O
,	O
but	O
naltrexone	O
at	O
doses	O
up	O
to	O
10	O
mg	O
/	O
kg	O
had	O
no	O
effect	O
on	O
the	O
discriminative	O
stimulus	O
effects	O
of	O
cocaine	O
.	O

Exercise	O
training	O
has	O
become	O
increasingly	O
important	O
in	O
the	O
treatment	O
of	O
heart	O
failure	O
patients	O
.	O

The	O
YccA	B
protein	I
was	O
found	O
to	O
be	O
degraded	O
in	O
an	O
FtsH	B
-	O
dependent	O
manner	O
in	O
vivo	O
and	O
in	O
vitro	O
,	O
whereas	O
the	O
YccA11	B
mutant	I
protein	I
,	O
lacking	O
eight	O
amino	O
acid	O
residues	O
within	O
the	O
amino	O
-	O
terminal	O
cytoplasmic	O
domain	O
,	O
was	O
refractory	O
to	O
the	O
degradation	O
.	O

A	O
conserved	O
role	O
for	O
L1	B
as	O
a	O
transmembrane	O
link	O
between	O
neuronal	O
adhesion	O
and	O
membrane	O
cytoskeleton	O
assembly	O
.	O

Binding	O
affinities	O
of	O
different	O
nucleotide	O
mono	O
-,	O
di	O
-	O
and	O
triphosphates	O
and	O
non	O
-	O
hydrolyzable	O
analogs	O
indicate	O
that	O
the	O
beta	O
-	O
phosphate	O
moiety	O
is	O
required	O
for	O
substrate	O
binding	O
.	O

However	O
,	O
it	O
is	O
only	O
one	O
-	O
half	O
and	O
one	O
-	O
third	O
the	O
size	O
of	O
the	O
proteolipids	O
from	O
M	O
.	O
thermoautotrophicum	O
and	O
M	O
.	O
jannaschii	O
,	O
respectively	O
.	O
ahaK	B
is	O
expressed	O
in	O
Escherichia	O
coli	O
,	O
and	O
it	O
is	O
incorporated	O
into	O
the	O
cytoplasmic	O
membrane	O
despite	O
the	O
different	O
chemical	O
natures	O
of	O
lipids	O
from	O
archaea	O
and	O
bacteria	O
.	O

In	O
this	O
report	O
we	O
studied	O
the	O
role	O
of	O
protein	B
-	I
tyrosine	I
phosphatase	I
SHP	I
-	I
2	I
in	O
ErbB	B
-	O
mediated	O
activation	O
of	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
(	O
MAPK	B
)	O
by	O
overexpressing	O
SHP	B
-	I
2	I
mutants	I
in	O
COS	O
-	O
7	O
cells	O
.	O

Intron	O
8	O
harbored	O
a	O
strong	O
erythroid	O
-	O
specific	O
enhancer	O
activity	O
which	O
was	O
orientation	O
-	O
dependent	O
.	O

The	O
intron	O
8	O
enhancer	O
region	O
was	O
not	O
activated	O
by	O
GATA	B
-	I
1	I
together	O
with	O
Sp1	B
in	O
transactivation	O
experiments	O
in	O
COS	O
-	O
1	O
cells	O
indicating	O
the	O
involvement	O
of	O
a	O
related	O
Sp1	B
protein	I
or	O
of	O
another	O
unidentified	O
erythroid	O
factor	O
.	O

The	O
cleavage	O
of	O
Fak	B
by	O
caspases	B
may	O
thus	O
play	O
an	O
important	O
role	O
in	O
the	O
execution	O
of	O
the	O
suicide	O
program	O
by	O
disabling	O
the	O
anti	O
-	O
apoptotic	O
function	O
of	O
Fak	B
.	O

Our	O
results	O
indicate	O
that	O
the	O
binding	O
of	O
CBF	B
/	O
NF	B
-	I
Y	I
to	O
the	O
inverted	O
CCAAT	O
box	O
is	O
responsible	O
for	O
transcriptional	O
activation	O
of	O
the	O
nTPH	B
gene	I
.	O

The	O
influence	O
of	O
p53	B
on	O
cytokine	O
-	O
triggered	O
Janus	B
kinase	I
-	O
STAT	B
signaling	O
was	O
investigated	O
in	O
human	O
hepatoma	O
Hep3B	O
cell	O
lines	O
engineered	O
to	O
constitutively	O
express	O
the	O
temperature	O
-	O
sensitive	O
Val135	B
mutant	I
of	I
p53	I
.	O

The	O
general	O
recombination	O
at	O
a	O
polarizing	O
voltage	O
of	O
300	O
V	O
is	O
less	O
than	O
2	O
%	O
for	O
dose	O
-	O
rates	O
up	O
to	O
about	O
100	O
mGy	O
min	O
-	O
1	O
.	O

Strengthening	O
the	O
biological	O
weapons	O
convention	O
and	O
implications	O
on	O
the	O
pharmaceutical	O
and	O
biotechnology	O
industry	O
.	O

A	O
role	O
for	O
RalGDS	B
and	O
a	O
novel	O
Ras	B
effector	O
in	O
the	O
Ras	B
-	O
mediated	O
inhibition	O
of	O
skeletal	O
myogenesis	O
.	O

Blocked	O
shift	O
/	O
supershift	O
analysis	O
indicates	O
that	O
Fos	B
family	I
member	O
proteins	O
especially	O
Fra	B
-	I
1	I
and	O
Fra	B
-	I
2	I
are	O
related	O
to	O
progression	O
and	O
no	O
changes	O
found	O
in	O
the	O
Jun	B
family	I
member	O
proteins	O
although	O
they	O
are	O
present	O
in	O
the	O
AP	B
-	I
1	I
/	I
DNA	I
binding	I
complex	I
.	O

Human	O
isoforms	O
,	O
designated	O
1	O
to	O
4	O
,	O
differ	O
from	O
each	O
other	O
by	O
the	O
start	O
codon	O
used	O
.	O

Role	O
of	O
the	O
transcription	O
start	O
site	O
core	O
region	O
and	O
transcription	B
factor	I
YY1	I
in	O
Rous	B
sarcoma	I
virus	I
long	I
terminal	I
repeat	I
promoter	I
activity	O
.	O

Addition	O
of	O
Rap	O
or	O
KN62	O
after	O
exposure	O
of	O
cells	O
to	O
progesterone	O
agonist	O
Org	O
2058	O
had	O
no	O
effect	O
on	O
induction	O
of	O
CAT	B
activity	O
.	O

The	O
Dax	B
-	I
1	I
gene	I
encodes	O
a	O
protein	O
that	O
is	O
structurally	O
related	O
to	O
members	O
of	O
the	O
orphan	B
nuclear	I
receptor	I
superfamily	I
.	O

He	O
was	O
administered	O
recombinant	B
IFN	I
alpha	I
-	I
2b	I
under	O
the	O
diagnosis	O
of	O
chronic	O
hepatitis	O
C	O
.	O

Regulation	O
at	O
37	O
degrees	O
C	O
,	O
therefore	O
,	O
involves	O
the	O
action	O
of	O
three	O
protein	O
kinase	O
cascades	O
that	O
repress	O
HSF1	B
through	O
phosphorylation	O
of	O
serine	O
residues	O
303	O
,	O
307	O
,	O
and	O
363	O
and	O
may	O
promote	O
growth	O
by	O
suppressing	O
the	O
heat	O
shock	O
response	O
.	O

In	O
these	O
cells	O
,	O
ras	B
-	O
induced	O
transition	O
is	O
accompanied	O
by	O
a	O
strong	O
induction	O
of	O
AP	B
-	I
1	I
-	O
binding	O
activity	O
along	O
with	O
increased	O
expression	O
of	O
CD44	B
mRNA	I
and	O
protein	O
.	O

Tensile	O
bond	O
strengths	O
between	O
resin	O
composite	O
and	O
bovine	O
dentin	O
using	O
dentin	O
adhesive	O
systems	O
(	O
Clearfil	O
Liner	O
Bond	O
II	O
:	O
LB	O
II	O
;	O
Scotchbond	O
Multi	O
-	O
Purpose	O
:	O
MP	O
)	O
bonding	O
systems	O
showed	O
a	O
large	O
scatter	O
among	O
students	O
and	O
dentists	O
.	O

We	O
demonstrate	O
that	O
Ddc1p	B
interacts	O
physically	O
in	O
vivo	O
with	O
Mec3p	B
,	O
and	O
this	O
interaction	O
requires	O
Rad17p	B
.	O

METHODS	O
:	O
Fibrotic	O
changes	O
involving	O
bone	O
marrow	O
were	O
evaluated	O
histologically	O
semiquantitatively	O
using	O
reticulin	B
fiber	O
impregnation	O
(	O
method	O
of	O
Gomori	O
).	O

In	O
canrenoate	O
-	O
treated	O
rats	O
,	O
ANP	B
infusion	O
caused	O
greater	O
increases	O
in	O
sodium	O
excretion	O
(	O
FENA	O
from	O
3	O
.	O
05	O
+/-	O
0	O
.	O
71	O
to	O
7	O
.	O
21	O
+/-	O
0	O
.	O
45	O
%;	O
P	O
<	O
0	O
.	O
05	O
;	O
n	O
=	O
8	O
)	O
than	O
saline	O
infusion	O
(	O
FENA	O
from	O
4	O
.	O
16	O
+/-	O
1	O
.	O
11	O
to	O
5	O
.	O
47	O
+/-	O
0	O
.	O
66	O
%;	O
n	O
=	O
6	O
),	O
despite	O
the	O
hypocapnia	O
.	O

We	O
then	O
studied	O
four	O
unrelated	O
Japanese	O
families	O
with	O
GSD	O
-	O
Ib	O
,	O
and	O
found	O
three	O
novel	O
mutations	O
:	O
a	O
four	O
-	O
base	O
deletion	O
/	O
two	O
-	O
base	O
insertion	O
,	O
a	O
point	O
mutation	O
within	O
a	O
consensus	O
splicing	O
donor	O
site	O
,	O
and	O
a	O
missense	O
mutation	O
(	O
W118R	O
).	O

To	O
gain	O
insight	O
into	O
the	O
expression	O
of	O
the	O
AtCP1	B
gene	I
,	O
northern	O
blot	O
analysis	O
was	O
carried	O
out	O
.	O

These	O
results	O
provide	O
the	O
first	O
demonstration	O
that	O
an	O
SR	B
protein	I
can	O
influence	O
splicing	O
of	O
specific	O
pre	O
-	O
mRNAs	O
in	O
vivo	O
.	O

When	O
cysteine	O
is	O
scanned	O
through	O
the	O
helices	O
,	O
characteristic	O
repeating	O
patterns	O
of	O
solvent	O
exposure	O
and	O
burial	O
are	O
observed	O
.	O

Specifically	O
,	O
I	O
use	O
molecular	O
markers	O
that	O
identify	O
particular	O
neuroectodermal	O
domains	O
,	O
all	O
neuroblasts	O
or	O
individual	O
neuroblasts	O
,	O
to	O
show	O
that	O
in	O
DER	B
mutant	I
embryos	O
(	O
1	O
)	O
intermediate	O
column	O
neuroblasts	O
do	O
not	O
form	O
,	O
(	O
2	O
)	O
medial	O
column	O
neuroblasts	O
often	O
acquire	O
identities	O
inappropriate	O
for	O
their	O
position	O
,	O
while	O
(	O
3	O
)	O
lateral	O
neuroblasts	O
develop	O
normally	O
.	O

The	O
heterogeneous	O
nuclear	B
ribonucleoprotein	I
C	I
protein	I
tetramer	I
binds	O
U1	B
,	O
U2	B
,	O
and	O
U6	B
snRNAs	I
through	O
its	O
high	O
affinity	O
RNA	O
binding	O
domain	O
(	O
the	O
bZIP	O
-	O
like	O
motif	O
).	O

The	O
mutant	O
protein	O
is	O
present	O
at	O
levels	O
slightly	O
greater	O
than	O
wild	O
-	O
type	O
,	O
but	O
exhibits	O
the	O
same	O
tissue	O
distribution	O
as	O
wild	O
-	O
type	O
protein	O
,	O
and	O
has	O
approximately	O
normal	O
affinity	O
for	O
known	O
target	O
sequences	O
(	O
though	O
no	O
DNA	O
targets	O
identified	O
to	O
date	O
require	O
the	O
first	O
cut	O
repeat	O
for	O
binding	O
).	O

METHODS	O
:	O
We	O
retrospectively	O
reviewed	O
242	O
adult	O
cadaveric	O
renal	O
transplant	O
recipients	O
treated	O
between	O
11	O
/	O
91	O
and	O
5	O
/	O
97	O
.	O

The	O
spectrum	O
of	O
age	O
-	O
associated	O
brain	O
abnormalities	O
:	O
their	O
measurement	O
and	O
histopathological	O
correlates	O
.	O

In	O
contrast	O
,	O
transcription	O
initiating	O
from	O
opuE	B
P	I
-	I
1	I
(	O
sigma	B
A	I
)	O
rose	O
in	O
proportion	O
to	O
the	O
external	O
osmolarity	O
and	O
was	O
maintained	O
at	O
high	O
levels	O
.	O

In	O
insects	O
,	O
arylalkylamine	B
N	I
-	I
acetyltransferases	I
(	O
AANATs	B
)	O
have	O
been	O
implicated	O
in	O
several	O
physiological	O
processes	O
,	O
including	O
sclerotization	O
,	O
inactivation	O
of	O
certain	O
neurotransmitters	O
,	O
and	O
,	O
similar	O
to	O
the	O
function	O
in	O
vertebrates	O
,	O
catalysis	O
of	O
the	O
rate	O
-	O
limiting	O
step	O
in	O
melatonin	O
biosynthesis	O
.	O

Arnt3	B
mRNA	I
was	O
expressed	O
in	O
brain	O
,	O
skeletal	O
muscle	O
,	O
13	O
.	O
5	O
-	O
day	O
embryos	O
,	O
and	O
P19	O
cells	O
treated	O
with	O
retinoic	O
acid	O
.	O

The	O
genomic	O
structure	O
and	O
chromosomal	O
location	O
of	O
the	O
human	B
TR2	I
orphan	I
receptor	I
,	O
a	O
member	O
of	O
the	O
steroid	B
receptor	I
superfamily	I
.	O

Correlation	O
of	O
skin	O
disorders	O
with	O
CD4	B
lymphocyte	O
counts	O
in	O
patients	O
with	O
HIV	O
/	O
AIDS	O
.	O

E2F	B
-	I
6	I
shares	O
significant	O
homology	O
with	O
E2Fs	B
1	I
-	I
5	I
,	O
especially	O
within	O
the	O
DNA	O
binding	O
,	O
heterodimerization	O
and	O
marked	O
box	O
domains	O
.	O

The	O
IE13	O
.	O
1	O
cell	O
line	O
was	O
able	O
to	O
complement	O
a	O
recombinant	O
virus	O
in	O
which	O
both	O
copies	O
of	O
the	O
IE	B
gene	I
were	O
replaced	O
by	O
insertion	O
of	O
the	O
Escherichia	B
coli	I
lacZ	I
gene	I
.	O

Thus	O
,	O
these	O
studies	O
on	O
rat	B
Std	I
promoter	I
function	O
indicate	O
that	O
(	O
i	O
)	O
HNF1	B
and	O
C	B
/	I
EBP	I
are	O
responsible	O
for	O
liver	O
specificity	O
of	O
the	O
rat	B
Std	I
gene	I
;	O
(	O
ii	O
)	O
androgenic	O
repression	O
of	O
the	O
gene	O
requires	O
the	O
presence	O
of	O
all	O
of	O
the	O
OCT	B
-	I
1	I
and	O
C	B
/	I
EBP	I
elements	I
between	O
positions	O
-	O
231	O
and	O
-	O
292	O
;	O
and	O
(	O
iii	O
)	O
AR	B
may	O
exert	O
its	O
negative	O
regulatory	O
effect	O
indirectly	O
through	O
transcriptional	O
interference	O
of	O
OCT	B
-	I
1	I
and	O
C	B
/	I
EBP	I
rather	O
than	O
through	O
a	O
direct	O
DNA	B
-	I
AR	I
interaction	O
.	O

Both	O
methods	O
were	O
employed	O
for	O
various	O
focal	O
-	O
film	O
distances	O
,	O
image	O
intensifier	O
tube	O
modes	O
and	O
laser	O
printer	O
formats	O
.	O

The	O
prothrombin	B
gene	I
G20210A	I
mutation	I
is	O
not	O
found	O
among	O
Japanese	O
patients	O
with	O
deep	O
vein	O
thrombosis	O
and	O
healthy	O
individuals	O
.	O

The	O
binding	O
of	O
NF	B
-	I
ATp	I
,	O
although	O
not	O
NF	B
-	I
AT4	I
,	O
to	O
this	O
enhancer	O
also	O
occurs	O
along	O
with	O
HTLV	O
-	O
I	O
-	O
mediated	O
infection	O
of	O
human	O
peripheral	O
blood	O
T	O
-	O
cells	O
.	O

Thus	O
,	O
TRAF2	B
initiates	O
SAPK	B
and	O
p38	B
activation	O
by	O
binding	O
two	O
proximal	O
protein	O
kinases	O
:	O
GCK	B
and	O
RIP	B
.	O

In	O
the	O
studies	O
described	O
in	O
this	O
report	O
,	O
we	O
have	O
investigated	O
the	O
signaling	O
pathway	O
(	O
s	O
)	O
that	O
are	O
responsible	O
for	O
CREB	B
activation	O
in	O
normal	O
T	O
cells	O
.	O

BACKGROUND	O
:	O
It	O
is	O
generally	O
accepted	O
that	O
smoking	O
increases	O
blood	O
pressure	O
and	O
inhibits	O
muscle	O
sympathetic	O
nerve	O
activity	O
(	O
SNA	O
).	O

After	O
that	O
report	O
,	O
carboxypeptidase	B
D	I
(	O
CPD	B
)	O
was	O
subsequently	O
purified	O
from	O
bovine	O
pituitary	O
and	O
characterized	O
as	O
a	O
novel	O
carboxypeptidase	B
E	I
(	O
CPE	B
)-	O
like	O
enzyme	O
,	O
with	O
many	O
characteristics	O
in	O
common	O
with	O
duck	O
gp180	B
(	O
Song	O
,	O
L	O
.,	O
Fricker	O
,	O
L	O
.	O
D	O
.,	O
1995	O
.	O

RA	O
-	O
treatment	O
of	O
these	O
transfectants	O
induced	O
morphologic	O
and	O
immunophenotypic	O
maturation	O
,	O
changes	O
in	O
RA	O
-	O
regulated	O
genes	O
,	O
and	O
a	O
G1	O
cell	O
cycle	O
arrest	O
in	O
a	O
manner	O
similar	O
to	O
parental	O
NT2	O
/	O
D1	O
cells	O
.	O

For	O
smaller	O
vessels	O
up	O
to	O
a	O
diameter	O
of	O
0	O
.	O
5	O
mm	O
,	O
treatments	O
at	O
16	O
and	O
18	O
J	O
/	O
cm2	O
showed	O
good	O
results	O
in	O
60	O
and	O
82	O
%	O
respectively	O
;	O
for	O
vessels	O
up	O
to	O
1	O
mm	O
in	O
27	O
and	O
33	O
%.	O

Pressure	O
ulcers	O
.	O

TBP	B
can	O
be	O
phosphorylated	O
in	O
vitro	O
by	O
extracts	O
of	O
U937	O
cells	O
or	O
by	O
bacterially	O
expressed	O
activated	O
ERK2	B
;	O
the	O
phosphorylation	O
sites	O
were	O
mapped	O
to	O
ERK	B
kinase	I
consensus	I
sites	I
in	O
the	O
TBP	B
amino	I
-	I
terminal	I
domain	I
.	O

Generally	O
ILC	O
and	O
ILVF	O
values	O
decreased	O
with	O
increasing	O
exposure	O
time	O
with	O
rate	O
constants	O
ranging	O
from	O
0	O
.	O
03	O
to	O
0	O
.	O
33	O
day	O
-	O
1	O
(	O
wet	O
and	O
lipid	O
weight	O
)	O
for	O
ILC	O
and	O
0	O
.	O
03	O
to	O
0	O
.	O
31	O
day	O
-	O
1	O
for	O
ILVF	O
.	O

The	O
present	O
study	O
sought	O
to	O
develop	O
an	O
equation	O
to	O
estimate	O
VO2peak	O
in	O
peripheral	O
arterial	O
occlusive	O
disease	O
(	O
PAOD	O
)	O
patients	O
with	O
intermittent	O
claudication	O
and	O
to	O
determine	O
independent	O
predictors	O
of	O
VO2peak	O
in	O
this	O
population	O
.	O

This	O
hypothesis	O
was	O
tested	O
by	O
introducing	O
mutations	O
at	O
each	O
of	O
the	O
three	O
histidine	O
pairs	O
,	O
the	O
H382	O
-	O
X2	O
-	O
H385	O
pair	O
,	O
the	O
H411	O
-	O
X2	O
-	O
H414	O
pair	O
and	O
the	O
H430	O
-	O
X5	O
-	O
H436	O
pair	O
,	O
which	O
constitute	O
the	O
histidine	O
-	O
rich	O
region	O
near	O
the	O
C	O
terminus	O
of	O
gp17	B
.	O

Furthermore	O
,	O
early	O
-	O
and	O
late	O
-	O
firing	O
origins	O
differ	O
not	O
in	O
the	O
timing	O
of	O
their	O
recruitment	O
of	O
an	O
Mcm	B
protein	I
,	O
but	O
in	O
the	O
timing	O
of	O
RPA	B
'	I
s	I
recruitment	O
.	O

CONCLUSION	O
:	O
Although	O
quantitative	O
and	O
qualitative	O
criteria	O
for	O
diagnosing	O
fatty	O
liver	O
on	O
helical	O
CT	O
can	O
be	O
determined	O
,	O
they	O
are	O
protocol	O
-	O
specific	O
.	O

JCAHO	O
revised	O
interpretation	O

A	O
human	O
SPT3	B
-	O
TAFII31	B
-	O
GCN5	B
-	O
L	B
acetylase	I
complex	O
distinct	O
from	O
transcription	B
factor	I
IID	I
.	O

Oleate	O
induced	O
steady	O
-	O
state	O
levels	O
of	O
M	B
-	I
CPT	I
I	I
mRNA	I
4	O
.	O
5	O
-	O
fold	O
.	O

Mapping	O
of	O
the	O
DNA	O
binding	O
domain	O
of	O
the	O
copper	O
-	O
responsive	O
transcription	O
factor	O
Mac1	B
from	I
Saccharomyces	I
cerevisiae	I
.	O

A	O
further	O
mechanism	O
increasing	O
specific	O
activation	O
was	O
cooperation	O
of	O
receptors	O
at	O
multiple	O
and	O
weak	O
HREs	O
,	O
which	O
was	O
accentuated	O
in	O
the	O
presence	O
of	O
both	O
the	O
AR	B
N	O
terminus	O
and	O
ligand	O
binding	O
domain	O
.	O

Co	O
-	O
transfection	O
of	O
the	O
Sp1	B
expression	O
plasmid	O
and	O
the	O
-	O
58	O
promoter	O
construct	O
into	O
Drosophila	O
Schneider	O
cells	O
revealed	O
that	O
Sp1	B
contributed	O
to	O
the	O
kinase	O
basal	O
promoter	O
activity	O
by	O
binding	O
to	O
the	O
non	O
-	O
consensus	O
site	O
in	O
the	O
-	O
58	O
region	O
.	O

Tyrosine	O
112	O
of	O
latent	B
membrane	I
protein	I
2A	I
is	O
essential	O
for	O
protein	B
tyrosine	I
kinase	I
loading	O
and	O
regulation	O
of	O
Epstein	O
-	O
Barr	O
virus	O
latency	O
.	O

The	O
only	O
abundant	O
viral	O
transcript	O
expressed	O
during	O
latency	O
is	O
the	O
latency	B
-	I
related	I
(	O
LR	B
)	O
RNA	O
.	O

To	O
improve	O
test	O
efficiency	O
,	O
we	O
modified	O
our	O
previously	O
introduced	O
contrast	O
/	O
color	O
card	O
test	O
by	O
including	O
a	O
patterned	O
test	O
stimulus	O
and	O
reducing	O
the	O
number	O
of	O
stimuli	O
in	O
both	O
experimental	O
phases	O
.	O

Plasma	O
was	O
tested	O
before	O
and	O
after	O
(	O
14	O
+/-	O
7	O
.	O
5	O
[	O
SD	O
]	O
days	O
)	O
surgery	O
for	O
IgG	B
antibodies	I
to	O
the	O
complex	O
of	O
heparin	B
/	I
platelet	I
factor	I
4	I
,	O
using	O
a	O
standardized	O
,	O
validated	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
).	O

CASE	O
REPORT	O
:	O
We	O
observed	O
a	O
congenital	O
skin	O
defect	O
located	O
exclusively	O
on	O
the	O
trunk	O
.	O

Anastrozole	O
is	O
the	O
first	O
aromatase	B
inhibitor	O
to	O
show	O
a	O
significant	O
survival	O
advantage	O
over	O
megestrol	O
acetate	O
in	O
post	O
-	O
menopausal	O
women	O
with	O
advanced	O
breast	O
cancer	O
.	O

W	O
.	O

This	O
suggests	O
that	O
while	O
underpredictions	O
of	O
pain	O
do	O
not	O
hurt	O
more	O
,	O
disruption	O
on	O
primary	O
tasks	O
and	O
physiological	O
impact	O
are	O
higher	O
.	O

Saccharomyces	O
cerevisiae	O
contains	O
four	O
known	O
acyl	B
-	I
CoA	I
synthetases	I
(	O
fatty	B
acid	I
activation	I
proteins	I
,	O
Faaps	B
).	O

Clone	O
39	O
was	O
a	O
homolog	O
of	O
CONSTANS	B
,	O
which	O
is	O
a	O
gene	O
involved	O
in	O
controlling	O
the	O
flowering	O
time	O
in	O
Arabidopsis	O
.	O

These	O
results	O
suggest	O
that	O
Thr115	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
regulation	O
of	O
MyoD	B
function	O
under	O
conditions	O
of	O
high	O
mitogenesis	O
.	O

Endoscopic	O
examinations	O
,	O
peripheral	O
white	O
blood	O
cell	O
(	O
WBC	O
)	O
counts	O
,	O
and	O
assays	O
of	O
myeloperoxidase	B
activity	O
(	O
MPO	B
)	O
in	O
homogenates	O
of	O
colon	O
mucosa	O
were	O
performed	O
after	O
one	O
week	O
(	O
4	O
%	O
DSS	O
model	O
)	O
and	O
eight	O
weeks	O
(	O
1	O
%	O
DSS	O
model	O
).	O

We	O
have	O
determined	O
the	O
molecular	O
lesions	O
of	O
nine	O
Scm	B
mutant	I
alleles	I
,	O
which	O
identify	O
functional	O
requirements	O
for	O
specific	O
domains	O
.	O

Besides	O
the	O
characterization	O
and	O
discussion	O
of	O
the	O
experimental	O
setup	O
used	O
,	O
the	O
rate	O
constants	O
obtained	O
are	O
discussed	O
and	O
compared	O
with	O
estimated	O
values	O
.	O

The	O
interaction	O
of	O
U1	B
-	I
70K	I
with	O
the	O
SRZ	B
proteins	I
is	O
confirmed	O
further	O
in	O
vitro	O
using	O
a	O
blot	O
overlay	O
assay	O
.	O

The	O
GEF	B
and	O
GAP	B
activities	O
for	O
Ypt1p	B
localize	O
to	O
particulate	O
cellular	O
fractions	O
.	O

The	O
high	O
density	O
of	O
tegumental	O
spines	O
on	O
posterior	O
half	O
of	O
the	O
body	O
and	O
the	O
distribution	O
of	O
type	O
II	O
papillae	O
on	O
dorsal	O
surface	O
are	O
considered	O
to	O
be	O
characteristic	O
of	O
C	O
.	O
armatus	O
.	O

Cotransfection	O
of	O
the	O
helicase	B
-	O
primase	B
proteins	O
,	O
one	O
of	O
which	O
was	O
fused	O
to	O
a	O
heterologous	O
activation	O
domain	O
,	O
led	O
to	O
Zta	B
-	O
dependent	O
superactivation	O
of	O
CAT	B
expression	O
.	O

Previous	O
genetic	O
studies	O
led	O
to	O
the	O
conclusion	O
that	O
nitrate	O
and	O
nitrite	O
induction	O
of	O
nasF	B
operon	I
expression	O
is	O
determined	O
by	O
a	O
transcriptional	O
antitermination	O
mechanism	O
.	O

As	O
PP2A	B
exerts	O
a	O
range	O
of	O
cellular	O
functions	O
including	O
cell	O
cycle	O
regulation	O
and	O
cell	O
fate	O
determination	O
,	O
we	O
were	O
surprised	O
to	O
find	O
that	O
these	O
embryos	O
develop	O
normally	O
until	O
postimplantation	O
,	O
around	O
embryonic	O
day	O
5	O
.	O
5	O
/	O
6	O
.	O
0	O
.	O

The	O
ARF	B
promoter	I
was	O
also	O
found	O
to	O
be	O
highly	O
responsive	O
to	O
E2F1	B
expression	O
,	O
in	O
keeping	O
with	O
previous	O
results	O
at	O
the	O
RNA	O
level	O
.	O

We	O
have	O
developed	O
a	O
new	O
method	O
for	O
estimation	O
of	O
regional	O
CBF	O
(	O
rCBF	O
)	O
and	O
cerebrovascular	O
reserve	O
capacity	O
on	O
a	O
pixel	O
-	O
by	O
-	O
pixel	O
basis	O
by	O
means	O
of	O
dynamic	O
magnetic	O
resonance	O
imaging	O
(	O
MRI	O
).	O

Although	O
E2FBP1	B
lacks	O
the	O
transactivation	O
domain	O
,	O
it	O
stimulates	O
E2F	B
site	O
-	O
dependent	O
transcription	O
in	O
cooperation	O
with	O
E2F	B
-	I
1	I
.	O

The	O
predicted	O
domain	O
structures	O
of	O
FkbB	B
and	O
FkbC	B
are	O
analogous	O
to	O
that	O
of	O
FkbA	B
and	O
comprise	O
30	O
fatty	B
-	I
acid	I
-	I
synthase	I
(	O
FAS	B
)-	O
like	O
domains	O
arranged	O
in	O
6	O
modules	O
.	O

Galphaq	B
,	O
Galpha12	B
,	O
and	O
Galpha13	B
,	O
but	O
not	O
Galphai	B
,	O
activate	O
SRF	B
through	O
RhoA	B
.	O

Gng3lg	B
transcripts	I
are	O
expressed	O
in	O
a	O
variety	O
of	O
tissues	O
including	O
both	O
brain	O
and	O
testes	O
.	O

However	O
the	O
sequence	O
surrounding	O
the	O
transcription	O
start	O
site	O
CTCA	O
(+	O
1	O
)	O
TTCC	O
was	O
similar	O
to	O
the	O
consensus	O
CTCA	O
(+	O
1	O
)	O
NTCT	O
(	O
N	O
is	O
any	O
nucleoside	O
)	O
for	O
an	O
initiator	O
element	O
found	O
in	O
terminal	B
deoxynucleotidyltransferase	I
and	O
a	O
number	O
of	O
other	O
highly	O
regulated	O
genes	O
.	O

An	O
electrophoretic	O
mobility	O
shift	O
assay	O
was	O
performed	O
to	O
characterize	O
the	O
binding	O
property	O
of	O
TR2	B
and	O
its	O
truncated	O
isoform	O
.	O

RESULTS	O
:	O
We	O
identified	O
a	O
full	O
-	O
length	O
cDNA	O
with	O
an	O
open	O
reading	O
frame	O
of	O
2883	O
bp	O
corresponding	O
to	O
a	O
predicted	O
protein	O
of	O
961	O
amino	O
acids	O
that	O
shares	O
greater	O
than	O
95	O
%	O
homology	O
with	O
the	O
rat	B
gamma	I
-	I
aminobutyric	I
acid	I
B	I
(	I
GABAB	I
)	I
receptor	I
.	O

Another	O
tentative	O
hotspot	O
mutation	O
in	O
the	O
third	O
patient	O
,	O
a	O
frame	O
shift	O
caused	O
by	O
a	O
G	O
nucleotide	O
insertion	O
in	O
a	O
monotonous	O
repeat	O
of	O
six	O
Gs	O
in	O
HPRT	B
exon	I
3	I
,	O
has	O
been	O
reported	O
previously	O
in	O
three	O
other	O
LN	O
patients	O
.	O

SRF	B
-	O
deficient	O
embryos	O
(	O
Srf	B
-/-)	O
have	O
a	O
severe	O
gastrulation	O
defect	O
and	O
do	O
not	O
develop	O
to	O
term	O
.	O

Large	O
-	O
scale	O
sequencing	O
of	O
two	O
regions	O
in	O
human	O
chromosome	O
7q22	O
:	O
analysis	O
of	O
650	O
kb	O
of	O
genomic	O
sequence	O
around	O
the	O
EPO	B
and	O
CUTL1	B
loci	I
reveals	O
17	O
genes	O
.	O

Renal	O
pathology	O
and	O
long	O
-	O
term	O
outcome	O
in	O
childhood	O
SLE	O
.	O

We	O
propose	O
that	O
two	O
pathways	O
regulate	O
Stat5	B
serine	O
phosphorylation	O
,	O
one	O
that	O
is	O
prolactin	B
-	O
activated	O
and	O
PD98059	O
-	O
resistant	O
and	O
one	O
that	O
is	O
constitutively	O
active	O
and	O
PD98059	O
-	O
sensitive	O
and	O
preferentially	O
targets	O
Stat5a	B
.	O

Dose	O
of	O
20	O
ig	O
were	O
administered	O
within	O
a	O
scheme	O
from	O
0	O
.	O
1	O
to	O
6	O
months	O
in	O
order	O
to	O
study	O
its	O
immunogenicity	O
,	O
which	O
was	O
evaluated	O
at	O
2	O
,	O
7	O
,	O
and	O
12	O
months	O
after	O
the	O
first	O
dose	O
.	O

This	O
association	O
was	O
independently	O
significant	O
for	O
patients	O
treated	O
primarily	O
(	O
not	O
for	O
recurrence	O
).	O

Copyright	O
1998	O
Academic	O
Press	O
.	O

An	O
intact	O
neurovascular	O
supply	O
is	O
essential	O
for	O
the	O
viability	O
of	O
a	O
muscle	O
flap	O
.	O

The	O
deduced	O
amino	O
acid	O
sequence	O
of	O
CBP90	B
had	O
no	O
significant	O
similarity	O
to	O
any	O
other	O
protein	O
,	O
but	O
it	O
had	O
a	O
proline	O
-	O
rich	O
domain	O
at	O
the	O
C	O
-	O
terminal	O
region	O
.	O

The	O
human	B
2	I
',	I
5	I
'-	I
oligoadenylate	I
(	I
2	I
-	I
5A	I
)	I
synthetases	I
are	O
members	O
of	O
a	O
family	O
interferon	B
(	O
IFN	B
)-	O
inducible	O
anti	B
-	I
viral	I
proteins	I
.	O

A	O
Chinese	O
(	O
HK	O
)	O
SF	O
-	O
36	O
survey	O
form	O
was	O
developed	O
by	O
an	O
iterative	O
translation	O
process	O
.	O

By	O
DNase	B
I	I
footprint	O
analysis	O
of	O
the	O
PNR	O
element	O
,	O
a	O
palindrome	O
of	O
two	O
high	O
-	O
affinity	O
Ets	B
-	I
binding	I
sites	I
(	O
CTTCCCTGGAAG	O
)	O
was	O
identified	O
.	O

To	O
modulate	O
transcription	O
,	O
regulatory	O
factors	O
communicate	O
with	O
basal	O
transcription	O
factors	O
and	O
/	O
or	O
RNA	B
polymerases	I
in	O
a	O
variety	O
of	O
ways	O
.	O

In	O
this	O
study	O
,	O
rabbits	O
were	O
used	O
to	O
evaluate	O
the	O
sutured	O
wound	O
reaction	O
with	O
Dexon	O
or	O
nylon	O
in	O
the	O
conjunctival	O
flap	O
1	O
,	O
4	O
,	O
7	O
,	O
14	O
and	O
28	O
days	O
after	O
trabeculectomy	O
surgery	O
with	O
or	O
without	O
the	O
use	O
of	O
mitomycin	O
-	O
C	O
.	O

The	O
mapping	O
was	O
completed	O
with	O
Southern	O
blotting	O
and	O
restriction	O
analysis	O
.	O

These	O
cognitive	O
deficits	O
were	O
prevented	O
in	O
animals	O
treated	O
with	O
MK	O
-	O
801	O
during	O
SE	O
.	O

A	O
synergistic	O
effect	O
on	O
HCK	B
promoter	I
activity	O
was	O
observed	O
at	O
high	O
concentrations	O
of	O
Sp1	B
.	O

Western	O
analyses	O
with	O
antisera	O
raised	O
against	O
Lu	B
-	I
ECAM	I
-	I
1	I
peptides	I
show	O
that	O
the	O
N	O
-	O
terminal	O
region	O
of	O
the	O
predicted	O
open	O
reading	O
frame	O
is	O
present	O
only	O
in	O
the	O
larger	O
size	O
proteins	O
(	O
i	O
.	O
e	O
.	O

Mammalian	O
sperm	O
motility	O
is	O
regulated	O
by	O
a	O
cascade	O
of	O
cAMP	O
-	O
dependent	O
protein	O
phosphorylation	O
events	O
mediated	O
by	O
protein	B
kinase	I
A	I
.	O

Partial	O
characterization	O
of	O
the	O
active	O
site	O
human	B
platelet	I
cAMP	I
phosphodiesterase	I
,	O
PDE3A	B
,	O
by	O
site	O
-	O
directed	O
mutagenesis	O
.	O

This	O
core	O
sequence	O
,	O
along	O
with	O
additional	O
nonspecific	O
downstream	O
nucleotides	O
,	O
is	O
sufficient	O
for	O
partial	O
suppression	O
of	O
spliceosome	O
assembly	O
and	O
splicing	O
of	O
BPV	O
-	O
1	O
pre	O
-	O
mRNAs	O
.	O

Retroviral	B
nucleocapsid	I
proteins	I
(	O
NCPs	B
)	O
are	O
CCHC	B
-	I
type	I
zinc	I
finger	I
proteins	I
that	O
mediate	O
virion	O
RNA	O
binding	O
activities	O
associated	O
with	O
retrovirus	O
assembly	O
and	O
genomic	O
RNA	O
encapsidation	O
.	O

It	O
is	O
now	O
well	O
established	O
that	O
progression	O
through	O
the	O
eukaryotic	O
cell	O
cycle	O
is	O
controlled	O
by	O
oscillations	O
in	O
the	O
activity	O
of	O
cyclin	B
-	I
dependent	I
kinases	I
(	O
CDKs	B
).	O

However	O
,	O
the	O
BCH	O
group	O
showed	O
inferior	O
gross	O
motor	O
performance	O
on	O
the	O
Bruininks	O
-	O
Oseretsky	O
Test	O
of	O
Motor	O
Proficiency	O
(	O
Bruininks	O
1978	O
).	O

Biol	O
.	O

P	B
-	I
CIP1	I
,	O
a	O
novel	O
protein	O
that	O
interacts	O
with	O
the	O
cytosolic	O
domain	O
of	O
peptidylglycine	B
alpha	I
-	I
amidating	I
monooxygenase	I
,	O
is	O
associated	O
with	O
endosomes	O
.	O

Resultant	O
activation	O
of	O
c	B
-	I
Jun	I
N	I
-	I
terminal	I
kinase	I
/	O
stress	B
-	I
activated	I
protein	I
kinase	I
(	O
JNK	B
/	O
SAPK	B
).	O

We	O
have	O
isolated	O
a	O
novel	O
human	B
cyclin	I
,	O
cyclin	B
E2	I
,	O
that	O
contains	O
significant	O
homology	O
to	O
cyclin	B
E	I
.	O

The	O
dopamine	B
D4	I
receptor	I
as	O
well	O
as	O
many	O
other	O
catecholaminergic	B
receptors	I
contain	O
several	O
putative	O
SH3	B
binding	I
domains	I
.	O

Pyk2	B
phosphorylation	O
increased	O
upon	O
adherence	O
of	O
FLG	O
29	O
.	O
1	O
cells	O
to	O
fibronectin	B
and	O
to	O
ST2	O
stromal	O
cells	O
.	O

RESULTS	O
:	O
Significant	O
changes	O
from	O
pretreatment	O
to	O
posttreatment	O
were	O
observed	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

Approximately	O
50	O
%	O
of	O
the	O
residues	O
are	O
conserved	O
among	O
all	O
three	O
sequences	O
,	O
yet	O
all	O
three	O
viruses	O
have	O
retained	O
response	O
elements	O
for	O
glucocorticoids	O
,	O
two	O
positionally	O
conserved	O
CCAAT	O
boxes	O
,	O
and	O
positionally	O
conserved	O
TATA	O
boxes	O
.	O

This	O
survey	O
included	O
3000	O
randomly	O
selected	O
Norwegians	O
above	O
18	O
years	O
of	O
age	O
who	O
received	O
the	O
European	O
Organization	O
for	O
Research	O
and	O
Treatment	O
of	O
Cancer	O
Core	O
Quality	O
of	O
Life	O
Questionnaire	O
(	O
EORTC	O
QLQ	O
-	O
C30	O
(+	O
3	O
)	O
by	O
mail	O
.	O

Down	O
-	O
regulation	O
of	O
IRS	B
-	I
1	I
is	O
linked	O
to	O
its	O
serine	O
phosphorylation	O
dependent	O
on	O
PI	B
3	I
-	I
kinase	I
activity	O
and	O
appears	O
required	O
for	O
differentiation	O
to	O
occur	O
,	O
as	O
IRS	B
-	I
1	I
is	O
not	O
modified	O
and	O
continues	O
to	O
accumulate	O
in	O
a	O
nondifferentiating	O
myoblast	O
cell	O
line	O
.	O

The	O
human	B
SHBG	I
proximal	I
promoter	I
was	O
analyzed	O
by	O
DNase	B
I	I
footprinting	O
,	O
and	O
the	O
functional	O
significance	O
of	O
6	O
footprinted	O
regions	O
(	O
FP1	O
-	O
FP6	O
)	O
within	O
the	O
proximal	O
promoter	O
was	O
studied	O
in	O
human	O
HepG2	O
hepatoblastoma	O
cells	O
.	O

We	O
have	O
introduced	O
a	O
mutation	O
(	O
Ser36	O
-->	O
Asn	O
)	O
into	O
this	O
domain	O
of	O
p190	B
that	O
decreased	O
its	O
ability	O
to	O
bind	O
guanine	O
nucleotide	O
when	O
expressed	O
as	O
a	O
hemagglutinin	B
(	O
HA	B
)-	O
tagged	O
protein	O
in	O
COS	O
cells	O
.	O

We	O
emphasize	O
that	O
ANCA	B
-	O
associated	O
vasculitis	O
is	O
another	O
important	O
complication	O
of	O
RA	O
.	O

Although	O
we	O
predicted	O
that	O
overexpression	O
of	O
the	O
COOH	O
-	O
terminal	O
domains	O
,	O
which	O
were	O
thought	O
to	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
SREBP	B
processing	O
,	O
would	O
result	O
in	O
disruption	O
of	O
the	O
SREBP	B
-	O
dependent	O
transcriptional	O
regulation	O
of	O
several	O
genes	O
,	O
the	O
mRNA	O
levels	O
for	O
3	B
-	I
hydroxy	I
-	I
3	I
-	I
methylglutaryl	I
coenzyme	I
A	I
(	I
HMG	I
CoA	I
)	I
synthase	I
in	O
these	O
two	O
cell	O
lines	O
were	O
regulated	O
in	O
a	O
sterol	O
-	O
dependent	O
manner	O
.	O

Yap1p	B
is	O
constitutively	O
nuclear	O
in	O
a	O
crm1	B
mutant	I
,	O
and	O
Crm1p	B
binds	O
to	O
a	O
nuclear	O
export	O
sequence	O
(	O
NES	O
)-	O
like	O
sequence	O
in	O
Yap1p	B
in	O
the	O
presence	O
of	O
RanGTP	B
.	O

Mean	O
intake	O
of	O
vitamin	O
A	O
amounted	O
to	O
1	O
.	O
1	O
and	O
0	O
.	O
9	O
mg	O
RE	O
/	O
day	O
for	O
men	O
and	O
women	O
,	O
respectively	O
;	O
the	O
contributions	O
of	O
meat	O
,	O
fats	O
and	O
oils	O
,	O
vegetables	O
and	O
dairy	O
products	O
to	O
total	O
intake	O
were	O
35	O
%,	O
24	O
%,	O
16	O
%,	O
and	O
16	O
%,	O
respectively	O
.	O

Also	O
,	O
the	O
amplitude	O
of	O
the	O
oscillatory	O
potentials	O
(	O
O1	O
+	O
O2	O
+	O
O3	O
+	O
O4	O
)	O
was	O
significantly	O
reduced	O
in	O
the	O
early	O
postoperative	O
period	O
.	O

Expression	O
of	O
p130	B
(	O
Cas	B
)	O
(	O
Cas	B
),	O
a	O
major	O
binding	O
protein	O
for	O
the	O
Crk	B
SH2	I
-	I
domain	I
,	O
also	O
induced	O
JNK	B
activation	O
,	O
which	O
was	O
blocked	O
by	O
the	O
SH2	B
-	I
mutant	I
of	O
Crk	B
.	O

The	O
divergence	O
in	O
primary	O
structure	O
between	O
the	O
sheep	O
CRF1	B
and	O
the	O
other	O
mammalian	B
CRF1s	I
is	O
primarily	O
localized	O
to	O
the	O
extracellular	O
amino	O
terminal	O
domain	O
of	O
the	O
receptor	O
(	O
18	O
of	O
22	O
divergent	O
residues	O
,	O
ovine	O
vs	O
human	B
CRF1	I
).	O

Recurrent	O
arterial	O
thrombotic	O
disease	O
on	O
young	O
onset	O
and	O
protein	B
S	I
deficiency	O
.	O

These	O
findings	O
suggest	O
that	O
late	O
MYO	O
/	O
M	O
is	O
more	O
useful	O
than	O
washout	O
rate	O
to	O
assess	O
the	O
effect	O
of	O
treatment	O
on	O
heart	O
failure	O
due	O
to	O
DCM	O
.	O

The	O
active	O
site	O
includes	O
the	O
acidic	O
triad	O
Asp53	O
(	O
the	O
site	O
of	O
phosphorylation	O
),	O
Asp10	O
and	O
Glu9	O
.	O

Consistent	O
with	O
these	O
findings	O
,	O
relatively	O
weak	O
transcriptional	O
silencing	O
by	O
the	O
native	O
VDR	B
was	O
observed	O
using	O
the	O
osteopontin	B
VDRE	O
.	O

MPO	B
was	O
labeled	O
with	O
1	O
mCi	O
125I	O
by	O
a	O
technique	O
of	O
self	O
-	O
labeling	O
in	O
the	O
presence	O
of	O
10	O
(-	O
4	O
)	O
M	O
hydrogen	O
peroxide	O
.	O

These	O
genes	O
were	O
expressed	O
in	O
a	O
Saccharomyces	O
cerevisiae	O
mutant	O
in	O
which	O
the	O
endogenous	B
ferrochelatase	I
gene	I
(	O
HEM15	B
)	O
had	O
been	O
deleted	O
,	O
and	O
the	O
phenotypes	O
of	O
the	O
transformants	O
were	O
characterized	O
.	O

Furthermore	O
,	O
using	O
transgenic	O
mouse	O
technology	O
we	O
localized	O
independent	O
cis	O
-	O
regulatory	O
elements	O
controlling	O
the	O
tissue	O
-	O
specific	O
expression	O
of	O
Pax6	B
.	O

Bioplastique	O
granuloma	O
presents	O
with	O
irregularly	O
shaped	O
cystic	O
spaces	O
of	O
varying	O
size	O
containing	O
jagged	O
,	O
translucent	O
,	O
nonbirefringent	O
foreign	O
bodies	O
whereas	O
Artecoll	O
granuloma	O
shows	O
numerous	O
round	O
vacuoles	O
nearly	O
identical	O
in	O
size	O
and	O
shape	O
enclosing	O
round	O
and	O
sharply	O
circumscribed	O
,	O
translucent	O
,	O
nonbirefringent	O
foreign	O
bodies	O
.	O

This	O
Tbx6	B
-	I
subfamily	I
gene	I
is	O
likely	O
to	O
participate	O
in	O
paraxial	O
mesoderm	O
formation	O
and	O
somitogenesis	O
in	O
human	O
embryo	O
.	O

In	O
addition	O
,	O
the	O
regulation	O
of	O
Glvr	B
-	I
1	I
gene	I
expression	O
also	O
has	O
potential	O
applications	O
to	O
gene	O
therapy	O
,	O
since	O
retroviral	O
vectors	O
carrying	O
gibbon	B
ape	I
leukemia	I
virus	I
envelope	I
proteins	I
are	O
used	O
for	O
gene	O
delivery	O
into	O
different	O
cell	O
types	O
.	O

Processing	O
of	O
the	O
polycistronic	O
precursor	O
requires	O
nucleases	O
also	O
involved	O
in	O
rRNA	O
processing	O
,	O
i	O
.	O
e	O
.,	O
Rnt1p	B
and	O
Rat1p	B
.	O

Furthermore	O
,	O
rhoA	B
-	O
mediated	O
SRE	O
activation	O
was	O
blocked	O
by	O
dominant	O
negative	O
mutants	O
of	O
PKC	B
-	I
alpha	I
or	O
PKC	B
-	I
epsilon	I
.	O

Nip7p	B
-	O
depleted	O
cells	O
exhibited	O
the	O
same	O
defects	O
as	O
Nop8p	B
-	O
depleted	O
cells	O
,	O
except	O
that	O
they	O
accumulated	O
27S	B
precursors	I
.	O

Overexpression	O
of	O
PTTG	B
in	O
transfected	O
NIH	O
3T3	O
cells	O
also	O
stimulated	O
expression	O
and	O
secretion	O
of	O
basic	B
fibroblast	I
growth	I
factor	I
,	O
a	O
human	B
pituitary	I
tumor	I
growth	I
-	I
regulating	I
factor	I
.	O

E1	B
,	O
a	O
DNA	B
helicase	I
,	O
collaborates	O
with	O
the	O
HPV	B
E2	I
protein	I
in	O
ori	O
-	O
dependent	O
replication	O
.	O

A	O
gapped	O
search	O
with	O
the	O
C	O
-	O
terminal	O
region	O
of	O
CDED	B
/	O
LIOR	B
revealed	O
a	O
36	O
-	O
41	O
%	O
similarity	O
to	O
several	O
proteins	O
related	O
to	O
signal	O
transduction	O
and	O
cell	O
replication	O
,	O
such	O
as	O
ORC1	B
and	O
KSR	B
.	O

Northern	O
blot	O
analysis	O
demonstrated	O
the	O
ubiquitous	O
expression	O
of	O
2	O
.	O
9	O
kb	O
and	O
3	O
.	O

A	O
comparison	O
of	O
the	O
clinical	O
profile	O
of	O
cavernous	O
malformations	O
with	O
and	O
without	O
associated	O
venous	O
malformations	O
.	O

This	O
region	O
of	O
hsp90	B
mediates	O
ATP	O
-	O
independent	O
chaperone	O
activity	O
,	O
overlaps	O
the	O
hsp90	B
dimerization	I
domain	I
,	O
and	O
includes	O
structural	O
elements	O
important	O
for	O
steroid	B
receptor	I
interaction	O
.	O

Sp1	B
'	O
s	O
role	O
in	O
transactivation	O
of	O
the	O
pgp2	B
/	O
mdr1b	B
promoter	O
was	O
tested	O
in	O
Drosophila	O
Schneider	O
cells	O
.	O

Transcription	O
readthrough	O
into	O
the	O
inverted	O
repeats	O
has	O
little	O
effect	O
on	O
this	O
event	O
.	O

The	O
high	O
conservation	O
of	O
the	O
3	O
'	O
terminus	O
suggests	O
that	O
this	O
region	O
directs	O
the	O
assembly	O
of	O
proteins	O
required	O
for	O
the	O
initiation	O
of	O
RNA	O
replication	O
.	O

The	O
3	O
.	O
3	O
-	O
fold	O
higher	O
expression	O
in	O
the	O
fetal	O
heart	O
than	O
in	O
the	O
adult	O
heart	O
suggests	O
that	O
HFHZ	B
mRNA	I
is	O
downregulated	O
in	O
the	O
process	O
of	O
development	O
.	O

Complete	O
recovery	O
of	O
liver	O
function	O
after	O
this	O
surgery	O
tended	O
to	O
be	O
slow	O
.	O

Although	O
both	O
transcripts	O
share	O
the	O
first	O
nine	O
exons	O
,	O
exon	O
10	O
of	O
ZIS	B
-	I
2	I
is	O
lacking	O
in	O
ZIS	B
-	I
1	I
,	O
and	O
instead	O
,	O
exon	O
11	O
(	O
10th	O
exon	O
)	O
of	O
ZIS	B
-	I
1	I
is	O
larger	O
in	O
size	O
,	O
leading	O
to	O
the	O
longer	O
3	O
'-	O
UTR	O
.	O

IFN	B
-	I
gamma	I
was	O
elevated	O
during	O
active	O
TB	O
when	O
compared	O
with	O
healthy	O
controls	O
,	O
declining	O
during	O
and	O
after	O
treatment	O
.	O

II	O
.	O

Airflow	O
through	O
the	O
dust	O
trap	O
was	O
controlled	O
with	O
a	O
vacuum	O
pump	O
.	O

We	O
conclude	O
that	O
(	O
i	O
)	O
we	O
have	O
identified	O
several	O
candidate	O
latency	O
genes	O
of	O
murine	O
gammaHV68	O
,	O
(	O
ii	O
)	O
expression	O
of	O
genes	O
during	O
latency	O
may	O
be	O
different	O
in	O
different	O
organs	O
,	O
consistent	O
with	O
multiple	O
latency	O
programs	O
and	O
/	O
or	O
multiple	O
cellular	O
sites	O
of	O
latency	O
,	O
and	O
(	O
iii	O
)	O
regions	O
of	O
the	O
viral	O
genome	O
(	O
v	B
-	I
bcl	I
-	I
2	I
gene	I
,	O
v	B
-	I
GCR	I
gene	I
,	O
and	O
gene	B
73	I
)	O
are	O
transcribed	O
during	O
latency	O
with	O
both	O
gammaHV68	O
and	O
primate	O
gammaherpesviruses	O
.	O

Chaotic	O
electron	O
dynamics	O
around	O
a	O
single	O
elliptically	O
shaped	O
antidot	O
.	O

The	O
Scales	O
of	O
Cognitive	O
Impairment	O
Rated	O
From	O
Institutional	O
Records	O
(	O
SCIRFIR	O
),	O
a	O
battery	O
based	O
on	O
commonly	O
used	O
dementia	O
rating	O
instruments	O
,	O
was	O
tested	O
on	O
the	O
records	O
of	O
26	O
chronically	O
institutionalized	O
,	O
elderly	O
schizophrenia	O
patients	O
,	O
for	O
the	O
purpose	O
of	O
retrospectively	O
evaluating	O
the	O
long	O
-	O
term	O
course	O
of	O
cognitive	O
change	O
in	O
schizophrenia	O
and	O
relating	O
it	O
to	O
available	O
autopsy	O
materials	O
.	O

It	O
was	O
demonstrated	O
that	O
the	O
processing	O
signals	O
in	O
the	O
transcript	O
,	O
i	O
.	O
e	O
.	O
both	O
donor	O
splice	O
sites	O
and	O
the	O
polyadenylation	O
site	O
located	O
in	O
the	O
muscle	O
-	O
specific	O
intron	O
,	O
have	O
to	O
be	O
weak	O
.	O

In	O
concert	O
with	O
the	O
coactivator	O
CREB	B
binding	I
protein	I
/	O
p300	B
,	O
which	O
interacts	O
with	O
GABPalpha	B
,	O
the	O
binding	O
of	O
GABPalpha	B
and	I
-	I
beta	I
to	O
the	O
dyad	O
symmetry	O
element	O
controls	O
the	O
induction	O
of	O
IL	B
-	I
16	I
promoter	I
in	O
T	O
cells	O
.	O

NH3	O
and	O
NO	O
interaction	O
with	O
Si	O
(	O
100	O
)-(	O
2	O
x	O
1	O
)	O
surfaces	O
.	O

Echo	O
modulation	O
in	O
Pr3	O
+:	O
YAlO3	O
.	O

Optically	O
detected	O
librons	O
and	O
phonons	O
in	O
crystalline	O
C60	O
.	O

Precision	O
measurement	O
of	O
the	O
pion	O
mass	O
difference	O
m	O
pi	O
--	O
m	O
pi	O
0	O
.	O

Factors	O
influencing	O
direct	O
-	O
immersion	O
(	O
DI	O
)-	O
SPME	O
process	O
were	O
also	O
checked	O
and	O
chosen	O
experimentally	O
.	O

In	O
addition	O
,	O
a	O
potent	O
splicing	O
enhancer	O
sequence	O
isolated	O
in	O
the	O
selection	O
specifically	O
binds	O
a	O
20	B
-	I
kDa	I
SR	I
protein	I
.	O

Electrophoretic	O
mobility	O
-	O
shift	O
assays	O
performed	O
with	O
the	O
HNF	B
-	I
3	I
X	O
and	O
Y	O
sites	O
demonstrated	O
that	O
both	O
sites	O
are	O
capable	O
of	O
binding	O
HNF	B
-	I
3alpha	I
and	O
HNF	B
-	I
3beta	I
.	O

In	O
addition	O
,	O
we	O
also	O
show	O
that	O
cdk7	B
may	O
phosphorylate	O
the	O
carboxy	O
-	O
terminal	O
domain	O
(	O
CTD	O
)	O
of	O
RNA	B
pol	I
II	I
in	O
the	O
absence	O
of	O
promoter	O
opening	O
.	O

The	O
inhibition	O
by	O
the	O
RIalpha	B
subunit	I
is	O
reversed	O
by	O
addition	O
of	O
nanomolar	O
concentrations	O
of	O
cAMP	O
(	O
Ka	O
=	O
40	O
nM	O
),	O
thus	O
demonstrating	O
that	O
PrKX	B
is	O
a	O
novel	O
,	O
type	B
I	I
cAMP	I
-	I
dependent	I
protein	I
kinase	I
that	O
is	O
activated	O
at	O
lower	O
cAMP	O
concentrations	O
than	O
the	O
holoenzyme	O
with	O
the	O
Calpha	B
subunit	I
of	O
cAMP	B
-	I
dependent	I
protein	I
kinase	I
.	O

This	O
construct	O
,	O
termed	O
pDeltaCREC	B
/	O
EBP	B
,	O
binds	O
C	B
/	I
EBPalpha	I
and	I
beta	I
but	O
not	O
CREB	B
,	O
yet	O
it	O
confers	O
a	O
nearly	O
complete	O
glucocorticoid	O
response	O
when	O
transiently	O
transfected	O
into	O
H4IIE	O
rat	O
hepatoma	O
cells	O
.	O

In	O
addition	O
,	O
in	O
vitro	O
mutagenesis	O
of	O
both	O
Engrailed	B
and	O
Pbx1	B
sites	I
indicated	O
that	O
other	O
unidentified	O
sites	O
are	O
responsible	O
for	O
the	O
transcriptional	O
enhancement	O
observed	O
with	O
the	O
intronic	O
fragment	O
.	O

High	O
-	O
affinity	O
site	O
-	O
specific	O
DNA	O
binding	O
by	O
POU	B
domain	I
transcription	I
factors	I
requires	O
both	O
the	O
POU	B
-	I
specific	I
and	O
the	O
POU	B
-	I
homeodomain	I
.	O

In	O
the	O
Oct	B
-	I
1	I
crystal	O
,	O
the	O
POU	B
-	I
specific	I
domain	I
recognizes	O
a	O
GCAT	O
half	O
-	O
site	O
,	O
while	O
the	O
corresponding	O
sequence	O
recognized	O
by	O
the	O
Pit	B
-	I
1	I
POU	I
-	O
specific	O
domain	O
,	O
GTAT	O
,	O
is	O
on	O
the	O
opposing	O
strand	O
.	O

Most	O
other	O
end	O
points	O
were	O
highly	O
significant	O
,	O
and	O
death	O
,	O
which	O
was	O
monitored	O
across	O
the	O
U	O
.	O
S	O
.	O
program	O
,	O
was	O
different	O
with	O
p	O
<	O
0	O
.	O
0001	O
.	O

Those	O
radiological	O
aspects	O
were	O
distributed	O
in	O
two	O
categories	O
:	O
1	O
)	O
type	O
I	O
-	O
presenting	O
variable	O
sinusoidal	O
filling	O
.	O

New	O
Langevin	O
equations	O
for	O
a	O
translating	O
and	O
simultaneously	O
rotating	O
asymmetric	O
top	O
.	O

Oscillatory	O
exchange	O
of	O
atoms	O
between	O
traps	O
containing	O
Bose	O
condensates	O
.	O

The	O
microphthalmia	B
-	I
TFE	I
(	O
MiT	B
)	O
subfamily	O
of	O
basic	B
helix	I
-	I
loop	I
-	I
helix	I
leucine	I
zipper	I
(	I
bHLH	I
-	I
ZIP	I
)	I
transcription	I
factors	I
,	O
including	O
TFE3	B
,	O
TFEB	B
,	O
TFEC	B
,	O
and	O
Mitf	B
,	O
has	O
been	O
implicated	O
in	O
the	O
regulation	O
of	O
tissue	O
-	O
specific	O
gene	O
expression	O
in	O
several	O
cell	O
lineages	O
.	O

The	O
dorsal	O
nerves	O
of	O
the	O
penis	O
were	O
anesthetized	O
bilaterally	O
with	O
lidocaine	O
.	O

Mutations	O
of	O
the	O
AP	B
-	I
1	I
site	I
of	O
the	O
TIMP	B
-	I
1	I
promoter	I
that	O
prevented	O
formation	O
of	O
HMAP	B
-	I
1	I
caused	O
a	O
70	O
%	O
loss	O
of	O
activity	O
in	O
transfected	O
activated	O
HSCs	O
.	O

Acoustic	O
transmission	O
spectra	O
in	O
the	O
Penrose	O
lattice	O
.	O

Cyclin	B
D1	I
-	I
associated	I
kinase	I
activity	O
and	O
protein	O
levels	O
were	O
increased	O
in	O
mammary	O
tumors	O
from	O
murine	O
mammary	O
tumor	O
virus	O
-	O
pp60	B
(	O
c	B
-	I
src527F	I
)	O
transgenic	O
mice	O
.	O

An	O
increase	O
in	O
bone	O
mineral	O
density	O
at	O
the	O
spine	O
,	O
total	O
hip	O
,	O
and	O
total	O
body	O
has	O
been	O
reported	O
with	O
raloxifene	O
but	O
seems	O
to	O
be	O
less	O
than	O
that	O
seen	O
with	O
estrogen	O
or	O
alendronate	O
therapy	O
.	O

However	O
,	O
in	O
those	O
studies	O
due	O
to	O
the	O
presence	O
of	O
thiol	O
agents	O
in	O
the	O
PKC	B
preparations	O
,	O
the	O
sensitive	O
reaction	O
of	O
BPO	O
with	O
redox	O
-	O
active	O
cysteine	O
residues	O
in	O
PKC	B
was	O
not	O
observed	O
.	O

Interestingly	O
,	O
Csx	B
/	O
Nkx2	B
.	O

The	O
costs	O
were	O
DM	O
11	O
,	O
562	O
for	O
a	O
PE	O
,	O
DM	O
12	O
,	O
477	O
for	O
a	O
VR	O
and	O
DM	O
7	O
,	O
532	O
for	O
a	O
MR	O
.	O

Each	O
of	O
these	O
genes	O
contains	O
a	O
putative	O
upstream	O
ORF	O
,	O
while	O
STA2	B
has	O
two	O
additional	O
in	O
-	O
frame	O
AUG	O
codons	O
5	O
'	O
to	O
the	O
major	O
cistron	O
.	O

In	O
addition	O
,	O
mapping	O
of	O
the	O
promoter	O
region	O
and	O
the	O
identification	O
of	O
putative	O
promoter	O
regulatory	O
sequences	O
should	O
give	O
insight	O
into	O
the	O
transcriptional	O
regulation	O
of	O
UCP2	B
expression	O
--	O
in	O
particular	O
by	O
anyone	O
of	O
the	O
above	O
mentioned	O
factors	O
--	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

On	O
the	O
other	O
side	O
,	O
when	O
the	O
aortic	O
ring	O
was	O
perfused	O
with	O
L	O
-	O
NNA	O
(	O
NO	O
-	O
synthesis	O
inhibitor	O
)	O
or	O
methylene	O
blue	O
(	O
soluble	O
cGMPase	B
inhibitor	O
),	O
the	O
changes	O
could	O
be	O
attenuated	O
.	O

Nevertheless	O
,	O
inactivation	O
of	O
the	O
cyclin	B
E	I
-	O
Cdk2	B
complex	O
in	O
response	O
to	O
mitogen	O
starvation	O
occurs	O
normally	O
in	O
MEFs	O
that	O
have	O
a	O
homozygous	O
deletion	O
of	O
the	O
p27	B
gene	I
.	O

Taken	O
together	O
,	O
these	O
results	O
are	O
consistent	O
with	O
the	O
possibility	O
that	O
p202	B
protein	I
contributes	O
to	O
the	O
cell	O
growth	O
retardation	O
activity	O
of	O
the	O
IFNs	B
,	O
at	O
least	O
in	O
part	O
,	O
by	O
modulating	O
p21	B
protein	I
levels	O
.	O

Similar	O
results	O
were	O
also	O
obtained	O
with	O
a	O
HepG2	O
hepatoblastoma	O
cell	O
line	O
carrying	O
wt	B
p53	I
.	O

The	O
H	O
-	O
reflex	O
recovery	O
curve	O
was	O
obtained	O
after	O
stimulation	O
of	O
the	O
median	O
nerve	O
at	O
the	O
elbow	O
and	O
recording	O
from	O
the	O
flexor	O
carpi	O
radialis	O
.	O

The	O
origins	O
of	O
reflected	O
light	O
changes	O
associated	O
with	O
neuronal	O
activity	O
(	O
optical	O
signals	O
)	O
were	O
investigated	O
in	O
rat	O
somatosensory	O
cortex	O
with	O
optical	O
imaging	O
,	O
microspectrophotometry	O
,	O
and	O
laser	O
-	O
Doppler	O
flowmetry	O
,	O
and	O
dynamic	O
changes	O
in	O
local	O
hemoglobin	B
concentration	O
and	O
oxygenation	O
were	O
focused	O
on	O
.	O

The	O
results	O
showed	O
that	O
IFN	B
-	I
gamma	I
stimulated	O
the	O
rapid	O
accumulation	O
of	O
interferon	B
regulated	I
factor	I
(	I
IRF	I
)-	I
1	I
mRNA	I
,	O
followed	O
by	O
a	O
delayed	O
and	O
dose	O
-	O
dependent	O
inhibition	O
of	O
alpha1	B
(	I
I	I
)	I
procollagen	I
mRNA	I
expression	O
in	O
skin	O
fibroblasts	O
from	O
several	O
different	O
donors	O
.	O

These	O
results	O
indicate	O
that	O
ATF	B
-	I
2	I
plays	O
a	O
central	O
role	O
in	O
TGF	B
-	I
beta	I
signaling	O
by	O
acting	O
as	O
a	O
common	O
nuclear	O
target	O
of	O
both	O
Smad	B
and	O
TAK1	B
pathways	O
.	O

MDS1	B
/	O
EVI1	B
,	O
located	O
on	O
chromosome	O
3	O
band	O
q26	O
,	O
encodes	O
a	O
zinc	B
-	I
finger	I
DNA	I
-	I
binding	I
transcription	I
activator	I
not	O
detected	O
in	O
normal	O
hematopoietic	O
cells	O
but	O
expressed	O
in	O
several	O
normal	O
tissues	O
.	O

The	O
JTc	O
delta	O
among	O
the	O
three	O
groups	O
did	O
not	O
differ	O
as	O
well	O
:	O
JTc	O
delta	O
of	O
the	O
VT	O
group	O
was	O
70	O
ms	O
+/-	O
30	O
ms	O
,	O
the	O
JTc	O
delta	O
of	O
the	O
PVC	O
group	O
was	O
60	O
msec	O
+/-	O
25	O
msec	O
,	O
and	O
the	O
JTc	O
delta	O
of	O
the	O
control	O
group	O
was	O
70	O
ms	O
+/-	O
30	O
ms	O
.	O

Site	O
-	O
directed	O
mutagenesis	O
of	O
binding	O
sites	O
for	O
the	O
repressor	B
proteins	I
BP1	I
and	O
BP2	B
in	O
the	O
upstream	O
portion	O
of	O
the	O
beta	B
globin	I
gene	I
flanking	I
region	I
led	O
to	O
a	O
4	O
-	O
6	O
fold	O
increase	O
in	O
promoter	O
activity	O
.	O

High	O
-	O
level	O
gains	O
(	O
HLGs	O
)	O
indicative	O
of	O
gene	O
amplifications	O
were	O
identified	O
at	O
11q13	O
in	O
two	O
cases	O
,	O
and	O
in	O
one	O
case	O
each	O
at	O
2q33	O
-	O
34	O
,	O
3q25	O
-	O
29	O
,	O
5p15	O
.	O
1	O
-	O
15	O
.	O
2	O
,	O
7q21	O
-	O
22	O
,	O
11p11	O
.	O
2	O
,	O
12p11	O
.	O
2	O
-	O
12	O
,	O
and	O
13q34	O
.	O

Interestingly	O
,	O
the	O
RNA	O
sequences	O
selected	O
by	O
the	O
mutated	O
zinc	B
knuckle	I
9G8	I
variant	I
are	O
efficiently	O
recognized	O
by	O
SRp20	B
,	O
in	O
agreement	O
with	O
the	O
fact	O
that	O
the	O
RBD	O
of	O
9G8	B
and	O
SRp20	B
are	O
similar	O
.	O

All	O
numbers	O
refer	O
to	O
nucleotide	O
positions	O
on	O
the	O
wild	O
-	O
type	O
HIV	O
-	O
1	O
transcript	O
.	O

A	O
mutation	O
linked	O
to	O
the	O
SOC1	B
gene	I
,	O
previously	O
defined	O
by	O
recessive	O
mutations	O
that	O
suppress	O
cbp1	B
ts	I
alleles	I
and	O
stabilize	O
many	O
mitochondrial	O
mRNAs	O
,	O
was	O
also	O
isolated	O
.	O

A	O
deletion	O
mutation	O
analysis	O
of	O
the	O
recombinant	O
protein	O
has	O
shown	O
that	O
the	O
N	O
-	O
terminal	O
region	O
and	O
the	O
two	O
leucine	O
zippers	O
are	O
necessary	O
for	O
the	O
binding	O
.	O

Type	O
I	O
cysts	O
(	O
with	O
a	O
high	O
K	O
+/	O
Na	O
+	O
ratio	O
)	O
tend	O
to	O
have	O
higher	O
total	O
PSA	B
than	O
Type	O
II	O
cysts	O
.	O

Despite	O
this	O
DNA	O
binding	O
activity	O
,	O
AP	B
-	I
1	I
reporter	I
activity	O
was	O
suppressed	O
in	O
these	O
cells	O
.	O

Troubled	O
CareNetwork	O
gets	O
pact	O
from	O
largest	O
teacher	O
union	O
in	O
Wis	O
.	O

METHODS	O
:	O
Between	O
August	O
1991	O
and	O
June	O
1994	O
,	O
198	O
men	O
with	O
clinical	O
T2	O
or	O
T3	O
classified	O
(	O
TNM	O
)	O
prostate	O
carcinoma	O
(	O
bone	O
scan	O
negative	O
)	O
who	O
were	O
at	O
high	O
risk	O
of	O
lymph	O
node	O
involvement	O
underwent	O
a	O
111In	O
-	O
capromab	O
pendetide	O
scan	O
prior	O
to	O
staging	O
lymphadenectomy	O
.	O

Immediately	O
after	O
surgery	O
,	O
dialysate	O
PGE2	O
and	O
adenosine	O
concentrations	O
were	O
3	O
.	O
7	O
+/-	O
0	O
.	O
7	O
and	O
296	O
+/-	O
127	O
nM	O
,	O
respectively	O
.	O

One	O
such	O
element	O
,	O
1P	O
,	O
was	O
employed	O
to	O
clone	O
from	O
a	O
rat	O
pituitary	O
cDNA	O
expression	O
library	O
a	O
novel	O
417	B
-	I
amino	I
acid	I
WD	I
protein	I
,	O
designated	O
PREB	B
(	I
PRL	I
regulatory	I
element	I
binding	I
)	I
protein	I
.	O

The	O
peroxisome	B
proliferator	I
-	I
activated	I
receptors	I
(	O
PPARs	B
)	O
are	O
members	O
of	O
the	O
nuclear	B
hormone	I
receptor	I
superfamily	I
.	O

The	O
Asian	O
mouse	O
Mus	O
castaneus	O
is	O
resistant	O
to	O
infection	O
by	O
the	O
polytropic	O
mink	O
cell	O
focus	O
-	O
inducing	O
(	O
MCF	O
)	O
subgroup	O
of	O
murine	O
leukemia	O
viruses	O
(	O
MuLVs	O
).	O

CCAAT	B
displacement	I
protein	I
binds	O
to	O
and	O
negatively	O
regulates	O
human	O
papillomavirus	O
type	O
6	O
E6	B
,	O
E7	B
,	O
and	O
E1	B
promoters	O
.	O

Using	O
an	O
RNase	B
H	I
protection	O
assay	O
and	O
specific	O
blocking	O
oligonucleotides	O
,	O
we	O
find	O
that	O
recognition	O
of	O
the	O
5	O
'	O
splice	O
-	O
site	O
(	O
5	O
'	O
ss	O
)	O
and	O
branchpoint	O
sequence	O
(	O
BPS	O
)	O
elements	O
by	O
U11	B
and	O
U12	B
snRNPs	I
,	O
respectively	O
,	O
displays	O
strong	O
cooperativity	O
,	O
requiring	O
both	O
sites	O
in	O
the	O
pre	O
-	O
mRNA	O
substrate	O
for	O
efficient	O
complex	O
formation	O
.	O

Analysis	O
of	O
lacZ	B
transcriptional	I
fusions	I
shows	O
that	O
the	O
KdgR	B
-	I
binding	I
sites	I
negatively	O
affect	O
the	O
expression	O
of	O
rsmB	B
.	O

In	O
the	O
cell	O
-	O
free	O
import	O
assay	O
,	O
beta	B
-	I
catenin	I
rapidly	O
migrates	O
into	O
the	O
nucleus	O
without	O
the	O
exogenous	O
addition	O
of	O
cytosol	O
,	O
Ran	B
,	O
or	O
ATP	O
/	O
GTP	O
.	O

Bacteria	O
can	O
also	O
cause	O
a	O
labyrinthitis	O
acting	O
directly	O
on	O
the	O
inner	O
ear	O
:	O
among	O
these	O
,	O
Treponemas	O
Pallidum	O
,	O
a	O
spirochaete	O
which	O
causes	O
syphilis	O
and	O
Borrelia	O
Burgdorferi	O
,	O
a	O
spirochaete	O
that	O
causes	O
Lyme	O
Disease	O
,	O
must	O
be	O
mentioned	O
.	O

These	O
findings	O
demonstrate	O
that	O
signature	O
-	O
tagged	O
mutagenesis	O
is	O
a	O
viable	O
approach	O
to	O
identify	O
bacterial	O
genes	O
associated	O
with	O
the	O
ability	O
to	O
infect	O
the	O
urinary	O
tract	O
.	O

Moreover	O
,	O
when	O
added	O
to	O
the	O
osteoclast	O
cultures	O
,	O
mrIhh	B
-	I
N	I
markedly	O
stimulated	O
the	O
formation	O
of	O
resorption	O
pits	O
on	O
dentine	O
slices	O
.	O

We	O
show	O
here	O
that	O
,	O
despite	O
their	O
structural	O
and	O
functional	O
similarities	O
,	O
the	O
pop1	B
and	O
pop2	B
genes	I
fail	O
to	O
complement	O
each	O
other	O
'	O
s	O
deletion	O
phenotypes	O
,	O
indicating	O
that	O
they	O
perform	O
non	O
-	O
redundant	O
,	O
but	O
potentially	O
interdependent	O
,	O
functions	O
in	O
proteolysis	O
.	O

Antithrombin	B
III	I
prevents	O
60	O
min	O
warm	O
intestinal	O
ischemia	O
reperfusion	O
injury	O
in	O
rats	O
.	O

Furthermore	O
,	O
the	O
validity	O
of	O
this	O
new	O
subset	O
of	O
questions	O
was	O
shown	O
to	O
be	O
significant	O
(	O
r	O
=	O
0	O
.	O
037	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
for	O
the	O
correlation	O
between	O
a	O
measure	O
of	O
the	O
severity	O
of	O
binocular	O
visual	O
field	O
loss	O
and	O
the	O
mean	O
score	O
of	O
the	O
variables	O
used	O
in	O
the	O
glaucoma	O
specific	O
subgroup	O
of	O
questions	O
.	O

Sequence	O
comparison	O
of	O
cytochromes	B
bd	I
and	O
their	O
homologs	O
from	O
various	O
organisms	O
demonstrates	O
that	O
the	O
proteins	O
can	O
be	O
classified	O
into	O
two	O
subfamilies	O
,	O
a	O
proteobacterial	O
type	O
including	O
E	B
.	I
coli	I
bd	I
and	O
a	O
more	O
widely	O
distributed	O
type	O
including	O
the	O
B	O
.	O
stearothermophilus	O
enzyme	O
,	O
suggesting	O
that	O
the	O
latter	O
type	O
is	O
evolutionarily	O
older	O
.	O

Solution	O
structure	O
and	O
mechanism	O
of	O
the	O
MutT	B
pyrophosphohydrolase	I
.	O

RESULTS	O
AND	O
CONCLUSIONS	O
:	O
Brandt	O
'	O
s	O
double	O
cuff	O
-	O
tubes	O
(	O
G2	O
)	O
succeed	O
in	O
avoiding	O
uncontrolled	O
increase	O
of	O
cuff	O
-	O
pressure	O
during	O
anaesthesia	O
with	O
N2O	O
.	O

Our	O
results	O
indicate	O
that	O
V3	B
peptides	O
from	O
all	O
major	O
clades	O
of	O
HIV	O
-	O
1	O
carried	O
by	O
HIV	B
-	I
2	I
gag	I
can	O
be	O
used	O
as	O
a	O
potential	O
HIV	O
/	O
AIDS	O
vaccine	O
.	O

In	O
XO	O
males	O
,	O
two	O
her	B
-	I
1	I
mRNAs	I
,	O
her	B
-	I
1a	I
and	O
her	B
-	I
1b	I
,	O
are	O
transcribed	O
from	O
two	O
separate	O
promoters	O
:	O
P1	O
,	O
located	O
in	O
the	O
5	O
'-	O
flanking	O
region	O
,	O
and	O
P2	O
,	O
located	O
in	O
the	O
large	O
second	O
intron	O
.	O

Receptor	B
protein	I
tyrosine	I
phosphatases	I
(	O
RPTPs	B
)	O
comprise	O
a	O
family	O
of	O
proteins	O
that	O
feature	O
intracellular	O
phosphatase	O
domains	O
and	O
an	O
ectodomain	O
with	O
putative	O
ligand	O
-	O
binding	O
motifs	O
.	O

In	O
contrast	O
,	O
the	O
loss	O
of	O
MAD2	B
staining	O
in	O
meiosis	O
was	O
not	O
correlated	O
with	O
initial	O
microtubule	O
attachment	O
but	O
was	O
correlated	O
with	O
a	O
measure	O
of	O
tension	O
:	O
the	O
distance	O
between	O
homologous	O
or	O
sister	O
kinetochores	O
(	O
in	O
meiosis	O
I	O
and	O
II	O
,	O
respectively	O
).	O

In	O
epithelial	O
cells	O
,	O
the	O
PH	B
domain	I
of	O
Akt	B
/	O
PKB	B
localised	O
to	O
sites	O
of	O
cell	O
-	O
cell	O
and	O
cell	O
-	O
matrix	O
contact	O
,	O
distinct	O
from	O
focal	O
contacts	O
,	O
even	O
in	O
the	O
absence	O
of	O
serum	O
.	O

The	O
motility	O
of	O
sperm	O
,	O
except	O
for	O
those	O
adjacent	O
to	O
both	O
electrodes	O
,	O
did	O
not	O
change	O
after	O
stimulation	O
for	O
60s	O
,	O
despite	O
a	O
high	O
electrical	O
energy	O
.	O

Regulatory	O
motifs	O
for	O
gene	O
expression	O
such	O
as	O
nuclear	B
-	I
factor	I
-	I
kappaB	I
-	I
binding	I
-	I
site	I
-	I
like	I
sequence	I
(	O
kappaB	B
site	I
)	O
and	O
nuclear	B
-	I
factor	I
-	I
interleukin	I
-	I
6	I
-	I
binding	I
-	I
site	I
-	I
like	I
sequence	I
(	O
NF	B
-	I
IL	I
-	I
6	I
site	I
)	O
were	O
found	O
in	O
the	O
5	O
'-	O
upstream	O
regulatory	O
region	O
.	O

Total	O
serum	O
calcium	O
was	O
7	O
.	O
8	O
+/-	O
0	O
.	O
8	O
mg	O
/	O
dl	O
,	O
whereas	O
ionized	O
calcium	O
was	O
5	O
.	O
7	O
+/-	O
0	O
.	O
7	O
mg	O
/	O
dl	O
,	O
phosphorus	O
3	O
.	O
2	O
+/-	O
1	O
.	O
2	O
mg	O
/	O
dl	O
,	O
and	O
alkaline	B
phosphatase	I
149	O
+/-	O
48	O
.	O
6	O
U	O
/	O
liter	O
.	O

Ischemia	O
and	O
reperfusion	O
markedly	O
increased	O
the	O
release	O
of	O
6	O
-	O
keto	O
-	O
PGF1	O
alpha	O
and	O
TXB2	O
.	O

Prostate	B
-	I
specific	I
antigen	I
(	O
PSA	B
)	O
promoter	O
-	O
driven	O
androgen	O
-	O
inducible	O
expression	O
of	O
sodium	B
iodide	I
symporter	I
in	O
prostate	O
cancer	O
cell	O
lines	O
.	O

In	O
a	O
series	O
of	O
16	O
full	O
-	O
scale	O
fire	O
tests	O
,	O
investigators	O
at	O
the	O
IIT	O
Research	O
Institute	O
have	O
concluded	O
that	O
automatic	O
door	O
control	O
in	O
the	O
room	O
of	O
fire	O
origin	O
can	O
significantly	O
reduce	O
the	O
spread	O
of	O
toxic	O
smoke	O
and	O
gases	O
.	O

In	O
this	O
paper	O
,	O
the	O
current	O
status	O
of	O
the	O
understanding	O
of	O
the	O
interaction	O
mechanisms	O
of	O
ultrasound	O
with	O
biological	O
media	O
and	O
the	O
factors	O
that	O
govern	O
different	O
biological	O
effects	O
are	O
surveyed	O
.	O

Here	O
we	O
show	O
that	O
calpeptin	B
inhibits	O
tyrosine	B
phosphatases	I
,	O
enhancing	O
tyrosine	O
phosphorylation	O
particularly	O
of	O
paxillin	B
.	O

We	O
suggest	O
that	O
FlgN	B
and	O
FliT	B
are	O
substrate	O
-	O
specific	O
flagellar	O
chaperones	O
that	O
prevent	O
oligomerization	O
of	O
the	O
HAPs	B
by	O
binding	O
to	O
their	O
helical	O
domains	O
before	O
export	O
.	O

Km	O
values	O
for	O
ammonium	O
,	O
2	O
-	O
oxoglutarate	O
,	O
NADH	O
,	O
glutamate	O
and	O
NAD	O
+	O
were	O
6	O
.	O
5	O
,	O
3	O
.	O
5	O
,	O
0	O
.	O
06	O
,	O
37	O
.	O
1	O
and	O
0	O
.	O
046	O
mM	O
,	O
respectively	O
.	O

Interferon	B
-	I
alpha	I
may	O
exacerbate	O
cryoblobulinemia	O
-	O
related	O
ischemic	O
manifestations	O
:	O
an	O
adverse	O
effect	O
potentially	O
related	O
to	O
its	O
anti	O
-	O
angiogenic	O
activity	O
.	O

Only	O
one	O
gene	O
,	O
fibronectin	B
(	O
FN	B
),	O
was	O
highly	O
overexpressed	O
(>	O
60	O
-	O
fold	O
)	O
in	O
LNCaP	O
-	O
r	O
cells	O
,	O
consistent	O
with	O
previously	O
reported	O
overexpression	O
of	O
FN	B
in	O
prostate	O
cancer	O
.	O

Insulin	B
stimulation	O
promoted	O
the	O
association	O
of	O
mIRS3	B
with	O
p85	B
,	O
SHP2	B
,	O
Nck	B
,	O
and	O
Shc	B
.	O

Two	O
evolutionarily	O
conserved	O
kinases	O
,	O
the	O
cyclin	B
B	I
(	O
Clb	B
)/	O
cyclin	B
-	I
dependent	I
kinase	I
(	O
Cdk	B
/	O
Cdc28p	B
)	O
and	O
Cdc7p	B
along	O
with	O
its	O
interacting	O
factor	O
Dbf4p	B
,	O
are	O
required	O
late	O
in	O
G1	O
to	O
initiate	O
DNA	O
replication	O
.	O

All	O
of	O
the	O
elements	O
exhibited	O
a	O
uniform	O
structure	O
.	O

In	O
contrast	O
,	O
the	O
deduced	O
amino	O
acid	O
sequence	O
of	O
a	O
second	O
family	O
(	O
ART5	B
)	O
of	O
transferases	O
,	O
cloned	O
from	O
murine	O
lymphoma	O
cells	O
and	O
expressed	O
in	O
high	O
abundance	O
in	O
testis	O
,	O
displays	O
a	O
hydrophobic	O
amino	O
terminus	O
,	O
consistent	O
with	O
a	O
signal	O
sequence	O
,	O
but	O
lacks	O
a	O
hydrophobic	O
signal	O
sequence	O
at	O
its	O
carboxyl	O
terminus	O
,	O
suggesting	O
that	O
the	O
protein	O
is	O
destined	O
for	O
export	O
.	O

The	O
coefficient	O
of	O
determination	O
,	O
r2	O
,	O
of	O
the	O
other	O
scores	O
ranged	O
from	O
0	O
.	O
56	O
to	O
0	O
.	O
61	O
.	O

The	O
IC50	O
values	O
for	O
rat	O
and	O
dog	O
urinary	O
bladder	O
were	O
3	O
.	O
9	O
x	O
10	O
(-	O
6	O
)	O
M	O
and	O
3	O
.	O
8	O
x	O
10	O
(-	O
6	O
)	O
M	O
,	O
respectively	O
.	O

Although	O
it	O
has	O
two	O
potential	O
binding	O
sites	O
,	O
the	O
purified	O
MerR	B
homodimer	I
binds	O
only	O
one	O
Hg	O
(	O
II	O
)	O
ion	O
,	O
employing	O
Cys82	O
from	O
one	O
monomer	O
and	O
Cys117	O
and	O
Cys126	O
from	O
the	O
other	O
.	O

Regression	O
analyses	O
identified	O
7	O
risk	O
and	O
7	O
protective	O
factors	O
with	O
minimal	O
overlap	O
.	O

During	O
1985	O
,	O
1990	O
,	O
and	O
1995	O
,	O
respectively	O
,	O
11	O
.	O
7	O
,	O
11	O
.	O
3	O
,	O
and	O
11	O
.	O
4	O
infants	O
per	O
100	O
,	O
000	O
live	O
births	O
had	O
a	O
diagnosis	O
of	O
HSV	O
(	O
P	O
=.	O
98	O
).	O

The	O
median	O
age	O
was	O
33	O
years	O
(	O
range	O
17	O
-	O
56	O
years	O
).	O

In	O
addition	O
,	O
these	O
cells	O
contained	O
one	O
,	O
two	O
,	O
or	O
multiple	O
nuclei	O
indicative	O
of	O
a	O
G2	O
/	O
M	O
delay	O
in	O
nuclear	O
division	O
and	O
also	O
a	O
defect	O
in	O
cytokinesis	O
and	O
/	O
or	O
cell	O
separation	O
.	O

DAF16	B
is	O
known	O
to	O
be	O
a	O
component	O
of	O
a	O
signaling	O
pathway	O
that	O
has	O
been	O
partially	O
dissected	O
genetically	O
and	O
includes	O
homologues	O
of	O
the	O
insulin	B
/	O
IGF	B
-	I
1	I
receptor	I
,	O
PtdIns	B
3	I
-	I
kinase	I
and	O
PKB	B
.	O

Modulation	O
of	O
human	B
heat	I
shock	I
factor	I
trimerization	O
by	O
the	O
linker	O
domain	O
.	O

They	O
also	O
occur	O
in	O
similar	O
locations	O
in	O
the	O
promoters	O
of	O
several	O
other	O
ribosomal	B
protein	I
genes	I
.	O

Both	O
carbachol	O
(	O
100	O
microM	O
)	O
and	O
EGF	B
(	O
10	O
nM	O
)	O
induced	O
Ras	B
activation	O
.	O

With	O
exon	O
trapping	O
,	O
we	O
could	O
isolate	O
five	O
potential	O
exons	O
from	O
the	O
YAC	O
946E12	O
that	O
spans	O
the	O
region	O
,	O
four	O
of	O
which	O
could	O
be	O
placed	O
in	O
the	O
contig	O
in	O
the	O
vicinity	O
of	O
the	O
breakpoints	O
.	O

Optimal	O
monitoring	O
of	O
ODA	O
remains	O
undefined	O
.	O

SRFDelta5	B
acts	O
as	O
a	O
naturally	O
occurring	O
dominant	O
negative	O
regulatory	O
mutant	O
that	O
blocks	O
SRF	B
-	O
dependent	O
skeletal	B
alpha	I
-	I
actin	I
,	O
cardiac	B
alpha	I
-	I
actin	I
,	O
smooth	B
alpha	I
-	I
actin	I
,	O
SM22alpha	B
,	O
and	O
SRF	B
promoter	O
-	O
luciferase	B
reporter	O
activities	O
.	O

The	O
potency	O
of	O
the	O
effect	O
of	O
Nim	O
(	O
0	O
.	O
5	O
mg	O
.	O
kg	O
-	O
1	O
i	O
.	O
p	O
.)	O
was	O
similar	O
to	O
that	O
of	O
NBP	O
(	O
10	O
mg	O
.	O
kg	O
-	O
1	O
i	O
.	O
p	O
.).	O

As	O
is	O
deduced	O
from	O
the	O
nucleotide	O
sequence	O
of	O
the	O
cDNA	O
,	O
CBS	B
-	I
1	I
contains	O
an	O
open	O
reading	O
frame	O
consisting	O
of	O
182	O
amino	O
acids	O
,	O
with	O
a	O
molecular	O
weight	O
of	O
19	O
.	O
5kDa	O
.	O

12	O
healthy	O
women	O
(	O
age	O
18	O
-	O
38	O
years	O
)	O
were	O
examined	O
using	O
the	O
2	O
-	O
hour	O
'	O
s	O
method	O
of	O
passive	O
leg	O
rising	O
(	O
PLR	O
)	O
in	O
follicular	O
(	O
FP	O
)	O
and	O
luteal	O
(	O
LP	O
)	O
phases	O
of	O
normal	O
ovulatory	O
cycle	O
.	O

Removal	O
of	O
each	O
of	O
three	O
contiguous	O
segments	O
from	O
the	O
N	O
-	O
terminal	O
half	O
specifically	O
inhibits	O
the	O
formation	O
of	O
5	B
.	I
8Ss	I
rRNA	I
,	O
whereas	O
deleting	O
part	O
of	O
the	O
C	O
-	O
terminal	O
region	O
of	O
the	O
protein	O
only	O
blocks	O
the	O
production	O
of	O
18S	B
rRNA	I
.	O

Ras	B
is	O
not	O
associated	O
with	O
the	O
tegument	O
.	O

A	O
recently	O
described	O
protein	O
,	O
metaxin	B
1	I
,	O
serves	O
as	O
a	O
component	O
of	O
a	O
preprotein	O
import	O
complex	O
in	O
the	O
outer	O
membrane	O
of	O
the	O
mammalian	O
mitochondrion	O
.	O

Slp1	B
represses	O
transcription	O
via	O
this	O
binding	O
site	O
in	O
yeast	O
cells	O
,	O
consistent	O
with	O
its	O
role	O
as	O
a	O
direct	O
repressor	O
of	O
ftz	B
stripes	O
in	O
interstripe	O
regions	O
during	O
late	O
stages	O
of	O
embryogenesis	O
.	O

The	O
penicillin	B
binding	I
proteins	I
(	O
PBPs	B
)	O
synthesize	O
and	O
remodel	O
peptidoglycan	O
,	O
the	O
structural	O
component	O
of	O
the	O
bacterial	O
cell	O
wall	O
.	O

The	O
high	B
density	I
lipoprotein	I
(	I
HDL	I
)	I
receptor	I
mediates	O
the	O
uptake	O
of	O
cholesterol	O
and	O
cholesteryl	O
esters	O
,	O
substrates	O
for	O
steroidogenesis	O
,	O
from	O
an	O
HDL	B
particle	O
in	O
the	O
adrenal	O
gland	O
and	O
gonads	O
.	O

D3S1261	B
is	O
physically	O
located	O
at	O
or	O
near	O
the	O
MITF	B
locus	I
,	O
while	O
D3S2465	B
and	O
D3S1766	B
are	O
flanking	O
the	O
locus	O
at	O
about	O
17	O
.	O
5	O
cM	O
genetic	O
distance	O
each	O
side	O
.	O

The	O
percentages	O
of	O
recovery	O
decreased	O
with	O
storage	O
time	O
,	O
although	O
the	O
addition	O
of	O
dispersant	O
(	O
Tris	O
-	O
Tween	O
80	O
)	O
before	O
storage	O
appeared	O
to	O
partially	O
prevent	O
adhesion	O
.	O

Point	O
mutations	O
of	O
the	O
site	O
that	O
suppressed	O
Pit	B
-	I
1	I
binding	O
in	O
vitro	O
restored	O
full	O
tiGH	B
promoter	I
activity	O
.	O

A	O
human	B
Raf	I
-	I
responsive	I
zinc	I
-	I
finger	I
protein	I
that	O
binds	O
to	O
divergent	O
sequences	O
.	O

BACKGROUND	O
:	O
The	O
MAZE	O
-	O
III	O
is	O
the	O
surgical	O
treatment	O
of	O
choice	O
for	O
medically	O
refractory	O
atrial	O
fibrillation	O
.	O

In	O
an	O
attempt	O
to	O
reduce	O
the	O
incidence	O
of	O
NSAID	O
-	O
induced	O
gastrointestinal	O
lesions	O
,	O
the	O
following	O
approaches	O
have	O
been	O
proposed	O
:	O
(	O
i	O
)	O
use	O
of	O
the	O
prostaglandin	O
analogue	O
misoprostol	O
,	O
which	O
is	O
an	O
antiulcer	O
drug	O
which	O
has	O
been	O
proven	O
to	O
be	O
as	O
effective	O
in	O
the	O
prevention	O
of	O
NSAID	O
-	O
induced	O
gastric	O
and	O
duodenal	O
ulcers	O
as	O
in	O
the	O
reduction	O
of	O
serious	O
upper	O
gastrointestinal	O
complications	O
;	O
(	O
ii	O
)	O
histamine	B
H2	I
receptor	I
antagonists	O
(	O
H2	O
antagonists	O
),	O
e	O
.	O
g	O
.	O
ranitidine	O
,	O
cimetidine	O
and	O
famotidine	O
,	O
which	O
are	O
useful	O
in	O
the	O
prevention	O
of	O
NSAID	O
-	O
induced	O
duodenal	O
ulcers	O
during	O
long	O
term	O
treatment	O
,	O
but	O
not	O
in	O
the	O
prevention	O
of	O
NSAID	O
-	O
induced	O
gastric	O
ulcers	O
;	O
(	O
iii	O
)	O
proton	O
pump	O
inhibitors	O
,	O
e	O
.	O
g	O
omeprazole	O
,	O
and	O
pantoprazole	O
,	O
whose	O
efficacy	O
in	O
preventing	O
NSAID	O
-	O
associated	O
ulcers	O
has	O
been	O
recently	O
demonstrated	O
;	O
and	O
(	O
iv	O
)	O
barrier	O
agents	O
,	O
e	O
.	O
g	O
.	O
sucralfate	O
,	O
which	O
cannot	O
be	O
recommended	O
as	O
prophylactic	O
agents	O
to	O
prevent	O
NSAID	O
-	O
induced	O
gastropathy	O
.	O

E2	B
point	O
mutants	O
unable	O
to	O
inhibit	O
cell	O
growth	O
did	O
not	O
repress	O
cdc25A	B
and	O
cdc25B	B
expression	O
,	O
nor	O
did	O
the	O
cell	O
cycle	O
inhibitors	O
hydroxyurea	O
and	O
mimosine	O
.	O

Our	O
data	O
therefore	O
indicate	O
that	O
it	O
is	O
possible	O
to	O
engineer	O
the	O
HA	B
envelope	I
glycoprotein	I
by	O
fusing	O
ligands	O
to	O
its	O
amino	O
-	O
terminal	O
end	O
without	O
affecting	O
its	O
fusion	O
activity	O
.	O

This	O
is	O
predicted	O
to	O
encode	O
a	O
315	O
-	O
residue	O
protein	O
containing	O
seven	O
hydrophobic	O
helical	O
regions	O
and	O
a	O
17	O
amino	O
acid	O
motif	O
characteristic	O
of	O
the	O
R7G	B
family	I
of	O
G	B
-	I
protein	I
coupled	I
membrane	I
-	I
bound	I
receptors	I
.	O

These	O
results	O
suggest	O
that	O
members	O
of	O
the	O
ATF	B
family	I
are	O
involved	O
in	O
mediating	O
the	O
transcriptional	O
regulation	O
of	O
the	O
KGF	B
gene	I
in	O
response	O
to	O
extracellular	O
stimuli	O
via	O
a	O
novel	O
CRE	O
regulatory	O
element	O
.	O

Simian	O
parainfluenza	O
virus	O
5	O
(	O
SV5	O
)	O
is	O
a	O
prototype	O
of	O
the	O
Paramyxoviridae	O
family	O
of	O
nonsegmented	O
negative	O
-	O
sense	O
RNA	O
viruses	O
.	O

CXCR4	B
is	O
a	O
chemokine	O
receptor	O
and	O
a	O
coreceptor	O
for	O
T	O
-	O
cell	O
-	O
line	O
-	O
tropic	O
(	O
X4	O
)	O
and	O
dual	O
-	O
tropic	O
(	O
R5X4	O
)	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV	O
-	O
1	O
)	O
isolates	O
.	O

Auditory	O
clicks	O
were	O
given	O
at	O
a	O
rate	O
of	O
20	O
s	O
(-	O
1	O
).	O

The	O
inhibition	O
of	O
StAR	B
gene	I
transcription	O
by	O
DAX	B
-	I
1	I
was	O
dose	O
-	O
dependent	O
reducing	O
transcription	O
to	O
6	O
%	O
of	O
control	O
levels	O
.	O

A	O
13	O
-	O
bp	O
cis	O
-	O
regulatory	O
element	O
in	O
the	O
LTR	O
promoter	O
of	O
the	O
tobacco	B
retrotransposon	I
Tto1	I
is	O
involved	O
in	O
responsiveness	O
to	O
tissue	O
culture	O
,	O
wounding	O
,	O
methyl	O
jasmonate	O
and	O
fungal	O
elicitors	O
.	O

Chemical	O
stability	O
tests	O
and	O
site	O
-	O
specific	O
mutagenesis	O
identified	O
amino	O
acids	O
H219	O
and	O
D63	O
of	O
RegS	B
and	O
RegR	B
,	O
respectively	O
,	O
as	O
the	O
phosphorylated	O
residues	O
.	O

67	O
393	O
bp	O
of	O
contiguous	O
DNA	O
located	O
between	O
markers	O
cdc18	B
and	O
cdc14	B
on	O
the	O
right	O
arm	O
of	O
fission	O
yeast	O
chromosome	O
II	O
has	O
been	O
sequenced	O
as	O
part	O
of	O
the	O
European	O
Union	O
Schizosaccharomyces	O
pombe	O
genome	O
sequencing	O
project	O
.	O

67	O
393	O
bp	O
of	O
contiguous	O
DNA	O
located	O
between	O
markers	O
cdc18	B
and	O
cdc14	B
on	O
the	O
right	O
arm	O
of	O
fission	O
yeast	O
chromosome	O
II	O
has	O
been	O
sequenced	O
as	O
part	O
of	O
the	O
European	O
Union	O
Schizosaccharomyces	O
pombe	O
genome	O
sequencing	O
project	O
.	O

G	B
-	I
CSF	I
(	O
480	O
micrograms	O
subcutaneously	O
(	O
s	O
.	O
c	O
.))	O
were	O
used	O
in	O
55	O
and	O
GM	B
-	I
CSF	I
(	O
400	O
micrograms	O
s	O
.	O
c	O
.)	O
in	O
28	O
chemotherapeutic	O
cycles	O
.	O

Overexpression	O
of	O
H411	B
cDNA	I
in	O
the	O
RAW	O
264	O
.	O
7	O
macrophage	O
cell	O
line	O
promoted	O
an	O
increased	O
growth	O
rate	O
,	O
suggesting	O
that	O
expression	O
of	O
H411	B
is	O
part	O
of	O
the	O
proliferative	O
cell	O
response	O
to	O
LPS	O
.	O

In	O
summary	O
,	O
Ca	O
(	O
2	O
+)-	O
dependent	O
activation	O
of	O
NO	O
production	O
mediates	O
apoptosis	O
after	O
TG	B
exposure	O
in	O
JT	O
/	O
Neo	O
cells	O
.	O

Accumulation	O
of	O
the	O
U4	B
/	O
U6	B
duplex	O
was	O
relieved	O
by	O
overexpression	O
of	O
wild	B
-	I
type	I
Prp44p	I
.	O

The	O
mysteries	O
of	O
geographic	O
variability	O
in	O
nonmelanoma	O
skin	O
cancer	O
incidence	O
.	O

Epidemiologic	O
evidence	O
indicates	O
that	O
estrogen	O
replacement	O
therapy	O
after	O
menopause	O
increases	O
breast	O
cancer	O
risk	O
.	O

This	O
report	O
presents	O
state	O
-	O
specific	O
MMRs	O
for	O
1987	O
-	O
1996	O
,	O
focusing	O
on	O
persistent	O
disparities	O
in	O
maternal	O
mortality	O
between	O
black	O
and	O
white	O
women	O
.	O

Preheparin	O
LPL	B
mass	O
level	O
did	O
not	O
significantly	O
differ	O
in	O
individuals	O
from	O
19	O
to	O
70	O
years	O
old	O
,	O
for	O
both	O
men	O
and	O
women	O
.	O

Expansins	B
are	O
a	O
family	O
of	O
proteins	O
that	O
catalyse	O
long	O
-	O
term	O
extension	O
of	O
isolated	O
plant	O
cell	O
walls	O
due	O
to	O
an	O
as	O
yet	O
unknown	O
biochemical	O
mechanism	O
.	O

A	O
.,	O
Bowers	O
,	O
K	O
.	O
E	O
,	O
and	O
Matthews	O
,	O
C	O
.	O

Spfkh1	B
is	O
transcribed	O
in	O
one	O
open	O
reading	O
frame	O
that	O
contains	O
the	O
DNA	O
binding	O
domain	O
,	O
nuclear	O
localization	O
signal	O
and	O
transactivation	O
domain	O
.	O

The	O
molecular	O
mechanism	O
of	O
Tax	B
-	O
mediated	O
trans	O
-	O
activation	O
has	O
been	O
well	O
investigated	O
.	O

One	O
of	O
these	O
SEBPs	B
,	O
SEBP2	B
,	O
was	O
shown	O
to	O
be	O
the	O
product	O
of	O
the	O
homeotic	B
gene	I
fork	I
head	I
.	O

In	O
insulin	B
-	O
responsive	O
cells	O
,	O
Akt	B
phosphorylates	O
and	O
inactivates	O
the	O
serine	B
/	I
threonine	I
kinase	I
glycogen	I
synthase	I
kinase	I
-	I
3	I
(	O
GSK	B
-	I
3	I
).	O

Copyright	O
1999	O
Academic	O
Press	O
.	O

At	O
baseline	O
,	O
serum	O
levels	O
of	O
lycopene	O
and	O
FLOP	O
were	O
abnormally	O
high	O
and	O
serum	O
FLOP	O
was	O
correlated	O
significantly	O
with	O
plasma	O
cyclosporine	O
levels	O
(	O
r	O
=	O
0	O
.	O
646	O
,	O
p	O
=	O
0	O
.	O
016	O
).	O

Adipocyte	O
differentiation	O
of	O
nontransformed	O
cells	O
also	O
markedly	O
represses	O
the	O
ability	O
of	O
SRF	B
to	O
bind	O
to	O
the	O
junB	B
SRE	O
,	O
the	O
c	B
-	I
fos	I
SRE	O
,	O
and	O
other	O
SREs	O
,	O
as	O
determined	O
by	O
mobility	O
shift	O
and	O
gel	O
supershift	O
assays	O
,	O
without	O
affecting	O
the	O
DNA	O
binding	O
characteristics	O
of	O
the	O
nuclear	O
protein	O
SP	O
-	O
1	O
.	O

The	O
core	B
enzyme	I
is	O
homologous	O
to	O
those	O
of	O
bacteriophages	O
T3	O
,	O
T7	O
and	O
SP6	O
whereas	O
the	O
specificity	O
factor	O
shows	O
similarities	O
with	O
bacterial	B
sigma	I
factors	I
.	O

The	O
Cr	B
.	I
psbA	I
-	I
4	I
ORF	I
contains	O
an	O
H	O
-	O
N	O
-	O
H	O
motif	O
,	O
and	O
possibly	O
a	O
GIY	O
-	O
YIG	O
motif	O
.	O

Sequencing	O
of	O
zebrafish	O
(	O
Danio	O
rerio	O
)	O
bacterial	O
artificial	O
chromosome	O
and	O
P1	O
artificial	O
chromosome	O
genomic	O
clone	O
fragments	O
and	O
of	O
cDNA	O
clones	O
has	O
led	O
to	O
the	O
identification	O
of	O
five	O
new	O
loci	O
coding	O
for	O
beta	O
subunits	O
of	O
proteasomes	O
(	O
PSMB	B
).	O

Previous	O
experimental	O
evidence	O
had	O
indicated	O
that	O
Reg1	B
might	O
target	O
Glc7	B
to	O
nuclear	O
substrates	O
such	O
as	O
the	O
Snf1	B
kinase	I
complex	I
.	O

We	O
report	O
the	O
construction	O
of	O
an	O
approximately	O
1	O
.	O
7	O
-	O
Mb	O
sequence	O
-	O
ready	O
YAC	O
/	O
BAC	O
clone	O
contig	O
of	O
8p22	O
-	O
p23	O
.	O

Chemical	O
uptake	O
into	O
human	O
stratum	O
corneum	O
in	O
vivo	O
from	O
volatile	O
and	O
non	O
-	O
volatile	O
solvents	O
.	O

We	O
have	O
tested	O
the	O
function	O
of	O
two	O
potential	O
NF	B
-	I
kappaB	I
-	I
like	I
sites	I
present	O
in	O
the	O
PAI	B
-	I
2	I
proximal	I
promoter	I
for	O
responsiveness	O
to	O
TNFalpha	B
using	O
chloramphenicol	B
acetyl	I
transferase	I
reporter	I
gene	I
deletion	O
and	O
mutation	O
analyses	O
.	O

Recent	O
molecular	O
analysis	O
has	O
revealed	O
that	O
the	O
S	B
locus	I
is	O
highly	O
polymorphic	O
and	O
contains	O
several	O
genes	O
,	O
i	O
.	O
e	O
.,	O
SLG	B
,	O
SRK	B
,	O
the	O
as	O
-	O
yet	O
-	O
unidentified	O
pollen	O
S	O
gene	O
(	O
s	O
),	O
and	O
other	O
linked	O
genes	O
.	O

Feed	O
intake	O
and	O
BW	O
gains	O
were	O
decreased	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
by	O
dietary	O
treatments	O
containing	O
M	O
.	O

The	O
N	O
terminus	O
of	O
beta	O
(	O
95	O
kDa	O
)	O
corresponds	O
to	O
alpha	O
with	O
the	O
integrase	B
domain	I
attached	O
to	O
the	O
C	O
terminus	O
(	O
32	O
kDa	O
).	O

In	O
early	O
Xenopus	O
embryos	O
,	O
the	O
transforming	B
growth	I
factor	I
-	I
beta	I
member	O
activin	B
induces	O
the	O
gene	B
Mix	I
.	I
2	I
by	O
stimulating	O
the	O
formation	O
of	O
a	O
multiprotein	O
complex	O
,	O
activin	B
-	I
responsive	I
factor	I
(	O
ARF	B
).	O

Natl	O
.	O

In	O
the	O
face	O
of	O
the	O
outbreak	O
,	O
there	O
was	O
a	O
delay	O
before	O
vaccination	O
was	O
able	O
to	O
stop	O
deaths	O
.	O

Here	O
we	O
show	O
that	O
a	O
novel	O
isoform	O
of	O
Rapl	B
GTPase	I
-	I
activating	I
protein	I
,	O
called	O
rap1GAPII	B
,	O
binds	O
specifically	O
to	O
the	O
alpha	O
-	O
subunits	O
of	O
the	O
G	B
(	I
i	I
)	I
family	I
of	O
heterotrimeric	B
G	I
-	I
proteins	I
.	O

A	O
portion	O
of	O
p193	B
is	O
nuclear	O
and	O
localizes	O
to	O
the	O
mitotic	O
spindle	O
.	O

The	O
main	O
issues	O
are	O
the	O
need	O
to	O
explain	O
a	O
number	O
of	O
still	O
unknown	O
mechanisms	O
,	O
to	O
determine	O
which	O
"	O
natural	O
diet	O
"	O
carries	O
the	O
minimum	O
coronary	O
risk	O
and	O
whether	O
"	O
new	O
"	O
foods	O
produced	O
by	O
modern	O
technology	O
are	O
really	O
needed	O
to	O
contrast	O
this	O
epidemic	O
.	O

A	O
novel	O
Drosophila	B
A	I
kinase	I
anchor	I
protein	I
,	O
Drosophila	B
A	I
kinase	I
anchor	I
protein	I
200	I
(	O
DAKAP200	B
),	O
is	O
predicted	O
to	O
be	O
involved	O
in	O
routing	O
,	O
mediating	O
,	O
and	O
integrating	O
signals	O
carried	O
by	O
cAMP	O
,	O
Ca	O
(	O
2	O
+),	O
and	O
diacylglycerol	O
(	O
Li	O
,	O
Z	O
.,	O
Rossi	O
,	O
E	O
.	O

A	O
tyrosine	O
-	O
based	O
sorting	O
signal	O
in	O
the	O
beta2	B
integrin	I
cytoplasmic	I
domain	I
mediates	O
its	O
recycling	O
to	O
the	O
plasma	O
membrane	O
and	O
is	O
required	O
for	O
ligand	O
-	O
supported	O
migration	O
.	O

NuA4	B
has	O
an	O
apparent	O
molecular	O
mass	O
of	O
1	O
.	O
3	O
MDa	O
.	O

Two	O
patients	O
with	O
recurrent	O
tumors	O
had	O
high	O
S	O
-	O
phase	O
fractions	O
both	O
on	O
the	O
first	O
resected	O
specimens	O
and	O
at	O
the	O
time	O
of	O
the	O
second	O
operation	O
.	O

Identification	O
of	O
eotaxin	B
-	I
3	I
will	O
further	O
promote	O
our	O
understanding	O
of	O
the	O
control	O
of	O
eosinophil	O
trafficking	O
and	O
other	O
CCR3	B
-	O
mediated	O
biological	O
phenomena	O
.	O

NF	B
-	I
kappaB	I
plays	O
a	O
critical	O
role	O
in	O
activation	O
of	O
HIV	O
-	O
1	O
gene	O
expression	O
by	O
cytokines	O
and	O
other	O
stimuli	O
,	O
but	O
the	O
signal	O
transduction	O
pathways	O
that	O
regulate	O
the	O
switch	O
from	O
latent	O
to	O
productive	O
infection	O
have	O
not	O
been	O
defined	O
.	O

ERK	B
MAP	I
kinase	I
links	O
cytokine	O
signals	O
to	O
activation	O
of	O
latent	O
HIV	O
-	O
1	O
infection	O
by	O
stimulating	O
a	O
cooperative	O
interaction	O
of	O
AP	B
-	I
1	I
and	O
NF	B
-	I
kappaB	I
.	O

Montelukast	O
reduces	O
airway	O
eosinophilic	O
inflammation	O
in	O
asthma	O
:	O
a	O
randomized	O
,	O
controlled	O
trial	O
.	O

Beta	B
1	I
integrin	I
-	O
and	O
proteoglycan	O
-	O
mediated	O
stimulation	O
of	O
T	O
lymphoma	O
cell	O
adhesion	O
and	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
signaling	O
by	O
thrombospondin	B
-	I
1	I
and	O
thrombospondin	B
-	I
1	I
peptides	I
.	O

This	O
cluster	O
consisted	O
of	O
four	O
apparently	O
unrelated	O
ESTs	O
and	O
two	O
genes	O
,	O
pregnancy	B
-	I
associated	I
plasma	I
protein	I
-	I
A	I
(	O
PAPP	B
-	I
A	I
)	O
and	O
a	O
novel	O
gene	O
(	O
tentatively	O
named	O
EST	B
-	I
YD1	I
).	O

Since	O
sildenafil	O
came	O
on	O
the	O
market	O
,	O
it	O
seems	O
that	O
the	O
place	O
of	O
MUSE	O
is	O
reduced	O
because	O
comparative	O
studies	O
give	O
better	O
results	O
for	O
sildenafil	O
than	O
MUSE	O
(	O
70	O
%	O
vs	O
40	O
%)	O
and	O
of	O
course	O
with	O
a	O
better	O
acceptance	O
.	O

During	O
both	O
encephalopathy	O
episodes	O
,	O
CSF	O
protein	O
and	O
immunoglobulin	B
G	I
(	O
IgG	B
)	O
levels	O
were	O
elevated	O
without	O
an	O
increased	O
IgG	B
index	O
or	O
IgG	B
synthesis	O
rate	O
.	O

The	O
healing	O
rate	O
in	O
HIV	O
-	O
positive	O
patients	O
was	O
66	O
percent	O
after	O
14	O
weeks	O
and	O
100	O
percent	O
after	O
32	O
weeks	O
;	O
the	O
corresponding	O
figures	O
for	O
patients	O
with	O
acquired	O
immunodeficiency	O
syndrome	O
were	O
0	O
and	O
50	O
percent	O
.	O

A	O
genetic	O
screen	O
in	O
yeast	O
has	O
allowed	O
us	O
to	O
identify	O
a	O
novel	O
transcriptional	O
factor	O
binding	O
to	O
the	O
GlRE	O
,	O
i	O
.	O
e	O
.	O
the	O
chicken	B
ovalbumin	I
upstream	I
promoter	I
-	I
transcription	I
factor	I
II	I
(	O
COUP	B
-	I
TFII	I
).	O

A	O
G22V	B
mutant	I
of	O
M	B
-	I
Ras	I
was	O
constitutively	O
active	O
and	O
its	O
expression	O
in	O
an	O
interleukin	B
-	I
3	I
(	O
IL	B
-	I
3	I
)-	O
dependent	O
mast	O
cell	O
/	O
megakaryocyte	O
cell	O
line	O
resulted	O
in	O
increased	O
survival	O
in	O
the	O
absence	O
of	O
IL	B
-	I
3	I
,	O
increased	O
growth	O
in	O
IL	B
-	I
4	I
,	O
and	O
,	O
at	O
high	O
expression	O
levels	O
,	O
in	O
factor	O
-	O
independent	O
growth	O
.	O

Mammalian	B
M	I
-	I
Ras	I
and	O
a	O
Caenorhabditis	O
elegans	O
orthologue	O
exhibit	O
conserved	O
structural	O
features	O
,	O
and	O
these	O
are	O
likely	O
to	O
mediate	O
activation	O
of	O
distinctive	O
signaling	O
paths	O
that	O
function	O
in	O
parallel	O
to	O
those	O
downstream	O
of	O
p21	B
Ras	I
.	O

All	O
were	O
experienced	O
hearing	O
aid	O
users	O
who	O
wore	O
linear	O
Class	O
D	O
instruments	O
with	O
input	O
compression	O
limiting	O
at	O
the	O
time	O
of	O
their	O
enrollment	O
in	O
this	O
study	O
.	O

Ribonuclease	O
protection	O
assays	O
revealed	O
that	O
hmg1	B
and	O
hmg2	B
are	O
differentially	O
expressed	O
in	O
a	O
developmentally	O
-	O
and	O
spatially	O
-	O
modulated	O
manner	O
during	O
morphogenesis	O
of	O
specialized	O
terpenoid	O
-	O
containing	O
pigment	O
glands	O
in	O
embryos	O
.	O

Twelve	O
patients	O
had	O
stage	O
IBG3	O
,	O
14	O
had	O
ICG1	O
,	O
9	O
had	O
ICG2	O
,	O
and	O
3	O
had	O
ICG3	O
disease	O
.	O

Immunofluoresence	O
data	O
indicated	O
that	O
once	O
bound	O
to	O
the	O
mutant	O
receptor	O
,	O
fluorescent	O
-	O
labeled	O
RAP	B
co	O
-	O
localized	O
with	O
markers	O
of	O
the	O
endosomal	O
pathway	O
,	O
whereas	O
,	O
in	O
cells	O
expressing	O
the	O
wild	O
-	O
type	O
receptor	O
,	O
RAP	B
fluorescence	O
co	O
-	O
localized	O
with	O
lysosomal	O
markers	O
.	O

IL	B
-	I
12	I
production	O
was	O
correlated	O
with	O
C3a	O
concentration	O
measured	O
at	O
the	O
outlet	O
of	O
hemodialyzer	O
after	O
15	O
min	O
of	O
dialysis	O
(	O
r	O
=	O
0	O
.	O
69	O
,	O
P	O
<	O
0	O
.	O
01	O
).	O

J	O
.	O

This	O
machinery	O
involves	O
a	O
secondary	O
structure	O
,	O
SECIS	O
element	O
,	O
in	O
the	O
selenoprotein	B
-	O
encoding	O
mRNA	O
,	O
directing	O
selenocysteine	O
insertion	O
at	O
the	O
position	O
of	O
an	O
opal	O
(	O
UGA	O
)	O
codon	O
,	O
normally	O
conferring	O
termination	O
of	O
translation	O
.	O

For	O
EPV	O
3	O
,	O
10	O
,	O
or	O
40	O
,	O
the	O
bias	O
exceeded	O
25	O
%	O
for	O
7	O
,	O
3	O
,	O
and	O
1	O
in	O
the	O
8	O
-	O
predictor	O
model	O
respectively	O
,	O
when	O
a	O
conventional	O
selection	O
criterion	O
was	O
used	O
(	O
alpha	O
=	O
0	O
.	O
05	O
).	O

Both	O
HERV	O
-	O
K	O
type	O
1	O
and	O
2	O
clones	O
were	O
isolated	O
.	O

Modification	O
of	O
dopamine	B
D2	I
receptor	I
activity	O
by	O
pergolide	O
in	O
Parkinson	O
'	O
s	O
disease	O
:	O
an	O
in	O
vivo	O
study	O
by	O
PET	O
.	O

nos	B
-	I
1	I
and	O
nos	B
-	I
2	I
,	O
two	O
genes	O
related	O
to	O
Drosophila	B
nanos	I
,	O
regulate	O
primordial	O
germ	O
cell	O
development	O
and	O
survival	O
in	O
Caenorhabditis	O
elegans	O
.	O

We	O
examined	O
Akt	B
activation	O
in	O
Lyn	B
-,	O
Syk	B
-	O
and	O
Btk	B
-	O
deficient	O
DT40	O
cells	O
and	O
B	O
cells	O
from	O
Lyn	B
(-/-)	I
mice	O
.	O

Thus	O
,	O
CHOP	B
not	O
only	O
is	O
a	O
negative	O
or	O
a	O
positive	O
regulator	O
of	O
C	B
/	I
EBP	I
target	O
genes	O
but	O
also	O
,	O
when	O
tethered	O
to	O
AP	B
-	I
1	I
factors	I
,	O
can	O
activate	O
AP	B
-	I
1	I
target	O
genes	O
.	O

RNase	B
MRP	I
is	O
a	O
ribonucleoprotein	O
endoribonuclease	O
that	O
has	O
been	O
shown	O
to	O
have	O
roles	O
in	O
both	O
mitochondrial	O
DNA	O
replication	O
and	O
nuclear	B
5	I
.	I
8S	I
rRNA	I
processing	O
.	O

Rac	B
causes	O
uncapping	O
of	O
actin	B
filaments	I
(	O
F	B
-	I
actin	I
)	O
at	O
the	O
plus	O
-	O
ends	O
,	O
through	O
phosphatidylinositol	O
4	O
,	O
5	O
bisphosphate	O
(	O
PIP2	O
),	O
and	O
eventually	O
induces	O
membrane	O
ruffling	O
.	O

RESULTS	O
:	O
Factors	O
associated	O
with	O
significantly	O
(	O
P	O
<.	O
05	O
)	O
increased	O
risk	O
of	O
treatment	O
failure	O
in	O
a	O
Cox	O
multivariate	O
analysis	O
included	O
age	O
older	O
than	O
45	O
years	O
(	O
relative	O
hazard	O
,	O
1	O
.	O
17	O
;	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
],	O
1	O
.	O
02	O
-	O
1	O
.	O
33	O
),	O
Karnofsky	O
performance	O
score	O
less	O
than	O
90	O
%	O
(	O
1	O
.	O
27	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
07	O
-	O
1	O
.	O
51	O
),	O
absence	O
of	O
hormone	O
receptors	O
(	O
1	O
.	O
31	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
15	O
-	O
1	O
.	O
51	O
),	O
prior	O
use	O
of	O
adjuvant	O
chemotherapy	O
(	O
1	O
.	O
31	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
10	O
-	O
1	O
.	O
56	O
),	O
initial	O
disease	O
-	O
free	O
survival	O
interval	O
after	O
adjuvant	O
treatment	O
of	O
no	O
more	O
than	O
18	O
months	O
(	O
1	O
.	O
99	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
62	O
-	O
2	O
.	O
43	O
),	O
metastases	O
in	O
the	O
liver	O
(	O
1	O
.	O
47	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
20	O
-	O
1	O
.	O
80	O
)	O
or	O
central	O
nervous	O
system	O
(	O
1	O
.	O
56	O
;	O
95	O
%	O
CI	O
,	O
0	O
.	O
99	O
-	O
2	O
.	O
46	O
[	O
approaches	O
significance	O
])	O
vs	O
soft	O
tissue	O
,	O
bone	O
,	O
or	O
lung	O
,	O
3	O
or	O
more	O
sites	O
of	O
metastatic	O
disease	O
(	O
1	O
.	O
32	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
13	O
-	O
1	O
.	O
54	O
),	O
and	O
incomplete	O
response	O
vs	O
complete	O
response	O
to	O
standard	O
-	O
dose	O
chemotherapy	O
(	O
1	O
.	O
65	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
36	O
-	O
1	O
.	O
99	O
).	O

Its	O
C	O
-	O
terminal	O
catalytic	O
domain	O
was	O
found	O
to	O
be	O
highly	O
conserved	O
in	O
the	O
homologues	O
p140	B
(	O
ras	B
-	O
GRF	B
)	O
and	O
Sos	B
.	O

Most	O
important	O
,	O
infection	O
of	O
the	O
cells	O
with	O
an	O
adenoviral	O
construct	O
expressing	O
this	O
mutant	O
inhibited	O
the	O
induction	O
of	O
VEGF	B
mRNA	I
under	O
conditions	O
that	O
mimic	O
hypoxia	O
.	O

The	O
first	O
algorithm	O
,	O
FOREPROJ	O
,	O
is	O
a	O
fast	O
-	O
forward	O
projection	O
algorithm	O
that	O
allows	O
calculation	O
of	O
the	O
3	O
-	O
D	O
attenuation	O
correction	O
factors	O
(	O
ACF	O
'	O
s	O
)	O
directly	O
from	O
a	O
two	O
-	O
dimensional	O
(	O
2	O
-	O
D	O
)	O
transmission	O
scan	O
,	O
without	O
first	O
reconstructing	O
the	O
attenuation	O
map	O
and	O
then	O
performing	O
a	O
3	O
-	O
D	O
forward	O
projection	O
.	O

In	O
gel	O
mobility	O
shift	O
assays	O
,	O
we	O
found	O
no	O
evidence	O
for	O
VDR	B
-	O
TR	B
heterodimer	O
interaction	O
with	O
any	O
tested	O
element	O
.	O

The	O
relative	O
importance	O
of	O
these	O
two	O
mechanisms	O
differed	O
in	O
a	O
response	O
element	O
-	O
specific	O
manner	O
.	O

Kinase	O
-	O
deficient	O
erbB	B
proteins	I
reduced	O
epidermal	B
growth	I
factor	I
(	O
EGF	B
)-	O
induced	O
tyrosine	O
phosphorylation	O
of	O
endogenous	O
Shc	B
proteins	I
and	O
also	O
reduced	O
immediate	O
and	O
sustained	O
EGF	B
-	I
induced	I
ERK	I
MAPK	I
activities	O
in	O
human	O
glioblastoma	O
cells	O
,	O
although	O
basal	O
ERK	B
MAPK	I
activities	O
were	O
unaffected	O
.	O

Amyloid	B
beta	I
-	I
protein	I
(	O
Abeta	B
)	O
is	O
the	O
main	O
constituent	O
of	O
amyloid	O
fibrils	O
found	O
in	O
senile	O
plaques	O
and	O
cerebral	O
vessels	O
in	O
Alzheimer	O
'	O
s	O
disease	O
(	O
AD	O
)	O
and	O
is	O
derived	O
by	O
proteolysis	O
from	O
the	O
beta	B
-	I
amyloid	I
precursor	I
protein	I
(	O
APP	B
).	O

The	O
expressed	O
G1	B
-	O
G2	B
bound	O
to	O
both	O
hyaluronan	O
and	O
link	B
protein	I
indicating	O
that	O
the	O
immunoglobulin	B
-	I
fold	I
motif	I
and	O
proteoglycan	O
tandem	O
repeat	O
loops	O
of	O
the	O
G1	B
domain	I
were	O
correctly	O
folded	O
.	O

Despite	O
i	O
.	O
v	O
.	O
steroid	O
therapy	O
,	O
[	O
NOexh	O
]	O
remained	O
elevated	O
throughout	O
recovery	O
(	O
37	O
.	O
9	O
+/-	O
4	O
.	O
8	O
ppb	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
until	O
discharge	O
(	O
40	O
.	O
9	O
+/-	O
4	O
.	O
3	O
ppb	O
,	O
p	O
<	O
0	O
.	O
001	O
).	O

It	O
contains	O
binding	O
sites	O
for	O
several	O
transcription	O
factors	O
,	O
for	O
example	O
:	O
(	O
i	O
)	O
a	O
well	O
-	O
characterized	O
binding	O
site	O
for	O
rel	B
/	O
NF	B
-	I
kappaB	I
transcription	O
factors	O
in	O
its	O
3	O
'-	O
end	O
(	O
the	O
H2TF1	B
or	O
kappaB1	B
element	I
),	O
(	O
ii	O
)	O
a	O
second	O
kappaB	B
site	I
(	O
the	O
kappaB2	B
element	I
),	O
which	O
is	O
located	O
immediately	O
adjacent	O
5	O
'	O
to	O
the	O
H2TF1	B
element	I
and	O
which	O
is	O
recognized	O
by	O
p65	B
/	O
relA	B
in	O
the	O
human	B
HLA	I
system	O
,	O
and	O
(	O
iii	O
)	O
an	O
AP	B
-	I
1	I
/	O
ATF	B
recognition	O
sequence	O
in	O
the	O
5	O
'	O
end	O
(	O
EnA	B
-	I
TRE	I
).	O

The	O
tumorigenic	O
E1A	B
+	O
cHa	B
-	I
ras	I
cells	O
are	O
characterized	O
by	O
high	O
and	O
constitutive	O
DNA	O
binding	O
activities	O
of	O
AP	B
-	I
1	I
,	O
in	O
contrast	O
to	O
nontransformed	O
cells	O
and	O
the	O
E1A	B
cells	O
.	O

A	O
proportion	O
of	O
APC	B
wild	O
-	O
type	O
colon	O
carcinomas	O
and	O
melanomas	O
also	O
contains	O
constitutive	O
nuclear	O
Tcf	B
-	I
4	I
/	O
beta	B
-	I
catenin	I
complexes	O
as	O
a	O
result	O
of	O
dominant	O
mutations	O
in	O
the	O
N	O
terminus	O
of	O
beta	B
-	I
catenin	I
that	O
render	O
it	O
insensitive	O
to	O
downregulation	O
by	O
APC	B
,	O
GSK3	B
beta	I
,	O
and	O
Axin	B
/	O
Conductin	B
.	O

This	O
report	O
describes	O
a	O
patient	O
with	O
a	O
previous	O
inferior	O
acute	O
myocardial	O
infarction	O
who	O
developed	O
right	O
ventricular	O
infarction	O
with	O
significant	O
anterior	O
lead	O
ST	O
segment	O
elevation	O
(	O
V1	O
-	O
V4	O
)	O
caused	O
by	O
the	O
loss	O
of	O
two	O
large	O
right	O
ventricular	O
branches	O
during	O
a	O
coronary	O
angioplasty	O
of	O
the	O
right	O
coronary	O
artery	O
.	O

PATIENTS	O
AND	O
METHODS	O
:	O
Immediately	O
before	O
radical	O
prostatectomy	O
,	O
bone	O
marrow	O
aspirates	O
from	O
both	O
sides	O
of	O
the	O
iliac	O
crest	O
were	O
taken	O
from	O
287	O
patients	O
.	O

LHbeta	B
is	O
expressed	O
in	O
pituitary	O
gonadotrope	O
cells	O
and	O
CGbeta	B
is	O
expressed	O
in	O
placental	O
trophoblast	O
cells	O
.	O

Human	B
LTBP	I
-	I
1	I
is	O
known	O
to	O
exist	O
in	O
different	O
forms	O
.	O

CONCLUSIONS	O
:	O
In	O
addition	O
to	O
the	O
superiority	O
of	O
octafluoropropane	O
-	O
filled	O
microspheres	O
to	O
air	O
-	O
filled	O
microspheres	O
for	O
LV	O
opacification	O
,	O
the	O
efficacy	O
of	O
OCTA	O
is	O
relatively	O
unaffected	O
by	O
impaired	O
LV	O
function	O
and	O
is	O
less	O
susceptible	O
to	O
the	O
effects	O
of	O
poor	O
echogenicity	O
than	O
AIR	O
.	O

Factor	B
XI	I
deficiency	O
is	O
a	O
rare	O
hereditary	O
bleeding	O
disorder	O
affecting	O
the	O
intrinsic	O
pathway	O
.	O

The	O
Ishasha	O
samples	O
show	O
a	O
range	O
encompassing	O
three	O
trophic	O
levels	O
.	O

S	O
.,	O
Kim	O
,	O
S	O
.	O

Nevertheless	O
,	O
in	O
view	O
of	O
the	O
potential	O
transmission	O
rates	O
of	O
HGV	O
and	O
the	O
lack	O
of	O
effective	O
immunization	O
,	O
HGV	O
should	O
be	O
regarded	O
as	O
a	O
potential	O
occupational	O
hazard	O
for	O
medical	O
and	O
dental	O
staff	O
.	O

Detection	O
of	O
poisoning	O
by	O
Impila	O
(	O
Callilepis	O
laureola	O
)	O
in	O
a	O
mother	O
and	O
child	O
.	O

In	O
simpler	O
organisms	O
,	O
the	O
ATP	B
sulfurylase	I
and	O
APS	B
kinase	I
reactions	O
are	O
catalyzed	O
by	O
separate	O
enzymes	O
encoded	O
by	O
two	O
or	O
three	O
genes	O
,	O
suggesting	O
that	O
a	O
fusion	O
of	O
separate	O
genes	O
during	O
the	O
course	O
of	O
evolution	O
generated	O
the	O
bifunctional	O
enzyme	O
.	O

In	O
HCMV	O
(	O
Towne	O
)-	O
infected	O
HF	O
cells	O
at	O
24	O
to	O
48	O
h	O
,	O
IE2	B
also	O
accumulated	O
in	O
newly	O
formed	O
viral	O
DNA	O
replication	O
compartments	O
containing	O
the	O
polymerase	B
processivity	I
factor	I
(	O
UL44	B
),	O
the	O
single	B
-	I
stranded	I
DNA	I
binding	I
protein	I
(	O
SSB	B
;	O
UL57	B
),	O
the	O
UL112	B
-	I
113	I
accessory	I
protein	I
,	O
and	O
newly	O
incorporated	O
bromodeoxyuridine	O
(	O
BrdU	O
).	O

Regulatory	O
regions	O
in	O
the	O
promoter	O
and	O
third	O
intron	O
of	O
the	O
growth	B
hormone	I
gene	I
in	I
rainbow	I
trout	I
,	O
Oncorhynchus	O
mykiss	O
walbaum	O
.	O

Although	O
most	O
SFV	O
genes	O
have	O
homologs	O
encoded	O
by	O
other	O
Chordopoxvirinae	O
,	O
the	O
SFV	O
genome	O
lacks	O
a	O
key	O
gene	O
required	O
for	O
the	O
production	O
of	O
extracellular	O
enveloped	O
virus	O
.	O

Serum	B
insulin	I
-	I
like	I
growth	I
factor	I
I	I
(	O
IGF	B
-	I
I	I
)	O
SD	O
score	O
increased	O
from	O
-	O
2	O
.	O
2	O
and	O
-	O
4	O
.	O
2	O
in	O
men	O
and	O
women	O
,	O
respectively	O
,	O
to	O
1	O
.	O
8	O
and	O
-	O
0	O
.	O
9	O
at	O
6	O
months	O
and	O
0	O
.	O
8	O
and	O
-	O
0	O
.	O
7	O
at	O
12	O
months	O
.	O

Reverse	O
transcription	O
(	O
RT	O
)-	O
PCR	O
products	O
were	O
synthesized	O
with	O
two	O
degenerate	O
primers	O
derived	O
from	O
the	O
conserved	O
motifs	O
of	O
various	O
tyrosine	B
kinases	I
.	O

The	O
role	O
of	O
transport	O
by	O
sea	O
ice	O
from	O
the	O
Kara	O
Sea	O
into	O
the	O
Arctic	O
Ocean	O
was	O
assessed	O
by	O
a	O
small	O
subgroup	O
at	O
GEOMAR	O
.	O

Studies	O
have	O
substantiated	O
the	O
involvement	O
of	O
numerous	O
loci	O
on	O
certain	O
chromosomes	O
;	O
in	O
excess	O
of	O
10	O
chromosomes	O
are	O
thought	O
to	O
be	O
involved	O
.	O

Based	O
on	O
subcellular	O
fractionation	O
,	O
the	O
47	B
-	I
kDa	I
P	I
-	I
CIP2	I
protein	I
is	O
mostly	O
cytosolic	O
.	O

Supershift	O
EMSAs	O
identified	O
that	O
upstream	B
stimulatory	I
factor	I
-	I
1	I
and	I
-	I
2	I
(	O
USF	B
-	I
1	I
and	I
-	I
2	I
)	O
were	O
part	O
of	O
these	O
complexes	O
.	O

It	O
may	O
be	O
dependent	O
on	O
location	O
of	O
a	O
focus	O
(	O
according	O
to	O
EEG	O
)	O
as	O
well	O
as	O
on	O
the	O
character	O
and	O
manifestation	O
of	O
the	O
accompanying	O
neuropsychologic	O
symptomatology	O
.	O

Phosphorylation	O
of	O
myosin	B
-	I
binding	I
subunit	I
(	O
MBS	B
)	O
of	O
myosin	B
phosphatase	I
by	O
Rho	B
-	I
kinase	I
in	O
vivo	O
.	O

We	O
show	O
here	O
that	O
the	O
third	O
SH3	B
domain	I
binds	O
to	O
Sos	B
,	O
a	O
guanine	B
nucleotide	I
exchange	I
factor	I
for	O
Ras	B
and	O
Rac	B
,	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

For	O
this	O
purpose	O
,	O
we	O
used	O
a	O
series	O
of	O
plasmid	O
constructs	O
encoding	O
different	O
forms	O
of	O
the	O
envelope	B
glycoprotein	I
E	I
of	I
the	I
flavivirus	I
tick	I
-	I
borne	I
encephalitis	I
virus	I
.	O

To	O
define	O
the	O
minimal	O
VDRE	O
binding	O
domain	O
for	O
human	B
VDR	I
(	O
hVDR	B
),	O
a	O
series	O
of	O
C	O
-	O
terminally	O
truncated	O
hVDR	B
mutants	I
(	O
Delta134	O
,	O
Delta113	O
,	O
Delta102	O
,	O
Delta90	O
,	O
Delta84	O
,	O
Delta80	O
,	O
and	O
Delta60	O
)	O
was	O
generated	O
and	O
expressed	O
in	O
bacteria	O
.	O

In	O
part	O
as	O
a	O
result	O
of	O
its	O
inability	O
to	O
sustain	O
radiative	O
loses	O
,	O
the	O
BB	O
resonator	O
has	O
extremely	O
low	O
RF	O
power	O
requirements	O
.	O

A	O
key	O
event	O
in	O
this	O
process	O
is	O
the	O
selective	O
recognition	O
of	O
the	O
target	O
membrane	O
by	O
the	O
vesicle	O
and	O
the	O
current	O
view	O
is	O
that	O
SNARE	B
protein	I
interactions	O
likely	O
play	O
a	O
central	O
role	O
in	O
vesicle	O
-	O
target	O
recognition	O
and	O
or	O
membrane	O
fusion	O
.	O

A	O
group	O
of	O
66	O
DSM	O
-	O
IV	O
paranoid	O
schizophrenic	O
in	O
-	O
patients	O
were	O
assessed	O
three	O
times	O
using	O
the	O
SAPS	O
,	O
SANS	O
,	O
BPRS	O
and	O
PAS	O
.	O

Furthermore	O
,	O
in	O
vivo	O
and	O
in	O
vitro	O
protein	O
-	O
protein	O
interaction	O
experiments	O
have	O
shown	O
that	O
SR33	B
protein	I
interacts	O
with	O
itself	O
and	O
with	O
SR45	B
protein	I
but	O
not	O
with	O
two	O
other	O
members	O
(	O
SRZ21	B
and	O
SRZ22	B
)	O
of	O
the	O
SR	B
family	I
that	O
are	O
known	O
to	O
interact	O
with	O
the	O
Arabidopsis	O
full	O
-	O
length	O
U	B
-	I
70K	I
only	O
.	O

Six	O
out	O
of	O
ten	O
hearts	O
from	O
macerated	O
stillborn	O
infants	O
showed	O
varying	O
degrees	O
of	O
positive	O
staining	O
.	O

A	O
novel	O
pleckstrin	B
homology	I
-	I
related	I
gene	I
family	I
defined	O
by	O
Ipl	B
/	O
Tssc3	B
,	O
TDAG51	B
,	O
and	O
Tih1	B
:	O
tissue	O
-	O
specific	O
expression	O
,	O
chromosomal	O
location	O
,	O
and	O
parental	O
imprinting	O
.	O

The	O
potential	O
for	O
highly	O
reactive	O
nanoparticles	O
(	O
RNP	O
)	O
to	O
absorb	O
destructively	O
,	O
i	O
.	O
e	O
.	O
to	O
neutralize	O
highly	O
toxic	O
substances	O
such	O
as	O
the	O
warfare	O
agents	O
GA	O
,	O
GB	O
,	O
HD	O
and	O
VX	O
,	O
has	O
been	O
demonstrated	O
in	O
the	O
laboratory	O
.	O

Transient	O
,	O
high	O
-	O
level	O
Ras	B
-	O
expression	O
induces	O
transcriptional	O
activation	O
of	O
p21	B
mediated	O
by	O
a	O
GC	O
-	O
rich	O
region	O
in	O
p21	B
promoter	I
-	O
83	O
-	O
54	O
bp	O
relative	O
to	O
the	O
transcription	O
initiation	O
site	O
containing	O
binding	O
sites	O
for	O
Sp1	B
-	I
family	I
transcription	I
factors	I
.	O

The	O
RET	B
/	O
PTC3	B
rearrangement	O
is	O
formed	O
by	O
fusion	O
of	O
the	O
ELE1	B
and	O
RET	B
genes	I
,	O
and	O
is	O
highly	O
prevalent	O
in	O
radiation	O
-	O
induced	O
post	O
-	O
Chernobyl	O
papillary	O
thyroid	O
carcinomas	O
.	O

With	O
this	O
GH	B
and	O
estrogen	O
treatment	O
regimen	O
,	O
most	O
girls	O
with	O
TS	O
can	O
grow	O
and	O
develop	O
much	O
more	O
in	O
conformity	O
with	O
their	O
healthy	O
peers	O
.	O

Higher	O
CYP3A23	B
basal	O
activity	O
appears	O
to	O
be	O
due	O
to	O
an	O
E	O
-	O
box	O
in	O
3A23SiteA	B
that	O
interacts	O
with	O
USF1	B
,	O
a	O
ubiquitous	O
bHLH	B
/	I
leucine	I
zipper	I
transcription	I
factor	I
.	O

Overexpression	O
of	O
CDP	B
/	O
cut	B
in	O
ROS	O
17	O
/	O
2	O
.	O
8	O
osteosarcoma	O
cells	O
results	O
in	O
repression	O
of	O
OC	B
promoter	I
activity	O
;	O
this	O
repression	O
is	O
abrogated	O
by	O
mutating	O
OC	B
box	I
I	I
.	O

Injection	O
of	O
double	O
-	O
stranded	O
RNA	O
into	O
C	O
.	O
elegans	O
results	O
in	O
embryonic	O
lethality	O
;	O
thus	O
,	O
the	O
SF1	B
gene	I
is	O
essential	O
not	O
only	O
in	O
yeast	O
but	O
also	O
in	O
at	O
least	O
one	O
metazoan	O
.	O

Snail	B
family	I
proteins	I
are	O
zinc	O
finger	O
transcriptional	O
regulators	O
first	O
identified	O
in	O
Drosophila	O
which	O
play	O
critical	O
roles	O
in	O
cell	O
fate	O
determination	O
.	O

Sequence	O
analysis	O
of	O
the	O
promoter	O
region	O
showed	O
no	O
TATA	O
box	O
but	O
identified	O
consensus	O
binding	O
motifs	O
for	O
Sp1	B
,	O
CREB	B
,	O
and	O
half	O
sites	O
of	O
the	O
estrogen	B
receptor	I
binding	I
site	I
.	O

The	O
DAP5	B
/	O
p86	B
apoptotic	O
form	O
was	O
more	O
potent	O
than	O
DAP5	B
/	O
p97	B
in	O
these	O
functional	O
assays	O
.	O

All	O
problems	O
were	O
associated	O
with	O
fractured	O
or	O
lost	O
screws	O
.	O

In	O
the	O
BF	O
ECT	O
group	O
the	O
-	O
age	O
based	O
dose	O
would	O
have	O
been	O
similarly	O
dependent	O
on	O
the	O
initial	O
seizure	O
threshold	O
level	O
.	O

Haycocknema	O
perplexum	O
n	O
.	O
g	O
.,	O
n	O
.	O
sp	O
.	O

AB004534	B
.	O

During	O
latency	O
,	O
more	O
than	O
1	O
%	O
of	O
neurons	O
in	O
ganglia	O
that	O
innervate	O
the	O
footpad	O
expressed	O
beta	B
-	I
galactosidase	I
,	O
with	O
the	O
number	O
of	O
positive	O
cells	O
remaining	O
constant	O
for	O
at	O
least	O
5	O
months	O
.	O

Both	O
receptors	O
utilize	O
protein	B
tyrosine	I
kinases	I
(	O
PTKs	B
)	O
for	O
the	O
phosphorylation	O
of	O
various	O
signaling	O
molecules	O
,	O
a	O
process	O
that	O
is	O
critical	O
for	O
the	O
function	O
of	O
both	O
receptors	O
.	O

Previously	O
,	O
we	O
showed	O
that	O
the	O
APRE	O
is	O
a	O
cytokine	O
[	O
tumor	B
necrosis	I
factor	I
-	I
alpha	I
(	O
TNFalpha	B
)]-	O
inducible	O
enhancer	O
by	O
binding	O
the	O
heterodimeric	B
nuclear	I
factor	I
-	I
kappaB	I
(	O
NF	B
-	I
kappaB	I
)	O
complex	O
Rel	B
A	I
x	O
NF	B
-	I
kappaB1	I
.	O

Angiotensin	B
II	I
induces	O
nuclear	B
factor	I
(	I
NF	I
)-	I
kappaB1	I
isoforms	I
to	O
bind	O
the	O
angiotensinogen	B
gene	I
acute	O
-	O
phase	O
response	O
element	O
:	O
a	O
stimulus	O
-	O
specific	O
pathway	O
for	O
NF	B
-	I
kappaB	I
activation	O
.	O

We	O
describe	O
a	O
case	O
of	O
acetaminophen	O
overdose	O
that	O
was	O
treated	O
with	O
both	O
hemodialysis	O
(	O
HD	O
)	O
and	O
NAC	O
due	O
to	O
severe	O
intoxication	O
and	O
slow	O
drug	O
clearance	O
.	O

Eastern	O
Cooperative	O
Oncology	O
Group	O
trial	O
E3186	O
was	O
initiated	O
to	O
explore	O
this	O
question	O
.	O

Two	O
Pax2	B
/	I
5	I
/	I
8	I
-	I
binding	I
sites	I
in	O
Engrailed2	B
are	O
required	O
for	O
proper	O
initiation	O
of	O
endogenous	O
mid	O
-	O
hindbrain	O
expression	O
.	O

AF154055	B
.	O

After	O
i	O
.	O
v	O
.	O
administration	O
of	O
500	O
mg	O
acetazolamide	O
and	O
disinfection	O
of	O
the	O
conjunctiva	O
,	O
50	O
micrograms	O
rt	B
-	I
PA	I
in	O
0	O
.	O
1	O
ml	O
(	O
BSS	O
)	O
and	O
0	O
.	O
5	O
ml	O
SF6	O
were	O
injected	O
intravitreally	O
.	O

The	O
differentiation	O
and	O
maintenance	O
of	O
a	O
neurotransmitter	O
phenotype	O
is	O
guided	O
by	O
the	O
interaction	O
of	O
exogenous	O
cues	O
with	O
intrinsic	O
genetic	O
machinery	O
.	O

Overexpression	O
of	O
ICBP90	B
in	O
COS	O
-	O
1	O
-	O
transfected	O
cells	O
induced	O
an	O
enhanced	O
expression	O
of	O
endogenous	B
topoisomerase	I
IIalpha	I
.	O

The	O
study	O
suggests	O
the	O
presence	O
of	O
an	O
anatomical	O
sphincter	O
at	O
the	O
RSJ	O
which	O
seems	O
to	O
regulate	O
the	O
passage	O
of	O
stools	O
from	O
the	O
sigmoid	O
colon	O
to	O
the	O
rectum	O
.	O

Isolation	O
of	O
cDNAs	B
encoding	I
gibbon	I
and	I
monkey	I
platelet	I
and	I
T	I
cell	I
activation	I
antigen	I
1	I
(	O
PTA1	B
).	O

Electron	O
microscopic	O
and	O
enzymatic	O
analyses	O
revealed	O
that	O
the	O
A118	O
genome	O
is	O
a	O
linear	O
,	O
circularly	O
permuted	O
,	O
terminally	O
redundant	O
collection	O
of	O
double	O
-	O
stranded	O
DNA	O
molecules	O
.	O

Moreover	O
,	O
increasing	O
the	O
dosage	O
of	O
wild	B
-	I
type	I
Fus3	I
intensifies	O
the	O
inhibition	O
of	O
both	O
Ty1	B
transposition	O
and	O
invasive	O
growth	O
.	O

Together	O
,	O
these	O
data	O
suggest	O
that	O
the	O
carboxyl	O
terminus	O
of	O
CFTR	B
contains	O
a	O
tyrosine	O
-	O
based	O
internalization	O
signal	O
that	O
interacts	O
with	O
the	O
endocytic	O
adaptor	O
complex	O
AP	B
-	I
2	I
to	O
facilitate	O
efficient	O
entry	O
of	O
CFTR	B
into	O
clathrin	B
-	O
coated	O
vesicles	O
.	O

We	O
have	O
addressed	O
these	O
issues	O
by	O
reconstituting	O
and	O
characterizing	O
the	O
KRAB	B
:	O
KAP	B
-	I
1	I
-	O
RBCC	B
interaction	O
using	O
purified	O
components	O
.	O

MBI	O
and	O
MMBI	O
showed	O
similar	O
Cmax	O
values	O
,	O
but	O
the	O
former	O
disappeared	O
slower	O
in	O
the	O
serum	O
than	O
the	O
latter	O
and	O
resulted	O
in	O
its	O
larger	O
AUC	O
values	O
.	O

The	O
level	O
of	O
subclinical	O
infection	O
was	O
75	O
%	O
among	O
seropositive	O
dogs	O
.	O

Patch	O
test	O
results	O
obtained	O
with	O
corticosteroid	O
allergic	O
patients	O
tested	O
with	O
a	O
large	O
corticosteroid	O
series	O
validated	O
the	O
earlier	O
classification	O
of	O
corticosteroid	O
molecules	O
in	O
four	O
groups	O
of	O
cross	O
-	O
reacting	O
molecules	O
:	O
i	O
.	O
e	O
.,	O
group	O
A	O
(	O
hydrocortisone	O
type	O
),	O
group	O
B	O
(	O
acetonides	O
),	O
group	O
C	O
(	O
betamethasone	O
type	O
-	O
non	O
esterified	O
)	O
and	O
group	O
D	O
(	O
esters	O
).	O

An	O
increase	O
in	O
the	O
level	O
of	O
serum	O
enzymes	O
,	O
such	O
as	O
aspartate	B
transaminase	I
,	O
alkaline	B
phosphatase	I
,	O
creatine	B
phosphokinase	I
,	O
lactate	B
dehydrogenase	I
after	O
D	O
.	O
russelli	O
venom	O
injection	O
in	O
albino	O
rats	O
is	O
indicative	O
of	O
cell	O
or	O
tissue	O
damage	O
.	O

Thus	O
,	O
the	O
induction	O
of	O
E2F	B
binding	O
to	O
the	O
E2F	B
-	I
1	I
promoter	I
by	O
the	O
E4	B
-	I
6	I
/	I
7	I
protein	I
observed	O
in	O
vitro	O
correlates	O
with	O
transactivation	O
of	O
E2F	B
-	I
1	I
promoter	I
activity	O
in	O
vivo	O
.	O

Dermatology	O
is	O
no	O
exception	O
.	O

4	O
.	O

Protein	O
sequence	O
analysis	O
reveals	O
that	O
MAN1	B
shares	O
a	O
conserved	O
globular	O
domain	O
of	O
approximately	O
40	O
amino	O
acids	O
,	O
which	O
we	O
term	O
the	O
LEM	B
module	I
,	O
with	O
inner	O
nuclear	O
membrane	O
proteins	O
lamina	B
-	I
associated	I
polypeptide	I
2	I
and	O
emerin	B
.	O

In	O
contrast	O
,	O
c	B
-	I
Src	I
activated	O
by	O
isoproterenol	O
led	O
to	O
tyrosine	O
phosphorylation	O
of	O
Shc	B
and	O
subsequent	O
Erk	B
activation	O
,	O
but	O
not	O
tyrosine	O
phosphorylation	O
of	O
cortactin	B
or	O
Stat3	B
.	O

For	O
wild	O
type	O
MutT	B
and	O
its	O
E53D	B
and	O
E44D	B
mutants	I
,	O
plots	O
of	O
log	O
(	O
k	O
(	O
cat	O
))	O
versus	O
pH	O
exhibited	O
a	O
limiting	O
slope	O
of	O
1	O
on	O
the	O
ascending	O
limb	O
and	O
then	O
a	O
hump	O
,	O
i	O
.	O
e	O
.,	O
a	O
sharply	O
defined	O
maximum	O
near	O
pH	O
8	O
followed	O
by	O
a	O
plateau	O
,	O
yielding	O
apparent	O
pK	O
(	O
a	O
)	O
values	O
of	O
7	O
.	O
6	O
+/-	O
0	O
.	O
3	O
and	O
8	O
.	O
4	O
+/-	O
0	O
.	O
4	O
for	O
an	O
essential	O
base	O
and	O
a	O
nonessential	O
acid	O
catalyst	O
,	O
respectively	O
,	O
in	O
the	O
active	O
quaternary	O
MutT	B
-	O
Mg	O
(	O
2	O
+)-	O
dGTP	O
-	O
Mg	O
(	O
2	O
+)	O
complex	O
.	O

Structural	O
changes	O
in	O
the	O
kinetically	O
more	O
damaged	O
E44D	O
mutant	O
detected	O
in	O
(	O
1	O
)	O
H	O
-(	O
15	O
)	O
N	O
HSQC	O
spectra	O
were	O
largely	O
limited	O
to	O
the	O
loop	O
I	O
-	O
helix	O
I	O
motif	O
,	O
suggesting	O
that	O
Glu	O
-	O
44	O
stabilizes	O
the	O
active	O
site	O
region	O
.	O

Immunity	O
acquired	O
by	O
mice	O
during	O
I	O
.	O
scapularis	O
nymphal	O
activity	O
in	O
early	O
summer	O
may	O
exclude	O
a	O
large	O
proportion	O
of	O
the	O
mouse	O
population	O
from	O
maintaining	O
E	O
.	O
phagocytophila	O
during	O
the	O
period	O
of	O
larval	O
activity	O
later	O
in	O
the	O
season	O
.	O

Activation	O
of	O
a	O
CRE	O
-	O
dependent	O
junB	B
promoter	I
/	O
chloramphenicol	B
acetyltransferase	I
(	O
CAT	B
)	O
reporter	O
gene	O
by	O
the	O
BCR	B
was	O
also	O
blocked	O
by	O
SB203580	O
.	O

EMSA	O
showed	O
that	O
nuclear	O
proteins	O
from	O
PC12	O
but	O
not	O
C6	O
or	O
Rat2	O
cells	O
bind	O
the	O
CRE	O
as	O
a	O
complex	O
containing	O
activating	B
transcription	I
factor	I
(	I
ATF	I
)-	I
4	I
and	O
CCAAT	B
enhancer	I
-	I
binding	I
protein	I
beta	I
,	O
while	O
both	O
PC12	O
and	O
C6	O
cell	O
nuclear	O
extracts	O
were	O
recruited	O
by	O
the	O
CCAAT	O
-	O
box	O
as	O
a	O
complex	O
containing	O
nuclear	B
factor	I
Y	I
.	O

Sulfhydryl	O
titration	O
with	O
iodoacetamide	O
,	O
monitored	O
by	O
quantitating	O
the	O
residual	O
thiols	O
after	O
reaction	O
with	O
a	O
maleimide	O
derivative	O
of	O
biotin	O
,	O
revealed	O
a	O
striking	O
difference	O
in	O
the	O
apparent	O
pK	O
(	O
a	O
)	O
values	O
of	O
the	O
cysteines	O
at	O
the	O
two	O
splice	O
junctions	O
.	O

The	O
results	O
showed	O
that	O
MIP	O
,	O
MMIF	O
,	O
FIC	O
,	O
Wimax	O
,	O
P0	O
.	O
1	O
and	O
minute	O
ventilation	O
(	O
Vr	O
)	O
were	O
significantly	O
increased	O
after	O
administration	O
of	O
methylphenidatum	O
and	O
aminophylline	O
.	O

Covalent	O
modification	O
of	O
the	O
transactivator	O
protein	O
IE2	B
-	O
p86	B
of	O
human	O
cytomegalovirus	O
by	O
conjugation	O
to	O
the	O
ubiquitin	B
-	I
homologous	I
proteins	I
SUMO	I
-	I
1	I
and	O
hSMT3b	B
.	O

73	O
:	O
658	O
-	O
666	O
,	O
1999	O
).	O

Protamine	B
and	O
heparin	O
doses	O
,	O
their	O
sum	O
(	O
Sigma	O
-	O
dose	O
)	O
and	O
differential	O
(	O
Delta	O
-	O
dose	O
)	O
doses	O
,	O
and	O
activated	O
clotting	O
times	O
were	O
tabulated	O
.	O

Its	O
cognate	O
binding	O
protein	O
,	O
REST	B
/	O
NRSF	B
,	O
is	O
an	O
essential	O
transcription	O
factor	O
;	O
its	O
null	O
mutations	O
result	O
in	O
embryonic	O
lethality	O
,	O
and	O
its	O
dominant	O
negative	O
mutants	O
produce	O
aberrant	O
expression	O
of	O
neuron	O
-	O
specific	O
genes	O
.	O

The	O
variations	O
were	O
caused	O
by	O
opposite	O
shifts	O
in	O
TSH	B
frequency	O
distribution	O
in	O
mothers	O
and	O
neonates	O
.	O

However	O
,	O
such	O
a	O
mechanism	O
was	O
not	O
detected	O
in	O
preliminary	O
observations	O
on	O
M	O
.	O
synoviae	O
.	O

The	O
transcription	O
factor	O
E2F	B
plays	O
an	O
important	O
role	O
in	O
G	O
(	O
1	O
)	O
to	O
S	O
phase	O
transition	O
in	O
the	O
higher	O
eukaryotic	O
cell	O
cycle	O
.	O

Of	O
the	O
153	O
patients	O
studied	O
,	O
CK	B
-	I
MB	I
results	O
were	O
positive	O
in	O
91	O
(	O
59	O
%)	O
patients	O
;	O
ECG	O
revealed	O
AMI	O
in	O
72	O
(	O
47	O
%)	O
patients	O
.	O

We	O
have	O
mapped	O
the	O
human	B
STAG3	I
gene	I
to	O
the	O
7q22	O
region	O
of	O
chromosome	O
7	O
;	O
six	O
human	B
STAG3	I
-	I
related	I
genes	I
have	O
also	O
been	O
mapped	O
:	O
two	O
at	O
7q22	O
near	O
the	O
functional	O
gene	O
,	O
one	O
at	O
7q11	O
.	O
22	O
,	O
and	O
three	O
at	O
7q11	O
.	O
23	O
,	O
two	O
of	O
them	O
flanking	O
the	O
breakpoints	O
commonly	O
associated	O
with	O
the	O
Williams	B
-	I
Beuren	I
syndrome	I
(	I
WBS	I
)	I
deletion	I
.	O

Selective	O
visual	O
attention	O
involves	O
dynamic	O
interplay	O
between	O
attentional	O
control	O
systems	O
and	O
sensory	O
brain	O
structures	O
.	O

However	O
,	O
the	O
a1	O
isoform	O
is	O
expressed	O
most	O
heavily	O
in	O
brain	O
and	O
heart	O
,	O
a2	O
in	O
liver	O
and	O
kidney	O
,	O
and	O
a3	O
in	O
liver	O
,	O
lung	O
,	O
heart	O
,	O
brain	O
,	O
spleen	O
,	O
and	O
kidney	O
.	O

The	O
pCMBS	O
-	O
reactive	O
sulfhydryl	O
groups	O
were	O
located	O
exclusively	O
in	O
the	O
exofacial	O
half	O
of	O
the	O
plasma	O
membrane	O
and	O
,	O
when	O
presented	O
in	O
a	O
helical	O
model	O
,	O
lie	O
along	O
one	O
side	O
of	O
the	O
helices	O
.	O

We	O
also	O
show	O
that	O
zygotically	O
activated	O
Xretpos	O
transcripts	O
are	O
restricted	O
to	O
ventro	O
-	O
posterior	O
specific	O
regions	O
and	O
induced	O
by	O
UV	O
-	O
irradiation	O
and	O
BMP	B
-	I
4	I
overexpression	O
in	O
cycloheximide	O
-	O
dependent	O
way	O
.	O
genesis	O
26	O
:	O
198	O
-	O
207	O
,	O
2000	O
.	O

It	O
has	O
a	O
grave	O
prognosis	O
with	O
>	O
70	O
%	O
mortality	O
in	O
3	O
months	O
,	O
despite	O
mechanical	O
ventilation	O
.	O

In	O
addition	O
,	O
expected	O
decreases	O
in	O
ATIC	B
enzymatic	O
function	O
in	O
ATIC	B
-	O
ALK	B
-	O
containing	O
lymphomas	O
may	O
render	O
these	O
tumors	O
more	O
sensitive	O
to	O
antifolate	O
drugs	O
such	O
as	O
methotrexate	O
.	O

Following	O
the	O
observation	O
that	O
non	O
-	O
organ	O
-	O
specific	O
antibodies	O
are	O
related	O
with	O
pregnancy	O
loss	O
and	O
preeclampsia	O
,	O
the	O
role	O
of	O
organ	O
-	O
specific	O
antibodies	O
is	O
currently	O
being	O
extensively	O
investigated	O
.	O

Rigid	O
point	O
feature	O
registration	O
using	O
mutual	O
information	O
.	O

Valuing	O
families	O
:	O
social	O
work	O
practice	O
with	O
families	O
from	O
a	O
strengths	O
perspective	O
.	O

Here	O
,	O
we	O
show	O
that	O
IRF	B
-	I
1	I
is	O
degraded	O
via	O
the	O
ubiquitin	B
-	O
proteasome	O
pathway	O
.	O

As	O
assessed	O
by	O
a	O
genetic	O
assay	O
that	O
measures	O
AAI	O
-	O
dependent	O
DNA	O
binding	O
,	O
TraM	B
inhibited	O
TraR	B
function	O
before	O
and	O
after	O
the	O
transcription	O
factor	O
had	O
bound	O
to	O
its	O
DNA	O
recognition	O
site	O
.	O

CONCLUSION	O
:	O
A	O
valve	O
-	O
like	O
mechanism	O
formed	O
by	O
the	O
capsulorhexis	O
rim	O
partially	O
adhered	O
to	O
the	O
IOL	O
optic	O
can	O
occur	O
postoperatively	O
.	O

Eight	O
patients	O
received	O
1	O
.	O
5	O
mg	O
of	O
adefovir	O
dipivoxil	O
per	O
kg	O
of	O
body	O
weight	O
,	O
and	O
six	O
patients	O
received	O
3	O
.	O
0	O
mg	O
of	O
adefovir	O
dipivoxil	O
per	O
kg	O
.	O

Depleted	O
and	O
enriched	O
U3O8	O
standard	O
reference	O
materials	O
were	O
used	O
to	O
calibrate	O
the	O
system	O
.	O

This	O
paper	O
reviews	O
the	O
middleware	O
-	O
based	O
approach	O
adopted	O
by	O
CEN	O
ENV	O
12967	O
-	O
1	O
and	O
the	O
specialisation	O
necessary	O
for	O
the	O
healthcare	O
record	O
based	O
on	O
CEN	O
ENV	O
12265	O
'	O
Electronic	O
Healthcare	O
Record	O
Architecture	O
'.	O

Here	O
we	O
describe	O
the	O
cloning	O
,	O
tissue	O
-	O
specific	O
expression	O
pattern	O
,	O
and	O
functional	O
characterization	O
of	O
two	O
novel	O
TEF	B
-	I
1	I
isoforms	I
,	O
TEF	B
-	I
1beta	I
and	O
TEF	B
-	I
1gamma	I
.	O

Therefore	O
the	O
binding	O
sites	O
for	O
liver	O
-	O
enriched	O
factors	O
,	O
present	O
in	O
the	O
hamster	B
CYP7A1	I
proximal	I
promoter	I
in	O
close	O
vicinity	O
and	O
conserved	O
between	O
species	O
,	O
constitute	O
a	O
regulatory	O
unit	O
important	O
for	O
basal	O
hepatic	O
expression	O
and	O
tissue	O
restriction	O
of	O
the	O
action	O
of	O
hormones	O
such	O
as	O
insulin	B
.	O

Although	O
MAP	B
(	I
mitogen	I
-	I
activated	I
protein	I
)	I
kinases	I
are	O
implicated	O
in	O
cell	O
proliferation	O
and	O
differentiation	O
in	O
many	O
cell	O
types	O
,	O
the	O
role	O
of	O
MAP	B
kinases	I
in	O
cardiac	O
hypertrophy	O
remains	O
unclear	O
.	O

Regulation	O
of	O
urokinase	B
plasminogen	I
activator	I
gene	I
transcription	O
in	O
the	O
RAW264	O
murine	O
macrophage	O
cell	O
line	O
by	O
macrophage	B
colony	I
-	I
stimulating	I
factor	I
(	O
CSF	B
-	I
1	I
)	O
is	O
dependent	O
upon	O
the	O
level	O
of	O
cell	O
-	O
surface	O
receptor	O
.	O

The	O
asymmetric	O
methylation	O
was	O
associated	O
with	O
tissue	O
-	O
specific	O
disruption	O
of	O
H19	B
genomic	O
imprinting	O
in	O
fetal	O
brain	O
.	O

The	O
comparison	O
of	O
the	O
expression	O
patterns	O
of	O
the	O
known	O
Kv4	B
family	I
members	I
shows	O
subtype	O
specificity	O
with	O
significant	O
overlaps	O
.	O

Importantly	O
,	O
concomitant	O
expression	O
of	O
constitutive	O
activated	O
Raf	B
and	O
V12N38	B
Ras	I
results	O
in	O
almost	O
complete	O
loss	O
of	O
TTF	B
-	I
1	I
activity	O
.	O

They	O
share	O
many	O
downstream	O
targets	O
,	O
including	O
remodeling	O
of	O
the	O
actin	B
cytoskeleton	O
,	O
activation	O
of	O
p70	B
(	I
S6	I
)	I
kinase	I
and	O
c	B
-	I
jun	I
N	I
-	I
terminal	I
kinase	I
(	O
JNK	B
),	O
and	O
regulation	O
of	O
transcription	O
and	O
cell	O
proliferation	O
.	O

Family	O
environment	O
was	O
an	O
important	O
influence	O
on	O
interpersonal	O
relationships	O
,	O
substance	O
use	O
,	O
and	O
social	O
support	O
.	O

To	O
investigate	O
the	O
molecular	O
mechanisms	O
of	O
this	O
Tax	B
-	O
mediated	O
inhibition	O
,	O
we	O
analyzed	O
its	O
effect	O
on	O
the	O
transcriptional	O
activity	O
of	O
the	O
myogenic	O
MyoD	B
protein	I
,	O
which	O
was	O
used	O
as	O
a	O
paradigm	O
of	O
bHLH	B
factors	I
.	O

The	O
cell	O
cycle	O
and	O
transcriptional	O
defects	O
caused	O
by	O
taf17	B
(	O
slm7	B
-	I
1	I
)	O
are	O
consistent	O
with	O
the	O
role	O
of	O
TAF	B
(	I
II	I
)	I
s	I
as	O
modulators	O
of	O
transcriptional	O
activation	O
and	O
may	O
reflect	O
a	O
role	O
for	O
TAF17	B
in	O
regulating	O
activation	O
by	O
SBF	B
and	O
MBF	B
.	O

A	O
pathway	O
for	O
regulation	O
of	O
B	B
lymphocyte	I
antigen	I
receptor	I
-	O
induced	O
calcium	O
flux	O
.	O

We	O
now	O
describe	O
a	O
second	O
RIM	B
protein	I
,	O
called	O
RIM2	B
,	O
that	O
is	O
highly	O
homologous	O
to	O
RIM1	B
and	O
also	O
expressed	O
primarily	O
in	O
brain	O
.	O

Inhibitor	B
-	I
1	I
(	O
I	B
-	I
1	I
)	O
and	O
inhibitor	B
-	I
2	I
(	O
I	B
-	I
2	I
)	O
selectively	O
inhibit	O
type	B
1	I
protein	I
serine	I
/	I
threonine	I
phosphatases	I
(	O
PP1	B
).	O

Scanning	O
mutations	O
throughout	O
the	O
AC	O
element	O
interfered	O
with	O
induction	O
but	O
allowed	O
us	O
to	O
define	O
five	O
overlapping	O
sites	O
for	O
regulatory	O
factors	O
in	O
AC	O
and	O
to	O
design	O
probes	O
binding	O
just	O
one	O
or	O
two	O
factors	O
.	O

These	O
results	O
indicate	O
that	O
virulence	O
-	O
associated	O
genes	O
and	O
their	O
overall	O
chromosomal	O
arrangement	O
are	O
relatively	O
well	O
conserved	O
between	O
B	O
.	O
henselae	O
and	O
other	O
gram	O
-	O
negative	O
bacteria	O
such	O
as	O
A	O
.	O
tumefaciens	O
.	O

Paxillin	B
acts	O
as	O
an	O
adaptor	O
molecule	O
in	O
integrin	B
signaling	O
.	O

In	O
addition	O
,	O
the	O
transcription	O
of	O
c	B
-	I
IAP2	I
promoter	I
was	O
strongly	O
up	O
-	O
regulated	O
when	O
CD40	B
or	O
Epstein	B
-	I
Barr	I
virus	I
latent	I
membrane	I
protein	I
1	I
was	O
overexpressed	O
.	O

These	O
studies	O
identify	O
several	O
of	O
the	O
signal	O
-	O
transduction	O
events	O
involved	O
in	O
the	O
apoptosis	O
of	O
malignant	O
B	O
cells	O
that	O
transpire	O
following	O
ligation	O
of	O
CD20	B
by	O
anti	B
-	I
CD20	I
antibodies	I
in	O
the	O
presence	O
of	O
Fc	B
-	I
receptor	I
-	O
expressing	O
cells	O
or	O
secondary	O
goat	O
anti	B
-(	I
mouse	I
Ig	I
)	I
antibodies	I
and	O
which	O
may	O
contribute	O
to	O
the	O
tumor	O
regressions	O
observed	O
in	O
mouse	O
models	O
and	O
clinical	O
trials	O
.	O

CONCLUSION	O
:	O
Treatment	O
of	O
sepsis	O
with	O
the	O
platelet	B
-	I
activating	I
factor	I
antagonist	O
BB	O
-	O
882	O
offers	O
no	O
advantage	O
over	O
placebo	O
on	O
survival	O
,	O
hemodynamic	O
status	O
,	O
respiratory	O
function	O
,	O
or	O
organ	O
failure	O
scores	O
.	O

In	O
vivo	O
dimethyl	O
sulfate	O
footprinting	O
of	O
the	O
cyclin	B
E	I
promoter	I
revealed	O
several	O
regions	O
of	O
protection	O
and	O
hypersensitivity	O
that	O
were	O
unique	O
to	O
infected	O
cells	O
.	O

CONCLUSION	O
:	O
More	O
than	O
50	O
%	O
of	O
patients	O
with	O
perennial	O
rhinitis	O
and	O
CRS	O
do	O
not	O
improve	O
after	O
surgery	O
,	O
a	O
response	O
that	O
may	O
be	O
predicted	O
by	O
more	O
cells	O
expressing	O
IL	B
-	I
5	I
mRNA	I
in	O
the	O
ethmoid	O
sinuses	O
.	O

Biol	O
.	O

On	O
the	O
basis	O
of	O
size	O
,	O
the	O
CRS	O
sequence	O
to	O
which	O
it	O
binds	O
,	O
and	O
its	O
tentative	O
identification	O
as	O
a	O
zinc	B
finger	I
protein	I
,	O
Adx	B
factor	I
has	O
been	O
identified	O
as	O
a	O
Kruppel	B
-	I
like	I
zinc	I
finger	I
protein	I
(	O
a	O
mouse	B
ZBP	I
-	I
89	I
homologue	I
).	O

Systemic	O
impact	O
of	O
risk	O
-	O
sharing	O
arrangements	O
.	O

The	O
MMA	B
,	I
DMA	I
,	I
and	I
TMA	I
methyltransferases	I
are	O
not	O
homologs	O
;	O
however	O
,	O
like	O
the	O
MMA	B
methyltransferase	I
gene	I
,	O
the	O
genes	O
encoding	O
the	O
DMA	B
and	I
TMA	I
methyltransferases	I
each	O
contain	O
a	O
single	O
in	O
-	O
frame	O
amber	O
codon	O
.	O

After	O
phosphorylation	O
,	O
STAT	B
proteins	I
are	O
transported	O
into	O
the	O
nucleus	O
and	O
exhibit	O
transcriptional	O
activity	O
.	O

Kidney	O
length	O
did	O
not	O
significantly	O
differ	O
between	O
right	O
and	O
left	O
,	O
however	O
,	O
kidney	O
width	O
,	O
cortical	O
thickness	O
and	O
size	O
did	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

SNAP	B
-	I
23	I
plays	O
an	O
important	O
role	O
in	O
the	O
regulation	O
of	O
vesicle	O
trafficking	O
in	O
mammalian	O
cells	O
.	O

In	O
an	O
attempt	O
to	O
understand	O
Wee1	B
regulation	O
during	O
cell	O
cycle	O
,	O
yeast	O
two	O
-	O
hybrid	O
screening	O
was	O
used	O
to	O
identify	O
Wee1	O
-	O
binding	O
protein	O
(	O
s	O
).	O

The	O
codon	O
usage	O
is	O
particularly	O
marked	O
for	O
the	O
gag	B
,	O
pol	B
,	O
and	O
env	B
genes	I
.	O

The	O
p53	B
-	I
homolog	I
p73beta	I
also	O
activated	O
the	O
PIG3	B
promoter	I
,	O
but	O
in	O
contrast	O
to	O
p53	B
,	O
the	O
proline	O
-	O
rich	O
domain	O
of	O
p73beta	B
(	I
residues	I
81	I
-	I
113	I
)	I
was	O
dispensable	O
to	O
induce	O
the	O
PIG3	B
promoter	I
.	O

Results	O
from	O
transient	O
assays	O
using	O
these	O
mutants	O
showed	O
that	O
the	O
DE1	O
received	O
signals	O
from	O
phytochromes	B
A	I
and	I
B	I
,	O
demonstrating	O
that	O
this	O
element	O
is	O
indeed	O
a	O
light	O
-	O
responsive	O
element	O
.	O

We	O
report	O
here	O
on	O
the	O
molecular	O
nature	O
of	O
an	O
EMS	O
-	O
induced	O
mutant	O
,	O
mn1	B
-	I
89	I
,	O
a	O
leaky	O
semidominant	O
allele	O
of	O
the	O
Miniature1	B
(	O
Mn1	B
)	O
seed	O
locus	O
that	O
encodes	O
a	O
seed	B
-	I
specific	I
cell	I
wall	I
invertase	I
,	O
INCW2	B
.	O

Estrogen	B
receptor	I
-	I
related	I
receptor	I
alpha	I
1	I
interacts	O
with	O
coactivator	O
and	O
constitutively	O
activates	O
the	O
estrogen	O
response	O
elements	O
of	O
the	O
human	B
lactoferrin	I
gene	I
.	O

Kaposi	O
'	O
s	O
sarcoma	O
-	O
associated	O
herpesvirus	O
viral	B
interferon	I
regulatory	I
factor	I
confers	O
resistance	O
to	O
the	O
antiproliferative	O
effect	O
of	O
interferon	B
-	I
alpha	I
.	O

T1	O
-	O
weighted	O
MRI	O
on	O
the	O
49th	O
postoperative	O
day	O
demonstrated	O
bilateral	O
and	O
symmetrical	O
hyperintense	O
lesions	O
in	O
the	O
globus	O
pallidus	O
.	O

The	O
interaction	O
does	O
not	O
depend	O
on	O
the	O
presence	O
of	O
the	O
correct	O
amino	O
-	O
terminal	O
DNA	O
binding	O
domain	O
or	O
the	O
amino	O
acid	O
sequences	O
between	O
the	O
DNA	O
binding	O
domain	O
and	O
the	O
last	O
ten	O
amino	O
acids	O
.	O

CONCLUSION	O
:	O
The	O
probability	O
of	O
cardiopulmonary	O
complications	O
increases	O
significantly	O
when	O
patients	O
develop	O
class	O
1	O
HELLP	O
syndrome	O
.	O

AMDA	O
white	O
paper	O
identifies	O
ways	O
to	O
improve	O
pharmaceutical	O
care	O
in	O
SNFs	O
.	O

Cerebral	O
vasculitis	O
secondary	O
to	O
Crohn	O
'	O
s	O
disease	O
seems	O
to	O
be	O
a	O
very	O
rare	O
phenomenon	O
.	O

These	O
studies	O
suggest	O
an	O
additional	O
component	O
or	O
cellular	O
environment	O
is	O
required	O
for	O
SPRK	B
activation	O
by	O
Cdc42	B
.	O

Update	O
on	O
maternal	O
-	O
fetal	O
infections	O
by	O
hepatitis	O
C	O
,	O
HIV	O
and	O
cytomegalovirus	O

Modeling	O
also	O
revealed	O
a	O
very	O
hydrophobic	O
surface	O
due	O
to	O
the	O
absence	O
of	O
H12	O
,	O
exposing	O
residues	O
from	O
H3	O
,	O
loop	O
3	O
-	O
4	O
,	O
H4	O
,	O
and	O
H11	O
.	O

RESULTS	O
:	O
Abnormal	O
color	O
perception	O
was	O
found	O
in	O
32	O
%	O
of	O
the	O
epilepsy	O
patients	O
treated	O
with	O
vigabatrin	O
monotherapy	O
and	O
28	O
%	O
of	O
the	O
epilepsy	O
patients	O
treated	O
with	O
carbamazepine	O
monotherapy	O
.	O

In	O
the	O
SPP2	O
screening	O
test	O
,	O
a	O
few	O
plates	O
were	O
not	O
seen	O
in	O
both	O
groups	O
.	O

Nor	O
is	O
such	O
adjustment	O
possible	O
unless	O
one	O
posits	O
a	O
model	O
that	O
relates	O
the	O
missing	O
observations	O
to	O
other	O
observed	O
information	O
for	O
each	O
subject	O
-	O
models	O
that	O
are	O
inherently	O
untestable	O
.	O

However	O
,	O
the	O
presence	O
of	O
effacement	O
seems	O
to	O
be	O
a	O
more	O
reliable	O
and	O
practical	O
parameter	O
that	O
will	O
be	O
preferred	O
in	O
that	O
prediction	O
.	O

The	O
data	O
are	O
compatible	O
with	O
the	O
idea	O
that	O
YLL031c	B
transfers	O
the	O
ethanolaminephosphate	O
to	O
the	O
inner	O
alpha1	O
-	O
2	O
-	O
linked	O
mannose	O
,	O
i	O
.	O
e	O
.	O
the	O
group	O
that	O
links	O
the	O
GPI	O
lipid	O
anchor	O
to	O
proteins	O
,	O
whereas	O
Mcd4p	B
and	O
Gpi7p	B
transfer	O
ethanolaminephosphate	O
onto	O
the	O
alpha1	O
-	O
4	O
-	O
and	O
alpha1	O
-	O
6	O
-	O
linked	O
mannoses	O
of	O
the	O
GPI	O
anchor	O
,	O
respectively	O
.	O

The	O
C	O
terminus	O
of	O
TRBP	B
binds	O
to	O
CBP	B
/	O
p300	B
and	O
DRIP130	B
,	O
a	O
component	O
of	O
the	O
DRIP	B
/	O
TRAP	B
/	O
ARC	B
complex	O
,	O
which	O
suggests	O
that	O
TRBP	B
may	O
activate	O
transcription	O
by	O
means	O
of	O
such	O
interactions	O
.	O

The	O
gene	O
amplification	O
model	O
of	O
Coquelle	O
et	O
al	O
.	O

Although	O
the	O
OC	B
promoter	I
is	O
activated	O
in	O
a	O
C	O
terminus	O
dependent	O
manner	O
,	O
the	O
MDR	B
,	O
LTR	O
and	O
BSP	B
promoters	I
are	O
repressed	O
by	O
three	O
distinct	O
mechanisms	O
,	O
either	O
independent	O
of	O
or	O
involving	O
the	O
AML	B
C	I
terminus	I
,	O
or	O
requiring	O
only	O
the	O
conserved	O
C	O
-	O
terminal	O
pentapeptide	O
VWRPY	O
.	O

Double	O
-	O
blind	O
,	O
placebo	O
-	O
controlled	O
trial	O
.	O

Here	O
,	O
it	O
is	O
shown	O
that	O
TAFII250	B
,	O
the	O
largest	O
subunit	O
of	O
TFIID	B
,	O
contains	O
two	O
tandem	O
bromodomain	O
modules	O
that	O
bind	O
selectively	O
to	O
multiply	O
acetylated	O
histone	B
H4	I
peptides	I
.	O

Endostatin	O
treatment	O
for	O
10	O
minutes	O
or	O
24	O
hours	O
induced	O
tyrosine	O
phosphorylation	O
of	O
Shb	B
and	O
formation	O
of	O
multiprotein	O
complexes	O
.	O

Here	O
,	O
we	O
show	O
that	O
the	O
zinc	B
finger	I
protein	I
Gis1	I
acts	O
as	O
a	O
dosage	O
-	O
dependent	O
suppressor	O
of	O
the	O
rim15Delta	B
defect	O
in	O
nutrient	O
limitation	O
-	O
induced	O
transcriptional	O
derepression	O
of	O
SSA3	B
.	O

Tumor	O
stages	O
were	O
IIB	O
(	O
T3	O
N0	O
)	O
in	O
52	O
%,	O
IIIA	O
in	O
15	O
%,	O
and	O
IIIB	O
in	O
27	O
%	O
of	O
patients	O
.	O

Moreover	O
,	O
expression	O
of	O
antisense	B
Ha	I
-	I
Ras	I
or	O
dominant	B
negative	I
Raf	I
-	I
1	I
abrogated	O
the	O
mitogenic	O
effect	O
of	O
TGF	B
-	I
beta1	I
in	O
TSU	O
-	O
Pr1	O
,	O
and	O
the	O
TGF	B
-	I
beta1	I
inhibition	O
of	O
DU145	O
was	O
switched	O
to	O
stimulation	O
by	O
V12Ha	B
-	I
Ras	I
transfection	O
.	O

This	O
demonstrates	O
that	O
treatment	O
of	O
the	O
graft	O
recipient	O
for	O
a	O
relatively	O
short	O
period	O
during	O
and	O
after	O
surgery	O
has	O
a	O
favorable	O
effect	O
on	O
the	O
survival	O
of	O
grafted	O
dopaminergic	O
neurons	O
.	O

The	O
relationships	O
among	O
blood	O
concentrations	O
of	O
thyroid	O
hormones	O
and	O
selenium	O
,	O
zinc	O
,	O
retinol	O
,	O
and	O
alpha	O
-	O
tocopherol	O
were	O
studied	O
in	O
44	O
healthy	O
Northern	O
Italian	O
oldest	O
-	O
old	O
subjects	O
(	O
age	O
range	O
,	O
90	O
-	O
107	O
yr	O
),	O
selected	O
by	O
the	O
criteria	O
of	O
the	O
SENIEUR	O
protocol	O
.	O

Investigations	O
using	O
hippocampal	O
slices	O
maintained	O
in	O
vitro	O
have	O
demonstrated	O
that	O
bursts	O
of	O
oscillatory	O
field	O
potentials	O
in	O
the	O
gamma	O
frequency	O
range	O
(	O
30	O
-	O
80	O
Hz	O
)	O
are	O
followed	O
by	O
a	O
slower	O
oscillation	O
in	O
the	O
beta	O
1	O
range	O
(	O
12	O
-	O
20	O
Hz	O
).	O

Karger	O
AG	O
,	O
Basel	O

Urinary	O
LTE4	O
increased	O
after	O
both	O
challenges	O
the	O
rise	O
being	O
higher	O
following	O
oral	O
as	O
compared	O
to	O
inhalation	O
provocation	O
(	O
p	O
=	O
0	O
.	O
0001	O
).	O

SETTING	O
:	O
University	O
of	O
Paris	O
VII	O
hospital	O
.	O
Patient	O
(	O
s	O
):	O
Nine	O
women	O
had	O
embolization	O
for	O
symptomatic	O
myoma	O
,	O
with	O
12	O
pregnancies	O
observed	O
.	O

Improving	O
fissure	O
sealant	O
quality	O
:	O
mechanical	O
preparation	O
and	O
filling	O
level	O
.	O

The	O
Menopause	O
-	O
Rating	O
-	O
Scale	O
(	O
MRS	O
I	O
)	O
was	O
used	O
in	O
clinical	O
practice	O
since	O
1992	O
.	O

The	O
presence	O
of	O
such	O
a	O
putative	O
RNA	O
-	O
binding	O
domain	O
suggests	O
a	O
mechanism	O
for	O
the	O
observed	O
autoregulation	O
of	O
bacteriophage	O
T4	B
DNA	I
polymerase	I
synthesis	O
by	O
binding	O
to	O
its	O
own	O
mRNA	O
.	O

Functional	O
studies	O
which	O
introduced	O
a	O
mutation	O
in	O
the	O
AP2	B
core	I
binding	I
region	I
as	O
well	O
as	O
cotransfection	O
experiments	O
using	O
an	O
AP2	B
expression	O
vector	O
revealed	O
that	O
AP2	B
exerts	O
a	O
repressive	O
role	O
on	O
the	O
HGF	B
gene	I
promoter	I
activity	O
.	O

Franz	O
Schubert	O
--	O
his	O
life	O
,	O
music	O
and	O
diseases	O

These	O
results	O
demonstrate	O
that	O
N	O
-	O
glycans	O
flanking	O
the	O
receptor	O
-	O
binding	O
site	O
of	O
the	O
HA	B
molecule	I
are	O
potent	O
regulators	O
of	O
influenza	O
virus	O
growth	O
,	O
with	O
the	O
glycan	O
at	O
Asn149	O
being	O
dominant	O
and	O
that	O
at	O
Asn123	O
being	O
less	O
effective	O
.	O

In	O
the	O
premating	O
period	O
male	O
rate	O
of	O
aggression	O
was	O
not	O
significantly	O
correlated	O
with	O
testosterone	O
level	O
.	O

Prevention	O
,	O
differential	O
diagnosis	O
and	O
therapy	O
of	O
travel	O
diarrhea	O

As	O
with	O
VP16	B
,	O
the	O
transactivation	O
function	O
of	O
Luman	B
is	O
also	O
regulated	O
by	O
HCF	B
.	O

GAP	O
JUNCTIONS	O
IN	O
THE	O
BRAIN	O
:	O
PREFACE	O
.	O

It	O
is	O
mainly	O
transcribed	O
in	O
neural	O
structures	O
and	O
in	O
developing	O
organs	O
characterized	O
by	O
epithelial	O
-	O
mesenchymal	O
interactions	O
.	O

ID	O
-	O
PaGIA	O
diphtheria	B
toxin	I
polymer	O
particle	O
diagnostic	O
agent	O
manufactured	O
by	O
DiaMed	O
AG	O
,	O
Switzerland	O
,	O
was	O
tried	O
at	O
bacteriological	O
laboratory	O
of	O
Institute	O
of	O
Childhood	O
Infections	O
in	O
St	O
.	O

Objective	O
responses	O
also	O
occurred	O
in	O
studies	O
that	O
explored	O
sequential	O
use	O
of	O
exemestane	O
after	O
failure	O
of	O
aminoglutethimide	O
(	O
26	O
%	O
with	O
exemestane	O
200	O
mg	O
/	O
day	O
)	O
or	O
other	O
nonsteroidal	O
aromatase	B
inhibitors	O
(	O
6	O
.	O
6	O
%	O
with	O
exemestane	O
25	O
mg	O
/	O
day	O
).	O

Endonuclease	B
III	I
(	O
Nth	B
)	O
of	O
Escherichia	O
coli	O
is	O
a	O
DNA	B
glycosylase	I
essential	O
for	O
the	O
removal	O
of	O
oxidised	O
pyrimidine	O
base	O
residues	O
from	O
DNA	O
.	O

The	O
duration	O
of	O
reactive	O
hyperemia	O
decreased	O
with	O
aging	O
,	O
but	O
the	O
difference	O
between	O
males	O
and	O
females	O
was	O
not	O
significant	O
at	O
any	O
age	O
.	O

Furthermore	O
,	O
this	O
study	O
looks	O
at	O
the	O
impact	O
of	O
synthesis	O
conditions	O
on	O
block	O
length	O
and	O
crystallinity	O
,	O
and	O
the	O
impact	O
of	O
the	O
blocking	O
on	O
both	O
,	O
crystallinity	O
and	O
solubility	O
of	O
the	O
polymers	O
.	O

Both	O
the	O
MVBF	O
and	O
the	O
maximum	O
EMG	O
activity	O
in	O
the	O
right	O
masseter	O
and	O
the	O
left	O
anterior	O
temporalis	O
muscles	O
were	O
significantly	O
decreased	O
during	O
muscle	O
pain	O
when	O
the	O
subjects	O
bit	O
on	O
the	O
painful	O
side	O
.	O

Members	O
of	O
the	O
titin	B
/	O
myosin	B
light	I
chain	I
kinase	I
family	O
play	O
an	O
essential	O
role	O
in	O
the	O
organization	O
of	O
the	O
actin	B
/	O
myosin	B
cytoskeleton	O
,	O
especially	O
in	O
sarcomere	O
assembly	O
and	O
function	O
.	O

Antithrombin	B
III	I
deficiency	O
:	O
when	O
substitute	O
,	O
when	O
heparin	O
?	O
Thrombosis	O
ABC	O
,	O
3	O
:	O
The	O
role	O
of	O
antithrombin	B
III	I

Specific	O
class	B
I	I
and	I
II	I
histone	I
deacetylases	I
(	O
HDACs	B
)	O
interact	O
in	O
vivo	O
with	O
BCoR	B
,	O
suggesting	O
that	O
BCoR	B
may	O
functionally	O
link	O
these	O
two	O
classes	O
of	O
HDACs	B
.	O

When	O
cells	O
were	O
microinjected	O
with	O
TFOs	O
designed	O
to	O
bind	O
to	O
a	O
30	O
-	O
bp	O
polypurine	O
site	O
situated	O
between	O
the	O
two	O
TK	B
genes	I
,	O
recombination	O
was	O
observed	O
at	O
frequencies	O
in	O
the	O
range	O
of	O
1	O
%,	O
2	O
,	O
500	O
-	O
fold	O
above	O
the	O
background	O
.	O

Only	O
transcripts	O
specific	O
for	O
TSGF	B
-	I
2	I
are	O
detected	O
in	O
ovary	O
and	O
testes	O
tissues	O
of	O
adults	O
as	O
well	O
as	O
in	O
puparia	O
,	O
while	O
neither	O
gene	O
is	O
expressed	O
during	O
the	O
larval	O
developmental	O
stages	O
.	O

Reliability	O
of	O
cervical	O
range	O
of	O
motion	O
using	O
the	O
OSI	O
CA	O
6000	O
spine	O
motion	O
analyser	O
on	O
asymptomatic	O
and	O
symptomatic	O
subjects	O
.	O

Double	O
mutant	O
analysis	O
suggests	O
that	O
Rad54p	B
and	O
Mus81p	B
act	O
in	O
one	O
pathway	O
for	O
the	O
repair	O
of	O
,	O
or	O
tolerance	O
to	O
,	O
UV	O
-	O
induced	O
DNA	O
damage	O
.	O

The	O
linear	O
plasmid	O
pCLU1	O
from	O
the	O
yeast	O
Kluyveromyces	O
lactis	O
normally	O
replicates	O
in	O
the	O
cytoplasm	O
,	O
with	O
the	O
aid	O
of	O
the	O
helper	O
linear	O
plasmid	O
pGKL2	O
,	O
using	O
terminal	B
protein	I
(	O
TP	B
)	O
as	O
a	O
primer	O
.	O

The	O
effectiveness	O
of	O
NRT	O
appears	O
to	O
be	O
largely	O
independent	O
of	O
the	O
intensity	O
of	O
additional	O
support	O
provided	O
to	O
the	O
smoker	O
.	O

8	O
%	O
(	O
95	O
%	O
CI	O
,	O
21	O
.	O
3	O
-	O
44	O
.	O
3	O
%).	O

In	O
contrast	O
,	O
the	O
action	O
of	O
GLP	B
-	I
1	I
at	O
the	O
CRE	O
was	O
not	O
blocked	O
by	O
cotransfection	O
with	O
M1	B
-	I
CREB	I
,	O
an	O
isoform	O
that	O
lacks	O
a	O
consensus	O
serine	O
residue	O
serving	O
as	O
substrate	O
for	O
PKA	B
-	O
mediated	O
phosphorylation	O
.	O

Six	O
distinct	O
Ets	B
mRNAs	I
were	O
identified	O
:	O
Ets2	B
,	O
Fli1	B
,	O
GABPalpha	B
,	O
SAP1	B
,	O
Elk1	B
,	O
and	O
PE1	B
.	O

A	O
2	O
kb	O
transcript	O
was	O
isolated	O
from	O
brain	O
that	O
encodes	O
a	O
approximately	O
57	O
kDa	O
protein	O
;	O
the	O
predicted	O
protein	O
contains	O
the	O
known	O
N	B
-	I
terminal	I
Ets	I
domain	I
of	O
PE1	B
and	O
a	O
novel	O
C	O
-	O
terminal	O
domain	O
with	O
signficant	O
homology	O
to	O
murine	B
ERF	I
.	O

Wnt	B
-	I
1	I
overexpression	O
in	O
mammary	O
epithelial	O
cells	O
induced	O
cyclin	B
D1	I
mRNA	I
and	O
targeted	O
overexpression	O
of	O
Wnt	B
-	I
1	I
in	O
the	O
mammary	O
gland	O
of	O
transgenic	O
mice	O
increased	O
both	O
ILK	B
activity	O
and	O
cyclin	B
D1	I
levels	O
.	O

Intravenous	O
versus	O
oral	O
administration	O
of	O
amitriptyline	O
in	O
patients	O
with	O
major	O
depression	O
.	O

Logistic	O
regression	O
analysis	O
revealed	O
that	O
physicians	O
were	O
3	O
.	O
6	O
times	O
more	O
likely	O
to	O
detect	O
thin	O
lesions	O
(</=	O
0	O
.	O
75	O
mm	O
)	O
compared	O
with	O
nonphysician	O
detectors	O
(	O
95	O
%	O
confidence	O
interval	O
[	O
95	O
%	O
CI	O
],	O
2	O
.	O
1	O
,	O
6	O
.	O
5	O
;	O
P	O
=	O
0	O
.	O
0001	O
).	O

VaI	O
and	O
VaII	O
co	O
-	O
immunoprecipitated	O
with	O
ErbB2	B
,	O
but	O
not	O
with	O
ErbB1	B
,	O
ErbB3	B
,	O
or	O
ErbB4	B
.	O

In	O
addition	O
to	O
its	O
effect	O
in	O
augmenting	O
the	O
neutrophil	O
response	O
to	O
eccentric	O
exercise	O
,	O
vitamin	O
E	O
causes	O
a	O
greater	O
increase	O
in	O
circulating	O
creatine	B
kinase	I
activity	O
,	O
perhaps	O
indicating	O
increased	O
skeletal	O
muscle	O
repair	O
.	O

This	O
study	O
demonstrated	O
that	O
the	O
PFA	O
-	O
100	O
analyzer	O
can	O
accurately	O
assess	O
vWF	B
-	O
dependent	O
platelet	O
function	O
and	O
detect	O
other	O
platelet	O
defects	O
under	O
high	O
shear	O
stress	O
in	O
complex	O
patient	O
populations	O
.	O

Using	O
an	O
oligomer	O
duplex	O
5	O
'-	O
A	O
(	O
GGGTTA	O
)(	O
5	O
)-	O
3	O
'/	O
5	O
'-(	O
TAACCC	O
)(	O
5	O
)	O
T	O
-	O
3	O
'	O
as	O
a	O
template	O
-	O
primer	O
,	O
we	O
show	O
that	O
both	O
the	O
Klenow	B
fragment	I
of	I
Escherichia	I
coli	I
DNA	I
polymerase	I
I	I
and	O
HIV	B
reverse	I
transcriptase	I
could	O
expand	O
telomere	O
DNA	O
sequences	O
as	O
well	O
,	O
giving	O
products	O
greater	O
than	O
the	O
size	O
of	O
the	O
template	O
DNA	O
.	O

Subsequently	O
,	O
HD	O
inhibited	O
healing	O
because	O
it	O
significantly	O
delayed	O
epithelialization	O
and	O
caused	O
protracted	O
inflammation	O
.	O

These	O
findings	O
were	O
reinforced	O
by	O
an	O
analysis	O
that	O
was	O
restricted	O
to	O
living	O
donor	O
transplants	O
without	O
acute	O
rejection	O
.	O

The	O
genome	O
of	O
the	O
human	O
herpesvirus	O
8	O
(	O
HHV	O
-	O
8	O
)	O
contains	O
a	O
cluster	O
of	O
open	O
reading	O
frames	O
(	O
ORFs	O
)	O
encoding	O
proteins	O
with	O
homology	O
to	O
the	O
cellular	O
transcription	O
factors	O
of	O
the	O
interferon	B
regulatory	I
factor	I
(	O
IRF	B
)	O
family	O
.	O

Transcriptional	O
regulation	O
of	O
fbp1	B
promoter	I
constructs	I
containing	O
only	O
UAS1	O
or	O
UAS2	O
confirms	O
that	O
the	O
PKA	B
and	O
MAPK	B
regulation	O
is	O
targeted	O
to	O
both	O
sites	O
.	O

The	O
ability	O
of	O
SMRT	B
to	O
associate	O
with	O
these	O
transcription	O
factors	O
and	O
thereby	O
to	O
mediate	O
repression	O
is	O
strongly	O
inhibited	O
by	O
activation	O
of	O
tyrosine	B
kinase	I
signaling	O
pathways	O
,	O
such	O
as	O
that	O
represented	O
by	O
the	O
epidermal	B
growth	I
factor	I
receptor	I
.	O

Patients	O
were	O
randomly	O
assigned	O
to	O
treatment	O
with	O
the	O
ACE	B
inhibitor	O
perindopril	O
(	O
and	O
the	O
diuretic	O
indapamide	O
for	O
those	O
with	O
no	O
definite	O
indication	O
for	O
or	O
contraindication	O
to	O
treatment	O
with	O
a	O
diuretic	O
)	O
or	O
matching	O
placebo	O
(	O
s	O
).	O

The	O
results	O
indicate	O
that	O
the	O
open	O
-	O
section	O
effect	O
decreases	O
the	O
torsional	O
stiffness	O
and	O
stress	O
concentration	O
effects	O
decrease	O
the	O
torsional	O
strength	O
of	O
a	O
long	O
bone	O
with	O
a	O
longitudinal	O
defect	O
.	O

The	O
role	O
of	O
daunorubicin	O
in	O
induction	O
therapy	O
for	O
adult	O
acute	O
myeloid	O
leukemia	O

TNF	B
-	I
alpha	I
induced	O
a	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
increase	O
in	O
cyclooxygenase	B
-	I
2	I
(	O
COX	B
-	I
2	I
)	O
expression	O
and	O
PGE2	O
formation	O
in	O
human	O
NCI	O
-	O
H292	O
epithelial	O
cells	O
.	O

A	O
2	O
.	O
3	O
-	O
kb	O
full	O
-	O
length	O
cDNA	O
clone	O
of	O
an	O
Atlantic	B
halibut	I
Mx	I
gene	I
was	O
isolated	O
from	O
a	O
liver	O
cDNA	O
library	O
.	O

A	O
Y	B
.	I
lipolytica	I
Kar2p	I
mutant	I
was	O
isolated	O
that	O
restored	O
interaction	O
with	O
an	O
Sls1p	B
mutant	I
,	O
suggesting	O
that	O
the	O
interaction	O
with	O
Sls1p	B
could	O
be	O
nucleotide	O
and	O
/	O
or	O
conformation	O
dependent	O
.	O

Platelet	O
counts	O
and	O
function	O
as	O
well	O
as	O
fibrinogen	B
and	O
von	B
Willebrand	I
factor	I
(	O
vWF	B
)	O
levels	O
were	O
determined	O
in	O
each	O
sample	O
.	O

The	O
manifestations	O
often	O
include	O
a	O
moderate	O
thrombocytopenia	O
and	O
,	O
less	O
commonly	O
,	O
hemolysis	O
.	O

Non	O
-	O
poliomyelitis	O
AFP	O
rate	O
had	O
increased	O
from	O
0	O
.	O
9	O
in	O
1997	O
to	O
2	O
.	O
8	O
in	O
1998	O
.	O

Picture	O
the	O
smell	O
.	O

The	O
aim	O
of	O
our	O
study	O
was	O
to	O
evaluate	O
the	O
level	O
of	O
oxidative	O
stress	O
in	O
healthy	O
controls	O
(	O
CTL	O
)	O
compared	O
with	O
CRF	O
and	O
HD	O
patients	O
before	O
(	O
pre	O
-	O
HD	O
)	O
and	O
after	O
(	O
post	O
-	O
HD	O
)	O
the	O
dialysis	O
session	O
,	O
carried	O
out	O
on	O
a	O
high	O
biocompatible	O
polyacrylonitrile	O
membrane	O
AN69	O
.	O

It	O
was	O
found	O
that	O
increase	O
in	O
the	O
RH	O
level	O
boosts	O
the	O
current	O
values	O
by	O
2	O
-	O
3	O
orders	O
of	O
magnitude	O
;	O
contrariwise	O
,	O
the	O
voltage	O
values	O
rise	O
by	O
about	O
three	O
times	O
with	O
drop	O
in	O
the	O
RH	O
.	O

Genomic	O
libraries	O
were	O
stored	O
as	O
frozen	O
cultures	O
in	O
a	O
96	O
-	O
well	O
format	O
,	O
each	O
well	O
containing	O
approximately	O
300	O
-	O
600	O
colonies	O
(	O
12	O
plates	O
for	O
small	O
library	O
,	O
four	O
for	O
medium	O
-	O
size	O
library	O
and	O
four	O
for	O
large	O
library	O
).	O

The	O
human	O
cDNA	O
clone	O
NFBD1	O
(	O
previously	O
designated	O
KIAA0170	O
)	O
encodes	O
a	O
novel	O
protein	O
(	O
2089	O
amino	O
acids	O
in	O
length	O
;	O
calculated	O
molecular	O
mass	O
226	O
,	O
440	O
D	O
)	O
with	O
possible	O
BRCT	B
domains	I
at	O
its	O
carboxy	O
terminus	O
(	O
amino	O
acid	O
residues	O
1894	O
-	O
2089	O
).	O

The	O
muskox	O
is	O
a	O
new	O
host	O
record	O
for	O
T	O
.	O
gondii	O
.	O

These	O
include	O
NPF	O
repeats	O
,	O
a	O
leucine	O
heptad	O
repeat	O
enriched	O
in	O
charged	O
residues	O
,	O
and	O
a	O
proline	O
-	O
rich	O
SH3	B
-	I
like	I
and	O
/	O
or	O
WW	O
domain	O
-	O
binding	O
site	O
in	O
the	O
N	O
-	O
terminal	O
domain	O
,	O
which	O
is	O
followed	O
by	O
a	O
membrane	O
core	O
containing	O
four	O
putative	O
transmembrane	O
spans	O
and	O
three	O
amphiphilic	O
segments	O
that	O
are	O
the	O
most	O
highly	O
conserved	O
structural	O
elements	O
.	O

We	O
show	O
here	O
that	O
this	O
difference	O
is	O
due	O
to	O
the	O
presence	O
of	O
a	O
Mot3	B
binding	I
site	I
in	O
OpA	B
.	O

The	O
article	O
deals	O
with	O
the	O
diagnosing	O
and	O
correction	O
of	O
reversible	O
ischemia	O
of	O
the	O
intestine	O
.	O

Analysis	O
of	O
Standard	O
Reference	O
Material	O
1846	O
,	O
Infant	O
Formula	O
,	O
gave	O
a	O
mean	O
value	O
of	O
0	O
.	O
95	O
+/-	O
0	O
.	O
088	O
mg	O
vitamin	O
K	O
/	O
kg	O
(	O
K	O
or	O
K1	O
?)	O
(	O
n	O
=	O
31	O
)	O
with	O
a	O
coefficient	O
of	O
variation	O
of	O
9	O
.	O
26	O
.	O

The	O
psychologic	O
factors	O
associated	O
wth	O
serious	O
illness	O
,	O
terminal	O
prognoses	O
,	O
and	O
dying	O
complicate	O
the	O
scenario	O
even	O
more	O
as	O
compared	O
with	O
that	O
of	O
nonmalignant	O
pain	O
.	O

LMP	B
-	I
1	I
is	O
targeted	O
to	O
the	O
plasma	O
membrane	O
,	O
where	O
it	O
binds	O
TRAF	B
,	O
TRADD	B
,	O
and	O
JAK	B
molecules	I
to	O
activate	O
NF	B
-	I
kappaB	I
-,	O
AP	B
-	I
1	I
-,	O
and	O
STAT	B
-	O
dependent	O
pathways	O
as	O
does	O
CD40	B
.	O

Deletion	O
of	O
an	O
intergenic	O
DNA	O
-	O
binding	O
site	O
for	O
this	O
complex	O
from	O
a	O
human	B
beta	I
-	I
globin	I
locus	I
construct	I
results	O
in	O
delayed	O
human	B
gamma	I
-	I
to	I
beta	I
-	I
globin	I
switching	O
in	O
transgenic	O
mice	O
,	O
suggesting	O
that	O
the	O
PYR	B
complex	I
acts	O
to	O
facilitate	O
the	O
switch	O
.	O

These	O
results	O
demonstrate	O
Ras	B
-	O
and	O
Raf	B
-	O
independent	O
ERK	B
MAPK	O
activation	O
maintains	O
cell	O
viability	O
following	O
heat	O
shock	O
.	O

Three	O
cDNAs	O
encoding	O
basic	B
leucine	I
zipper	I
(	I
bZIP	I
)-	I
type	I
ABRE	I
-	I
binding	I
proteins	I
were	O
isolated	O
by	O
using	O
the	O
yeast	O
one	O
-	O
hybrid	O
system	O
and	O
were	O
designated	O
AREB1	B
,	O
AREB2	B
,	O
and	O
AREB3	B
(	O
ABA	B
-	I
responsive	I
element	I
binding	I
protein	I
).	O

Analysis	O
of	O
intron	O
/	O
exon	O
boundaries	O
of	O
the	O
genomic	O
BAC	O
clones	O
demonstrate	O
that	O
junctin	B
,	O
junctate	B
,	O
and	O
aspartyl	B
beta	I
-	I
hydroxylase	I
result	O
from	O
alternative	O
splicing	O
of	O
the	O
same	O
gene	O
.	O

It	O
is	O
now	O
estimated	O
that	O
inactivation	O
mutants	O
of	O
PTEN	B
exist	O
in	O
60	O
%	O
of	O
all	O
forms	O
of	O
solid	O
tumors	O
.	O

The	O
growth	B
factor	I
receptor	I
-	I
bound	I
protein	I
2	I
(	O
Grb2	B
)	O
adaptor	O
when	O
complexed	O
with	O
Sos	B
(	O
Son	B
of	I
sevenless	I
),	O
the	O
exchange	O
factor	O
of	O
Ras	B
,	O
conveys	O
the	O
signal	O
induced	O
by	O
tyrosine	B
kinase	I
-	I
activated	I
receptor	I
to	O
Ras	B
by	O
recruiting	O
Sos	B
to	O
the	O
membrane	O
,	O
allowing	O
activation	O
of	O
Ras	B
.	O

In	O
addition	O
,	O
a	O
noncanonical	O
C	B
/	I
EBP	I
-	I
binding	I
site	I
within	O
the	O
Gadd45gamma	B
promoter	I
where	O
C	B
/	I
EBPbeta	I
and	O
C	B
/	I
EBPdelta	I
could	O
bind	O
,	O
was	O
identified	O
by	O
electrophoretic	O
mobility	O
shift	O
assay	O
(	O
EMSA	O
)	O
and	O
reporter	O
gene	O
analysis	O
.	O

Multiple	O
transcription	O
start	O
sites	O
were	O
revealed	O
by	O
primer	O
extension	O
analysis	O
of	O
the	O
mouse	O
gene	O
,	O
and	O
transfection	O
constructs	O
containing	O
the	O
prospective	O
promoter	O
generated	O
transcriptional	O
activity	O
comparable	O
to	O
that	O
of	O
the	O
SV40	B
promoter	I
.	O

From	O
two	O
inhibitor	O
scaffolds	O
,	O
we	O
have	O
identified	O
potent	O
and	O
selective	O
inhibitors	O
for	O
sensitized	O
kinases	O
from	O
five	O
distinct	O
subfamilies	O
.	O

HYPOTHESIS	O
:	O
The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
oxidative	O
susceptibility	O
of	O
apolipoprotein	B
B	I
-	I
containing	I
lipoproteins	I
and	O
antioxidant	O
status	O
in	O
patients	O
with	O
acute	O
coronary	O
syndromes	O
and	O
chronic	O
stable	O
angina	O
pectoris	O
.	O

Post	O
-	O
operative	O
functional	O
outcome	O
is	O
related	O
to	O
pre	O
-	O
operative	O
functional	O
status	O
.	O

Intracellular	O
localization	O
studies	O
using	O
the	O
mDAP	B
-	I
3	I
/	O
EGFP	B
fusion	O
protein	O
,	O
cell	O
fractionation	O
and	O
protease	O
protection	O
experiments	O
localized	O
mDAP	B
-	I
3	I
to	O
the	O
mitochondrial	O
matrix	O
.	O

The	O
high	O
selectivity	O
of	O
arrestins	B
for	O
this	O
particular	O
functional	O
form	O
of	O
receptor	O
ensures	O
their	O
timely	O
binding	O
and	O
dissociation	O
.	O

They	O
also	O
negatively	O
modulate	O
the	O
PI	B
3	I
-	I
kinase	I
catalytic	O
activity	O
but	O
to	O
different	O
extents	O
,	O
dependent	O
on	O
the	O
unique	O
N	O
-	O
terminal	O
structure	O
of	O
each	O
isoform	O
.	O

The	O
Drosophila	B
melanogaster	I
suppressor	I
of	I
sable	I
gene	I
,	O
su	O
(	O
s	O
),	O
encodes	O
a	O
novel	O
,	O
150	O
-	O
kDa	O
nuclear	O
RNA	O
binding	O
protein	O
,	O
SU	O
(	O
S	O
),	O
that	O
negatively	O
regulates	O
RNA	O
accumulation	O
from	O
mutant	O
alleles	O
of	O
other	O
genes	O
that	O
have	O
transposon	O
insertions	O
in	O
the	O
5	O
'	O
transcribed	O
region	O
.	O

This	O
interaction	O
inhibits	O
the	O
histone	B
acetyltransferase	I
activity	O
of	O
p300	B
,	O
resulting	O
in	O
drastic	O
reduction	O
of	O
nucleosomal	O
histone	B
acetylation	O
and	O
alteration	O
of	O
chromatin	O
structure	O
.	O

Recombinant	B
BRI1	I
-	I
KD	I
autophosphorylated	O
on	O
serine	O
(	O
Ser	O
)	O
and	O
threonine	O
(	O
Thr	O
)	O
residues	O
with	O
p	O
-	O
Ser	O
predominating	O
.	O

Cost	O
-	O
effectiveness	O
of	O
interferon	B
beta	I
-	I
1b	I
in	O
slowing	O
multiple	O
sclerosis	O
disability	O
progression	O
.	O

Mn2	O
+	O
increased	O
both	O
the	O
junction	O
binding	O
and	O
cleaving	O
activities	O
of	O
the	O
mutant	O
proteins	O
.	O

Spores	O
from	O
Rhizopus	O
stolonifer	O
were	O
suspended	O
in	O
distilled	O
water	O
(	O
1	O
x	O
10	O
(	O
6	O
)	O
spores	O
/	O
mL	O
)	O
and	O
used	O
as	O
starter	O
.	O

Overexpression	O
of	O
Trdpm1	B
in	O
a	O
dpm1	O
(+)::	O
his7	B
/	I
dpm1	I
(+)	I
S	O
.	O
pombe	O
diploid	O
resulted	O
in	O
a	O
4	O
-	O
fold	O
increase	O
in	O
specific	O
DPM	B
synthase	I
activity	O
.	O

The	O
LMW	B
FGF	I
-	I
2	I
up	O
-	O
regulated	O
the	O
PKC	B
epsilon	I
levels	O
by	O
1	O
.	O
6	O
-	O
fold	O
;	O
by	O
contrast	O
the	O
HMW	B
isoform	I
down	O
-	O
regulated	O
the	O
level	O
of	O
this	O
PKC	B
isotype	I
by	O
about	O
3	O
-	O
fold	O
and	O
increased	O
the	O
amount	O
of	O
PKC	B
delta	I
by	O
1	O
.	O
7	O
-	O
fold	O
.	O

We	O
conclude	O
from	O
this	O
study	O
that	O
Arix	B
and	O
NBPhox	B
exhibit	O
indistinguishable	O
and	O
independent	O
transcriptional	O
regulatory	O
properties	O
on	O
the	O
DBH	B
promoter	I
.	O

The	O
authors	O
present	O
the	O
only	O
two	O
studies	O
that	O
have	O
proved	O
successful	O
in	O
treating	O
animal	O
models	O
of	O
osteoarthritis	O
using	O
gene	O
therapy	O
,	O
and	O
propose	O
an	O
overview	O
of	O
several	O
strategies	O
for	O
the	O
development	O
of	O
gene	O
therapy	O
in	O
osteoarthritis	O
treatment	O
in	O
the	O
future	O
.	O

Elevation	O
of	O
intracellular	O
Ca	O
(	O
2	O
+)	O
levels	O
are	O
also	O
involved	O
because	O
treatment	O
with	O
receptor	O
-	O
associated	O
protein	O
,	O
nifedipine	O
,	O
MK801	O
,	O
removal	O
of	O
Ca	O
(	O
2	O
+)	O
from	O
the	O
medium	O
and	O
dantrolene	O
all	O
served	O
to	O
inhibit	O
calcium	O
elevation	O
and	O
attenuate	O
the	O
activation	O
of	O
CREB	B
.	O

These	O
probable	O
border	O
sequences	O
are	O
closely	O
related	O
to	O
those	O
of	O
other	O
known	O
T	O
-	O
regions	O
and	O
define	O
a	O
second	O
T	O
-	O
region	O
of	O
pTiChry5	O
,	O
called	O
T	O
-	O
right	O
(	O
TR	O
),	O
that	O
confers	O
production	O
of	O
the	O
Amadoriopines	O
.	O

Further	O
,	O
Tax	B
-	O
mediated	O
apoptosis	O
was	O
effectively	O
prevented	O
by	O
ectopic	O
expression	O
of	O
the	O
p300	B
coactivator	I
.	O

This	O
-	O
2485	O
/-	O
2458	O
element	O
bound	O
PPARalpha	B
and	O
PPARgamma	B
from	O
brown	O
fat	O
nuclei	O
.	O

The	O
gene	O
is	O
separated	O
into	O
four	O
exons	O
by	O
three	O
short	O
introns	O
,	O
and	O
the	O
open	O
reading	O
frame	O
consists	O
of	O
6660	O
base	O
pairs	O
(	O
bp	O
)	O
capable	O
of	O
encoding	O
a	O
polypeptide	O
of	O
2220	O
amino	O
acid	O
residues	O
.	O

VEGF	B
promoter	I
activity	O
in	O
transient	O
transfections	O
was	O
decreased	O
by	O
either	O
pharmacological	O
or	O
genetic	O
inhibition	O
of	O
EGFR	B
,	O
Ras	B
,	O
or	O
phosphatidylinositol	B
3	I
'-	I
kinase	I
[	O
PI	O
(	O
3	O
)	O
kinase	O
].	O

Botulinum	B
toxin	I
A	I
in	O
the	O
treatment	O
of	O
hemiplegic	O
spastic	O
foot	O
drop	O
--	O
clinical	O
and	O
functional	O
outcomes	O
.	O

Abbreviations	O
:	O
CAS	B
,	O
CRK	B
-	I
associated	I
substrate	I
;	O
CH	B
,	O
calponin	B
-	I
homology	I
domain	I
;	O
CSK	B
,	O
C	B
-	I
terminal	I
SRC	I
kinase	I
;	O
E6	B
,	O
Papillomavirus	B
E6	I
protein	I
;	O
FAK	B
,	O
focal	B
adhesion	I
kinase	I
;	O
GIT	B
,	O
GRK	B
interacter	I
;	O
GPCR	B
,	O
heterotrimeric	B
-	I
G	I
-	I
protein	I
-	I
coupled	I
receptor	I
;	O
GRK	B
,	O
G	B
-	I
protein	I
-	I
coupled	I
-	I
receptor	I
kinase	I
;	O
MAPK	B
,	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
(	O
ERK	B
,	O
p38	B
,	O
JNK	B
);	O
PAK	B
,	O
p21	B
-	I
activated	I
kinase	I
;	O
PBS	B
,	O
paxillin	B
-	I
binding	I
subdomain	I
;	O
PIX	B
,	O
PAK	B
-	I
interacting	I
exchange	I
factor	I
;	O
PKL	B
,	O
paxillin	B
kinase	I
linker	I
;	O
POR1	B
,	O
partner	B
of	I
Rac	I
;	O
PS	O
,	O
phosphoserine	O
;	O
PT	O
,	O
phosphothreonine	O
;	O
PY	O
,	O
phosphotyrosine	O
;	O
RTK	B
,	O
growth	B
factor	I
receptor	I
tyrosine	I
kinase	I
;	O
SH	B
,	O
SRC	B
-	I
homology	I
domain	I
.	O

In	O
15	O
ventilator	O
-	O
dependent	O
,	O
SB	O
,	O
and	O
actively	O
expiring	O
patients	O
,	O
we	O
found	O
that	O
the	O
difference	O
PEEP	O
(	O
i	O
),	O
dyn	O
-	O
Pga	O
,	O
total	O
decay	O
(	O
mean	O
+/-	O
SD	O
,	O
5	O
.	O
7	O
+/-	O
1	O
.	O
9	O
cm	O
H	O
(	O
2	O
)	O
O	O
)	O
was	O
quite	O
similar	O
to	O
PEEP	O
(	O
i	O
),	O
dyn	O
ref	O
(	O
5	O
.	O
3	O
+/-	O
1	O
.	O
9	O
cm	O
H	O
(	O
2	O
)	O
O	O
).	O

Of	O
208	O
eligible	O
subjects	O
,	O
82	O
received	O
supervised	O
IPT	O
at	O
a	O
dose	O
of	O
900	O
mg	O
twice	O
weekly	O
for	O
6	O
mo	O
(	O
Regimen	O
A	O
),	O
73	O
received	O
unsupervised	O
IPT	O
900	O
mg	O
twice	O
weekly	O
for	O
6	O
mo	O
(	O
Regimen	O
B	O
),	O
and	O
53	O
received	O
unsupervised	O
IPT	O
300	O
mg	O
daily	O
for	O
6	O
mo	O
(	O
Regimen	O
C	O
).	O

Our	O
results	O
indicate	O
that	O
Shh	B
can	O
drive	O
continued	O
cycling	O
in	O
immature	O
,	O
proliferating	O
CGNPs	O
.	O

The	O
QT	O
interval	O
was	O
related	O
to	O
various	O
components	O
of	O
the	O
insulin	B
resistance	O
syndrome	O
,	O
including	O
BP	O
and	O
insulin	B
sensitivity	O
.	O

The	O
data	O
provide	O
strong	O
evidence	O
that	O
ThlA	B
is	O
involved	O
in	O
the	O
metabolism	O
of	O
both	O
acid	O
and	O
solvent	O
formation	O
,	O
whereas	O
the	O
physiological	O
function	O
of	O
ThlB	B
has	O
yet	O
to	O
be	O
elucidated	O
.	O

In	O
addition	O
,	O
npm3	B
,	O
which	O
is	O
usually	O
coactivated	O
with	O
fgf8	B
by	O
MMTV	O
insertion	O
,	O
was	O
not	O
up	O
-	O
regulated	O
by	O
androgens	O
in	O
SC	O
-	O
3	O
cells	O
.	O

CONCLUSION	O
:	O
SPT	O
is	O
more	O
useful	O
than	O
WST	O
in	O
differentiating	O
patients	O
predisposed	O
to	O
aspiration	O
.	O

The	O
swa2	B
-	I
1	I
allele	I
recovered	O
from	O
the	O
original	O
screen	O
carries	O
a	O
point	O
mutation	O
in	O
its	O
tetratricopeptide	O
repeat	O
(	O
TPR	O
)	O
domain	O
,	O
a	O
motif	O
not	O
found	O
in	O
auxilin	B
but	O
known	O
in	O
other	O
proteins	O
to	O
mediate	O
interaction	O
with	O
heat	B
-	I
shock	I
proteins	I
.	O

The	O
time	O
course	O
of	O
RNA1	B
replication	O
and	O
RNA3	B
synthesis	O
in	O
induced	O
yeast	O
paralleled	O
that	O
in	O
yeast	O
transfected	O
with	O
natural	O
FHV	O
virion	O
RNA	O
.	O

Nevertheless	O
,	O
protein	B
kinase	I
A	I
stimulation	O
induces	O
CREMalpha	B
to	O
activate	O
the	O
complex	O
native	O
promoter	O
in	O
the	O
phosphoenolpyruvate	B
carboxykinase	I
(	O
PEPCK	B
)	O
gene	O
.	O

Induced	O
expression	O
of	O
Rnd3	B
is	O
associated	O
with	O
transformation	O
of	O
polarized	O
epithelial	O
cells	O
by	O
the	O
Raf	B
-	O
MEK	B
-	O
extracellular	O
signal	O
-	O
regulated	O
kinase	O
pathway	O
.	O

The	O
activity	O
of	O
the	O
transcription	B
factor	I
CREB	I
is	O
regulated	O
by	O
extracellular	O
stimuli	O
that	O
result	O
in	O
its	O
phosphorylation	O
at	O
a	O
critical	O
serine	O
residue	O
,	O
Ser133	O
.	O

This	O
study	O
is	O
a	O
further	O
and	O
more	O
extensive	O
validation	O
of	O
the	O
clinician	O
rated	O
NIMH	O
-	O
LCM	O
-	O
p	O
.	O

The	O
Aie1	B
locus	I
was	O
mapped	O
to	O
mouse	O
chromosome	O
7A2	O
-	O
A3	O
by	O
fluorescent	O
in	O
situ	O
hybridization	O
.	O

Chaperones	O
/	O
HSPs	B
thus	O
play	O
important	O
roles	O
within	O
cell	O
cycle	O
processes	O
.	O

Where	O
UMDNJ	O
is	O
headed	O
.	O

CONCLUSION	O
:	O
Our	O
results	O
suggest	O
that	O
AIF	O
peak	O
saturation	O
leads	O
to	O
a	O
significant	O
systematic	O
error	O
in	O
the	O
determination	O
of	O
CBV	O
and	O
CBF	O
values	O
and	O
has	O
necessarily	O
to	O
be	O
taken	O
into	O
account	O
for	O
dynamic	O
contrast	O
-	O
enhanced	O
MR	O
perfusion	O
studies	O
.	O

Furthermore	O
,	O
transfection	O
of	O
cells	O
with	O
the	O
spacer	O
-	O
RING	O
domain	O
alone	O
suppressed	O
the	O
antiapoptotic	O
function	O
of	O
the	O
N	O
-	O
terminal	O
BIR	B
domain	O
of	O
c	B
-	I
IAP1	I
and	O
induced	O
apoptosis	O
.	O

Ketanserin	O
,	O
a	O
hypotensive	O
drug	O
with	O
5	B
-	I
HT2	I
receptor	I
antagonism	O
,	O
when	O
administered	O
by	O
topical	O
infusion	O
of	O
a	O
0	O
.	O
25	O
%	O
w	O
/	O
v	O
solution	O
by	O
corneal	O
and	O
scleral	O
applications	O
,	O
was	O
found	O
to	O
lower	O
intraocular	O
pressure	O
with	O
four	O
times	O
more	O
activity	O
than	O
its	O
metabolite	O
,	O
ketanserinol	O
.	O

It	O
was	O
subsequently	O
shown	O
that	O
Tip60	B
had	O
histone	B
acetyltransferase	I
(	O
HAT	B
)	O
activity	O
.	O

Characterization	O
of	O
the	O
microtubule	O
binding	O
domain	O
of	O
microtubule	B
actin	I
crosslinking	I
factor	I
(	O
MACF	B
):	O
identification	O
of	O
a	O
novel	O
group	O
of	O
microtubule	B
associated	I
proteins	I
.	O

We	O
show	O
that	O
in	O
contrast	O
to	O
SRC1	B
,	O
direct	O
binding	O
of	O
CBP	B
to	O
the	O
estrogen	B
receptor	I
is	O
weak	O
,	O
suggesting	O
that	O
SRC1	B
functions	O
primarily	O
as	O
an	O
adaptor	O
to	O
recruit	O
CBP	B
and	O
p300	B
.	O

Fecal	O
samples	O
were	O
collected	O
at	O
the	O
beginning	O
and	O
end	O
of	O
each	O
trial	O
period	O
and	O
were	O
analyzed	O
for	O
gastrointestinal	O
nematode	O
eggs	O
and	O
Giardia	O
cyst	O
.	O

ORFA	O
and	O
ccdA	B
were	O
constitutively	O
cotranscribed	O
as	O
determined	O
by	O
primer	O
extension	O
analysis	O
.	O

These	O
cells	O
produced	O
P2Y	B
(	I
11	I
)	I
mRNA	I
during	O
culture	O
.	O

Among	O
eight	O
graminaceous	O
species	O
tested	O
,	O
Ids3	B
expression	O
was	O
observed	O
only	O
in	O
Fe	O
-	O
deficient	O
roots	O
of	O
H	O
.	O
vulgare	O
and	O
Secale	O
cereale	O
.	O
which	O
not	O
only	O
secrete	O
2	O
'-	O
deoxymugineic	O
acid	O
(	O
DMA	O
),	O
but	O
also	O
mugineic	O
acid	O
(	O
MA	O
)	O
and	O
3	O
-	O
epihydroxymugineic	O
acid	O
(	O
epiHMA	O
,	O
H	O
.	O
vulgare	O
),	O
and	O
3	O
-	O
hydroxymugineic	O
acid	O
(	O
HMA	O
,	O
S	O
.	O
cereale	O
).	O

In	O
contrast	O
,	O
high	O
COUP	B
-	I
TFI	I
expression	O
impeded	O
the	O
neuronal	O
differentiation	O
of	O
P19	O
cells	O
induced	O
with	O
RA	O
,	O
resulting	O
in	O
cell	O
cultures	O
lacking	O
neurons	O
.	O

Because	O
PET	O
is	O
also	O
useful	O
for	O
the	O
pretreatment	O
and	O
follow	O
-	O
up	O
evaluation	O
,	O
the	O
use	O
of	O
stereotactic	O
PET	O
in	O
these	O
patients	O
can	O
enable	O
an	O
accurate	O
comparison	O
of	O
PET	O
-	O
based	O
metabolic	O
data	O
with	O
MR	O
-	O
based	O
anatomical	O
data	O
.	O

Inhibition	O
of	O
the	O
Mek	B
/	O
Erk	B
pathway	O
in	O
Rat1	O
/	O
ras	B
cells	O
,	O
using	O
the	O
Mek	B
inhibitor	O
,	O
PD98059	O
,	O
resulted	O
in	O
complete	O
cytoskeletal	O
recovery	O
,	O
indistinguishable	O
from	O
that	O
induced	O
by	O
HR12	O
.	O

Addition	O
of	O
synthetic	O
tyrosine	O
-	O
phosphorylated	O
peptides	O
derived	O
from	O
betac	O
cytoplasmic	O
tyrosines	O
prior	O
to	O
GM	B
-	I
CSF	I
stimulation	O
inhibited	O
the	O
in	O
vitro	O
activation	O
of	O
STAT5	B
.	O

The	O
structure	O
of	O
the	O
free	O
SH2	B
domain	I
has	O
been	O
compared	O
to	O
that	O
of	O
the	O
SH2	B
complexed	O
with	O
a	O
doubly	O
phosphorylated	O
peptide	O
derived	O
from	O
polyomavirus	B
middle	I
T	I
antigen	I
(	O
MT	B
).	O

Patients	O
underwent	O
pretreatment	O
cystoscopy	O
and	O
detailed	O
tumor	O
mapping	O
,	O
and	O
were	O
treated	O
with	O
75	O
mg	O
.	O
/	O
m	O
.	O
2	O
cisplatin	O
on	O
day	O
1	O
and	O
1	O
gm	O
./	O
m	O
.	O
2	O
daily	O
,	O
5	O
-	O
fluorouracil	O
on	O
days	O
1	O
to	O
4	O
and	O
definitive	O
radiotherapy	O
.	O

Increased	O
levels	O
of	O
anticardiolipin	B
immunoglobulin	I
G	I
may	O
also	O
cause	O
bleeding	O
.	O

Bupropion	O
to	O
aid	O
smoking	O
cessation	O
.	O

PM	O
12	O
or	O
18	O
mg	O
/	O
kg	O
daily	O
plus	O
a	O
standard	O
dose	O
of	O
SB	O
for	O
21	O
days	O
was	O
statistically	O
more	O
effective	O
than	O
SB	O
in	O
producing	O
a	O
final	O
cure	O
for	O
patients	O
with	O
VL	O
in	O
Bihar	O
,	O
India	O
.	O

Adjuvant	O
therapy	O
for	O
colon	O
cancer	O
]	O
Surgery	O
alone	O
may	O
fail	O
to	O
cure	O
a	O
considerable	O
number	O
of	O
locally	O
advanced	O
colon	O
cancers	O
.	O

There	O
were	O
significant	O
differences	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
between	O
the	O
fracture	O
and	O
nonfracture	O
groups	O
in	O
the	O
total	O
femur	O
BMD	O
(	O
13	O
%),	O
trabecular	O
BMD	O
in	O
the	O
distal	O
radius	O
(	O
4	O
%),	O
and	O
the	O
fractal	O
dimension	O
in	O
the	O
radiographs	O
(	O
FD2	O
)	O
(	O
3	O
%).	O

Because	O
the	O
number	O
of	O
parameters	O
required	O
by	O
a	O
Volterra	O
series	O
grows	O
rapidly	O
with	O
both	O
the	O
length	O
of	O
its	O
memory	O
and	O
the	O
order	O
of	O
its	O
nonlinearity	O
,	O
methods	O
for	O
identifying	O
these	O
models	O
from	O
measurements	O
of	O
input	O
/	O
output	O
data	O
are	O
limited	O
to	O
low	O
-	O
order	O
systems	O
with	O
relatively	O
short	O
memories	O
.	O

NiCl	O
(	O
2	O
)-	O
induced	O
MCP	B
-	I
1	I
synthesis	O
required	O
activation	O
of	O
NF	B
-	I
kappaB	I
since	O
mutation	O
of	O
NF	B
-	I
kappaB	I
-	I
binding	I
sites	I
in	O
the	O
promoter	O
resulted	O
in	O
complete	O
loss	O
of	O
inducible	O
promoter	O
activity	O
.	O

Previous	O
studies	O
have	O
demonstrated	O
that	O
tissue	O
-	O
restricted	O
transcription	O
factors	O
including	O
PU	B
.	I
1	I
and	O
PU	B
.	I
1	I
interaction	I
partner	I
(	O
PIP	B
)	O
function	O
synergistically	O
with	O
c	B
-	I
Fos	I
plus	O
c	B
-	I
Jun	I
to	O
stimulate	O
the	O
kappaE3	B
'-	I
enhancer	I
in	O
3T3	O
cells	O
.	O

An	O
int6	B
deletion	I
(	O
int6Delta	B
)	O
mutant	O
was	O
viable	O
but	O
grew	O
slowly	O
in	O
minimal	O
medium	O
.	O

PFK	B
-	I
A	I
mRNA	O
was	O
more	O
abundantly	O
expressed	O
in	O
all	O
tissues	O
than	O
were	O
the	O
PFK	B
-	I
B	I
and	O
PFK	B
-	I
C	I
genes	I
.	O

Deletion	O
analysis	O
showed	O
that	O
the	O
-	O
321	O
/+	O
41	O
sequence	O
was	O
sufficient	O
for	O
both	O
the	O
constitutive	O
promoter	O
activity	O
and	O
auto	O
-	O
activation	O
and	O
electrophoretic	O
mobility	O
shift	O
assays	O
identified	O
the	O
interaction	O
of	O
C	B
/	I
EBPs	I
and	O
Sp1	B
to	O
this	O
region	O
.	O

We	O
compare	O
the	O
results	O
of	O
this	O
algorithm	O
with	O
the	O
results	O
obtained	O
with	O
two	O
other	O
algorithms	O
,	O
the	O
optimal	O
algorithm	O
for	O
monochannel	O
nonoverlapping	O
noise	O
and	O
the	O
optimal	O
algorithm	O
for	O
multichannel	O
additive	O
noise	O
,	O
and	O
we	O
show	O
that	O
in	O
both	O
cases	O
improvement	O
can	O
be	O
obtained	O
.	O

Expression	O
of	O
SREBP	B
-	I
1a	I
stimulated	O
StAR	B
promoter	I
activity	O
in	O
the	O
context	O
of	O
COS	O
-	O
1	O
cells	O
and	O
human	O
granulosa	O
-	O
lutein	O
cells	O
.	O

